Citrus Sinensis ID: 007351
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | yes | no | 0.530 | 0.454 | 0.733 | 1e-150 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.517 | 0.412 | 0.755 | 1e-148 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.542 | 0.483 | 0.635 | 1e-126 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.504 | 0.430 | 0.580 | 1e-116 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.514 | 0.433 | 0.576 | 1e-115 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.385 | 0.358 | 0.726 | 1e-110 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.487 | 0.441 | 0.596 | 1e-110 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.553 | 0.467 | 0.563 | 1e-107 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.387 | 0.327 | 0.702 | 1e-107 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.398 | 0.382 | 0.691 | 1e-106 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 531 bits (1369), Expect = e-150, Method: Compositional matrix adjust.
Identities = 239/326 (73%), Positives = 282/326 (86%), Gaps = 4/326 (1%)
Query: 258 SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
+S +N+GIGT V I+VAV ++ F+L G+ VWCLR+R+K +S ++G + PSP+ S++
Sbjct: 269 NSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 318 TDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGE 377
+DS++ + QSSAP+ S + GGLG+S+++F+YEELVKAT+GF+ +NLLGE
Sbjct: 329 SDSAFFRMQSSAPVGASKRSGSY---QSQSGGLGNSKALFSYEELVKATNGFSQENLLGE 385
Query: 378 GGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437
GGFG VYKG LPDGR VA+KQLKIGGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DR
Sbjct: 386 GGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDR 445
Query: 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497
RLLIYDYV NN LYFHLHGE + VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS
Sbjct: 446 RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 498 NILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557
NILL++NF+A+VSDFGLA+LALD NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGV
Sbjct: 505 NILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564
Query: 558 VLLELITGRKPVDASQPLGDESLVEW 583
VLLELITGRKPVD SQPLGDESLVEW
Sbjct: 565 VLLELITGRKPVDTSQPLGDESLVEW 590
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 526 bits (1356), Expect = e-148, Method: Compositional matrix adjust.
Identities = 238/315 (75%), Positives = 274/315 (86%), Gaps = 1/315 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLH G P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 569 VDASQPLGDESLVEW 583
VDASQPLGDESLVEW
Sbjct: 630 VDASQPLGDESLVEW 644
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 220/346 (63%), Positives = 263/346 (76%), Gaps = 17/346 (4%)
Query: 246 GNGTNPSSPESSSSPSNNGIGTAGTVV----IAVAVGIIAFSLIGLVVWCLRRRKKEVSG 301
GN T PSS S GI G +V + SL + VW R+RK++ G
Sbjct: 219 GNNTLPSSSPGKSEVGTGGIVAIGVIVGLVFL---------SLFVMGVWFTRKRKRKDPG 269
Query: 302 LNGVYIM-PSPLGSSSTTDSSYIKTQSSA-PLIGSGPGSDFVNSPQDPGGLGHSRSMFTY 359
Y M PS S +D ++SSA P + S GSD++ + D G + + RS F+Y
Sbjct: 270 TFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSY 329
Query: 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR 419
+EL + T GF+++NLLGEGGFG VYKG L DGREVA+KQLKIGG QGEREFKAEVEIISR
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+HHRHLV+LVGYCIS+ RLL+YDYVPNNTL++HLH GRPV+ W TRV++AAGAARG+A
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIA 449
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA--LDANTHITTRVMGTFGYMA 537
YLHEDCHPRIIHRDIKSSNILLDN+FEA V+DFGLAK+A LD NTH++TRVMGTFGYMA
Sbjct: 450 YLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMA 509
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
PEYA+SGKL+EK+DV+S+GV+LLELITGRKPVD SQPLGDESLVEW
Sbjct: 510 PEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEW 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 210/362 (58%), Positives = 249/362 (68%), Gaps = 56/362 (15%)
Query: 260 PSNNGIGTAGTVVIAVAVGIIAFSLIGL--VVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
P+N+G G G + A I F++I L VV+ +RR+KK +
Sbjct: 224 PANSGGGYQGKTMAGFA--IAGFAVIALMAVVFLVRRKKKR--------------NIDAY 267
Query: 318 TDSSYI-----KTQSSAPLIG-------SGPGSDFVNSPQDP----------GGLGHSRS 355
+DS Y+ +S L G SGPG NS Q GG G++RS
Sbjct: 268 SDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGG--YNSQQQSNSGNSFGSQRGGGGYTRS 325
Query: 356 --------------MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
FTYEEL T+GF+ N+LGEGGFG VYKG L DG+ VA+KQLK+
Sbjct: 326 GSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKV 385
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
G GQG+REFKAEVEIISR+HHRHLVSLVGYCI+D RLLIY+YVPN TL HLHG+GRPV
Sbjct: 386 GSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPV 445
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
L+WA RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ FEAQV+DFGLAKL
Sbjct: 446 LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDST 505
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
TH++TRVMGTFGY+APEYA SGKLT++SDVFSFGVVLLELITGRKPVD QPLG+ESLV
Sbjct: 506 QTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLV 565
Query: 582 EW 583
EW
Sbjct: 566 EW 567
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 197/342 (57%), Positives = 240/342 (70%), Gaps = 30/342 (8%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSA 329
T+V G +LIG+V R++K+ + N +P P + S ++ Q
Sbjct: 246 TMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHP--NFSVKSDGFLYGQDPG 303
Query: 330 PLIGSGP-GSDFVNSPQ---------------------------DPGGLGHSRSMFTYEE 361
SGP GS + NS Q D LG ++ F+YEE
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEE 363
Query: 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH 421
L + T GFA +N+LGEGGFG VYKG L DG+ VA+KQLK G GQG+REFKAEVEIISR+H
Sbjct: 364 LAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVH 423
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
HRHLVSLVGYCISD RLLIY+YV N TL HLHG+G PVL+W+ RV+IA G+A+GLAYL
Sbjct: 424 HRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYL 483
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
HEDCHP+IIHRDIKS+NILLD+ +EAQV+DFGLA+L TH++TRVMGTFGY+APEYA
Sbjct: 484 HEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYA 543
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
SSGKLT++SDVFSFGVVLLEL+TGRKPVD +QPLG+ESLVEW
Sbjct: 544 SSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEW 585
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 170/234 (72%), Positives = 211/234 (90%)
Query: 350 LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE 409
LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+KG LP G+EVA+KQLK G GQGERE
Sbjct: 261 LGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGERE 320
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
F+AEVEIISR+HHRHLVSL+GYC++ +RLL+Y++VPNN L FHLHG+GRP ++W+TR+K
Sbjct: 321 FQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLK 380
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
IA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D FEA+V+DFGLAK+A D NTH++TRV
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 440
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
MGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELITGR+PVDA+ D+SLV+W
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDW 494
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 398 bits (1022), Expect = e-110, Method: Compositional matrix adjust.
Identities = 192/322 (59%), Positives = 240/322 (74%), Gaps = 26/322 (8%)
Query: 287 LVVWCLRRRKKEVSGLNGV-YIMPSPLGSSSTTDSSYIKTQSSAPLIG------------ 333
+ + C R++KK+ +N + Y +P G + + + Y K ++
Sbjct: 207 ICICCNRKKKKKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQ 266
Query: 334 ---SGPGSDFVN--------SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGS 382
SGP SD N SPQ LGH++S FTY+EL AT+GFA NLLG+GGFG
Sbjct: 267 QPVSGPHSDASNLTGRTAIPSPQ-AATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGY 325
Query: 383 VYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442
V+KG LP G+EVA+K LK+G GQGEREF+AEV+IISR+HHRHLVSLVGYCIS +RLL+Y
Sbjct: 326 VHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVY 385
Query: 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502
+++PNNTL FHLHG+GRPVLDW TRVKIA G+ARGLAYLHEDCHPRIIHRDIK++NILLD
Sbjct: 386 EFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLD 445
Query: 503 NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
+FE +V+DFGLAKL+ D TH++TRVMGTFGY+APEYASSGKL++KSDVFSFGV+LLEL
Sbjct: 446 FSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLEL 505
Query: 563 ITGRKPVDASQPLGDESLVEWV 584
ITGR P+D + + D SLV+W
Sbjct: 506 ITGRPPLDLTGEMED-SLVDWA 526
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 205/364 (56%), Positives = 255/364 (70%), Gaps = 28/364 (7%)
Query: 243 NTPGNGTNPSSPESSSSPSNN----GIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKE 298
N NG +S +S+ S GIG AG +V I+ I V + R++KK
Sbjct: 240 NANSNGDGGTSQQSNESNYTEKTVIGIGIAGVLV------IL---FIAGVFFVRRKQKKG 290
Query: 299 VSG-LNGVYIMPSPLGSSSTTDSSYIKT----QSSAPLIGSGPGSDFVNSPQ------DP 347
S + Y+ P+ + ++ Y + SSA S P ++ + +P+ D
Sbjct: 291 SSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQ--NSSPDTNSLGNPKHGRGTPDS 348
Query: 348 GGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE 407
+G S+ FTYEEL + T+GF ++GEGGFG VYKG L +G+ VAIKQLK +G
Sbjct: 349 AVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGY 408
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
REFKAEVEIISR+HHRHLVSLVGYCIS+ R LIY++VPNNTL +HLHG+ PVL+W+ R
Sbjct: 409 REFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRR 468
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527
V+IA GAA+GLAYLHEDCHP+IIHRDIKSSNILLD+ FEAQV+DFGLA+L A +HI+T
Sbjct: 469 VRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIST 528
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV--N 585
RVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRKPVD SQPLG+ESLVEW
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 586 LIDA 589
LI+A
Sbjct: 589 LIEA 592
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 165/235 (70%), Positives = 207/235 (88%)
Query: 349 GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER 408
GLG + F YEEL +AT+GF++ NLLG+GGFG V+KG L +G+EVA+KQLK G QGER
Sbjct: 334 GLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGER 393
Query: 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EF+AEV IISR+HHRHLV+LVGYCI+D +RLL+Y++VPNNTL FHLHG+GRP ++W++R+
Sbjct: 394 EFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRL 453
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
KIA G+A+GL+YLHE+C+P+IIHRDIK+SNIL+D FEA+V+DFGLAK+A D NTH++TR
Sbjct: 454 KIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTR 513
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
VMGTFGY+APEYASSGKLTEKSDVFSFGVVLLELITGR+P+D + D SLV+W
Sbjct: 514 VMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDW 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 168/243 (69%), Positives = 210/243 (86%), Gaps = 1/243 (0%)
Query: 350 LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE 409
LG ++S FTY+EL AT GF D NLLG+GGFG V+KG LP G+EVA+K LK G GQGERE
Sbjct: 265 LGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGERE 324
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
F+AEV+IISR+HHR+LVSLVGYCI+D +R+L+Y++VPN TL +HLHG+ PV++++TR++
Sbjct: 325 FQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLR 384
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
IA GAA+GLAYLHEDCHPRIIHRDIKS+NILLD NF+A V+DFGLAKL D NTH++TRV
Sbjct: 385 IALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRV 444
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDA 589
MGTFGY+APEYASSGKLTEKSDVFS+GV+LLELITG++PVD S + D++LV+W + A
Sbjct: 445 MGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPLMA 503
Query: 590 KIL 592
+ L
Sbjct: 504 RAL 506
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | ||||||
| 225423802 | 726 | PREDICTED: proline-rich receptor-like pr | 0.551 | 0.461 | 0.815 | 1e-162 | |
| 356494796 | 724 | PREDICTED: proline-rich receptor-like pr | 0.546 | 0.458 | 0.765 | 1e-157 | |
| 356502698 | 747 | PREDICTED: proline-rich receptor-like pr | 0.624 | 0.507 | 0.681 | 1e-155 | |
| 255546929 | 811 | ATP binding protein, putative [Ricinus c | 0.550 | 0.411 | 0.793 | 1e-153 | |
| 297838635 | 482 | hypothetical protein ARALYDRAFT_894642 [ | 0.540 | 0.680 | 0.735 | 1e-151 | |
| 15221470 | 708 | protein kinase-like protein [Arabidopsis | 0.530 | 0.454 | 0.733 | 1e-148 | |
| 356567172 | 756 | PREDICTED: proline-rich receptor-like pr | 0.627 | 0.503 | 0.627 | 1e-147 | |
| 79352581 | 762 | proline-rich extensin-like receptor kina | 0.517 | 0.412 | 0.755 | 1e-147 | |
| 298204391 | 436 | unnamed protein product [Vitis vinifera] | 0.487 | 0.678 | 0.798 | 1e-145 | |
| 12321185 | 760 | Pto kinase interactor, putative [Arabido | 0.514 | 0.410 | 0.755 | 1e-145 |
| >gi|225423802|ref|XP_002277905.1| PREDICTED: proline-rich receptor-like protein kinase PERK9 [Vitis vinifera] gi|297737910|emb|CBI27111.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1494), Expect = e-162, Method: Compositional matrix adjust.
Identities = 274/336 (81%), Positives = 304/336 (90%), Gaps = 1/336 (0%)
Query: 249 TNPSSPESS-SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYI 307
N S+P S +S S GIGT GTV I + +G++ LIG+ CLR+RKK+VSGLNG Y+
Sbjct: 281 VNNSTPNGSPNSTSKGGIGTVGTVAIGLVLGLVVLVLIGVAFLCLRKRKKKVSGLNGGYV 340
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
MP+ LGSS +DSS+ KT SSAPLIGSG GSDFV SP +PGGLG+SRS FTYEELVKAT+
Sbjct: 341 MPATLGSSPRSDSSFTKTLSSAPLIGSGSGSDFVYSPSEPGGLGNSRSWFTYEELVKATN 400
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
GF+ QNLLGEGGFGSVYKGYLPDGRE+A+KQLKIGG QGEREFKAEVEIISRIHHRHLVS
Sbjct: 401 GFSTQNLLGEGGFGSVYKGYLPDGREIAVKQLKIGGAQGEREFKAEVEIISRIHHRHLVS 460
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
LVGYCIS+ +RLL+YDYVPNNTLYFHLHGEGRPV+DWATRVK+AAGAARG+AYLHEDCHP
Sbjct: 461 LVGYCISESQRLLVYDYVPNNTLYFHLHGEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 520
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
R+IHRDIKSSNILL+ NFEAQVSDFGLAKLALDA+TH+TTRVMGTFGYMAPEYASSGKLT
Sbjct: 521 RVIHRDIKSSNILLNYNFEAQVSDFGLAKLALDADTHVTTRVMGTFGYMAPEYASSGKLT 580
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
EKSDVFSFGVVLLELITGRKPVDASQP+GDESLVEW
Sbjct: 581 EKSDVFSFGVVLLELITGRKPVDASQPVGDESLVEW 616
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356494796|ref|XP_003516269.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-157, Method: Compositional matrix adjust.
Identities = 258/337 (76%), Positives = 291/337 (86%), Gaps = 5/337 (1%)
Query: 247 NGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVY 306
NGT SSP+ G V I+V G + IG+++WC+RR+K++V ++G Y
Sbjct: 281 NGTENSSPDGGGDGIG----IGGVVAISVVAGFLLLGFIGVLIWCMRRKKRKVL-VSGDY 335
Query: 307 IMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKAT 366
+MPS L SS +DSS+ KT SSAPL+ SG GSD V +P +PGGLGHSRS F+YEEL+KAT
Sbjct: 336 VMPSTLASSPESDSSFFKTHSSAPLVQSGSGSDVVYTPSEPGGLGHSRSWFSYEELIKAT 395
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+GF+ QNLLGEGGFG VYKG LPDGRE+A+KQLKIGGGQGEREFKAEVEIISRIHHRHLV
Sbjct: 396 NGFSTQNLLGEGGFGCVYKGCLPDGREIAVKQLKIGGGQGEREFKAEVEIISRIHHRHLV 455
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
SLVGYCI D++RLL+YDYVPNNTLYFHLHGEG+PVL+WA RVKIAAGAARGL YLHEDC+
Sbjct: 456 SLVGYCIEDNKRLLVYDYVPNNTLYFHLHGEGQPVLEWANRVKIAAGAARGLTYLHEDCN 515
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
PRIIHRDIKSSNILLD N+EA+VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL
Sbjct: 516 PRIIHRDIKSSNILLDFNYEAKVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 575
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
TEKSDV+SFGVVLLELITGRKPVDASQPLGDESLVEW
Sbjct: 576 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502698|ref|XP_003520154.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 276/405 (68%), Positives = 318/405 (78%), Gaps = 26/405 (6%)
Query: 200 TQTPPTPASPIAPRPSNSSP----------NSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
T TPPTP+S AP +++ N PPP ++ LS P +P P+ NGT
Sbjct: 246 TSTPPTPSSQPAPTSNSTPRSSPPSPPSTTNLAPPPPSRVLSSP--LPSPAQ-----NGT 298
Query: 250 NPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMP 309
SP+ T G V I+V G + IG+++WC+RR+K+++ ++G Y+MP
Sbjct: 299 KNPSPDGGGDGIG----TGGVVAISVVAGFLLLGFIGVLIWCMRRQKRKLP-VSGGYVMP 353
Query: 310 SPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGF 369
S L SS +DSS+ KT SSAPL+ SG GSD V +P DPGGLG+SRS F+YEEL+K T+GF
Sbjct: 354 STLASSPESDSSFFKTHSSAPLVQSGSGSDVVYTPSDPGGLGNSRSWFSYEELIKVTNGF 413
Query: 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+ QNLLGEGGFG VYKG LPDGR++A+KQLKIGGGQGEREFKAEVEII RIHHRHLVSLV
Sbjct: 414 STQNLLGEGGFGCVYKGCLPDGRDIAVKQLKIGGGQGEREFKAEVEIIGRIHHRHLVSLV 473
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
GYCI D RRLL+YDYVPNN LYFHLHGEG+PVL+WA RVKIAAGAARGLAYLHEDC+PRI
Sbjct: 474 GYCIEDSRRLLVYDYVPNNNLYFHLHGEGQPVLEWANRVKIAAGAARGLAYLHEDCNPRI 533
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
IHRDIKSSNILLD NFEA+VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK
Sbjct: 534 IHRDIKSSNILLDFNFEAKVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 593
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFK 594
SDV+SFGVVLLELITGRKPVDASQPLGDESLVE +DA F+
Sbjct: 594 SDVYSFGVVLLELITGRKPVDASQPLGDESLVE----MDAATFFQ 634
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546929|ref|XP_002514522.1| ATP binding protein, putative [Ricinus communis] gi|223546126|gb|EEF47628.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 265/334 (79%), Positives = 300/334 (89%)
Query: 250 NPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMP 309
N S+PE+S SP + GIGT G V I V VGII S++GL V C+R+R+KE GLNG Y+MP
Sbjct: 365 NTSAPENSKSPGDGGIGTGGIVAIGVVVGIIMLSIVGLAVLCMRKRRKEAHGLNGGYVMP 424
Query: 310 SPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGF 369
SPLGSS TD + K Q++ PL+GSG +D+V SP GGLG+SRS F YEEL+K+T+GF
Sbjct: 425 SPLGSSPRTDLNLSKAQTTIPLMGSGSSTDYVYSPSGSGGLGNSRSWFMYEELLKSTNGF 484
Query: 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+ QNLLGEGGFGSVYKG LPDGREVA+KQLK+GGGQGEREFKAEVEIISRIHHRHLVSLV
Sbjct: 485 SSQNLLGEGGFGSVYKGCLPDGREVAVKQLKVGGGQGEREFKAEVEIISRIHHRHLVSLV 544
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
GYCISD+RRLL+YDYVPNNTL+FHLHGEGRPVL+WA RVKIAAGAARG+AYLHEDCHPR+
Sbjct: 545 GYCISDNRRLLVYDYVPNNTLHFHLHGEGRPVLNWAARVKIAAGAARGIAYLHEDCHPRV 604
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
IHRDIKSSNILLDNNFEA+VSDFGLAKLA+DA+TH+TTRVMGTFGYMAPEYASSGKLT+K
Sbjct: 605 IHRDIKSSNILLDNNFEAKVSDFGLAKLAIDADTHVTTRVMGTFGYMAPEYASSGKLTDK 664
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
SDVFS+GVVLLELITGRKPVDASQPLGDESLV+W
Sbjct: 665 SDVFSYGVVLLELITGRKPVDASQPLGDESLVQW 698
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297838635|ref|XP_002887199.1| hypothetical protein ARALYDRAFT_894642 [Arabidopsis lyrata subsp. lyrata] gi|297333040|gb|EFH63458.1| hypothetical protein ARALYDRAFT_894642 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 245/333 (73%), Positives = 291/333 (87%), Gaps = 5/333 (1%)
Query: 254 PESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLG 313
P+SS+S + +GIGT V I+VAV ++ F+LIG+ VWC+RRR+K +S ++G + PSP+
Sbjct: 96 PDSSNSTNGSGIGTGAVVGISVAVALVVFTLIGIFVWCVRRREKRLSAVSGGDVTPSPMS 155
Query: 314 SSSTTDSSYIKTQSSAPLIG---SGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFA 370
S++ +DS++ + QSSAP++G SG + + Q GGLG+S+++F+YEELVKAT+GF+
Sbjct: 156 STARSDSAFFRMQSSAPVVGEKRSGSHQTYFSQSQ-SGGLGNSKALFSYEELVKATNGFS 214
Query: 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+NLLGEGGFG VYKG LPDGR VA+KQLKIGGGQG+REFKAEVE +SRIHHRHLVS+VG
Sbjct: 215 QENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVG 274
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+CIS DRRLLIYDYV NN LYFHLHGE + VLDWATRVKIAAGAARGLAYLHEDCHPRII
Sbjct: 275 HCISGDRRLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRII 333
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRDIKSSNILL++NF+A+VSDFGLA+LALD NTHITTRV+GTFGYMAPEYASSGKLTEKS
Sbjct: 334 HRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKS 393
Query: 551 DVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
DVFSFGVVLLELITGRKPVD SQPLGDESLVEW
Sbjct: 394 DVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 426
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221470|ref|NP_177036.1| protein kinase-like protein [Arabidopsis thaliana] gi|75337798|sp|Q9SX31.1|PERK9_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK9; AltName: Full=Proline-rich extensin-like receptor kinase 9; Short=AtPERK9 gi|5734709|gb|AAD49974.1|AC008075_7 Contains PF|00069 Eukaryotic protein kinase domain [Arabidopsis thaliana] gi|14334806|gb|AAK59581.1| putative protein kinase [Arabidopsis thaliana] gi|21280865|gb|AAM44925.1| putative protein kinase [Arabidopsis thaliana] gi|332196707|gb|AEE34828.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1369), Expect = e-148, Method: Compositional matrix adjust.
Identities = 239/326 (73%), Positives = 282/326 (86%), Gaps = 4/326 (1%)
Query: 258 SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
+S +N+GIGT V I+VAV ++ F+L G+ VWCLR+R+K +S ++G + PSP+ S++
Sbjct: 269 NSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 318 TDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGE 377
+DS++ + QSSAP+ S + GGLG+S+++F+YEELVKAT+GF+ +NLLGE
Sbjct: 329 SDSAFFRMQSSAPVGASKRSGSY---QSQSGGLGNSKALFSYEELVKATNGFSQENLLGE 385
Query: 378 GGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437
GGFG VYKG LPDGR VA+KQLKIGGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DR
Sbjct: 386 GGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDR 445
Query: 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497
RLLIYDYV NN LYFHLHGE + VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS
Sbjct: 446 RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 498 NILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557
NILL++NF+A+VSDFGLA+LALD NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGV
Sbjct: 505 NILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564
Query: 558 VLLELITGRKPVDASQPLGDESLVEW 583
VLLELITGRKPVD SQPLGDESLVEW
Sbjct: 565 VLLELITGRKPVDTSQPLGDESLVEW 590
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567172|ref|XP_003551795.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1359), Expect = e-147, Method: Compositional matrix adjust.
Identities = 261/416 (62%), Positives = 314/416 (75%), Gaps = 35/416 (8%)
Query: 201 QTPPTPASP--------------------------IAPRPSNSSPNSPPPPSTKRLSPPP 234
+T P+ ASP P S+ + P PP+ K + P
Sbjct: 209 KTTPSHASPPSVSETPPKPPSSDVPPPSTLPSTPPSDPSGSSPPASLPDPPTNKTVVGGP 268
Query: 235 GIPVPS------TENTPGNGTNPSSPESSSSPSNN-GIGTAGTVVIAVAVGIIAFSLIGL 287
+ +PS T +GTN S S+++PS++ G+ T G+V I + VG I SL+ +
Sbjct: 269 KVSLPSLPTEKPTARPTNDGTNSMS--SNNTPSHSGGLSTGGSVAIGIVVGFIVLSLLVM 326
Query: 288 VVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDP 347
VW +++KK+ +G G Y PSP SS + + +++ QS A +GSG GSDFV SP +P
Sbjct: 327 AVWFAQKKKKKGTGSRGSYAAPSPFTSSHNSGTLFLRPQSPANFLGSGSGSDFVYSPSEP 386
Query: 348 GGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE 407
GG+ SRS FTYEEL++AT+GF+ QNLLGEGGFG VYKG L DGREVA+KQLKIGGGQGE
Sbjct: 387 GGVSSSRSWFTYEELIQATNGFSAQNLLGEGGFGCVYKGLLIDGREVAVKQLKIGGGQGE 446
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
REF+AEVEIISR+HHRHLVSLVGYCIS+ +RLL+YDYVPN+TL++HLHGE RPVLDW TR
Sbjct: 447 REFRAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDYVPNDTLHYHLHGENRPVLDWPTR 506
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527
VK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILLD N+EAQVSDFGLAKLALD+NTH+TT
Sbjct: 507 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDLNYEAQVSDFGLAKLALDSNTHVTT 566
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
RVMGTFGYMAPEYA+SGKLTEKSDV+SFGVVLLELITGRKPVDASQP+GDESLVEW
Sbjct: 567 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPIGDESLVEW 622
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79352581|ref|NP_173940.2| proline-rich extensin-like receptor kinase 10 [Arabidopsis thaliana] gi|310947343|sp|Q9C660.2|PEK10_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK10; AltName: Full=Proline-rich extensin-like receptor kinase 10; Short=AtPERK10 gi|332192534|gb|AEE30655.1| proline-rich extensin-like receptor kinase 10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 526 bits (1356), Expect = e-147, Method: Compositional matrix adjust.
Identities = 238/315 (75%), Positives = 274/315 (86%), Gaps = 1/315 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLH G P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 569 VDASQPLGDESLVEW 583
VDASQPLGDESLVEW
Sbjct: 630 VDASQPLGDESLVEW 644
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204391|emb|CBI16871.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1345), Expect = e-145, Method: Compositional matrix adjust.
Identities = 238/298 (79%), Positives = 269/298 (90%), Gaps = 2/298 (0%)
Query: 287 LVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPL-IGSGPGSDFVNSPQ 345
+ W +++RKK+ +GLN Y MPSP SS +DS +++ SS+ L +GSG GSDFV SP
Sbjct: 18 MAAWFVQKRKKKRAGLNIGYTMPSPFASSQNSDSVFLRPHSSSALPLGSGSGSDFVYSPP 77
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
DP G +SR F+YEELV+ATDGF+ QNLLGEGGFG VYKG+L DGREVA+KQLKIGGGQ
Sbjct: 78 DPVG-SNSRPWFSYEELVEATDGFSSQNLLGEGGFGCVYKGFLADGREVAVKQLKIGGGQ 136
Query: 406 GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
GEREFKAEVEIISR+HHRHLVSLVGYCIS+ +RLL+YD+VPN+TL++HLHGEGRPV+DWA
Sbjct: 137 GEREFKAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDFVPNDTLHYHLHGEGRPVMDWA 196
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
TRVK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILLD NFEAQVSDFGLAKLALDANTH+
Sbjct: 197 TRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDMNFEAQVSDFGLAKLALDANTHV 256
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
TTRVMGTFGYMAPEYASSGKLTEKSDV+SFGVVLLELITGRKPVDASQPLGDESLVEW
Sbjct: 257 TTRVMGTFGYMAPEYASSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEW 314
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12321185|gb|AAG50687.1|AC079829_20 Pto kinase interactor, putative [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 238/315 (75%), Positives = 274/315 (86%), Gaps = 3/315 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLHG P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHGT--PGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 567
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 568 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 627
Query: 569 VDASQPLGDESLVEW 583
VDASQPLGDESLVEW
Sbjct: 628 VDASQPLGDESLVEW 642
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | ||||||
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.495 | 0.395 | 0.764 | 2.7e-123 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.490 | 0.420 | 0.751 | 5.8e-121 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.495 | 0.441 | 0.678 | 4.3e-109 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.418 | 0.392 | 0.698 | 2.8e-98 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.410 | 0.350 | 0.726 | 3.2e-97 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.415 | 0.386 | 0.692 | 1.8e-96 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.425 | 0.407 | 0.664 | 8.8e-96 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.408 | 0.370 | 0.705 | 3.3e-95 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.392 | 0.330 | 0.735 | 6.8e-95 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.495 | 0.419 | 0.600 | 2.7e-93 |
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1212 (431.7 bits), Expect = 2.7e-123, P = 2.7e-123
Identities = 231/302 (76%), Positives = 260/302 (86%)
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGXXX-XXXXXYIKTQSSAPLIGSGPGSDFV 341
+LIG+VV CL++RKK +S + G Y+MP+P+ +KTQSSAPL+G+ +
Sbjct: 343 TLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSSAPLVGNRSSNRTY 402
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG LPD R VA+KQLKI
Sbjct: 403 LSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI 462
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
GGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN LYFHLH G P
Sbjct: 463 GGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG 522
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A VSDFGLAKLALD
Sbjct: 523 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDC 582
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV
Sbjct: 583 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 642
Query: 582 EW 583
EW
Sbjct: 643 EW 644
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 5.8e-121, P = 5.8e-121
Identities = 227/302 (75%), Positives = 260/302 (86%)
Query: 282 FSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGXXXXXXXXYIKTQSSAPLIGSGPGSDFV 341
F+L G+ VWCLR+R+K +S ++G + PSP+ + + QSSAP +G+ S
Sbjct: 293 FTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAP-VGASKRSGSY 351
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
S GGLG+S+++F+YEELVKAT+GF+ +NLLGEGGFG VYKG LPDGR VA+KQLKI
Sbjct: 352 QSQS--GGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKI 409
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
GGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DRRLLIYDYV NN LYFHLHGE + V
Sbjct: 410 GGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE-KSV 468
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL++NF+A+VSDFGLA+LALD
Sbjct: 469 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDC 528
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD SQPLGDESLV
Sbjct: 529 NTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLV 588
Query: 582 EW 583
EW
Sbjct: 589 EW 590
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 207/305 (67%), Positives = 247/305 (80%)
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYIMP-SPLGXXXXXXXXYIKTQSSAP-LIGSGPGSDF 340
SL + VW R+RK++ G Y MP S ++SSAP + S GSD+
Sbjct: 251 SLFVMGVWFTRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDY 310
Query: 341 VNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLK 400
+ + D G + + RS F+Y+EL + T GF+++NLLGEGGFG VYKG L DGREVA+KQLK
Sbjct: 311 MYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLK 370
Query: 401 IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP 460
IGG QGEREFKAEVEIISR+HHRHLV+LVGYCIS+ RLL+YDYVPNNTL++HLH GRP
Sbjct: 371 IGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRP 430
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-- 518
V+ W TRV++AAGAARG+AYLHEDCHPRIIHRDIKSSNILLDN+FEA V+DFGLAK+A
Sbjct: 431 VMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQE 490
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
LD NTH++TRVMGTFGYMAPEYA+SGKL+EK+DV+S+GV+LLELITGRKPVD SQPLGDE
Sbjct: 491 LDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDE 550
Query: 579 SLVEW 583
SLVEW
Sbjct: 551 SLVEW 555
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 181/259 (69%), Positives = 222/259 (85%)
Query: 330 PLIGSGPGSDF----VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVY 384
P + S GSD+ V P PG LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+
Sbjct: 231 PFMSSSGGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVH 290
Query: 385 KGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444
KG LP G+EVA+KQLK+G GQGEREF+AEVEIISR+HHRHLVSLVGYCI+ +RLL+Y++
Sbjct: 291 KGVLPSGKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEF 350
Query: 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504
VPNN L HLHGEGRP ++W+TR+KIA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D
Sbjct: 351 VPNNNLELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFK 410
Query: 505 FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
FEA+V+DFGLAK+A D NTH++TRVMGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELIT
Sbjct: 411 FEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELIT 470
Query: 565 GRKPVDASQPLGDESLVEW 583
GR+PVDA+ D+SLV+W
Sbjct: 471 GRRPVDANNVYVDDSLVDW 489
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 181/249 (72%), Positives = 209/249 (83%)
Query: 335 GPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREV 394
G G S D +G ++ FTYEEL T+GF+ N+LGEGGFG VYKG L DG+ V
Sbjct: 319 GGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLV 378
Query: 395 AIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
A+KQLK+G GQG+REFKAEVEIISR+HHRHLVSLVGYCI+D RLLIY+YVPN TL HL
Sbjct: 379 AVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHL 438
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
HG+GRPVL+WA RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ FEAQV+DFGL
Sbjct: 439 HGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGL 498
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
AKL TH++TRVMGTFGY+APEYA SGKLT++SDVFSFGVVLLELITGRKPVD QP
Sbjct: 499 AKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQP 558
Query: 575 LGDESLVEW 583
LG+ESLVEW
Sbjct: 559 LGEESLVEW 567
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 959 (342.6 bits), Expect = 1.8e-96, P = 1.8e-96
Identities = 178/257 (69%), Positives = 221/257 (85%)
Query: 332 IGSGPGSDF----VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG 386
+ S GSD+ V P PG LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+KG
Sbjct: 238 MSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKG 297
Query: 387 YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446
LP G+EVA+KQLK G GQGEREF+AEVEIISR+HHRHLVSL+GYC++ +RLL+Y++VP
Sbjct: 298 ILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVP 357
Query: 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
NN L FHLHG+GRP ++W+TR+KIA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D FE
Sbjct: 358 NNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFE 417
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
A+V+DFGLAK+A D NTH++TRVMGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELITGR
Sbjct: 418 AKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGR 477
Query: 567 KPVDASQPLGDESLVEW 583
+PVDA+ D+SLV+W
Sbjct: 478 RPVDANNVYVDDSLVDW 494
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 8.8e-96, Sum P(2) = 8.8e-96
Identities = 172/259 (66%), Positives = 215/259 (83%)
Query: 334 SGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE 393
SGP + P LG ++S FTY+EL AT GF D NLLG+GGFG V+KG LP G+E
Sbjct: 249 SGPSRPVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKE 308
Query: 394 VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
VA+K LK G GQGEREF+AEV+IISR+HHR+LVSLVGYCI+D +R+L+Y++VPN TL +H
Sbjct: 309 VAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYH 368
Query: 454 LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
LHG+ PV++++TR++IA GAA+GLAYLHEDCHPRIIHRDIKS+NILLD NF+A V+DFG
Sbjct: 369 LHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFG 428
Query: 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
LAKL D NTH++TRVMGTFGY+APEYASSGKLTEKSDVFS+GV+LLELITG++PVD S
Sbjct: 429 LAKLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSI 488
Query: 574 PLGDESLVEWVNLIDAKIL 592
+ D++LV+W + A+ L
Sbjct: 489 TM-DDTLVDWARPLMARAL 506
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
Identities = 182/258 (70%), Positives = 217/258 (84%)
Query: 334 SGPGSDFVN--------SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYK 385
SGP SD N SPQ LGH++S FTY+EL AT+GFA NLLG+GGFG V+K
Sbjct: 270 SGPHSDASNLTGRTAIPSPQ-AATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHK 328
Query: 386 GYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445
G LP G+EVA+K LK+G GQGEREF+AEV+IISR+HHRHLVSLVGYCIS +RLL+Y+++
Sbjct: 329 GVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFI 388
Query: 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505
PNNTL FHLHG+GRPVLDW TRVKIA G+ARGLAYLHEDCHPRIIHRDIK++NILLD +F
Sbjct: 389 PNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSF 448
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
E +V+DFGLAKL+ D TH++TRVMGTFGY+APEYASSGKL++KSDVFSFGV+LLELITG
Sbjct: 449 ETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITG 508
Query: 566 RKPVDASQPLGDESLVEW 583
R P+D + + D SLV+W
Sbjct: 509 RPPLDLTGEMED-SLVDW 525
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 175/238 (73%), Positives = 206/238 (86%)
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
D LG ++ F+YEEL + T GFA +N+LGEGGFG VYKG L DG+ VA+KQLK G GQ
Sbjct: 348 DSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQ 407
Query: 406 GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
G+REFKAEVEIISR+HHRHLVSLVGYCISD RLLIY+YV N TL HLHG+G PVL+W+
Sbjct: 408 GDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWS 467
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ +EAQV+DFGLA+L TH+
Sbjct: 468 KRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHV 527
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
+TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLEL+TGRKPVD +QPLG+ESLVEW
Sbjct: 528 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEW 585
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 188/313 (60%), Positives = 235/313 (75%)
Query: 289 VWCLRRRKKEVSGL--NGVYIMPSPLGXXXXXXXXYIKT--QSSAPLIGSGPGSDFVNSP 344
V+ +RR++K+ S + Y+ P+ + Y + ++ S P ++ + +P
Sbjct: 280 VFFVRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNP 339
Query: 345 Q------DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQ 398
+ D +G S+ FTYEEL + T+GF ++GEGGFG VYKG L +G+ VAIKQ
Sbjct: 340 KHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQ 399
Query: 399 LKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG 458
LK +G REFKAEVEIISR+HHRHLVSLVGYCIS+ R LIY++VPNNTL +HLHG+
Sbjct: 400 LKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKN 459
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
PVL+W+ RV+IA GAA+GLAYLHEDCHP+IIHRDIKSSNILLD+ FEAQV+DFGLA+L
Sbjct: 460 LPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLN 519
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
A +HI+TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRKPVD SQPLG+E
Sbjct: 520 DTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEE 579
Query: 579 SLVEWVN--LIDA 589
SLVEW LI+A
Sbjct: 580 SLVEWARPRLIEA 592
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SX31 | PERK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7331 | 0.5304 | 0.4548 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 607 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-29 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-27 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-25 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-24 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-21 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-21 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-20 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-19 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-18 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-18 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-18 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-16 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-15 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-15 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 9e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-14 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 3e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-13 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-13 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-13 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-12 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 6e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 4e-11 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 4e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-11 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 8e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-10 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-10 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 3e-10 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 8e-10 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-09 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-09 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-09 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-09 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 1e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-08 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 3e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-08 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 4e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 4e-08 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 5e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 7e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 7e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-08 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 8e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-08 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 1e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-07 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-07 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 3e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 3e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 4e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-07 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 5e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-07 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 6e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 7e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-07 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 8e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 9e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-07 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-06 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 1e-06 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 1e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-06 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-06 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-06 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 3e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-06 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 4e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-06 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 5e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 5e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-06 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 5e-06 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 5e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 6e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 6e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 6e-06 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 6e-06 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 7e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 7e-06 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 7e-06 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 7e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 7e-06 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 7e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 8e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 9e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-06 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 9e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 9e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-05 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 2e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 2e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 2e-05 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PHA03321 | 694 | PHA03321, PHA03321, tegument protein VP11/12; Prov | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 2e-05 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-05 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 3e-05 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 3e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 3e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 3e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 3e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 3e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 3e-05 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 3e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 3e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 3e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 4e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 4e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 4e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 4e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 4e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 4e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 5e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 5e-05 | |
| TIGR01628 | 562 | TIGR01628, PABP-1234, polyadenylate binding protei | 5e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 5e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 6e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 6e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 6e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 6e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 7e-05 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 7e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 7e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 7e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 7e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-05 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 8e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 8e-05 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 8e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 9e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-05 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 9e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 9e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 9e-05 | |
| PRK13335 | 356 | PRK13335, PRK13335, superantigen-like protein; Rev | 9e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 1e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 1e-04 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 1e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 1e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 1e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 1e-04 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 1e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 2e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-04 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 2e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 2e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 2e-04 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 2e-04 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 2e-04 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 2e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 2e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-04 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 2e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 2e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 2e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 2e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 2e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 2e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 3e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 3e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 3e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 3e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 3e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 3e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 3e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 3e-04 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 3e-04 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 3e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-04 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 4e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 4e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 4e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 4e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 4e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 4e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 5e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 5e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 5e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 5e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 5e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 5e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 5e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 5e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 5e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 5e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 5e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 5e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 5e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 6e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 6e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 6e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 6e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 6e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 6e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 6e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 6e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 6e-04 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 6e-04 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 6e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 6e-04 | |
| PHA03309 | 2033 | PHA03309, PHA03309, transcriptional regulator ICP4 | 6e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 6e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 7e-04 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 7e-04 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 7e-04 | |
| pfam03359 | 342 | pfam03359, GKAP, Guanylate-kinase-associated prote | 7e-04 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 8e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-04 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 8e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 8e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 8e-04 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-04 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 8e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 9e-04 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 9e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 9e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 9e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 9e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 9e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 9e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 9e-04 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 9e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-04 | |
| pfam04502 | 321 | pfam04502, DUF572, Family of unknown function (DUF | 9e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.001 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.001 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.001 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.001 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.001 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 0.001 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 0.001 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 0.001 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 0.001 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.001 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.001 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.001 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 0.001 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.001 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.001 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 0.001 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.002 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 0.002 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 0.002 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.002 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.002 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 0.002 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.002 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.002 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.002 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.002 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.002 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.002 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 0.002 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 0.002 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.002 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.002 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.002 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 0.002 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.002 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.002 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.002 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.002 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.002 | |
| pfam03353 | 316 | pfam03353, Lin-8, Ras-mediated vulval-induction an | 0.002 | |
| pfam05505 | 717 | pfam05505, Ebola_NP, Ebola nucleoprotein | 0.002 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.002 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 0.002 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.003 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.003 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.003 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.003 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.003 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.003 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.003 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.003 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.003 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.003 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.003 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.003 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.003 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.003 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.003 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.003 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 0.003 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.003 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.003 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.003 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.003 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.003 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 0.003 | |
| PRK11907 | 814 | PRK11907, PRK11907, bifunctional 2',3'-cyclic nucl | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.004 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.004 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.004 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.004 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.004 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.004 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.004 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.004 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.004 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 0.004 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.004 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.004 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.004 | |
| PLN03188 | 1320 | PLN03188, PLN03188, kinesin-12 family protein; Pro | 0.004 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.004 | |
| TIGR03895 | 602 | TIGR03895, protease_PatA, cyanobactin maturation p | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 3e-60
Identities = 72/192 (37%), Positives = 107/192 (55%), Gaps = 9/192 (4%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
LGEGGFG+VY G++VAIK +K E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ L+ +Y +L L E L ++I GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--NG-IIHR 116
Query: 493 DIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEKS 550
D+K NILLD+ N + +++DFGL+KL L ++ + ++GT YMAPE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 551 DVFSFGVVLLEL 562
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 5e-56
Identities = 76/221 (34%), Positives = 109/221 (49%), Gaps = 14/221 (6%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
+ LGEG FG VY G+ VAIK +K + +RE E++I+ ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
L +D+ L+ +Y L+ L GR D A L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSK-- 116
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRD+K NILLD + +++DFGLA+ LD +TT V GT YMAPE
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
+ D++S GV+L EL+TG+ P GD+ L+E I
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 9e-53
Identities = 79/201 (39%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK-----AEVEIISRIHHRHLVSL 428
LG G FG+VYK G+ VA+K LK + E+ K E+ I+ R+ H ++V L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ D L+ +Y L+ +L G L KIA RGL YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLT 547
IIHRD+K NILLD N +++DFGLAK L +++ +TT V GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 548 EKSDVFSFGVVLLELITGRKP 568
K DV+S GV+L EL+TG+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L +VA+K LK G + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C + ++ +Y+P L L G L +++A A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK---N 122
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
+HRD+ + N L+ N ++SDFGL++ + + + R G +MAPE GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKDGKF 181
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T KSDV+SFGV+L E+ T G +P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 3e-52
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L EVA+K LK Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C ++ +++ +Y+P L +L L + + A ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
IHRD+ + N L+ N ++SDFGL++ D + + +MAPE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
KSDV+SFGV+L E+ T G +P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 8e-52
Identities = 72/203 (35%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L EVA+K LK Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+G C ++ ++ +Y+ L Y + RP L + + A ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
IHRD+ + N L+ N ++SDFGL++ D + + +MAPE GK
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T KSDV+SFGV+L E+ T G +P
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 373 NLLGEGGFGSVYKGYLPDG----REVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGEG FG VYKG L EVA+K LK + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-------HGEGRPVLDWATRVKIAAGAARGLAY 480
L+G C ++ L+ +Y+ L +L + L + A A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAP 538
L + +HRD+ + N L+ + ++SDFGL++ + + + + G +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD-VYDDDYYRKKTGGKLPIRWMAP 176
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
E G T KSDV+SFGV+L E+ T G P
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 373 NLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLV 429
LLG G FGSVY D G +A+K +++ G E + E+ I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 430 GYCISDDRR-LLIY-DYVPNNTLYFHLHGEGR---PVL-DWATRVKIAAGAARGLAYLHE 483
G +++ L I+ +YV +L L G+ PV+ + ++ GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYLHS 119
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYAS 542
+ I+HRDIK +NIL+D++ +++DFG AK L T V GT +MAPE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ +D++S G ++E+ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGG-GQGEREF-KAEVEIISRIHHRHL 425
+ +G+G FG VY DG+ +K++ + + ERE EV+I+ +++H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLH---GEGRP-----VLDWATRVKIAAGAARG 477
+ + ++ +Y L + EG+P +LDW ++ +A
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------ 115
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L YLH +I+HRDIK NI L +N ++ DFG++K+ L + + V+GT Y++
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLS 171
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
PE + KSD++S G VL EL T + P +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 76/229 (33%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 375 LGEGGFGSVY----KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V K G+ A+K LK I + E I+SRI+H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 428 LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDC 485
L Y + +L L+ +Y P L+ HL EGR R + AA L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FS-EERARFYAAEIVLALEYLHSL- 112
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K NILLD + +++DFGLAK + T GT Y+APE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFK 594
+ D +S GV+L E++TG+ P A I KIL
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDR----------KEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F +G+GGFG VYK + G+EVAIK +K+ + + + E++I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G + D ++ ++ +L L + L + + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
IIHRDIK++NILL ++ E ++ DFGL+ D T +GT +MAPE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYD 175
Query: 548 EKSDVFSFGVVLLELITGRKP 568
K+D++S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 75/242 (30%), Positives = 116/242 (47%), Gaps = 21/242 (8%)
Query: 373 NLLGEGGFGSVYKG-YLPD----GREVAIKQLKI-GGGQGEREFKAEVEIISRIHHRHLV 426
LGEG FG V Y P G +VA+K L G Q +F+ E+EI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 427 SLVGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C R LI +Y+P+ +L +L R ++ + ++ +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPEYA 541
R IHRD+ + NIL+++ ++SDFGLAK+ + + + G F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLIDAKILFKLVFLCQ 600
+ K + SDV+SFGV L EL T G + P E L I+ +L+ L +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPA-EFLRMIGIAQGQMIVTRLLELLK 240
Query: 601 QN 602
+
Sbjct: 241 EG 242
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 16/202 (7%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
F + LG G FG V++G + VAIK LK +++F+ EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
C + +I + + +L L EG+ VL A+ + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-----ANTHITTRVMGTFGYMAPEYAS 542
IHRD+ + NIL+ + +V+DFGLA+L + ++ I + + APE AS
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAAS 177
Query: 543 SGKLTEKSDVFSFGVVLLELIT 564
G + KSDV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 14/198 (7%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G FG V G G++VA+K LK + F AE +++ + H +LV L+G +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ ++ +Y+ +L +L GR V+ A ++ A G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
+ + N+L+ + A+VSDFGLAK +A+ + G + APE K + KSD
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKSD 181
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 375 LGEGGFGSVYKGY-LPDGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG +P+G VAIK L+ + +E E +++ + H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLHE 483
+G C+S + LI +P L ++ + +L+W ++ A+G++YL E
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYAS 542
R++HRD+ + N+L+ +++DFGLAK L +D + +MA E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKPVD 570
T KSDV+S+GV + EL+T G KP +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLV 429
N +G G FG VY L G +A+K+++I + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G + ++ + +Y TL L GR +LD GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH-GR-ILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV---MGTFGYMAPEYASSGKL 546
+HRDIK +NI LD+N ++ DFG A + T + V GT YMAPE + GK
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 547 TEK---SDVFSFGVVLLELITGRKP 568
+D++S G V+LE+ TG++P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHL 425
F N +G+G FG V+K D R A+KQ+ + +A E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLD---WATRVKIAAGAARGLAYL 481
+ + + ++ +Y N L+ L + GRP+ + W + GLA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H +I+HRDIKS N+ LD ++ D G+AKL L NT+ ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELC 173
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
EKSDV++ GVVL E TG+ P DA
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 74/198 (37%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VA+K LK G E F E +I+ ++ H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 435 DDRRLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +Y+ +L L GEG+ L V +AA A G+AYL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
+ + NIL+ N +++DFGLA+L D T R F + APE A+ G+ T KSD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 5/195 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V++G + VA+K LK G + +F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ ++ + + +L +L G L + +AA A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFS 554
+ N+L+ N +V+DFGLA++ + + APE A + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 555 FGVVLLELIT-GRKP 568
FG++L E++T GR P
Sbjct: 190 FGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSL 428
+L+G G FG VYKG L G VAIKQ+ + + E + E++++ + H ++V
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 429 VGYCISDDRRLLIYDYVPNNTLY-----FHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+G + D +I +Y N +L F E V + +V +GLAYLHE
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SLVAVYVYQV------LQGLAYLHE 117
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+IHRDIK++NIL + +++DFG+A L+ + V+GT +MAPE
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
+ SD++S G ++EL+TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 6/197 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + R+VAIK ++ G E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
L+++++ + L +L + R T + + G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFS 554
+ N L+ N +VSDFG+ + LD +T + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 555 FGVVLLELIT-GRKPVD 570
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 68/209 (32%), Positives = 110/209 (52%), Gaps = 21/209 (10%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V +G L P +E VAIK LK G +R +F E I+ + H +++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL-HGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
L G ++I +Y+ N +L L +G+ V + G A G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR-----VMGTFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL++ D+ TT+ + T APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T SDV+SFG+V+ E+++ G +P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-28
Identities = 67/252 (26%), Positives = 94/252 (37%), Gaps = 8/252 (3%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P P P A S++P PP + P + P + P P + P + P PP + P
Sbjct: 2708 PEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPAT-PGGPARPARPPTTAGP 2766
Query: 64 TSSSPP---ASSPPTSSPPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ +PP A+ PP PA + S PSP + P + P + P + P
Sbjct: 2767 PAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAG 2826
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
PP ++ P+ P PP PP ++ P PP RSP + P PP
Sbjct: 2827 PLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRL 2886
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P + A+PP PP P P P P P PPPP + P
Sbjct: 2887 ARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPT 2946
Query: 237 PVPSTENTPGNG 248
P+ P
Sbjct: 2947 TDPAGAGEPSGA 2958
|
Length = 3151 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 74/207 (35%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 375 LGEGGFGSVYKGY--LPDGRE--VAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FGSV KG + G+E VA+K LK G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLD---WATRVKIAAGAARGLAYLHEDC 485
G C + +L+ + P L +L PV D A +V A G+AYL E
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESK 114
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTF--GYMAPEYAS 542
H +HRD+ + N+LL N +A++SDFG+++ AL A + + G + + APE +
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
GK + KSDV+S+GV L E + G KP
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + G+ A K+L ++ +GE+ E +I+ ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ D L+ + L +H++ G P A + AA GL +LH+ RI+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+RD+K N+LLD++ ++SD GLA + L I R GT GYMAPE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVYDFSV 175
Query: 551 DVFSFGVVLLELITGRKP 568
D F+ G L E+I GR P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 6e-28
Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHR 423
+ LGEG FG VY D + VA+K L + F E++I++ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLH 482
++V L + + L+ +YV +L L GR L + + I A L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 483 EDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTH-----ITTRVMGTFGYM 536
IIHRDIK NILLD + ++ DFGLAKL D + + + +GT GYM
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 537 APEYASSGKL---TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
APE L + SD++S G+ L EL+TG P + + S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG+G G VYK + P G+ A+K++ + G + ++ E++ + ++V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--KIAAGAARGLAYLHEDCHPRII 490
+ ++ +Y+ +L + V V IA +GL YLH H II
Sbjct: 69 YKEGEISIVLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRDIK SN+L+++ E +++DFG++K+ + T V GT YM+PE + +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 551 DVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDA 589
D++S G+ LLE G+ P + L+ A
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPS------FFELMQA 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 375 LGEGGFGSVYKGYL----PDGRE--VAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LGEG FG V+ G P+ + VA+K LK R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHG--------EGRPV--LDWATRVKIAAGAA 475
G C D +++++Y+ + L + HG P+ L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT--- 532
G+ YL +HRD+ + N L+ + ++ DFG+++ D T RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 533 -FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 47/216 (21%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-----FKAEVEIISRIHHRHLVSL 428
+GEG +G VYK G VA+K++++ + E+E E++++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GL 478
S + ++++Y+ ++ E VK + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMKQLLEGL 113
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMA 537
YLH I+HRDIK SNIL++N+ +++DFGLA + T RV+ T Y
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 538 PE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
PE Y + D++S G +L EL G+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 70/201 (34%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 374 LLGEGGFGSVYK-GYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C S RR L+ +Y+P +L +L + R LD + A+ +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPEYASS 543
R +HRD+ + NIL+++ ++ DFGL K+ + R G F Y APE +
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 544 GKLTEKSDVFSFGVVLLELIT 564
K + SDV+SFGVVL EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 79/281 (28%), Positives = 105/281 (37%), Gaps = 17/281 (6%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGP AA +SP P + P P P + + P PP + P PP+ PA+ PP
Sbjct: 2723 PGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRR 2782
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPS----PPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ PA + + S +P + PP+ P A+ PP SP P+ P + P P
Sbjct: 2783 LTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPP 2842
Query: 122 PPPNSPPSP------PSDPPANSPPPSNP---PSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P P P P PP +P P+ PP + P S + PP
Sbjct: 2843 PGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPP 2902
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P P +PP P P PP P PP P P P + P PS P
Sbjct: 2903 DQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQP 2962
Query: 233 PPGIPVPSTENTPGNGTNPSSPE----SSSSPSNNGIGTAG 269
G VP P +P +SS+P G +
Sbjct: 2963 WLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSR 3003
|
Length = 3151 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G VYK G+EVAIK++++ Q + E+ I+ H ++V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-----IAAGAA---RGLAYLHEDC 485
D ++ +Y+ +L ++ V+ IA +GL YLH
Sbjct: 86 VGDELWVVMEYMDGGSL--------TDIITQ-NFVRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR------VMGTFGYMAPE 539
+IHRDIKS NILL + +++DFG A +T V+GT +MAPE
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPE 186
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
K D++S G++ +E+ G P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 368 GFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGG-GQGEREFKA-EVEIISRIHHRH 424
F LG+G +GSVYK L D + A+K++ +G Q ERE E+ I++ ++H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHL---HGEGRPV---LDWATRVKIAAGAARGL 478
++S + ++ ++ +Y P L + + + + W +++ RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYM 536
LHE +I+HRD+KS+NILL N ++ D G++K+ A T I GT YM
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
APE + KSD++S G +L E+ T P +A
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 75/198 (37%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VA+K LK G E F E +I+ ++ H LV L +S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +Y+ +L F GEGR L V +AA A G+AY+ + IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
++S+NIL+ + +++DFGLA+L D T R F + APE A G+ T KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRIHHR 423
F ++G+G FG V D +++ A+K + K R E I+ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 424 HLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYL 481
LV+L Y D+ + L+ D + L +HL + V +VK L YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H IIHRDIK NILLD ++DF +A + +T T+ GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTS-GTPGYMAPEVL 171
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
+ D +S GV E + G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGE---REFKAEVEIISRIHHRHLVS 427
LLG G FGSVY+G L DG A+K++ + G G+ ++ + E+ ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYLHED 484
+G +D + + VP +L L G PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----GTFGYMAPE 539
+HRDIK +NIL+D N +++DFG+AK + G+ +MAPE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171
Query: 540 Y-ASSGKLTEKSDVFSFGVVLLELITGRKP 568
A G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 375 LGEGGFGSVYKGYL--PDGRE----VAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVS 427
LGEG FG VYKG L P+ R VAIK LK + ++EF+ E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL--------------HGEGRPVLDWATRVKIAAG 473
L+G C + ++++Y+ + L+ L + LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G+ YL +HRD+ + N L+ ++SDFGL++ A+ + RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186
Query: 533 ---FGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
+M PE GK T +SD++SFGVVL E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 71/240 (29%), Positives = 107/240 (44%), Gaps = 35/240 (14%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G VAIK + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG-----EGRPVLDWATRVKI---AAGAARGLA 479
L+G + L++ + + L +L E P L T K AA A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH----ITTRVMGTFGY 535
YL + +HRD+ + N ++ + ++ DFG+ + D + + +
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP---LGDESLVEWVNLIDAKIL 592
MAPE G T KSDV+SFGVVL E+ T A QP L +E ++++V ID L
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSNEEVLKFV--IDGGHL 240
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A+KQ+ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 428 LVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C+ DD L I+ +Y+P ++ L G + + TR K G+ YLH +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN-- 123
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMAPEYASSG 544
I+HRDIK +NIL D+ ++ DFG +K + T V GT +M+PE S
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
K+DV+S G ++E++T + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 50/239 (20%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGG-GQGERE-FKAEVE 415
YE L +G+G FG+V K DG+ + K++ G + E++ +EV
Sbjct: 2 YEVL----------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 416 IISRIHHRHLVSLVG---------------YCISDDRRLLIYDYVPNNTLYFHLHGEGRP 460
I+ + H ++V YC D LI Y E
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-YI----EEEF 106
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCH------PRIIHRDIKSSNILLDNNFEAQVSDFGL 514
+ T++ +A L+E CH ++HRD+K +NI LD N ++ DFGL
Sbjct: 107 IWRILTQLLLA---------LYE-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
AK+ L ++ +GT YM+PE + EKSD++S G ++ EL P A
Sbjct: 157 AKI-LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VAIK ++ G E +F E +++ ++ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +Y+ N L +L E + L + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+ N L+ + +VSDFGLA+ LD T+ F + PE + + KSDV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 553 FSFGVVLLELITGRK 567
+SFGV++ E+ + K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 71/267 (26%), Positives = 101/267 (37%), Gaps = 17/267 (6%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP------PKSSPPPPPVSKPPTTSPPP 55
+ PSP PP ++ PPPP +P P P P+ P P VS+P
Sbjct: 2612 APPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLG 2671
Query: 56 SPP-ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
AS+PP A+ P S ++PP P P P + + +P PP ++
Sbjct: 2672 RAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQA 2731
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + P P + P+ P+ P + P P + PP P P +P + PP+ P
Sbjct: 2732 SPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAP-----APPAAPAAGPPRRLTRP 2786
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+S ++ P P PP P A P A P + PPP S + +PPP
Sbjct: 2787 AVASLSESRESLP--SPWDPADPPAAVLAPAAALPPAASP---AGPLPPPTSAQPTAPPP 2841
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
P G P PS
Sbjct: 2842 PPGPPPPSLPLGGSVAPGGDVRRRPPS 2868
|
Length = 3151 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 73/197 (37%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ ++ +Y+ +L L GE L V +AA A G+AY+ + +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ N +V+DFGLA+L D T R F + APE A G+ T KSDV
Sbjct: 129 RAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L EL T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKI--GGGQGEREFKA-------EVEIISRIHHR 423
L+G G FGSVY G G +A+KQ+++ + ++ E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V +G + D + +YVP ++ L+ G + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR------VMGTFGYMA 537
IIHRDIK +NIL+DN ++SDFG++K L+AN+ T + G+ +MA
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE T K+D++S G +++E++TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 373 NLLGEGGFGSVYKG----YLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
N LG G FG VY+G L G VA+K L+ G E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLA 479
+V L+G C+ ++ + +I + + L +L G P+L + I A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 480 YLHEDCHPRIIHRDIKSSNILL-----DNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
YL E H IHRD+ + N L+ D + ++ DFGLA+ + + + G
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLP 176
Query: 535 --YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571
+MAPE GK T +SDV+SFGV++ E++T G++P A
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LGEG +GSVYK + G+ VAIK + + +E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 433 ISDDRRLLIYDY-----------VPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+ ++ +Y + N TL T +IAA +GL
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTLKGL 112
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
YLH + + IHRDIK+ NILL+ +A+++DFG++ D T V+GT +MAP
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAP 168
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K+D++S G+ +E+ G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 69/197 (35%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VAIK LK G E F AE ++ ++ H LV L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +Y+ N +L L L + +AA A G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ +++DFGLA+L D T R F + APE + G T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T GR P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHH 422
D LG G G V K P G+ +A+K +++ E K E++I+ + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNS 58
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGR---PVLDWATRVKIAAGAARGL 478
++V G ++ + +Y+ +L +GR +L KIA +GL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGL 113
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYM 536
YLHE IIHRD+K SNIL+++ + ++ DFG++ ++ A T + GT YM
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYM 166
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
APE + KSD++S G+ L+EL TGR P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 34/208 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSLV 429
LGEG +G VYK G VA+K++++ E + E+ ++ + H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPR 488
++ + L+++Y + L +L P+ +K I RGLAY H H R
Sbjct: 65 DVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLS--PNLIKSIMYQLLRGLAYCHS--H-R 118
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAPE------ 539
I+HRD+K NIL++ + +++DFGLA+ + L TH V+ T Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEILLGSK 174
Query: 540 -YASSGKLTEKSDVFSFGVVLLELITGR 566
Y+++ D++S G + E+ITG+
Sbjct: 175 HYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 374 LLGEGGFGSVYKGYL-PDGREVAIKQL-KIGGGQGEREFKA-----EVEIISRI-HHRHL 425
++GEG F +V +E AIK L K Q +E K E E+++R+ H +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKR---QLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ L Y D+ L + +Y PN L ++ G LD AA L YLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSK 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-----------ALDANTHITTRVM--- 530
IIHRD+K NILLD + +++DFG AK+ N
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 531 -----GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
GT Y++PE + + SD+++ G ++ +++TG+ P S
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-24
Identities = 70/244 (28%), Positives = 87/244 (35%), Gaps = 21/244 (8%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSN---PPKSSPPPPPVSKPPTTSPPPSPPA 59
P+P PPAA ++ PP ++ P S + P + PP V P PP + PA
Sbjct: 2766 PPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPA 2825
Query: 60 SN-PPTSSSPPASSPPTSSPPPASNPPTSS----------PPPSPPASSPPTISPPPPVS 108
PP +S+ P + PP PPP S P S PP PA+ P + PP
Sbjct: 2826 GPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRR 2885
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S P P P P A PP P PP P PP R P + P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAP 2945
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P P A+ P V P + P P PS +P S PP T
Sbjct: 2946 TTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQ-------PAPSREAPASSTPPLTG 2998
Query: 229 RLSP 232
Sbjct: 2999 HSLS 3002
|
Length = 3151 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 372 QNLLGEGGFGSV--YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
+LGEG FG V Y Y P G VA+K LK GQ +K E+ I+ ++H +
Sbjct: 9 IRVLGEGHFGKVSLYC-YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 425 LVSLVGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+V G C LI +YVP +L +L + L+ A + A G+AYLH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPE 539
IHRD+ + N+LLDN+ ++ DFGLAK + + + R G F Y A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT 564
K + SDV+SFGV L EL+T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ LP+ + VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRV-----------KIAAGAA 475
G C L++++Y+ + L + HG +L V IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFG 534
G+ YL H +HRD+ + N L+ ++ DFG+++ + + + R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 374 LLGEGGFGSVYKG--YLPDGR--EVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSL 428
LG+G FG V +G G+ VA+K LK +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL------DWATRVKIAAGAARGLAYLH 482
G + +++ + P +L L + D+A ++ A G+ YL
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT----RVMGTFGYMAP 538
R IHRD+ + NILL ++ + ++ DFGL + H +V F + AP
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLIDAKILFKL 595
E + + SDV+ FGV L E+ T G +P W L ++IL K+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--------------WAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 375 LGEGGFGS--VYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG +Y+ D V K++ + + R+ E+ I+S + H ++++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 431 YCISDDRRLLI-YDYVPNNTLY------FHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+ + DD LLI +Y TLY E VL + ++ A ++Y+H+
Sbjct: 67 HFM-DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA------VSYIHK 119
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
I+HRDIK+ NI L ++ DFG++K+ + T V+GT YM+PE
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQG 175
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K KSD+++ G VL EL+T ++ DA+ PL
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +Y+ N L +L E + +++ G+AYL + IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+ N L+D+ +VSDFGL++ LD T+ V F + PE K + KSDV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 553 FSFGVVLLELIT-GRKPVD 570
++FGV++ E+ + G+ P +
Sbjct: 185 WAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 64/217 (29%), Positives = 113/217 (52%), Gaps = 22/217 (10%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---GEREFKA---EVEIISRIHHRHLV 426
+LG+G +G+VY G G+ +A+KQ+++ E+E++ EV+++ + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHE 483
+G C+ D+ + ++VP ++ L+ G PV T+ + G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----GTFGYMAP 538
+C ++HRDIK +N++L N ++ DFG A+ H T M GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
E + KSD++S G + E+ TG+ P+ + L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-23
Identities = 67/267 (25%), Positives = 89/267 (33%), Gaps = 11/267 (4%)
Query: 3 APSPGPPAANSSSP--PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A G A SS P P + PT+ +++PP P P P + S P PP
Sbjct: 2667 ARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEP-APHALVSATPLPPGP 2725
Query: 61 NPPTSSSPPASSPPTSSPPPAS--NPPTSSPPPSPPASSPPTISPPP--PVSNPPTRSPP 116
+SP + P PA P + P PP ++ P PP P + PP R
Sbjct: 2726 AAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTR 2785
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVPPQNPPPP 174
P ++ + P PA+ P P+ PP P+ PP S P PP P
Sbjct: 2786 PAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGP 2845
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P S P AP PP PA+P P + + + PP
Sbjct: 2846 PPPSLPLGGSVAPGG--DVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPD 2903
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
P P P P
Sbjct: 2904 QPERPPQPQAPPPPQPQPQPPPPPQPQ 2930
|
Length = 3151 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLV 429
++G G VY LP+ +VAIK++ + Q E + EV+ +S+ +H ++V
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ D L+ Y+ +L + R LD A + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR--VMGTFGYMAPEYASSG 544
IHRDIK+ NILL + +++DFG+ A LA + R +GT +MAPE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 545 K-LTEKSDVFSFGVVLLELITGRKP 568
K+D++SFG+ +EL TG P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 70/210 (33%), Positives = 113/210 (53%), Gaps = 18/210 (8%)
Query: 370 ADQNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
Q ++G G FG V++G L P +E VAIK LK G + +R +F +E I+ + H +
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-GEGRPVLDWATRVKIAAGAARGLAYL 481
++ L G ++I +Y+ N L Y H GE V + G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL 123
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPE 539
+ + +HRD+ + NIL+++N E +VSDFGL+++ D T+ T+ + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T SDV+SFG+V+ E+++ G +P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
++ LG G +G VY+G VA+K LK + E EF E ++ I H +LV L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +I +++ L +L R ++ + +A + + YL + I
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTE 548
HRD+ + N L+ N +V+DFGL++L + +T+ T F + APE + K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL-MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 549 KSDVFSFGVVLLELIT-GRKP---VDASQ 573
KSDV++FGV+L E+ T G P +D SQ
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 378 GGFGSVY---KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
G +G V+ K G AIK +K I Q ++ E +I+S+ ++V L
Sbjct: 4 GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPYVVKLY- 59
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
Y + L L+ +Y+P L L G LD A L YLH + I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GI 114
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLAL-------DANTHITTRVMGTFGYMAPEYAS 542
IHRD+K NIL+D+N +++DFGL+K+ L + + R++GT Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
++ D +S G +L E + G P P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 375 LGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLV 426
LG G FG V +K G+ A+K L + Q E E I+ I H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIRHPFLV 64
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L G DD L L+ +YVP L+ HL GR A + AA L YLH
Sbjct: 65 NLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA---RFYAAQVVLALEYLH-S 119
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM---GTFGYMAPEYA 541
I++RD+K N+LLD++ +++DFG AK + R GT Y+APE
Sbjct: 120 LD--IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEII 170
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
S + D ++ G+++ E++ G P P+
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G + V AA GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD++ ++SD GLA + T I RV GT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+ T D ++ G +L E+I G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
+G+G FG VYKG L EVA+K + + F E EI+ + H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ ++ + VP +L L + L ++++ AA G+ YL IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKS 550
D+ + N L+ N ++SDFG+++ + + + + + APE + G+ T +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREE-EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 551 DVFSFGVVLLELITG 565
DV+S+G++L E +
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G P D V AA GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD+ ++SD GLA + + I RV GT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+ T D + G ++ E+I G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 75/246 (30%), Positives = 105/246 (42%), Gaps = 30/246 (12%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG GGFG V R A+K +K + GQ + +E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
D + + ++ +Y L+ L G D T A YLH
Sbjct: 60 RT-FKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---G 113
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKLT 547
II+RD+K N+LLD+N ++ DFG AK L T T GT Y+APE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYD 170
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQP---------LGDESLVEWVNLID--AKILFKLV 596
D +S G++L EL+TGR P L +E+ N ID AK L K
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ- 229
Query: 597 FLCQQN 602
L ++N
Sbjct: 230 -LLRRN 234
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ P+ + VA+K LK ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG-------EGRPV--LDWATRVKIAAGAARG 477
G C+ D +++++Y+ + L + HG EG L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYM 536
+ YL +HRD+ + N L+ N ++ DFG+++ + + + M +M
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
PE K T +SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 372 QNLLGEGGFGSVYKGYL-PDG--REVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH +++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG----EGRPVLDWATR----------VKIAA 472
+L+G C L +Y P+ L L E P A + AA
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ + MG
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 184
Query: 533 FG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T SDV+S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 375 LGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ D VA+K LK ++F+ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG-------EGRPV-----LDWATRVKIAAGA 474
G C D +++++Y+ + L + HG +G+P L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTF 533
A G+ YL +HRD+ + N L+ N ++ DFG+++ + + + M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 62/199 (31%), Positives = 110/199 (55%), Gaps = 20/199 (10%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG FG+V +G Y G++VA+K +K + F E +++++HH++LV L+G I
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLG-VI 68
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ ++ + + L L GR ++ ++ + A G+ YL +++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 494 IKSSNILLDNNFEAQVSDFGLAKL---ALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+ + NIL+ + A+VSDFGLA++ +D N+ + + + APE K + KS
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVD-NSKLPVK------WTAPEALKHKKFSSKS 178
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+S+GV+L E+ + GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-22
Identities = 73/288 (25%), Positives = 94/288 (32%), Gaps = 22/288 (7%)
Query: 3 APSPGPPAANS-----SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
AP P PA S +PP + P SP PP P P PSP
Sbjct: 2574 APRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSP 2633
Query: 58 PASNPPTSSSPPASSPP----TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
A+ P P P +P S P + +S P P + P
Sbjct: 2634 AANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVG 2693
Query: 114 S------PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
S PPPP TP P + P P P+ P P + P + P+ P
Sbjct: 2694 SLTSLADPPPPPPTPEPAPHALVSATPL--PPGPAAARQASPALPAAPAPPAVPAGPATP 2751
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P + PAP A P + PP T P AS R S SP P P
Sbjct: 2752 GGPARPARPPTTAGPPAPAPPAAPAA--GPPRRLTRPAVASLSESRESLPSPWDPADPPA 2809
Query: 228 KRLSPPPGIPV---PSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
L+P +P P+ P P++P P + G+V
Sbjct: 2810 AVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVA 2857
|
Length = 3151 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 432 CISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + L I +Y+ +L +L GR VL +K + + YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRD+ + N+L+ + A+VSDFGL K A ++T T ++ + APE K + KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKL--PVKWTAPEALREKKFSTKS 180
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
++G+G FG VY G L DG+++ A+K L +I + +F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR---VKIAAG----AARGLAY 480
L+G C+ + P L + HG+ R + T VK G A+G+ Y
Sbjct: 61 LLGICLPSEG-------SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA---NTHITTRVMGTFGYMA 537
L + +HRD+ + N +LD +F +V+DFGLA+ D + H T +MA
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELIT 564
E + K T KSDV+SFGV+L EL+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 72/238 (30%), Positives = 117/238 (49%), Gaps = 37/238 (15%)
Query: 375 LGEGGFGSVY----KGYLP---------DGRE--VAIKQLKIGGGQGER-EFKAEVEIIS 418
LGEG FG V+ +G DG+ VA+K L+ + R +F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 419 RIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL----------HGEGRPVLDWATRV 468
R+ + +++ L+G C+SDD +I +Y+ N L L H P + A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITT 527
+A A G+ YL +HRD+ + N L+ N++ +++DFG+++ + + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP---LGDESLVE 582
R + +MA E GK T SDV++FGV L E+ T K QP L DE ++E
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK----EQPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 32/214 (14%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F D +G G FG+VY E VAIK++ G Q +++ EV + ++ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR----VKIAA---GAARG 477
+ G + + L+ +Y G +L+ + V+IAA GA +G
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL---------GSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLH IHRDIK+ NILL +++DFG A L AN+ + GT +MA
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179
Query: 538 PEY---ASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE G+ K DV+S G+ +EL RKP
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G +VAIK LK G E F E +I+ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +++ +L F G+G+ L V +AA A G+AY+ + IHRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERMNY---IHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
++++NIL+ +N +++DFGLA+L D T R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 40/240 (16%)
Query: 375 LGEGGFGSVY------------KGYLPDGRE-----VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ K + + VA+K L+ R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-------GEGRPVLDWATR 467
+SR+ ++ L+G C D +I +Y+ N L + H L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-IT 526
+ +A A G+ YL +HRD+ + N L+ N+ +++DFG+++ ++ + +
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP---LGDESLVE 582
R +MA E GK T KSDV++FGV L E++T R+ QP L D+ ++E
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY + +VA+K LK G + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +I +Y+ +L L + + + +A A G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++N+L+ + +++DFGLA++ D T R F + APE + G T KSDV
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T G+ P
Sbjct: 188 WSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E I+ +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G P D + AA GL L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD+ ++SD GLA + T + RV GT GYMAPE ++
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
K T D + G ++ E+I G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVG 430
++GEG +G V K G VAIK+ K + + A EV+++ ++ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
R L+++YV L L L + +AY H II
Sbjct: 68 AFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NII 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPE----YASSGK 545
HRDIK NIL+ + ++ DFG A+ L + +T V T Y APE + GK
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGK 181
Query: 546 LTEKSDVFSFGVVLLELITGR 566
DV++ G ++ EL+ G
Sbjct: 182 ---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 4e-21
Identities = 74/275 (26%), Positives = 100/275 (36%), Gaps = 18/275 (6%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP---PPSPPASNPPTSSSP 68
++ PPPP+ PP P P + P P P P S+P TS P +PP S P +
Sbjct: 2547 DAGDPPPPL--PPAAPPAAPDRSVPPPRPAPRP-SEPAVTSRARRPDAPPQSARPRAPVD 2603
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP-PTRSPPPPSSTPPPNSP 127
P +PP P T +P P PP+ SP P P P P P S
Sbjct: 2604 DRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSR 2663
Query: 128 P---SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP----- 179
P S PP P P S+ PP P P P S
Sbjct: 2664 PRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPP 2723
Query: 180 -PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP--RPSNSSPNSPPPPSTKRLSPPPGI 236
P + A A+P + PP P TP P P P+ + P +P PP+ PP +
Sbjct: 2724 GPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRL 2783
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
P+ + + + SP + P + A +
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAAL 2818
|
Length = 3151 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE----------FKAEVEIISRIHH 422
L+G+G +G VY + G +A+KQ+++ R ++E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLA 479
++V +G+ +++ + +YVP ++ L GR ++ + T + GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAP 538
YLH I+HRD+K+ N+L+D + ++SDFG++K + D + M G+ +MAP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 539 EYASSGK--LTEKSDVFSFGVVLLELITGRKP 568
E S + K D++S G V+LE+ GR+P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-21
Identities = 69/280 (24%), Positives = 94/280 (33%), Gaps = 24/280 (8%)
Query: 3 APSPGPPAANSSSPPP-PVSNP-----------PTISPPPPVSNPPKSSPPPPPVSKPPT 50
P+ P A + S PPP P P P P P P PP+
Sbjct: 2556 PPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPS 2615
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
PP + PP S SP A+ P PP P P+P S P +
Sbjct: 2616 PLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRL--GRA 2673
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
S PP P A+ PPP P P P P P+ Q
Sbjct: 2674 AQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPE--PAPHALVSATPLPPGPAAARQA 2731
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
P P++ +PPA A P + P PPT A P AP P + PP RL
Sbjct: 2732 SPALPAAP----APPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPR----RL 2783
Query: 231 SPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
+ P + + + + +P+ P ++ + A +
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAAS 2823
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-21
Identities = 73/285 (25%), Positives = 98/285 (34%), Gaps = 32/285 (11%)
Query: 3 APSPGP-PAANSSSPPPPVSNPPTISPPPPVSNP--------------------PKSSPP 41
AP PG + +PP P P I P PV P PP
Sbjct: 2495 APDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGDPPPP 2554
Query: 42 PPPVSKPPTT--SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP + P S PP PA P + + P + P A P +PP
Sbjct: 2555 LPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPP 2614
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
SP PP ++ P PPPPS +P N P P P + P+ P
Sbjct: 2615 --SPLPPDTHAP--DPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRL 2670
Query: 160 KRSP-PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP-PTQTPPTPASPIAPRPSNS 217
R+ S PPQ P ++ P +A PP P P P A+P+ P P+ +
Sbjct: 2671 GRAAQASSPPQRPRRR--AARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAA 2728
Query: 218 SPNSPPPPSTKRLSPPPGIPV-PSTENTPGNGTNPSSPESSSSPS 261
SP P+ P P P P + P + + P+
Sbjct: 2729 RQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPA 2773
|
Length = 3151 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRH 424
+ + + LGEG GSV K L + + + + ++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 425 LVSLVGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRV------KIAAGAAR 476
+V G + + + +Y +L + V R+ KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFG 534
GL+YLH +IIHRDIK SNILL + ++ DFG++ ++ A T GT
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV--DASQPLGDESLVEWV 584
YMAPE + SDV+S G+ LLE+ R P + PLG L+ ++
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 73/211 (34%), Positives = 115/211 (54%), Gaps = 23/211 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREV----AIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
+LG G FG+VYKG ++P+G V AIK L + G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHGE---GRPVLDWATRVKIAAGAARGLAYLH 482
L+G C+S +L + +P+ L Y H H + + +L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYA 541
E R++HRD+ + N+L+ + +++DFGLA+L D + +MA E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571
K T +SDV+S+GV + EL+T G KP D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+V+L + D L+ + L FH++ G P + + AA GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
++RD+K NILLD+ ++SD GLA + + I RV GT GYMAPE ++
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNNQ 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ T D + G ++ E+I G+ P +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 371 DQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++N++ G G+ YKG + +G + +K++ E + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G C S+ LI++Y+ L L L W R KIA G A+ L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+ ++ I++D E + +L+L T+ + Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
SD++ FG++L+EL+TG+ P DA S+VEW
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFG-VHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
F +G+G FG VYK + VAIK + + + E E E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
G +L +I +Y + L G+ LD I GL YLHE+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSC-LDLLKPGK--LDETYIAFILREVLLGLEYLHEE- 117
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSG 544
IHRDIK++NILL + +++DFG++ +L + T +GT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQS 173
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
EK+D++S G+ +EL G P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 391 GREVAIKQLKIGGGQGERE---FKAEVEIISRIHHRHLVSLV--GYCISDDRRLLIYDYV 445
G EVAIK L+ + E + F+ E + +R++H ++V+L+ G +++YV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---D 502
P TL L +G L ++ LA H I+HRD+K NI++
Sbjct: 62 PGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 503 NNFEAQVSDFGLAKL------ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFG 556
A+V DFG+ L A A TT V+GT Y APE +T SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 557 VVLLELITGRKPV 569
++ LE +TG++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 375 LGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
LGEG FG V K VA+K LK E R+ +E ++ +++H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-----------------------LDW 464
L G C D LLI +Y +L L E R V L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLR-ESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
+ A +RG+ YL E +++HRD+ + N+L+ + ++SDFGL++ + +++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 525 IT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+ ++ +MA E T +SDV+SFGV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 30/215 (13%)
Query: 372 QNLLGEGGFGSVYKGYLP-DGREV--AIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
++++GEG FG V + + DG ++ AIK LK + + R+F E+E++ ++ HH +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIA 471
+L+G C + + +Y P L L HG L ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLLQFA 125
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
+ A G+ YL E + IHRD+ + N+L+ N ++++DFGL++ + MG
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178
Query: 532 TFG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 44/218 (20%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRIHHRHLV 426
LGEG + VYK GR VAIK++K+G + ++ F A E++++ + H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 427 SLVGYCISDDRRLLIYDYVP--------NNTLYFHLHGEGRPVLDWATRVK-IAAGAARG 477
L+ L+++++ + ++ +K RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT-----------PADIKSYMLMTLRG 114
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L YLH + I+HRD+K +N+L+ ++ +++DFGLA+ N +T +V+ T Y A
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 538 PE-------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE Y D++S G + EL+ R P
Sbjct: 171 PELLFGARHYGVG------VDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 23/222 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGRE----VAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVS 427
LLG G FG+V+KG ++P+G VAIK ++ G Q +E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLH---GEGRP--VLDWATRVKIAAGAARGLAYLH 482
L+G C +L + P +L H+ P +L+W ++ A+G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYA 541
E ++HR++ + NILL ++ Q++DFG+A L D + + +MA E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582
G+ T +SDV+S+GV + E+++ G +P +P L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FG V KG Y ++ VAIK LK + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C ++ +L+ + L L G+ + + + V++ + G+ YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTF--GYMAPEYASSGKLT 547
HRD+ + N+LL N A++SDFGL+K AL A +++ R G + + APE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
+SDV+S+G+ + E + G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-19
Identities = 49/213 (23%), Positives = 70/213 (32%), Gaps = 3/213 (1%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP 79
V P + P SS PP ++P + P +P A P +++ PA + +P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPG 646
Query: 80 PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP---PA 136
A+ P AS P P PP P+ P + P+ P PA
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPA 706
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
+PP PP ++ SP + P PP P P PA PP+ P
Sbjct: 707 ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAP 766
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
P P+ P +R
Sbjct: 767 AAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRR 799
|
Length = 824 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-19
Identities = 60/276 (21%), Positives = 92/276 (33%), Gaps = 10/276 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP-PPSPPAS 60
SP PP +S PPPP P + P P P P P + P + PA+
Sbjct: 102 REGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAA 161
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP-PS 119
++S ++ P SSP + P+S P PP++ P SP PP + P + P+
Sbjct: 162 VASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPA 221
Query: 120 STPPPNSPPSPPSDPPANSPPPS-----NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P ++ + +S S P + P P P+ + P R + P
Sbjct: 222 PAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSR 281
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP---PPPSTKRLS 231
P + +SP P + P AS + SS +S S
Sbjct: 282 PGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAV 341
Query: 232 PPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGT 267
P P S + S + +
Sbjct: 342 SPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSS 377
|
Length = 1352 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 47/244 (19%)
Query: 357 FTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLK-IGGGQGEREFKAEV 414
FT E+L D +G G FG+V K + P G +A+K+++ + ++ ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 415 EIISRIHHRHLVSLV---------GYC--------ISDDRRLLIYDYVPNNTLYFHLHGE 457
+++ R +V G C IS D+ Y +++
Sbjct: 54 DVVMR--SSDCPYIVKFYGALFREGDCWICMELMDISLDK------------FYKYVYEV 99
Query: 458 GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517
+ V+ KIA + L YL E+ IIHRD+K SNILLD N ++ DFG++
Sbjct: 100 LKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 518 ALDANTHITTRVMGTFGYMAPE-YASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+D+ TR G YMAPE S +SDV+S G+ L E+ TG+ P
Sbjct: 158 LVDSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
Query: 575 LGDE 578
+ D+
Sbjct: 216 VFDQ 219
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 45/230 (19%), Positives = 73/230 (31%), Gaps = 14/230 (6%)
Query: 1 MSAPSPGPPAANSSSPPP---PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
M A PG + PV+ P + P + P ++PP P + P +
Sbjct: 360 MLAFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAP-AAAPAAAAAARA 418
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
A+ P S P + +P P+P A+ P P +
Sbjct: 419 VAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAA 478
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
P +P + P+ + PP P P P+ + +P ++ P P ++
Sbjct: 479 A---PARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDA---APAGWVAESIPDPATA 532
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P A + P T P APRP +S + P
Sbjct: 533 DPDDAFETLAPAPAAAPAPRAAAATEPVV----APRPPRASASGLPDMFD 578
|
Length = 700 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 374 LLGEGGFGSVYKGYL--PDGR--EVAIKQLKIGG-GQGE-REFKAEVEIISRIHHRHLVS 427
+LGEG FGSV +G L DG +VA+K +K+ E EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 428 LVGYCISDDRR------LLIYDYVPNNTLY---FHLHGEGRPV-LDWATRVKIAAGAARG 477
L+G C ++I ++ + L+ + G P L T +K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYM 536
+ YL IHRD+ + N +L + V+DFGL+K + + R+ ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
A E + T KSDV++FGV + E+ T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 17/212 (8%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYC 432
LG G GSV K ++P G +A K + IG ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----KIAAGAARGLAYLHEDCHPR 488
++++ + +++ +L ++ +G P+ V KIA GL YL+ + H R
Sbjct: 73 LNENNICMCMEFMDCGSLD-RIYKKGGPI-----PVEILGKIAVAVVEGLTYLY-NVH-R 124
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I+HRDIK SNIL+++ + ++ DFG++ +++ I +GT YM+PE GK T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTV 181
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESL 580
KSDV+S G+ ++EL G+ P S D
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 41/222 (18%), Positives = 60/222 (27%), Gaps = 10/222 (4%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNP----PKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P + + P + P P P + P P + PP + P + A+ P
Sbjct: 365 PGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPA 424
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP--PPVSNPPTRSPPPPSST 121
S P + +P P+P A+ P P + P +
Sbjct: 425 RRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAA 484
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P+ PP PP P P P S+P P +
Sbjct: 485 PAAAPAPADDDPPPWEELPPEFA---SPAPAQPDAAPAGWVAESIPDPATADPDDAFETL 541
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PA P + P P P A + P
Sbjct: 542 APAPAAAPAPRAAAATEP-VVAPRPPRASASGLPDMFDGDWP 582
|
Length = 700 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 373 NLLGEGGFGSVYKGYLP-DGREV--AIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLVS 427
+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIAA 472
L+G C L +Y P+ L L + L + AA
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAA 119
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ + MG
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 172
Query: 533 FG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V +G L P RE VAIK LK G + +R +F +E I+ + H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHED 484
L G ++I +++ N L F +G+ V+ V + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRVMG---TFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL++ D + T T +G + APE
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T SDV+S+G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKI----GGGQGE--REFKAEVEIISRIHHRHLV 426
LG G F S Y+ + G +A+KQ+ Q E + E+ +++R++H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
++G D L +++ ++ L G A + RGL+YLHE+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 487 PRIIHRDIKSSNILLDNNFE-AQVSDFGLA-KLALDAN--THITTRVMGTFGYMAPEYAS 542
+IIHRD+K +N+L+D+ + +++DFG A +LA +++GT +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDA 571
+ DV+S G V++E+ T + P +A
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + G+ A K+L ++ +G E I++++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y L L+ + L +H++ E P A GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
RII+RD+K N+LLDN+ ++SD GLA D + T GT G+MAPE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D F+ GV L E+I R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 24/222 (10%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLHGE---GRPVLDWATRVKI 470
+++ + + H+ L+G C++ +L I +P L Y H + + +L+W ++
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRV 529
A+G+ YL E R++HRD+ + N+L+ +++DFGLAK L D +
Sbjct: 119 ----AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVD 570
+MA E T +SDV+S+GV + EL+T G KP D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
LLG+G FG V+KG L D VA+K K Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-EDCHPRIIH 491
++ + VP L + + L VK A AA G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD+ + N L+ N ++SDFG+++ D + + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 552 VFSFGVVLLE 561
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-19
Identities = 43/210 (20%), Positives = 69/210 (32%), Gaps = 7/210 (3%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP-PASN 61
A +P A +++ P + P P P + P ++ + P SP P A+
Sbjct: 378 AAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAAR 437
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
++ P + P +P A P ++ P + + P P +P P
Sbjct: 438 QASARGPGGAPAPAPAPAAA--PAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDD 495
Query: 122 PPP--NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV--PPQNPPPPPSS 177
PPP PP S PA P P++ +P P P P ++
Sbjct: 496 PPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAA 555
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
+ P P S +P P A
Sbjct: 556 ATEPVVAPRPPRASASGLPDMFDGDWPALA 585
|
Length = 700 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 44/208 (21%), Positives = 72/208 (34%), Gaps = 6/208 (2%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
+ P + P P+P A+ P ++ PA+ P + PA+ + +P SP
Sbjct: 372 AGPATAAAAPVAQ---PAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSP 428
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
+ P+ P P + P+ + P A P P + P +
Sbjct: 429 APEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAA 488
Query: 159 PKRSPPSVPP-QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
P + PP + PP +S P AP ++P P T P +AP P+ +
Sbjct: 489 PAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAA 548
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+P + P P S P
Sbjct: 549 P--APRAAAATEPVVAPRPPRASASGLP 574
|
Length = 700 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 375 LGEGGFGSV-YKGYLPDG----REVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P+G +VA+K LK GG + K E+EI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C D LI +++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT---RVMGTFGYMAPEYASS 543
+ +HRD+ + N+L+++ + ++ DFGL K + T F Y APE
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 544 GKLTEKSDVFSFGVVLLELIT 564
K SDV+SFGV L EL+T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V G L P RE VAIK LK G + +R +F +E I+ + H +++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L G +++ +Y+ N +L + H V+ V + G A G+ YL +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSDM 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG--YMAPEYAS 542
+ +HRD+ + NIL+++N +VSDFGL+++ D T G + APE +
Sbjct: 126 GY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
K T SDV+S+G+V+ E+++ G +P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-18
Identities = 47/219 (21%), Positives = 69/219 (31%), Gaps = 4/219 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P AA PP P S+ P P + P P P + P+ ++ P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAA---PAAPAAPAPAGAAAAPAEASAAP 643
Query: 63 PTSSSPPASSP-PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ P P + P + A + P +P P P + P +
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAP 703
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P +PP+ +D PA PP + ++ P P P P P P PP
Sbjct: 704 APAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPA 763
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
+P A A P PP + +P
Sbjct: 764 PAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDAE 802
|
Length = 824 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 54/204 (26%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 374 LLGEGGFGSVY--KGYLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLV 429
++G G FG V+ + D + V IKQ+ + + A E +++ + H +++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ D +++ +Y P TL ++ +LD T + L ++H I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 490 IHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRD+K+ NILLD + ++ DFG++K+ L + + T V+GT Y++PE +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISPELCEGKPYNQ 180
Query: 549 KSDVFSFGVVLLELITGRKPVDAS 572
KSD+++ G VL EL + ++ +A+
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++ +LG+G +G VY L +AIK++ + + E+ + S + HR++V +
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLD-WATRVKIAAGAARGLAYLHEDCHPR 488
G + + + VP +L L + P+ D T + GL YLH++ +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 489 IIHRDIKSSNILLDNNFEA--QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK- 545
I+HRDIK N+L+ N + ++SDFG +K N T GT YMAPE G
Sbjct: 129 IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPR 186
Query: 546 -LTEKSDVFSFGVVLLELITGRKP 568
+D++S G ++E+ TG+ P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 375 LGEGGFGSVYKGYL----PDGREVAIKQLKIGGGQG-ER-EFKAEVEIISRIHHRHLVSL 428
+GEG FG K L DG++ IK++ I ER E + EV ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 429 VGYCISDDRRLLIY---DYVPNNTLYFHLHGEG------RPVLDWATRVKIAAGAARGLA 479
Y S + +Y DY LY ++ + +LDW ++ +A L
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LK 115
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H+ +I+HRDIKS NI L + ++ DFG+A++ L++ + +GT Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPE 171
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT 564
+ KSD+++ G VL E+ T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 70/213 (32%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 375 LGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHR-HL 425
LG G +G V+ G G+ A+K LK + + + E +++ + L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
V+L Y D +L LI DYV L+ HL+ RV IA L +LH+
Sbjct: 68 VTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAE-IVLALDHLHQ- 123
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
II+RDIK NILLD+ ++DFGL+K L GT YMAPE G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 545 KLTEKS--DVFSFGVVLLELITGRKP--VDASQ 573
D +S GV+ EL+TG P VD Q
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427
+LG G FG+VYKG ++PDG VAIK L+ + +E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLH 482
L+G C++ +L + +P L ++ + +L+W ++ A+G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTHITTRVMGTFGYMAPEYA 541
E R++HRD+ + N+L+ + +++DFGLA+L +D + +MA E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573
+ T +SDV+S+GV + EL+T G KP D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 374 LLGEGGFGSVYKG-YL---PDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
+GEG FG VY+G Y+ + VA+K K RE F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G +++ ++ + P L +L + LD A+ + + + LAYL R
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRDI + N+L+ + ++ DFGL++ D + + ++ +MAPE + + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 549 KSDVFSFGVVLLE-LITGRKP 568
SDV+ FGV + E L+ G KP
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-18
Identities = 50/213 (23%), Positives = 76/213 (35%), Gaps = 9/213 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A GPPA SS PP + P + P + P + P +P + P +
Sbjct: 594 AAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHH 653
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + P AS P A ++PPP+P ++P + P P + PP+
Sbjct: 654 PKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAG- 712
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ PP S P +P PP P P+ PP P P P+++P
Sbjct: 713 QADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAA 772
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
PP+P P + A +
Sbjct: 773 APPPSP--------PSEEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-18
Identities = 57/264 (21%), Positives = 81/264 (30%), Gaps = 8/264 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S A SSP P + PP S PP ++ P PP P ++ SP +
Sbjct: 165 DAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAP 224
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+++ +S SS +S P P P P
Sbjct: 225 GRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGP 284
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+S P S P+ PS+P S P P + S S SS
Sbjct: 285 ASSSSSPRERSPSPS----PSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAA 340
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS----SPNSPPPPSTKRLSPPPGIP 237
SP + PS PPP P +P P + S S P +
Sbjct: 341 VSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARR 400
Query: 238 VPSTENTPGNGTNPSSPESSSSPS 261
+T P PS ++ ++
Sbjct: 401 RDATGRFPAGRPRPSPLDAGAASG 424
|
Length = 1352 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-18
Identities = 43/221 (19%), Positives = 66/221 (29%), Gaps = 10/221 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
+ P + P + P P + P +PPA+ PA++ A+ P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAA----APAAAAAA--RAVAAAPAR 425
Query: 87 SSPPPSP-PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
SP P A+ + P P P++ P + P A + P P
Sbjct: 426 RSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAP 485
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
+ P P P + PP P P A P+ P
Sbjct: 486 AAAPAPADDDPPPWEELPPEFA---SPAPAQPDAAPAGWVAESIPDPATADPDDAFETLA 542
Query: 206 PASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPG 246
PA AP P ++ P + G+P + P
Sbjct: 543 PAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMFDGDWPA 583
|
Length = 700 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 375 LGEGGFGSVYKG--YLP---DGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGE FG +YKG YLP + VAIK LK I Q EF+ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIAAG 473
+G + ++++Y+ L+ L G + LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGT 532
A G+ YL +H+D+ + NIL+ ++SD GL++ A+ + + + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE GK + SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 32/236 (13%)
Query: 375 LGEGGFGSVY------------KGYLPDGRE-----VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ K + D VA+K L+ + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-------GEGRPVLDWATR 467
+SR+ +++ L+ CI+ D +I +Y+ N L + H + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-IT 526
+ +A A G+ YL +HRD+ + N L+ N+ +++DFG+++ + + I
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
R + +M+ E GK T SDV++FGV L E++T K SQ L DE ++E
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ-LSDEQVIE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + + G+ A K+L ++ GE+ E EI+ +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
S L+ + L +H++ G L+ + +A G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+RD+K N+LLD+ ++SD GLA D T T+ GT GYMAPE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 551 DVFSFGVVLLELITGRKP 568
D F+ G + E++ GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G +G VYK + G VAIK +K+ G + E+ ++ H ++V+ G
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA---AGAARGLAYLHEDCHP 487
+ D+ ++ +Y +L P+ + ++IA +GLAYLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAYLHET--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-----NTHITTRVMGTFGYMAPEYA- 541
IHRDIK +NILL + + +++DFG++ L A + I GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ-LTATIAKRKSFI-----GTPYWMAPEVAA 174
Query: 542 --SSGKLTEKSDVFSFGVVLLELITGRKP 568
G K D+++ G+ +EL + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 9e-18
Identities = 58/204 (28%), Positives = 71/204 (34%), Gaps = 24/204 (11%)
Query: 2 SAPSPGPPAANSSSPP---PPVSNPPTISPPPPVSNPPKSSPPPPPVS------------ 46
S P P A +P PP ++P PPP + P PPP P
Sbjct: 2800 SPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPG 2859
Query: 47 -----KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+PP+ SP P A P + S+ A P PP P A PP
Sbjct: 2860 GDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQP 2919
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP-PANSPPPSNPPSNLPPPPPSSVEPPK 160
P PP P PPPP P P P +P +DP A P + P L P V P+
Sbjct: 2920 QPQPPPPPQPQPPPPPP---PRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPR 2976
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSP 184
P P P S+ P
Sbjct: 2977 FRVPQPAPSREAPASSTPPLTGHS 3000
|
Length = 3151 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGY 431
L+G G +G+VY+G +P GR VA+K + + + + + EV ++S++ ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 432 --CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
RL +I +Y ++ + + P+ + V I L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV-IIREVLVALKYIHKV---G 121
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+IHRDIK++NIL+ N ++ DFG+A L L+ N+ + +GT +MAPE + GK +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 549 -KSDVFSFGVVLLELITGRKP 568
K+D++S G+ + E+ TG P
Sbjct: 181 TKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 45/206 (21%), Positives = 70/206 (33%), Gaps = 12/206 (5%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ P T+++ P + P ++ PA+ P + PP+ PA++P + V+ P R P P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPE 431
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ + P P P P ++ P P V P ++P
Sbjct: 432 ALAAARQ--ASARGPGGAPAPAPAP----AAAPAAAARPAAAGPRPVAAAAAAAPARAAP 485
Query: 180 PKNSPPAPIAVPPSNVPPP------PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
PA PP PP P Q PA +A + + P P
Sbjct: 486 AAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAP 545
Query: 234 PGIPVPSTENTPGNGTNPSSPESSSS 259
P P P P +S+S
Sbjct: 546 AAAPAPRAAAATEPVVAPRPPRASAS 571
|
Length = 700 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VAIK + G E +F E +++ ++ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +++ N L +L + + L + + G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFS 554
+ N L+ + +VSDFG+ + LD ++ + PE + K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 555 FGVVLLELIT-GRKP 568
FGV++ E+ T G+ P
Sbjct: 187 FGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 30/213 (14%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F + +G G FG+VY E VA+K++ G Q +++ EV+ + ++ H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 425 LVSLVGYCISDDRRLLIYDYV---PNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+ G + + L+ +Y ++ L H +P+ + V+IAA GA +GL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQE----VEIAAITHGALQGL 134
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
AYLH +IHRDIK+ NILL + +++DFG A + AN+ + GT +MAP
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186
Query: 539 EY---ASSGKLTEKSDVFSFGVVLLELITGRKP 568
E G+ K DV+S G+ +EL RKP
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFK---AEVEIISRIHH 422
F D +G G FG+VY + D R VAIK++ G Q +++ EV+ + RI H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGLA 479
+ + G + + L+ +Y + L +P+ + V+IAA GA +GLA
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDL-LEVHKKPLQE----VEIAAITHGALQGLA 139
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
YLH +IHRDIK+ NILL + +++DFG A +A AN+ + GT +MAPE
Sbjct: 140 YLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPE 191
Query: 540 Y---ASSGKLTEKSDVFSFGVVLLELITGRKPV 569
G+ K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 375 LGEGGFGSVYK----GYLPDGRE--VAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427
+G+G FG V++ G LP VA+K LK + +F+ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 428 LVGYCISDDRRLLIYDYV--------------------PNNTLYFHLHGEGRPVLDWATR 467
L+G C L+++Y+ ++T G L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-------LALD 520
+ IA A G+AYL E + +HRD+ + N L+ N +++DFGL++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
N I R +M PE + T +SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 31/252 (12%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG-----EGRPVLDWAT---RVKIAAGAARGLA 479
L+G L+I + + L +L E PV + +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMAP 538
YL+ + + +HRD+ + N ++ +F ++ DFG+ + + + + + + +M+P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV---NLIDA----- 589
E G T SDV+SFGVVL E+ T +P Q + +E ++ +V L+D
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---QGMSNEQVLRFVMEGGLLDKPDNCP 247
Query: 590 KILFKLVFLCQQ 601
+LF+L+ +C Q
Sbjct: 248 DMLFELMRMCWQ 259
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
+GEG +G VYK G VAIK++K+ A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRII 490
L+++++ + LY + R + + + +K +GLA+ H I+
Sbjct: 67 FRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPE--SLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L++ +++DFGLA+ T V+ T Y APE +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTP 179
Query: 550 SDVFSFGVVLLELITGR 566
D++S G + EL++ R
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
L+G G +G VYKG ++ G+ AIK + + G + E E K E+ ++ + HHR++ + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 432 CIS------DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
I DD+ L+ ++ ++ + L I RGL++LH+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
++IHRDIK N+LL N E ++ DFG++ LD +GT +MAPE + +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 546 LTE-----KSDVFSFGVVLLELITGRKPVDASQPL 575
+ KSD++S G+ +E+ G P+ P+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A KQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D ++ L I+ +Y+P ++ L G L + K G++YLH +
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTR-VMGTFGYMAPEYAS 542
I+HRDIK +NIL D+ ++ DFG +K L + R V GT +M+PE S
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
K+DV+S G ++E++T + P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 19/207 (9%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG G FG VY Y D GRE+A+KQ+ E +E A E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D +++L I+ +Y+P ++ L G + + TR + +G++YLH +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTR-RYTRQILQGVSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD---ANTHITTRVMGTFGYMAPEYA 541
I+HRDIK +NIL D+ ++ DFG +K + T I + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
S K+DV+S ++E++T + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKI----GGGQGEREFKAEVEIISRI 420
F + +G+G F VYK L DGR VA+K+++I + K E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF---HLHGEGRPVLD---WATRVKIAAGA 474
H +++ + I ++ ++ + L H + R + + W V++
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC--- 116
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
L ++H RI+HRDIK +N+ + ++ D GL + + T ++GT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPY 171
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
YM+PE KSD++S G +L E+ + P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQ--LKIGGGQGEREFKAEVEIISRIHHRHLVSL--- 428
+GEG G V+K G VA+K+ L+ G + E++ + H ++V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 429 --VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G L+ +Y+P+ L L E RP+ + + +G+AY+H +
Sbjct: 68 FPHGSGFV-----LVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN-- 118
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--YASSG 544
I+HRD+K +N+L+ + +++DFGLA+L + + + + T Y APE Y +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR- 176
Query: 545 KLTEKSDVFSFGVVLLELITGR 566
K D+++ G + EL+ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-17
Identities = 64/289 (22%), Positives = 97/289 (33%), Gaps = 33/289 (11%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A A + P + PP +N +S+P + P + P
Sbjct: 51 AAVTVVAGAAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPG 110
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P+S PP +PP +SPPP+ P S + PP + PP P S
Sbjct: 111 PSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASP---AAVASDAA 167
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P S P + PS+PP+ PP P + P+ S P P+ +P ++
Sbjct: 168 SSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRS 227
Query: 183 S------------------------------PPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
+ PAPI +P P + P +
Sbjct: 228 AADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASS 287
Query: 213 RPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
S + P PS+ P P P S+ ++ ++ SS SSS S
Sbjct: 288 SSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESS 336
|
Length = 1352 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLV 429
Q +LG G G+VYK Y L R +A+K + + + +++ +E+EI+ + +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 430 GYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G ++R + +++ +L Y + VL +IA +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI---PEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+I+HRD+K SN+L++ + ++ DFG++ +++ I +GT YMAPE S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYG 171
Query: 548 EKSDVFSFGVVLLELITGRKP 568
SDV+S G+ +EL GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 66/247 (26%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE-----------------VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ + + ++ VA+K L+ + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH------GEGR--------- 459
+SR+ +++ L+G C+ +D +I +Y+ N L + H G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LA 518
P + +++ + +A A G+ YL +HRD+ + N L+ N +++DFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG-- 576
I R + +MA E GK T SDV++FGV L E++ + QP G
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGEL 245
Query: 577 -DESLVE 582
DE ++E
Sbjct: 246 TDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 374 LLGEGGFGSVYKGYLPDGRE------VAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLV 426
LG G FG V+ E V +K L K + EF+ E+++ ++ H+++V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL-------HGEGRPVLDWATRVKIAAGAARGLA 479
L+G C + +I +Y L L P L +V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+L R +HRD+ + N L+ + E +VS L+K ++ + + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582
+ KSDV+SFGV++ E+ T G P L DE ++
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPF---YGLSDEEVLN 229
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 40/221 (18%)
Query: 374 LLGEGGFGSVYKGYL-----PDGR-EVAIKQLKIGGGQGEREFK---AEVEIISRI-HHR 423
LGEG FG V K P+ VA+K LK E++ +E+E++ I H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR---------------V 468
++++L+G C + ++ +Y + L L RP ++A+ V
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI--- 525
A ARG+ +L + IHRD+ + N+L+ + +++DFGLA+ D + HI
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR---DIH-HIDYY 188
Query: 526 --TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
TT +MAPE T +SDV+SFGV+L E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 57/248 (22%), Positives = 78/248 (31%), Gaps = 8/248 (3%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P + PP SP S+ S P+S P T+ PS P + P
Sbjct: 134 LSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEP 193
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPP--------ASSPPTISPPPPVSNPPTRS 114
P S+ P A+SP + SSP P+P ASS + S +
Sbjct: 194 PPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPEN 253
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P P P N P P++ P P S P P P
Sbjct: 254 ECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPR 313
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
SSS + + + S+ P P+ +P PS P + P KR P
Sbjct: 314 ASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSR 373
Query: 235 GIPVPSTE 242
P+
Sbjct: 374 APSSPAAS 381
|
Length = 1352 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++I + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+++ ++ ++ L + R + + R + L +LH ++IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPEYA-----SSGKLT 547
+K+ NILL + + +++DFG+ AK T +GT +MAPE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ L+EL P P+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK---------IGGGQGEREFKAEVEIISRIHHR 423
+LG+G FG V L E+ A+K LK + E+ A H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L + DR + +YV L FH+ GR D AA GL +LHE
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHE 114
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTHITTRVMGTFGYMAPEYAS 542
II+RD+K N+LLD+ +++DFG+ K L T T+ GT Y+APE S
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDA 571
D ++ GV+L E++ G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
++GEG +G VYK + G+ VAIK + I + E E K E I+ + +H ++ + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 432 CISDDRRLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVK-------------IAAGAARG 477
I + ++ L+ + G V D ++ I RG
Sbjct: 72 FIKKNPP------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLHE+ ++IHRDIK NILL N E ++ DFG++ LD+ +GT +MA
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMA 181
Query: 538 PEY-ASSGKLTE----KSDVFSFGVVLLELITGRKP 568
PE A + +SDV+S G+ +EL G+ P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG VY+G +VA+K L + Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR------VKIAAGAARGLA 479
V L+G R ++ + + L L E RP + + + A A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTH-ITTRVMGTFGY 535
YL E+ IHRDI + N LL A+++DFG+A+ A+ + R M +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE G T K+DV+SFGV+L E+ + G P
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFK---AEVEIISRIHH 422
F+D +G G FG+VY + D R VAIK++ G Q +++ EV + ++ H
Sbjct: 17 FSDLREIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 423 RHLVSLVGYCISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+ + G + + L+ +Y + + + +H + ++ A + GA +GLAYL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY- 540
H +IHRD+K+ NILL ++ DFG A + AN + GT +MAPE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 541 --ASSGKLTEKSDVFSFGVVLLELITGRKPV 569
G+ K DV+S G+ +EL + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GRE-----VAIKQLKIGGGQGERE-FKAEVEIISRI-HHRHLV 426
LG G FG V + + VA+K LK ERE +E++I+S + +H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDC 485
+L+G C L+I +Y L L + L + + A+G+A+L ++C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI---TTRVMGTFGYMAPEYAS 542
IHRD+ + N+LL + ++ DFGLA+ ++ + ++ R+ +MAPE
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216
Query: 543 SGKLTEKSDVFSFGVVLLELIT 564
+ T +SDV+S+G++L E+ +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 51/245 (20%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGERE-FKA----EVEIISRI 420
D F +GEG +G VYK D G VA+K++++ E+E F E++I+ ++
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKILRQL 63
Query: 421 HHRHLVSLVGYCISDDRRL----------LIYDYVPNNTLYF-----------HLHGEGR 459
+HR++V+L L L+++Y+ ++ + H+ +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKL- 517
+L+ GL Y CH + +HRDIK SNILL+N + +++DFGLA+L
Sbjct: 124 QLLE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 518 ALDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ + T +V+ T Y PE + DV+S G +L EL T + A+Q L
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
Query: 577 DESLV 581
L+
Sbjct: 226 QLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 375 LGEGGFGSVYKGYLPDGR---EVAIKQLKIG-GGQGERE-FKAEVEIISRIHHRHLVSLV 429
LGEG FGSV +G L +VA+K +KI + E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 430 GYCISDDRR------LLIYDYVPNNTLYFHLH----GEGRPVLDWATRVKIAAGAARGLA 479
G C+ ++I ++ + L+ L G+ L VK A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYMAP 538
YL IHRD+ + N +L+ N V+DFGL+K + + + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
E + T KSDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 21/208 (10%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A+KQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D +R L I+ +++P ++ L G + + TR K G++YLH +
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTR-KYTRQILEGVSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK----LALDANTHITTRVMGTFGYMAPEY 540
I+HRDIK +NIL D+ ++ DFG +K + L + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPEV 180
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K+D++S G ++E++T + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 28/134 (20%), Positives = 36/134 (26%), Gaps = 3/134 (2%)
Query: 78 PPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
P P +S + + S PP SS P+ P P
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP-PQNPPPPPSSSPPKNSPPAPIAVPPSN 194
+ PS+ P +P P P PPPPP P S P S
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 195 VPPPPTQTPPTPAS 208
P P +
Sbjct: 267 TPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 378 GGFGSVYKGY-LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
G FGSVY G AIK LK I Q KAE I+ V+ + Y
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 433 I-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S D L+ +Y+ + G DWA + A G+ LH+ IIH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GIIH 120
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RDIK N+L+D +++DFGL++ L + +GT Y+APE + SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 552 VFSFGVVLLELITGRKPVDASQP 574
+S G V+ E + G P A P
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 12/139 (8%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A + A +P P + P +P + P + P + P P +PPA
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPA-- 424
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P ++P ++P A P ++P A +PP + P V+ P +P P ++
Sbjct: 425 -------PVAAPAAAAPAAA---PAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVAS 474
Query: 122 PPPNSPPSPPSDPPANSPP 140
P +P + +
Sbjct: 475 AAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 368 GFADQNLLGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQGE-------REFKAEVEII 417
+ + +G G +G VYK DG+E AIK+ K Q RE + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALL 56
Query: 418 SRIHHRHLVSLVGYCISD-DRRL-LIYDYVPNNTLY---FHLHGEGRPVLDWATRVKIAA 472
+ H ++VSLV + D+ + L++DY ++ FH + + + +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPP-SMVKSLLW 115
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLA-------KLALDA 521
G+ YLH + ++HRD+K +NIL+ + + D GLA K D
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 522 NTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELIT 564
+ V+ T Y APE + T+ D+++ G + EL+T
Sbjct: 173 D-----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 43/217 (19%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHH-RHLVSLVG 430
+G G G VYK + G +A+KQ+ + G + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 431 YCISD--------------DRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
Y I+D D+ L I +P + L G K+
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDIL-------G----------KMTVAIV 124
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ L YL E H +IHRD+K SNILLD + ++ DFG++ +D+ TR G Y
Sbjct: 125 KALHYLKEK-H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAY 180
Query: 536 MAPEYASSGKLTEK----SDVFSFGVVLLELITGRKP 568
MAPE K +DV+S G+ L+EL TG+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLV 429
+G G FG V+ A+K + I + E+ E ++ + H ++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 430 GYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ D+R L + +YVP L+ +L GR +T + A+ L YLH
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
I++RD+K NILLD +++DFG AK D T + GT Y+APE S
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHN 176
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ D ++ G+++ E++ G P P G
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 374 LLGEGGFGSVYKGYLPDGRE----VAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG+GG+G V++ G + A+K LK + + KAE I+ + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA----TRVKIAAGAARGLAY 480
V L+ Y +L LI +Y+ L+ HL EG + D A + + +A L +
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
LH II+RD+K NILLD +++DFGL K ++ T +T GT YMAPE
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEI 171
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
+ D +S G ++ +++TG P A
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ +VA+K +K G E F AE ++ + H LV L ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +++ +L L + + +A A G+A++ + + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ + +++DFGLA++ D T R F + APE + G T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L+E++T GR P
Sbjct: 187 WSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGG--GQGERE-FKAE---VEIISRIHHRHLVS 427
LG G FG V Y G AIK LK G + E E E E + H LV+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L ++D + +Y L H+H + V V AA GL YLHE+
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+I++RD+K N+LLD +++DFGL K + +T GT ++APE + T
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTETSYT 179
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D + GV++ E++ G P
Sbjct: 180 RAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQGERE-FKAEVEIISRI 420
D +LL EG FG ++ G L D EV +K +K + + E ++ +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 421 HHRHLVSLVGYCISD-DRRLLIYDYVPNNTLYFHL----HGEGRPVLDWATR--VKIAAG 473
H++++ ++ CI D + ++Y Y+ L L GE +T+ V +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G++YLH+ +IH+DI + N ++D + +++D L++ + H +G
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGDN 178
Query: 533 ----FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MA E + + + SDV+SFGV+L EL+T G+ P
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 375 LGEGGFGSVY--KGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVG 430
+GEG FG +Y K D IK++ + + + K EV +++++ H ++V+
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 431 YCISDDRRLLIYDYVPNNTLYFHL---HG---EGRPVLDWATRVKIAAGAARGLAYLHED 484
+ R ++ +Y L + G +L W ++ + GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDR 120
Query: 485 CHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+I+HRDIKS NI L N A++ DFG+A+ L+ + + +GT Y++PE +
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDAS 572
K+D++S G VL EL T + P + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L + VAIK LK G EFK E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-----HGEG---------RPVLDWATRVKIAAG 473
L+G + +I+ Y ++ L+ L H + + L+ A V I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G+ +L ++H+D+ + N+L+ + ++SD GL + A+ + ++MG
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNS 186
Query: 533 ---FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M+PE GK + SD++S+GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 59/266 (22%), Positives = 85/266 (31%), Gaps = 9/266 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P S S VS+ ++ V+ PP P P PA+
Sbjct: 26 ATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPP--TGPPPGPGTEAPANE 83
Query: 62 PPTSSSP------PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
++ + PAS SP P PPP+PP +SPP P
Sbjct: 84 SRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGS 143
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P P P + + P+ +++ + P + P P PP PP
Sbjct: 144 PGPPPAASPPAAGASPAAVASDAASSR-QAALPLSSPEETARAPSSPPAEPPPSTPPAAA 202
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
S PP+ S P + P + AS S SS P + L P
Sbjct: 203 SPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAP 262
Query: 236 IPVPSTENTPGNGTNPSSPESSSSPS 261
I +P+ PSS +S S
Sbjct: 263 ITLPTRIWEASGWNGPSSRPGPASSS 288
|
Length = 1352 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
F +G+G FG V+KG D R VAIK + + + E E + E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ G + + +I +Y+ + L AT +K +GL YLH +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE 120
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+ IHRDIK++N+LL + +++DFG+A D T V GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 374 LLGEGGFGSVY---KGYLPD-GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVS 427
+LG+G FG V+ K PD G+ A+K LK + K E +I++ ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 428 LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDC 485
L Y + +L LI D++ L+ L E V+ VK A A L +LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS-- 116
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K NILLD +++DFGL+K ++D GT YMAPE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRG 174
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
T+ +D +SFGV++ E++TG P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 7e-16
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVEIISRI 420
+G G +G V GR+VAIK KI F E++++ +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIK--KI-----SNVFDDLIDAKRILREIKLLRHL 56
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPN-NTLYF-------HLHG---EGRPVLDWATRVK 469
H +++ L +L + N +Y LH +P+ D ++
Sbjct: 57 RHENIIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--DHIQ 106
Query: 470 -IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
RGL YLH + +IHRD+K SNIL+++N + ++ DFGLA+ + +
Sbjct: 107 YFLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARG---VDPDEDEK 160
Query: 529 VMGTFG-----YMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE SS + T+ D++S G + EL+T +
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--------------EVEII 417
LGEG +G V K Y G+ VAIK++KI + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 418 SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR-----VK-IA 471
+ I H +++ LV + D L+ D + + + V+D R VK I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA----------KLALDA 521
GL LH+ +HRD+ +NI +++ +++DFGLA L+ D
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 522 NT----HITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
+T++V+ T Y APE + K D++S G + EL+TG+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDG-------REVAIKQLKIGGGQGERE-----FKAEVE 415
+A LG G FG VYK + +E+ + G + ER+ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 416 II-SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL------HGEGRPVLDWATRV 468
II ++ H ++V + +DR ++ D + L H W V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
++ L YLH++ RI+HRD+ +NI+L + + ++DFGLAK + +T+
Sbjct: 121 QMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTS- 172
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
V+GT Y PE + EK+DV++FG +L ++ T + P
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLVSLVGYC 432
LGEG + +VYKG E VA+K++ + +G E+ ++ + H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 433 ISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++++ +L+++Y+ + Y HG LD T +G+A+ HE+ R++H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
RD+K N+L++ E +++DFGLA+ + NT V T Y AP+ + S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTS 181
Query: 551 -DVFSFGVVLLELITGR 566
D++S G ++ E+ITGR
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-15
Identities = 33/189 (17%), Positives = 53/189 (28%), Gaps = 1/189 (0%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A P A + +P + P S P P + P +
Sbjct: 616 AAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGG 675
Query: 63 PTSSSPPASSPPTSSPPPASNPPTS-SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
++PP + P + PA P +P P+ + P + P +
Sbjct: 676 AAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAA 735
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P P DPP + P+ PP P P ++ P + + S
Sbjct: 736 DDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
Query: 182 NSPPAPIAV 190
V
Sbjct: 796 EDRRDAEEV 804
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 34/132 (25%), Positives = 42/132 (31%), Gaps = 2/132 (1%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P P + + P S + PP+S P PS P P S
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP-PPPTQT 202
S+LPP P S P P NP PPP + P P + + P PP
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPT-NPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 203 PPTPASPIAPRP 214
P P I
Sbjct: 267 TPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 45/272 (16%), Positives = 77/272 (28%), Gaps = 39/272 (14%)
Query: 2 SAPSPGP-----PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+ P+PG A++ V+ + P + ++ P + P PP +
Sbjct: 379 AVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPA---PPAT 435
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP---PASSPPTISPPPPVSNPPTR 113
+ P + + S P AS+P + +PP P R
Sbjct: 436 ADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPR 495
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANS--PPPSNPPSNLPPPPPSSVEPPKR---------- 161
+ P ++TP P+ + P PP P++ P R
Sbjct: 496 AAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDV 555
Query: 162 --------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
S P+++P PA P Q P A
Sbjct: 556 LRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAA--------PRVAVQVPTPRARAATGD 607
Query: 214 PSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+ + R +PPP +P + P
Sbjct: 608 APPNGAARAEQAAESRGAPPPWEDIPPDDYVP 639
|
Length = 830 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 41/114 (35%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHIT 526
KI+ RGL YL E +I+HRD+K SNIL+++ E ++ DFG++ +D AN+ +
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580
TR YM+PE T +SD++S G+ L+E+ GR P+ E++
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 375 LGEGGFGSVYKGYLPDGRE-VAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G+GG+G V+ D E VA+K++K + R E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE------ 483
Y DD L L +YVP G+ R +L+ V ++ AR Y+ E
Sbjct: 68 YAFQDDEYLYLAMEYVPG--------GDFRTLLN-NLGV-LSEDHAR--FYMAEMFEAVD 115
Query: 484 DCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-ANTHITTRVMGTFGYMAPEYA 541
H IHRD+K N L+D + +++DFGL+K + AN+ V+G+ YMAPE
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVL 170
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL 586
D +S G +L E + G P S P +E+ W NL
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NET---WENL 210
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVA------IKQLKIGGGQGEREFKAEVE--IISRIHHR 423
Q LG+G FG+VY + D + VA +K++ +G +A E ++S++ H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH-----GEGRP---VLDWATRVKIAAGAA 475
+V + D +I +Y L L G+ V +W ++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
G+ Y+H+ RI+HRD+K+ NI L NN ++ DFG+++L L + + T GT Y
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYY 171
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLEL 562
M+PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 43/230 (18%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
L+G+GG G VY Y P R VA+K+++ ++ F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67
Query: 430 GYCISDDRRLLIYD--YVPNNTLYFHL------------HGEGRPVLDWATRVKIAAGAA 475
Y I D + Y Y+ TL L E V + I
Sbjct: 68 -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKIC 123
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK---------LALDANTH-- 524
+ Y+H ++HRD+K NILL E + D+G A L +D +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 525 ------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
I +++GT YMAPE +E +D+++ GV+L +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++G GGFG VY D G+ A+K L +I QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 430 --GYCI----------SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
G C + D+ I D + L++HL G V A G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILG 109
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L ++H +++RD+K +NILLD + ++SD GLA H + +GT GYMA
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 538 PEYASSGKLTEKS-DVFSFGVVLLELITGRKP 568
PE G + S D FS G +L +L+ G P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 49/229 (21%), Positives = 56/229 (24%), Gaps = 18/229 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P P PP A S P P +S + + P P P PP
Sbjct: 130 PKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPP--- 186
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
A+ P P P PP P P P P P PP
Sbjct: 187 ------RQAAFPQQGPPEQPPGYP--QPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQ 238
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
PP PPP P PP P PP P P P
Sbjct: 239 QPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQP---PPQNQPTPHPGLPQGQNAP 295
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
PP + P P Q P + S S +
Sbjct: 296 LPPPQQPQLLPLVQQPQGQQRGPQF----REQLVQLSQQQREALSQEEA 340
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
F +G+G FG VYKG +EV AIK + + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDC 485
G + + +I +Y+ + L +P L+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE- 120
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
R IHRDIK++N+LL + +++DFG+A D T V GT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 6/129 (4%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
+ P P+ P ++ P +P + P + P ++ P +PP+ P + P
Sbjct: 371 EAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV-AAP 429
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
+ P+ P P++V + PP P + P + +P +A P
Sbjct: 430 AAAAPAAAPAAAPAAV-----ALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPA 484
Query: 201 QTPPTPASP 209
TP
Sbjct: 485 AARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 30/139 (21%), Positives = 51/139 (36%), Gaps = 8/139 (5%)
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
P A+ + + + + PA+ P + PA++P + P PP +PP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAA--PPAAAPP 423
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P + P +P + P+ PA PP P +V P R P + P P+
Sbjct: 424 APVAAPAAAAPAAAPAAAPAAVALAPAPP---AQAAPETVAIPVRVAPEPAVASAAPAPA 480
Query: 177 SSPPKNSPPAPIAVPPSNV 195
++P +V
Sbjct: 481 AAPA---AARLTPTEEGDV 496
|
Length = 618 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 60/241 (24%)
Query: 351 GHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGERE 409
G RS+ +E+L N +GEG +G VY+ E VA+K++++ + E
Sbjct: 1 GRCRSVTEFEKL----------NRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNE 45
Query: 410 FKA-------EVEIISRIHHRHLVSL---------------VGYCISDDRRLLIYDYVPN 447
E+ ++ + H ++V L + YC D LL N
Sbjct: 46 RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DN 100
Query: 448 NTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
F ++VK + RGL YLHE+ IIHRD+K SN+LL +
Sbjct: 101 MPTPFS-----------ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGC 146
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITG 565
+++DFGLA+ +T +V+ T Y APE T D+++ G +L EL+
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 566 R 566
+
Sbjct: 206 K 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFKAEV----EIISRIHHRHLVSL 428
+LG+G FG V L E AIK LK K V ++ + R +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK----------KDVVLEDDDVECTMVERRVLAL 51
Query: 429 VG--------YCI--SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL 478
+C + + + +Y+ L FH+ GR A AA GL
Sbjct: 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGL 109
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
+LH+ II+RD+K N+LLD + +++DFG+ K ++ +T GT Y+AP
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAP 165
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K E D +SFGV+L E++ G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 374 LLGEGGFGSVY-----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRH 424
+LG G +G V+ G+ G+ A+K LK + + + E +++ I
Sbjct: 7 VLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA-ARGLAYLH 482
+ + Y D +L LI DY+ L+ HL R V+I +G L +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH 122
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
+ II+RDIK NILLD+N ++DFGL+K + GT YMAP+
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 543 SGKLTEKS--DVFSFGVVLLELITGRKP 568
G D +S GV++ EL+TG P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
F +G+G FG V+KG D R VAIK + + + E E + E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ G + D + +I +Y+ + L E P LD I +GL YLH +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYLHSE 120
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+ IHRDIK++N+LL + E +++DFG+A D +GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQS 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSL 428
L+GEG +G V K + G+ VAIK K + ++ K E+ ++ ++ H +LV+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 429 VGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ R L++++V + + L + +G LD + K RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY-ASSG 544
IIHRDIK NIL+ + ++ DFG A+ L A + T + T Y APE
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 545 KLTEKSDVFSFGVVLLELITG 565
K D+++ G ++ E++TG
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
++G G +G VYKG ++ G+ AIK + + + E E K E+ ++ + HHR++ + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 432 CIS------DDRRLLIYDYVPNNTLYFHLHGEGRPVL--DWATRVKIAAGAARGLAYLHE 483
I DD+ L+ ++ ++ + L DW I RGLA+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++IHRDIK N+LL N E ++ DFG++ LD +GT +MAPE +
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 544 GKLTE-----KSDVFSFGVVLLELITGRKPVDASQPL 575
+ + +SD++S G+ +E+ G P+ P+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-15
Identities = 44/234 (18%), Positives = 70/234 (29%), Gaps = 15/234 (6%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P P + P P+ + P A + P + PA P ++ P+ +++P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAAR-PAAPAAPAAPAAPA--PAGAAAAPAEASAAPAPG 646
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
P P P PA PP P P + P +
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDG--WPAKAGGAAPAAPPPAPAP----AAPAAPAGAAPAQ 700
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P+ P + A A PS P PP P P P + + P
Sbjct: 701 PAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPP 760
Query: 222 PPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAV 275
PP P P P + +P + + + + S + A V + +
Sbjct: 761 PPAP------APAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDAEEVAMEL 808
|
Length = 824 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++G GGFG VY D G+ A+K L +I QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 430 G-------YCIS-----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
C+S D+ I D + L++HL G V A AA G
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILG 109
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L ++H +++RD+K +NILLD + ++SD GLA H + +GT GYMA
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 538 PEYASSGKLTEKS-DVFSFGVVLLELITGRKP 568
PE G + S D FS G +L +L+ G P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-15
Identities = 36/182 (19%), Positives = 58/182 (31%), Gaps = 1/182 (0%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A P A +++ P S P P +P + P + +
Sbjct: 621 PAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA 680
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP + +P A + P + P P ++ PP+ A P P SP
Sbjct: 681 PPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASA-PSPAADDPV 739
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P P PP A + PP P P ++ P S ++ P +
Sbjct: 740 PLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRR 799
Query: 182 NS 183
++
Sbjct: 800 DA 801
|
Length = 824 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS------ 427
+G+G FG VY+ D R A+K L ++E A+ E+ I R+++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 428 ---LVGYCIS---DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+VG S D L+ DY+ L++HL EGR D A + IA L +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIAE-LVLALEHL 112
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H+ I++RD+K NILLD + DFGL+K L N T GT Y+APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVL 168
Query: 542 SSGK-LTEKSDVFSFGVVLLELITGRKPVDASQ 573
K T+ D +S GV++ E+ G P A
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 39/141 (27%), Positives = 45/141 (31%), Gaps = 11/141 (7%)
Query: 47 KPPTTSPPPS---PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
+ P PP A T+S + + P SS P P SPP
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P S+ P P PSS PP P P SPPP PPPPP PP +
Sbjct: 206 SPSDSSLP----PAPSSFQSDT-PPPSPESPTNPSPPPGPAA---PPPPPVQQVPPLSTA 257
Query: 164 PSVPPQNPPPPPSSSPPKNSP 184
PP P
Sbjct: 258 KPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 31/132 (23%), Positives = 43/132 (32%), Gaps = 2/132 (1%)
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P PP + NS S P + + + P + P PS PP+
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 165 SVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPP 224
PP P S ++PP P + PPP PP P P S + P P
Sbjct: 207 PSDSSLPPAPS--SFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSA 264
Query: 225 PSTKRLSPPPGI 236
+T +
Sbjct: 265 SATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 25/122 (20%), Positives = 42/122 (34%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
+ P P P + P + PA+ P ++S PA+ P + P P + P
Sbjct: 372 AAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAA 431
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
++P +P A+ P P + + P P + S P A P+
Sbjct: 432 AAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPT 491
Query: 147 NL 148
Sbjct: 492 EE 493
|
Length = 618 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 47/260 (18%), Positives = 88/260 (33%), Gaps = 6/260 (2%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
AP G PA + + P P + V + P + + A
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP + +PPA++ P + A S P ++ + S P +
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAP 485
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P+P + P+ + P + P + P P +PP+ P PP P +++P
Sbjct: 486 PDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPA-PEARPPTPAAAAPAA 544
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ A A+ + + A +P+ + P + K +P + VP+
Sbjct: 545 RAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPA-----AAPAAAPKPAAPRVAVQVPTP 599
Query: 242 ENTPGNGTNPSSPESSSSPS 261
G P + + + +
Sbjct: 600 RARAATGDAPPNGAARAEQA 619
|
Length = 830 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 63/243 (25%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKA---- 412
YE L K LGEG FG VYK + GR VA+K++ + E++ F
Sbjct: 10 YEILGK----------LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR 56
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL-----DWA-- 465
E++I+ ++ H ++V L+ + + + G V D +
Sbjct: 57 EIKILKKLKHPNVVPLID---------MAVERPDKSK---RKRGSVYMVTPYMDHDLSGL 104
Query: 466 ---TRVKIAAGAAR--------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
VK+ + G+ YLHE+ I+HRDIK++NIL+DN +++DFGL
Sbjct: 105 LENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161
Query: 515 AKLALD----------ANTHITTRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELI 563
A+ T T ++ T Y PE + T D++ G V E+
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 564 TGR 566
T R
Sbjct: 222 TRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 375 LGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHRHLVSLVG 430
+G+G +G V + DG++ IK+L + RE KA E +++S++ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLH---GEGRP---VLDWATRVKIAAGAARGLAYLHE 483
+D L ++ + LY L G+ P V++W ++ +A L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHE 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
I+HRD+K+ N+ L +V D G+A++ L+ + + ++GT YM+PE S+
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTLIGTPYYMSPELFSN 176
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDA 571
KSDV++ G + E+ T + +A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
++G G FG V+ D +V A+K L+ I Q +AE +I++ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y D+ L L+ +Y+P L L + + A R IA L +H+
Sbjct: 67 Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVL-ALDSVHKLGF- 122
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAK-----------------LALDANTHITTR-- 528
IHRDIK NIL+D + +++DFGL K L N + R
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 529 ---------VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+GT Y+APE + D +S GV+L E++ G P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 375 LGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KG + VA+K LK + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 430 GYCISDDRRLL--IYDYVP-NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C ++ L+ + + P N L + H + + + +V + G+ YL E
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET-- 114
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF--GYMAPEYASS 543
+HRD+ + N+LL A++SDFGL+K L D N + + G + + APE +
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN-YYKAKTHGKWPVKWYAPECMNY 172
Query: 544 GKLTEKSDVFSFGVVLLELIT-GRKP 568
K + KSDV+SFGV++ E + G+KP
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 67/231 (29%), Positives = 118/231 (51%), Gaps = 41/231 (17%)
Query: 354 RSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FK 411
RS+ YE+L N + EG +G VY+ G VA+K+LK+ + E+E F
Sbjct: 2 RSVDEYEKL----------NRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFP 48
Query: 412 A----EVEIISRIHHRHLVSL----VGYCISD-DRRLLIYDYVPNN--TLYFHLHGEGRP 460
E+ I+ ++ H ++V++ VG S+ D+ ++ +YV ++ +L +
Sbjct: 49 ITSLREINILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQ 105
Query: 461 VLDWATRVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
+ VK + G+A+LH++ I+HRD+K+SN+LL+N ++ DFGLA+
Sbjct: 106 -----SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157
Query: 520 DANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
T V+ T Y APE + + + D++S G + EL+T +KP+
Sbjct: 158 SPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 43/246 (17%), Positives = 68/246 (27%), Gaps = 37/246 (15%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++A + AA +P + T + PP + P PP +
Sbjct: 399 VTAVTGAAGAA--LAPKAAAAAAATRAEAPPAA-------PAPPATADRGDDAADGD--- 446
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + A + S P + AS+P + +PP P R+ P ++
Sbjct: 447 -APVPAKANARASADSRCDERDAQPPADS---GSASAPASDAPPDAAFEPAPRAAAPSAA 502
Query: 121 TPPPNSPPSPPSDPPANS--PPPSNPPSNLPPPPPSSVEPPKR----------------- 161
TP P+ + P PP P++ P R
Sbjct: 503 TPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMR 562
Query: 162 --SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
S P ++ P AP P T P + A +
Sbjct: 563 VSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAES 622
Query: 220 NSPPPP 225
PPP
Sbjct: 623 RGAPPP 628
|
Length = 830 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHRHLVSLV 429
+LG+G FG V L GR A+K LK + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 430 GYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
C + DR + ++V L FH+ R D A AA L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K N+LLD+ +++DFG+ K + N T+ GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-FNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 549 KSDVFSFGVVLLELITGRKPVDA 571
D ++ GV+L E++ G P +A
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 25/228 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G + R VA+K + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL--------HGEGRPVLDWATRVKIAAGAARGL 478
L+G L++ + + + L +L + GRP +++AA A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMA 537
AYL+ + +HRD+ + N ++ ++F ++ DFG+ + + + + + + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584
PE G T SD++SFGVVL E+ + +P Q L +E ++++V
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---QGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFK---AEVEI-ISRIHHRHLVSLV 429
+G+G FG V + DG+ A+K L+ ++E K AE + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ D+ + DYV L+FHL E R + R AA A L YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARF-YAAEIASALGYLHS---LNI 117
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
I+RD+K NILLD+ ++DFGL K ++ + T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 550 SDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 43/273 (15%), Positives = 71/273 (26%), Gaps = 26/273 (9%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
PA P V P + S P + + ++
Sbjct: 360 PAVTGGGAPGGGVPA---RVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAA 416
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
A++ +PP A PP ++ A + + PP +S
Sbjct: 417 AAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGS 476
Query: 129 S--PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
+ P SD P ++ P + P + P R+P + ++ P + P+ PP
Sbjct: 477 ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPT 536
Query: 187 PIAVPPS------------------NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P A P+ V A P A + P P
Sbjct: 537 PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA---APKPAAPRVA 593
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P P + + P S
Sbjct: 594 VQVPTPRARAATGDAPPNGAARAEQAAESRGAP 626
|
Length = 830 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 38/136 (27%), Positives = 49/136 (36%), Gaps = 5/136 (3%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P P A T+S P + P + P PP+ SP PS PP P
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSD---PPSSSPGVPSFPSPPEDP 204
Query: 128 PSP--PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
SP S PPA S S+ P P P + PP + P PP PP S++ P
Sbjct: 205 SSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSA 264
Query: 186 APIAVPPSNVPPPPTQ 201
+ P +
Sbjct: 265 SATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 31/131 (23%), Positives = 44/131 (33%), Gaps = 4/131 (3%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P PP+ + + S P +++P S P SPP + P+
Sbjct: 150 PGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSD 209
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P P S PPP PT PPP PP P + P+ P ++
Sbjct: 210 SSLPPAP--SSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLS--TAKPTPPSAS 265
Query: 148 LPPPPPSSVEP 158
P P +
Sbjct: 266 ATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 373 NLLGEGGFGSV----YKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG V +KG G AIK LK I + + E I+ + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V+++ ++R + ++V L+ HL GR D A A YLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY--HAELVLAFEYLHSK- 137
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K N+LLDN +V+DFG AK D T + GT Y+APE S
Sbjct: 138 --DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKG 191
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
+ D ++ GV+L E I G P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G FG V G+ A+K LK + E E ++ H L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +YV L+FHL E R + TR A L YLH +I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRF-YGAEIVSALDYLHSG---KI 116
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASSGKLTE 548
++RD+K N++LD + +++DFGL K + DA T T GT Y+APE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGR 174
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ + V L EG P L +++ AA G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKS 550
D+ + N L+ ++SDFG+++ D + +T M + APE + G+ + +S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 551 DVFSFGVVLLE 561
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 30/135 (22%), Positives = 43/135 (31%), Gaps = 5/135 (3%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P ++ T + P P ++ PS P+ SS
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
+S PP S + PP S P+ P+ P +PPPP PP ST P P
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPV-----QQVPPLSTAKPTPP 262
Query: 128 PSPPSDPPANSPPPS 142
+ + P
Sbjct: 263 SASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 44/229 (19%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE------REFK 411
YEEL +GEG +G+VYK L GR VA+K++++ + RE
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI- 49
Query: 412 AEVEIISRIHHRHLVSLVGYC--ISDDRRL---LIYDYVPNN-TLYFHLHGEGRPVLDWA 465
A ++ + H ++V L+ C DR L L++++V + Y + P L
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPE 107
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
T + RG+ +LH H RI+HRD+K NIL+ ++ + +++DFGLA++ +
Sbjct: 108 TIKDLMRQLLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMAL 163
Query: 526 TTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
T+ V+ T Y APE YA+ D++S G + EL R+P
Sbjct: 164 TSVVV-TLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G V GR+VA+K++ + Q EV I+ H ++V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDC 485
D ++ +++ EG + D T + + + L++LH
Sbjct: 87 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR--VMGTFGYMAPEYAS 542
+IHRDIKS +ILL ++ ++SDFG A+++ + + R ++GT +MAPE S
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVIS 188
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G++++E++ G P PL
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-13
Identities = 57/250 (22%), Positives = 70/250 (28%), Gaps = 39/250 (15%)
Query: 2 SAPSPGPPAANSSSPPPP-------VSNPPTISPPPPV-SNPPKSSPPPPPVSKPPTTSP 53
S ++ SP P + P P + PK P PP +
Sbjct: 88 GPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQPQPQ 147
Query: 54 PPS-------------PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P+ P PP P PP + P PP PP
Sbjct: 148 TPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGY---- 203
Query: 101 ISPPPPVSNPPTRSPP-----PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
P PP +P P P + P PP P PP P S PPPP
Sbjct: 204 --PQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPP-- 259
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
+PP++ PQ PPP P N P PP Q P P+
Sbjct: 260 PQPPQQQQQPPQPQAQPPP---QNQPTPHPGLPQ--GQNAPLPPPQQPQLLPLVQQPQGQ 314
Query: 216 NSSPNSPPPP 225
P
Sbjct: 315 QRGPQFREQL 324
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLV 426
LLG+G FG V K G+ A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+L + DR + +Y L+FHL E R + R A L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALGYLHSC-- 114
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASSGK 545
+++RD+K N++LD + +++DFGL K + D T GT Y+APE
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDND 171
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 64/223 (28%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA--------EVEIISRI-HHRH 424
LG+G FGSVY G VAIK++K ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR-------- 476
+V L +D +++Y+ N +G+P + R
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP---------FSESVIRSIIYQILQ 110
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI------TTRVM 530
GLA++H+ H HRD+K N+L+ +++DFGLA+ I T V
Sbjct: 111 GLAHIHK--H-GFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYV- 159
Query: 531 GTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE Y+S D+++ G ++ EL T R
Sbjct: 160 STRWYRAPEILLRSTSYSS------PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 24/134 (17%), Positives = 48/134 (35%), Gaps = 4/134 (2%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A P ++ +P P P + P +P ++ P + + +PP
Sbjct: 363 AFKPAAAAEAAAPAEKKTPA----RPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPP 418
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
+ PP+ + P ++ + P+ P PP ++P + P +A P+ P
Sbjct: 419 AAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPA 478
Query: 201 QTPPTPASPIAPRP 214
A+ + P
Sbjct: 479 PAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 9/127 (7%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP---PSPPASS 97
P K P +P A+ +++ PA + P A+ ++PP P P ++
Sbjct: 373 AAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAA----PAAAASAPAAPPAAAPPAPVAA 428
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P +P + P P+ P + P +P P+ + P +
Sbjct: 429 PAAAAPAAAPAAAPAAVALAPAPPAQA--APETVAIPVRVAPEPAVASAAPAPAAAPAAA 486
Query: 158 PPKRSPP 164
+
Sbjct: 487 RLTPTEE 493
|
Length = 618 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 42/232 (18%), Positives = 66/232 (28%), Gaps = 24/232 (10%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP AA + + PP + P + +P P + + + P
Sbjct: 411 APKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQP 470
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P S AS+P + +PP A+ P A+ P + +P +
Sbjct: 471 PADSGS-ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPA 529
Query: 123 PPNSPPSPPSDPPA-----------------------NSPPPSNPPSNLPPPPPSSVEPP 159
P PP+P + PA + P +
Sbjct: 530 PEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAA 589
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
R VP +PP + A A PPP PP P++
Sbjct: 590 PRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPPWEDIPPDDYVPLS 641
|
Length = 830 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-13
Identities = 23/142 (16%), Positives = 38/142 (26%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P P+ P P + T+ P + A + PP +S P +P TS
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
+ + S P S P ++ P+ P
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 148 LPPPPPSSVEPPKRSPPSVPPQ 169
P V+ + P +
Sbjct: 481 WKATNPVEVKKEPVATPKALKK 502
|
Length = 647 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 375 LGEGGFGSVYKGYLPDGREVA---IKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
+G G FG V G G A +K+L+ E+ F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRV--KIAAGAARGLAYLHEDCHP 487
CI LL+ ++ P L +L G V ++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYMAPEYASS--- 543
IH D+ N L + ++ D+GLA + +IT ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 544 ----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
T+KS+++S GV + EL T A QP D S
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLS 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
+ +LG G FG + +G L P RE VAI L+ G +R F AE + + H ++V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L G + +++ +Y+ N L + H EG+ L + + G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQ--LVAGQLMGMLPGLASGMKYLSEM 126
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG--TFGYMAPEYAS 542
+ +H+ + + +L++++ ++S F +L D + I T + G + APE
Sbjct: 127 GY---VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ SDV+SFG+V+ E+++ G +P
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-13
Identities = 41/204 (20%), Positives = 60/204 (29%), Gaps = 12/204 (5%)
Query: 59 ASNPPTSSSPPASSPPTS--SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
P ++ P S P A+ P + P +P A +P + P ++
Sbjct: 588 VGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGV 647
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P + SD P P++ P P P
Sbjct: 648 AAPEHHPKHVAVPDASDGGDGWPAK------AGGAAPAAPPPAPAPAAPAAPAGAAPAQP 701
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P +PPA A P+ PP Q AS +P + P P P + P
Sbjct: 702 APAPAATPPAGQADDPAAQPPQAAQG----ASAPSPAADDPVPLPPEPDDPPDPAGAPAQ 757
Query: 237 PVPSTENTPGNGTNPSSPESSSSP 260
P P P + P S S
Sbjct: 758 PPPPPAPAPAAAPAAAPPPSPPSE 781
|
Length = 824 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 48/242 (19%), Positives = 55/242 (22%), Gaps = 20/242 (8%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
SP S P P S + P PP A
Sbjct: 86 SVGPDSDLSQKTSTFSP----CQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQA-- 139
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP--SPPSDPPANSPPP 141
P P + +S + R P PP P PP P
Sbjct: 140 ---PESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGP 196
Query: 142 SNPPSNLPPPPPSSVEPPK-----RSPPSVPPQNPPPPPSSSPPKN----SPPAPIAVPP 192
P P PP E + +P P Q P PP P P P
Sbjct: 197 PEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMP 256
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPS 252
P PP Q P P P N P P + PP
Sbjct: 257 PPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQGQQR 316
Query: 253 SP 254
P
Sbjct: 317 GP 318
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G VYK L G A+K +K+ G + E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 434 SDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S ++ + +Y +L +H+ G L + +GLAYLH +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTE 548
RDIK +NILL +N + +++DFG+A + A +GT +MAPE A+ +G +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 39/214 (18%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-------EVEIISRIHHRHLV 426
+GEG +G VYKG G+ VA+K++++ E E + E+ ++ + H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL-----ESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV---LDWATRVKIAAGAARGLAYLHE 483
L + + R LI++++ ++ + + P +D A VK +YL++
Sbjct: 63 CLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD-AELVK---------SYLYQ 109
Query: 484 D------CHP-RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
CH R++HRD+K N+L+DN +++DFGLA+ A + T + T Y
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYR 168
Query: 537 APE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
APE S + + D++S G + E+ T +KP+
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 32/170 (18%)
Query: 421 HHRHLVSLVGYCISDDRR-LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+ + + L Y ++ + +LI DY+ + L+ L EG+ L A KI L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALN 123
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVM--GTFGY 535
LH+ H IIH DIK N+L D + ++ D+GL K I T GT Y
Sbjct: 124 DLHK--H-NIIHNDIKLENVLYD-RAKDRIYLCDYGLCK-------IIGTPSCYDGTLDY 172
Query: 536 MAPEYASSGKLTEKSDVFSF-----GVVLLELITGRKPVDASQPLGDESL 580
+PE K+ + SF GV+ EL+TG+ P + DE L
Sbjct: 173 FSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEEL 214
|
Length = 267 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 25/127 (19%), Positives = 44/127 (34%)
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P ++ + P+ P A +P + P P++ S P+ PP PP P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
++P +P A A P+ V P +A + + + + P
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 236 IPVPSTE 242
+ TE
Sbjct: 486 ARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-13
Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 5/161 (3%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
+P P P PP S++P AS+ T++P A PP + P PPAS+P P
Sbjct: 363 APLPEPEV--PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
+ + S+P A S P N +SV P + P +
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRA---RPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
++ P P+A P + + P A+ +A
Sbjct: 478 AYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAKLAA 518
|
Length = 647 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 52/224 (23%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G V K ++P G +A+K+++ A V S+ R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR-----------ATVN--SQEQKRLLMDL----- 50
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEG-----------------RPVLDWATRV------KI 470
D + D T Y L EG + V D + KI
Sbjct: 51 --DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKI 108
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A + L YLH +IHRD+K SN+L++ N + ++ DFG++ +D+ T
Sbjct: 109 AVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDA 164
Query: 531 GTFGYMAPEY----ASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
G YMAPE + KSDV+S G+ ++EL TGR P D
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-----EVEIISRIHHRHLVSL 428
+GEG +G VYK G VA+K++++ + E E E+ ++ ++H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP- 487
+ S+++ L+++++ + L ++ LD +G+AY CH
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY----CHSH 118
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAPEYASSG 544
R++HRD+K N+L+D +++DFGLA+ + + TH V+ T Y APE
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGS 174
Query: 545 KLTEKS-DVFSFGVVLLELITGRKP 568
+ D++S G + E++ R+P
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAIKQ+ + + E+ ++ H ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
IKS NILL + +++DFG A++ + + T ++GT +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 553 FSFGVVLLELITGRKPVDASQPL 575
+S G++ +E++ G P PL
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
+LG+G FG V L G A+K LK + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 430 GYCI--SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
YC + + + +++ L FH+ +GR L AT AA GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK--- 115
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
II+RD+K N++LD + +++DFG+ K + + +T GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D +SFGV+L E++ G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 29/101 (28%), Positives = 41/101 (40%), Gaps = 10/101 (9%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P P PT+++P P +P P++ P ++ PP + PPPV
Sbjct: 362 PVPAPQPAKPTAAAPSPVRP---TPAPSTRPKAAAAANIPPKEPVRETATPPPV------ 412
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
PP P + P P++P S P A P P P PP
Sbjct: 413 -PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-13
Identities = 56/240 (23%), Positives = 73/240 (30%), Gaps = 24/240 (10%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP----------- 90
P P P P PP +PPA S + P P
Sbjct: 2483 PAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEE 2542
Query: 91 -PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP-PSNPPSNL 148
S A PP PP P RS PPP P P+ P ++PP + P + +
Sbjct: 2543 LASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPV 2602
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P P PPPPS SP N P PPP + PA
Sbjct: 2603 DDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPT----VPPPERPRDDPAP 2658
Query: 209 PIAPRPSNSS-------PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
RP + +SPP +R + P + S + P P + +
Sbjct: 2659 GRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSA 2718
|
Length = 3151 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA---TRV-----------KI 470
+++L+G C D +I +Y L +L P ++++ RV
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529
ARG+ YL + IHRD+ + N+L+ N +++DFGLA+ + + + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYC 432
LG+G +GSVYK + P G +A+K++++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPV--LDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + +Y+ +L L+ G + +I +GL +L E+ + II
Sbjct: 69 FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK--LALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
HRD+K +N+L++ N + ++ DFG++ +A A T+I G YMAPE SG +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 549 ------KSDVFSFGVVLLELITGRKP 568
+SDV+S G+ +LE+ GR P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFK---AEVEIISRI-HHRHLVSL 428
+LG+G FG V+ L + AIK LK + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 429 VGYCISDDRRLLIY--DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
YC + L + +Y+ L FH+ + L AT AA GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSK-- 115
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I++RD+K NILLD + +++DFG+ K + + T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
D +SFGV+L E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLVG 430
+G+G FG V + D + + A+K ++ E AE ++++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDCHPRI 489
S ++ L+ ++ L+ HL EGR L +R + A L LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFYTAELLCALENLHK---FNV 114
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
I+RD+K NILLD + DFGL KL + + T GT Y+APE T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNM-KDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 550 SDVFSFGVVLLELITGRKP 568
D ++ GV+L E++TG P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 28/135 (20%), Positives = 46/135 (34%), Gaps = 9/135 (6%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P A++ P + P + + P+P + P A + P+ PP+ PP P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
+ + P P P++ PAP A P + P PA A
Sbjct: 426 VA------APAAAAPAAAPAAAPAAVAL---APAPPAQAAPETVAIPVRVAPEPAVASAA 476
Query: 213 RPSNSSPNSPPPPST 227
++P + T
Sbjct: 477 PAPAAAPAAARLTPT 491
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 25/151 (16%), Positives = 36/151 (23%), Gaps = 2/151 (1%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P + P PP S+ P AS T++P A PPPP S P P T
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTA-AVAPPQAPAVPPPPASAPQQAPAVPLPETT 419
Query: 123 PPNSPPSPP-SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ + P+ P + + + P P+
Sbjct: 420 SQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAY 479
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
P P
Sbjct: 480 RWKATNPVEVKKEPVATPKALKKALEHEKTP 510
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-12
Identities = 27/154 (17%), Positives = 44/154 (28%), Gaps = 12/154 (7%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
P + P P V P+ A ++ A + PPP ++ P +P P
Sbjct: 361 PAAPLPEPEVPPQSA---APAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
++ ++ + + S P + P NS P P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKS------EPAAASRARPVNSALERLASVR-PAPSALE 470
Query: 156 VEPPKRSPPSVPPQNPP--PPPSSSPPKNSPPAP 187
P K+ NP + PK A
Sbjct: 471 KAPAKKEAYRWKATNPVEVKKEPVATPKALKKAL 504
|
Length = 647 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 374 LLGEGGFGSVYKGYLP----DGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVS 427
+LG+G FGSV + L ++VA+K LK I EF E + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----------GRPV-LDWATRVKIAAGAA 475
L+G +S R +P L F HG+ P L T V+ A
Sbjct: 66 LIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG-TFG 534
G+ YL IHRD+ + N +L+ N V+DFGL+K + +
Sbjct: 124 SGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T SDV++FGV + E++T G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+V+ + G+EVAIKQ+ + + E+ ++ + + ++V+ + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D A + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS N+LL + +++DFG + +T V GT +MAPE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E++ G P PL
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-12
Identities = 30/131 (22%), Positives = 44/131 (33%), Gaps = 10/131 (7%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
A + A++ P +P P + P + P P++ P P P+P PP+ +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ PPP + P P P + P PAP A P P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPA----------PAPAAAPEPTAAPAPAPPAAPAPAAAPA 495
Query: 199 PTQTPPTPASP 209
P PA
Sbjct: 496 APAAPAAPAGA 506
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-12
Identities = 28/157 (17%), Positives = 44/157 (28%), Gaps = 9/157 (5%)
Query: 91 PSPPASSP--PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P+ P P P S P S T +P + P + P PP+ P +P P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE--- 417
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ + P ++S + A + P + P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+ +N P +T P E TP
Sbjct: 478 AYRWKATNPVEVKKEPVAT----PKALKKALEHEKTP 510
|
Length = 647 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAIKQ+ + + E+ ++ + ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS NILL + +++DFG + +T V GT +MAPE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E++ G P PL
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 382 SVYKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC--ISDD 436
S+YKG + +EV I+ K G + E++ + RI +++ + G+ I DD
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRD 493
R LI +Y L L E L + T++ +A +GL L++ P +++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKN 148
Query: 494 IKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASS--GKLTEKS 550
+ S + L+ N++ ++ GL K L+ ++ V Y + + + + T K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 551 DVFSFGVVLLELITGRKPVD 570
D++S GVVL E+ TG+ P +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++ + ++ E+EI++ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D + ++ ++ P + + R + + +V I L YLH +IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---KIIHRD 135
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR---VMGTFGYMAPEYASSGKLTE-- 548
+K+ N+LL + + +++DFG++ N R +GT +MAPE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 549 ---KSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ L+E+ P P+
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 18/103 (17%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--------HITT 527
RGL Y+H +IHRD+K SN+L++ + E ++ DFG+A+ + T ++ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 528 RVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPV 569
R Y APE S + T D++S G + E++ GR+ +
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 55/219 (25%), Positives = 76/219 (34%), Gaps = 13/219 (5%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
P+ PP S+ P P P PSPP P P +
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKPVTP---EAPSPPIEEEPPQPKAVVPRPLSPYTAYEDL 380
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P +SP P+PP+SSP + V+ P PS N P P+ A P +
Sbjct: 381 KPPTSPIPTPPSSSPASSKSVDAVAKPAE-PDVVPSPGSASNVPEVEPAQVEAKKTRPLS 439
Query: 144 P---------PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P++ P P+ V P S SVP P +++ +PP P S
Sbjct: 440 PYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSP 499
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
PPT SP AP + ++ +PP
Sbjct: 500 YAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPP 538
|
Length = 576 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 374 LLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGY 431
++GEG FG ++ ++ ++ A+K++++ E + E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGE-GR-----PVLDWATRVKIAAGAARGLAYLHEDC 485
+D ++ +Y L + + G+ +L W ++ + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
R++HRDIKS NI L N + ++ DFG A+L + T V GT Y+ PE +
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
KSD++S G +L EL T + P A+ W NLI
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANS---------WKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 59/225 (26%)
Query: 371 DQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA---------EVEIISRI 420
+ + +G G +G V + GR+VAIK+L R F++ E+ ++ +
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHM 71
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK----------- 469
H +++ L+ D +Y H G D VK
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQD------VYLVTHLMGA---DLNNIVKCQKLSDDHIQF 122
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTR 528
+ RGL Y+H IIHRD+K SNI ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 529 VMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE Y + D++S G ++ EL+TG+
Sbjct: 180 -----WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS NILL + +++DFG + + ++GT +MAPE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E+I G P PL
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFK---AEVEIIS-RIHHRHLVSL 428
+LG+G FG V L EV AIK LK + + E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ DR + +YV L F + + D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+I+RD+K NILLD +++DFG+ K + N TT GT Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGI-LNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 549 KSDVFSFGVVLLELITGRKPVDA 571
D ++ GV++ E++ G+ P +A
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 15/132 (11%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P+ AA +++P + P + P + P PP + PP P + PA+
Sbjct: 379 KTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASA---PAAPPAAAPP---APVAAPAAA 432
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + P ++P + P +P + P P P + +P P ++
Sbjct: 433 APA-------AAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEP--AVASAAPAPAAAP 483
Query: 122 PPPNSPPSPPSD 133
P+ D
Sbjct: 484 AAARLTPTEEGD 495
|
Length = 618 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 49/244 (20%), Positives = 76/244 (31%), Gaps = 38/244 (15%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP----PPPPVSKPPTTSPPPSP 57
+A P A +++ S PP + S+P PP +P + PS
Sbjct: 442 AADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSA 501
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS--------------- 102
+ PA++ +P A+ P + PP+P A++P +
Sbjct: 502 ATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGM 561
Query: 103 -------------PPPPVSNPPTRSPPPPS---STPPPNSPPSPPSDPPANS-PPPSNPP 145
P + P P P P + + PP +
Sbjct: 562 RVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAE 621
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP--APIAVPPSNVPPPPTQTP 203
S PPP + P P S P P +S P +A P++ P PP T
Sbjct: 622 SRGAPPPWEDIPPDDYVPLSADEGFGGPDDGFVPVFDSGPDDVRVAPKPADAPAPPVDTR 681
Query: 204 PTPA 207
P P
Sbjct: 682 PLPP 685
|
Length = 830 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM----G 531
RGL Y+H ++HRD+K SN+LL+ N + ++ DFGLA++A H T +
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA 171
Query: 532 TFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGR 566
T Y APE + K K+ D++S G +L E+++ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFG 534
RGL YLH I+HRDIK N+L+++N ++ DFGLA++ D + H+T V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 535 YMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
Y APE S T D++S G + EL+ R A P+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 35/84 (41%), Positives = 53/84 (63%), Gaps = 1/84 (1%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPEYASSGKL 546
+IHRDIKS+NILL +N ++ DFG +K+ A + + GT Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 547 TEKSDVFSFGVVLLELITGRKPVD 570
++K+D+FS GV+L EL+T ++P D
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V DG+ A+K L+ + + ++ AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ ++ + D+V L+FHL E R + R A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD+ ++DFGL K + A + TT GT Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 11/138 (7%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ A P ++ A++ P ++P PA+ P ++ P+P A+ P +P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAP---------- 435
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P+ P + P+ + P + PS P+ P P P +PP+ P P
Sbjct: 436 -APAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAP 494
Query: 174 PPSSSPPKNSPPAPIAVP 191
++P + A
Sbjct: 495 AAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 32/135 (23%), Positives = 46/135 (34%), Gaps = 3/135 (2%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P P + + + S P SS P + P+ PS P
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
+ S +P S+ P SP P++ PP P +PP P PP S P PP +
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK---PTPPSA 264
Query: 155 SVEPPKRSPPSVPPQ 169
S P ++
Sbjct: 265 SATPAPIGGITLDDD 279
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P +A+ S PP P+ PP + P S PP S + +PPPSP PT+
Sbjct: 177 ADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPE---SPTN 233
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
SPP PP PP S+ P+PP++S +
Sbjct: 234 PSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 31/131 (23%), Positives = 41/131 (31%), Gaps = 9/131 (6%)
Query: 30 PPVSNPPK--------SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA 81
P PP + S P + P S S+PP+SS S P P +
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ + P PS S P SP P +NP P PP P + P
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESP-TNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 142 SNPPSNLPPPP 152
+ P
Sbjct: 266 ATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 45/136 (33%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L +H+ G+ V AA A GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFS 554
N++LD +++DFG+ K + TTR GT Y+APE + + D ++
Sbjct: 129 LDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 555 FGVVLLELITGRKPVD 570
FGV+L E++ G+ P D
Sbjct: 187 FGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 10/199 (5%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LLG+G FG V GR A+K L+ I E ++ H L +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +Y L+FHL E R + R A L YLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARF-YGAEIVSALEYLHSR---DV 116
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
++RDIK N++LD + +++DFGL K + + T GT Y+APE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 550 SDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR--------------VKI 470
+++L+G C D +I +Y L +L P +++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ D + HI
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIH-HIDYYKK 198
Query: 531 GTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
T G +MAPE T +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYK----GYLPDGRE----VAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V + G + VA+K LK + + +E+E++ I H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA---TR-----------VKI 470
+++L+G C + +I +Y L L P D+ T+ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529
A ARG+ YL R IHRD+ + N+L+ + +++DFGLA+ D + + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-12
Identities = 25/146 (17%), Positives = 40/146 (27%), Gaps = 3/146 (2%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPAS-SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
A P P P P +++P S A+ +P PP P P P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ A + + R S + P+ S + +P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 189 AVP--PSNVPPPPTQTPPTPASPIAP 212
A +N + TP +
Sbjct: 478 AYRWKATNPVEVKKEPVATPKALKKA 503
|
Length = 647 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
RGL Y+H ++HRD+K SN+LL+ N + ++ DFGLA+ + +T V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 536 MAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
APE + + T DV+S G + EL+ GRKP+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 35/128 (27%), Positives = 45/128 (35%), Gaps = 12/128 (9%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A + NS + S PP S S P PP P+ S P P+
Sbjct: 161 ADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPS--S 218
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S +PP S ++P S PP PP PP + PT PP S+TP
Sbjct: 219 FQSDTPPPSPESPTNP--------SPPPGPAAPPPPPVQQVPPLSTAKPT--PPSASATP 268
Query: 123 PPNSPPSP 130
P +
Sbjct: 269 APIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G FG V GR A+K LK + E E ++ H L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +Y L+FHL E R + R A L YLH + +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALDYLHSE--KNV 117
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
++RD+K N++LD + +++DFGL K + + T GT Y+APE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176
Query: 550 SDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 374 LLGEGGFGSVY---KGYLPD-GREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG G +G V+ K D G+ A+K L+ + + + E ++ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA-RGLAYLHE 483
+ + Y + +L LI DYV ++ HL+ D V+ +G L +LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALEHLHK 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA-S 542
I++RDIK NILLD+ ++DFGL+K L T GT YMAPE
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
G + D +S G+++ EL+TG P
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-11
Identities = 28/125 (22%), Positives = 50/125 (40%), Gaps = 3/125 (2%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
G A +++ P + P +P P + P ++ P P + P +P P+P P
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA---P 441
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P+ + + S PP A+ +P P+ +P PP + P +P P++
Sbjct: 442 PSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPA 501
Query: 123 PPNSP 127
P
Sbjct: 502 APAGA 506
|
Length = 824 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGG---GQGEREFKAEV 414
YE+L K +GEG +G+V+K + E VA+K++++ G + E+
Sbjct: 2 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EI 50
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN-TLYF-HLHGEGRPVLDWATRVKIAA 472
++ + H+++V L SD + L+++Y + YF +G+ +D
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMF 106
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG- 531
+GLA+ H ++HRD+K N+L++ N E +++DFGLA+ I R
Sbjct: 107 QLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSA 158
Query: 532 ---TFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGRKPV 569
T Y P+ KL S D++S G + EL +P+
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G VYK + G AIK +K+ G+ + E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 434 SDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
D+ + ++ +L +H+ G L + ++ +GL YLH +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTE 548
RDIK +NILL +N +++DFG++ + A +GT +MAPE A+ G +
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSA-QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V + + + A+K L+ I + E+ +E ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ D+ + DY+ L++HL E R L+ R AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD+ ++DFGL K ++ N T+ GT Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 41/201 (20%), Positives = 55/201 (27%), Gaps = 11/201 (5%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSP-PASNPPTSSSPPASSPPTSSPPPASNPPTSSPP-PSP 93
P + P PP TS P P P P P + P PT+ P P+
Sbjct: 90 PSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAY 149
Query: 94 PASSPPTISPPPPVSNPP--TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P P R PP + + +P + P +
Sbjct: 150 QQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRR 209
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P P P PPP + P P + V P P
Sbjct: 210 DYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP-------G 262
Query: 212 PRPSNSSPNSPPPPSTKRLSP 232
P + +P P T RL+P
Sbjct: 263 PLAAQPAPAPGPGEPTARLNP 283
|
Length = 617 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 25/127 (19%), Positives = 45/127 (35%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P +P +P + +++ + P PA P + P P+ A +
Sbjct: 393 APAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGG 452
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
SPPP + +P P ++ P +P P PA + P+ P + P
Sbjct: 453 APSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATL 512
Query: 160 KRSPPSV 166
+ P +
Sbjct: 513 RERWPEI 519
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 32/130 (24%), Positives = 43/130 (33%), Gaps = 5/130 (3%)
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLP-----PPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
PN P + +N ++ P P S +PP SP +PP PSS
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIP 237
+ PPAP + PP P P P PP ST + +PP
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 238 VPSTENTPGN 247
P+
Sbjct: 267 TPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-11
Identities = 29/159 (18%), Positives = 44/159 (27%), Gaps = 6/159 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
P P P S P S T +P V+ P + PPPP S P P P +
Sbjct: 363 APLPEPEVPPQ---SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETT 419
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ ++ ++ S P +S P S+ ++ P P P
Sbjct: 420 SQLLAARQQLQRAQGATKAKKSEPAAASRAR-PVNSALERLASVRPA--PSALEKAPAKK 476
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
+P P L +
Sbjct: 477 EAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAK 515
|
Length = 647 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+H LV L ++ R + +YV L FH+ + R + + R +A + L Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNY 111
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
LHE II+RD+K N+LLD+ +++D+G+ K L T+ GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEI 167
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
D ++ GV++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K VA+K LK + + +E+E++ I H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA--------------TRVKI 470
+++L+G C D ++ +Y L +L P +D++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTRV 529
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ + + + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 68/227 (29%), Positives = 80/227 (35%), Gaps = 10/227 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S + P P PP + P I PPP P + SP P P++
Sbjct: 322 SQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNL 381
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP--------PPPVSNPPTR 113
PP + P SS PT PP A PP P S P S P P PP S P
Sbjct: 382 PPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHS 441
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS--VEPPKRSPPSVPPQNP 171
P P PA PPPS P S PP +S +PP + PS
Sbjct: 442 GLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAG 501
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
P PP P A P + PPPP P P P ++ S
Sbjct: 502 PGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQS 548
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 63/236 (26%), Positives = 85/236 (36%), Gaps = 4/236 (1%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGPP ++ P P+ +PP P PP P S+ S P ++ P
Sbjct: 271 PGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQ 330
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPAS--SPPTISPPPPVSNPPTRSPPPPSSTPP 123
PP S P PPT+ P P S PP + P P P+ PPPP+ P
Sbjct: 331 PPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPL 390
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+ P P P A+ PP P + P + P S+PP+ P S
Sbjct: 391 SSLPTHHP--PSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPP 448
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P ++ P PP+ + P +S S PP S S P P
Sbjct: 449 QSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGP 504
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
LGEG + +V+KG VA+K++++ +G EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA-GAARGLAYLHEDCHPRIIH 491
++ L+++Y+ ++ L +L G L VKI RGL+Y H +I+H
Sbjct: 73 HTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEKS 550
RD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 551 DVFSFGVVLLELITGR 566
D++ G +L E+ TGR
Sbjct: 186 DMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L +H+ G+ V AA + GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFS 554
N++LD+ +++DFG+ K + +TTR GT Y+APE + + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 555 FGVVLLELITGRKPVDA 571
+GV+L E++ G+ P D
Sbjct: 187 YGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVY-KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V DG A+K L+ I + + AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ ++ + DYV L+FHL E R L+ R AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARF-YAAEVASAIGYLHS---LN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K NILLD+ ++DFGL K ++ T+ GT Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + +A ++ + E E + E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ ++ + + RP+ + RV + L YLHE+ +IIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR---VMGTFGYMAPEYASSGKLTE-- 548
+K+ NIL + + +++DFG++ NT R +GT +MAPE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 549 ---KSDVFSFGVVLLELITGRKPVDASQPL 575
K+DV+S G+ L+E+ P P+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 29/125 (23%), Positives = 49/125 (39%), Gaps = 2/125 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
+P A+ P +++ PA++P ++ PA+ + PA +P PP +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P S PP +P + P+ PA +P P+ P+ PP P+ P P
Sbjct: 446 GNAPAGGAP--SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAP 503
Query: 169 QNPPP 173
Sbjct: 504 AGADD 508
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 4e-11
Identities = 30/167 (17%), Positives = 47/167 (28%), Gaps = 13/167 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+AP P P S+ P + T +P V+ P + PPPP S P +P P
Sbjct: 362 AAPLPEPEVPPQSAAPAASA-QATAAPTAAVAPPQAPAVPPPPASAPQQ-APAVPLP--- 416
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
TS A + + S + V P+ P+
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKK 476
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
+ P + P ++E K +P
Sbjct: 477 EAYRWKATNPVEVKKEPVAT-------PKALKKALEHEK-TPELAAK 515
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 68/273 (24%), Positives = 94/273 (34%), Gaps = 31/273 (11%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
PP + PP + P P S+ PP P P P P +P + S P+ P
Sbjct: 175 PQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHP 234
Query: 74 PTSSPPP-------ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP---PPPSSTPP 123
P AS P PS P PP+ + + P PSS PP
Sbjct: 235 QRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP 294
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLP---------------PPPPSSVEPPKRSPPSVPP 168
+ PP P + P S+ P P PP+ P + PP+ P
Sbjct: 295 QPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPI 354
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P PP P+P PSN+PPPP P++ P++ P++ PPP
Sbjct: 355 PQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPA------LKPLSSLPTHHPPSAHPPPLQL 408
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P VP+ + S+ S
Sbjct: 409 MPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHS 441
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 50/232 (21%), Positives = 74/232 (31%), Gaps = 8/232 (3%)
Query: 16 PPPPVSNPPTISPPPPVSNPPKSSPP-PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
P P+ P P + +P PP V P S + + P
Sbjct: 627 PLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLP 686
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P PP +P P P ++PP + P + R P P + + P
Sbjct: 687 IQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARP 746
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP-------PSSSPPKNSPPAP 187
PA +P + PP+ P P P PPQ PP P P+ PP + P
Sbjct: 747 PAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQAGPTS 806
Query: 188 IAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
+ + P P T + P+ P + +R + P P
Sbjct: 807 MQLMPRAAPGQQGPTKQILRQLLTGGVKRGRPSLKKPAALERQAAAGPTPSP 858
|
Length = 991 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 35/193 (18%), Positives = 54/193 (27%), Gaps = 8/193 (4%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P + P P+ P P + P + P P+ + S P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAA-PAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 135 PANSPPPSNPPSNLPPPP-PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP-P 192
+P +P P K + P P P++ P P
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 193 SNVPPPPTQTPPTPASPIAP----RPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
+ PP P P A PS ++ + P P P P P
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 249 TNPSSPESSSSPS 261
++P ++ PS
Sbjct: 766 -PAAAPAAAPPPS 777
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 25/92 (27%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P P P ++ P P P ++ P + A+N P ++ P PP PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P S P + I PV P +PP P
Sbjct: 422 PHTPESAPKLTRAAI----PVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
G++VA+K++ + Q EV I+ HH ++V + + D ++ +++
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL----- 101
Query: 451 YFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502
EG + D T + + R L+YLH +IHRDIKS +ILL
Sbjct: 102 ------EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152
Query: 503 NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
++ ++SDFG + ++GT +MAPE S + D++S G++++E+
Sbjct: 153 SDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 563 ITGRKPVDASQPL 575
I G P PL
Sbjct: 212 IDGEPPYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 38/101 (37%), Positives = 62/101 (61%), Gaps = 5/101 (4%)
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
K++ RGLAYL E +I+HRD+K SNIL+++ E ++ DFG++ +D+ +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569
+GT YM+PE + +SD++S G+ L+EL GR P+
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKI---GGGQGEREFKAEVEIISRIHHRH 424
F + +G G F VY+ L DG VA+K+++I + + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL---YFHLHGEGRPVLD---WATRVKIAAGAARGL 478
++ I D+ ++ + L H + R + + W V++ + L
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA----L 119
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
++H R++HRDIK +N+ + ++ D GL + + T ++GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E KSD++S G +L E+ + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 65/239 (27%), Positives = 85/239 (35%), Gaps = 16/239 (6%)
Query: 1 MSAPSPGPPAANSSSPPPP----VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+ AP GP + P S P P PV +P ++ PP S P TS P
Sbjct: 564 LPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQ 623
Query: 57 PPASNPPTSSSP----PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
P P P P + P P P P P + I P + T
Sbjct: 624 WPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANT 683
Query: 113 RSPP---PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P P + PPP +P P PPA P + P+ P R+ P
Sbjct: 684 MLPIQWAPGTMQPPPRAPT--PMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAP 741
Query: 170 NPPPPPSSSPPKNSPPAPI---AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPP 225
PP+++P + PPA A PP+ P PT PP A P + +P PPP
Sbjct: 742 GRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPP 800
|
Length = 991 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 428 LVGY--CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
LVG C RL L+ +YV L FH+ + R + + R AA L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YAAEICIALNFLHER 115
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
II+RD+K N+LLD + +++D+G+ K L T+ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTSTFCGTPNYIAPEILRGE 171
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVD 570
+ D ++ GV++ E++ GR P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 26/119 (21%), Positives = 45/119 (37%), Gaps = 1/119 (0%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P + P ++ P + P + P + A P + P + P +PP + +
Sbjct: 392 GAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAG 451
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
PSPP ++ P+ P P + P + P + PP P+ PA P+
Sbjct: 452 GAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPA-PPAAPAPAAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 63/228 (27%), Positives = 86/228 (37%), Gaps = 12/228 (5%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
++K P+ PP + + P P P A +PP PP P A P +SP
Sbjct: 320 LAKIPSQRVPPKESDA-----ADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPY 374
Query: 105 PPVSN--PPTRSPPPPSSTPPPNSPPSPPSDPPA--NSPPPSNPPSNLPPPPPSSVEPPK 160
+ PPT P P S+ P +S PA + P SN+P P+ VE K
Sbjct: 375 TAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKK 434
Query: 161 RSP--PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-PRPSNS 217
P P ++ PP S SP + +P S+VP P P T A+ A P P+N
Sbjct: 435 TRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANM 494
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGI 265
P SP P P + TN +S+P
Sbjct: 495 RPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALA 542
|
Length = 576 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 73/285 (25%), Positives = 95/285 (33%), Gaps = 10/285 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
SAPS P S PP SP PP + P + P
Sbjct: 228 SAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQ 287
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P+S+ P S PP P + P P S PP P +P P
Sbjct: 288 HPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIK 347
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPP-----PPPSSVEPPKRSPPSVPPQNPPPP-- 174
PPP +P + PP PS P PPP +++P P PP PPP
Sbjct: 348 PPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQ 407
Query: 175 --PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P S P ++ P P + S PP T P P P + P
Sbjct: 408 LMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGP-PQSPFAQHPFTSGGLPAIG 466
Query: 233 PPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAV 277
PP ST P ++ S P S+ PS+ G G + + +
Sbjct: 467 PPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQI 511
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 9/186 (4%)
Query: 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
GR+VA+K + + Q EV I+ H+++V + + + ++ +++ L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510
+ + R L+ + + L YLH +IHRDIKS +ILL + ++S
Sbjct: 106 T-DIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLS 159
Query: 511 DFGL-AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569
DFG A+++ D ++GT +MAPE S + D++S G++++E++ G P
Sbjct: 160 DFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
Query: 570 DASQPL 575
+ P+
Sbjct: 218 FSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 375 LGEGGFGSVYKGYLPDG---REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG V G + G +V +K+L++ Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL---DWATRVKIAAGAARGLAYLHEDCHP 487
C LL+ ++ P L +L + L D T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMAPEYASS--G 544
IH D+ N LL + ++ D+GL+ + ++T ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 545 KL-----TEKSDVFSFGVVLLELIT-GRKP 568
L T++S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 8/96 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK----LALDANTHITTRVMG 531
+ L Y+H +IHRD+K SNILL+++ +++DFGLA+ L + + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 532 TFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE S + T+ D++S G +L E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 65/240 (27%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQL----------KIGGGQGE 407
YE+L K +GEG +G V+K + G+ VAIK+ KI
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----- 47
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPN---NTLYFHLHGEGRPVLD 463
E+ ++ ++ H +LV+L+ R+L L+++Y + N L + G +
Sbjct: 48 ---LREIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VP 98
Query: 464 WATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
KI + + + H+ +C IHRD+K NIL+ + ++ DFG A++
Sbjct: 99 EHLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
Query: 523 THITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
T V T Y APE Y DV++ G V EL+TG QPL
Sbjct: 155 DDYTDYV-ATRWYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG-------QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 65/247 (26%), Positives = 93/247 (37%), Gaps = 27/247 (10%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP-----------PVSKPPTT 51
AP+P P + P + T PPPP + P + PP P++ P
Sbjct: 254 APAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPP 313
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PPP PA + + S P P P P PT +PP + +
Sbjct: 314 DPPPPAPAGDAEEEDDEDGAMEVVSPLPR----PRQHYPLGFPKRRRPTWTPPSSLEDLS 369
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
P ++ P S A +P P + P + V P SVP P
Sbjct: 370 AGRHHPKRASLPTRKRRSARH---AATPFARGPGGDDQTRPAAPV------PASVPTPAP 420
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNV--PPPPTQTPPTPASPIA-PRPSNSSPNSPPPPSTK 228
P P+S+PP + P P A P S+ PPP + PP PA+ A P +++ + +
Sbjct: 421 TPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRER 480
Query: 229 RLSPPPG 235
R PPG
Sbjct: 481 RPPEPPG 487
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 4/118 (3%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
S + PA+ P +++ PA++ P A+ P P P+P + P
Sbjct: 390 GAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAA--PAPAAAPQPA--PAPAPAPAPPSPA 445
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
P P PS+ P P +P PP+ P P P++ P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAP 503
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 28/137 (20%), Positives = 43/137 (31%), Gaps = 11/137 (8%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A + P + + P P ++P P P PA
Sbjct: 384 RLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPA------- 436
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
P + P + PA P+ P +P A P + P P P P + P P +
Sbjct: 437 -PAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPE---PTAAPAPAPPAAPAPAA 492
Query: 127 PPSPPSDPPANSPPPSN 143
P+ P+ P A +
Sbjct: 493 APAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 45/208 (21%), Positives = 65/208 (31%), Gaps = 9/208 (4%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P PPA+ + + S A + + A+ P P P T +
Sbjct: 22 PRPPATPGDAADDLLSGSQGQLVSDSA--ELAAVTVVAGAAACDRFEPPTGPPPGPGTEA 79
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P S + P S + PA P+ P + P PPP + P P P +
Sbjct: 80 PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLR 139
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P SP +P A S A+ P ++ PP+ S PP
Sbjct: 140 PVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPP 199
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSN 262
SSP S+S+ S
Sbjct: 200 AAA-------SPRPPRRSSPISASASSP 220
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 23/93 (24%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 15 SPPPPVSNPPTISPPPPVS-NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
P P PT + P PV P S+ P + P A+ PP P A
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P + + P P +PP PP
Sbjct: 422 PHTPESAPKLTRAAIPVDEKPKYTPP---APPK 451
|
Length = 585 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 10/138 (7%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L + + GR V AA A GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVF 553
N++LD+ +++DFG+ K + D +TT+ GT Y+APE + + D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 554 SFGVVLLELITGRKPVDA 571
+FGV+L E++ G+ P +
Sbjct: 186 AFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 30/82 (36%), Positives = 41/82 (50%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
++ ++PPPP +PPP +P P P A +PPP+ PP SS P + S P
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSP 576
Query: 168 PQNPPPPPSSSPPKNSPPAPIA 189
P P P+ SP K+S P I
Sbjct: 577 PPPIPEEPTPSPTKDSSPEEID 598
|
Length = 620 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 428 LVGY--CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
LVG C + RL + ++V L FH+ + R + + R +A + L +LHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNFLHER 115
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASS 543
II+RD+K N+LLD +++D+G+ K + +T T+ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRG 170
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVD 570
D ++ GV++ E++ GR P D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 25/98 (25%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P P P + PS P +P + P A + PP P PPP P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
P P P ++ P P PP PP +
Sbjct: 422 PHTPESAPKLTRAAIP---VDEKPKYTPP---APPKEE 453
|
Length = 585 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 41/202 (20%), Positives = 58/202 (28%), Gaps = 16/202 (7%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
PS G PA P ++ P + P P + P +PP P + P
Sbjct: 90 PSAGEPAPPP--PHARRTSEPELPRPGR--RPYEGYGGPRADDRPPGLPRQDQLPTARP- 144
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP--PPPSST 121
+ PA P PP P S P + P +
Sbjct: 145 ---AYPAYQQR-PEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAG 200
Query: 122 PPPNSPPSPPSDPPA-NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P D P + P ++ P PPP + + P + P P
Sbjct: 201 RPEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPS- 259
Query: 181 KNSPPAPIAVPPSNVPPPPTQT 202
P P+A P+ P P T
Sbjct: 260 ---APGPLAAQPAPAPGPGEPT 278
|
Length = 617 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 63/239 (26%), Positives = 78/239 (32%), Gaps = 9/239 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S PP S P PP+ S P PP+ P PP S P PP +P
Sbjct: 299 LAQSQVPPLPLPSQAQPHSHTPPSQSALQP-QQPPREQPLPPAPSMPHIKPPPTTPIPQL 357
Query: 62 PPTS--------SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S P P++ PPP + P SS P P S+ P P S P
Sbjct: 358 PNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQS 417
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P S P S P + P S P +S P PP P + P
Sbjct: 418 VPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPA 477
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P + + PP P PP + + PPPP + P
Sbjct: 478 APPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA-- 412
M YE++ K GEG +G VYK E +A+K++++ E+E +
Sbjct: 1 MDQYEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVP 45
Query: 413 -----EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
E+ ++ + H ++V L S+ R L+++Y+ L H + P R
Sbjct: 46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPR 102
Query: 468 V--KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA-QVSDFGLAKLALDANTH 524
+ RG+AY H R++HRD+K N+L+D A +++DFGLA+ A
Sbjct: 103 LIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVR 158
Query: 525 ITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T + T Y APE S + D++S G + E++ +
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-10
Identities = 14/83 (16%), Positives = 30/83 (36%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P + + +++ AS+P + A P +PP + ++PP + + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 112 TRSPPPPSSTPPPNSPPSPPSDP 134
P ++ P + P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
D + LGEG + +VYKG +G+ VA+K +++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAA-GAARGLAYL 481
++V L + + L+++YV + Y H G VK+ RGL+Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLFLFQLLRGLSYI 119
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-Y 540
H+ I+HRD+K N+L+ + E +++DFGLA+ A +H + + T Y P+
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 541 ASSGKLTEKSDVFSFGVVLLELITG 565
S + + D++ G + +E+I G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
+GEG +G VYK G VA+K++++ A E+ ++ ++H ++V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLAYLHE 483
++++ L++++ LH + + +D + I + GLA+
Sbjct: 68 IHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF--- 115
Query: 484 DCHP-RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
CH R++HRD+K N+L++ +++DFGLA+ A T + T Y APE
Sbjct: 116 -CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 543 SGKL-TEKSDVFSFGVVLLELITGR 566
K + D++S G + E++T R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA-- 412
+ TY++L K LGEG + +VYKG G+ VA+K++++ +G F A
Sbjct: 4 LETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIR 52
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIA 471
E ++ + H ++V+L + L+++Y+ + Y G G L
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFL 109
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
RGLAY H R++HRD+K N+L+ E +++DFGLA+ A + + +
Sbjct: 110 FQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV 165
Query: 532 TFGYMAP-------EYASSGKLTEKSDVFSFGVVLLELITGR 566
T Y P EY++S D++ G + E+ TGR
Sbjct: 166 TLWYRPPDVLLGSTEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 375 LGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGY 431
LGEG + +VYKG L D VA+K++++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-II 490
++ L+++Y+ + L +L G + ++ + RGL Y CH R ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNY----CHRRKVL 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
D++ G + E+ TGR PL S VE
Sbjct: 186 IDMWGVGCIFYEMSTGR-------PLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA--EVEIISRIH---HRHLVSL 428
+G G +G+VYK P G VA+K +++ + EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 429 VGYCIS--DDRRL---LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+ C + DR L++++V + L +L P L T + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+C I+HRD+K NIL+ + + +++DFGLA++ + T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLLQ 181
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPV 569
D++S G + E+ RKP+
Sbjct: 182 STYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 46/210 (21%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKI---GGGQGEREFKAEVEIISRIHHRH 424
F + +G G F VY+ L D + VA+K+++I + ++ E++++ +++H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL---YFHLHGEGRPVLD---WATRVKIAAGAARGL 478
++ + I D+ ++ + L + + R + + W V++ + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA----V 119
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
++H R++HRDIK +N+ + ++ D GL + + T ++GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E KSD++S G +L E+ + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 19/238 (7%)
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGEREF 410
++ SM E L TD + +G+G +G VYK DG A+K L E E
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EI 65
Query: 411 KAEVEIISRI-HHRHLVSLVGYCISDDRRL-----LIYDYVPNNTLYFHLHGEGR--PVL 462
+AE I+ + +H ++V G D+ + L+ + ++ + G L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
D A I GA GL +LH + RIIHRD+K +NILL ++ DFG++
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 523 THITTRVMGTFGYMAPEYASSGKLTEKS-----DVFSFGVVLLELITGRKPVDASQPL 575
T V GT +MAPE + + + S DV+S G+ +EL G P+ P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-10
Identities = 62/232 (26%), Positives = 81/232 (34%), Gaps = 30/232 (12%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++ P+ + + PP PP PPP P+ PPP P PP P P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPL-- 2943
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
PT+ P A P + P P A P V+ P R P P S
Sbjct: 2944 ------------APTTDPAGAGEPSGAVPQPWLGALVPGR------VAVPRFRVPQPAPS 2985
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNL-----PPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S P + S+ S+L PPP S++ P +
Sbjct: 2986 REAPASSTPPLTGHSL--SRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADSLF 3043
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-PRPSNSSPNSPPPPS 226
S ++ A +PP P P P PA+P A R S SS PPP S
Sbjct: 3044 DSDSERSDLEALDPLPPE--PHDPFAHEPDPATPEAGARESPSSQFGPPPLS 3093
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 8e-10
Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 1/122 (0%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
+ P + P ++ P +P P + PA + P+ + P P P+ P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPA-PAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSP 444
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
+ P P PP ++ P P A P P P PA AP +
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 223 PP 224
Sbjct: 505 GA 506
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P+P P +++P P P + P + PP PV + T P P P +
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAA--AAANIPPKEPVRETATPPPVPPRPVA- 418
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
PP +P ++ T + P P +PP P
Sbjct: 419 PPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-10
Identities = 39/166 (23%), Positives = 45/166 (27%), Gaps = 8/166 (4%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP---PPPPVSKPPTTSPPPSP 57
+ P AA PP P P PP +P + P P P P PP
Sbjct: 180 LPQGMPPRQAAFPQQGPPE---QPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQL 236
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP--TISPPPPVSNPPTRSP 115
P PP PPP P PP P A PP +P P +
Sbjct: 237 PQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPL 296
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
PPP P + S E KR
Sbjct: 297 PPPQQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQREALSQEEAKR 342
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 367 DGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
D F + LG G G V+K + P G +A K + + R + E++++ + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+V G SD + +++ +L L GR +V IA +GL YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 122
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+I+HRD+K SNIL+++ E ++ DFG++ +D+ + +GT YM+PE
Sbjct: 123 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT 177
Query: 545 KLTEKSDVFSFGVVLLELITGRKPV 569
+ +SD++S G+ L+E+ GR P+
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 39/187 (20%), Positives = 52/187 (27%), Gaps = 7/187 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ SS P P S+ + P +P P P S ++S S +S+
Sbjct: 267 TRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSS 326
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
TSSS +S SP P+ S P P P P P P +
Sbjct: 327 SSTSSSSESSRGAAVSPGPSP----SRSPSPSRPPPPAD--PSSPRKRPRPSRAPSSPAA 380
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP-PPSSSPP 180
A + P P + P PS P
Sbjct: 381 SAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPW 440
Query: 181 KNSPPAP 187
SPP P
Sbjct: 441 PGSPPPP 447
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 47/198 (23%), Positives = 64/198 (32%), Gaps = 9/198 (4%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P + P++ P P+ +S+P S P+ S P S P P+S +SS
Sbjct: 258 PRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSS 317
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
S +SS T S P PS +P SP PP PPA+ P P
Sbjct: 318 SSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSP---SPSRPP--PPADPSSPRKRPRPS 372
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P + + + P P + + A
Sbjct: 373 RAPSSPAASAGRPTRRRARAAVAGRARRRDAT---GRFPAGRPRPSPLDAGAASGAFYAR 429
Query: 209 PIAPRPSNSS-PNSPPPP 225
PS P SPPPP
Sbjct: 430 YPLLTPSGEPWPGSPPPP 447
|
Length = 1352 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 59/248 (23%), Positives = 87/248 (35%), Gaps = 6/248 (2%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + +P P ++ + P S PT + + P PTS + A+ TS
Sbjct: 443 PHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSP 502
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P + P +SP + +P SP P V T + PP+ T + SP
Sbjct: 503 TPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSP--QVTEE 560
Query: 138 SPPPSNPPSNLPPPPP---SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
SP + + P S+V + S P P PSSS + P
Sbjct: 561 SPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLT 620
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSP-PPPSTKRLSPPPGIPVPSTENTPGNGTNPSS 253
P T +P P ++ S SP P P T PG S + T
Sbjct: 621 SAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMP 680
Query: 254 PESSSSPS 261
+++SPS
Sbjct: 681 NPNATSPS 688
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G V + G+ VA+K++ + Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDC 485
D ++ +++ EG + D T + + + L+ LH
Sbjct: 88 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ- 135
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPEYASS 543
+IHRDIKS +ILL ++ ++SDFG + + R ++GT +MAPE S
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G++++E++ G P PL
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
++ LY +L RP L + I GL YLH RIIHRD+K+ NI +++ +
Sbjct: 140 SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQ 195
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 563
+ D G A+ + A + + GT APE + K K+D++S G+VL E++
Sbjct: 196 VCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 55/235 (23%), Positives = 79/235 (33%), Gaps = 9/235 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P P + P P + +S P P S P T S P ++ P
Sbjct: 565 PAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQW 624
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSP--PPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
P P P P P + +P PP P + P P
Sbjct: 625 PMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTM 684
Query: 147 NLPPPPPSSVEPPKRSP-PSVPPQNPP---PPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P +++PP R+P P PP PP P+++ + PPA P +
Sbjct: 685 LPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRA 744
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPV---PSTENTPGNGTNPSSP 254
P A+P RP ++P PP+ +P P P P+ + P P P
Sbjct: 745 RPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPP 799
|
Length = 991 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-09
Identities = 16/98 (16%), Positives = 33/98 (33%), Gaps = 6/98 (6%)
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P +++ PT + + + P + P +P P + PA P P+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAA-----AAA 91
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
++ P + + P +P + A +A
Sbjct: 92 AAAAPAAPPAAAAAAAPAAAAVEDEVTPLR-GAAAAVA 128
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 14/140 (10%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P + PA+ P P A++ + SP +S P +P +++ P
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQ----PSAAAAASPSPSQSSAAA---QPSAPQSATQPAG 422
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
+PP +PP P P ST P P+ P S S P S P +
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQF--KEEKKIPVSKVSSLGP-----STLRPIQ 475
Query: 162 SPPSVPPQNPPPPPSSSPPK 181
N P+ + +
Sbjct: 476 EKAEQATGNIKEAPTGTQKE 495
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 12/120 (10%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
K S P P + P A+ P+++ + +P SS P A P
Sbjct: 364 QKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSA--------PQ 415
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP--SSVEPPKRSP 163
+ P PP S PP + P P + P+ P SS+ P P
Sbjct: 416 SATQPAGT--PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIIS 418
T+ + D +G G FG V G+ VAIK++ + + RE K ++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLK 64
Query: 419 RIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF---------HLHGEGRPVLDWATRVK 469
+ H +++SL IS P +YF H RP+ +
Sbjct: 65 HLRHENIISLSDIFIS-----------PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY- 112
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
RGL Y+H ++HRD+K SNIL++ N + ++ DFGLA++ T
Sbjct: 113 FLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGY 165
Query: 530 MGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGR 566
+ T Y APE + K + D++S G + E++ G+
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHIT-TRVMGTF 533
R L Y+H + HRD+K NIL + + + ++ DFGLA++A D T I T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 534 GYMAPEYASS--GKLTEKSDVFSFGVVLLELITGR 566
Y APE S K T D++S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 375 LGEGGFGSVYKGYLPDGR--EVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG G FG V + VAIK+ + I Q + F +E +I++ I+H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G + L+ ++V + L R D AA YL
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEYLQS---LN 151
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K N+LLD + +++DFG AK+ +D T+ + GT Y+APE + +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVGHGK 207
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFL 598
+D ++ G+ + E++ G P A++PL LI KIL +++
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPL----------LIYQKILEGIIYF 247
|
Length = 340 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 31/150 (20%), Positives = 51/150 (34%), Gaps = 5/150 (3%)
Query: 94 PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
P++S + R + P + PS + PA +P P+ P
Sbjct: 365 PSASDDERGLLARLERLERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAA----PAAA 420
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
++ P P+ P P PPS + + AP PP+ P P A
Sbjct: 421 AAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSP-PPAAAPSAQPAPAPAAAPEPTAA 479
Query: 214 PSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
P+ + P +P P + P P + +
Sbjct: 480 PAPAPPAAPAPAAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 3/95 (3%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P PT++ P + P+ P + P + PP PP P + P
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPP 420
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P L E PK +PP+ P +
Sbjct: 421 V---PHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/197 (26%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 375 LGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGY 431
LGEG + +V+KG L + VA+K++++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-II 490
+D L+++Y+ + L ++ G + ++ + RGLAY CH R ++
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAY----CHRRKVL 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 550 SDVFSFGVVLLELITGR 566
D++ G + E+ +GR
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 24/111 (21%), Positives = 42/111 (37%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+APS A ++ P + +P P + P +P P P P + P S
Sbjct: 397 AAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSP 456
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP ++ +P ++ P + P +PP +P ++ P P
Sbjct: 457 PPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 4e-09
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 3/80 (3%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
++P ++ A+ + P+ A + P +PP +PP P++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAA---AAPAAPPKPAAAAAAA 93
Query: 126 SPPSPPSDPPANSPPPSNPP 145
+ P+ P A + P +
Sbjct: 94 AAPAAPPAAAAAAAPAAAAV 113
|
Length = 1228 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 32/128 (25%), Positives = 46/128 (35%), Gaps = 19/128 (14%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPP--PSPPASNPPTSSSPPASSPPTSS 77
V N ++P P S K P P + +P P P P + P SP ++ P
Sbjct: 374 VRNDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQ 433
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPP--------------VSNPPTRSPPPPSSTPP 123
PP A + P PPSP AS+P ++ P N + P SS+
Sbjct: 434 PPVARSAPL---PPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDA 490
Query: 124 PNSPPSPP 131
+
Sbjct: 491 AQTGVFEG 498
|
Length = 620 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFK--------AEVEIISRI-HHRH 424
+GEG F V K G+ AIK +K + FK E++ + R+ H +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 425 LVSL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYL 481
++ L V + R L+++ + N LY + G RP+ + RVK + L ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMN-LYELIKGRKRPLPE--KRVKSYMYQLLKSLDHM 116
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH---ITTRVMGTFGYMAP 538
H I HRDIK NIL+ ++ +++DFG + + I+TR Y AP
Sbjct: 117 H---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAP 167
Query: 539 E-YASSGKLTEKSDVFSFGVVLLELIT 564
E + G K D+++ G V E+++
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 406 GEREFKA-EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLD 463
G+R A E I+ I+H ++ L G + LI + LY +L + + D
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-LYCYLAAKRNIAICD 183
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523
+ I R + YLHE+ RIIHRDIK+ NI +++ + + DFG A +D N
Sbjct: 184 I---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ GT APE + D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP-PKSSPPPPPVSKPPTTSPPPSPPA 59
+A +P A +++ P + P + P P P P +PP P + P +P P P A
Sbjct: 401 AAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAA 460
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
+ + PA++P ++ P + P +P +P A + P
Sbjct: 461 APSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGA 506
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 26/98 (26%), Positives = 32/98 (32%), Gaps = 3/98 (3%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P P + PSP PA S P + PP E P P PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P P+++P A P + P T P A
Sbjct: 422 PH---TPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKA 456
|
Length = 585 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFH----LHGEGRPVLDWATRVKIAAGAARGLA 479
++V L Y +S+D L+ + L+ H L+ V WA + +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
LH + I+ RD+ +NILLD+ Q++ F D+ M Y APE
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-----SLVEWVN 585
+ TE D +S G +L EL+TG+ V+ P G ++ EWV+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVS 202
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 24/90 (26%), Positives = 30/90 (33%), Gaps = 1/90 (1%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
P P P + SP P P TR ++ PP P + PP P P PP
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPP 420
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P + P P+ PP P
Sbjct: 421 VP-HTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 7e-09
Identities = 21/79 (26%), Positives = 34/79 (43%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ S AS+P +P P +PP + PS P + +P PP + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 120 STPPPNSPPSPPSDPPANS 138
T P +PP+ ++ P +
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-09
Identities = 48/174 (27%), Positives = 62/174 (35%), Gaps = 22/174 (12%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK-- 160
P PV P + P ++ P+ P DP A P P+ LP P P+
Sbjct: 2475 PGAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRML 2534
Query: 161 ---RSPPSVPPQNPPPPPSSSPPKNSPPAP-IAVPPSNVPPPPTQ-----------TPPT 205
R + + PP PP P AP +VPP P P++ PP
Sbjct: 2535 TWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQ 2594
Query: 206 PASPIAPR-----PSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
A P AP P +P SP PP T PPP P P+ + P
Sbjct: 2595 SARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPP 2648
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 23/88 (26%), Positives = 29/88 (32%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P P+ P S+ P PP S P S PP + PP PP
Sbjct: 191 SPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQ 250
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSP 89
P S+ + P S+ P T
Sbjct: 251 VPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 9e-09
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
P ++ PT++ + A+S P +P P +PP P +PP P + A +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAA---AAPAAPPKPAAAAAAAA 94
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSP 163
P + P + P ++ + +P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ ++ +T V+ T Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWY 181
Query: 536 MAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
APE + T+ D++S G ++ E++TG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 57/210 (27%)
Query: 358 TYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA---- 412
YE+L K +G+G FG V+K + + VA+K++ + E E +
Sbjct: 13 KYEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPIT 57
Query: 413 ---EVEIISRIHHRHLVSLVGYC------ISDDRR--LLIYDY--------VPNNTLYFH 453
E++I+ + H ++V+L+ C + + L++++ + N + F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117
Query: 454 LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
L E + K+ GL Y+H + +I+HRD+K++NIL+ + +++DFG
Sbjct: 118 L-SEIK---------KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164
Query: 514 LAKL----ALDANTHITTRVMGTFGYMAPE 539
LA+ T RV+ T Y PE
Sbjct: 165 LARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-----HITTRVM 530
GL Y+H ++HRD+K N+L++ + E ++ DFGLA+ N +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYV- 170
Query: 531 GTFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGRKPV 569
T Y APE S + K+ DV+S G +L EL+ GRKPV
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 28/93 (30%), Positives = 35/93 (37%), Gaps = 1/93 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
PS P + SPP S+P S PP S+ +PPP P S + PP
Sbjct: 186 DPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPP 245
Query: 62 PPTSSSPPASSP-PTSSPPPASNPPTSSPPPSP 93
PP PP S+ PT A+ P
Sbjct: 246 PPVQQVPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-08
Identities = 14/82 (17%), Positives = 30/82 (36%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P S +++ A++ S+P A + P P ++ +PP P + + P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 118 PSSTPPPNSPPSPPSDPPANSP 139
+ P+ + +P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-08
Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP-PSPPASSPPT 100
P + P + + AS P + + A + P +PP A+ P P + A++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 101 ISPPPPVSNPPTRSPPPPSSTP 122
P + P + TP
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-08
Identities = 17/78 (21%), Positives = 34/78 (43%)
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P +T+ P + A+ +S+P A+ + PA PP ++ P +PP + + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 107 VSNPPTRSPPPPSSTPPP 124
+ P + P++
Sbjct: 97 AAPPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 23/103 (22%), Positives = 35/103 (33%), Gaps = 3/103 (2%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS-PPSPPSDPPANSPPPSNP 144
+S P P + P + P + S +P +S P + A P + P
Sbjct: 368 DASGGRGPKQHIKPVFTQP--AAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPP 425
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
++ PP V PP +P +V P K S P
Sbjct: 426 TVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGP 468
|
Length = 614 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 47/271 (17%), Positives = 66/271 (24%), Gaps = 37/271 (13%)
Query: 4 PSPGPPAANSSSPPPPVSNPPT---ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
P PGP P P P P + P + P P P P
Sbjct: 362 PVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYY 421
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + P + + + T P + P
Sbjct: 422 APAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQP---AAQEPLY 478
Query: 121 TPPPNSPPSPPSDPP--ANSPPPSNPP------------------SNLPPPPPSSVEPPK 160
P P +P P+ PP + P P V+ P+
Sbjct: 479 QQPQPVEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPE 538
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP----ASPIAPRPSN 216
S+ + P P V + + T P A+ PRP
Sbjct: 539 PIKSSLKAPSVAAVPPVEAAAAVSPLASGVKKATLATGAAATVAAPVFSLANSGGPRPQV 598
Query: 217 SSPNSPPPPSTKRLSPPP-------GIPVPS 240
P P KR+ P GI +PS
Sbjct: 599 KEGIGPQLPRPKRIRVPTRRELASYGIKLPS 629
|
Length = 1355 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 30/128 (23%), Positives = 36/128 (28%), Gaps = 5/128 (3%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPP-ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
A SP PP AS P P A PP +P P P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQP- 128
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P+ P P P P P P + P P + +P + P P
Sbjct: 129 -VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSA--PQPAQQAFQPAEPVAAPQPEPVAEP 185
Query: 174 PPSSSPPK 181
P PK
Sbjct: 186 APVMDKPK 193
|
Length = 333 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 17/121 (14%), Positives = 36/121 (29%)
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P+ P + P+ + P+ P + + A P PP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 201 QTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
P A+P A + + + P + +P P + +P ++ +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 261 S 261
+
Sbjct: 486 A 486
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 28/146 (19%), Positives = 47/146 (32%), Gaps = 14/146 (9%)
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P + A +P P+ P++ + + P P +++ P AP A
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPA---AAPAAAASA---PAAPPA 419
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP----PGIPVPSTENTP 245
P P P A AP +P P + + ++ P P V S P
Sbjct: 420 AAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAP 479
Query: 246 GNGTNPSSPESSSSPSNNGIGTAGTV 271
+ + +P+ G TV
Sbjct: 480 A----AAPAAARLTPTEEGDVWHATV 501
|
Length = 618 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 18/171 (10%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPPASNPPTS 65
PP + P + I P + P P +PP +P P P + PP
Sbjct: 654 PPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGR 713
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP---PTRSPPP----- 117
+ PA++ + PPA+ P + PP + P + P + P P P R+ PP
Sbjct: 714 AQRPAAAT-GRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPG 772
Query: 118 -PSSTPPPNSPPSPPSDP---PANSPPPSNPPSNL---PPPPPSSVEPPKR 161
P+ PPP +PP+P P P PPP P+++ P P P K+
Sbjct: 773 APTPQPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQ 823
|
Length = 991 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 23/79 (29%), Positives = 33/79 (41%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
PS S +S+P +P + PP + S+P A++P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 115 PPPPSSTPPPNSPPSPPSD 133
P PS TPP N+ +PPS
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/81 (29%), Positives = 34/81 (41%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
S + A +PPP P P P +P +PP PP PP +S +
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 189 AVPPSNVPPPPTQTPPTPASP 209
+ PP +P PT +P +SP
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/79 (30%), Positives = 32/79 (40%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
S T PPP P P PP+ +P T+PPP+PP P + + + +
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 81 ASNPPTSSPPPSPPASSPP 99
P P PSP S P
Sbjct: 576 PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 30/85 (35%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
+S PP P PPA PP + PPT PPP P + + PA
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPP---PTATQASSNAPAQ 569
Query: 97 SPPTISPPPPVSNPPTRSPPPPSST 121
P SPPPP+ PT SP SS
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 19/77 (24%), Positives = 35/77 (45%)
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
P S+ ++ A+ S+P +P A +P +P PP + P P P ++ +P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 129 SPPSDPPANSPPPSNPP 145
+PP+ A +P +
Sbjct: 98 APPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 13/82 (15%), Positives = 30/82 (36%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P + P + + ++ P P +PP + + PP ++ A++ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 77 SPPPASNPPTSSPPPSPPASSP 98
+PP A+ + +P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PG AA +++ + + P P +P PP +PP A+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPA--AAAPAAPPKPAAAAAAAA 94
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
+ + P ++ ++P A+ +P A
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPLRGAAA 125
|
Length = 1228 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS---- 543
+HRDIK N+LLD N +++DFG T ++ +GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 544 -GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
GK + D +S GV + E++ G P A ESLVE
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 22/88 (25%), Positives = 29/88 (32%), Gaps = 8/88 (9%)
Query: 149 PPPPPSSVEPPKRSP--PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P P P+ SP P+ P P +++ P P VPP P P
Sbjct: 364 PAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPH 423
Query: 207 ASPIAPR------PSNSSPNSPPPPSTK 228
AP+ P + P PP K
Sbjct: 424 TPESAPKLTRAAIPVDEKPKYTPPAPPK 451
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 20/81 (24%), Positives = 30/81 (37%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
++S P + PP P P + P TPPP P + + A + P++
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 145 PSNLPPPPPSSVEPPKRSPPS 165
P P + P K S P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-08
Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 2/83 (2%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S+ P + ++ S PA++P +P P P + P++ P P + + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPA--PAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 134 PPANSPPPSNPPSNLPPPPPSSV 156
P A +
Sbjct: 96 PAAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-08
Identities = 15/82 (18%), Positives = 29/82 (35%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P + P ++ + P +P PA+ P + A + P A+ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 89 PPPSPPASSPPTISPPPPVSNP 110
PP+ A++ P + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/209 (22%), Positives = 59/209 (28%), Gaps = 8/209 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS-NPPTS 87
P P P P+ P S P P P P S PT
Sbjct: 549 PGETKEGEVGKKPGPAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTR 608
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPP---PSSTPPPNSPPSPPSDPPANSPPPSNP 144
P P SP P S + PPP PSS P P S P SP P
Sbjct: 609 PKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFD 668
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
P ++ +S + S + P P + P PP P
Sbjct: 669 PKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKL-PR 727
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
P P P++ P + +PP
Sbjct: 728 DEEFPFEPI---GDPDAEQPDDIEFFTPP 753
|
Length = 943 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 63/255 (24%), Positives = 84/255 (32%), Gaps = 38/255 (14%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS-----------------SPPPPPVS 46
P AA+ P P P PP PP+ PP P+
Sbjct: 329 PPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIP 388
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP--- 103
PP++SP +S + + PA SP ASN P P + P +SP
Sbjct: 389 TPPSSSP----ASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRP-LSPYAR 443
Query: 104 ----PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS------PPPSNPPSNLPPPPP 153
PP S PT S +S P+ P PA + PPP+N P
Sbjct: 444 YEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVY 503
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
++PP P+ P P ++ K AP Q P P SP
Sbjct: 504 DDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADE--QHHAQPKPRPLSPY-TM 560
Query: 214 PSNSSPNSPPPPSTK 228
+ P + P PS
Sbjct: 561 YEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 20/85 (23%), Positives = 31/85 (36%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
S+ + S P + P + P A P PPP+ +S + P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSP 130
S+PP P P+ +P +S P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 29/85 (34%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
S ASN + PP SPP PPA PP P + P +PP P ++ +
Sbjct: 514 SGSASNTAKTPPPPQKSPP----PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPP 140
P S+PPP P P P +S P
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 11/81 (13%), Positives = 26/81 (32%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
++P + S P + PA+ P + +P + + PP ++
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 95 ASSPPTISPPPPVSNPPTRSP 115
+ + P + +P
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 4e-08
Identities = 66/277 (23%), Positives = 105/277 (37%), Gaps = 18/277 (6%)
Query: 4 PSPGPPAANSSSPPPPVSNPPT-ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P+ G P +SS P ++P + + P + P + P + P T +P A++P
Sbjct: 469 PTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSP 528
Query: 63 P---TSSSPPASSPPTS--SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+ A+SPPT S P A++P + P ++P S P +++ T
Sbjct: 529 TPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHG 588
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP---PSSVEPPKRSPPSVPPQNPPPP 174
S+ P + P PS ++S P SN S P P+ E PSVP
Sbjct: 589 TGSS-PTSQQPGIPS--SSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVST 645
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
S P + S+ P + T P N + SP PS ++ + P
Sbjct: 646 LSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMP------NPNATSPSAPSGQKTAVPT 699
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
N+ T+ S+ +S+SP N T
Sbjct: 700 VTSTGGKANSTTKETSGSTLMASTSPHTNEGAFRTTP 736
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 38/174 (21%), Positives = 53/174 (30%), Gaps = 8/174 (4%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP--PPSPPASSP-PTISPPPPVSNP 110
P P PP +S + PT + P P T P P+P + P N
Sbjct: 336 PVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNE 395
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P P + P P P P+ P P+ +P + Q
Sbjct: 396 PLQQPVQPQQPYYAPAAEQPAQQP--YYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQ 453
Query: 171 PP-PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P S+ + + P A P P P P P + P PP
Sbjct: 454 STFAPQSTYQTEQTYQQPAAQEPLYQQPQP--VEQQPVVEPEPVVEETKPARPP 505
|
Length = 1355 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 52/227 (22%), Positives = 63/227 (27%), Gaps = 9/227 (3%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P V+ P N P P +P +PP+ P+ P
Sbjct: 53 PEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQ 112
Query: 77 SPPPASNP--PTSSPPPSPPASSPPTISPPPPVSNP--PTRSPPPPSSTPPPNSPPSPPS 132
P P P P S P PPA P P PP P PP N PP S
Sbjct: 113 QPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQS 172
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
P + P P PP+ + P S+ Q P S PP P
Sbjct: 173 APQVSGLYPEESPYQPQSYPPN-----EPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMY 227
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P P+ P + S PPPS
Sbjct: 228 GGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQ 274
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 363 VKATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE---FKAEVEIIS 418
+KA D F ++G G FG V ++V A+K L + F E +I++
Sbjct: 40 MKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 419 RIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA----TRVKIAAG 473
+ +V L Y DD+ L ++ +Y+P L + P WA V +A
Sbjct: 99 HANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLALD 156
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGT 532
A + + IHRD+K N+LLD + +++DFG K+ + T V GT
Sbjct: 157 AIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 533 FGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
Y++PE S G + D +S GV L E++ G P +SLV
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 31/139 (22%), Positives = 44/139 (31%), Gaps = 9/139 (6%)
Query: 2 SAPSPGP-PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
AP+ P AA ++ P + P P ++P P PP PP +
Sbjct: 452 PAPAAAPAAAARPAAAGPR--PVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASP 509
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + PA S P PA+ P + P +P P + P
Sbjct: 510 APAQPDAAPAGWVAESIPDPATADP---DDAFETLAPAPAAAPAPRAAAATEPVVAP--- 563
Query: 121 TPPPNSPPSPPSDPPANSP 139
PP S P + P
Sbjct: 564 RPPRASASGLPDMFDGDWP 582
|
Length = 700 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 5e-08
Identities = 19/137 (13%), Positives = 34/137 (24%), Gaps = 6/137 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSS---PPPPPVSKPPTTSPPPSPP 58
+A A + PP P S T S P
Sbjct: 384 TAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEP 443
Query: 59 ASNP---PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
A+ P +S+ + +P P A++P + P + +
Sbjct: 444 AAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKA 503
Query: 116 PPPSSTPPPNSPPSPPS 132
TP + + +
Sbjct: 504 LEHEKTPELAAKLAAEA 520
|
Length = 647 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 26/77 (33%), Positives = 35/77 (45%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
+ S + PP SPP P PP P + PP PPPPP++ + +P +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 171 PPPPPSSSPPKNSPPAP 187
PPPP P SP
Sbjct: 575 SPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 21/81 (25%), Positives = 32/81 (39%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ S+ + P P + P P P A++PP PPPP + S P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 124 PNSPPSPPSDPPANSPPPSNP 144
+ PP P +P + S+P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 375 LGEGGFGSVYKG--YLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIH---HRHLVS 427
+GEG +G V+K GR VA+K++++ G+ EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 428 LVGYCI-----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
L C + + L++++V + L +L P + T + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
R++HRD+K NIL+ ++ + +++DFGLA++ + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPV 569
D++S G + E+ RKP+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 390 DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV-GYCISDDRRLLIYDYVPNN 448
++V +K + GG RE ++I+ I HR +++L+ Y +++ Y
Sbjct: 118 QRKKVIVKAV-TGGKTPGRE----IDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KC 170
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
L+ ++ G L+ + I LAYLH IIHRD+K+ NI LD A
Sbjct: 171 DLFTYVDRSGPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV 225
Query: 509 VSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567
+ DFG A KL +T GT +PE + K+D++S G+VL E+
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 568 PVDASQ 573
+ Q
Sbjct: 286 TLFGKQ 291
|
Length = 392 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 32/122 (26%), Positives = 41/122 (33%), Gaps = 7/122 (5%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
S P + P P+ P P ++ P S S Q P P S++ P +PP
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQ-PSAPQSATQPAGTPPTVS 428
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
PP+ VP P T P RP+ P S S P P E
Sbjct: 429 VDPPAAVPVNPPSTAPQAV-----RPAQFKEEKKIPVSKVS-SLGPSTLRPIQEKAEQAT 482
Query: 249 TN 250
N
Sbjct: 483 GN 484
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 24/109 (22%), Positives = 34/109 (31%), Gaps = 4/109 (3%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
PV P +P P + SP + P+ + PA PPT S
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P ++ P P S P + P +S + P T P
Sbjct: 429 VDPPAAVPV---NPPSTAPQAVRPAQFKEEKKIPVSKVSSLG-PSTLRP 473
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 26/129 (20%), Positives = 35/129 (27%), Gaps = 8/129 (6%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP--PVSNPPTRSPPPPSSTPP 123
A + +P PP A + PP V P P+ P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
P + P P P P P P + + P P P P +
Sbjct: 130 QQPAYQPQPEQP---LQQPVSPQVAPAPQPVHSAPQP-AQQAFQPAEPVAAPQPEPV--A 183
Query: 184 PPAPIAVPP 192
PAP+ P
Sbjct: 184 EPAPVMDKP 192
|
Length = 333 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 535 YMAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
ARG+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV+L E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 45/212 (21%), Positives = 66/212 (31%), Gaps = 19/212 (8%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+PP + P + + PPP P A++P + PP + P + PP+
Sbjct: 256 APPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDP 315
Query: 127 PPSPPSDPPANSP----------PPSNPPSNLPPPPPSSVEPPKRSPPSV--------PP 168
PP P+ P P + P P P P S+ P
Sbjct: 316 PPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHHP 375
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
+ P P A P P PAS P P+ ++PPPP+T
Sbjct: 376 KRASLPTRKRRSARHAATPFARGPGG-DDQTRPAAPVPASVPTPAPTPVPASAPPPPATP 434
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
S PG P++ + P
Sbjct: 435 LPSAEPGSDDGPAPPPERQPPAPATEPAPDDP 466
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 29/101 (28%), Positives = 39/101 (38%), Gaps = 5/101 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP--PKSSPPPPPVSKPPTTSPPPSPPA 59
++ SP P ++S P S P S P S P P S P P + + P PP
Sbjct: 180 ASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPG 239
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P PP S+ P PP++S P+P
Sbjct: 240 PAAP-PPPPVQQVPPLSTAKPT--PPSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 7e-08
Identities = 13/90 (14%), Positives = 26/90 (28%), Gaps = 2/90 (2%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P + ++ S P +P A P ++ ++PP + A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA--AAA 94
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
+ P A++ + P R
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSL 428
++GEG +G V K + +E VAIK+ K + E K E++++ + ++V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 429 VGYCISDDRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ L+++YV N L G P K+ + + + +H CH
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP------PEKVRSYIYQLIKAIHW-CHK 118
Query: 488 R-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRDIK N+L+ +N ++ DFG A+ + + T + T Y +PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 547 TEKSDVFSFGVVLLELITGR 566
+ D++S G +L EL G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 27/171 (15%), Positives = 51/171 (29%), Gaps = 8/171 (4%)
Query: 95 ASSPPTISPPPPVSNP-PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
A+ T+ PP S S P + +P N S
Sbjct: 450 ANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASLISK- 508
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--PSNVPPPPT---QTPPTPAS 208
S+ K S P P P +S K + A S++ P + ++P
Sbjct: 509 STGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEHSVP 568
Query: 209 PIAPRPSNSSPNSPPP-PSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSS 258
+ + ++ ST + + + +P + ++P +S
Sbjct: 569 LVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 23/81 (28%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
S+ T+ PP P P+PP P +PPP PP +S+ P P+
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPP--TATQASSNAPAQIPAD 573
Query: 131 PSDPPANSPPPSNPPSNLPPP 151
S PP P+ P+ P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 8e-08
Identities = 13/82 (15%), Positives = 26/82 (31%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + PT + + + P + PP+ A P + A++ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 78 PPPASNPPTSSPPPSPPASSPP 99
PPA+ + + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 33/218 (15%), Positives = 45/218 (20%), Gaps = 7/218 (3%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
S GP A + P + K P +P P PP
Sbjct: 85 SKGPAAKTKPAKEPKNESGKEEEKEKEQVKEEKKKKKEKPKEEPKDRKPKEEAKEKRPPK 144
Query: 65 SSSPPASSPPTSSPPPASNPPTS-SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
P PP PP PP ++
Sbjct: 145 EK-EKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQRQAAREA 203
Query: 124 PNSPPSPPSDPP-----ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
P P + ++ S S + P P PS +
Sbjct: 204 VKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEISRRSSSSLKKPDPSPSMA 263
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P+ + P P A P PR
Sbjct: 264 SPETRESSKRTETRPRTSLRPPSARPASARPAPPRVKR 301
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 26/81 (32%), Positives = 31/81 (38%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S+S PP SPPPP PP P P PP + AS+ + P SS
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 73 PPTSSPPPASNPPTSSPPPSP 93
PP P + PT P
Sbjct: 576 PPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE---FKAEVEIISRIHHRHLVSLV 429
++G G FG V L + +V A+K L E F+ E +++ ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL- 66
Query: 430 GYCISDDRRL-LIYDY-VPNNTLYFHLHGEGRPVLDWA----TRVKIAAGAARGLAYLHE 483
Y D+ L L+ DY V + L E R D A + IA + L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+HRDIK NIL+D N +++DFG ++ T ++ +GT Y++PE +
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 544 -----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
GK + D +S GV + E++ G P A ESLVE
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 55/197 (27%), Positives = 71/197 (36%), Gaps = 23/197 (11%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP---PVSKPPTTSPPPSP 57
M P P P +PP + P P P + PPPP P+S PT PP +
Sbjct: 343 MPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAH 402
Query: 58 PA---------SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT-------- 100
P + PP + S PP AS P S PP S
Sbjct: 403 PPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGL 462
Query: 101 -ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
PPP T + PP +S+ + PS P P PP + P E P
Sbjct: 463 PAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEP 522
Query: 160 KRSPPSVPPQNPPPPPS 176
+ PP PP++P P P+
Sbjct: 523 ESPPP--PPRSPSPEPT 537
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 23/80 (28%), Positives = 29/80 (36%)
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
LP S + P NP PPP+ P A PS P + P PA
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 208 SPIAPRPSNSSPNSPPPPST 227
P P P+ + + PPS
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 26/83 (31%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S+ A PP P PPA +PP P P PPP ++ N+P P+D
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 136 ANSPPPSNPPSNLPPPPPSSVEP 158
PPP P SS E
Sbjct: 576 --PPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 2/81 (2%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+ S + P PP + P + P + PPT PPPP++T S +P P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQA--SSNAPAQIP 571
Query: 135 PANSPPPSNPPSNLPPPPPSS 155
+SPPP P P P S
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDS 592
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 26/81 (32%), Positives = 34/81 (41%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
+ S PP PPP + PP P + P PPPP + + S AP +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 195 VPPPPTQTPPTPASPIAPRPS 215
PPPP PTP+ P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 21/101 (20%), Positives = 33/101 (32%), Gaps = 2/101 (1%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
GP P + P + +P +SS P + T P +PP +
Sbjct: 371 GGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVD 430
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
++ P P S+ P A P P S ++ P
Sbjct: 431 PPAAVPV--NPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 31/126 (24%), Positives = 41/126 (32%), Gaps = 4/126 (3%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P + + PSP P +S P PP A PP +P P+ PA P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASA-QPRQPVQQPPEAQVPPQHAPRPAQPAPQP 128
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPN--SPPSPPSDPPANSPPPSNPPSNLPPPPPS-S 155
P P + P P P P P+ P P P P+
Sbjct: 129 VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPV 188
Query: 156 VEPPKR 161
++ PKR
Sbjct: 189 MDKPKR 194
|
Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 29/82 (35%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKL 546
+++HRD+KS+NI L ++ DFG +K D+ + + + GT Y+APE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
++K+D++S GV+L EL+T +P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV-MGTFGYMAPEYASS--- 543
+HRDIK N+LLD N +++DFG + L L A+ + + V +GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 544 --GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
G+ + D +S GV + E++ G P A ESLVE
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 42/135 (31%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 11 ANSSSPPPPVSNPPTISPP---PPVSNPPKSSPP--PPPVSKPPTTSPPPS-PPASNPPT 64
+N+ P SNP + P P +NPP S+ P PP S PP ++ P S P SN P
Sbjct: 410 SNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPL 469
Query: 65 SSSPPASSPPTSSP-----------PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
S++PP+S+ S PA+N PT++ P + S P ++ P
Sbjct: 470 SNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFG 529
Query: 114 SPP---PPSSTPPPN 125
S P ++T PN
Sbjct: 530 SAPYGGNAATTADPN 544
|
Length = 1560 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/148 (21%), Positives = 44/148 (29%), Gaps = 11/148 (7%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPAS 71
S PPPV+ P P P P ++ P + +P SP A+ P T + P
Sbjct: 51 PSPQAPPPVAQLPQ---PLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGP 107
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+ PT P P P T +P + P + P+
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMV-------TQNPANSPLDQPAQQRALQQLQQRYG-APASG 159
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPP 159
P N S L P P
Sbjct: 160 QLPSQQQSAQKNDESQLQQQPNGETPPQ 187
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/157 (21%), Positives = 47/157 (29%), Gaps = 11/157 (7%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
P+ PPPV+ P+ P PPP + P + + SP A+ P T + P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPP--TQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPA 108
Query: 84 PPTSSPPPSP--PASSPP--TISPPPPVSNPPTRSPPPPSSTPP---PNSPPSPPSDPPA 136
PT P P P T +P + P + P S P A
Sbjct: 109 GPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSA 168
Query: 137 NSPPPSNPPS--NLPPPPPSSVEPPKRSPPSVPPQNP 171
S N PP + ++
Sbjct: 169 QKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 375 LGEGGFGSVYKGY---LPDGR-----EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG + D EV +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-LDWATRVKIAAGAARGLAYLHEDC 485
G C+ D +++ +YV +L +L + + W ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR----VMGTFGYMAPEYA 541
+ H ++ + N+LL + + + KL+ D IT ++ ++ PE
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS-DPGISITVLPKEILLERIPWVPPECI 176
Query: 542 SSGK-LTEKSDVFSFGVVLLELITG-RKPVDASQP 574
+ + L+ +D +SFG L E+ +G KP+ A
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 37/169 (21%), Positives = 57/169 (33%), Gaps = 18/169 (10%)
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP---PSPPASSPPTISP 103
K P +PP+ PP S S PASSP S + + S P ++ + S
Sbjct: 638 KSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSA 697
Query: 104 P--PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
P PPV +P R PP P S P++ + S ++ +VE
Sbjct: 698 PAPPPVPDPYDR--PPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQ--AVEQQAT 753
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P V + P +++ + S V + I
Sbjct: 754 HQPQVQAEAQSPASTTALTQTSSE---------VQDTELNLVLLSSGSI 793
|
Length = 944 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA--- 465
F E +I++ + +V L Y DDR L ++ +Y+P L + P WA
Sbjct: 90 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY 147
Query: 466 -TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANT 523
V +A A + + IHRD+K N+LLD + +++DFG K+ +
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 524 HITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
T V GT Y++PE S G + D +S GV L E++ G P A +G S
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 580 LV 581
+
Sbjct: 258 KI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 52/207 (25%), Positives = 73/207 (35%), Gaps = 36/207 (17%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS----------SPPPPPVSKPPTT 51
+AP G A + P + PP PP P + + SP P P P
Sbjct: 291 AAPPDGVWGAALAGAPLALPAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLG 350
Query: 52 SPPPSPPASNPPTS--------SSPPASSPPTS---SPPPASNP--------PTSSPPPS 92
P P PP+S P +S PT S A+ P + P
Sbjct: 351 FPKRRRPTWTPPSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAP 410
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
PAS P P P S PP + P PS+ P + P+PP P P P P
Sbjct: 411 VPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPP-------PERQPPAPATEPAP 463
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ +++ ++ + PP PP +
Sbjct: 464 DDPDDATRKALDALRERRPPEPPGADL 490
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 37/187 (19%), Positives = 52/187 (27%), Gaps = 5/187 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P P K + + S P + P + A++ S
Sbjct: 760 NPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKR 819
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+ S P PPP S+ S P+ P P
Sbjct: 820 KSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEP 879
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN-----VPPPPTQTPP 204
P + PPK + + P P P P +P P P P VPP TP
Sbjct: 880 RARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPA 939
Query: 205 TPASPIA 211
A+ +A
Sbjct: 940 PSAAALA 946
|
Length = 1352 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 34/130 (26%), Positives = 43/130 (33%), Gaps = 19/130 (14%)
Query: 149 PPPPPSSVEPPKR--------------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P P E + +P PPSSSP S P+P P S
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
P + S P S N PPP PPP VP P+ P
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK-----PTPP 262
Query: 255 ESSSSPSNNG 264
+S++P+ G
Sbjct: 263 SASATPAPIG 272
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/192 (25%), Positives = 69/192 (35%), Gaps = 19/192 (9%)
Query: 2 SAPSPGPPAANSSSPPP--PVSNPPTISPPP---PVSNPPKSSPPPPPVSKPPTTSP--- 53
++P P PP+++ +S V+ P P SN P+ P K SP
Sbjct: 384 TSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYAR 443
Query: 54 -----PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS---PPPSPPASSPPTISPPP 105
PP+ P+ PT SP SS + P + P T++ P P P +
Sbjct: 444 YEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVY 503
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS--NLPPPPPSSVEPPKRSP 163
PPT SP P + + NS PP+ + P P + P
Sbjct: 504 DDLKPPT-SPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYE 562
Query: 164 PSVPPQNPPPPP 175
PP +P P P
Sbjct: 563 DLKPPTSPTPSP 574
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 20/78 (25%), Positives = 29/78 (37%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
S S A+ ++ PA +P P + P + + P+ P SPP PV P
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 112 TRSPPPPSSTPPPNSPPS 129
T P P + P
Sbjct: 422 TEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 22/80 (27%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S + S+P PA +P P S P T + +PPP P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKT-KQAATTPSPPPAKASPPIPVPA 419
Query: 136 ANSPPPSNPPSNLPPPPPSS 155
+ P PP+N PPS
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 24/81 (29%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+ + PPP P PP+ P P + P PPPPP P S P P
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPP----PTATQASSNAPAQIPA 572
Query: 174 PPSSSPPKNSPPAPIAVPPSN 194
S PP P P S+
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 17/82 (20%), Positives = 26/82 (31%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
++S+ + PP PP P P P+ A P PPP + + +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 123 PPNSPPSPPSDPPANSPPPSNP 144
P P P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P+A S + +P P S PP P P +K T+P P P ++PP
Sbjct: 361 PSAFISEIANASAPANP-TPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 69 PASSPPTSSPPPASNPPTSS 88
+ P + P A+N P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-07
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 3/82 (3%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
P + P ++ + AS+P + P P + PP + +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 137 NSPPPSNPPSNLPPPPPSSVEP 158
+PP + P ++VE
Sbjct: 97 AAPPAAAAA---AAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 55/254 (21%), Positives = 78/254 (30%), Gaps = 4/254 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A +P + P P +P + P P P + + P+P
Sbjct: 62 ADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPY 121
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S P P PP P SPP P +S P S
Sbjct: 122 YPPPSQPQPPPAQQPQAQQPQPPP-QVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLY 180
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE---PPKRSPPSVPPQNPPPPPSSSP 179
P SP P S PP P S P S + PP+ SP P
Sbjct: 181 PEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPS 240
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
+ PP+ PPP++ + AP+ S+ S ++ P P +P+
Sbjct: 241 GQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPMS 300
Query: 240 STENTPGNGTNPSS 253
S + G +P S
Sbjct: 301 SAPMSGGGSGSPQS 314
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 29/164 (17%), Positives = 38/164 (23%), Gaps = 22/164 (13%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP----TSSPPPASNPPTSSPPPSPPAS 96
P P P P P P + PA + P A+ P T + P P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPA-- 108
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP--SDPPANSPPPSNPPSNLPPPPPS 154
PTI P P P + P NSP P P++
Sbjct: 109 -GPTIQTEPGQLYPVQV--PVMVTQNPANSPLDQPAQQRALQQLQQRYGAPAS------- 158
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ Q P P +
Sbjct: 159 ----GQLPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESE 198
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 5/112 (4%)
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPS-NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
PP + P+ PPA +P + P+ P P VE KR + +++P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLT---AQREQLVARAAAP 108
Query: 180 PKNSPPAPIAVP-PSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
AP A + + A+ PR + + R+
Sbjct: 109 AAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARI 160
|
Length = 484 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV-MGTFGYMAPEYASSGKLTE 548
+HRDIK N+L+D +++DFG A L AN + +++ +GT Y+APE ++
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 549 KS------DVFSFGVVLLELITGRKP 568
K D +S GV+ E+I GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
L+ G +G+VY + R+ A+K++ I Q ++ F E +I++ + +VS+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 429 VGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+C + +R L + +YV L G +D A R+ A L YLH +
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFAE-TVLALEYLH---N 119
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL--------------DANTHITTRVMGT 532
I+HRD+K N+L+ + +++DFGL+K+ L D + +V GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y+APE + D ++ G++L E + G P
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGT 532
A+G+ +L ++C IHRD+ + N+LL + A++ DFGLA+ + D+N +
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+S+G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 49/286 (17%), Positives = 78/286 (27%), Gaps = 23/286 (8%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPP---PPVSKPPTTSPPPSPPASN 61
+ G A +P V++ +I+ P P K + PPS +
Sbjct: 418 NSGILAWGLKTPGLAVNDERSIAVSSDGITDVLDPPSPLRLHSSDKVIDSVSPPSKRRVS 477
Query: 62 PPTSSSPPASSPPTSSPPPASNPP-----------TSSPPPSPPASSPPTISPPPPVSNP 110
P S A P ++ P +S TSS S + +P
Sbjct: 478 APASRLDDAKRPEVTATPESSGSDSEGGASGREDETSSDAESVVSIKELRPRIGFINKSP 537
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P +SPP T + PS + P PS
Sbjct: 538 PPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKF--VIGTDPFAFANTVRLTDNMRGG 595
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP---PPPST 227
S P ++ P+ P S++ P T TP+S + N+ +S P
Sbjct: 596 NGVGSSVKPKGSASSKPLTGPGSDL-KPATLNGKTPSSSLVGAARNAGASSKVKIPSGLG 654
Query: 228 KRLSPPPG---IPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
SP + + P + G +
Sbjct: 655 GFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTES 700
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE----REFKAEVEIISRIHHRHLVS 427
N +G G G+VYK + P GR A LK+ G E R+ E+EI+ ++H ++V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYA---LKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ ++ +++ +L EG + D +A G+AYLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRR--- 187
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS---- 543
I+HRDIK SN+L+++ +++DFG++++ L +GT YM+PE ++
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 544 GKLTEKS-DVFSFGVVLLELITGRKP 568
G + D++S GV +LE GR P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 45/242 (18%), Positives = 73/242 (30%), Gaps = 21/242 (8%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP----ASNPPTS 65
+ SS P S+P + P + P S+ V P + S + PT
Sbjct: 388 SNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTL 447
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS---PPPPVSNPPTRSPPPPSSTP 122
+S P P S +SP S PP + N P + + +
Sbjct: 448 ASIPDEKPSNISVF---EDSETSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSS 504
Query: 123 -PPNSPPSPP-SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
PP SP + P + P +L S P++ + S +
Sbjct: 505 IPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRS 564
Query: 181 KNSPPAP----IAVPPSNVPPPPTQTPPTPASPIA---PRPSNSSPNSPPPPSTKR--LS 231
+ + P+ +P P + T +S + P P+ P L
Sbjct: 565 VSDIEGERIGRYNLLPTRIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHENLL 624
Query: 232 PP 233
PP
Sbjct: 625 PP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 375 LGEGGFGSVYKGYL---PDGR--------EVAIKQLKIGGGQGEREFKAEVEIISRIHHR 423
LG+G F ++YKG L D V +K L F ++S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-LDWATRVKIAAGAARGLAYLH 482
HLV L G C+ D+ +++ +YV L LH E V L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 483 EDCHPRIIHRDIKSSNILL-------DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ +++H ++ NIL+ ++SD G+ L + +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPW 170
Query: 536 MAPEYASSG--KLTEKSDVFSFGVVLLEL 562
+APE +G LT +D +SFG LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G +G VYK DG++ A+KQ++ G G + E+ ++ + H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 432 CISD-DRRL-LIYDYVPNN---TLYFHLHGEG--RPVLDWATRVK-IAAGAARGLAYLHE 483
+S DR++ L++DY ++ + FH + +PV VK + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 484 DCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMA 537
+ ++HRD+K +NIL+ +++D G A+L + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 538 PEYASSGK-LTEKSDVFSFGVVLLELIT 564
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISP----PPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
+ A +++P P + P +P PP + P S P+P
Sbjct: 409 APAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAP 468
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+ P ++ PA +PP + P A+ ++P A T+
Sbjct: 469 APAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 27/82 (32%), Positives = 39/82 (47%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
G + + +PPPP +PP +P PP+ P ++PPP P PPT + S + P S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 67 SPPASSPPTSSPPPASNPPTSS 88
SPP P +P P +
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 28/95 (29%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 66 SSPPASSPPTSSPPPASNPP-TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
S S +S P P SPPP+P S P +PP PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 125 NSPPSP-PSDPPANSPPPSNPP-------SNLPPP 151
+ PSP P AN+PP N + L P
Sbjct: 421 PTEPSPTPPANAANAPPSLNLEELWQQILAKLELP 455
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 24/77 (31%), Positives = 30/77 (38%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
SN K+ PPP PP +PP P + P + PP T + A + P
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 93 PPASSPPTISPPPPVSN 109
PP PT SP S
Sbjct: 578 PPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 16/77 (20%), Positives = 22/77 (28%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
S + T P P P S+P T+ PP + P P+ P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 96 SSPPTISPPPPVSNPPT 112
PT + P
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 3e-07
Identities = 14/82 (17%), Positives = 29/82 (35%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P ++ + S P+ PA P + P+ P++ P + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 171 PPPPPSSSPPKNSPPAPIAVPP 192
PP +++ + V P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 16/82 (19%), Positives = 28/82 (34%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P + P+ + A + P + PP + P+ PP+ +++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 182 NSPPAPIAVPPSNVPPPPTQTP 203
P A A P+ TP
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 153 PSSVEPPKR------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P+SV+P R P S +++ AP A P+ P P P
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPA-APAPAPPAAAAP 80
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
A+P P + ++ +P P + P E TP
Sbjct: 81 AAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/240 (21%), Positives = 64/240 (26%), Gaps = 7/240 (2%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
+S+ S T PP + + +P P PA P
Sbjct: 29 LSHEEAQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQ 88
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
A P + P P PPS P PPA P P P
Sbjct: 89 QSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVP 148
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPK-----NSPPAPIAVPPSNVPPPPTQTPPTP 206
+ P + P QNPPP S+P P P N P P + P
Sbjct: 149 QQQQYQSPPQQP--QYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPP 206
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
S P P P P P PS + P + S PS G
Sbjct: 207 YSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHG 266
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 13/96 (13%), Positives = 22/96 (22%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
PP + PP + PA+ ++ +P A + P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
P + + P P A
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADA 148
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (125), Expect = 3e-07
Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 6/146 (4%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P K + P+ A+ P +++PPA + ++P A+ P + P A++PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKA--AAAPAKAAAAPAKAAAPPAKAAAPPAKAA 268
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP + PP + PP +PP+ A + P+ P + PP ++
Sbjct: 269 APPAK----AAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAA 324
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIA 189
PP +++PP + AP+
Sbjct: 325 APPAKAATPPAKAAAPPAKAAAAPVG 350
|
Length = 357 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 18/69 (26%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ P A+ + PA+ PP ++PP P A + P + P P P + PP+ +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAP-APPAAAAPPARSAD 439
Query: 124 PNSPPSPPS 132
P + S
Sbjct: 440 PAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 19/76 (25%), Positives = 30/76 (39%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A + +P P S PP P ++ P PP +K P P+ P
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 61 NPPTSSSPPASSPPTS 76
PT + A++PP+
Sbjct: 424 PSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 13/80 (16%), Positives = 25/80 (31%)
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
P S + A + + + P + P +PP+ PP P+++ + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 186 APIAVPPSNVPPPPTQTPPT 205
A + P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 11/106 (10%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
I P + P ++ P P + + SP +S S+P +++ P
Sbjct: 370 SGGRGPKQHIKPV--FTQP--AAAPQPSAAAAASPSPSQ---SSAAAQPSAPQSATQPAG 422
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+PP S P ++ P +PP+++P + P P S
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQ----FKEEKKIPVSKVS 464
|
Length = 614 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 28/139 (20%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPS-PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
SN S+P S P + P S P +NPP S++P S+PP S+PP ++ P +++
Sbjct: 410 SNAGYSNPG---NSNPGYNNAPNSNTPYNNPPNSNTP-YSNPPNSNPPYSNLPYSNT--- 462
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P SN P + PP S+ ++ + AN P + P +N P
Sbjct: 463 --------------PYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAA 508
Query: 152 PP------SSVEPPKRSPP 164
+SV P S P
Sbjct: 509 NNFHGAAGNSVGNPFASRP 527
|
Length = 1560 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 16/108 (14%), Positives = 35/108 (32%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+PPA+ P ++ PP ++ P + PA+ +P A +P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
+ P + + + P +P ++V ++
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ A D T ++ TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 535 YMAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSN--PPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P ++++ P P P ++ P ++ P P V PS + +
Sbjct: 163 PLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAAT 222
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
+P A + P + P PT S PA+ P
Sbjct: 223 PAPAAPATPDGAAP----LPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 373 NLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
N++G G FG VY+ D E VAIK++ Q + E+ I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 432 ----CISDDRRLL----IYDYVPNNT----LYFHLHGEGRPVLDWATRVKIAA-GAARGL 478
C + + + + +++P ++ + P+ VK+ + R L
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF----LVKLYSYQLCRAL 183
Query: 479 AYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDAN---THITTRVMGTFG 534
AY+H I HRD+K N+L+D N ++ DFG AK L ++I +R
Sbjct: 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF----- 235
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITG 565
Y APE + T D++S G ++ E+I G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A N +T V+ + Y
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNFMMTPYVVTRY-YR 189
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITG 565
APE E D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 21/79 (26%), Positives = 31/79 (39%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
SA + PPP + P + P + PP PPPP ++ + +P P S+
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 62 PPTSSSPPASSPPTSSPPP 80
PP + PT P
Sbjct: 576 PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 25/88 (28%), Positives = 30/88 (34%), Gaps = 9/88 (10%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
PS S S P P P+ +PPP + PS PP+ P
Sbjct: 361 PSAFISEIANASAPAN-------PTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASP 413
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
P P EP + P PP N P S
Sbjct: 414 PIPVPAEPTE--PSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-07
Identities = 16/85 (18%), Positives = 32/85 (37%), Gaps = 2/85 (2%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P +++ P + A++ S P P ++P P+ PP + P+ P P A + +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAA--PAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAA 94
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVP 167
P + ++ P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 41/224 (18%), Positives = 59/224 (26%), Gaps = 9/224 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS---SPPPASN 83
+P PV+ P + P ++P P P + P + P P S P N
Sbjct: 335 APVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYN 394
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P P P P P +P P + + +
Sbjct: 395 EPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQS 454
Query: 144 P--PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP----SNVPP 197
P + + +P + P PQ P P A PP V
Sbjct: 455 TFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVVEPEPVVEETKPARPPLYYFEEVEE 514
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ A+ P P P S K S PV +
Sbjct: 515 KRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAVPPVEAA 558
|
Length = 1355 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 17/100 (17%), Positives = 29/100 (29%), Gaps = 7/100 (7%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P ++ PPP + P+ S P A + P+ + E +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 171 PPPPPSSS-------PPKNSPPAPIAVPPSNVPPPPTQTP 203
P + + + A A P VP
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 375 LGEGGFGSVYKGYLPDG---REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G +G VYK DG +E A+KQ++ G G + E+ ++ + H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 432 CIS-DDRRL-LIYDYVPNN---TLYFHLHGEG--RPVLDWATRVK-IAAGAARGLAYLHE 483
+S DR++ L++DY ++ + FH + +P+ + VK + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 484 DCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMA 537
+ ++HRD+K +NIL+ +++D G A+L + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 538 PEYASSGK-LTEKSDVFSFGVVLLELIT 564
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 34/105 (32%), Positives = 59/105 (56%), Gaps = 12/105 (11%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGT 532
A+G+++L ++C IHRD+ + NILL + ++ DFGLA+ + D+N +
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT------GRKPVDA 571
+MAPE + T +SDV+S+G++L E+ + PVD+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 20/85 (23%), Positives = 27/85 (31%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
+ S S A PP P PT P + PP PP ++ S P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDP 134
+ PPP P P+ +
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
S P + P ++ PA+ T+ + ++P P+ P +N
Sbjct: 159 GQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNA--VVAPSQAN 216
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
T + P P++ P+ P+D S P ++P
Sbjct: 217 VDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 43/265 (16%), Positives = 67/265 (25%), Gaps = 28/265 (10%)
Query: 8 PPAANSSSPPPPVSNPPTI----SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
A P P + P ++ +S K P S P
Sbjct: 10 TKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSSAP---RQ 66
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
++PP + PT++ P +S PT + P T +P SP T
Sbjct: 67 IQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPES--------SPSARRLTRS 118
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
D + L + +R P S P+++ +
Sbjct: 119 EGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAA 178
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
+ AS R S S N P P +P + S
Sbjct: 179 L-----FKDDEIRQEVDAARSDQASQ--SRLSRSRGNPPAIP--PDAAPRQPMLTRSAGG 229
Query: 244 TP----GNGTNPSSPESSSSPSNNG 264
N P+S + G
Sbjct: 230 RFEGEDENLERNLQPQSPITLDKKG 254
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P SN + + S+ S+ ++ +++ +P S+P + P SN P + PP
Sbjct: 383 PHSNA-SYNCAAYSNAAQSNAAQSNAGFSNAGYSNPGNSNPGYNNAP--NSNTPY-NNPP 438
Query: 118 PSSTP---PPNSPPSPPSDPPANSPPPSNPP-SNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S+TP PPNS P P S+ P ++ P SN P SN PP S+ + + +
Sbjct: 439 NSNTPYSNPPNSNP-PYSNLPYSNTPYSNAPLSN--APPSSAKDHHSAYHAAYQHRAANQ 495
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
P ++ P N P A + +P A RP S+P +T + P
Sbjct: 496 PAANLPTANQPAA---------NNFHGAAGNSVGNPFASRPFGSAPYGGNAATT---ADP 543
Query: 234 PGIPVPSTENTPGNGTNPSSPESSSSPS 261
GI E+ P GTN E S S
Sbjct: 544 NGI--AKREDHPEGGTNRQKYEQSDEES 569
|
Length = 1560 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (121), Expect = 7e-07
Identities = 31/139 (22%), Positives = 56/139 (40%), Gaps = 3/139 (2%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-STPPPNSPPSPPSDP 134
++ P ++ P A+ +PP + P ++ P+ + PP +PP+
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKA 267
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS--PPAPIAVPP 192
A + PP+ PP + PP ++ + P +++ P + PPA A PP
Sbjct: 268 AAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPP 327
Query: 193 SNVPPPPTQTPPTPASPIA 211
+ PP + PA A
Sbjct: 328 AKAATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ A+ +T V+ T Y
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 180
Query: 536 MAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
APE + + D++S G ++ E++TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 23/80 (28%), Positives = 31/80 (38%)
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S++ +PP P PP +P P P PPP+ PP + + P S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 178 SPPKNSPPAPIAVPPSNVPP 197
SPP P P P + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 22/82 (26%), Positives = 29/82 (35%), Gaps = 4/82 (4%)
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
PS AN+ P+NP P PP + P + + PS P K SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQP----SAPKTKQAATTPSPPPAKASPPIP 416
Query: 188 IAVPPSNVPPPPTQTPPTPASP 209
+ P+ P P
Sbjct: 417 VPAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 8e-07
Identities = 14/76 (18%), Positives = 23/76 (30%), Gaps = 1/76 (1%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
+P + + P++ K P P ++PPK + A A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAP-PAAAAPAAPPKPAAAAAAAAA 95
Query: 192 PSNVPPPPTQTPPTPA 207
P+ P P A
Sbjct: 96 PAAPPAAAAAAAPAAA 111
|
Length = 1228 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 59/267 (22%), Positives = 90/267 (33%), Gaps = 44/267 (16%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN--------PP 85
P +++PP P +++P P+ +S +SSS SS + S +S+ P
Sbjct: 377 PPSRNTPPSAP-----SSNPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPPR 431
Query: 86 TSSPPPSPPAS------------SPPTISPPPPVSNPP---------------TRSPPPP 118
T+SP P PP++ +P +SP VS+ P P
Sbjct: 432 TASPEPEPPSTNKWQLDNWLNKVNPHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPE 491
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
S PPP S P P + P S P +R+ P+ P +
Sbjct: 492 SKEPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQSEAPPQRRTVGKKQPKKPEKASAGD 551
Query: 177 --SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ S P + S PP T S + PP ++ P
Sbjct: 552 ERTGLRPESEPGTLPYGSSVQTPPDRPKAATKGSRKPSPRKEPKSSVPPAAEKRKYKSPS 611
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
I S E + ++ SPE S P
Sbjct: 612 KIVPKSREFIETDSSSSDSPEDESLPP 638
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
A+G+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 51/233 (21%), Positives = 74/233 (31%), Gaps = 48/233 (20%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP------T 112
S+P + PP P T+ PP PP + P + PP
Sbjct: 244 ISHPLRGDIAAPAPPPVVGEGADRAPETARGATGPPP--PPEAAAPNGAAAPPDGVWGAA 301
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSP--------------PPSNPPSNLPP------PP 152
+ P + PP+ PP P+ P + P P P
Sbjct: 302 LAGAPLALPAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTP 361
Query: 153 PSSVE-------PPKRSPPSVPPQNPPP---------PPSSSPPKNSPPAPIAVPPSNVP 196
PSS+E PKR+ + P + + P P +VP
Sbjct: 362 PSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPT 421
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
P P PP PA+P+ P S + P PP ++ PP + P + T
Sbjct: 422 PVPASAPPPPATPL-PSAEPGSDDGPAPPPERQ---PPAPATEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 27/138 (19%), Positives = 35/138 (25%), Gaps = 12/138 (8%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
A + S P PP ++ P P P + P P
Sbjct: 70 RVNHAPANAQEHEAARPS--PQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQ 127
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P P + P P Q P P + P+ AP P P P +
Sbjct: 128 PVQQ---PAYQPQPEQPLQQPVSPQVAPAPQPVHSAP-------QPAQQAFQPAEPVAAP 177
Query: 211 APRPSNSSPNSPPPPSTK 228
P P P K
Sbjct: 178 QPEPVAEPAPVMDKPKRK 195
|
Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ D LG G G V+ D + VA+K++ + Q + E++II R+ H ++V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 428 LVGYCISDDRRL--LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA---------- 475
+ L + N++Y + ++ + G
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYI-----VQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 476 ---RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTH--ITTRV 529
RGL Y+H ++HRD+K +N+ ++ + ++ DFGLA++ +H +
Sbjct: 122 QLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 530 MGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
+ T Y +P S T+ D+++ G + E++TG+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
ARG+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573
+MAPE T +SDV+SFGV+L E+ + G P Q
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASS---- 543
+IHRD+K N+LLD + +++DFG K+ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
G + D +S GV L E++ G P A +G S +
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 37/182 (20%), Positives = 48/182 (26%), Gaps = 12/182 (6%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P PG P PP + + P + P P + P P
Sbjct: 111 PRPGRRPYEGYGGPRADDRPPGLPRQDQL---PTARPAYPAYQQRPEPGAWPRAADDYGW 167
Query: 64 --TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-- 119
P +P PAS P P + P + P P
Sbjct: 168 QQQRLGFPPRAPY---ASPASYAPEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRD 224
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
T P PP PP + + P PS+ P P P P P +
Sbjct: 225 RTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLAAQPAPAP--GPGEPTARLN 282
Query: 180 PK 181
PK
Sbjct: 283 PK 284
|
Length = 617 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 21/75 (28%), Positives = 31/75 (41%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
++ P + P P S PP P +P T+ SPP + P PA
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 86 TSSPPPSPPASSPPT 100
S PP+ A++PP+
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 43/222 (19%), Positives = 83/222 (37%), Gaps = 17/222 (7%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P T+ P+ P+ P ++ +++ PTS P + T SP + + + P
Sbjct: 443 PHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRT----TSATPN 498
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ PT + P++T P S + + +P + PP + P + P V
Sbjct: 499 ATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVT 558
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
++P ++ ++P + + + PT P P S+S+P S ++
Sbjct: 559 EESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSS--PTSQQPGIPSSSHSTPRS----NS 612
Query: 228 KRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAG 269
+P P+ G + E+ S PS + T
Sbjct: 613 TSTTPLLTSAHPT-------GGENITEETPSVPSTTHVSTLS 647
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 27/123 (21%), Positives = 36/123 (29%), Gaps = 5/123 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPV--SKPPTTSPPPSPPASNPPTSSSPPASS--PPTSSPPPAS 82
P + + P P +PP S P P PP + PP + P +P P
Sbjct: 71 VNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQ 130
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P P P P P P + P P +P A P
Sbjct: 131 QPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQP-EPVAEPAPVM 189
Query: 143 NPP 145
+ P
Sbjct: 190 DKP 192
|
Length = 333 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 37/163 (22%), Positives = 53/163 (32%), Gaps = 8/163 (4%)
Query: 53 PPPSPPASN-PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PP P AS PP + S+ P P P P + P
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKP 569
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
++ P + + P P P P + P P P+ + PK P++P
Sbjct: 570 SKIP---TLSKKPEFPKDPKH--PKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSP 624
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P S PK PP P P + +P P +P+P
Sbjct: 625 KRPESPKSPKRPPPPQRPSSPER--PEGPKIIKSPKPPKSPKP 665
|
Length = 943 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 39/133 (29%), Positives = 53/133 (39%), Gaps = 14/133 (10%)
Query: 31 PVSNPPKSSPP--PPPVSKPPTTSPPPS-PPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
SNP S+P P S P +PP S P SNPP S+ P ++ P +++P SN P S
Sbjct: 413 GYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTP--YSNAPLS 470
Query: 88 SPPPSPPASSPPTISPP-------PPVSNPPTRSPPP--PSSTPPPNSPPSPPSDPPANS 138
+ PPS P +N PT + P NS +P + P S
Sbjct: 471 NAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFGS 530
Query: 139 PPPSNPPSNLPPP 151
P + P
Sbjct: 531 APYGGNAATTADP 543
|
Length = 1560 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 37/136 (27%), Positives = 51/136 (37%), Gaps = 29/136 (21%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPP-------PPPVSKPPTT 51
+A P +N P SN P +PP P SNPP S+PP P S P +
Sbjct: 411 NAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPLS 470
Query: 52 SPPPSP-------------------PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ PPS PA+N PT++ P A++ ++ NP S P S
Sbjct: 471 NAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFGS 530
Query: 93 PPASSPPTISPPPPVS 108
P + P
Sbjct: 531 APYGGNAATTADPNGI 546
|
Length = 1560 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 25/159 (15%), Positives = 31/159 (19%), Gaps = 18/159 (11%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P SP PP + P P + + P ++P SP PP
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTP-----TGSPAA--NPPAT 100
Query: 108 SNPPTRSPPPPSSTPP-PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
P P T P P P N
Sbjct: 101 FALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRAL----------QQLQ 150
Query: 167 PPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
P + S P T T
Sbjct: 151 QRYGAPASGQLPSQQQSAQKNDESQLQQQPNGETPPQQT 189
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 5/136 (3%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P K++ P + P + PP+ A+ P +++ PA + + P A+ PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKA--AAPPAKAAAPPAKAA 268
Query: 90 PPSPPASSPP--TISPPPPVSNPPTRSPPPPSST-PPPNSPPSPPSDPPANSPPPSNPPS 146
P A++PP +PP + PP ++ P+ P + P+ A + PP+
Sbjct: 269 APPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPA 328
Query: 147 NLPPPPPSSVEPPKRS 162
PP + PP ++
Sbjct: 329 KAATPPAKAAAPPAKA 344
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 35/159 (22%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPT-TSPPPSPPAS 60
+A + AA ++ P + +P + P K++ PP + P + P+ A+
Sbjct: 196 AAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAA 255
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P +++PPA + + P A+ PP + P A++PP + + P + P +
Sbjct: 256 PPAKAAAPPAKA--AAPPAKAAAPPAKAAAPPAKAAAPPAKA----AAAPAKAAAAPAKA 309
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
P +PP+ A + PP+ PP + P
Sbjct: 310 AAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 63/263 (23%), Positives = 96/263 (36%), Gaps = 56/263 (21%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG V D + A+K L+ + KAE +I++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR- 488
Y D L + DY+P + L G D A R IA L E H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIAE-----LTCAIESVHKMG 121
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA--------------------------------- 515
IHRDIK NIL+D + +++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 516 --------KLALDANTHITTR-VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ + ++GT Y+APE T+ D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 567 KPVDASQPLGDE-SLVEWVNLID 588
P A P + ++ W +
Sbjct: 242 PPFLADTPAETQLKVINWETTLH 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 16/99 (16%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
SAP+ PP +PP PV+ P ++P P + P + P+PPA
Sbjct: 411 ASAPAA----------------PPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQ 454
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P + + P P + A+ P ++P + +
Sbjct: 455 AAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 25/111 (22%), Positives = 35/111 (31%), Gaps = 6/111 (5%)
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT-PASPIA 211
P++ P P VPPQ+ P S+ A VPPPP P PA P+
Sbjct: 361 PAAPLPE----PEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLP 416
Query: 212 PRPSNSSPNSPPPPSTKRLSPPPGI-PVPSTENTPGNGTNPSSPESSSSPS 261
S + + P ++ P N +PS
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPS 467
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 23/122 (18%), Positives = 37/122 (30%), Gaps = 6/122 (4%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P A P P PP + P + + + P PPP +S P+ +P P+ S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSS 253
+ Q + A + P S R + S P +
Sbjct: 421 QLLAARQQLQRAQGATKAKKSE------PAAASRARPVNSALERLASVRPAPSALEKAPA 474
Query: 254 PE 255
+
Sbjct: 475 KK 476
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 48/182 (26%), Positives = 65/182 (35%), Gaps = 18/182 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNP--------PTISPPPPVSNPPKSSPPPPPVSKPPTTS 52
+ PSP P S+ PPPP P P + PPP+ P+S P ++PP +
Sbjct: 368 LQGPSPFP-QMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLT 426
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
S P S S PP S P PP S P + PP ++ +
Sbjct: 427 QSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGS 486
Query: 113 RSPPPPSSTPPPNSPPSPPSDP---------PANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
+ P + + P PP P A P PP P P P+ V P +
Sbjct: 487 QPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHAS 546
Query: 164 PS 165
S
Sbjct: 547 QS 548
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 18/79 (22%), Positives = 26/79 (32%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S S A++ +P P + P +P PS+ + +P P SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 147 NLPPPPPSSVEPPKRSPPS 165
P P P
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 25/85 (29%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPP 199
++ + PPPP S PP +PP PQ P +PP P A A + P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPP--LPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 200 TQTPPTPASPIAPRPSNSSPNSPPP 224
+PP PI P+ S P
Sbjct: 573 DSSPP---PPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 32/107 (29%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 8 PPAANSSSPPPPVSNPPTIS-PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
P S+ P PV PP PP P + +P P P P P P P +
Sbjct: 93 QPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQ---QPAYQPQPEQPLQQPVSPQ 149
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
PA P S+P PA P A P ++ P PV + P R
Sbjct: 150 VAPAPQPVHSAPQPA--QQAFQPAEPVAAPQPEPVAEPAPVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 17/100 (17%), Positives = 33/100 (33%), Gaps = 2/100 (2%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ P A++P + PPPA+ P S P +P A P + ++ P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
+P + + L ++ P + +
Sbjct: 112 EAQAPAAPAERAAAEN--AARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 19/103 (18%), Positives = 31/103 (30%), Gaps = 2/103 (1%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
PP + P + PPP + P S P P P A + A + P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ P A ++ + + +P P V +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 15/103 (14%), Positives = 33/103 (32%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP +++P A+ PP ++ P A + P + P R+ P +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
+ P+ + + + + P P + +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P S + P P + PP +PP P A P +++ PA +P PP A+ PP S
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARP-AAARPAPAPA---PPAAAAPPARS 437
Query: 89 PPPSPPASSPPT 100
P+ AS+
Sbjct: 438 ADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 15/97 (15%), Positives = 25/97 (25%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
+ P S + P+P A T ++ + T+ P + PS
Sbjct: 155 SQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQ 214
Query: 94 PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
P + P +P P P
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 29/117 (24%), Positives = 40/117 (34%), Gaps = 5/117 (4%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
++ PP + P + T P S PT P+SSP + S P
Sbjct: 147 SLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLES 206
Query: 85 PT--SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
P+ PP S T S +S+ S +T P S S S P + S
Sbjct: 207 PSNLQVTTDVPPPYSNGT-SRSSTMSSSANLSIISSLAT--PRSGESFRSTPTSGSS 260
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
LGEG + +VYKG +G+ VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 432 CISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + +++Y+ + Y H G L RGLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLAYIH---GQHIL 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L+ E +++DFGLA+ + ++ V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 550 SDVFSFGVVLLELITGR 566
D++ G + +E++ G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 375 LGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGERE----FKAEVEIISRIH 421
LG G +Y G L E IK + R+ F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H+H+V L G C+ D +++ ++V L +H + L + K+A A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV-LTTPWKFKVAKQLASALSYL 121
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG-LAKLALDANTHITT----RVMGTFGYM 536
ED ++H ++ + NILL E + G KL+ D IT + ++
Sbjct: 122 -ED--KDLVHGNVCTKNILLAR--EGIDGECGPFIKLS-DPGIPITVLSRQECVERIPWI 175
Query: 537 APEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
APE K L+ +D +SFG L E+ + PL D++L E
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 31/166 (18%), Positives = 48/166 (28%), Gaps = 28/166 (16%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP---PPPPVSKPPTTSPPPSPPASNP- 62
G + +S + P + T + P PP+S PT + PP P
Sbjct: 83 GSSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQR 142
Query: 63 ---------------------PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
++ S+ PT PA+ P+ A + PT
Sbjct: 143 IELPGNISDALSQQQGQVNAASQNAQGNTSTLPT---APATVAPSKGAKVPATAETHPTP 199
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
P P + PP + P S + S P S+
Sbjct: 200 PQKPATKKPAVNHHKTATVAVPPATSGKPKSGAASARALSSAPASH 245
|
Length = 327 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 18/76 (23%), Positives = 24/76 (31%)
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
S + S P +P P+ P P P + + PS PP PP
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 183 SPPAPIAVPPSNVPPP 198
P +N PP
Sbjct: 423 EPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 17/78 (21%), Positives = 28/78 (35%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
S ++ + P P +PP + P++ + S PP + PP P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 98 PPTISPPPPVSNPPTRSP 115
P SP PP +
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 13/80 (16%), Positives = 24/80 (30%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ P + + ++ P P++ P +P P PP + + AP
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 189 AVPPSNVPPPPTQTPPTPAS 208
A P + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 33/186 (17%), Positives = 48/186 (25%), Gaps = 11/186 (5%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP---------PVS 108
P N + P A + ++ + P +PP +S P P +
Sbjct: 309 PLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQT 368
Query: 109 NPPTRSPPPPSSTPPPN-SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
P +P P + P+ + P P P P + +P P P
Sbjct: 369 GEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQP 428
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP-ASPIAPRPSNSSPNSPPPPS 226
Q P P+ P S P T P A P P
Sbjct: 429 AQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQP 488
Query: 227 TKRLSP 232
P
Sbjct: 489 VVEPEP 494
|
Length = 1355 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 53/261 (20%), Positives = 78/261 (29%), Gaps = 11/261 (4%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A +S + V + P V+ + P V+ + PP+P +P
Sbjct: 34 AQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVN----AALPPAPAPQSPQPDQQQQ 89
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ +PP+ P P P P PPP PP P P PP
Sbjct: 90 SQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQA---QQPQPPPQ 146
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P SPP PPP S + P+ P P S PP P+ +A
Sbjct: 147 VPQQQQYQSPPQQPQYQQNPPPQAQSAPQV----SGLYPEESPYQPQSYPPNEPLPSSMA 202
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
+ P PP+Q P P + + PP + P
Sbjct: 203 MQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSK 262
Query: 250 NPSSPESSSSPSNNGIGTAGT 270
+S +P + +
Sbjct: 263 GNHGSVASYAPQGSSQSYSTA 283
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 13/110 (11%), Positives = 28/110 (25%), Gaps = 3/110 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
PP + P ++ PPP + + P P + + P +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
+P A + + + P P + + +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPR---PRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 41/162 (25%), Positives = 56/162 (34%), Gaps = 9/162 (5%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P V+ T S P S P S +P S P + L P + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQ--GTT 225
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP-----PPTQTPPTPASPIAPRPSNS 217
S P PPPS P SP P + + TQ TP + R +S
Sbjct: 226 TSSNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHS 285
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
+ + PPP+TKR P P+ G+ SSP +
Sbjct: 286 T--ATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGVQA 325
|
Length = 408 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 24/92 (26%), Positives = 31/92 (33%), Gaps = 6/92 (6%)
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P P P +P + + P P P PS+ P + P P PP P +
Sbjct: 362 PVPAPQPAKP---TAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVA 418
Query: 209 PIAPRPSNSSPNSPP---PPSTKRLSPPPGIP 237
P P S+P P K PP P
Sbjct: 419 PPVPHTPESAPKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 54/221 (24%), Positives = 75/221 (33%), Gaps = 13/221 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP-PASN 61
P P P PP S PT P S+ P SS V+KP PSP ASN
Sbjct: 367 VPRPLSPYTAYEDLKPPTSPIPT-----PPSSSPASSKSVDAVAKPAEPDVVPSPGSASN 421
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + T P + PP SP ++P +SP ++ P T
Sbjct: 422 VPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVP----DT 477
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P + + PPAN P S PP+S P P +
Sbjct: 478 APATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGN--- 534
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
++PP +A + P P P P++ +P+
Sbjct: 535 SAPPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-06
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 3/86 (3%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
P + P+ ++ P +P + P P P P ++ +PP P A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA---AA 93
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPP 223
PP A+ AP + P
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-06
Identities = 13/86 (15%), Positives = 24/86 (27%), Gaps = 3/86 (3%)
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
P + P ++ + P + +P + AP A P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAA---AA 94
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRL 230
PA+P A + + + L
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 34/180 (18%), Positives = 50/180 (27%), Gaps = 6/180 (3%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP--PASNPPTSSPP 90
K + V +PP S S P S P T + + T S P + S
Sbjct: 444 KARKKLANKTSTVMEPPYGSTESSVP-STPSTRRNDRNITSNTPSLKRTPNLTKSSLSQE 502
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
S + S T P +S + ++ S S+P S
Sbjct: 503 ASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGAN-GNASSDLSSPGSINSK 561
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P SV P + + S P + + S + PP TP
Sbjct: 562 SPEHSV--PLVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 10/111 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPPPPPV--SKPPTTSP-- 53
++A +P AA +++ PPP + P +S P P +
Sbjct: 48 LAALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
P +P A P + A+ + ++P P PA + ++
Sbjct: 108 PAAPEAQAPAAPAERAAAENA---ARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
A GL +LH + + IHRD+K +NILL ++ DFG++ L + +GT
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTP 188
Query: 534 GYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+MAPE + + DV+S G+ +EL G P+ P+
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 15/78 (19%), Positives = 26/78 (33%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P + + P P + PPP +P + +PP + + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 77 SPPPASNPPTSSPPPSPP 94
P+ PP ++ P
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-06
Identities = 13/78 (16%), Positives = 23/78 (29%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P ++ P+ + + P P+ P PP + + P A A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 195 VPPPPTQTPPTPASPIAP 212
PP A+ +
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-06
Identities = 14/72 (19%), Positives = 26/72 (36%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ AA +S+P + +P P + PP P + + P +PPA+
Sbjct: 44 PTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAA 103
Query: 62 PPTSSSPPASSP 73
+ + A
Sbjct: 104 AAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-06
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 1/87 (1%)
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP-PAPIAVPPSNVPPPPTQTPPTPASPI 210
P S+ P + + + P ++ +P PAP A PP P A+P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 211 APRPSNSSPNSPPPPSTKRLSPPPGIP 237
AP + ++ ++P G
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 5/105 (4%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP- 78
++ P +P P + P VS+P + P+P + +
Sbjct: 51 LAPPAAAAPAAA---QPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 79 PPASNPPTSSPPPSPPASSPPTI-SPPPPVSNPPTRSPPPPSSTP 122
P A + P A+ + P R P ++
Sbjct: 108 PAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 35/198 (17%), Positives = 52/198 (26%), Gaps = 25/198 (12%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
+ + + P+SS + P SN S +P + S +
Sbjct: 379 SISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVS-SRRVGTPGSKSDRVGAVL 437
Query: 105 P------PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP-PSSVE 157
P P S S SP S PPP P
Sbjct: 438 LRRMNIKPTLASIPDEKPSNISVFED-SETSPNSSTLLRDPPPKKCGEESGHLPNNPFFN 496
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
K + S+PP +P + P + P + I+ S S S
Sbjct: 497 KLKLTLSSIPPLSPRQSIITLPTPSRPASRIS----------------SLSLRLGSYSGS 540
Query: 218 SPNSPPPPSTKRLSPPPG 235
+ PP P+ G
Sbjct: 541 IVSPPPYPTLVSRKGAAG 558
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 20/73 (27%), Positives = 30/73 (41%), Gaps = 7/73 (9%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP+P A + +P P + PPP + PP P + P P A+ P
Sbjct: 381 APAPPSAAWGAPTPAAP-------AAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAP 433
Query: 63 PTSSSPPASSPPT 75
P S+ PA++
Sbjct: 434 PARSADPAAAASA 446
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 23/85 (27%), Positives = 33/85 (38%), Gaps = 1/85 (1%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP-PTPASPIAP 212
S+ P +P P + P S +P + PAP P N P+Q T A+P
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPA 226
Query: 213 RPSNSSPNSPPPPSTKRLSPPPGIP 237
P+ +P P +S P P
Sbjct: 227 APATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 43/192 (22%), Positives = 58/192 (30%), Gaps = 23/192 (11%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP-PTSSPPPSPPASSPPTIS 102
P S + N S S SS SSP A+N + P IS
Sbjct: 61 PTEHESQQSSNNAGAEKNIDLSGSSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDIS 120
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP-----------ANSPPPSNPPSNLPPP 151
PP +S PT++ PP TP P + A S S LP
Sbjct: 121 APP-ISPTPTQAAPPQ--TPNGQQRIELPGNISDALSQQQGQVNAASQNAQGNTSTLPTA 177
Query: 152 PPSSVEPPKRSPPSV---PPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P + P+ P P P + P N + PP T P +
Sbjct: 178 PATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKT-----ATVAVPPATSGKPKSGA 232
Query: 209 PIAPRPSNSSPN 220
A S++ +
Sbjct: 233 ASARALSSAPAS 244
|
Length = 327 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 20/90 (22%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP-PPPVSNP----PTRSPPP 117
P+ + AS + P + S PP ++S + PP + PT P
Sbjct: 87 PSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPTA 146
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
+TP P P PS P ++
Sbjct: 147 QPATPDERRSPRQRPPVSGEPPTPSTPDAH 176
|
Length = 226 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 30/84 (35%), Positives = 43/84 (51%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
A + + PA+ +PPP PP+++ +P P PP +PP P P +PP
Sbjct: 24 AGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPP 83
Query: 130 PPSDPPANSPPPSNPPSNLPPPPP 153
PP+DP A PPP +P + PP P
Sbjct: 84 PPADPNAPPPPPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 19/75 (25%), Positives = 26/75 (34%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
AN+S+P P P PP P+ + PP P P PT
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 66 SSPPASSPPTSSPPP 80
SP + ++PP
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 26/81 (32%), Positives = 34/81 (41%), Gaps = 1/81 (1%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
S + PPQ PPPP+ +PP P A A PP+ PPPPT T + +P
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTAT-APPPTPPPPPPTATQASSNAPAQIP 571
Query: 214 PSNSSPNSPPPPSTKRLSPPP 234
+S P P T +
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDS 592
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 23/82 (28%), Positives = 31/82 (37%), Gaps = 4/82 (4%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P + + P + TP PN P P P S P + + P PPP+ PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQP--SAPKTKQAATTPSPPPAKASPPI--P 416
Query: 164 PSVPPQNPPPPPSSSPPKNSPP 185
P P P P ++ P
Sbjct: 417 VPAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 32/180 (17%), Positives = 45/180 (25%), Gaps = 23/180 (12%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A P SP P P + P + PP + P + +
Sbjct: 45 AEFPWDPSPQAPP---------PVAQLPQPLPQPPPTQALQALPAGDQQQHN---TPTGS 92
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P+ P P P ++ P P + P NSP P
Sbjct: 93 PAANPPATFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQ---PAQQRALQQL 149
Query: 201 QTP-PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
Q PAS P S+ + L P P +G E+
Sbjct: 150 QQRYGAPASGQLPSQQQSAQKNDESQ----LQQQPNGETP---PQQTDGAGDDESEALVR 202
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 22/106 (20%), Positives = 33/106 (31%), Gaps = 6/106 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
PP + P + PPP P S P +P A P A ++
Sbjct: 53 PPAAAAPAAAQPPPAAA--PAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVAR----AA 106
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P +P A +P + N R ++ P P P +
Sbjct: 107 APAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (114), Expect = 6e-06
Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 12/147 (8%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPA--SNPPTSSPPPSPPASSPPT--ISPPPPVSNPPTRS 114
A+ P S A++P ++ PA + PP + A++ P +PP + PP ++
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKA 267
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP+ +PP+ + PPA + + PP+ P + P ++ + PP
Sbjct: 268 AAPPAKAA---APPAKAAAPPAKA---AAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPA 321
Query: 175 PSSSPPKN--SPPAPIAVPPSNVPPPP 199
+++PP +PPA A PP+ P
Sbjct: 322 KAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 45/225 (20%), Positives = 67/225 (29%), Gaps = 13/225 (5%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
T + S P +N SS + SP SS + A + P+ +PPP +S
Sbjct: 172 TPASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSP 231
Query: 110 PPTRSPPPPSSTPPPNS-------PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
S S P S S + + NL + V S
Sbjct: 232 NNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPSIRNLRGLNSALVSFLNVS 291
Query: 163 PPSVPP---QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
S+ P+ SP S +P S+ T+ T +P PS +P
Sbjct: 292 SSSLAFSALNGKEVSPTGSPSTRSFARV--LPKSSPNNLLTEILTTGVNPPQSLPSLLNP 349
Query: 220 NSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNG 264
ST + +N N + S SS +
Sbjct: 350 VF-LSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYSSNVPSP 393
|
Length = 777 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 61/251 (24%), Positives = 78/251 (31%), Gaps = 29/251 (11%)
Query: 4 PSPGP-PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
PSP PA +S P + +SP K P P P S+
Sbjct: 72 PSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSDDEDEAERPSKRPRSDS 131
Query: 63 PTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNP---------- 110
+SSS PA P P PA++ S +P + + P + P
Sbjct: 132 ISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSD 191
Query: 111 ----PTRSPPPPSSTPPPNSPPSPPSDPPAN-------SPPPSNPPSNLPPPPPSSVEPP 159
P P SS P S P P + PPP SV P
Sbjct: 192 GFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAP 251
Query: 160 KRSPP-SVPPQNPPPPPSSSPPKNSPPAPIAVPPS----NVPPPPTQTPPTPASPIAPRP 214
S P + N P P P PAP AV S VP + + A+P+
Sbjct: 252 DDSTPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQGF 311
Query: 215 SNSSPNSPPPP 225
SN N P
Sbjct: 312 SNFGSNMYSEP 322
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 21/78 (26%), Positives = 28/78 (35%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P +S +S P P P + PP S P T + SPP + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 88 SPPPSPPASSPPTISPPP 105
PSP + +PP
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 31/126 (24%), Positives = 37/126 (29%), Gaps = 9/126 (7%)
Query: 20 VSNPPTISPPPPVSNPPKSSP----PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
V + SP PP S P P A PP + PA P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQ 127
Query: 76 SSPPPASNPPTSSP---PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN--SPPSP 130
PA P P P SP + P P P P + P P + P+P
Sbjct: 128 PVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAP 187
Query: 131 PSDPPA 136
D P
Sbjct: 188 VMDKPK 193
|
Length = 333 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 44/205 (21%), Positives = 57/205 (27%), Gaps = 24/205 (11%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGP + S P +S P P PK P +P + P P + P
Sbjct: 561 PGPAKEHKPSKIPTLSKKPEF---PKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPEL 617
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P S SP PP P SP P I PP S PP +
Sbjct: 618 LDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKI---------IKSPKPPKSPKPPFD 668
Query: 126 ------------SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+ + + S L P + P +P +PP+ P
Sbjct: 669 PKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRD 728
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPP 198
P P A PP
Sbjct: 729 EEFPFEPIGDPDAEQPDDIEFFTPP 753
|
Length = 943 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 36/182 (19%), Positives = 52/182 (28%), Gaps = 13/182 (7%)
Query: 1 MSAPSPGPPAANSSS---PPPPVSNPPTI-SPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
AN +S PP S ++ S P N + P + + P +
Sbjct: 440 KQRAKARKKLANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKS-- 497
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S +S S+ T T P+ SS + N +
Sbjct: 498 ---SLSQEASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSS 554
Query: 117 PPS--STPPPNS-PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P S S P +S P D + S P KRSP S P ++
Sbjct: 555 PGSINSKSPEHSVPLVRVFDIHLRASTTKGRHST-PSTNEKKKRLLKRSPLSPPKESVAT 613
Query: 174 PP 175
P
Sbjct: 614 TP 615
|
Length = 619 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 36/226 (15%), Positives = 57/226 (25%), Gaps = 15/226 (6%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+S P S PP S S P + + + P S P +
Sbjct: 398 SSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSN 457
Query: 111 PTRSPPP---PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP--PKRSPPS 165
+ P+S+ PP + P+NP N SS+ P P++S +
Sbjct: 458 ISVFEDSETSPNSSTLLRDPPPKKC-GEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIIT 516
Query: 166 VPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-------SPIAPRPSNSS 218
+P + P SS ++ P S I
Sbjct: 517 LPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRSVSDIEGERIGRY 576
Query: 219 PNSPP--PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
P P + S+ +P N
Sbjct: 577 NLLPTRIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHEN 622
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 3/72 (4%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+PP A+ + P+ P PP +PP P + P + P+ P P + +PP+
Sbjct: 381 APAPPSAAWGAPTPAAPAAP---PPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARS 437
Query: 135 PANSPPPSNPPS 146
+ S
Sbjct: 438 ADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 29/128 (22%), Positives = 34/128 (26%), Gaps = 9/128 (7%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S PP + P P P PV P T+ P + P
Sbjct: 633 SGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRV-------ARGDPVRP 685
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
+ A P PP PP P P S S T PP P PP
Sbjct: 686 TAHHAALRAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPP--EPEPPG 743
Query: 133 DPPANSPP 140
A+
Sbjct: 744 AEQADGAE 751
|
Length = 753 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 18/87 (20%), Positives = 25/87 (28%), Gaps = 3/87 (3%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
+ + PP P PP P PP P +PP PP + P
Sbjct: 513 QSGSASNTAKTPPP---PQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 206 PASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ +P P +P P
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 17/115 (14%), Positives = 36/115 (31%), Gaps = 7/115 (6%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP--PPNSPPSPPSDP 134
+PP A+ P + PPP+ ++ + P P + + + P+ P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
A +P + P+ P +++ ++ A I
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAA-----APRPRVPADAAAAVADAVKARIE 161
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 11/82 (13%), Positives = 29/82 (35%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
+++ PA++P ++P + + +P + + V+ + P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAA 227
Query: 125 NSPPSPPSDPPANSPPPSNPPS 146
+ P + P + S P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAA 249
|
Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 31/161 (19%), Positives = 40/161 (24%), Gaps = 16/161 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPP-PVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+ P PA P P +P P S P P
Sbjct: 139 LPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYD 198
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ P P P + P P PPP + P PP
Sbjct: 199 AGRPEYDQR---RRDYDHPRPDWDRPRRDRTDRP--------EPPPGAGHVHRGGPGPPE 247
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
+ P P P A P + P P P++ PK
Sbjct: 248 ----RDDAPVVPIRPSAPGPLAAQPAPAPGPGEPTARLNPK 284
|
Length = 617 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A +P P A ++P S P ++ P + P+ + P T+ P+P A
Sbjct: 173 ATTPAPAAPVDTTPTN--SQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAAPAT 230
Query: 63 PTSSSP-PASSPPTSSPPPASNP 84
P ++P P S+P N
Sbjct: 231 PDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 43/173 (24%), Positives = 61/173 (35%), Gaps = 10/173 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P K++ P VS P P P S P T A++ S S P +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTY--PSQVTPQSQPATQGHQTATANQRLS----STEPVGT 221
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
+ ++ P PPP P+ SP P ST + S D ++ PP+
Sbjct: 222 QGTTTSSNPEPQTEPPPS-QRGPSGSPQHPPSTTSQDQ--STTGDGQEHTQRRKTPPATS 278
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
P S P + P P P+++ S P P + PP P TQ
Sbjct: 279 NRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSP-PHSSPPGVQANPTTQ 330
|
Length = 408 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 9e-06
Identities = 13/74 (17%), Positives = 24/74 (32%), Gaps = 3/74 (4%)
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP P +P ++ P A+ ++ P+ ++ P + P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 113 RSPPPPSSTPPPNS 126
+P P NS
Sbjct: 451 AAPQPA---VRLNS 461
|
Length = 598 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 35/167 (20%), Positives = 50/167 (29%), Gaps = 14/167 (8%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
SNP + A + P SSPP A+ S
Sbjct: 759 SNPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASK 818
Query: 120 STPPPNSP------PSPPSDPPANSPPP------SNPPSNLPPPPPSSVEPPKRSPPSVP 167
++P P P A + PP S+ + + +R P
Sbjct: 819 RKSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPE 878
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P+ P +PPK + AP A P+ P P + P P P P
Sbjct: 879 PRARPGAA--APPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDP 923
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 34/159 (21%), Positives = 47/159 (29%), Gaps = 6/159 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S P A ++ P + K +S P PP +
Sbjct: 783 GAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAA 842
Query: 62 ---PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
PP SS + S P ++ A P P + P + PP + + P
Sbjct: 843 ARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPA 902
Query: 119 SSTPPPNSP---PSPPSDPPANSPPPSNPPSNLPPPPPS 154
P P PP P PP +L P PS
Sbjct: 903 PRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPAPS 941
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 22/99 (22%), Positives = 32/99 (32%), Gaps = 1/99 (1%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P +S S P + P SPP P P A + + PP S P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
P P P ++ P N + + + P T+
Sbjct: 421 PTEPSPTPPANAANAPPSLNLEELWQQI-LAKLELPSTR 458
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 19/81 (23%), Positives = 25/81 (30%), Gaps = 3/81 (3%)
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
S + P+ P+ PPP P PK + P PP S P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 185 PAPIAVPPSNVPPPPTQTPPT 205
P P P PP+
Sbjct: 421 PTE---PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 23/83 (27%), Positives = 30/83 (36%)
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
S + PPPP SPP +P P+ P + PPP PP A+ + P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 222 PPPPSTKRLSPPPGIPVPSTENT 244
PP P P S+
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 31/119 (26%), Positives = 35/119 (29%), Gaps = 19/119 (15%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP---PNSPPSPPSDPPANSPPP 141
PSP S P P P R P P P P PSP S P PP
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 142 SNPPSNLPPPPPSSVEPPKRS-PPSV---------------PPQNPPPPPSSSPPKNSP 184
+ LPP P +S S P V + P SSS +
Sbjct: 436 VARSAPLPPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDAAQTG 494
|
Length = 620 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 22/153 (14%), Positives = 33/153 (21%), Gaps = 8/153 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP-PPPPVSKPPTTSPPPSP---- 57
+P PP A P P + P ++P P + P T + P P
Sbjct: 52 SPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPT 111
Query: 58 --PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P + P P S P +
Sbjct: 112 IQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKN 171
Query: 116 PPPSSTPPPNSPPSPP-SDPPANSPPPSNPPSN 147
PN P +D + +
Sbjct: 172 DESQLQQQPNGETPPQQTDGAGDDESEALVRLR 204
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 19/75 (25%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P+PP+++ +P P + PP +PP PP +P P + PA +P P + PP
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPP-----VPPAAPARPAAARPAPAPAPPAAAA--PP 434
Query: 151 PPPSSVEPPKRSPPS 165
+ +
Sbjct: 435 ARSADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 460 PVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-L 517
P L + V + A G+ +L ++C +HRD+ + N+L+ ++ DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
D+N +MAPE + T SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 53/224 (23%), Positives = 69/224 (30%), Gaps = 18/224 (8%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
+P P + P + P P S P+ S V T SP TS+ P A +
Sbjct: 215 GFTPHPSLPQPQSPLKPSPSSARPQQSESFSDVWPASTQSP-------REETSAEPLAPA 267
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P+S P + + S P S+ P PS+T P PP+
Sbjct: 268 SPSSRRPSTAQEEQIACSSPQAEPEQGVQSYVPQSSDSRPSCFPAPSTTQPTFLPPNTNK 327
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRS-----PPSVPPQNPP---PPPSSSPPKNSP 184
+ P P S PS Q+PP P SS S
Sbjct: 328 KAKRDRRPQMVTPKQEGGAAVSQNHDGGTVRAPRGRPSGSGQSPPSNSPLLSSLADTPSG 387
Query: 185 PAPIAVPPSNVPPPPTQTPPTPASPIAPR-PSNSSPNSPPPPST 227
A P S +PP Q AS P P +S P
Sbjct: 388 AA--HQPASLLPPAVVQQQLEDASDKQPPTPGSSLVPQPDEQEL 429
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 35/227 (15%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G G V+ L G+ A+K L + K E EI++ + H L +L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
++ L+ DY P L+ L + L AA L YLH I
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GI 124
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI------------------------ 525
++RD+K NILL + +SDF L+K + +
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 526 -TTRVM---GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ R GT Y+APE S D ++ G++L E++ G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 31/168 (18%), Positives = 48/168 (28%), Gaps = 10/168 (5%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A + + P PPV P + + + S
Sbjct: 765 PAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRL---RRSGPAADAASRTASKRKS 821
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+ S PA P ++ PP +S P ++ P P +
Sbjct: 822 RSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRA 881
Query: 127 PPSPPSDPP-ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P + P A + PP+ P+ P P P P +PP P P
Sbjct: 882 RPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGP------MPPGGPDP 923
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 23/80 (28%), Positives = 27/80 (33%), Gaps = 1/80 (1%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P A S PT +P P P P T SPPP AS P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPP-AKASPPIPVPA 419
Query: 68 PPASSPPTSSPPPASNPPTS 87
P PT A+ PP+
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 16/80 (20%), Positives = 25/80 (31%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
PS ++S P + P SPPP P + P + P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 64 TSSSPPASSPPTSSPPPASN 83
+ P ++ PP+ N
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 17/78 (21%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ S + ++P P P P S P SPP + PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 142 SNPPSNLPPPPPSSVEPP 159
+ PP ++ PP
Sbjct: 421 P-TEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 35/214 (16%), Positives = 53/214 (24%), Gaps = 16/214 (7%)
Query: 1 MSAPSPGPPAANSSS--PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
M+ P GP + SS P + + N + P + S
Sbjct: 407 MTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSNISVFEDSET 466
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ N T P N P + +S PP ++ P P
Sbjct: 467 SPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIITLPTPSRPASR 526
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS---SVE--------PPKRSPPSVP 167
S+ S P S S SV P +P
Sbjct: 527 ISSLSLRLGSYSGSIVSPPPYP--TLVSRKGAAGLSFNRSVSDIEGERIGRYNLLPTRIP 584
Query: 168 PQNPPPPPSSSPPKN-SPPAPIAVPPSNVPPPPT 200
++S ++ S P+P V P
Sbjct: 585 ALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRF 618
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 19/103 (18%), Positives = 29/103 (28%), Gaps = 16/103 (15%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
S+T P + P+P + P P P+V PQ S
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAP------------APAVDPQQNAVVAPSQ 214
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
++ P P+ P P P + PN+
Sbjct: 215 ANVDTAATPAPAAPA----TPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 39/191 (20%), Positives = 61/191 (31%), Gaps = 15/191 (7%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P + S P S P P P + + T++ +S P + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
++ P PPP P+ SP P ST + S D ++ PP+ P
Sbjct: 228 SNPEPQTEPPPS-QRGPSGSPQHPPSTTSQDQ--STTGDGQEHTQRRKTPPATSNRRSPH 284
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
S P + P P P+++ S P P + P A+P
Sbjct: 285 STATPPPTTKRQETGRPTPRPTATTQSGSSP------------PHSSPPGVQANPTTQNL 332
Query: 215 SNSSPNSPPPP 225
+ PP P
Sbjct: 333 VDCKELDPPKP 343
|
Length = 408 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 29/127 (22%), Positives = 37/127 (29%), Gaps = 10/127 (7%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
PP A P + + P P P + PS A P P
Sbjct: 634 GFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPV--RPTAHHAA 691
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
R+P P P PP PPP P + P P SS+ +PP P
Sbjct: 692 L-RAPQAP-------RPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPG 743
Query: 171 PPPPPSS 177
+
Sbjct: 744 AEQADGA 750
|
Length = 753 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 13/70 (18%), Positives = 21/70 (30%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P PP +P + A +P + P + P + + P P
Sbjct: 392 PSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPAA 451
Query: 174 PPSSSPPKNS 183
P + NS
Sbjct: 452 APQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 44/221 (19%), Positives = 64/221 (28%), Gaps = 10/221 (4%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P AA S + N SP + ++ P P P + A P ++S
Sbjct: 360 PLAAASCDANAVIENTELQSPSAQTAEKETAAKKPQPR--------PEAETAQTPVQTAS 411
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
A + P SN + PP A + ++ + + TPP N
Sbjct: 412 AAAMPSEGKTAGPVSNQENNDVPPWEDAPDEAQTAAGTAQTSAKSIQTASEAETPPENQV 471
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
+ P S PS P + E + + P P + PP
Sbjct: 472 SKNKAADNETDAPLSEVPSENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCPPED 531
Query: 188 IA--VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
A PP P T A A N+P P
Sbjct: 532 GAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPP 572
|
Length = 709 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 20/150 (13%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS--LVG 430
LL G VY L E + LKI + + + EV I+ + + L ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYV--LKINPSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-- 488
SD L+ +++ TL + + IA A LA LH+ P
Sbjct: 61 SGESDGWSYLLMEWIEGETLD---------EVSEEEKEDIAEQLAELLAKLHQ--LPLLV 109
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
+ H D+ NIL+D+ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 52/239 (21%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
++G G FG V D G A+K+L+ + Q +AE +I++ + +V L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA-HVRAERDILAEADNPWVVKL 66
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y D+ L LI +Y+P + L + + TR IA LA + H
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETI---LAI--DSIHK 119
Query: 488 -RIIHRDIKSSNILLDNNFEAQVSDFGL----------------AKLALDANTHITTRVM 530
IHRDIK N+LLD ++SDFGL + ++ M
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 531 ---------------------GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
GT Y+APE ++ D +S GV++ E++ G P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223041 PHA03321, PHA03321, tegument protein VP11/12; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 65/250 (26%), Positives = 82/250 (32%), Gaps = 33/250 (13%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPP----------PPVSNPPKSSPPPPPVSKPPTT 51
S PG PA + PPP S P + P P P
Sbjct: 427 SRQPPGAPAPRRDNDPPPPPRARPGSTPACARRARAQRARDAGPEYVDPLGALRRLPAGA 486
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS--- 108
+PPP P A+ P + P PP T P PPA++PP P +
Sbjct: 487 APPPEPAAAPSPATYYTRMGGGPPRLPPRNRATETLRPDWGPPAAAPPEQMEDPYLEPDD 546
Query: 109 -NPPTRSPPPPSSTPPPNSPPSPPSDPPANS------------PPPSNPPSNLPPPPPSS 155
R ++T P P+P DP P P + LP P +
Sbjct: 547 DRFDRRDGAAAAATSHPREAPAPDDDPIYEGVSDSEEPVYEEIPTPRVYQNPLPRPMEGA 606
Query: 156 VEPPKRSPPSVPPQNPPPPPSS--SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-P 212
EPP P+ P P P SPP P PP P +P PA P P
Sbjct: 607 GEPPDLDAPTSPWVEEENPIYGWGDSPLFSPPPAARFP----PPDPALSPEPPALPAHRP 662
Query: 213 RPSNSSPNSP 222
RP +P+ P
Sbjct: 663 RPGALAPDGP 672
|
Length = 694 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 33/115 (28%), Positives = 44/115 (38%), Gaps = 2/115 (1%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPP--PPVSKPPTTSPPPSPPASNPPT 64
G A + S+ P S P P P ++P P S P T P + P+ P
Sbjct: 377 GASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPW 436
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+PPA P PA P +SP P P S PP + +P + PS
Sbjct: 437 DDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 10/131 (7%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
++ P ++ P S P S T P P + PA+ SS PA+
Sbjct: 370 SLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQG----PQGTAPAAGMTPSSAAPATPA 425
Query: 85 PTSSPPPSPP-ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P+++P P P +PP PP PP +P P ++P P +P S S +++PP
Sbjct: 426 PSAAPSPRVPWDDAPPA---PPRSGIPPRPAPRMPEASPVPGAPDSVAS--ASDAPPTLG 480
Query: 144 PPSNLPPPPPS 154
PS+ PS
Sbjct: 481 DPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 5/116 (4%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S P P S PP P + P + P+ PA++ + S A +
Sbjct: 302 SDPEPLPASLPP--PPVRRPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQN 359
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
+ S P S+ +S P + + + P P +S P P S P
Sbjct: 360 KDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMP---SPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 30/206 (14%), Positives = 50/206 (24%), Gaps = 26/206 (12%)
Query: 30 PPVSNP---PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P++NP ++ PPV+ + + P+ P + SP T
Sbjct: 128 GPITNPNVKRRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDT 187
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-----STPPPNSPPSPPSDPPANSPPP 141
S + ++ NPP +S S + + S S
Sbjct: 188 SKETTTEKTEGKTSVKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEESEEE 247
Query: 142 SNP-PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP------------- 187
S L + P + S +
Sbjct: 248 SGKRDVILEDESAEPTGLDEDEDEDEPKPSGERSDSEEETEEKEKEKRKRLKKMMEDEDE 307
Query: 188 ----IAVPPSNVPPPPTQTPPTPASP 209
VP S V ++ P P P
Sbjct: 308 DEEMEIVPESPVEEEESEEPEPPPLP 333
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 17/77 (22%), Positives = 27/77 (35%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S + P P P P P A +++ P+ P +SPP
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 87 SSPPPSPPASSPPTISP 103
+ P P+PPA++
Sbjct: 422 TEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 16/79 (20%), Positives = 22/79 (27%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
S + P + P P P S P T +P S P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 74 PTSSPPPASNPPTSSPPPS 92
PT P ++PP
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 28/122 (22%), Positives = 39/122 (31%), Gaps = 4/122 (3%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP-PSNPPSNLPPPPPSSVEPPKR 161
V+ P SP P P P P P P P P+ L P P+S P++
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEP-DLPQPDRHPGPAKPEAPGARPAEL--PSPASAPTPEQ 432
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
PP PP P +S P+N V + + + S+S
Sbjct: 433 QPPVARSAPLPPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDAAQ 492
Query: 222 PP 223
Sbjct: 493 TG 494
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 40/199 (20%), Positives = 56/199 (28%), Gaps = 15/199 (7%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP------PPPSST 121
P + P + P + T++ P T +PP + P P P T
Sbjct: 309 PLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQT 368
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLP-----PPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P P+P P + N P P P P P P P
Sbjct: 369 GEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQP 428
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P +P V + Q+ P S + P + P P P
Sbjct: 429 AQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPL---YQQPQPVE 485
Query: 237 PVPSTENTPG-NGTNPSSP 254
P E P T P+ P
Sbjct: 486 QQPVVEPEPVVEETKPARP 504
|
Length = 1355 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 22/114 (19%), Positives = 32/114 (28%)
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
R P++ + P + P + PP + V P P+ P P
Sbjct: 69 HRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQP 128
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPP 225
P+ P P P P P + P PA + P P
Sbjct: 129 VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPV 182
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 33/123 (26%), Positives = 47/123 (38%), Gaps = 11/123 (8%)
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
N P+ + A P P + PP +S +P R P PP+ PP + P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQ----YQPPYASAQP--RQPVQQPPEAQVPPQHAPRP 121
Query: 181 KNSPPAPIAVPPSNVPPP-PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P P+ P P P Q P +P AP+P +S P P+ + P + P
Sbjct: 122 AQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPAPQPV----HSAPQPAQQAFQPAEPVAAP 177
Query: 240 STE 242
E
Sbjct: 178 QPE 180
|
Length = 333 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 43/223 (19%), Positives = 55/223 (24%), Gaps = 14/223 (6%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
S P S P + + P P PK PPP S P P + PP
Sbjct: 602 SAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPK 661
Query: 65 SSSPPAS--------SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S PP + + T+ S P P + T P
Sbjct: 662 SPKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPL 721
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV---EPPKRSPPSVPPQNPPP 173
PP P P DP A P + PP E P +P
Sbjct: 722 PPKLPRDEEFPFEPIGDPDAEQPDDIEFFT---PPEEERTFFHETPADTPLPDILAEEFK 778
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P + P S P+ P +
Sbjct: 779 EEDIHAETGEPDEAMKRPDSPSEHEDKPPGDHPSLPKKRHRLD 821
|
Length = 943 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 3/88 (3%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST---PP 123
S P + T+ P P + +P + P P +P + PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA 220
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P+ P+ P +P P++ P
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPA 248
|
Length = 331 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 20/101 (19%), Positives = 33/101 (32%), Gaps = 1/101 (0%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
T+P + ++P + P A + P ++S P T +
Sbjct: 82 AEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPE-ASSTSATDEAATDPPATAAARDGP 140
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
+ PT P P P P +PP S P ++ L
Sbjct: 141 TPDPTAQPATPDERRSPRQRPPVSGEPPTPSTPDAHVAGTL 181
|
Length = 226 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 28/76 (36%), Positives = 35/76 (46%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
I+ P + P PPPPS+ +P +PP PP +PP P PPP +P
Sbjct: 30 AIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPN 89
Query: 160 KRSPPSVPPQNPPPPP 175
PP V P PPPP
Sbjct: 90 APPPPPVDPNAPPPPA 105
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 16/87 (18%), Positives = 24/87 (27%), Gaps = 8/87 (9%)
Query: 78 PPP-------ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
P P PP+ P P + P + P + P P
Sbjct: 378 PTPDEALRRLQEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVP 437
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVE 157
A + PP+ + P +S E
Sbjct: 438 -DAAAAAAAPPAPAAAPQPAVRLNSFE 463
|
Length = 598 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 24/135 (17%), Positives = 32/135 (23%), Gaps = 4/135 (2%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP-PPASNPPTS 87
PP + P P + P S PP +P PP S
Sbjct: 55 YPPRETGSGGGVATSTIYTVP-RPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGAS 113
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
SP ++SP + SS P
Sbjct: 114 SPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPS--ESLKVKNGGK 171
Query: 148 LPPPPPSSVEPPKRS 162
+ P S + KRS
Sbjct: 172 VYPKGFSKHKTHKRS 186
|
Length = 580 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-----FKAEVEIISRIHHR-HLVS 427
+GEG +G VYK G+ VA+K+ ++ + + E E+ ++ + ++V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRL---EMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 428 L--VGYCISDDRRLLIY---DYVPNNTLYF---HLHGEGRPVLDWATRVKIAAGAARGLA 479
L V + + + +Y +Y+ ++ F + G GRP L T +G+A
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKGVA 124
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEA-QVSDFGLAK---LALDANTHITTRVMGTFG 534
+ CH ++HRD+K N+L+D +++D GL + + + + TH T
Sbjct: 125 H----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLW 176
Query: 535 YMAPE-YASSGKLTEKSDVFSFGVVLLELITG 565
Y APE S + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/74 (21%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP + + P + +P + +PP A+ PP +P PP +P
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPP-TPV 182
Query: 100 TISPPPPVSNPPTR 113
+ P P +R
Sbjct: 183 ARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 23/75 (30%), Positives = 32/75 (42%), Gaps = 5/75 (6%)
Query: 10 AANSSSPPP-----PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
AAN+++P P S PP+ P S P ++PP V P T +P ++ T
Sbjct: 27 AANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVET 86
Query: 65 SSSPPASSPPTSSPP 79
SP PT P
Sbjct: 87 PQSPTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 28/129 (21%), Positives = 46/129 (35%), Gaps = 10/129 (7%)
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+ P ++ P+S SS A+ P P V+ + +
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
P P+ P N+ P P S+ E + S ++ +++ P S P A P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNI-------TSTANGPTTSLP---AAP 407
Query: 192 PSNVPPPPT 200
SN+P PT
Sbjct: 408 ASNIPVSPT 416
|
Length = 421 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/104 (25%), Positives = 36/104 (34%), Gaps = 5/104 (4%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPP----ASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P V KP P PA+ + PP + + P+ +P T +PP +P P
Sbjct: 42 PLVPKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP 101
Query: 99 PTISPPPP-VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ PP P P P P P +P P P
Sbjct: 102 APVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 22/119 (18%), Positives = 34/119 (28%), Gaps = 4/119 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ P A ++P P P P +P P + P+ + P
Sbjct: 683 PAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLP 742
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
P PA +P PPPA P + PP+ ++ S
Sbjct: 743 PEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPS----EEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 15/107 (14%)
Query: 166 VPPQNPPPP---------PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P PP +++ + P ++ PP+ +P P+ P P +
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 217 SSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
S +S PP P + +P + TNPS P ++P
Sbjct: 206 SPSDSSLPP------APSSFQSDTPPPSPESPTNPSPPPGPAAPPPP 246
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 13/78 (16%), Positives = 21/78 (26%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
+ + + P P P P + S P +SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 81 ASNPPTSSPPPSPPASSP 98
+ P + P + A
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 29/135 (21%), Positives = 47/135 (34%), Gaps = 13/135 (9%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P P S + K++P PQ P + P P++ P P Q P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENT-PGNGTNPSSPE----SSS 258
++P+ P P S P + PG+ + S + N S + SSS
Sbjct: 436 VARSAPLPPSPQAS-----APRNVASGK--PGVDLGSWQGKFMNFTRNGSRKQPVQASSS 488
Query: 259 SPSNNGIGTAGTVVI 273
+ G+ G +
Sbjct: 489 DAAQTGVF-EGVAEL 502
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 29/149 (19%), Positives = 39/149 (26%), Gaps = 6/149 (4%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S PPA S P SP AS P T P ++ ++P PP
Sbjct: 648 PPSRAPPA---SLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVP 704
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P + PP P + SV + + V
Sbjct: 705 DPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQ---QATHQPQVQAE 761
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
P T +S + N S
Sbjct: 762 AQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQN---PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P PP ++ P + P+ PP P PP + + P + PAP PP+ PP
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 203 PPTPASPIAPR 213
P A+ R
Sbjct: 439 DPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
+ P ++P P+ P + PT S P V+ P P +P D A P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPA--PAVDPQQNAVVAPSQANVDTAATPAP 225
Query: 141 PSNPPSNLPPPPPSSVEPPKRSP 163
+ + P P+
Sbjct: 226 AAPATPDGAAPLPTDQAGVSTPA 248
|
Length = 331 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 31/188 (16%), Positives = 39/188 (20%), Gaps = 18/188 (9%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A PP + PT + P P P T +P SP A S
Sbjct: 60 KSSAPRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSE 119
Query: 67 S-------PPASSPPTSSPP----PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
A P SS PP S S P + + +
Sbjct: 120 GVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAAL 179
Query: 116 PPPSSTPPPNSP-------PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S S N P + P S
Sbjct: 180 FKDDEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRSAGGRFEGEDENLE 239
Query: 169 QNPPPPPS 176
+N P
Sbjct: 240 RNLQPQSP 247
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 38/207 (18%), Positives = 51/207 (24%), Gaps = 18/207 (8%)
Query: 16 PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP--PPSPPASNP-PTSSSPPASS 72
PP + + P+ P P + P PP P P ASS
Sbjct: 55 YPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASS 114
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P + + P A + S +S S PP S
Sbjct: 115 PRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELS-----EEEEHSRPPPSESLKVKNG 169
Query: 133 ---DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-------SSPPKN 182
P S ++ S + K S P Q S +
Sbjct: 170 GKVYPKGFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQLKELSGSLKNLLHLDDSAET 229
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASP 209
P P +V PP T P P
Sbjct: 230 DPATRQVPVPVHVLYPPLLTEYVPYKP 256
|
Length = 580 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 22/103 (21%), Positives = 31/103 (30%), Gaps = 3/103 (2%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P P A+ + PP + + + P+ P T++PP P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEP 106
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
P P P P +PP P P P P
Sbjct: 107 PKPKPVEKPKPKPKPQQKVEAPPAPKPE---PKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 31/118 (26%), Positives = 40/118 (33%), Gaps = 6/118 (5%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP----ASSPPTISPP 104
+TS S P S+ S S SS P N P S P SP +SS +S
Sbjct: 8 GSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P S R S P SP + S + + S S+ P + S
Sbjct: 68 RPSSLSRGRLSSRFVS-PSRGSPSAAASLNGSLA-TASTSGSSSPSRSRRTTSSDLSS 123
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELI 563
APE E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 2/70 (2%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
S P + P +P +S PT +P PP S S P S+ + +
Sbjct: 75 SKPKTGTGKVAPPAATP--TSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAP 132
Query: 137 NSPPPSNPPS 146
SP S P S
Sbjct: 133 ESPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PP+PP +P P S+ R P T P + +P P +P
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQP-TVQNPAQQPTVQNPAQQPQQQPQQ 231
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P + +P ++P PPQ S N
Sbjct: 232 QPVQPAQQPTPQNPAQQPPQTEQGHKRSREQGN 264
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 20/80 (25%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P PQ P ++ P PAP P + P + P P P +PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA-TPPPVPPRPVAPP 420
Query: 224 PPSTKRLSPP-PGIPVPSTE 242
P T +P +P E
Sbjct: 421 VPHTPESAPKLTRAAIPVDE 440
|
Length = 585 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 22/107 (20%), Positives = 33/107 (30%), Gaps = 11/107 (10%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN--------- 182
SD A +PP + P+ PP + P S P+ P P P +
Sbjct: 46 SDLAALAPPAAAAPA--AAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVA 103
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
AP A P + A+ R + ++P P
Sbjct: 104 RAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 24/121 (19%), Positives = 28/121 (23%), Gaps = 2/121 (1%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
PP A P + P P P P P
Sbjct: 634 GFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALR 693
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P P PP PP + P +P +S A PP PP Q
Sbjct: 694 --APQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADGAE 751
Query: 207 A 207
Sbjct: 752 N 752
|
Length = 753 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 5e-05
Identities = 11/71 (15%), Positives = 19/71 (26%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
+ PP P +P A + A++P P A + +
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 97 SPPTISPPPPV 107
+P P
Sbjct: 448 APAAAPQPAVR 458
|
Length = 598 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 18/90 (20%), Positives = 25/90 (27%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + PP + ++ P P T +PP +P P P
Sbjct: 57 PAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPK 116
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P P +PP P P P
Sbjct: 117 PKPKPQQKVEAPPAPKPEPKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|130689 TIGR01628, PABP-1234, polyadenylate binding protein, human types 1, 2, 3, 4 family | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 25/132 (18%), Positives = 39/132 (29%), Gaps = 18/132 (13%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSP------PSVP---PQNPPPPPSSSPPKNSPPAPIAV 190
P P + +PP P P+ P P P P +
Sbjct: 380 PRMRQLPMGSPMGGAMGQPPYYGQGPQQQFNGQPLGWPRMSMMPTPMGP--GGPLRPNGL 437
Query: 191 PPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP-STENTPGNGT 249
P + P A A +P PP+ + L +P P ST + G
Sbjct: 438 A----PMNAVRAPSRNAQNAAQKP--PMQPVMYPPNYQSLPLSQDLPQPQSTASQGGQNK 491
Query: 250 NPSSPESSSSPS 261
+ +S++P
Sbjct: 492 KLAQVLASATPQ 503
|
These eukaryotic proteins recognize the poly-A of mRNA and consists of four tandem RNA recognition domains at the N-terminus (rrm: pfam00076) followed by a PABP-specific domain (pfam00658) at the C-terminus. The protein is involved in the transport of mRNA's from the nucleus to the cytoplasm. There are four paralogs in Homo sapiens which are expressed in testis (GP:11610605_PABP3 ), platelets (SP:Q13310_PABP4 ), broadly expressed (SP:P11940_PABP1) and of unknown tissue range (SP:Q15097_PABP2). Length = 562 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 28/112 (25%), Positives = 38/112 (33%), Gaps = 6/112 (5%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP + PPP P +P PP P +P P P PK P V P
Sbjct: 59 EPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVKKVEEQPK 118
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
P + P +P P + + A+ A +P S + P S
Sbjct: 119 REVKPVEPRPASP------FENTAPARPTSSTATAAASKPVTSVSSGPRALS 164
|
Length = 246 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 32/188 (17%), Positives = 45/188 (23%), Gaps = 16/188 (8%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN-PPTRSPPPPSSTPPPNSP-- 127
S + S +P SP +S T P SN R P S + +
Sbjct: 379 SISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLL 438
Query: 128 ------PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P+ S P S + P S R PP + P
Sbjct: 439 RRMNIKPTLASIPDEKPSNISVFEDSETSPNSS---TLLRDPPP-KKCGEESGHLPNNPF 494
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ S++PP + + S S S S P
Sbjct: 495 FNKLKLT---LSSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLV 551
Query: 242 ENTPGNGT 249
G
Sbjct: 552 SRKGAAGL 559
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 1/69 (1%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P P + PP +++PP P + P A+ P + PP+ A + P
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP-PAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 104 PPPVSNPPT 112
S
Sbjct: 441 AAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 24/99 (24%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P ++ P +P P T P S TP + P+P DP N+ PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTT---PTNSQTPAVATAPAPAVDPQQNAVVA---PSQ 214
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
++ P + P P S P P A
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 24/103 (23%), Positives = 31/103 (30%), Gaps = 10/103 (9%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P S++ P T +P PV P +S P T P P N + S
Sbjct: 163 PLDTSTTTDPA----TTPAPAAPVDTTPTNSQTPAV----ATAPAPAVDPQQNAVVAPSQ 214
Query: 69 PASSPPTSSPPPASNPPTSSP--PPSPPASSPPTISPPPPVSN 109
+ P A P + P S P P V N
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNALVMN 257
|
Length = 331 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 28/106 (26%), Positives = 34/106 (32%), Gaps = 9/106 (8%)
Query: 84 PPTSSPPPSPPASSPPTISPPPP--VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
P P PA++ + PP PS P +PP+ P +P P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPE---PAP 103
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
PP P P PK P P P P P AP
Sbjct: 104 VEPP----KPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 20/82 (24%), Positives = 27/82 (32%), Gaps = 4/82 (4%)
Query: 127 PPSPPSDPPANSPPPSNPPSN----LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
PP+PP + PA P + S+ P P+ + QNP P P +
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQ 232
Query: 183 SPPAPIAVPPSNVPPPPTQTPP 204
P N P QT
Sbjct: 233 PVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 62/240 (25%), Positives = 73/240 (30%), Gaps = 38/240 (15%)
Query: 32 VSNPPKSSPPPPPVSK----PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA------ 81
S + PP VS PP SPP P S P + P++ P +PP
Sbjct: 542 RSGRRQKRATPPKVSPSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQA 601
Query: 82 ---SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS--PPSPPSDPPA 136
PP S P P SS P P V S+ P P S D
Sbjct: 602 KCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDGSG 661
Query: 137 NSPPPSN--PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI------ 188
PS+ P+ PP S P PSV P S SP PI
Sbjct: 662 IQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEEQP 721
Query: 189 -----------AVPPSNVPPPPTQTP----PTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
++ P PPP Q P P + AP P P P P P
Sbjct: 722 RYEDPDDPLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQ 781
|
Length = 1000 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 7e-05
Identities = 23/119 (19%), Positives = 45/119 (37%)
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P ++ +P + P P +++ P + A P+ P PP+
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
PA P ++P++ P P+ P P P+ P P++P + ++P+
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
|
Length = 824 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 26/130 (20%), Positives = 40/130 (30%), Gaps = 15/130 (11%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVP 167
R P P P + P A + PS S+ P P S P +PP+V
Sbjct: 370 SGGRGPKQHIK-PVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 168 PQNPPP---PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT------PASPIAPRPSNSS 218
P P S+ P+ PA P ++ P A + + +
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEK---KIPVSKVSSLGPSTLRPIQEKAEQATGNI 485
Query: 219 PNSPPPPSTK 228
+P +
Sbjct: 486 KEAPTGTQKE 495
|
Length = 614 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 32/200 (16%), Positives = 41/200 (20%), Gaps = 22/200 (11%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPP---KSSPPPPPVSKPPT--TSPPPSPPASNPPTSSSP 68
P PP K P + S P P
Sbjct: 126 EEPKDRKPKEEAKEKRPPKEKEKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPN 185
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSP-------------PTISPPPPVSNPPTRSP 115
PP + P P + T SP + +
Sbjct: 186 KKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEI 245
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
SS+ PSP P P +S+ PP P S P P
Sbjct: 246 SRRSSSSLKKPDPSPSMASPETRESSKRTE----TRPRTSLRPPSARPASARPAPPRVKR 301
Query: 176 SSSPPKNSPPAPIAVPPSNV 195
+ SNV
Sbjct: 302 KEIVTVLQDAQGVGKIVSNV 321
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P+PP++ + ++PP ++ PP + P + PA +P PP + PP RS
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAP----APPAAAAPPARS 437
Query: 115 PPPPSSTPPPNSPPS 129
P ++
Sbjct: 438 ADP---AAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 12/71 (16%), Positives = 22/71 (30%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
PP+ PP P + + P ++ + P + ++ PP
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 128 PSPPSDPPANS 138
+P NS
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 30/161 (18%), Positives = 49/161 (30%), Gaps = 1/161 (0%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
+ +S P S P + + A++ T+ S P P P AS PP
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLP-ASLPPPPVR 317
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P V +P P + P+ P+ ++ S + P S S
Sbjct: 318 RPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSF 377
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP ++ ++ P + P P T
Sbjct: 378 LEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 17/72 (23%), Positives = 26/72 (36%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P A +++ + P P PP +S P PP + P P + P P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 66 SSPPASSPPTSS 77
+ P + P S
Sbjct: 185 ADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
ARG+ +L ++C +HRD+ + N+LL ++ DFGLA+ + + +++ TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 534 ---GYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T SDV+S+G++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 24/91 (26%), Positives = 33/91 (36%), Gaps = 8/91 (8%)
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
S+S +PP P PP P PP P A P P PPPP+ + S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTP--------PPPPPTATQASSNA 566
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSNNGI 265
+P+ + P +P + S I
Sbjct: 567 PAQIPADSSPPPPIPEEPTPSPTKDSSPEEI 597
|
Length = 620 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 45/240 (18%), Positives = 76/240 (31%), Gaps = 16/240 (6%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS- 67
++SPP ++ P + P P ++ P V+ P+ + SS
Sbjct: 535 VTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPT 594
Query: 68 ------PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P +S S ++ P +S P+ + P ++ T SP P T
Sbjct: 595 SQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGT 654
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
S P S P + +P P +S P +VP ++S K
Sbjct: 655 TSQVSGPGNSSTSR--YPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTK 712
Query: 182 NSPPAPIAVPPS-------NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ + + S P T P S + + SPP + + P P
Sbjct: 713 ETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVP 772
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S P ++ + + P ++ + PP + P P P A
Sbjct: 89 DAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPTAQ- 147
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
++P P PP + PPT S P + A
Sbjct: 148 ---PATPDERRSPRQRPPVSGEPPTPSTPDAHVAG 179
|
Length = 226 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 33/127 (25%), Positives = 44/127 (34%), Gaps = 8/127 (6%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPP---PSPPASN-PPTSSSPPASSP 73
P S+P T SP VS+ + P P P A P S+ P S+
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 74 PTSS----PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S P PA P+ S P S P + PP +S P P P+
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPT 228
Query: 130 PPSDPPA 136
+ PA
Sbjct: 229 ISASQPA 235
|
Length = 430 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 20/122 (16%), Positives = 33/122 (27%), Gaps = 14/122 (11%)
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
+PPA++ P + PPP + P S P + P P +
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRP---AAPAAEPAP-WLVEHAKRLTAQREQLVARAAA 107
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P + E + P+ + + P P P A +
Sbjct: 108 PAAP-EAQAPAAPAERAAAENAARRLARAAAAAPR---------PRVPADAAAAVADAVK 157
Query: 212 PR 213
R
Sbjct: 158 AR 159
|
Length = 484 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 2/65 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPT--ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+ + G P + + PPP + PP +P P + P +P PP + PP S P+ A
Sbjct: 385 PSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAAA 444
Query: 60 SNPPT 64
S
Sbjct: 445 SAGDR 449
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 8/107 (7%)
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
NS S P D + P + P P P + ++P P P +
Sbjct: 156 QNSGQSVPLDTSTTTDPATTPA---PAAPVDTTPTNSQTPAVATAPAPAVDPQQNAV--V 210
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
P+ V + P P P A+P+ P++ + S P L
Sbjct: 211 APSQANVDTAATPAPAAPATPDGAAPL---PTDQAGVSTPAADPNAL 254
|
Length = 331 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 45/280 (16%), Positives = 75/280 (26%), Gaps = 15/280 (5%)
Query: 12 NSSSPPPPVSNP--PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
SSS P + P S P + P S T S SP + PP S
Sbjct: 174 ASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSPNN 233
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
S SP P + ++ + +S S V S+ + S
Sbjct: 234 LFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSV-PSIRNLRGLNSALVSFLNVSS 292
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
A + +P + PS+ + P S P ++ P
Sbjct: 293 SSLAFSALNGKEVSPTGS-----PSTRSFARVLPKSSPNNLLTEILTTG-VNPPQSLPSL 346
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSS-PNSPPPPSTKRLSPPPGIPVPSTENT---- 244
+ P + + + + P + S + P ST N
Sbjct: 347 LNPVFLSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYSSNVPSPSSSESTRNILGNI 406
Query: 245 -PGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFS 283
P T+ + +S ++ + I S
Sbjct: 407 SPNFKTSSNLTNLNSLLKEKLSNSSSVSATDILGPSIIVS 446
|
Length = 777 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 21/99 (21%), Positives = 29/99 (29%), Gaps = 6/99 (6%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSN------LPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P P P P A P+ PP S++P +PP+ P + P P
Sbjct: 45 PKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPV 104
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
PK P P P P + +
Sbjct: 105 EPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKA 143
|
Length = 226 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 20/77 (25%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
PP +P S P+ P SPP S P S + P S+V P + +
Sbjct: 83 KVAPPAATPTSAPT--PTPSPPAS-PASGMSAAPASAV------EEKSPSEESATATAPE 133
Query: 179 PPKNSPPAPIAVPPSNV 195
P S P+ + S +
Sbjct: 134 SPSTSVPSSGSDAASTL 150
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|139494 PRK13335, PRK13335, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 16/82 (19%), Positives = 29/82 (35%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P+ S S P + T +P ++ + +P V+
Sbjct: 74 PKLEKAPNTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTPKTKVT 133
Query: 109 NPPTRSPPPPSSTPPPNSPPSP 130
PP+ + P P + ++P SP
Sbjct: 134 TPPSTNTPQPMQSTKSDTPQSP 155
|
Length = 356 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 7/179 (3%)
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPS--PPSDPPANSPPPSNPPS---NLPPPPPSS 155
+ P + + P TP SPP P P A P P +P + +L PP
Sbjct: 328 VPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPI 387
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
PP SP S + P+ SP + VP + P SP A R
Sbjct: 388 PTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKT-RPLSPYA-RYE 445
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIA 274
+ P + P P+ P S P ++ ++++ P N + V
Sbjct: 446 DLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYD 504
|
Length = 576 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 34/188 (18%), Positives = 47/188 (25%), Gaps = 9/188 (4%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S+ PA PP P P R+ P P + P+ P
Sbjct: 91 SAGEPAPPPP---HARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYP 147
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP--PAPIAVPPS 193
A P P P ++ PP+ P P+S P+ A P
Sbjct: 148 AYQQRPE--PGAWPRAADDY--GWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPE 203
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSS 253
P P R P PP P P + P
Sbjct: 204 YDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGP 263
Query: 254 PESSSSPS 261
+ +P+
Sbjct: 264 LAAQPAPA 271
|
Length = 617 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 29/180 (16%), Positives = 37/180 (20%), Gaps = 15/180 (8%)
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
P+ P P P T P P P ++ P
Sbjct: 90 PSAGEPAP----PPPHAR---RTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTA 142
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA----SPIAPRP 214
P P P ++ + PP P P A RP
Sbjct: 143 RPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRP 202
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG----TNPSSPESSSSPSNNGIGTAGT 270
P E PG G P PE +P +A
Sbjct: 203 EYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPG 262
|
Length = 617 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 18/79 (22%), Positives = 22/79 (27%)
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS 231
P S S PA P+ PPP P P + A + P PP
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 232 PPPGIPVPSTENTPGNGTN 250
P P P +
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 20/79 (25%), Positives = 32/79 (40%), Gaps = 3/79 (3%)
Query: 2 SAPSPGPPAANSSSPP--PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+A SP P +++++ P P + P +PP +PP + P PP + P P
Sbjct: 396 AAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKE- 454
Query: 60 SNPPTSSSPPASSPPTSSP 78
S + P T P
Sbjct: 455 EKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 23/79 (29%), Positives = 30/79 (37%), Gaps = 5/79 (6%)
Query: 2 SAPSPGPPAANSSSP-PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A +P P AA ++SP P S S P + P + PP VS P + P P S
Sbjct: 386 PAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQP---AGTPPTVSVDP-PAAVPVNPPS 441
Query: 61 NPPTSSSPPASSPPTSSPP 79
P + P P
Sbjct: 442 TAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 28/129 (21%), Positives = 37/129 (28%), Gaps = 3/129 (2%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
P SP P + LP P P Q P+ SP N P
Sbjct: 46 EFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFA--L 103
Query: 192 PSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNP 251
P+ P QT P P P + N P + + P +G P
Sbjct: 104 PAGPAGPTIQTEPGQLYP-VQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLP 162
Query: 252 SSPESSSSP 260
S +S+
Sbjct: 163 SQQQSAQKN 171
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 13/104 (12%), Positives = 27/104 (25%), Gaps = 5/104 (4%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
+ P ++P A PP ++P ++P P P + R +P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAA-EPAPWLVEHAKRLTAQ--REQLVARAAAP 108
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
+ P+ + + + P
Sbjct: 109 AAPEAQAPAAPAERAA--AENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 2/69 (2%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P P S P + PPP + P P P A + P + P+ P PP ++ P + +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP--PAAPARPAAARPAPAPAPPAAAAPPARSAD 439
Query: 164 PSVPPQNPP 172
P+
Sbjct: 440 PAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 9/73 (12%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP + P + P+ P PPA +PP P P++ P +P PP PP
Sbjct: 384 PPSAAWGAPTPAAPAAP--PPAAAPPVPPAA----PARPAAARP---APAPAPPAAAAPP 434
Query: 175 PSSSPPKNSPPAP 187
S+ P + A
Sbjct: 435 ARSADPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 20/65 (30%), Positives = 27/65 (41%), Gaps = 8/65 (12%)
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
PPS P + P + PP+ PP PP++ P + P+ P P PPA
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAA--------PPA 435
Query: 187 PIAVP 191
A P
Sbjct: 436 RSADP 440
|
Length = 576 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 22/148 (14%), Positives = 37/148 (25%), Gaps = 31/148 (20%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN--------------- 83
S P + + P S+PP S PT + PP +
Sbjct: 93 SSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDA 152
Query: 84 ----------------PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
TS+ P +P +P + P + P P++ P +
Sbjct: 153 LSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNH 212
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ + SS
Sbjct: 213 HKTATVAVPPATSGKPKSGAASARALSS 240
|
Length = 327 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 33/165 (20%), Positives = 49/165 (29%), Gaps = 18/165 (10%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP-SNPPSNLPPPPPSS----VEPPKRS 162
N + S +S S + P S PP S P+ PP + +E P
Sbjct: 90 GNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNI 149
Query: 163 PPSVPPQ----NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
++ Q N + P AP V PS P P P P +
Sbjct: 150 SDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPA 209
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
N + G P S+ SS+P+++
Sbjct: 210 VNHHKTATVAVPPATSGKPKSGA---------ASARALSSAPASH 245
|
Length = 327 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P ++ + PPP + ++P P+ P PP +PP P + P +PPPP + PN+P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPA--DPNAP 91
Query: 128 PSPPSDPPANSPPPSNP 144
P PP DP A PP P
Sbjct: 92 PPPPVDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 23/124 (18%), Positives = 33/124 (26%), Gaps = 8/124 (6%)
Query: 102 SPPPPVSNPPTRSPPPPSSTP-PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
PP + P P P P P + P + P P++
Sbjct: 635 FPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSR--VARGDPVRPTAHHAAL 692
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
R PQ P P PP P + P + +P +P P P +
Sbjct: 693 R-----APQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQA 747
Query: 221 SPPP 224
Sbjct: 748 DGAE 751
|
Length = 753 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 14/64 (21%), Positives = 22/64 (34%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P + + KP +P P PPA++ PT + P + P P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 88 SPPP 91
+ P
Sbjct: 185 ADPR 188
|
Length = 418 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 18/80 (22%), Positives = 23/80 (28%), Gaps = 1/80 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKP-PTTSPPPSPPAS 60
+ P G A + S P PP P+ +P PP KP P P P
Sbjct: 65 TQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQK 124
Query: 61 NPPTSSSPPASSPPTSSPPP 80
+ P P
Sbjct: 125 VEAPPAPKPEPKPVVEEKAA 144
|
Length = 226 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 24/72 (33%), Positives = 32/72 (44%), Gaps = 2/72 (2%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P + K +PP + PT P PSPPAS S+ PAS+ SP S T+
Sbjct: 77 PKTGTGKVAPPAATPTSAPT--PTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 91 PSPPASSPPTIS 102
PS S + +
Sbjct: 135 PSTSVPSSGSDA 146
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 26/93 (27%), Positives = 36/93 (38%), Gaps = 17/93 (18%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
VSKP T + +PP T +S P PT SPP + P S +P ++
Sbjct: 74 VSKPKTGTGKVAPP---AATPTSAPT---PTPSPPAS---PASGMSAAPASAVEE----- 119
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+P S + P S PS SD +
Sbjct: 120 ---KSPSEESATATAPESPSTSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 21/77 (27%), Positives = 30/77 (38%), Gaps = 2/77 (2%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
S P + +PP A+ +P PSPPAS +S P + ++ P S
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 127 PPSPPSDPPANSPPPSN 143
P S P + S S
Sbjct: 135 P--STSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 26/120 (21%), Positives = 38/120 (31%), Gaps = 3/120 (2%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S+ A P PP P P P S +S S
Sbjct: 118 SPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSALQ--SESLIA 175
Query: 114 SPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P P + +P SDP + + P +L PP ++ P + P++ P
Sbjct: 176 QPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISASQPA 235
|
Length = 430 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 1/107 (0%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+ A P +S +P +S P + S+ P+RS PS P+S
Sbjct: 110 FTVVSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRS-ASPSRKFSPSSTIQQSPQL 168
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
++ P S S P SS+ P S ++ P SS K
Sbjct: 169 TPSNKPASPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDK 215
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 23/87 (26%), Positives = 26/87 (29%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P A P P V + P P S P P PV +P + P P
Sbjct: 120 ETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVDSMAIAVPAIDTP 179
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSP 89
T PPA PP P S
Sbjct: 180 VTLELPPAPQPPPPVVPQPSTMVVHRR 206
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 22/86 (25%), Positives = 31/86 (36%), Gaps = 7/86 (8%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S P + S S S+ + S PP SS P P + P+ S P+ P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPP-------SSTSPRPRRRKPSASSLLHTPSILPL 53
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSP 89
S P+ T P + P +P
Sbjct: 54 PKLSSPSPPSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 59/248 (23%), Positives = 78/248 (31%), Gaps = 17/248 (6%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P P PP+P NP + A NP PPP+ P
Sbjct: 283 PVEPEPLPVPAPVPPTPEDDNPRPTDDEFAVPNFNEGLDVPDNPQDPVPPPNEGKDGNPN 342
Query: 101 IS--PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
PP P S PP+ PPN P S+ ++ P NPP+ P P
Sbjct: 343 EENLFPPGDDEVPDESNVPPN---PPNVPGGSNSEFSSDVENPPNPPN--PDIPEQEPNI 397
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
P+ S VP P P + P P P + + +
Sbjct: 398 PEDSNKEVPEDVPMEPEDDRDNNFNEPKKPENKGDGQNEPVIPKPLDNERDQSNKNKQVN 457
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSS---------SPSNNGIGTAG 269
P + S R + P G + N P PE S SNNG AG
Sbjct: 458 PGN-RHNSEDRYTRPHGRNNENRNYNNKNSDIPKHPERSEHEQPEDKKKKSSNNGYKIAG 516
Query: 270 TVVIAVAV 277
V+ +A+
Sbjct: 517 GVIAGLAL 524
|
Length = 576 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 47/231 (20%), Positives = 69/231 (29%), Gaps = 15/231 (6%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
PAA + PP + P PP + P ++PP +P + P + P + +
Sbjct: 716 RPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPT 775
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPT----ISPPPPVSNPPTRSPPPPSSTPP 123
P PP +PP P +P P PP + PT + P PT+ T
Sbjct: 776 P---QPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGG 832
Query: 124 PNS--PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P PS V+ P PP + P S
Sbjct: 833 VKRGRPSLKKPAALERQAAAGPTPSPGSGTSDKIVQAPVFYPPVLQPIQVMRQLGSVRAA 892
Query: 182 NSPPAPIAVPP------SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
+ A P PT PP+ + + P+ S
Sbjct: 893 AASTVTQAPTEYTGERRGVGPMHPTDIPPSKRAKTDAYVESQPPHGGQSHS 943
|
Length = 991 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 40/165 (24%), Positives = 55/165 (33%), Gaps = 13/165 (7%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNP---PTRSPPPPSSTPPPNSPPSPPSDPP 135
P +NP + P + P P+ P P + P P + P P P
Sbjct: 716 PAGANPFSLDDFEFSPMKALLDDGPHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQ 775
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV 195
P P P P +P + P Q P P + P P P+A P
Sbjct: 776 PQYQQPQQPV----APQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQ 831
Query: 196 PPPPTQTPPTPASPIAP---RPSNSSP---NSPPPPSTKRLSPPP 234
P P + + P R +S P + P PS L+PPP
Sbjct: 832 QPQQPVAPQPQDTLLHPLLMRNGDSRPLHKPTTPLPSLDLLTPPP 876
|
Length = 1355 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 28/168 (16%), Positives = 44/168 (26%), Gaps = 12/168 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A SP SS PP+ +PP +S P S +
Sbjct: 626 LDALSPKEGDGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQ 685
Query: 61 NPPTSSSPPASSP---PTSSP---PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P ++ S+P P P PP P + P ++ +
Sbjct: 686 SVPEAALASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSEL 745
Query: 115 PP-PPSSTPPPNSPPSPPSD-----PPANSPPPSNPPSNLPPPPPSSV 156
+T P S S + NL S+
Sbjct: 746 QAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSSGSI 793
|
Length = 944 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 36/219 (16%), Positives = 55/219 (25%), Gaps = 35/219 (15%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPP----------------------ASNPPTS 87
A P+S S S T++ A +P
Sbjct: 575 ANVQSAQSAAEAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSDLDALSPKEG 634
Query: 88 SPPPSPPA---SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
S +PP+ +PP +S P + +S P + S P +
Sbjct: 635 DGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELA--THQSVPEAAL 692
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
S P PP +P R PP P +S+ + A + S
Sbjct: 693 ASGSAPAPPPVPDPYDR-----PPWEEAPEVASANDGPNNAAEGNLSESV---EDASNSE 744
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
A P++ V TE
Sbjct: 745 LQAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTEL 783
|
Length = 944 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 3/62 (4%)
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS 231
P PPS++ +P AP A PP+ PP P P PA P A RP+ + R +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP---PAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 232 PP 233
P
Sbjct: 439 DP 440
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 2/69 (2%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+P P + P P + PP +PP P P P+++ P +P P A P
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPP--VPPAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 198 PPTQTPPTP 206
P
Sbjct: 439 DPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 3/92 (3%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
S P S + P + P +P + + A +P P+ P PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS---QANV 217
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ P P P + P + A ++ P +
Sbjct: 218 DTAATPAPAAPATPDGAAPLPTDQAGVSTPAA 249
|
Length = 331 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 28/176 (15%), Positives = 40/176 (22%), Gaps = 6/176 (3%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
SS+P + PP P + P + P P S+P
Sbjct: 53 KMPKVFQKSSAPRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSA 112
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSP--PASSPPTISPP--PPVSNPPTRSPPPPSS 120
+ + P P S PPVS S P++
Sbjct: 113 RRLTRSEGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPAT 172
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
+ D + S P PP P+ P S
Sbjct: 173 ALASAALFKD--DEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRS 226
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 28/131 (21%), Positives = 41/131 (31%), Gaps = 6/131 (4%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSS-SPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
PP + T+ P S A N P S P S PT P+S+P + S P + + S
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPS 208
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
+ V P + S+ + S S P SS+
Sbjct: 209 NLQV--TTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRS---TPTSGSSSIN 263
Query: 158 PPKRSPPSVPP 168
P +
Sbjct: 264 PVSGLDEAEED 274
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 14/76 (18%), Positives = 24/76 (31%), Gaps = 3/76 (3%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S PP P PA++ + P P + P + +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAA---PAAGGPAAALAAVPDAAAAAAAPP 447
Query: 134 PPANSPPPSNPPSNLP 149
PA +P P+ ++
Sbjct: 448 APAAAPQPAVRLNSFE 463
|
Length = 598 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 32/201 (15%), Positives = 50/201 (24%), Gaps = 6/201 (2%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
T+ A+ P P P + + + A+ P PVSN PP P
Sbjct: 384 TAEKETAAKKP--QPRPEAETAQTPVQTASAAAMPSEGKTAGPVSNQENNDVPPWEDAPD 441
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+ + A S ++ P S + + + P P + P N
Sbjct: 442 EAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATP-ND 500
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
P P P P PPP E
Sbjct: 501 EAVETETFAHEAPAEPF---YGYGFPDNDCPPEDGAEIPPPDWEHAAPADTAGGGADEEA 557
Query: 244 TPGNGTNPSSPESSSSPSNNG 264
G ++P + +
Sbjct: 558 EAGGIGGNNTPSAPPPEFSTE 578
|
Length = 709 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 24/159 (15%), Positives = 33/159 (20%), Gaps = 2/159 (1%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
SP + T+ P + TS+ PP
Sbjct: 20 SPEGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVPRPPR 79
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S P PP P +S+P + + P + P P
Sbjct: 80 GPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPI 139
Query: 147 NLPPPP--PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
S E PP P S
Sbjct: 140 GESNSSSEELSEEEEHSRPPPSESLKVKNGGKVYPKGFS 178
|
Length = 580 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 18/80 (22%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP-TSSPPPSPPASSPPTIS 102
P+S+ T PP+ + + + + + P PP S P P A P
Sbjct: 114 PLSEIDTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAP 173
Query: 103 PPPPVSNPPTRSPPPPSSTP 122
P P R+ P + P
Sbjct: 174 AAKPPPTPVARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/80 (20%), Positives = 23/80 (28%), Gaps = 4/80 (5%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
T PP+ ++ P + TP P + P A P P+
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKT----TPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAA 175
Query: 146 SNLPPPPPSSVEPPKRSPPS 165
P P + R P S
Sbjct: 176 KPPPTPVARADPRETRVPMS 195
|
Length = 418 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL--PPPP 152
A++P + P S PP+ P S P +PPS + P +P + P S P
Sbjct: 30 ATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQS 89
Query: 153 PSSVEPPKRSPP 164
P++ + P P
Sbjct: 90 PTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 24/100 (24%), Positives = 33/100 (33%), Gaps = 10/100 (10%)
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
P + + PP + + + P+ P PP+ P P+ VEPPK P
Sbjct: 57 PAATQALPTQPPEGAAEAVRAGDAAA---PSLDPATVAPPNTPVEPEPAPVEPPKPKPVE 113
Query: 166 VPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
P P P P P P P + PT
Sbjct: 114 KPKPKPKPQQKVEAPPAPKPEP-------KPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 26/107 (24%), Positives = 31/107 (28%), Gaps = 8/107 (7%)
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
P P A + PP A + P +P T +PP P P
Sbjct: 47 PGDRDEPDMMPAA-TQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP---- 101
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P +PP P P P P P PP P P P
Sbjct: 102 -APVEPP--KPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 23/130 (17%), Positives = 37/130 (28%), Gaps = 5/130 (3%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPP 111
S + + +S P SS + SS P + PAS P + S+
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
S+ S P SP + ++L ++ SP
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFVSPSRGSPSAA---ASLNGSLATASTSGSSSPSRSRRTTS 118
Query: 172 PPPPSSSPPK 181
S + P
Sbjct: 119 SDLSSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 20/87 (22%), Positives = 27/87 (31%), Gaps = 1/87 (1%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
PP+PP P P + + PT P PA P +P P +
Sbjct: 173 PPNPP-REAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQ 231
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPP 140
P P+ P P +P P
Sbjct: 232 QPVQPAQQPTPQNPAQQPPQTEQGHKR 258
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 25/86 (29%), Positives = 33/86 (38%), Gaps = 7/86 (8%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
SSS +S S +S+ + S PPS ++SP P S+ P P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPS--STSPRPRRRKPSASSLLH---TPSILPLPK 55
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPP 150
S PSPPS P + L P
Sbjct: 56 LSSPSPPSVTLP--PAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 21/75 (28%), Positives = 33/75 (44%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+S+ PTS S +S +SS +S P ++SP P S ++ P + P S P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPS 60
Query: 118 PSSTPPPNSPPSPPS 132
P S P + +
Sbjct: 61 PPSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 34/140 (24%), Positives = 41/140 (29%), Gaps = 12/140 (8%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P S S P S P + P S S P P + P S
Sbjct: 210 PPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPRETLDPKSPEK 269
Query: 69 PASSPPTSSPPPAS-NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
T + P S S SP +SP P P P + SP
Sbjct: 270 APPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSP------KAESPKPLA-----SP 318
Query: 128 PSPPSDPPANSPPPSNPPSN 147
P DP + P P +PP N
Sbjct: 319 GKSPRDPLSPRPKPQSPPVN 338
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 31/149 (20%), Positives = 46/149 (30%), Gaps = 23/149 (15%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
S+ S +S+ P SSP A P S P + S+ ++ P T
Sbjct: 264 DPTETSSEDGYSFSRSSAYPNSSPRQALPPSISLPQNT---STSGSLHSAQTSRRPNTTF 320
Query: 115 PPPPSS---------------TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
SS PP+S P + PS+ P S
Sbjct: 321 DKAASSGTKDSLWSPSSLCGMATPPSSIGMSPLILSLS---PSHLSGRAPGTTGSG--KG 375
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ + S P +PPPP + + A
Sbjct: 376 EPASESTPSTSPPPPGLADDIVRAIFATS 404
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 29/106 (27%), Positives = 35/106 (33%), Gaps = 5/106 (4%)
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P A PP P PP S PS++ P + S P P PS
Sbjct: 179 GGNIPGAIQPP--PPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAP 236
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P+ PP + P P PPP P A P+N
Sbjct: 237 PASIPAPPIPPVIQYVAPP---PVPPPQPIIPIQHIRAVTGETPAN 279
|
Length = 582 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 34/121 (28%), Positives = 41/121 (33%), Gaps = 21/121 (17%)
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
P A PP P P S +P ASS P P NP
Sbjct: 179 GGNIPGAIQPP-------------PPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFL 225
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK--RSPPSVPPQN 170
P P + PP S P+PP PP + P PPP + P + R+ P N
Sbjct: 226 PGPSPAQPSAPPASIPAPP------IPPVIQYVAPPPVPPPQPIIPIQHIRAVTGETPAN 279
Query: 171 P 171
P
Sbjct: 280 P 280
|
Length = 582 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 27/125 (21%), Positives = 35/125 (28%), Gaps = 16/125 (12%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P SS S S+ S P P I P N P P + P
Sbjct: 12 PISSISFLSVVSCSTTSSNSKQP----------EKKPEIKPN---ENTPKIPKKPDNKEP 58
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
N+ ++ P S P P P + E P P+ P P + P N
Sbjct: 59 SENNNNKSNNENKDEENPSSTNPEKKPDPSKNKEEI---EKPKDEPKKPDKKPQADQPNN 115
Query: 183 SPPAP 187
Sbjct: 116 VHADQ 120
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 22/40 (55%), Positives = 23/40 (57%), Gaps = 6/40 (15%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
PP N PPPPP PP PPS PP PPPPP + K S
Sbjct: 5 PPGNPPPPPP----PPGFEPPSQPP--PPPPPGVNVKKRS 38
|
Length = 2365 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 4/47 (8%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
++ PP +PP PP PP PPS PP PPPP +V+ R S+
Sbjct: 2 ASLPPGNPPPPP--PPPGFEPPSQPP--PPPPPGVNVKKRSRKQLSI 44
|
Length = 2365 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 23/101 (22%)
Query: 488 RIIHRDIKSSNILLD-------------NNFE----AQVSDFGLAK-LALDANTHITTRV 529
R++HRD+K NI L NN A++ DFGL+K + +++ H
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SC 201
Query: 530 MGTFGYMAPEYA--SSGKLTEKSDVFSFGVVLLELITGRKP 568
+GT Y +PE + +KSD+++ G ++ EL +G+ P
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 4/78 (5%)
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
PAP P+ P P + P P++ + + P P T PP +P
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA---TPPPVPPRPV 417
Query: 242 ENTPGNGTNPSSPESSSS 259
P T S+P+ + +
Sbjct: 418 A-PPVPHTPESAPKLTRA 434
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 22/85 (25%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 167 PPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
P ++S P N PAP PP P A+ +P P+ +SP P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 227 TKRLSPPPGIPVPSTENTPGNGTNP 251
SP P P + P
Sbjct: 421 PTEPSPTP--PANAANAPPSLNLEE 443
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 25/87 (28%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+ PP+ SPP P P +P P PP P P + +S N+P
Sbjct: 517 ASNTAKTPPPPQKSPPPP--APTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 230 LSPPPGIPVPSTENTPGNGTNPSSPES 256
PPP P+ T SSPE
Sbjct: 575 SPPPPIPEEPTPSP-----TKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 3e-04
Identities = 12/80 (15%), Positives = 23/80 (28%)
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
P S++ P + A A + P + P PA + ++P P + +P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 234 PGIPVPSTENTPGNGTNPSS 253
+
Sbjct: 98 APPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 40/191 (20%), Positives = 66/191 (34%), Gaps = 10/191 (5%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPP---PVSKPPTTSPPPSPPASNPPTSSSPP 69
SSP P+ S P SN ++P P T PS P++ ++ SP
Sbjct: 590 GSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSP- 648
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP----PTRSPPPPSSTPPPN 125
P + S P SS P P P ++P ++ P ++
Sbjct: 649 --GPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGK 706
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
+ + + ++P +N + PPS + P +SPP +
Sbjct: 707 ANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQ 766
Query: 186 APIAVPPSNVP 196
A + VPP+ P
Sbjct: 767 ATVPVPPTQHP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 6/77 (7%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
P + + PPP + PP PP + P + P+P PPA + P
Sbjct: 378 ERGAPAPPSAAWGAPTPAAP-AAPPPAAAPP---VPPAAPARPAAARPAPAPAPPAAAAP 433
Query: 141 PSNPPSNLPPPPPSSVE 157
P+ S P S+ +
Sbjct: 434 PA--RSADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 24/136 (17%), Positives = 36/136 (26%), Gaps = 10/136 (7%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+S P ++ P+S ++P + +P P+ SP +
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTP---ISDRLRPRSVTPTRGRRPSSSPRSLSNPT 202
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
SP T PP S + S S P RS S
Sbjct: 203 TLESPSNLQVTTD-----VPPPYSNGTSRSSTMSSSANLSIISSLATP--RSGESFRSTP 255
Query: 171 PPPPPSSSPPKNSPPA 186
S +P A
Sbjct: 256 TSGSSSINPVSGLDEA 271
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 29/109 (26%), Positives = 45/109 (41%), Gaps = 2/109 (1%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
GP + +++ P P + P + P P ++P P S P+ P PP S
Sbjct: 387 EGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRS 446
Query: 66 SSPPASSP--PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP +P P +SP P + +S +PP P+ + S P T
Sbjct: 447 GIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 6/120 (5%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P+ S P + T +P P ++P P +++P P+++P SP P
Sbjct: 380 APSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAP---SPRVPW 436
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ P P PP S PP P P P P S ++ PP PS P
Sbjct: 437 DDAP---PAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 31/160 (19%), Positives = 41/160 (25%), Gaps = 1/160 (0%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
SS ++ P S P RS + D + P P++LPPPP
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPPPPVRR 318
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P + P + + S T P + A
Sbjct: 319 PRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSFL 378
Query: 216 NSS-PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
SPP T L P V S P S
Sbjct: 379 EDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 6/116 (5%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSP---PPASNPPTSSPPPSPPASSPPTISPPPP 106
T P+S SS+ SS SP P + +++ + + P
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 107 VSNPPTRSPP---PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
V+ P T + P P + P P S N +N P+ P P+S P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPV 413
|
Length = 421 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 19/71 (26%), Positives = 29/71 (40%), Gaps = 1/71 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
PPAA +S P P +PP + P + P + T P P+++
Sbjct: 80 GTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATA-TAPESPSTS 138
Query: 62 PPTSSSPPASS 72
P+S S AS+
Sbjct: 139 VPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 45/184 (24%), Positives = 53/184 (28%), Gaps = 6/184 (3%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P +S P +PPP P P P P PP + P A S
Sbjct: 729 PLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQAQGVQVS 788
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
S P + P P P P P PP S
Sbjct: 789 SYPGYAGPWGLRAQ-HPRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSAGHGQDQ 847
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
S P PP S P + P S + P SSP +P PI P+ P
Sbjct: 848 VSQFPHLQSETGPPRLQLSQVP--QLPYSQTLVSSSAPSWSSPQPRAPIRPI---PTRFP 902
Query: 197 PPPT 200
PPP
Sbjct: 903 PPPM 906
|
Length = 1000 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 11/57 (19%), Positives = 17/57 (29%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP 79
P +PP P + P P +P + P + P P P +
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 13/58 (22%), Positives = 20/58 (34%), Gaps = 3/58 (5%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P+ A P + S TS P A+ + PP P ++PP +
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAA---AAPAPPPNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 33/170 (19%), Positives = 55/170 (32%), Gaps = 12/170 (7%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPP--PVSNPPKSSPPPPPVSKPPT--------TSPPP 55
P PP + ++ + N P P P P ++ V+ +P
Sbjct: 538 PKPPDSFANVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRT 597
Query: 56 SPPASNPPTSSSPPASS--PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ P A + P +++ PP P P T++ P P +
Sbjct: 598 VSRILALRDAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEV 657
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P +P +P P +SP P ++L P S+ P SP
Sbjct: 658 FMGYPFQSPHLGAPSGSPPGKDRDSPDLPRPTTSLHPKLLSAHHHPGSSP 707
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 40/181 (22%), Positives = 51/181 (28%), Gaps = 11/181 (6%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S P PPT P P + T+ P SPP P + P SP
Sbjct: 118 SYSAYDRKPASGFKPPTPPSTPCSPVNPQETVRQLQPSGPLSNSSPPSPHTPLPNQSPLP 177
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP-------PSSSPPKN 182
PP +SP S P + S P PP ++ PP P P
Sbjct: 178 PPM----SSPDSSYPSEHRFQRQLSEPCLPFPPPPGRGSRDGRPPYHRQMSEPLVPYPPQ 233
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTE 242
P P Q P I P + + +S P G E
Sbjct: 234 GFKQEYHDPLYEEAGVPNQGPFPHPMMIKQEPRDFTYDSEVPGCHSSYGRAEGFYSNRHE 293
Query: 243 N 243
Sbjct: 294 G 294
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 10/114 (8%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P K P P + S +P S ++++ + SP T P S P + SPP
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTS--PPAGHLGSPP 608
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
A+ +S P+ SPP P +P SP S S ++P S++
Sbjct: 609 ATPSKIVS--------PSTSPPASHLGSPSTTPSSPESSIKVASTETASPESSI 654
|
Length = 670 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 17/76 (22%), Positives = 22/76 (28%)
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
S N P + +P N P P + PS T P+P A P
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 222 PPPPSTKRLSPPPGIP 237
P T + P
Sbjct: 422 TEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 7/97 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P+ P + +++ P +P S S P S P + P + PP+ N
Sbjct: 384 TQPAAAPQPSAAAAASP---SPSQSSAAAQPSAPQ--SATQPAGTPPTVSVDPPAAVPVN 438
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
PP S+ P + P P + P P
Sbjct: 439 PP--STAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 52/287 (18%), Positives = 90/287 (31%), Gaps = 21/287 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P P ++ +PP S P PKSS PP + + P +
Sbjct: 560 SEPGTLPYGSSVQTPPDRPKAATKGSRKPSPRKEPKSSVPPAAEKRKYKSPSKIVPKSRE 619
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ S + SP S PP+S P ++ +S T P S+ +++
Sbjct: 620 FIETDSSSSDSPEDESLPPSSQSPGNTESSKESCASLRT---PVCRSSVGSQNDLSKDRL 676
Query: 122 PPP---NSPPSPPSDPPANSP----PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P SP D + S +P P PPK +
Sbjct: 677 LSPMRETELLSPLRDSEERYSLWVKIDLDLLSRIPGHPYKKGVPPKPAEKDSLSAPKKQT 736
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQ---------TPPTPASPIAPRPSNSSPNSPPPP 225
++ K+S + +P+S + S+S+ S
Sbjct: 737 SKTASEKSSSKGKRKHKNDEEADKIESKKQRLEEKSSSCSPSSSSSHHHSSSNKESRKSS 796
Query: 226 STKR--LSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
K + P P P+ S+ P + + + S++G +A +
Sbjct: 797 RNKEEEMLPSPSSPLSSSSPKPEHPSRKRPRRQEDTSSSSGPFSASS 843
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 9/135 (6%)
Query: 49 PTTSPPPSPPASNPPTSSSPP--ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P S PS ++ P+ S+ AS + P P + P + P + S + P P
Sbjct: 367 PVESLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAP 426
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
S P P ++PP+PP P P P ++ P P SV +PP++
Sbjct: 427 -------SAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTL 479
Query: 167 PPQNPPPPPSSSPPK 181
+ + S P+
Sbjct: 480 GDPSDTAEHTPSGPR 494
|
Length = 624 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 20/93 (21%), Positives = 27/93 (29%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P + P+ P V P PP P + + P P T
Sbjct: 123 ADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVDSMAIAVPAIDTPVTL 182
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
PP+P P P V + +R SS
Sbjct: 183 ELPPAPQPPPPVVPQPSTMVVHRRSRIKRTRSS 215
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
++ SS+ +SPPS S P P ++ + P P PK S PS P
Sbjct: 7 TSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPL----PKLSSPSPP 62
Query: 168 PQNPPPPPSSSPPKNSP 184
PP ++ P+ +P
Sbjct: 63 SVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 25/126 (19%), Positives = 34/126 (26%), Gaps = 21/126 (16%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVS---KPPTTSPPPSPPA------- 59
++ S+ S P P S P S TS P+
Sbjct: 268 TSSEDGYSFSRSSAYPNSSPRQALPPSISLPQNTSTSGSLHSAQTSRRPNTTFDKAASSG 327
Query: 60 --------SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
S+ ++PP+S + S S P S P S P
Sbjct: 328 TKDSLWSPSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTGSGKGE---PASESTPS 384
Query: 112 TRSPPP 117
T PPP
Sbjct: 385 TSPPPP 390
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 21/96 (21%), Positives = 29/96 (30%), Gaps = 3/96 (3%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPP--TSSPPPASNPPTSSPPPSPPASSPPTI 101
SK P P P + P P P ++ N +P + P P
Sbjct: 29 SNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNP-EKKPDP 87
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
S P P P P + P + +D P N
Sbjct: 88 SKNKEEIEKPKDEPKKPDKKPQADQPNNVHADQPNN 123
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 58/222 (26%), Positives = 87/222 (39%), Gaps = 56/222 (25%)
Query: 411 KAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
KAE +I++ + +V L Y D D + DY+P + L G D A R
Sbjct: 49 KAERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA-RFY 106
Query: 470 IAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLA------------- 515
IA L E H IHRDIK NIL+D + +++DFGL
Sbjct: 107 IAE-----LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 516 ------KLALD------------------------ANTH---ITTRVMGTFGYMAPEYAS 542
+ ++D A H + ++GT Y+APE
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEW 583
T+ D +S GV+L E++ G+ P A PL + ++ W
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 28/87 (32%), Positives = 34/87 (39%), Gaps = 4/87 (4%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS----PPTSSPPPASNPPTSSPP 90
SP PP PP +PP SP AS T SPP P ++ P A P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPP 117
SS PP + + P +PPP
Sbjct: 64 AGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 31/164 (18%), Positives = 43/164 (26%), Gaps = 3/164 (1%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P+ P A + + P + + P S P+ A+
Sbjct: 760 NPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKR 819
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P S P R P + PPP SS S PA P
Sbjct: 820 KSRSHTPDGGSESSGPARPPGAAAR---PPPARSSESSKSKPAAAGGRARGKNGRRRPRP 876
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGN 247
P P + + + PP P P V PG
Sbjct: 877 PEPRARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGG 920
|
Length = 1352 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 42/168 (25%), Positives = 52/168 (30%), Gaps = 20/168 (11%)
Query: 80 PASNPPTSSPPPSPPASS--------PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
P P S PP P S P P + P + P
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKP 569
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
S P S P P P P + PKR P++ P PK P + +P
Sbjct: 570 SKIPTLSKKPEFPKDPKHPKDPEEPKKPKR------PRSAQRPTRPKSPKL--PELLDIP 621
Query: 192 PSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
S P ++P P P P SSP P P + PP P P
Sbjct: 622 KSPKRPESPKSPKRPPPPQRP----SSPERPEGPKIIKSPKPPKSPKP 665
|
Length = 943 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 22/145 (15%), Positives = 42/145 (28%), Gaps = 5/145 (3%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PPS + + P ++ + S P + + S P P +
Sbjct: 648 PPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDPY 707
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
PP E P+ + + P N + ++ A + V T P A
Sbjct: 708 DRPP-WEEAPEVASANDGPNN---AAEGNLSESVEDASNS-ELQAVEQQATHQPQVQAEA 762
Query: 210 IAPRPSNSSPNSPPPPSTKRLSPPP 234
+P + + + L+
Sbjct: 763 QSPASTTALTQTSSEVQDTELNLVL 787
|
Length = 944 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 4/129 (3%)
Query: 111 PTRSPPPPSST-PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P ++ P+ PP + P+ A + PP+ PP + PP ++
Sbjct: 222 PAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKA 281
Query: 170 NPPPPPSSSPPKN--SPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPPPPS 226
PP +++PP + PA A P+ P + PA + P + + P P
Sbjct: 282 AAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPP 341
Query: 227 TKRLSPPPG 235
K + P G
Sbjct: 342 AKAAAAPVG 350
|
Length = 357 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 37/125 (29%), Positives = 50/125 (40%), Gaps = 8/125 (6%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPP 140
++ P+ S P + TI P P + P + P TP +P +P PS P+
Sbjct: 378 ASAPSGSAAEGPASGGAATI--PTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPS---- 431
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P P + PP PP S PP R P +P +P P S S P PS+
Sbjct: 432 PRVPWDDAPPAPPRSGIPP-RPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTP 490
Query: 201 QTPPT 205
P T
Sbjct: 491 SGPRT 495
|
Length = 624 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 24/160 (15%), Positives = 40/160 (25%), Gaps = 5/160 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
A +P +++ TS S T PP + P S
Sbjct: 31 AERDDFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDS 90
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P+ P PP + SP + N P + NS
Sbjct: 91 LPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSS----- 145
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+ ++ PP+ + + + KR
Sbjct: 146 SEELSEEEEHSRPPPSESLKVKNGGKVYPKGFSKHKTHKR 185
|
Length = 580 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 6/78 (7%)
Query: 16 PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
P + PK++ P P PP S P P A+ PP P ++ P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPE---PPAASKPTPPAAAKPPE---PAPAAKPP 178
Query: 76 SSPPPASNPPTSSPPPSP 93
+P ++P + P S
Sbjct: 179 PTPVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 23/95 (24%), Positives = 29/95 (30%), Gaps = 3/95 (3%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
PP PP +P P P + +S P + P P P PA P
Sbjct: 173 PP--NPPREAPAPGLPKTFT-SSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQP 229
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
PV +P P+ PP S N
Sbjct: 230 QQQPVQPAQQPTPQNPAQQPPQTEQGHKRSREQGN 264
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 20/92 (21%), Positives = 28/92 (30%), Gaps = 6/92 (6%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
PP +PP PA P + + +P P P +P P +P P
Sbjct: 173 PP--NPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNP----AQQPQ 226
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
P + P P N PP +
Sbjct: 227 QQPQQQPVQPAQQPTPQNPAQQPPQTEQGHKR 258
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 40/195 (20%), Positives = 61/195 (31%), Gaps = 17/195 (8%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
SPPAS T + P S S ++SP SS SP SN P
Sbjct: 117 KKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLTPSNKP-A 175
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS--------------SVEPP 159
SP +P +S P + S S+P + V+
Sbjct: 176 SPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDKKDITTDEKYLETFLAEVDEE 235
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
+ S +N PP + + +S +P S ++ + ++P P S
Sbjct: 236 QHMITSSAGKNATPPETINSFGSS--SPSFWNYSRNASDAARSLKKRSYQLSPSPVPSKQ 293
Query: 220 NSPPPPSTKRLSPPP 234
+ P PP
Sbjct: 294 KASTSPKKGEGEPPN 308
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 24/82 (29%), Positives = 31/82 (37%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+ PP S P P +SS P++S + P + P PSP S P
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 102 SPPPPVSNPPTRSPPPPSSTPP 123
S P P P + PP PP
Sbjct: 239 SIPAPPIPPVIQYVAPPPVPPP 260
|
Length = 582 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 19/35 (54%), Positives = 20/35 (57%), Gaps = 9/35 (25%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP NPP PPPPP EPP + PP PPPP
Sbjct: 5 PPGNPP---PPPPPPGFEPPSQPPP------PPPP 30
|
Length = 2365 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 19/106 (17%), Positives = 33/106 (31%), Gaps = 4/106 (3%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP--ASSPPTSSPPPASNPPTSSP 89
+S P + P + P +PPA P + A++ ++P + P SP
Sbjct: 102 MSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRAKSP 161
Query: 90 PPSPPASSPPTISPPP--PVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P+ A+ PT + P + P
Sbjct: 162 RPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKKKT 207
|
Length = 209 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 4/106 (3%)
Query: 20 VSNPPTISPPPPVSNP--PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
+S P T + P V+ P P P PP P +P + A+ + PA S
Sbjct: 102 MSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRAKSP 161
Query: 78 PP--PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P A+ PT + + P + P + T
Sbjct: 162 RPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKKKT 207
|
Length = 209 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 13/83 (15%), Positives = 17/83 (20%)
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
S S + P P P P A+ P P P + S P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 236 IPVPSTENTPGNGTNPSSPESSS 258
P +
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 35/142 (24%), Positives = 42/142 (29%), Gaps = 11/142 (7%)
Query: 28 PPPPVSNP---PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP--PAS 82
P P+ P P P P + P P + P P P +
Sbjct: 740 PHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVA 799
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP------SDPPA 136
P P P A P P PV+ P P P P P P
Sbjct: 800 PQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDSRPL 859
Query: 137 NSPPPSNPPSNLPPPPPSSVEP 158
+ P P +L PPPS VEP
Sbjct: 860 HKPTTPLPSLDLLTPPPSEVEP 881
|
Length = 1355 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 15/67 (22%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ PP++ P+ +PPP+ P P PP + P P P P +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAP---PVPPAAPARPAAARPAPAPAPPAAAAPPARS 437
Query: 180 PKNSPPA 186
+ A
Sbjct: 438 ADPAAAA 444
|
Length = 576 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 10/74 (13%), Positives = 19/74 (25%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
PP+ P P A + + ++ + V + + PP
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 119 SSTPPPNSPPSPPS 132
+ P S
Sbjct: 448 APAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 12/71 (16%), Positives = 23/71 (32%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
PP P+ A+ +++P A P + ++ PP+P
Sbjct: 390 GPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAP 449
Query: 94 PASSPPTISPP 104
A+ P +
Sbjct: 450 AAAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 13/70 (18%), Positives = 20/70 (28%)
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
PPS PP P A + + + P P + PP P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 177 SSPPKNSPPA 186
++P
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP---PTISPPPPVS 108
P P PP P + ++P A+ P + P + A+ P + PP +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 109 NPPTRSPPPPS 119
P + S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 32/157 (20%), Positives = 45/157 (28%), Gaps = 5/157 (3%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
+ SS P + + A + S P PAS PP P
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPP--PPV 316
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPP--PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P P P + P P +ST S + D + P S ++
Sbjct: 317 RRPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASS 376
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
PP S+ P P +S+P S P
Sbjct: 377 FLEDDDFGSPPLDLTTSL-RHMPSPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 3/119 (2%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
++ P + + + P + P + P V+ T+ S A + + P
Sbjct: 302 AAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLP 361
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
T + P A P S + + +N PT S P + P N P SP S
Sbjct: 362 GTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLP---AAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 21/117 (17%), Positives = 33/117 (28%), Gaps = 6/117 (5%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P + +++ PS A P ++ + + S
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSAT---TTQASAVALSSAGVLPSDVTL 360
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP---PSNPPSNLPPPPPS 154
+ P P P ST + AN P P+ P SN+P P S
Sbjct: 361 PGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 18/72 (25%), Positives = 27/72 (37%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
S P + S + +S+ + SSPP+S+ P S P P + SPP
Sbjct: 4 SNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPPS 63
Query: 106 PVSNPPTRSPPP 117
P + P
Sbjct: 64 VTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 36/149 (24%), Positives = 46/149 (30%), Gaps = 10/149 (6%)
Query: 63 PTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
S +PPP S+ P+ S P P+S + P + SS
Sbjct: 195 TNSFKEVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSS 254
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P P P S A PP + S E + + P S P
Sbjct: 255 APKPRETLDPKSPEKA-------PPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSP 307
Query: 181 KNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
K P P+A P P P P P SP
Sbjct: 308 KAESPKPLA-SPGKSPRDPLSPRPKPQSP 335
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLI---YDYVPNNTLYFHLHGEG-----RPVLDW 464
E+ + R++H +++ + S+ +I YD+ LY ++ E RP+L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLL-K 267
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
TR I + Y+H+ ++IHRDIK NI L+ + + + DFG A
Sbjct: 268 QTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+GT +PE + E +D++S G++LL++++
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 38/109 (34%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+P+ PA + P P P P + PP ++P PP + P + P PA P
Sbjct: 85 SPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPA--PACPP 142
Query: 63 PTSSSPPASSPPTSSPPPASNPP---TSSPPPSPPASSPPTISPPPPVS 108
T PPA PT P PA+ P PPP PA+S PTI P S
Sbjct: 143 STRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAAS 191
|
Length = 280 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 1/76 (1%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
P P S + S P+ S+P T +PPP+ + SPP + P++
Sbjct: 296 NGVEPEPTGSVSDRPRHLSSDSSPSPPDTSDSDPSTETPPPASLSHSPPA-AFERPLALS 354
Query: 111 PTRSPPPPSSTPPPNS 126
P R S
Sbjct: 355 PKRKREGDKKQKKKKS 370
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 48/228 (21%), Positives = 75/228 (32%), Gaps = 33/228 (14%)
Query: 2 SAPSPGPPAANSSSP---PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
SA PA S+P P V P T P P + P+++P P + PP+T+ P
Sbjct: 181 SADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPST 240
Query: 59 ASNPPTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNPPT---- 112
P + + P + + P P PP ++ P + T++ ++ P +
Sbjct: 241 TIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAPEASRYELTVTQIIQIAIPASIIAC 300
Query: 113 -----------------RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
R P PP P PS N + L PP S
Sbjct: 301 VFLGSCACCLHRRCRRRRRRPARIYRPP---SPVAPSISAVNEAALARLGDELKRHPPES 357
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
KR Q P ++ ++ PA + + S P
Sbjct: 358 PRRSKRR----SSQTMVPSLTAISEESEAPAVVELSRSPRRPGGPTAR 401
|
Length = 401 |
| >gnl|CDD|165564 PHA03309, PHA03309, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 13/199 (6%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
SSS +SS +SS P+S P S+ P P+ SPP +P + R PS+ P
Sbjct: 1816 SSSSSSSSSSSSSSSPSSRPSRSATPSLSPSPSPPRRAPVDRSRSGRRRERDRPSANPFR 1875
Query: 125 NSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+P +D + P + P NL + P R P P + PS S P++S
Sbjct: 1876 WAPRQRSRADHSPDGTAPGDAPLNLE-------DGPGRGRPIWTPSSATTLPSRSGPEDS 1928
Query: 184 ---PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP--NSPPPPSTKRLSPPPGIPV 238
+ PP+ + P P +T S + P S+P PP R + P
Sbjct: 1929 VDETETEDSAPPARLAPSPLETSRAEDSEDSEYPEYSNPRLGKSPPALKSREARRPSSKQ 1988
Query: 239 PSTENTPGNGTNPSSPESS 257
P ++ NG S S+
Sbjct: 1989 PRRPSSGKNGHTDVSAASA 2007
|
Length = 2033 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 17/76 (22%), Positives = 25/76 (32%), Gaps = 3/76 (3%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
A + P P + + PPP P +P ++ P+ P PS
Sbjct: 49 KAAEQMAAPEAAEAAPL---PAAAESIASPEVPPPVPPAPAQEGEAPAAEQPSAVPAPSA 105
Query: 144 PPSNLPPPPPSSVEPP 159
P+ P PS P
Sbjct: 106 APAPAEPVEPSLAANP 121
|
Length = 931 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 17/104 (16%), Positives = 29/104 (27%), Gaps = 1/104 (0%)
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
+R + P S+ AP + P AP P+ +
Sbjct: 381 LERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA 440
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P+ PP PS + P P ++ +P+
Sbjct: 441 PPSPAGNAPAGGAPSPPPAAAPSAQPAPA-PAAAPEPTAAPAPA 483
|
Length = 824 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 21/78 (26%), Positives = 28/78 (35%), Gaps = 8/78 (10%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKR---SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
P + P ++ P + P PP PP+ + AP A PS VP
Sbjct: 45 GPVAKAAEQMAAPEAAEAAPLPAAAESIASPEVPPPVPPAPAQE---GEAPAAEQPSAVP 101
Query: 197 PPPTQTPPTPASPIAPRP 214
P P PA P+ P
Sbjct: 102 APSAA--PAPAEPVEPSL 117
|
Length = 931 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 29/118 (24%), Positives = 39/118 (33%), Gaps = 7/118 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A P PP P V P V + PP V++ + + + +P
Sbjct: 39 AAIPLPPKPQGDRDEPRVL-------PAVVQVVALPTQPPEGVAQEIQDAGDAAAASVDP 91
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ PP S P P A P PP PPA + P P P P P+
Sbjct: 92 QPVAQPPVESTPAGVPVAAQTPKPVKPPKQPPAGAVPAKPTPKPEPKPVAEPAAAPTG 149
|
Length = 226 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 23/155 (14%), Positives = 32/155 (20%), Gaps = 2/155 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P +NSS P KS S +
Sbjct: 1210 DDKPDNKKSNSSGSDQEDDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEFSSDDLSKEG 1269
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
++P S SPPP S P SSP + + +
Sbjct: 1270 KPKNAPKRVSAVQYSPPPPSKRPDGESNGGSKPSSPTKKKVKKRLE--GSLAALKKKKKS 1327
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
+ S S L P +
Sbjct: 1328 EKKTARKKKSKTRVKQASASQSSRLLRRPRKKKSD 1362
|
Length = 1388 |
| >gnl|CDD|217512 pfam03359, GKAP, Guanylate-kinase-associated protein (GKAP) protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 24/154 (15%), Positives = 39/154 (25%), Gaps = 13/154 (8%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTT-------SPPPSPPASNPPTS 65
P +I S + P S+ T+
Sbjct: 2 GHKKAKKKRKPSSIGISDDESATDSEAEPKGFREFQSVGVQVEDEKLQRRRFKRSSSVTA 61
Query: 66 SSPPASSP---PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN---PPTRSPPPPS 119
+ P + + P + PPP S+ TR+
Sbjct: 62 NVQADLELEGFPGLPVVRHVSTEDKALQFGPSFQRESSEDSPPPSSSTYSAGTRTVSTQG 121
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
+ + P PS + S + S+LPPP P
Sbjct: 122 QSAYLSDPKRRPSSEASESETVAFDESDLPPPDP 155
|
Length = 342 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 28/113 (24%), Positives = 37/113 (32%), Gaps = 11/113 (9%)
Query: 50 TTSPPPSPPAS-NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
T P P + N S + + + SP + + SP SP T P P+
Sbjct: 4 ETKEPEDPADNVNDVVSEASSPETDLSLSPSQSEQNIENDGQNSPETQSPLTELQPSPL- 62
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
PP ++ P S P NP S P PPP KR
Sbjct: 63 -------PPNTTLDAPVSDSQGDESSSEQ--QPQNPNSTEPAPPPKKRRRRKR 106
|
Length = 808 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV------MG 531
L Y+HE I H DIK NI++D N + D+G+A + HI G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLE 561
T Y + + +T + D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 27/226 (11%), Positives = 51/226 (22%), Gaps = 1/226 (0%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P + PPP S P + + S P KP
Sbjct: 522 SIKELRPRIGFINKSPPPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFA 581
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ + + + P S+ P + +
Sbjct: 582 FANTVRLTDNMRGGNGVGSSVKPKGSASSKPLTGPGSDLKPATLNGKTPSSSLVGAARNA 641
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ P SP + ++ P K++ P + N +
Sbjct: 642 GASSKVKIPSGLGGFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTESA 701
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
++ N P P P P++ ++S
Sbjct: 702 STTDVFQNFAGLN-KKTPVGGPFQPKPPLSRALDSASSPGGSGGKP 746
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 9/102 (8%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
S P + T +P + + +P + P + P +
Sbjct: 159 GQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAV--------ATAPAPAVDPQQNAVV 210
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
PS ++ P + P ++ P ++ S P +P
Sbjct: 211 APSQANVDTAATPAPAAP-ATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 27/197 (13%), Positives = 44/197 (22%), Gaps = 33/197 (16%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
+P + PT + P S PPKS P K + S + T +
Sbjct: 147 APAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDTSKETTTEKTEGKTSVKAAS 206
Query: 75 TSSPPPASNPPTSS----PPPSPPASSPPTISPPPPVSNPPTRSPP----PPSSTPPPNS 126
PP + SS + S S + S+ P
Sbjct: 207 LKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEESEEESGKRDVILEDESAEPTGLD 266
Query: 127 PPSPPSDPPANSPPPSNPPSN-------------------------LPPPPPSSVEPPKR 161
+P + + + P P E +
Sbjct: 267 EDEDEDEPKPSGERSDSEEETEEKEKEKRKRLKKMMEDEDEDEEMEIVPESPVEEEESEE 326
Query: 162 SPPSVPPQNPPPPPSSS 178
P P+ +
Sbjct: 327 PEPPPLPKKEEEKEEVT 343
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 27/101 (26%), Positives = 35/101 (34%), Gaps = 11/101 (10%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP------PPPPVSKPPTTSPPPSP 57
P+ G S + PP NPP +P P + SS P P +P +P P
Sbjct: 159 PAGGTYILASGTYIPP--NPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQP 216
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
NP P P PA P +P PP +
Sbjct: 217 TVQNPA---QQPQQQPQQQPVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 29/100 (29%), Positives = 38/100 (38%), Gaps = 7/100 (7%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
PPP + P S +P AS+ P + P S P P + P +PP S PA
Sbjct: 187 QPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPS--APPASIPAPP 244
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P + PP PPP P + + PAN
Sbjct: 245 IPPVIQYVAP--PP---VPPPQPIIPIQHIRAVTGETPAN 279
|
Length = 582 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 32/202 (15%), Positives = 52/202 (25%), Gaps = 7/202 (3%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A S +P + P P + P + + S +
Sbjct: 57 TARSDTPATAAAPAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVASAAEDMIAAMALRQ 116
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP-----VSNPPTRSPPPPSSTPPP 124
S P +P A S P P+ A + P +S P + +T P
Sbjct: 117 PVSVPRQAPAAAPVRAASIPSPAAQALAHAAAVRTAPRQEHALSAVPEQLFADFLTTAPV 176
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
P A +P P+ + + + + + P PP P
Sbjct: 177 PRAPVQAPVVAAPAPVPAIAAALAAHAAYAQDDDEQLDDDGFDLDDALPQ--ILPPAALP 234
Query: 185 PAPIAVPPSNVPPPPTQTPPTP 206
P +A P P
Sbjct: 235 PIVVAPAAPAALAAVAAAAPAP 256
|
Length = 559 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 3/58 (5%)
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520
D VK + A L YLH IIHRD+K N+L+ N +++DFGL+K+ L+
Sbjct: 102 DEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 31/103 (30%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP ++ PP + TP PN P P P P P P
Sbjct: 9 PPGLAGLVANVPPAAAPTPQPN--PVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMT 66
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN--VPPPPTQTPP 204
P V Q P + P +PPA A P VPPPP TP
Sbjct: 67 PHVVQQAP-----AQPAPAAPPAAGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 16/97 (16%), Positives = 24/97 (24%), Gaps = 1/97 (1%)
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
P+ P + P +P A S P + A A +P+ + P
Sbjct: 370 SGGRGPKQHIKP-VFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
P PP + SS
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSS 465
|
Length = 614 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 26/121 (21%), Positives = 36/121 (29%), Gaps = 7/121 (5%)
Query: 77 SPPPASNPPTSSPPPSPPASSPP-TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S + SS +P P + + P+ P+S P S+P
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVT---PTRGRRPSSSPRSLSNPT 202
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV 195
PSN PPP S RS N S + P S + + P S
Sbjct: 203 TLE-SPSNLQVTTDVPPPYSNGTS-RSSTMSSSANLSIISSLATP-RSGESFRSTPTSGS 259
Query: 196 P 196
Sbjct: 260 S 260
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 35/181 (19%), Positives = 46/181 (25%), Gaps = 5/181 (2%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P P N S P T S + SS S ++
Sbjct: 225 PPPNLSPNNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPSIRNLRGLNSAL 284
Query: 64 TSSSPPASSPPT-SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S +SS S+ PT SP A P SP ++ T PP S P
Sbjct: 285 VSFLNVSSSSLAFSALNGKEVSPTGSPSTRSFARVLPKSSPNNLLTEILTTGVNPPQSLP 344
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+P + P S + P PSSS
Sbjct: 345 SLLNPVF--LSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYS--SNVPSPSSSESTR 400
Query: 183 S 183
+
Sbjct: 401 N 401
|
Length = 777 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 9e-04
Identities = 16/77 (20%), Positives = 24/77 (31%), Gaps = 6/77 (7%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P P PP +P A A + P P A P + ++ P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAA--AAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 224 PPSTKRLSPPPGIPVPS 240
P + P P + + S
Sbjct: 449 PAAA----PQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 9e-04
Identities = 12/70 (17%), Positives = 23/70 (32%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P S PP P + +P A+ ++ PA++ A+ +P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 91 PSPPASSPPT 100
+P +
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 4/118 (3%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
++ P S +SS P + P+ + PS + T++ A + ++ P+
Sbjct: 301 VAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD--- 357
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP-SPPSDPPANSPPPS 142
+ P ++ P P P+S T+ + T N P S P+ P +N P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSP 415
|
Length = 421 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 17/74 (22%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
S ++ S + +SS + S PP+S P ASS P+ + SP
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSS-TSPRPRRRKPSASSLLHTPSILPLPKLSSPSP 61
Query: 116 PPPSSTPPPNSPPS 129
P + P +
Sbjct: 62 PSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 16/58 (27%), Positives = 24/58 (41%), Gaps = 1/58 (1%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
P P P S +PPP + P T ++ PA++ P + P + P P P
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAE-KPKKDKPRRERKPKP 69
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 17/58 (29%), Positives = 24/58 (41%), Gaps = 1/58 (1%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP-PASN 83
P P P ++P PPP +K + + PA+ P + P P P PAS
Sbjct: 15 EQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 25/179 (13%), Positives = 34/179 (18%), Gaps = 14/179 (7%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
S + V + K P +K +S T +
Sbjct: 1183 KSSADKSKKASVVGNSKRVDSDEKRKLDDKPDNKKSNSSGSDQEDDEEQKTKPKKSSVKR 1242
Query: 74 PTSSPPPASNPPTSSPPP-SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
S +S + S S P + SPPPPS P S
Sbjct: 1243 LKSKKNNSSKSSEDNDEFSSDDLSKEGKPKNAPKRVSAVQYSPPPPSKRPDGESNGGSKP 1302
Query: 133 DPPANSPPPS--------NPPSNLPPPPP-----SSVEPPKRSPPSVPPQNPPPPPSSS 178
P S + S P S
Sbjct: 1303 SSPTKKKVKKRLEGSLAALKKKKKSEKKTARKKKSKTRVKQASASQSSRLLRRPRKKKS 1361
|
Length = 1388 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 63/248 (25%), Positives = 98/248 (39%), Gaps = 47/248 (18%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGERE----FKAEVEIISRIH 421
D F ++G G FG V D G A+K L+ E+E +AE +I+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 422 HRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+V + Y D R L LI +++P + L + + + AT+ IA +
Sbjct: 60 GAWVVKMF-YSFQDKRNLYLIMEFLPGGDM-MTLLMKKDTLSEEATQFYIAE-TVLAIDA 116
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN--------TH-------- 524
+H+ IHRDIK N+LLD ++SDFGL A+ TH
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 525 ------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ +GT Y+APE + D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 567 KPVDASQP 574
P + P
Sbjct: 234 PPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|218115 pfam04502, DUF572, Family of unknown function (DUF572) | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 9e-04
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 3/88 (3%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P+ +SS +S S S P+SS +S P +S+ R
Sbjct: 224 DNTPSPKSGSSSPAKPTSILKKSAAKRSEAPSSS---KAKKNSRGIPKPRDALSSLVVRK 280
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P ST S P S+ P + S
Sbjct: 281 KAAPESTSQSPSSAEPTSESPQTAGNSS 308
|
Family of eukaryotic proteins with undetermined function. Length = 321 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 32/175 (18%), Positives = 48/175 (27%), Gaps = 21/175 (12%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTR--SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
P + P + +S + S + + + P
Sbjct: 19 EFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVA---------GAAACDRFEPPT 69
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
PPP P + P S + P+S + SP P P PP
Sbjct: 70 GPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPP--------GPSSPDPPPPTP 121
Query: 208 SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
P +P PS + S PPP P+ +P S SS +
Sbjct: 122 PPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAV--ASDAASSRQAAL 174
|
Length = 1352 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 44/220 (20%), Positives = 57/220 (25%), Gaps = 12/220 (5%)
Query: 8 PPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PPAA PP + P PP P + PP ++P +P P PP PP
Sbjct: 726 PPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPA 785
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP-- 122
P +P PP A P + P PT + + P P
Sbjct: 786 PQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGGVKRGRPSLKKPAA 845
Query: 123 -----PPNSPPSPPSDPPAN--SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
PSP S P PP P + + + S Q P
Sbjct: 846 LERQAAAGPTPSPGSGTSDKIVQAPVFYPPVLQPIQVMRQLGSVRAAAASTVTQAPTEYT 905
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P P + S
Sbjct: 906 GERRGVGPMHPTDIPPSKRAKTDAYVESQPPHGGQSHSFS 945
|
Length = 991 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 68/319 (21%), Positives = 96/319 (30%), Gaps = 59/319 (18%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSS-----PPPPPVSKPPT------------ 50
PP P P+S + P P+ +P + PP V +
Sbjct: 457 PPTQPLEGPTGPLSVQAPLEPWQPLPHPQVTPVILHQPPAQGVQAHGSMLDLLEKDDEDM 516
Query: 51 ------TSPPPSPP-------------------ASNPPTSSSPPASSPPTSSPPPASNPP 85
T PPSPP + P ++ P P P
Sbjct: 517 EQRVMATLLPPSPPQPRAGRRAPCVYTEDLDIESDEPASTEPVHDQLLPAPGLGPLQIQP 576
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS--STPPPNSPP--------SPPSDPP 135
+SP S ASS P+ + P P+++P PP+ S P S P P P
Sbjct: 577 LTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPL 636
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSP-----PSVPPQNPPPPPSSSPPKNSPPAPIAV 190
P N P P VE P +P Q P ++ P P +
Sbjct: 637 RMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQP 696
Query: 191 PP-SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
PP + P P PP A A + P + P + + PG PG
Sbjct: 697 PPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPG-RARPPAAAPGRAR 755
Query: 250 NPSSPESSSSPSNNGIGTA 268
P++ + P G
Sbjct: 756 PPAAAPGRARPPAAAPGAP 774
|
Length = 991 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 24/113 (21%), Positives = 33/113 (29%), Gaps = 16/113 (14%)
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
K+ PP S+ S P+ N+ TP +P + S S
Sbjct: 447 KKLANKTSTVMEPPYGSTESSVPSTPSTRR-NDRNITSN---TPSLKRTPNLTKSSLSQE 502
Query: 220 NSPPPPSTK------------RLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
S ST L P S N +G N ++ SSP
Sbjct: 503 ASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSP 555
|
Length = 619 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (95), Expect = 0.001
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 3/129 (2%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN--SPPA 186
+ P+ A + PP+ P + P ++ PP +++PP +PPA
Sbjct: 220 AAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPA 279
Query: 187 PIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
A PP+ PP + PA + AP + ++P P K +PP P +
Sbjct: 280 KAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAA 339
Query: 246 GNGTNPSSP 254
++P
Sbjct: 340 PPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P + P P++ PP +PP P A P P P PA+ P S + P +
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARS-ADPAA 442
Query: 222 PP 223
Sbjct: 443 AA 444
|
Length = 576 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 41/200 (20%), Positives = 52/200 (26%), Gaps = 30/200 (15%)
Query: 5 SPGPPAANSSSPPPPVSNPPTI----------SPPPPVSNPPKSSPPPPPVSKPPTTSPP 54
A S S PP+ P P PPKSS + P
Sbjct: 456 PHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPESKEPPPKSSSKEKRRPRTAQKGPE 515
Query: 55 P------SPPASNPPTSSSPPASSPPTSSPPPASN-----PPTSSPPPSPPASSPPTISP 103
SP S P P ++ S P + P S P
Sbjct: 516 SGRGKQKSPAQSEAPPQRRTVGKKQPKKPEKASAGDERTGLRPESEPGTLPYGSSVQTPP 575
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P + P P P + PP+ S P S S
Sbjct: 576 DRPKAATKGSRKPSPRKEPKSSVPPAAEK---------RKYKSPSKIVPKSREFIETDSS 626
Query: 164 PSVPPQNPPPPPSSSPPKNS 183
S P++ PPSS P N+
Sbjct: 627 SSDSPEDESLPPSSQSPGNT 646
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 25/125 (20%), Positives = 37/125 (29%), Gaps = 6/125 (4%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
+ N S PP K + PS + S T P SS P
Sbjct: 141 LRNAWSSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVT----PTRGRRPSSSPR 196
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
S S+P T+ P + PP + T ++ S + +S +
Sbjct: 197 SL--SNPTTLESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRST 254
Query: 152 PPSSV 156
P S
Sbjct: 255 PTSGS 259
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 17/76 (22%), Positives = 30/76 (39%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A S S+ P P + P+ P + +PP P +K P + + +
Sbjct: 161 NAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKTATVAV 220
Query: 62 PPTSSSPPASSPPTSS 77
PP +S P S ++
Sbjct: 221 PPATSGKPKSGAASAR 236
|
Length = 327 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 10/153 (6%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+ ++S P VS+P S P S P ++ +++ P + +
Sbjct: 175 SKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTSS------ 228
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT-RSPPPPSSTPPPNSPPS 129
+ P + PPP+ P+ SP P +S + + ++PP S+ P+S +
Sbjct: 229 NPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTAT 288
Query: 130 PPSDPPANS---PPPSNPPSNLPPPPPSSVEPP 159
PP P P + P PP
Sbjct: 289 PPPTTKRQETGRPTPRPTATTQSGSSPPHSSPP 321
|
Length = 408 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 37/154 (24%), Positives = 51/154 (33%), Gaps = 19/154 (12%)
Query: 16 PPPPVSNPPTISPPPPVSNP-------PKSSPPP----PPVSKPPTTSPPPSPPASNPPT 64
P V+ T S P VS+P P+S P + +S P +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASS-------PPTISPPPPVSNP-PTRSPP 116
S+ P + PP S P+ +P S S+ PP SN S
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTA 287
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P T P P A + S+PP + PP
Sbjct: 288 TPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPP 321
|
Length = 408 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 25/69 (36%), Positives = 32/69 (46%)
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
PPP ++ P +PP PP PP P P +PP P A P + PPP P P +
Sbjct: 46 PPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPPPA 105
Query: 209 PIAPRPSNS 217
P R N+
Sbjct: 106 PEPGRIDNA 114
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 14/71 (19%), Positives = 20/71 (28%)
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
P S PP P + A +P P + L P ++ P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 166 VPPQNPPPPPS 176
PQ S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 12/66 (18%), Positives = 20/66 (30%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
PP+ PP P + + + P P ++ P + A P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 194 NVPPPP 199
P P
Sbjct: 451 AAPQPA 456
|
Length = 598 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 31/155 (20%), Positives = 40/155 (25%), Gaps = 13/155 (8%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKS--------SPPPPPVSKPPTTSPPPSPPASNP 62
N+ PP + + KS +PP VSK P S
Sbjct: 429 ENNDVPPWEDAPDEAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEV 488
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P S P + P +P P PP PPP
Sbjct: 489 P--SENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCPP---EDGAEIPPPDWEHA 543
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P +D A + + PPP S E
Sbjct: 544 APADTAGGGADEEAEAGGIGGNNTPSAPPPEFSTE 578
|
Length = 709 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
PS PA + S P P +PP PP+S PP P + P SP P P S
Sbjct: 415 TPSSAAPATPAPSAAPSPRVPWDDAPP----APPRSGIPPRPAPRMPEASPVPGAPDSVA 470
Query: 63 PTSSSPPASSPPTSSPPPASNPPTS 87
S +PP P+ + + P +
Sbjct: 471 SASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 32/155 (20%), Positives = 46/155 (29%), Gaps = 8/155 (5%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S+ P S + + S P P P S PP P P +
Sbjct: 266 SSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPP--PPVRRPRVKH 323
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P P + + PA ++S S A + + S P S S
Sbjct: 324 PEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSFLEDDDF 383
Query: 122 PPPNSPPSP-----PSDPPANSP-PPSNPPSNLPP 150
P + PS ++P PPS P + L
Sbjct: 384 GSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 22/156 (14%), Positives = 33/156 (21%), Gaps = 21/156 (13%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP + P P P P++ PP + PP
Sbjct: 55 YPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASREL----PPGPTPVPPGGFR 110
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
+ P S+SP P A S+ +
Sbjct: 111 GASSP--RLGADSTSPRFLYQVNF---------------PVILAPIGESNSSSEELSEEE 153
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
S S + G + + S S
Sbjct: 154 EHSRPPPSESLKVKNGGKVYPKGFSKHKTHKRSEFS 189
|
Length = 580 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 115 PPPPSSTPPPNSPPSPPSD---PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
P PP P P P + S ++P P+ P+ P +V+ P + P P Q P
Sbjct: 174 PNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQP 233
Query: 172 PPPPSSSPPKNSPPAP 187
P P+N P
Sbjct: 234 VQPAQQPTPQNPAQQP 249
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 19/73 (26%), Positives = 27/73 (36%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP+PG P +SS + P + P V NP + P +P +
Sbjct: 180 APAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQPVQPAQQ 239
Query: 63 PTSSSPPASSPPT 75
PT +P P T
Sbjct: 240 PTPQNPAQQPPQT 252
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 28/132 (21%), Positives = 37/132 (28%), Gaps = 14/132 (10%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSP------PASSPPTSSPPPASN--PPTSSPPPSPPA 95
P P T P S +S P P + P ++ P S P
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 96 SSPPTISPPPP--VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
S I+ P P + +R+ P S P P + PP S PP P
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPI--AAS--PPGPQ 224
Query: 154 SSVEPPKRSPPS 165
P
Sbjct: 225 EGPTISASQPAQ 236
|
Length = 430 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 22/111 (19%), Positives = 29/111 (26%), Gaps = 4/111 (3%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P + P + P P V P P P P P
Sbjct: 108 KVLGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVD 167
Query: 182 NS-PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS 231
+ P P + PP P P P+ P+PS + R S
Sbjct: 168 SMAIAVPAIDTPVTLELPPA---PQPPPPVVPQPSTMVVHRRSRIKRTRSS 215
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 21/78 (26%), Positives = 29/78 (37%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
SS P S+ +S S S+PP+S+SP S+ P P S
Sbjct: 2 SSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSP 61
Query: 98 PPTISPPPPVSNPPTRSP 115
P PP + P +P
Sbjct: 62 PSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 4/58 (6%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
P +PP P++ P P P + + P + P P + P+R P
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKK----DKPRRERKPKP 69
|
Length = 475 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 14/60 (23%), Positives = 18/60 (30%), Gaps = 2/60 (3%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P + P S S TS PA++ +PPP PP S
Sbjct: 268 AAAQPATAAPAPSRMTDTNDSKSVTS--QPAAAAAAPAPPPNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (94), Expect = 0.001
Identities = 29/109 (26%), Positives = 42/109 (38%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P + P P +P A P + PA + P ++ P P P P + PP+
Sbjct: 84 PSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPAPACPPS 143
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PP PT P P + ++ PP P A+ P P+ P
Sbjct: 144 TRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAASP 192
|
Length = 280 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 2/124 (1%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+ AS P + + ++PP S P+ P S+P P V P T P
Sbjct: 153 ATNASLFPLGLAAFPAEGTLAAPPLGEGSADGSCDPALPLSAPRL--GPADVFVPATPRP 210
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P ++ P +P + P ++ P+ + P ++ E P P PP
Sbjct: 211 TPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPA 270
Query: 176 SSSP 179
+++P
Sbjct: 271 NATP 274
|
Length = 401 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 18/89 (20%), Positives = 26/89 (29%), Gaps = 7/89 (7%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P +PPA +P ++ RS + + P P PP+
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPA- 404
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P S E P P+ P
Sbjct: 405 ------PEPARSAEAPPLVAPAAAPAGLA 427
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 15/80 (18%), Positives = 24/80 (30%), Gaps = 2/80 (2%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P +PP P + + ++ + A +P P +P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAA--TAAGAPLPDFDPRPRGPP 403
Query: 91 PSPPASSPPTISPPPPVSNP 110
PA S P + P
Sbjct: 404 APEPARSAEAPPLVAPAAAP 423
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 15/82 (18%), Positives = 22/82 (26%), Gaps = 2/82 (2%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPP--PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P ++PP P V + + A P P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAP 405
Query: 77 SPPPASNPPTSSPPPSPPASSP 98
P ++ P P + PA
Sbjct: 406 EPARSAEAPPLVAPAAAPAGLA 427
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 16/84 (19%), Positives = 24/84 (28%), Gaps = 2/84 (2%)
Query: 80 PASNPPTSSPPPSPPASSPPTISP--PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P+ +PP PA ++ S + ++ P P PPA
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAP 405
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKR 161
P S L P + R
Sbjct: 406 EPARSAEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/110 (25%), Positives = 35/110 (31%), Gaps = 3/110 (2%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNP-PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
S P V + P ++ P P PA +P T+ PP
Sbjct: 351 ASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFC 410
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNP 144
P +SP P S P T P P PP P AN P +P
Sbjct: 411 GDPGLVSPYNPQS-PGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPGHP 459
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 18/98 (18%), Positives = 24/98 (24%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
T S P ++ + T P P + P ++ PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQF 409
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
SP P S P P P P P
Sbjct: 410 CGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 25/113 (22%), Positives = 34/113 (30%), Gaps = 7/113 (6%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P+ A+ + P + P P I P +P T PP P
Sbjct: 355 APSRVLAAAAKVAVIAAPQ----THTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFC 410
Query: 122 PPPN-SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P P P + P P +PP P + P V P +P
Sbjct: 411 GDPGLVSPYNPQSPGTSYGPE--PVGPVPPQPTNPYVMPISMANMVYPGHPQE 461
|
Length = 663 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/119 (28%), Positives = 47/119 (39%), Gaps = 34/119 (28%)
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLA-----------------KLALD-----------A 521
IHRDIK N+LLD+ ++SDFGL L D A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 522 NTHITTR------VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
T R +GT Y+APE + D +S GV++ E++ G P + P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 8/113 (7%)
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT 466
+A +++R+H + RRL + + + E L
Sbjct: 92 GALLEALARLLARLH-SVPPEALPLARRLRRRLKLLRQLAAALRR-LVAAELLDRLAELW 149
Query: 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-AQVSDFGLAKLA 518
+AA A A ++H D+ N+L+D V DF A L
Sbjct: 150 ERLLAALLALLPAL-----PLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 34/173 (19%), Positives = 51/173 (29%), Gaps = 19/173 (10%)
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV--EPPKRSPPSVPPQNPPP 173
PPP + P PPP N PP V +P ++P PP
Sbjct: 257 PPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDPP 316
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPP---------------PTQTPPTPASPIAPRPSNSS 218
PP+ + P P PT TPP+ ++
Sbjct: 317 PPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSA--GRHH 374
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
P P+ KR S + + T P++P +S P+ +
Sbjct: 375 PKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASA 427
|
Length = 3151 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 43/167 (25%), Positives = 57/167 (34%), Gaps = 4/167 (2%)
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
+SSP SP S+ + + P S PP A S PP P + PP
Sbjct: 149 SSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQ-- 206
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P + P+ PQ P P S P P + P P +Q P P +P + P
Sbjct: 207 --GSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHP 264
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
+S PP P + PS+ G S PS
Sbjct: 265 QSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPS 311
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 17/68 (25%), Positives = 23/68 (33%), Gaps = 3/68 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS---SPPPPPVSKPPTTSPPPSPPA 59
P P P + PPT PPPP + S + P S PP P+P
Sbjct: 529 KSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPPIPEEPTPSP 588
Query: 60 SNPPTSSS 67
+ +
Sbjct: 589 TKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 17/99 (17%), Positives = 26/99 (26%), Gaps = 8/99 (8%)
Query: 163 PPSVPP-------QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P SV P P ++ + A A P+ P P PA P A
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA-PPAAAAP 80
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
+ P + P + + +P
Sbjct: 81 AAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 17/80 (21%), Positives = 26/80 (32%), Gaps = 2/80 (2%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+P+ P + P P P + + + P P S P PP +
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARS--A 440
Query: 63 PTSSSPPASSPPTSSPPPAS 82
P SP AS+P +
Sbjct: 441 PLPPSPQASAPRNVASGKPG 460
|
Length = 620 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 41/170 (24%), Positives = 58/170 (34%), Gaps = 12/170 (7%)
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN-SPPSPPSDPPANSPPPSNPPSN 147
PP P AS P +P S P P P P+ +
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAK--EH 567
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
P P+ + P+ P++P P P+ S P P S P P +P
Sbjct: 568 KPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPR-SAQRPTR-PKSPKLPELLDIPKSPK 625
Query: 208 SPIAPRPSNSSPNSPPPPSTKRLSP--PPGIPVPSTENTPGNGTNPSSPE 255
P +P+ SP PPPP + SP P G + + P + P P+
Sbjct: 626 RPESPK----SPKRPPPP-QRPSSPERPEGPKIIKSPKPPKSPKPPFDPK 670
|
Length = 943 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (93), Expect = 0.002
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 2/101 (1%)
Query: 9 PAANSSSPPPPVSNPPT--ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A +++PP + PP +PP + PP + PP + P +P + +
Sbjct: 249 APAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAK 308
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
+ A + + P A+ PP + P A++PP + PV
Sbjct: 309 AAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAAAAPV 349
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 18/86 (20%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
+P P+ + P ++ P P P P P + +AP +N + P P+
Sbjct: 170 TDPATTPAPAAPVDTTPTNSQTPAVATAPAP-AVDPQQNAVVAPSQANVDTAATPAPAA- 227
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSP 254
P P + G T + P
Sbjct: 228 --PATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 16/93 (17%), Positives = 25/93 (26%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
G A S S P +S+PP + + P +
Sbjct: 81 GAEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGP 140
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
+P ++ P + S PP S P
Sbjct: 141 TPDPTAQPATPDERRSPRQRPPVSGEPPTPSTP 173
|
Length = 226 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 24/67 (35%), Positives = 29/67 (43%)
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P PPPPPS++ +P AP PP PP P P A P P N+ P P P+
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNA 100
Query: 228 KRLSPPP 234
P
Sbjct: 101 PPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/61 (37%), Positives = 29/61 (47%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P AA + +P P PP +PP P + P ++PPPPP PP P A P
Sbjct: 44 PPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPP 103
Query: 63 P 63
P
Sbjct: 104 P 104
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/63 (36%), Positives = 27/63 (42%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P PP + + PP P A P P PP PA P AP P PN+PP
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPP 102
Query: 224 PPS 226
PP+
Sbjct: 103 PPA 105
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 67/319 (21%), Positives = 93/319 (29%), Gaps = 43/319 (13%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSN-------PPKSSPPPPPVSKPP----TTSPPP 55
+ S P S+ T + P++N SS P S +TS
Sbjct: 37 NSTPNSFSPIPSKASSSATFTLNLPINNSVNHKITSSSSSRRKPSGSWSVAISSSTSGSQ 96
Query: 56 SPPASNPPTSSSPPASS--------PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
S P +S +P SS T S+ SS S +S P P
Sbjct: 97 SLLMELPSSSFNPSTSSRNKSNSALSSTQQGNANSSVTLSSSTASSMFNSNKLPLPNPNH 156
Query: 108 SNPPTR---------SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
SN T +P SS P N S P + S P PSS
Sbjct: 157 SNSATTNQSGSSFINTPASSSSQPLTNLVVSSIKRFPYLT---SLSPFFNYLIDPSSDSA 213
Query: 159 PKRS--------PPSVPPQN--PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ PP++ P N S P S I + S+ T + S
Sbjct: 214 TASADTSPSFNPPPNLSPNNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPS 273
Query: 209 PIAPRPSNSSPNS--PPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
R NS+ S S+ S G V T + P+SS + I
Sbjct: 274 IRNLRGLNSALVSFLNVSSSSLAFSALNGKEVSPTGSPSTRSFARVLPKSSPNNLLTEIL 333
Query: 267 TAGTVVIAVAVGIIAFSLI 285
T G ++ +
Sbjct: 334 TTGVNPPQSLPSLLNPVFL 352
|
Length = 777 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 20/122 (16%), Positives = 29/122 (23%), Gaps = 6/122 (4%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
P + P P + P P P + A + P + +
Sbjct: 635 FPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRA 694
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P A P PPPP P S + + PP P
Sbjct: 695 PQAPR------PGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQAD 748
Query: 153 PS 154
+
Sbjct: 749 GA 750
|
Length = 753 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 6/70 (8%), Positives = 15/70 (21%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
PP +P + + + + P + P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 182 NSPPAPIAVP 191
+P + +
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 10/67 (14%), Positives = 17/67 (25%)
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
P P P+ P ++ P P + P +++ P
Sbjct: 392 PSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPAA 451
Query: 186 APIAVPP 192
AP
Sbjct: 452 APQPAVR 458
|
Length = 598 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 19/106 (17%), Positives = 24/106 (22%), Gaps = 5/106 (4%)
Query: 157 EPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P R S +S+ P + P + P P P
Sbjct: 54 LYPPRETGS-----GGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGG 108
Query: 217 SSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
S P SP V G + SS E S
Sbjct: 109 FRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEE 154
|
Length = 580 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 20/66 (30%), Positives = 29/66 (43%), Gaps = 1/66 (1%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P ++ P + A+ +P P + PT PP +S P P + PP PA PPP+
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPT-PEPPAASKPTPPAAAKPPEPAPAAKPPPTPV 182
Query: 145 PSNLPP 150
P
Sbjct: 183 ARADPR 188
|
Length = 418 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 2/73 (2%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-SSPPKNSPPAPIAVPPSNVPPPP-TQTP 203
+N P + VE P+ +PPS + P P+ ++PP AP P + P +TP
Sbjct: 28 ANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETP 87
Query: 204 PTPASPIAPRPSN 216
+P + P N
Sbjct: 88 QSPTTKQVPTEIN 100
|
Length = 291 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 24/117 (20%), Positives = 38/117 (32%), Gaps = 8/117 (6%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNP-PKSSPPPPPVSKPPTTSPPP--SPPASNPPTS 65
+S+ P + + P P P ++ P P +
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGT 363
Query: 66 SSPPASSPPTSSPPPASNPPT--SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ PA+ P P P S T SS ++ PT S P + P + P P+S
Sbjct: 364 VALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLP---AAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 25/131 (19%), Positives = 34/131 (25%), Gaps = 4/131 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
VS+ S P S S A + P SS P + +SS
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
S S S + SP S + + S + + S PS
Sbjct: 62 FGLSKQRPS----SLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTT 117
Query: 149 PPPPPSSVEPP 159
S P
Sbjct: 118 SSDLSSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 13/59 (22%), Positives = 20/59 (33%), Gaps = 3/59 (5%)
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP---TPASPIAPRPSNSSPNSPPPPS 226
PP +S P +P P + P + + S A P + S + P S
Sbjct: 86 PPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSGS 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P + P ++ PT +P PP+S P +P S SP + + P P
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPPAS-PASGMSAAPASAVEEKSPSEESATATAPESP 135
Query: 153 PSSVEPPKRSPPS 165
+SV S
Sbjct: 136 STSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 25/132 (18%), Positives = 33/132 (25%), Gaps = 2/132 (1%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P S P T SP VS+ P P PP P P+ ++
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 153 PSSVEPPKRSPPSVPPQ--NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
S + P P P S P +VPP P P
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPT 228
Query: 211 APRPSNSSPNSP 222
+ +
Sbjct: 229 ISASQPAQRDHA 240
|
Length = 430 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 3/37 (8%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
PP + PP PPPPP +PP+ PPP PP N S
Sbjct: 5 PPGNPPP---PPPPPGFEPPSQPPPPPPPGVNVKKRS 38
|
Length = 2365 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 38/209 (18%), Positives = 56/209 (26%), Gaps = 22/209 (10%)
Query: 11 ANSSSPPPPVSNPPTISPPPPV---SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
A P + P + S + P S PP S +
Sbjct: 486 AKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSFA 545
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP-------PVSNPPTRSPP---- 116
A++ +SP P P + ++P P T S
Sbjct: 546 NVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILALR 605
Query: 117 ----PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP----PPPPSSVEPPKRSPPSVPP 168
P + T PS S PPP P LP P PS +
Sbjct: 606 DAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEVFMGYPFQS 665
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ P S P K+ + P +++ P
Sbjct: 666 PHLGAPSGSPPGKDRDSPDLPRPTTSLHP 694
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 31/104 (29%), Positives = 43/104 (41%), Gaps = 5/104 (4%)
Query: 7 GPPAANSSSP--PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
G P + +S+P SN S P P +SPP + PP T P+++PP
Sbjct: 564 GNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
S SP T+ P S+ +S + P SS S VS
Sbjct: 624 SH---LGSPSTTPSSPESSIKVASTETASPESSIKVASTESSVS 664
|
Length = 670 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 34/114 (29%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS-SPPKNSPPA 186
P + P S SN + PS+V P SPP+ +PP PS P SPPA
Sbjct: 566 PGSTNSTPTGSAASSN--TTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 187 PIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
S++ P T TP+SP + S+ + P S K S + + S
Sbjct: 624 ------SHLGSPST----TPSSPESSIKVASTETASPESSIKVASTESSVSMVS 667
|
Length = 670 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 21/111 (18%), Positives = 36/111 (32%), Gaps = 3/111 (2%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+ P N P + P PPA P +P P+ A++ + P + P
Sbjct: 99 ATSMSEPATENKPAEVTTPVEPMGLPETPPAV--PVPAPAPAVAAAAAQAAAAPKAPAKP 156
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
+SP P + P + + P P ++ P K+
Sbjct: 157 RAKSPRPAAKAAPKPTETITAKKAKKTAAAPK-PTADKTATPAKKTTKKKK 206
|
Length = 209 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 1/111 (0%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P + P S PA PA ++P P+P ++ P +P P
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPST 226
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
+ P + P ST + PP+ P PP ++ P
Sbjct: 227 TTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPT-PGGGEAPPANATPAP 276
|
Length = 401 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 4/117 (3%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A + PP+ P P V P T P P AS P T+ +P
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTAS-PETTPTPS 225
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
++ P S+ PA + ++P + T +PP P +PP ++ P S
Sbjct: 226 TTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGG---EAPPANATPAPEAS 279
|
Length = 401 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 18/89 (20%), Positives = 22/89 (24%), Gaps = 6/89 (6%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P +PP PA S A ++ P P P
Sbjct: 346 PSEGVAAVAPPAPAPADLTQR---LNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGP 402
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P P P RS P P +P
Sbjct: 403 PAPE---PARSAEAPPLVAPAAAPAGLAL 428
|
Length = 504 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 17/96 (17%), Positives = 24/96 (25%), Gaps = 1/96 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A P +++ V P + P P P S P + PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQ-THTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQ 408
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ P S P PP P
Sbjct: 409 FCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPY 444
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 25/130 (19%), Positives = 33/130 (25%), Gaps = 6/130 (4%)
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
N S + + + P + P R P P P P+ SP P
Sbjct: 345 NEILKTASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYP 404
Query: 185 PAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS----PPPGIPVPS 240
P P + P P + P P P P P +S PG P
Sbjct: 405 PVPQFCGDPGLVSPYNPQSPGTSYG--PEPVGPVPPQPTNPYVMPISMANMVYPGHPQEH 462
Query: 241 TENTPGNGTN 250
Sbjct: 463 GHERKRKRGG 472
|
Length = 663 |
| >gnl|CDD|217509 pfam03353, Lin-8, Ras-mediated vulval-induction antagonist | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 21/75 (28%), Positives = 29/75 (38%), Gaps = 15/75 (20%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPP---------------SSSPPKNSPPAPIAVPPSNVPPP 198
S++ P+ SVP Q PP P S+S + S P P + PP VP P
Sbjct: 190 STMSRPQEVKQSVPAQQAPPNPQQPMPSASSESATSKSASTSRESSPQPQSPPPRRVPAP 249
Query: 199 PTQTPPTPASPIAPR 213
+ A I +
Sbjct: 250 TVDSTAKEAEQITYQ 264
|
LIN-8 is a nuclear protein, present at the sites of transcriptional repressor complexes, which interacts with LIN-35 Rb.Lin35 Rb is a product of the class B synMuv gene lin-35 which silences genes required for vulval specification through chromatin modification and remodelling. The biological role of the interaction has not yet been determined however predictions have been made. The interaction shows that class A synMuv genes control vulval induction through the transcriptional regulation of gene expression. LIN-8 normally functions as part of a protein complex however when the complex is absent, other family members can partially replace LIN-8 activity. Length = 316 |
| >gnl|CDD|147601 pfam05505, Ebola_NP, Ebola nucleoprotein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 44/228 (19%), Positives = 60/228 (26%), Gaps = 47/228 (20%)
Query: 4 PSPGP----PAANSSSPPPPVSNPPTISPPPPVSNP------------------------ 35
P PGP P S TI PP V +P
Sbjct: 410 PFPGPIEDDVQPRPMDDDPDDSRDTTI--PPGVVDPIDGESTEYSSYSDSFVGTNDDLVL 467
Query: 36 -------PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
S P P + + PP S P + S +N
Sbjct: 468 FNLDEDDDDSKPIPEQAASTYGQTSRERQGIPEPPPGSHQPGNR--ASQDLNNNNQKQED 525
Query: 89 PPPSPPASSPPTISPPPPV---SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
+P + PV P ++ SS PP S D P +
Sbjct: 526 ESTNPIGKTSLRYQELTPVQEEDEPEDQTDDDDSSLPPLES-----DDDPGSDNEQGVDL 580
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ + PP P + ++ P QNP P S +S PS
Sbjct: 581 TEVAPPAPVYRDEKEQDEIPHPAQNPQDPTGSIGNVDSDILRSNSKPS 628
|
This family consists of Ebola and Marburg virus nucleoproteins. These proteins are responsible for encapsidation of genomic RNA. It has been found that nucleoprotein DNA vaccines can offer protection from the virus. Length = 717 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 21/93 (22%), Positives = 28/93 (30%), Gaps = 1/93 (1%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
+ PP P + P V P P P T+ +P + P PP
Sbjct: 195 LDPPEPPEPTVDEAAPETEVEATPAAESPAEPAEETAETTPEETEDAPEEENNKPVK-PP 253
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P SP + P P P+ P P
Sbjct: 254 VPKPYISPDEYPSAPLPPELPQLLQPSLVIPFP 286
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 43/231 (18%), Positives = 67/231 (29%), Gaps = 8/231 (3%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTT-SPPPSPPASNPPTS 65
+P PPV P P P S +S V +PP P P +
Sbjct: 407 KASEPTYGTPRPPVEKP---RPEVPQSLETATSHGSAQVPEPPPVHDLEPGPLHDQHSMA 463
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P A PP + P +P P+ P S
Sbjct: 464 PCPVAQLPPGPLQDLEPGDQLPGVVQDGRPACAPVPAPAGPIVRPWEASLSQVPGVAFAP 523
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN--PPPPPSSSPPKNS 183
P P P P + P PP +++ P + V + P P + +PP++
Sbjct: 524 VMPQPMPVEPVPVPTVALERPVCPAPPLIAMQGPGETSGIVRVRERWRPAPWTPNPPRSP 583
Query: 184 PPAPIAVPPSNVPPP--PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ + + P Q P + S P P +++ P
Sbjct: 584 SQMSVRDRLARLRAEAQPYQASVEVQPPQLTQVSPQQPMEYPLEPEQQMFP 634
|
Length = 935 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 15/59 (25%), Positives = 22/59 (37%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ P P P+ S P+ PA P + P P P P+ P + P + P
Sbjct: 208 AEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDSGP 266
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
I GA RGL YLH++ + IHR+IK+S+IL+ + VS GL+ L +V
Sbjct: 106 ILFGALRGLNYLHQNGY---IHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 530 MGTFG--------YMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKP 568
+ F +++PE KSD++S G+ EL TGR P
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 46/183 (25%), Positives = 82/183 (44%), Gaps = 20/183 (10%)
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRV 468
F ++S++ H HL + G C+ +++ ++V + L L E GR + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL------DNNFE-AQVSDFGLAKLALDA 521
+A A L+YL + ++H ++ + NILL + ++SD G++ AL
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLEL-ITGRKPVDASQPLGDES 579
+ ++APE G L+ +D +SFG LLE+ G P+ P E
Sbjct: 178 EERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 580 LVE 582
E
Sbjct: 233 FYE 235
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 13/101 (12%), Positives = 23/101 (22%), Gaps = 9/101 (8%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPP---PPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
+ L PP ++ + P + P P +P +
Sbjct: 49 AALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQ--REQLVARAA 106
Query: 203 PPTPASPIAPRPSNSSPNSPPPPS----TKRLSPPPGIPVP 239
P AP + +P P +P
Sbjct: 107 APAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPAD 147
|
Length = 484 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 12/133 (9%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP--PPPPSSVE 157
++ PP PSS N+P S P + +P PS+ P P+++E
Sbjct: 147 SLGPPLQHRKRDAV-TASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLE 205
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKN--SPPAPIAVPPSNVPP-PPTQTPPTPASPIAPRP 214
P S V PPP + + + S A +++ S P TP S
Sbjct: 206 SP--SNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGS---- 259
Query: 215 SNSSPNSPPPPST 227
S+ +P S +
Sbjct: 260 SSINPVSGLDEAE 272
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 10/102 (9%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
S+ +++ P + P + + S PP ++ PP++ P
Sbjct: 88 SDAGSQASPDDDAQPAAEAEAADQSAPP--EASSTSATDEAATDPPATAAARDGPTPDPT 145
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
Q P SP + P + PP TP +
Sbjct: 146 AQPATPDERRSPRQRPPV--------SGEPPTPSTPDAHVAG 179
|
Length = 226 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 25/81 (30%), Positives = 35/81 (43%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P +N + PPPPP + +P PP P +P P + PPP ++P P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 90 PPSPPASSPPTISPPPPVSNP 110
PP P + PP P + N
Sbjct: 94 PPVDPNAPPPPAPEPGRIDNA 114
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 11/78 (14%), Positives = 22/78 (28%), Gaps = 4/78 (5%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
SP PP P + + P+ + P +++
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAP----AAGGPAAALAAVPDAAAAA 443
Query: 70 ASSPPTSSPPPASNPPTS 87
A+ P ++ P + S
Sbjct: 444 AAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 15/71 (21%), Positives = 21/71 (29%), Gaps = 1/71 (1%)
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P +P PP P + + P P + P P A + PP
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAA-AAPPAP 449
Query: 201 QTPPTPASPIA 211
P PA +
Sbjct: 450 AAAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 14/75 (18%), Positives = 22/75 (29%), Gaps = 4/75 (5%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
PP P PP P +P + + A + P + P+ P +
Sbjct: 391 PPSPGGG----GGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAP 446
Query: 163 PPSVPPQNPPPPPSS 177
P P +S
Sbjct: 447 PAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 1 MSAPSPGPPAANSS-SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
SA +P A S P V+ + + P V+ P T + P + P
Sbjct: 313 SSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGTVALPAAEPV 372
Query: 60 SN-PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
+ P S+ T + +N PT+S P +P ++ P +
Sbjct: 373 NMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVS 414
|
Length = 421 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 24/112 (21%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS--STPPPNSPPSPPSDPPANSPPPS 142
++S S P SS +S + P + ++PP +SP S +
Sbjct: 8 GSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 143 NPPSNLPPPPPS-SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P S S V P + SP + N +S+ +SP S
Sbjct: 68 RPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSS 119
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 23/126 (18%), Positives = 35/126 (27%), Gaps = 6/126 (4%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
+ ++S + + SS P SPP S PA N +S
Sbjct: 3 ASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRL---NAPASPPSSSPARNT-SS 58
Query: 66 SSPPASSPPTSSPPPASNPPTS--SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
SS S S + SP P+++ S + SP T
Sbjct: 59 SSSFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTS 118
Query: 124 PNSPPS 129
+
Sbjct: 119 SDLSSG 124
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 19/91 (20%), Positives = 28/91 (30%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P P + P ++P P S T P P+P
Sbjct: 108 KVLGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVD 167
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
+++ P + P PP+ PPP P P
Sbjct: 168 SMAIAVPAIDTPVTLELPPAPQPPPPVVPQP 198
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 1/80 (1%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
SNP + S + +SS + S PP ++P R P S++ ++P P ++ PP
Sbjct: 4 SNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKP-SASSLLHTPSILPLPKLSSPSPP 62
Query: 142 SNPPSNLPPPPPSSVEPPKR 161
S + P +R
Sbjct: 63 SVTLPPAATTQTPQLNPLQR 82
|
Length = 590 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 15/61 (24%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
PPSP A+ P + A+ ++ P A+ P P P P P S
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRER----KPKPAS 71
Query: 109 N 109
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 14/61 (22%), Positives = 22/61 (36%), Gaps = 2/61 (3%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
+ P P P +P PP P K++ P + P +P P + P P +
Sbjct: 14 AEQPAPAPPSPAAAPAPP--PPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
Query: 74 P 74
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 14/57 (24%), Positives = 21/57 (36%), Gaps = 2/57 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
P + P S SK T+ P + A PP +PPA+ P + +
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPP--PNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS-NPPSNL---PPPPPSSVEPPKRSPP 164
NP + + P S N+ S SD P+ PS +PP+ PP PS + P SPP
Sbjct: 565 NPGSTNSTPTGSAASSNTTFS--SDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPP 622
Query: 165 SVPPQNPPPPPSS-SPPKNSPPAPIAVPPSNVPPPPTQT 202
+ +P PSS A P S++ T++
Sbjct: 623 ASHLGSPSTTPSSPESSIKVASTETASPESSIKVASTES 661
|
Length = 670 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 32/100 (32%), Positives = 37/100 (37%), Gaps = 15/100 (15%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
S+ P+ PSPP PP S P AS T PP P A PP +
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRS-------------PDASPEETPPSPPGPGAEPPPGRAA 50
Query: 104 PPPVSNPPTRSPPP--PSSTPPPNSPPSPPSDPPANSPPP 141
P R P S+ P PP D PA +PPP
Sbjct: 51 GPAAPRRRPRGCPAGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 30/154 (19%), Positives = 50/154 (32%), Gaps = 6/154 (3%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
L PP P++P P P+ +P P P TP
Sbjct: 168 AEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPR-----PTPRTTASPETTP 222
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
P++ +P + S + + + P P+ G P++ + S
Sbjct: 223 T-PSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAPEASRY 281
Query: 264 GIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKK 297
+ + IA+ IIA +G CL RR +
Sbjct: 282 ELTVTQIIQIAIPASIIACVFLGSCACCLHRRCR 315
|
Length = 401 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 18/105 (17%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
+ P P + +S S P + P+ + NSP +P
Sbjct: 4 ETKEPEDPADNVNDVVS---------EASSPETDLSLSPSQSEQNIENDGQNSPETQSPL 54
Query: 146 SN---LPPPPPSSVEPP------KRSPPSVPPQNPPPPPSSSPPK 181
+ P PP ++++ P S PQNP + PPK
Sbjct: 55 TELQPSPLPPNTTLDAPVSDSQGDESSSEQQPQNPNSTEPAPPPK 99
|
Length = 808 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 22/88 (25%), Positives = 27/88 (30%), Gaps = 8/88 (9%)
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS----VPPQNPPPPPSSSPPKNSPP 185
P A +PP P +E RS S P P P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNR--LEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPP 403
Query: 186 APIAVPPSNVPPPPTQTPPTPASPIAPR 213
AP P + PP P + +A R
Sbjct: 404 AP--EPARSAEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 20/99 (20%), Positives = 29/99 (29%), Gaps = 3/99 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ + P+ A+ + P + + P S P S P
Sbjct: 352 SLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGI---PYSVPARSPMTAYPPVPQ 408
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
DP SP P P P PP+ + P V P
Sbjct: 409 FCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 26/116 (22%), Positives = 33/116 (28%), Gaps = 5/116 (4%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
S + V P ++ P+ P P P PA SP + PP
Sbjct: 354 TAPSRVLAAAAKVAVIAAP-QTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGD 412
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P V P P P + P P P P P +P S P
Sbjct: 413 PGLVSP---YNPQSPGTSYGPEPVGPVPP-QPTNPYVMPISMANMVYPGHPQEHGH 464
|
Length = 663 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 43/210 (20%), Positives = 80/210 (38%), Gaps = 26/210 (12%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER--EFKAEVEIISRIHHRHLVSLVGYC 432
+ + K + P VA+K++ + E + E+ ++ H +++ V
Sbjct: 10 FEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 433 ISDDRRLLIYDYVP--NNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
I D ++ + + H EG P L A I L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIH---SKGF 122
Query: 490 IHRDIKSSNILLDNNFEAQVSDF---------GLAKLALDANTHITTRVMGTFGYMAPE- 539
IHR +K+S+ILL + + +S G + + + + + +++PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEV 179
Query: 540 -YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ EKSD++S G+ EL G P
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 33/155 (21%), Positives = 67/155 (43%), Gaps = 30/155 (19%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQ------------LKIGGGQGEREFKAEVEIISRIH 421
L+ +G +Y G G + IK+ +I + ER + E ++SR
Sbjct: 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERI---RRERT-RNEARLLSRAR 55
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+ + V Y + D + ++ +Y+ L + V++ ++ R + L
Sbjct: 56 KAGVNTPVVYDVDPDNKTIVMEYIEGKPL--------KDVIE-EGNDELLREIGRLVGKL 106
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
H+ I+H D+ +SNI++ ++ + + DFGL K
Sbjct: 107 HKA---GIVHGDLTTSNIIVRDD-KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 19/110 (17%), Positives = 40/110 (36%), Gaps = 2/110 (1%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPP 58
P+ P AA ++ ++ + P ++ P P K +P
Sbjct: 291 AEEPAVAPMAAIRAAHVETAADKGERAAKPAAADKAADKPADRPDAAEKAAEKPAEAAPR 350
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
A++ P + +S P +++ +P + A++P +PP S
Sbjct: 351 AADKPAGQAADPASSSADKPGASADAAARTPARARDAAAPDADTPPGGAS 400
|
Length = 413 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
PPPP + PPP + P P PA+SPPP+ P S P P S PP +S
Sbjct: 144 PPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPT-PASPPPAKAPKSSHPPLKS 202
Query: 163 P 163
P
Sbjct: 203 P 203
|
Length = 274 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 19/62 (30%), Positives = 25/62 (40%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P P P P PP + PP S +P + P P + P +P +S PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 102 SP 103
SP
Sbjct: 202 SP 203
|
Length = 274 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 19/53 (35%), Positives = 24/53 (45%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
+PPPP S PPPPP ++ SPPP + PP P A + T
Sbjct: 54 TVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPAENT 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 20/70 (28%), Positives = 27/70 (38%), Gaps = 1/70 (1%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
+S P + + PP PPAS+ PPPP + PPP P P P
Sbjct: 45 ASIPGLEDVTVQTTPP-PPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPA 103
Query: 136 ANSPPPSNPP 145
N+ + P
Sbjct: 104 ENTVTVAKDP 113
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 24/168 (14%), Positives = 44/168 (26%), Gaps = 13/168 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP-------PPPVSKPPTTSP 53
+ A P A P V + P V P+ P ++ P T P
Sbjct: 869 VVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVVVETTHPEVIAAPVTEQP 928
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ + P ++ ++ + P ++ P
Sbjct: 929 QVITESDVAVAQEVAEHAEPVVEPQDETADIEEAAETAEVVVAEPEVVAQPAAPVVAEVA 988
Query: 114 SPPPPSSTPPPNSPPSPPSDPP-----ANSPPPSNP-PSNLPPPPPSS 155
+ + P P+ + A +P P P +P P S
Sbjct: 989 AEVETVTAVEPEVAPAQVPEATVEHNHATAPMTRAPAPEYVPEAPRHS 1036
|
Length = 1068 |
| >gnl|CDD|237019 PRK11907, PRK11907, bifunctional 2',3'-cyclic nucleotide 2'-phosphodiesterase/3'-nucleotidase precursor protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 13/90 (14%), Positives = 25/90 (27%), Gaps = 4/90 (4%)
Query: 38 SSPPPPPVSKPPTTSPPPSPP--ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
++ P + P+ A S + P A+ +P S A
Sbjct: 19 TASNPKLAQAEEIVTTTPATSTEAEQTTPVESDATEEADNTETPVAATTAAEAPSSSETA 78
Query: 96 SSPPTISPPPPVSNPPTRSPPPP--SSTPP 123
+ S + R+ P ++ P
Sbjct: 79 ETSDPTSEATDTTTSEARTVTPAATETSKP 108
|
Length = 814 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+P T PP P ++ P+P +PP S P P + P P++ PPP+ PP PP
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPP-APAAAVPAPAAAPPPSDPPQPP 138
Query: 132 SDP 134
P
Sbjct: 139 RAP 141
|
Length = 141 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 38/165 (23%), Positives = 51/165 (30%), Gaps = 11/165 (6%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+P S + SP SP SS +SP P V + P + S
Sbjct: 55 RQTPRQSRRSKRAAHAYPSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRR--RSSS 112
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P D P P S+ S P+ PP+ P P++S A A
Sbjct: 113 PSDDEDEAERPSKRPRSD---------SISSSSSPAKPPEACLPSPAASTQDELSEASAA 163
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P+ PP T S R + P P + S P
Sbjct: 164 PLPTPSLSPPHTPTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQ 208
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 21/103 (20%), Positives = 32/103 (31%), Gaps = 10/103 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVS-NPPKSSPPPPPVSKPPTTS------- 52
A PG P P + P ++ PV ++ P +P
Sbjct: 652 GEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRAPQAPRPGGPPGGGGGLP 711
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
PPP PA+ P +S + + PP PP +
Sbjct: 712 PPPDLPAAAGPAPC--GSSLIASPTAPPEPEPPGAEQADGAEN 752
|
Length = 753 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 10/75 (13%), Positives = 20/75 (26%), Gaps = 7/75 (9%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
G P +P P + + P + P ++ P + + P +
Sbjct: 394 PGGGGGGPPGGGGAPGAPAAAAAPGAAAA----APAAGGPAAALAAVPDAAAAAAAPPAP 449
Query: 62 PPTSSSPPASSPPTS 76
P + S
Sbjct: 450 AAA---PQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 16/101 (15%), Positives = 33/101 (32%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P++ + P + + T + + T + PA+ P
Sbjct: 317 TPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGTVALPAAEPVNMQP 376
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P S+ T + T++ P + ++P + P P S
Sbjct: 377 QPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 47/230 (20%), Positives = 68/230 (29%), Gaps = 9/230 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP--A 59
S P P+ S P P P + PP+S PP + P S
Sbjct: 448 STPERPGPSDQPSVPVEPAHLTPVEHTTVILHQPPQS-PPTVAIKPAPPPSRRRRGACVV 506
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ + P S PP +P R PP
Sbjct: 507 YDDDIIEVIDVETTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRG--PPK 564
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
++PP +PPS + P + P + P PP + + P + PPSS+P
Sbjct: 565 ASPPVMAPPS--TGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAP 622
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+P + T P P S R PS++R
Sbjct: 623 RDMAPSVVRMFLRERLLEQSTG--PKPKSFWEMRAGRDGSGIQQEPSSRR 670
|
Length = 1000 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 14/63 (22%), Positives = 21/63 (33%), Gaps = 1/63 (1%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ P +PP P + P P + P + + P A P P P P S
Sbjct: 14 AEQPAPAPPSPAAAPAPPPPAKT-AAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
Query: 156 VEP 158
+
Sbjct: 73 WKL 75
|
Length = 475 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 14/53 (26%), Positives = 21/53 (39%), Gaps = 4/53 (7%)
Query: 68 PPASSPPTSSPPPASNPPTS-SPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
PA++ P S +N S + P+ A++P PPP P P
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPA---PPPNPPATPPEPPARRG 320
|
Length = 656 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 15/55 (27%), Positives = 20/55 (36%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P + P PS N S S P A + P+ PP+ PP + S
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 30/171 (17%), Positives = 44/171 (25%), Gaps = 11/171 (6%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV 156
P P P + P S + P PP S
Sbjct: 485 QAKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSF 544
Query: 157 EP-PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP-------SNVPPPPTQTPPTPAS 208
+ + P P P P+ + + V P ++ P A
Sbjct: 545 ANVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILAL 604
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSP---PPGIPVPSTENTPGNGTNPSSPES 256
A P+ + + P PS+ S PP P NPS +S
Sbjct: 605 RDAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQS 655
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP-PTSSPPPSPPASSPPT 100
PP ++ PP + P P P A P P PT P P P ++ P
Sbjct: 9 PPGLAGLVANVPPAAAPTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMTPH 68
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
+ P P P ++ P P PP+ P
Sbjct: 69 VVQQAPAQPAPAAPPAAGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 19/77 (24%), Positives = 26/77 (33%), Gaps = 5/77 (6%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP---PPSSTP 122
+PPA +P + S P ++ P P +P R PP P S
Sbjct: 353 VAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAPEPARSAE 412
Query: 123 PPNSPPSPPSDPPANSP 139
P P P+ PA
Sbjct: 413 AP--PLVAPAAAPAGLA 427
|
Length = 504 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 30/210 (14%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP------ 118
+ +P P A P +P P+P A +P +P S T P
Sbjct: 80 GEAGSEPAPAAPEPEAAPEPEAPAPAPTPAAEAPAPAAPQAGGSGEATEVKMPELGESVT 139
Query: 119 -----------SSTPPPNSPPSPPSDPPANSPPPSNPPSNL---PPPPPSSVE------- 157
T + P S ++ PS L P +VE
Sbjct: 140 EGTVTSWLKAVGDTVEVDEPLLEVSTDKVDTEIPSPVAGTLLEIRAPEDDTVEVGTVLAI 199
Query: 158 -PPKRSPPSVPPQNPPPPPSSSPPKNSP-PAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
+ P+ P + P PS + + +P PA A + PP P P A+P A P
Sbjct: 200 IGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPV 259
Query: 216 NSSPNSP-PPPSTKRLSPPPGIPVPSTENT 244
+S + P P ++L+ G+ + + + T
Sbjct: 260 SSGDSGPYVTPLVRKLAKDKGVDLSTVKGT 289
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 29/77 (37%), Positives = 36/77 (46%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P PP P PPPP + PP + P P S P +S P +SPP + P +S+PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 88 SPPPSPPASSPPTISPP 104
SP SP PP
Sbjct: 202 SPMAGTFYRSPAPGEPP 218
|
Length = 274 |
| >gnl|CDD|215621 PLN03188, PLN03188, kinesin-12 family protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 27/86 (31%), Positives = 35/86 (40%), Gaps = 16/86 (18%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS----PPPASNPPTSSPPPSPPAS 96
P + + ++ SP NP + S P+S SS PPP N TS P ++
Sbjct: 7 PRNAILRETSSGEEQSP---NPSSHKSKPSSRKLKSSKENAPPPDLNSLTSDLKPDHRSA 63
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTP 122
S SP PP PPSS P
Sbjct: 64 SAKLKSPLPP---------RPPSSNP 80
|
Length = 1320 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 13/53 (24%), Positives = 17/53 (32%), Gaps = 3/53 (5%)
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P +T P P PP P PP P P P + +P +
Sbjct: 260 LPRATRLPEPEPQPP---PPPPPPEPPEPEEEPDEPDQTDPDDGEETDQIPEE 309
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|234383 TIGR03895, protease_PatA, cyanobactin maturation protease, PatA/PatG family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 6/92 (6%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
S A+ S+ I P + +P PV+ P + P + A
Sbjct: 237 TSEQDGVEEASGCGVQGTIESSTSVIPPGRA----AEPAPVSIPVAAPGEGATPAA--AQ 290
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
++ P + P + PASN T S PS
Sbjct: 291 IELSAGVLPNAISPATPVRPASNGVTPSQAPS 322
|
This model describes a protease domain associated with the maturation of various members of the cyanobactin family of ribosomally produced, heavily modified bioactive metabolites. Members include the PatA protein and C-terminal domain of the PatG protein of Prochloron didemni, TenA and a region of TenG from Nostoc spongiaeforme var. tenue, etc. Length = 602 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.24 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 99.03 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.64 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.35 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 98.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 98.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 98.17 | |
| PLN02236 | 344 | choline kinase | 98.09 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 98.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 98.05 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 98.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 98.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.93 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.9 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.8 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.78 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.6 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 97.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.45 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 97.41 | |
| PTZ00296 | 442 | choline kinase; Provisional | 97.36 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=406.64 Aligned_cols=232 Identities=66% Similarity=1.092 Sum_probs=202.9
Q ss_pred CCCCccHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEE
Q 007351 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432 (607)
Q Consensus 353 s~~~~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 432 (607)
....|.++++.+++++|...++||+|+||.||+|.+.+|..||||++.....+..++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34468999999999999999999999999999999999999999988754433256699999999999999999999999
Q ss_pred EeCCc-eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 433 ISDDR-RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 433 ~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
.+++. .+||||||.+|+|.++|+......++|..|++|+.++|+||+|||+.+.+.|||||||+.|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 99994 99999999999999999986543689999999999999999999999888899999999999999999999999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
||+++..............||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+.........+.+|+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999765431222221117999999999999999999999999999999999999988876545555677775
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=386.43 Aligned_cols=198 Identities=32% Similarity=0.508 Sum_probs=180.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.+|...+.||+|+||.||+|+++ ++..||||.+..+ ..+..+.+..|+++|+.|+|+|||+|+++++.++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45777888999999999999965 6899999999766 44555678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC------CcEEEEecccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN------FEAQVSDFGLAKL 517 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~------~~vkL~DFGls~~ 517 (607)
||.+|+|.++++.+++ +.+...+.++.||+.||++||++ +|||||||++||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998875 99999999999999999999999 99999999999999754 4689999999998
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
... ..+....+|+..|||||+++...|+.|+|+||+|++||||++|+.||+.
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 763 3445667899999999999999999999999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=414.71 Aligned_cols=234 Identities=27% Similarity=0.500 Sum_probs=202.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
+.+.+..+.||+|+||+||+|+.. +...||||.+|.++.. .+.+|+||+++|..|+|+|||+|+|+|.+++-.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345666789999999999999853 3456999999987766 678999999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC--------CC----CCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 439 LLIYDYVPNNTLYFHLHGEG--------RP----VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
+||+|||..|||.++|+.+. .. .+...+.+.||.|||.||+||-++ .+|||||..|||||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999996532 12 278889999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccccCCccee-eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 007351 507 AQVSDFGLAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~ 584 (607)
|||+||||+|.....+++.. .+-+...|||+||.|+.++|++++|||||||+|||+|+ |+.||.+. ++++.++.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl---Sn~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL---SNQEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc---chHHHHHHH
Confidence 99999999998776665543 35667889999999999999999999999999999998 99999874 466666655
Q ss_pred hHhh--------HHHHHHHHHHhhhcCCC
Q 007351 585 NLID--------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~~~--------~~~~~~i~~~C~~~~~~ 605 (607)
+... -..+..|..+||+..++
T Consensus 719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred HcCCcccCCCCCCHHHHHHHHHHhhcCcc
Confidence 5433 37889999999988764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=389.74 Aligned_cols=229 Identities=36% Similarity=0.585 Sum_probs=192.1
Q ss_pred CcccceecccCcEEEEEEEeCCCcE-EEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCC-ceEEEEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYDY 444 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~-VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~Ey 444 (607)
+...+.||+|+||+||+|.+ .|+. ||||++...... ..++|.+|+.+|.+|+|+|||+|+|+|.+.. ..+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 44556699999999999999 5555 999999754322 2568999999999999999999999999887 79999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-EEecCCCCCCEEEcCCC-cEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~~~ 522 (607)
+.+|+|+.+|+......+++..+++|+.||++||+|||++ + |||||||++||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999885455699999999999999999999998 7 99999999999999997 99999999998765432
Q ss_pred cceeeccccCCCCCchhhhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--hHh-------hHHH
Q 007351 523 THITTRVMGTFGYMAPEYAS--SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV--NLI-------DAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~--~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~--~~~-------~~~~ 591 (607)
...+...||..|||||++. ...|+.|+|||||||+||||+||+.||.+... ......+ +.. ....
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp~~p~~~~~~ 274 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRPPIPKECPPH 274 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCCCCccCCHH
Confidence 2233367999999999999 56999999999999999999999999987543 1111111 111 2477
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+..++.+||+.++.
T Consensus 275 l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 275 LSSLMERCWLVDPS 288 (362)
T ss_pred HHHHHHHhCCCCCC
Confidence 88899999998875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=372.86 Aligned_cols=230 Identities=30% Similarity=0.431 Sum_probs=196.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-eEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-RLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~Ey 444 (607)
+++.+++||+|..|.|||++++ +++.+|+|++..+.+ ..++++.+|+++++.++|+|||.+||.|+.++. ..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3556789999999999999986 688899999965433 445789999999999999999999999999995 9999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|++|+|..++...++ +.+..+.+|+++|++||.|||+ + +||||||||.||||+..|.|||||||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999987655 8999999999999999999996 5 9999999999999999999999999999977554
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCCchhHHHHHhH---------hhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ--PLGDESLVEWVNL---------IDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~--~~~~~~l~~~~~~---------~~~~~~ 592 (607)
+...++||..|||||.|.+..|+.++||||||+.|+||++|++||.... ..+.-+++.+.=. .....+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef 311 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF 311 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 4567899999999999999999999999999999999999999997641 1222233332211 123668
Q ss_pred HHHHHHhhhcCCC
Q 007351 593 FKLVFLCQQNSNS 605 (607)
Q Consensus 593 ~~i~~~C~~~~~~ 605 (607)
..++..|+++++.
T Consensus 312 ~~FV~~CL~Kdp~ 324 (364)
T KOG0581|consen 312 RSFVSCCLRKDPS 324 (364)
T ss_pred HHHHHHHhcCCcc
Confidence 9999999998864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=390.21 Aligned_cols=230 Identities=32% Similarity=0.524 Sum_probs=200.3
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++..+.||+|.||.||.|.+++..+||||.++.. ....++|.+|+++|++|+|.|||+|+|+|..++.++||||||..|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456889999999999999977779999999865 344678899999999999999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 528 (607)
+|.++|+..++..+...+++.++.||++||+||+++ ++|||||.++||||++++.|||+||||+|...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999987777899999999999999999999999 99999999999999999999999999999666655555555
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHhh--------HHHHHHHHHHh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLID--------AKILFKLVFLC 599 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~~--------~~~~~~i~~~C 599 (607)
..-..+|.|||.+....|+.|+|||||||+||||+| |+.||.+.. ..+.++.+.... -..+.++...|
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 556789999999999999999999999999999998 899987642 334444433222 37788899999
Q ss_pred hhcCCC
Q 007351 600 QQNSNS 605 (607)
Q Consensus 600 ~~~~~~ 605 (607)
|+.++.
T Consensus 441 W~~~P~ 446 (468)
T KOG0197|consen 441 WHEDPE 446 (468)
T ss_pred hhCCcc
Confidence 988764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=366.00 Aligned_cols=202 Identities=34% Similarity=0.525 Sum_probs=181.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|+++++||+|+||+||.++.+ +++.+|+|+|+.+.. .+.+..++|..||.+++|++||+|+..|++++.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357999999999999999999854 688999999975432 3345688999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
+||+.||.|+.+|++++. +.+...+.++..|+.||.|||++ +|||||||++|||||++|+|+|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999998876 88898999999999999999999 9999999999999999999999999999865544
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.. ....++||..|||||++++..|+..+|+|||||+||||++|..||.+.+
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 33 3445799999999999999999999999999999999999999998653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=372.90 Aligned_cols=232 Identities=30% Similarity=0.495 Sum_probs=198.0
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhH-HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+..+.+++.||+|.||.|.+|+..++.+||||+++..+.... ++|.+|+++|.+|+|+||++|+|+|..++.++||+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 356778899999999999999997789999999997766655 7899999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC-c
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN-T 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~-~ 523 (607)
|++|+|..+|..+....++....++|+.||+.||+||.+. ++|||||.++|||+|.++++||+|||++|.+...+ .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999887665567777889999999999999998 99999999999999999999999999999655443 4
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCCchhHHHHHhH-h-------------
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLGDESLVEWVNL-I------------- 587 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt--g~~Pf~~~~~~~~~~l~~~~~~-~------------- 587 (607)
+.+++.+...+|||.|.|+.++|+.++|||+||++|||+++ .+.||... .++..++-.-. +
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcceeccCCC
Confidence 46778889999999999999999999999999999999875 77788653 23322221111 1
Q ss_pred -hHHHHHHHHHHhhhcC
Q 007351 588 -DAKILFKLVFLCQQNS 603 (607)
Q Consensus 588 -~~~~~~~i~~~C~~~~ 603 (607)
....+.++++.||+-+
T Consensus 771 ~cp~~lyelml~Cw~~e 787 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRE 787 (807)
T ss_pred cCcHHHHHHHHHHhchh
Confidence 1245569999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.87 Aligned_cols=200 Identities=26% Similarity=0.431 Sum_probs=181.6
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.+|+++++||+|+|+.||+++. +.|+.||+|++..+ .....+.+.+||+|.+.|+|+|||+|++||++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 78999999999643 3344567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|+|.+++|.++++.+ ..+.+.+++.+++||+.||.|||++ +|+|||||..||||+++.+|||+|||||.......
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999998843 4599999999999999999999999 99999999999999999999999999998776443
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. .....+||..|+|||++....+...+||||+||+||-||.|+.||+..
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 3 344578999999999999999999999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=384.79 Aligned_cols=232 Identities=28% Similarity=0.470 Sum_probs=196.8
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
..+++.++||.|.||.||+|+++ ....||||.||.... +++++|+.|..||.+++|+||++|.|+....+-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 35678899999999999999986 345799999997654 4556899999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
.|||++|.|+.+|+.++.+ |.+.++..++++|+.||.||-+. ++|||||..+||||+.+..+||+||||+|.+.++
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999988765 99999999999999999999999 9999999999999999999999999999987655
Q ss_pred Ccceeec--cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NTHITTR--VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~~~~~~--~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.....+. ..-..+|.|||.|..++|+..+|||||||+|||.|+ |..||++.. +.+.++-+... .-.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---NQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---hHHHHHHHHhccCCCCCCCCcH
Confidence 4222221 223569999999999999999999999999999886 999998643 33333322221 137
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+|.++||+++.+
T Consensus 862 aL~qLMldCWqkdR~ 876 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRN 876 (996)
T ss_pred HHHHHHHHHHHHHhh
Confidence 889999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=344.23 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=177.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh--HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
+.|+.+..+|+|+||.||||+.+ +|+.||||++....... .+-.+|||++|++|+|+|+|+|+.+|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46777889999999999999976 69999999997544322 2447899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||+..-|.++-+... .++.+.+.++++|+++|+.|+|++ +|||||||++||||+.+|.+||||||+||.... ..
T Consensus 82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 999887766655443 489999999999999999999999 999999999999999999999999999998765 34
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
...+.++.|+.|+|||++.+ ..|+..+||||+||++.||++|..-|.+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 45677889999999999998 689999999999999999999999998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=362.26 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=178.3
Q ss_pred CCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 441 (607)
+.|++++.||+|.||.|||++ +.+|+.||+|+++....+. .....|||.||++|+|+||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778899999999999998 4589999999998776443 35678999999999999999999998877 688999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||++ ||.-++...+ ..|...++..+++||+.||+|||.+ +|+|||||..|||||++|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999975 5666665533 3589999999999999999999999 9999999999999999999999999999988777
Q ss_pred CcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....+..|-|+.|++||+|+|. .|+..+|+||.||||.||+.|+..|.+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 66667778899999999999985 6999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.70 Aligned_cols=229 Identities=31% Similarity=0.507 Sum_probs=186.3
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHH--ccCCCceeEEeEEEeCC----ceEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD----RRLLIY 442 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~lV~ 442 (607)
.++.++||+|.||.||||.+ +++.||||++.. ++...|++|-+|++. ++|+||++|+++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 45668899999999999999 679999998863 456679999999986 57999999999877655 789999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc------CCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
||.+.|+|.++|..+. ++|....+|+.-|++||+|||+. +++.|+|||||++||||.+|+++.|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999998764 89999999999999999999965 47899999999999999999999999999998
Q ss_pred ccccCCcc-eeeccccCCCCCchhhhcCCCCC------chhhHHHHHHHHHHHHcCCCCCC-CC-C--------CCCc--
Q 007351 517 LALDANTH-ITTRVMGTFGYMAPEYASSGKLT------EKSDVFSFGVVLLELITGRKPVD-AS-Q--------PLGD-- 577 (607)
Q Consensus 517 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~------~~~DVwSlGvll~ELltg~~Pf~-~~-~--------~~~~-- 577 (607)
++...... -....+||.+|||||+|.+.... .+.||||+|+|||||+++..-++ +. . .+..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 76533221 12337899999999999875432 36899999999999999755442 10 0 0111
Q ss_pred --hh--------------HHHHHhHhhHHHHHHHHHHhhhcCC
Q 007351 578 --ES--------------LVEWVNLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 578 --~~--------------l~~~~~~~~~~~~~~i~~~C~~~~~ 604 (607)
++ ...|.+....+.+.+.+.+|||+|+
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDa 487 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDA 487 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCch
Confidence 11 1126666667899999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=345.25 Aligned_cols=230 Identities=26% Similarity=0.413 Sum_probs=191.4
Q ss_pred CCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeE-EEeCC-ceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGY-CISDD-RRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~-~~~~~-~~~lV 441 (607)
.+|++++.||+|.||.|||+. +.+|+.||.|.++.+.. +..+++..|+.+|++|+|+|||+++++ +.++. ..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999998 45899999999985433 344579999999999999999999993 43444 48999
Q ss_pred EEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
||||++|+|..+++. ..++.+.+..+++++.|++.||.++|.+. ++ |+|||||+.||+|+.+|.+||+||||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999877753 34556999999999999999999999832 24 99999999999999999999999999998
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------- 587 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------- 587 (607)
+.... ......+||.+||+||+|.+..|+.|+||||+||+||||+.-+.||.+. +++++.+.+
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCCCCCcH
Confidence 76543 3455689999999999999999999999999999999999999999874 444433322
Q ss_pred --hHHHHHHHHHHhhhcCC
Q 007351 588 --DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 --~~~~~~~i~~~C~~~~~ 604 (607)
....+..|+.-|++.+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~ 269 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDP 269 (375)
T ss_pred HHhhhHHHHHHHHHccCCc
Confidence 23567788888887654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=356.10 Aligned_cols=236 Identities=30% Similarity=0.529 Sum_probs=190.3
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
+.....+.+.+++.||+|.||+||+|+|. .+||||+++...-. ..+.|++|+.+|++-+|.||+-|+|||.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33334456778899999999999999984 47999999876543 44679999999999999999999999998777
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
.||..||+|.+|+.+||..+ ..|+....+.|++||++||.|||.+ +|||||||..||+|++|+.|||.||||+...
T Consensus 463 AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999999866 3589999999999999999999999 9999999999999999999999999998643
Q ss_pred cc-CCcceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------CCchhH---HHHHh
Q 007351 519 LD-ANTHITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQP------LGDESL---VEWVN 585 (607)
Q Consensus 519 ~~-~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~------~~~~~l---~~~~~ 585 (607)
.. ........-.|...|||||+++. ..|+.++|||||||++|||++|.+||..... ++.+.+ .-..+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 21 11222233457889999999975 4688899999999999999999999984321 111111 11222
Q ss_pred HhhHHHHHHHHHHhhhcC
Q 007351 586 LIDAKILFKLVFLCQQNS 603 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~ 603 (607)
....+.+++|+.+||.-+
T Consensus 619 s~~pk~mk~Ll~~C~~~~ 636 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFD 636 (678)
T ss_pred ccCHHHHHHHHHHHHhcC
Confidence 333568899999999654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.37 Aligned_cols=232 Identities=30% Similarity=0.469 Sum_probs=189.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHH--ccCCCceeEEeEEEeCC----ceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD----RRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~ 439 (607)
..++.+.+.||+|.||.||+|+| .|+.||||++. .++++.+.+|.+|++. |+|.||+.|++.-..+. .+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35688889999999999999999 89999999886 3567889999999986 59999999998755443 568
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
||.+|.+.|+|+++|..+ .++.+..++++.-+|.||+|||.. +++.|.|||||++||||.+++.+.|+||||
T Consensus 286 LvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999874 489999999999999999999953 688999999999999999999999999999
Q ss_pred ccccccCCcc---eeeccccCCCCCchhhhcCCCC------CchhhHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 007351 515 AKLALDANTH---ITTRVMGTFGYMAPEYASSGKL------TEKSDVFSFGVVLLELITG----------RKPVDASQPL 575 (607)
Q Consensus 515 s~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~------~~~~DVwSlGvll~ELltg----------~~Pf~~~~~~ 575 (607)
|......... .....+||.+|||||+|.+... -..+||||||++|||+..+ +.||.+....
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9866544222 2345689999999999976432 2468999999999999862 5677654332
Q ss_pred CchhHHH-----------------HHhHhhHHHHHHHHHHhhhcCCC
Q 007351 576 GDESLVE-----------------WVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 576 ~~~~l~~-----------------~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
|-..++ |.+.-....+.+|..+||.++++
T Consensus 443 -DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 443 -DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred -CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 222223 55555568889999999988764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.25 Aligned_cols=200 Identities=30% Similarity=0.494 Sum_probs=173.0
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 437 (607)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++..... ......++|+++|++|+|+|||+++++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688889999999999999984 5899999999963211 123446899999999999999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEeccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGL 514 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGl 514 (607)
.||||||++||+|++++-.++. +.+..-..+++||+.||.|||++ ||+||||||+||||..+ ..+||.|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999987765 66666688999999999999999 99999999999999655 7899999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|+...+ ...+..++||..|.|||+|.++. +..++|||||||+||-+|+|..||.+.
T Consensus 326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 998753 34456688999999999998654 345889999999999999999999765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=388.03 Aligned_cols=234 Identities=29% Similarity=0.507 Sum_probs=197.1
Q ss_pred hCCCcccceecccCcEEEEEEEeCC--Cc----EEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD--GR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~--g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.+..+..+.||+|+||.||+|++.+ |. .||||.++... .+++.+|++|..+|++++|+|||+|+|+|...+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456778999999999999999753 33 49999997654 44567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 439 LLIYDYVPNNTLYFHLHGEG-----RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
+|++|||++|+|..+|++.+ ...+...+++.|+.|||+||+||+++ ++|||||..+||||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998751 23588899999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeecc-ccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHH-HHhHhh--
Q 007351 514 LAKLALDANTHITTRV-MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE-WVNLID-- 588 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~-~~~~~~-- 588 (607)
|||.+.+.+.+..... +...+||+||.++.+.|+.|+|||||||+|||||+ |..||.+.. +.++.. |.+-.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVLLDVLEGGRLD 924 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHHHHHHhCCccC
Confidence 9997766665544433 56679999999999999999999999999999998 999998653 233333 333222
Q ss_pred -----HHHHHHHHHHhhhcCCC
Q 007351 589 -----AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 -----~~~~~~i~~~C~~~~~~ 605 (607)
-+.+.+++..||++++.
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe 946 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPE 946 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChh
Confidence 36667999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=361.93 Aligned_cols=231 Identities=24% Similarity=0.393 Sum_probs=199.4
Q ss_pred CCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
..|...+.||+|+.|.||.++ ..+++.||||++.......++.+.+|+.+|+.++|+|||++++.|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 568888999999999999998 4578999999998877777788999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|++||+|||||..+..... .
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999887643 89999999999999999999999 999999999999999999999999999987765433 5
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-------HhHhhHHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-------VNLIDAKILFKLVFL 598 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-------~~~~~~~~~~~i~~~ 598 (607)
+...+||..|||||++..+.|+.|+|||||||+++||+-|+.||-.++.+-..-|..- ........+++++.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 6678999999999999999999999999999999999999999986544322111110 001123678899999
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++-+.
T Consensus 506 cL~~dv 511 (550)
T KOG0578|consen 506 CLVVDV 511 (550)
T ss_pred Hhhcch
Confidence 997653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=356.81 Aligned_cols=198 Identities=33% Similarity=0.534 Sum_probs=181.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.... .++.+.+++|++|++.|+|+|||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 67899999885332 2344668999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.| +|+.+|...+. +.++.++.|+.|++.||.|||++ +|+|||+|++||||+.+|.+||||||+++.+.. +.
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9977 99999988776 99999999999999999999999 999999999999999999999999999997654 55
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.+..+..||..|||||++.+..|+..+|+||||||+|||+.|+.||..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 677788999999999999999999999999999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=351.94 Aligned_cols=231 Identities=26% Similarity=0.389 Sum_probs=193.7
Q ss_pred HhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
+..++|..+++||+|+|++||+|+. +.++++|||++..+.. +....+.+|-++|.+| +|+.|++|+.-|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3447899999999999999999985 4789999999864322 2234578899999999 799999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
|+|+||+++|+|..+++..+. |++...+.++.+|+.||+|||++ ||||||||++|||||+||++||.|||.++.+
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998876 89999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcc------------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH
Q 007351 519 LDANTH------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 519 ~~~~~~------------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~ 586 (607)
...... ....+|||-.|.+||+|..+..+..+|||+|||+||+|+.|+.||.+. .+++-+.++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-----NeyliFqkI 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-----NEYLIFQKI 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-----cHHHHHHHH
Confidence 432211 124489999999999999999999999999999999999999999864 333333333
Q ss_pred hh---------HHHHHHHHHHhhhcCC
Q 007351 587 ID---------AKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ~~---------~~~~~~i~~~C~~~~~ 604 (607)
++ .....+|+.+.+..++
T Consensus 300 ~~l~y~fp~~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 300 QALDYEFPEGFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHhcccCCCCCCHHHHHHHHHHHccCc
Confidence 33 2556666666665443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.29 Aligned_cols=218 Identities=28% Similarity=0.474 Sum_probs=185.0
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCc
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNT 449 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 449 (607)
..++.||.|+-|.||+|++ .++.||||+++ +.-..+|+.|++|+|+||+.|.|+|...-.+|||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3468899999999999999 78999999775 223457899999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeecc
Q 007351 450 LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529 (607)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~ 529 (607)
|+.+|+.... +.-..++.|.++||.||+|||.+ +|||||||.-||||..+..|||+|||-++...+.. ....+
T Consensus 199 L~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSF 271 (904)
T KOG4721|consen 199 LYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSF 271 (904)
T ss_pred HHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhhh
Confidence 9999987654 78888899999999999999999 99999999999999999999999999999877653 34457
Q ss_pred ccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-----hhHHHH-HhHhhHHHHHHHHHHhhhc
Q 007351 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-----ESLVEW-VNLIDAKILFKLVFLCQQN 602 (607)
Q Consensus 530 ~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-----~~l~~~-~~~~~~~~~~~i~~~C~~~ 602 (607)
.||..|||||+|++....+|+|||||||||||||||..||.+.+.... .+.+.+ +-...-+.++-|+..||+.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999999987543211 122221 2222346667788888854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=341.69 Aligned_cols=237 Identities=25% Similarity=0.385 Sum_probs=200.2
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhH-HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.++||.|..+.||+|+. ..++.||||++..+..+.. ..+++|+..|+.++|+||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999995 4689999999987655544 779999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|++.++++..-...|++..+..|++++++||.|||++ |.||||||+.||||+++|.|||+|||.+-.+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999887677799999999999999999999999 999999999999999999999999999876665544
Q ss_pred cee---eccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--------------chhHHHHH
Q 007351 524 HIT---TRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLG--------------DESLVEWV 584 (607)
Q Consensus 524 ~~~---~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~--------------~~~l~~~~ 584 (607)
+.. ..++|+..|||||+++. .-|+.|+|||||||+.+||.+|+.||.....+. ...+.+-.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 333 44689999999999765 358999999999999999999999997654221 00011111
Q ss_pred hHhhHHHHHHHHHHhhhcCCC
Q 007351 585 NLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~~~~~~~~~i~~~C~~~~~~ 605 (607)
+....+..++++..|+++|++
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~ 282 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPS 282 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcc
Confidence 222335778999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.42 Aligned_cols=199 Identities=30% Similarity=0.444 Sum_probs=180.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|+..+.||.|+||+|.+++.+ +|..+|+|+++.... ++.+...+|..+|+.+.|+++++|++-|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999965 688999999975432 33445788999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.||.|+.+|++.++ +++...+.++.||+.||+|||.+ +|++||||++|||||.+|.+||+|||++++..+.
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999998776 89999999999999999999999 9999999999999999999999999999976543
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~ 574 (607)
....+||..|+|||++..+.|+..+|+|+|||++|||+.|..||.+...
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 4457899999999999999999999999999999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.85 Aligned_cols=201 Identities=30% Similarity=0.480 Sum_probs=177.6
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecC----Cc-hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG----GG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~----~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 438 (607)
..+|.+++.||+|.||+|++|.. .+|+.||||++..+ .. ...+.+.+|+.+|+.++ |+||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45799999999999999999975 47899999977543 12 23456778999999999 99999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKL 517 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~ 517 (607)
+||||||.+|+|++++.+.++ +.+.+..++++||+.|++|||++ +|+|||||++|||++.+ +++||+|||++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999988554 88899999999999999999999 99999999999999999 9999999999987
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGK-LT-EKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~-~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.. .........+|+..|+|||+|.+.. |+ .++||||+||+||-|++|+.||++.
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 63 2223445678999999999999977 86 6899999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=342.20 Aligned_cols=230 Identities=29% Similarity=0.464 Sum_probs=189.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 443 (607)
.+|..++.||+|.||.||++... +|+..|||.+...+....+.+.+|+++|++|+|+|||+++|.....+ .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45778899999999999999975 48999999998765444667999999999999999999999855544 5889999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEeccccccccc--
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALD-- 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~~~-- 520 (607)
|+.+|+|.+++.+.+. .+.+..++++.+||++||+|||++ ||||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998776 699999999999999999999999 9999999999999999 79999999999987653
Q ss_pred CCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----------h
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----------D 588 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----------~ 588 (607)
........+.||..|||||++..+ ....++|||||||++.||+||+.||.+. ......+ .... .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~--~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEAL--LLIGREDSLPEIPDSL 248 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHH--HHHhccCCCCCCCccc
Confidence 222233457899999999999953 3445899999999999999999999864 1111111 1111 1
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
.....+++.+|...++
T Consensus 249 s~~a~~Fl~~C~~~~p 264 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDP 264 (313)
T ss_pred CHHHHHHHHHHhhcCc
Confidence 2467888999987765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.10 Aligned_cols=200 Identities=27% Similarity=0.462 Sum_probs=176.1
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchh--HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|...+.||+|.||.||+|+. ++|+.||||+++..+..+ .....|||+.|+.++|+||+.|+++|-..+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999994 589999999998765443 3467899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||+ .+|...++++.. .+.-.++..++.++++||+|||++ .|+|||||+.|+||+.+|.+||+|||+++.+...+.
T Consensus 82 fm~-tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 678888887654 588888999999999999999999 999999999999999999999999999998876554
Q ss_pred ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. ....+.|+.|+|||+|.|. .|+..+||||.|||+.||+.|..-|.+.
T Consensus 157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 3 3334789999999999874 6899999999999999999988877764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.40 Aligned_cols=231 Identities=24% Similarity=0.332 Sum_probs=191.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|+.++.||+|+||.||+|+-+ +|+.+|+|+|+..... +.+.++.|-.+|...++++||+||..|.+.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 478999999999999999999854 7999999999865433 334578899999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc-
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD- 520 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~- 520 (607)
|||+.||++..+|...+. |.+...+.++.+++.||+.||++ |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999987765 88899999999999999999999 999999999999999999999999999842211
Q ss_pred --------------C---------C-----cce-----------------eeccccCCCCCchhhhcCCCCCchhhHHHH
Q 007351 521 --------------A---------N-----THI-----------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSF 555 (607)
Q Consensus 521 --------------~---------~-----~~~-----------------~~~~~gt~~y~APE~l~~~~~~~~~DVwSl 555 (607)
. . ... ....+||.-|||||+|++..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0 000 012579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhHhh-------HHHHHHHHHHhhh
Q 007351 556 GVVLLELITGRKPVDASQPLGD-ESLVEWVNLID-------AKILFKLVFLCQQ 601 (607)
Q Consensus 556 Gvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~~~-------~~~~~~i~~~C~~ 601 (607)
||||||||.|..||..+..... .+++.|...+. ....++++.+|+.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence 9999999999999987654432 25556665443 2444555555554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=358.27 Aligned_cols=200 Identities=31% Similarity=0.479 Sum_probs=177.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 440 (607)
.++|...++||+|+||+|+++.++ +++.+|||+++... .++.+..+.|.+|+...+ |+.+++|+.+|.++++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999976 67899999998654 334456788999998885 9999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.||++..+.+. ..+++..++.++..|+.||+|||++ +|||||||.+|||||.+|.|||+||||++....
T Consensus 447 vmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999994443332 3489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. ......++||..|||||+|.+..|+..+|+|+|||+|||||.|+.||.+.
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred C-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 33567789999999999999999999999999999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.34 Aligned_cols=201 Identities=28% Similarity=0.498 Sum_probs=181.9
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
..+|++.+.||+|.||+|-+++. ..|++||||.++....+ +...+++||+||..|+|+||+++|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35688889999999999999985 58999999999755444 445589999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||..+|.|++|+..++. +.+.+.++|++||..|+.|+|++ +|||||||.+|||||+++++||+||||+..+.+.
T Consensus 132 MEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999987765 99999999999999999999999 9999999999999999999999999999988665
Q ss_pred CcceeeccccCCCCCchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+. ...++|...|.+||++.|..|. ..+|-|||||+||-|+.|.+||++.+
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 43 4558899999999999998885 67999999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=345.63 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=178.0
Q ss_pred hhCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCC-ceEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDD-RRLL 440 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~l 440 (607)
..++|.+.+.||.|.||.||+|+ ..+|+.||||+|+.+-. +++-.-+||++.|++|+ |+||++|.+++.+++ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678999999999999999998 45799999999986543 33344689999999999 999999999999988 8899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||+. +|+++++.+ +..|.+..++.|+.||++||+|||++ |+.|||||++||||.....|||+|||+||....
T Consensus 88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 9999965 588888877 56799999999999999999999999 999999999999999888999999999997754
Q ss_pred CCcceeeccccCCCCCchhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 521 ANTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.. -.+.++.|+.|+|||+|+ ...|+.++|||++|||++||++-+.-|.+..
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 43 356678999999999876 4678999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.78 Aligned_cols=231 Identities=29% Similarity=0.403 Sum_probs=189.1
Q ss_pred CcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
|++.++||+|+||.||+|.+ .+|+.||||++.... ...+..+.+|+++|+.++|+||+.+++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999986 478999999986432 22334678999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+|+|..++.......+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999998887655545689999999999999999999998 99999999999999999999999999998653322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH-------hhHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL-------IDAKILFKLV 596 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~-------~~~~~~~~i~ 596 (607)
......|+..|||||++.+..++.++|||||||+||||++|+.||........ +.+.+.... .....+.+++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 12345689999999999999999999999999999999999999986543211 111111110 1235677888
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 237 ~~~l~~~P 244 (285)
T cd05631 237 RMLLTKNP 244 (285)
T ss_pred HHHhhcCH
Confidence 88987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.65 Aligned_cols=230 Identities=28% Similarity=0.433 Sum_probs=191.5
Q ss_pred CCCcccceecccCcEEEEEEEeCC--C--cE-EEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD--G--RE-VAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~--g--~~-VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
++....+.||+|+||.||+|+++. + .. ||||..+.. ......+|.+|.++|+.|+|+|||+|||++..+.-.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 456677999999999999999753 2 23 899999852 245567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+||||+|.||+|.++|+.... .+...++++++.+.++||+|||++ +++||||..||||++.++.+||+||||++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999988764 589999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceee-ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH---------h
Q 007351 519 LDANTHITT-RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL---------I 587 (607)
Q Consensus 519 ~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~---------~ 587 (607)
.. ..... ......+|+|||.+....|+.++|||||||++||+++ |..||.+.. ..++..|+.. .
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHHhcCccCCCCCC
Confidence 31 11111 2245789999999999999999999999999999999 788998753 2344444411 1
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+..++..||..++.
T Consensus 388 ~p~~~~~~~~~c~~~~p~ 405 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPE 405 (474)
T ss_pred CHHHHHHHHHHhccCChh
Confidence 247778888899977653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.84 Aligned_cols=226 Identities=29% Similarity=0.367 Sum_probs=189.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 68899999987432 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++...+. +.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...+..
T Consensus 98 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999876553 78888899999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i 595 (607)
....|+..|||||++.+..++.++|||||||+||||++|+.||.+... ..+.+... ......+.++
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKILAGRLKFPNWFDGRARDL 245 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCcCCCCCCCHHHHHH
Confidence 234689999999999999999999999999999999999999975421 11111110 0123557789
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 246 i~~~L~~dP 254 (329)
T PTZ00263 246 VKGLLQTDH 254 (329)
T ss_pred HHHHhhcCH
Confidence 999998765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.11 Aligned_cols=233 Identities=26% Similarity=0.386 Sum_probs=184.6
Q ss_pred HHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--------------hHHHHHHHHHHHHHccCCCcee
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------------GEREFKAEVEIISRIHHRHLVS 427 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--------------~~~~~~~Ei~il~~l~HpnIv~ 427 (607)
.+..+.|++++.||+|.||+|.+|+.. +++.||||++..+... ..+.+++||.+|++|+|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999954 7899999999532211 1247899999999999999999
Q ss_pred EEeEEEe--CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC
Q 007351 428 LVGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (607)
Q Consensus 428 l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (607)
|+.+..+ .+..|||+|||..|.+...-. ....+.+.+.++++++++.||+|||.+ ||||||||+.|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9999875 457899999999886643222 222388999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccccC----CcceeeccccCCCCCchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 007351 506 EAQVSDFGLAKLALDA----NTHITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~----~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~ 577 (607)
++||+|||.+...... ......+.+||..|||||++.++. ...+.||||+||+||+|+.|+.||.+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----- 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----- 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-----
Confidence 9999999999865222 222334578999999999988732 245789999999999999999999763
Q ss_pred hhHHHHHhHhh-----------HHHHHHHHHHhhhcCCC
Q 007351 578 ESLVEWVNLID-----------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 578 ~~l~~~~~~~~-----------~~~~~~i~~~C~~~~~~ 605 (607)
..+.-+.++++ ...+++++++.+++++.
T Consensus 323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~ 361 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPE 361 (576)
T ss_pred hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChh
Confidence 22222333322 46778888888887764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.80 Aligned_cols=226 Identities=25% Similarity=0.339 Sum_probs=188.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|... +|+.||||+++... .+..+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.++++..+. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...+..
T Consensus 81 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999999876543 88899999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
....|+..|+|||++.+..++.++|||||||+||||++|+.||.+... ..+.+.... .....+.++
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~l 228 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKILAGKLEFPRHLDLYAKDL 228 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcCCCccCCHHHHHH
Confidence 234689999999999998999999999999999999999999976431 111111110 113467889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 229 i~~~l~~dp 237 (291)
T cd05612 229 IKKLLVVDR 237 (291)
T ss_pred HHHHcCCCH
Confidence 999987764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.52 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=187.7
Q ss_pred CCcccceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++|+.+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 357899999986422 22345678899999999 499999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+|+|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999887654 388999999999999999999998 9999999999999999999999999999865
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHHhH-------hhH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWVNL-------IDA 589 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~~~~~-------~~~ 589 (607)
............|+..|||||++.+.. ++.++|||||||+||||++|+.||.......... +.+.... ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG 235 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 443333334467899999999998754 7889999999999999999999997543222211 1111100 123
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|++.++
T Consensus 236 ~~~~~li~~~l~~dp 250 (332)
T cd05614 236 PEAQDLLHKLLRKDP 250 (332)
T ss_pred HHHHHHHHHHcCCCH
Confidence 567889999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.56 Aligned_cols=235 Identities=27% Similarity=0.444 Sum_probs=185.7
Q ss_pred hCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC-
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD- 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~- 436 (607)
.++|++.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++|+.+ +|+||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35688999999999999999974 1356799999975433 3345689999999999 8999999999887654
Q ss_pred ceEEEEEecCCCchhHhhhcCC----------------------------------------------------------
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEG---------------------------------------------------------- 458 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 458 (607)
..++||||+.+|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999998886532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCC
Q 007351 459 --RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGY 535 (607)
Q Consensus 459 --~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y 535 (607)
...+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12377888899999999999999998 9999999999999999999999999999865432221 12233456789
Q ss_pred CchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhhhcCCC
Q 007351 536 MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 536 ~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~~~~~~ 605 (607)
||||++.+..++.++|||||||+||||++ |+.||.+... +..+.+.... .....+.+++.+||+.++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999997 9999976432 1111111110 1135678999999987753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=340.06 Aligned_cols=223 Identities=26% Similarity=0.377 Sum_probs=184.0
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++||+|+||.||+++.+ +|+.||||+++... ......+++|+++|++++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78899999997432 223356788999999999999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 528 (607)
+|+.++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 9998887654 488999999999999999999999 999999999999999999999999999975432222 2234
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHhhh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLCQQ 601 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C~~ 601 (607)
.+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.+++.+|++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 568999999999999999999999999999999999999997542 1222221111 123567788889987
Q ss_pred cCC
Q 007351 602 NSN 604 (607)
Q Consensus 602 ~~~ 604 (607)
.++
T Consensus 232 ~dP 234 (323)
T cd05571 232 KDP 234 (323)
T ss_pred CCH
Confidence 764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.67 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=172.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhH--HHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 442 (607)
.|++++.|++|.||.||+|+++ +++.||+|+++....... ...+|||.+|.+++|+|||++..+.... +..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4667789999999999999965 788999999986542221 3468999999999999999999987754 4689999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||+. +|..+++... +.|...+...++.|+++||+|||++ .|+|||||++|+|++++|.+||+|||+||.+....
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99964 6888887765 4588889999999999999999999 89999999999999999999999999999876653
Q ss_pred cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
. ..+..+.|+.|+|||+|++. .|++.+||||+|||+.||++++.-|.++.
T Consensus 232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 3 35567789999999999874 69999999999999999999999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.39 Aligned_cols=223 Identities=27% Similarity=0.374 Sum_probs=183.2
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++|+.++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 78999999997432 233456788999999999999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 528 (607)
+|..++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 9998887654 488999999999999999999998 999999999999999999999999999875432221 2233
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhhh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQQ 601 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~~ 601 (607)
..|+..|||||++.+..++.++|||||||+||||++|+.||..... ..+.+... ......+.+++.+|++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 5689999999999999999999999999999999999999975421 11111111 0113566788888887
Q ss_pred cCC
Q 007351 602 NSN 604 (607)
Q Consensus 602 ~~~ 604 (607)
.++
T Consensus 232 ~dP 234 (323)
T cd05595 232 KDP 234 (323)
T ss_pred CCH
Confidence 664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.39 Aligned_cols=228 Identities=28% Similarity=0.391 Sum_probs=189.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++|..++|+||+++++++..++..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 58899999997432 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997654 388899999999999999999999 999999999999999999999999999986543
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhHh-----------hHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNLI-----------DAK 590 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~~-----------~~~ 590 (607)
......|+..|||||++.+..++.++|||||||+||||++|+.||.+...... ..+..|...+ ...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 22345689999999999999999999999999999999999999976432111 1112222111 135
Q ss_pred HHHHHHHHhhhcC
Q 007351 591 ILFKLVFLCQQNS 603 (607)
Q Consensus 591 ~~~~i~~~C~~~~ 603 (607)
.+.+++.+|++..
T Consensus 232 ~~~~li~~~l~~~ 244 (333)
T cd05600 232 EAWDLITKLINDP 244 (333)
T ss_pred HHHHHHHHHhhCh
Confidence 6778888898654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.96 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=174.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+++|++++.+++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 68899999997432 223356888999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999987654 389999999999999999999998 99999999999999999999999999987543211
Q ss_pred c----------------------------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCC
Q 007351 523 T----------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 523 ~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~P 568 (607)
. ......+|+..|||||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 007351 569 VDAS 572 (607)
Q Consensus 569 f~~~ 572 (607)
|.+.
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.32 Aligned_cols=238 Identities=25% Similarity=0.332 Sum_probs=192.2
Q ss_pred hCCCcccceecccCcEEEEEEEeCCC-cEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeE-EE---eC---C
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDG-REVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGY-CI---SD---D 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g-~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~-~~---~~---~ 436 (607)
..++++.++|.+|+|+.||++++..+ .+||+|++...+....+.+++||++|++|+ |+|||.+++. .. .+ .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45688999999999999999998766 999999998887778889999999999997 9999999993 22 11 2
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
+.+|+||||.+|.|.++|..+....|.+.++++|++|+++|+.+||. +++.|||||||.+||||++++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 56899999999999999987666669999999999999999999999 57789999999999999999999999999986
Q ss_pred ccccCCcc--------eeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHH
Q 007351 517 LALDANTH--------ITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWV 584 (607)
Q Consensus 517 ~~~~~~~~--------~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~~~ 584 (607)
.....-.. ......-|..|+|||+|. +..+++|+|||+|||+||-||....||++...+...+ ..++.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P 274 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFP 274 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence 43222110 011235788999999875 5678999999999999999999999999874433221 11221
Q ss_pred h-HhhHHHHHHHHHHhhhcCC
Q 007351 585 N-LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~-~~~~~~~~~i~~~C~~~~~ 604 (607)
. .-....+.+|+..||+.++
T Consensus 275 ~~p~ys~~l~~LI~~mL~~nP 295 (738)
T KOG1989|consen 275 PFPNYSDRLKDLIRTMLQPNP 295 (738)
T ss_pred CCccHHHHHHHHHHHHhccCc
Confidence 1 1234566778888887665
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.15 Aligned_cols=226 Identities=25% Similarity=0.380 Sum_probs=179.4
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
|+..+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++|+.++|+||+++++++..++..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 456688999999999999865 689999999865433 334678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.... .+.+..+.++++||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99886432 256677889999999999999998 999999999999999999999999999986543221 22
Q ss_pred eccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHH
Q 007351 527 TRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILF 593 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~ 593 (607)
...+|+..|+|||++.. ...+.++|||||||+||||++|+.||..........+..... ......+.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 34578999999998753 233468999999999999999999997433221111111111 01135678
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+||+.++
T Consensus 306 ~li~~~l~~~P 316 (353)
T PLN00034 306 HFISCCLQREP 316 (353)
T ss_pred HHHHHHccCCh
Confidence 99999998765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=335.94 Aligned_cols=223 Identities=28% Similarity=0.384 Sum_probs=183.4
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++|+.++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997432 233456889999999999999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 528 (607)
+|..++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9988887654 488999999999999999999998 99999999999999999999999999987543222 12234
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHhhh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLCQQ 601 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C~~ 601 (607)
.+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.+++.+|++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEDIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHhccCCccCCCCCCHHHHHHHHHHcC
Confidence 568999999999999999999999999999999999999997542 1122211110 012456788888887
Q ss_pred cCC
Q 007351 602 NSN 604 (607)
Q Consensus 602 ~~~ 604 (607)
.++
T Consensus 232 ~dP 234 (328)
T cd05593 232 KDP 234 (328)
T ss_pred CCH
Confidence 664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.64 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=172.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +|+.||||++.... ......+++|+++|+.++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999864 78899999986432 223356888999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999987654 378888999999999999999998 99999999999999999999999999996332110
Q ss_pred c----------------------------------------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHH
Q 007351 523 T----------------------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFG 556 (607)
Q Consensus 523 ~----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlG 556 (607)
. ......+|+..|||||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 000124689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 007351 557 VVLLELITGRKPVDAS 572 (607)
Q Consensus 557 vll~ELltg~~Pf~~~ 572 (607)
|+||||++|+.||.+.
T Consensus 236 vil~elltG~~Pf~~~ 251 (377)
T cd05629 236 AIMFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhhhcCCCCCCCC
Confidence 9999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.82 Aligned_cols=227 Identities=24% Similarity=0.307 Sum_probs=185.6
Q ss_pred CCCcccceecccCcEEEEEEEeCC--CcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~--g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.+.||+|+||.||+|.+++ +..||||++.... ......+.+|+++|+.++|+||+++++++..++..+||
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458889999999999999998643 3689999986432 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|..++..... +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999976554 88999999999999999999999 9999999999999999999999999999865322
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------hhHHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------IDAKILFKL 595 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------~~~~~~~~i 595 (607)
.....|+..|||||++.+..++.++|||||||+||||++|+.||.+..... ...+..+. .......++
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHHHhcCCCCCCCCCCHHHHHH
Confidence 223568999999999999889999999999999999999999997643210 00111110 013455677
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.+.
T Consensus 259 i~~~l~~dp 267 (340)
T PTZ00426 259 MKKLLSHDL 267 (340)
T ss_pred HHHHcccCH
Confidence 788877653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=308.62 Aligned_cols=229 Identities=28% Similarity=0.417 Sum_probs=195.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++++.||+|.||.||.|+.+ ++-.||||++.... ...+.++++|++|-..|+|+||+++|+||.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56889999999999999999965 56789999985332 234567999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||..+|.|+..|+......+++.....+++|+|.||.|+|.. +|+|||||++|+|++.++.+||+|||-+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999976666799999999999999999999998 99999999999999999999999999997543
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh-------HHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID-------AKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~-------~~~~~~i 595 (607)
...+...+||+-|++||++.+..++..+|+|++|++.||++.|..||+... ..+..+-.+.++ .+...++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCCcccChhHHHH
Confidence 233555789999999999999999999999999999999999999998754 223332222222 3566788
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|+.+++
T Consensus 253 I~~ll~~~p 261 (281)
T KOG0580|consen 253 ISRLLVKNP 261 (281)
T ss_pred HHHHhccCc
Confidence 888887665
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.82 Aligned_cols=221 Identities=26% Similarity=0.348 Sum_probs=182.2
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||+|+.. +++.||||+++... ......+.+|+++|++++|+||+++++++..++..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 57899999987432 23345688999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
.+++...+. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 999876543 88999999999999999999998 99999999999999999999999999997543322 2233456
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-Hh------HhhHHHHHHHHHHhhhcC
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VN------LIDAKILFKLVFLCQQNS 603 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~------~~~~~~~~~i~~~C~~~~ 603 (607)
|+..|||||++.+..++.++|||||||++|||++|+.||.+.. ...+.+. .+ ......+.+++.+|++.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999999999999999997532 1111111 00 011356778889998766
Q ss_pred C
Q 007351 604 N 604 (607)
Q Consensus 604 ~ 604 (607)
+
T Consensus 232 p 232 (312)
T cd05585 232 P 232 (312)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.89 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=174.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|+.. +|+.||||+++... ......+++|+++|+.++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999965 68899999997432 223356788999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999987654 389999999999999999999999 99999999999999999999999999987542211
Q ss_pred cc-------------------------------------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcC
Q 007351 523 TH-------------------------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565 (607)
Q Consensus 523 ~~-------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg 565 (607)
.. .....+||..|||||++.+..++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124689999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 007351 566 RKPVDAS 572 (607)
Q Consensus 566 ~~Pf~~~ 572 (607)
+.||.+.
T Consensus 236 ~~Pf~~~ 242 (364)
T cd05599 236 YPPFCSD 242 (364)
T ss_pred CCCCCCC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=324.98 Aligned_cols=233 Identities=27% Similarity=0.479 Sum_probs=186.9
Q ss_pred CCCcccceecccCcEEEEEEEeCC-----------------CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-----------------GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSL 428 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-----------------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l 428 (607)
++|++.++||+|+||.||+|.+++ +..||||+++..... ...+|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998532 336999998754333 34579999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEG-----------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (607)
++++..++..+|||||+.+|+|.+++.... ...+.+..+++++.||++||+|||++ +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999998885432 12367788899999999999999998 9999
Q ss_pred cCCCCCCEEEcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 007351 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKP 568 (607)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt--g~~P 568 (607)
||||++||||++++.+||+|||+++....... .......++..|||||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 22334456789999999998899999999999999999986 5677
Q ss_pred CCCCCCCCchhHHHHHhHh---------------hHHHHHHHHHHhhhcCCC
Q 007351 569 VDASQPLGDESLVEWVNLI---------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 569 f~~~~~~~~~~l~~~~~~~---------------~~~~~~~i~~~C~~~~~~ 605 (607)
|.+.. ..+..++.... ....+.+++.+||+.++.
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 76532 22322222111 125678999999987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.70 Aligned_cols=204 Identities=26% Similarity=0.327 Sum_probs=178.1
Q ss_pred CCCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++++.||.|.-|.||++++++ +..+|+|+|...... .....+.|-+||+.++|+.++.||+.++.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356778999999999999999864 588999999654332 2345778999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc--
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-- 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~-- 520 (607)
|||.||+|..+++.+....+.+..++.++..|+.||+|||-. |||+||||++||||.+||+|+|+||+|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999998888899999999999999999999998 999999999999999999999999999742210
Q ss_pred -------------------------------CCc----------------------ceeeccccCCCCCchhhhcCCCCC
Q 007351 521 -------------------------------ANT----------------------HITTRVMGTFGYMAPEYASSGKLT 547 (607)
Q Consensus 521 -------------------------------~~~----------------------~~~~~~~gt~~y~APE~l~~~~~~ 547 (607)
... .....+|||..|+|||+|.|.-.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011236899999999999999999
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 548 EKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 548 ~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
..+|||+|||+|||||.|+.||.+..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999998754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.76 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=174.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 678899999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.++.|..+.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99988776554433 3488899999999999999999998 999999999999999999999999999987643332
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 2233456899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=319.13 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=172.8
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCC-ceeEEeEEEeCC------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRH-LVSLVGYCISDD------ 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~------ 436 (607)
..|...++||+|.||.||+|+. .+|+.||+|+++....+ .-....+|+.+|+.|+|.| ||+|++++..++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466678899999999999995 47899999999876553 2245789999999999999 999999999877
Q ss_pred ceEEEEEecCCCchhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
..+|||||++ -+|..++..... ..++...++.+++||++||+|||++ +|+|||||+.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7789999995 568887776543 3577788999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
|+...- .....+..++|..|+|||+|++. .|....||||+|||+.||++++.-|.+..
T Consensus 167 Ara~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 985542 22235567889999999999986 78999999999999999999999998753
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.05 Aligned_cols=230 Identities=25% Similarity=0.359 Sum_probs=189.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999975 68999999997432 234457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999987763 488999999999999999999998 99999999999999999999999999998654433
Q ss_pred ----------------------------cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 007351 523 ----------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (607)
Q Consensus 523 ----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~ 574 (607)
........|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999976431
Q ss_pred CCc-hhHHHHHhHhh-------HHHHHHHHHHhhh
Q 007351 575 LGD-ESLVEWVNLID-------AKILFKLVFLCQQ 601 (607)
Q Consensus 575 ~~~-~~l~~~~~~~~-------~~~~~~i~~~C~~ 601 (607)
... ..+.+|...+. ...+.+++..|++
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~ 270 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC 270 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence 110 01111111111 4566788888885
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.62 Aligned_cols=200 Identities=27% Similarity=0.343 Sum_probs=172.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.|++++.||+|+||.||+|+.. +++.||||+++... ......+++|+++|++++|+||+++++++.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 67899999997532 2334568999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC-
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~- 522 (607)
|+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999998876543 78888899999999999999998 99999999999999999999999999975321100
Q ss_pred ---------------------------------------------cceeeccccCCCCCchhhhcCCCCCchhhHHHHHH
Q 007351 523 ---------------------------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557 (607)
Q Consensus 523 ---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGv 557 (607)
.......+|+..|||||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012357999999999999989999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 007351 558 VLLELITGRKPVDAS 572 (607)
Q Consensus 558 ll~ELltg~~Pf~~~ 572 (607)
+||||++|+.||...
T Consensus 237 il~elltG~~Pf~~~ 251 (381)
T cd05626 237 ILFEMLVGQPPFLAP 251 (381)
T ss_pred HHHHHHhCCCCCcCC
Confidence 999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.86 Aligned_cols=201 Identities=23% Similarity=0.311 Sum_probs=174.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.++||+|+||.||+++.. +++.||+|+++.. .......+.+|+++++.++|+||+++++++..++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 5789999998632 222345688999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|.+++... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999988654 378888999999999999999998 9999999999999999999999999999866443
Q ss_pred CcceeeccccCCCCCchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~----~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
........+|+..|||||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 33223346799999999998764 3778999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=330.16 Aligned_cols=224 Identities=28% Similarity=0.419 Sum_probs=182.0
Q ss_pred ceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+.||+|+||.||+++. .+++.||||+++... ......+.+|+++|+.++|+||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999987432 22334678899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|++++...+. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999876543 77888889999999999999998 999999999999999999999999999875433222
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh------HhhHHHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN------LIDAKILFKLVFL 598 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~------~~~~~~~~~i~~~ 598 (607)
......|+..|||||++.+..++.++|||||||+||||++|+.||...... ..+.+..+ ......+.+++.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 223356899999999999888999999999999999999999999764211 01111111 0113556788888
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.++
T Consensus 234 ~l~~~p 239 (323)
T cd05584 234 LLKRNP 239 (323)
T ss_pred HcccCH
Confidence 887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.89 Aligned_cols=223 Identities=27% Similarity=0.381 Sum_probs=182.2
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++++.++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78899999997432 233456788999999999999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
+|..++.... .+.+..++.++.||+.||+|||+ + +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9998887654 48999999999999999999997 6 899999999999999999999999999875432222 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C~ 600 (607)
...|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 3568999999999999999999999999999999999999997542 1222222110 12355677888888
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~dP 235 (325)
T cd05594 232 KKDP 235 (325)
T ss_pred hcCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.54 Aligned_cols=199 Identities=29% Similarity=0.418 Sum_probs=175.5
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+++.. +|..||+|+++.... ...+.+.+|+++|++++|+||+++++++..++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999975 678899999876533 334579999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++..... +.+..+.+++.||+.||.|||+.+ +|+|||||++||||++++.+||+|||+++...+..
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999876543 888999999999999999999852 69999999999999999999999999997654322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2345689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.48 Aligned_cols=223 Identities=28% Similarity=0.421 Sum_probs=179.9
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|++. +++.||||+++... ....+.+..|.+++..+ +|+||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57889999997432 22334456677777654 799999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..+++.... +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999988876543 88899999999999999999998 99999999999999999999999999997543322 2233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~ 600 (607)
...|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+-.. ......+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSILNDRPHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 4568999999999999999999999999999999999999997642 111111110 112355678888888
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~~P 235 (316)
T cd05592 232 ERDP 235 (316)
T ss_pred cCCH
Confidence 7764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.81 Aligned_cols=196 Identities=28% Similarity=0.389 Sum_probs=173.9
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-C-----CCceeEEeEEEeCCceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-H-----RHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~~l 440 (607)
+|.+.++||+|.||.|.||... +++.||||++|.+ ....++.+.|+++|..|+ | -|||++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999854 6999999999843 334566778999999997 3 479999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC--CcEEEEeccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN--FEAQVSDFGLAKLA 518 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DFGls~~~ 518 (607)
|+|.+ ..+|+++|+.+....+....++.|+.||+.||.+||+. +|||+||||+||||.+- .+|||||||.+++.
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 46799999999888999999999999999999999998 99999999999999653 47999999999976
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ..+.++.|+|||+|+|..|+.+.||||||||+.||++|..-|.++
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 44322 456788999999999999999999999999999999999888875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.15 Aligned_cols=233 Identities=25% Similarity=0.401 Sum_probs=197.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
..|..+++||+|.||.||||.+. .++.||+|++......+ .+++++|+.+|..++++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45888899999999999999954 68899999998765544 46799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
|.+|++.+.|+.... +++..+..|+++++.||.|||.+ +.+|||||+.||||..+|.+||+|||++.........
T Consensus 93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999976553 57778888999999999999999 9999999999999999999999999999876554433
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH------HHHhHhhHHHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV------EWVNLIDAKILFKLVFL 598 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~------~~~~~~~~~~~~~i~~~ 598 (607)
+..++||..|||||++++..|+.|+|||||||+.+||.+|.-||.+..++.-..++ .+.. .....+++++..
T Consensus 168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEA 245 (467)
T ss_pred -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHH
Confidence 46789999999999999999999999999999999999999999765432111100 1111 234567889999
Q ss_pred hhhcCCCC
Q 007351 599 CQQNSNSI 606 (607)
Q Consensus 599 C~~~~~~~ 606 (607)
|++.+++.
T Consensus 246 CL~k~P~~ 253 (467)
T KOG0201|consen 246 CLDKNPEF 253 (467)
T ss_pred HhhcCccc
Confidence 99988753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=321.52 Aligned_cols=224 Identities=22% Similarity=0.334 Sum_probs=183.8
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCchh---HHHHHHHHHHHHHccCCCceeEEeEEEe----CCceEEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIY 442 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 442 (607)
.....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++|+||++++|++.+ ....++||
T Consensus 23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 3347899999999999999 89999999997543322 3568899999999999999999999877 34678999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.++++.+. .+.+...++++.|++.||.|||+.. +++|||||++|||+++++.+||+|||+++......
T Consensus 102 Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999998754 4889999999999999999999732 78899999999999999999999999998653322
Q ss_pred cceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---------HhhHHH
Q 007351 523 THITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN---------LIDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~---------~~~~~~ 591 (607)
....|+..|||||++.+ ..++.++|||||||++|||++|+.||.+.. ..++.+... ......
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 250 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLKLPLDCPLE 250 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCCCCCcCcHH
Confidence 23457889999999976 688999999999999999999999998643 222222220 012467
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 251 l~~li~~cl~~dp~ 264 (283)
T PHA02988 251 IKCIVEACTSHDSI 264 (283)
T ss_pred HHHHHHHHhcCCcc
Confidence 88999999987764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.90 Aligned_cols=228 Identities=26% Similarity=0.354 Sum_probs=185.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +|++|+++++++..++..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999865 57899999987432 22334567788888877 5889999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++...+. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999988876544 88999999999999999999998 99999999999999999999999999997543222
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
.......|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.++
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMSKEAVAI 231 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 12334568999999999999999999999999999999999999997642 2222221111 123556778
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 232 i~~~l~~~p 240 (323)
T cd05616 232 CKGLMTKHP 240 (323)
T ss_pred HHHHcccCH
Confidence 888887654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.83 Aligned_cols=226 Identities=28% Similarity=0.440 Sum_probs=181.7
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHH---HccCCCceeEEeEEEeCCceEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIIS---RIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~---~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++. .++|+||+++++++..++..+||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999865 68899999997432 222345667766654 56799999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|..+++.. .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998887643 489999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHhH------hhHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVNL------IDAKILFK 594 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~~------~~~~~~~~ 594 (607)
. ......+|+..|||||++.+..++.++|||||||+||||++|+.||.+... .++.+ ..+. .....+.+
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~p~~~~~~~~~ 230 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEVRYPRFLSREAIS 230 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2 223346789999999999999999999999999999999999999976421 11111 1110 11355677
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 231 li~~~L~~dP 240 (324)
T cd05589 231 IMRRLLRRNP 240 (324)
T ss_pred HHHHHhhcCH
Confidence 8888887654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.14 Aligned_cols=228 Identities=26% Similarity=0.361 Sum_probs=184.3
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccC-CCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~ 442 (607)
+|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++..++| .+|+++++++..++..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999865 57789999987432 2334567889999999976 45888999999899999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999988876543 78899999999999999999998 99999999999999999999999999987532222
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ..++.+.... .....+.++
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~l 231 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYPKSLSKEAVSI 231 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 1 2234568999999999999999999999999999999999999997642 1222221110 113456678
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 232 i~~~l~~~P 240 (324)
T cd05587 232 CKGLLTKHP 240 (324)
T ss_pred HHHHhhcCH
Confidence 888887654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=328.39 Aligned_cols=202 Identities=26% Similarity=0.351 Sum_probs=173.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++..++|+||+++++++..++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 68899999986421 223355889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999886532 2478889999999999999999999 99999999999999999999999999997655433
Q ss_pred cceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......+|+..|||||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 333333568999999999873 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=330.01 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=174.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++..++|+||+++++++..++..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 67889999986421 223345888999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999976332 478888999999999999999998 99999999999999999999999999998665443
Q ss_pred cceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
........|+..|||||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 333334568999999999875 46788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.74 Aligned_cols=232 Identities=29% Similarity=0.399 Sum_probs=189.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.|++.++||+|+||.||++... +++.||||+++.... .....+.+|+++|+.++|+||+.+++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 688999999864322 223457889999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+|+|.+++.......+.+..++.++.||++||+|||++ +|+|||||++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888765545689999999999999999999998 999999999999999999999999999976533222
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHhH-------hhHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l~~~~~~-------~~~~~~~~i 595 (607)
.....|+..||+||++.+..++.++|||||||++|||++|+.||.+....... .+.+.... .....+.++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 22346889999999999889999999999999999999999999864321111 11111110 123567889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 236 i~~~l~~~P 244 (285)
T cd05605 236 CRQLLTKDP 244 (285)
T ss_pred HHHHccCCH
Confidence 999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.22 Aligned_cols=231 Identities=23% Similarity=0.391 Sum_probs=188.2
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|.++ .+..||||+++.... .....|.+|+.+|++++|+||+++++++..++..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999863 356899999876533 3345789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|.+++.... ..+.+..+++++.||++||+|||++ +++|||||++||||++++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999887643 2488999999999999999999998 9999999999999999999999999987654322
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKIL 592 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~ 592 (607)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+..... ....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2222222345678999999999999999999999999999875 999997642 22222222111 13678
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+||+.++
T Consensus 238 ~~li~~c~~~~p 249 (266)
T cd05064 238 HQLMLDCWQKER 249 (266)
T ss_pred HHHHHHHcCCCc
Confidence 889999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.45 Aligned_cols=201 Identities=24% Similarity=0.303 Sum_probs=173.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.++||+|+||.||+++.. +++.||||+++... ......+.+|+++|+.++|+||+++++++.+++..+||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 357899999999999999999865 68899999986421 22334578899999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|..+++.. .+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999988654 277888889999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~----~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
........+|+..|||||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 32223345689999999998753 4788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.97 Aligned_cols=231 Identities=26% Similarity=0.462 Sum_probs=190.7
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+++++++..+|||.++.. .....+|.+|+++|++++|+||+++++++..++..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357888999999999999999988889999988633 3345678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|.++++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999998875432 488999999999999999999998 999999999999999999999999999986543322222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~ 597 (607)
....++.+|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..++.. ......+.+++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 22335668999999998889999999999999999999 899997542 222222221 112356789999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+||+.++.
T Consensus 236 ~c~~~~p~ 243 (256)
T cd05114 236 SCWHEKPE 243 (256)
T ss_pred HHccCCcc
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.37 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=200.7
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
++.+-.+.++...+.||.|.||.||.|.|+ -...||||.++.+. ...++|++|..+|+.++|+|+|+|+|+|..+--.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 344444556677789999999999999986 46789999998543 3467899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
|||.|||-+|+|.+||+..++..+.-..++.++.||..||+||..+ ++|||||..+||||.++..|||+||||+|++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999999888888889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH-HhHh----hHHHH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW-VNLI----DAKIL 592 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~-~~~~----~~~~~ 592 (607)
..+.+...........|.|||.|..+.|..|+|||+|||+||||.| |-.||.+.+.-....|+|. .++. .....
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHH
Confidence 7766655555556789999999999999999999999999999998 7788876421111122211 0110 12567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+|...||+=.+
T Consensus 496 YeLMraCW~WsP 507 (1157)
T KOG4278|consen 496 YELMRACWNWSP 507 (1157)
T ss_pred HHHHHHHhcCCc
Confidence 889999997544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.45 Aligned_cols=201 Identities=24% Similarity=0.401 Sum_probs=170.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++|+.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999975 688999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+. ++|.+++.... ..+....++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 996 56766665432 2478888999999999999999999 999999999999999999999999999875432221
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|||||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2233567899999999875 45888999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.51 Aligned_cols=206 Identities=23% Similarity=0.294 Sum_probs=176.4
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 436 (607)
++....++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++|+||+++++++..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33444578999999999999999999975 67899999986322 223445789999999999999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++||||+.+|+|..+++.. .+....++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999988654 278888899999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.............+|+..|||||++.+. .++.++|||||||+||||++|+.||...
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 6644333233446799999999998754 3788999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.05 Aligned_cols=230 Identities=33% Similarity=0.573 Sum_probs=184.9
Q ss_pred cccceecccCcEEEEEEEeC-----CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~-----~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++.+.||+|.||.||+|.+. .+..|+||+++..... ..++|.+|+++|++++|+||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999986 2567999999654333 46789999999999999999999999998888999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+|+|.++|+......+++..+++|+.||++||.|||++ +|+|+||+++||||++++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999987555699999999999999999999998 999999999999999999999999999987632222
Q ss_pred -ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILF 593 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~ 593 (607)
.......+...|+|||++.+..++.++||||||++||||++ |+.+|.+. ...++.+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccceeccchhHHHH
Confidence 22233446778999999998889999999999999999999 78888654 233333322111 136688
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+||+.++.
T Consensus 236 ~li~~C~~~~p~ 247 (259)
T PF07714_consen 236 SLIQQCWSHDPE 247 (259)
T ss_dssp HHHHHHT-SSGG
T ss_pred HHHHHHcCCChh
Confidence 999999987753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.22 Aligned_cols=223 Identities=27% Similarity=0.390 Sum_probs=182.1
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|+||+++++++..++..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57899999987432 23334577899999876 799999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 999988876543 88899999999999999999999 999999999999999999999999999975433222 233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C~ 600 (607)
...|+..|||||++.+..++.++|||||||++|||++|+.||.... ...+.+.... .....+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVLYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 4568999999999999899999999999999999999999997642 2222222111 01356678888888
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~dp 235 (321)
T cd05591 232 TKNP 235 (321)
T ss_pred ccCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=340.77 Aligned_cols=197 Identities=29% Similarity=0.440 Sum_probs=176.4
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
-|++++.||+|+-|.|..|++ .+|+.+|||++....+ .....+.+||-||+.|.|+||++||++++++.++|||+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 377889999999999999985 4899999999964422 223468999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+|.|+++|..++. +.+.+..++++||+.|+.|+|.. +|+|||||++|+|||++++|||+|||+|.....+
T Consensus 93 yv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred ecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 9999999999988776 88899999999999999999998 9999999999999999999999999999865433
Q ss_pred ceeeccccCCCCCchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~-~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.+....+|..+|.|||+++|+.|+ .++||||-|||||-||+|++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 344557899999999999999986 579999999999999999999984
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.99 Aligned_cols=193 Identities=26% Similarity=0.430 Sum_probs=168.1
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||++++. +++.||||+++... ......+++|+.+++.+ +|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 68899999997532 22334588899999998 699999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence 99988886654 389999999999999999999999 999999999999999999999999999875322221 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
...|+..|||||++.+..++.++|||||||++|||++|+.||+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 45789999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.42 Aligned_cols=232 Identities=26% Similarity=0.470 Sum_probs=193.1
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|.+.+++.||||.++... ...+.+.+|++++++++|+||+++++++..++..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688999999999999999998888999999886432 335678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++......+.+..+++++.||++||+|||++ +++|||||++|||+++++.+||+|||+++...+......
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999998765555688999999999999999999998 999999999999999999999999999987644332222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.++.... ....+.+++.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 33345678999999998889999999999999999998 999997532 22222222211 1357788999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+|++.++.
T Consensus 239 ~~l~~~p~ 246 (261)
T cd05072 239 TCWKEKAE 246 (261)
T ss_pred HHccCCcc
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.43 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=173.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+++++ +++.||||++.... ......+.+|+.++..++|+||+++++++..++..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999975 57789999986321 222345888999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.++++..+. .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976332 488889999999999999999998 99999999999999999999999999997654433
Q ss_pred cceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......+|+..|||||++. ...++.++|||||||+||||++|+.||.+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 33334457999999999986 346788999999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.49 Aligned_cols=198 Identities=28% Similarity=0.439 Sum_probs=174.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||++.+. +++.||+|+++.... .....+.+|+++|+.++|+||++++++|..++..+|||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 67999999999999999999976 678899998876433 3345689999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.++++..+. +.+..+.+++.||++||+|||+.+ +|+|||||++||||++++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 85 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999999876543 788889999999999999999742 69999999999999999999999999997653321
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2334688999999999998999999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.36 Aligned_cols=232 Identities=21% Similarity=0.275 Sum_probs=191.1
Q ss_pred CCcccceecccCcEEEEEEEeC-C-CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-D-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.|.+.++||+|+||.||++... + ++.||+|.+..........+++|+++|+.++|+||+++++++..++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 3 6789999876665555667889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
.+|+|.++|+.. ....+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998877542 233578889999999999999999998 999999999999999999999999999986644322
Q ss_pred -ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILFK 594 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~ 594 (607)
......+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..++.+.... .....+.+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22344578999999999999999999999999999999999999997532 1122221110 11356788
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.++.
T Consensus 302 li~~~L~~dP~ 312 (478)
T PTZ00267 302 LLDPLLSKNPA 312 (478)
T ss_pred HHHHHhccChh
Confidence 99999987653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.84 Aligned_cols=237 Identities=25% Similarity=0.350 Sum_probs=198.8
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhH-HHHHHHHHHHHHccCCCceeEEeE
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGY 431 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~ 431 (607)
..++...+++++...++.+|.||+||+|.|+ +.++|.||.++....+-+ ..|+.|..+|..+.|+|+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4455566678899999999999999999664 456788999987665544 468899999999999999999999
Q ss_pred EEeCC-ceEEEEEecCCCchhHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC
Q 007351 432 CISDD-RRLLIYDYVPNNTLYFHLHG------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 432 ~~~~~-~~~lV~Ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (607)
+.++. .-+++|.++..|+|..+|.. ...+.+...++..++.|++.||+|||++ +|||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 88765 55888999999999998873 2334567788899999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccccCCccee-eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHH
Q 007351 505 FEAQVSDFGLAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582 (607)
Q Consensus 505 ~~vkL~DFGls~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~ 582 (607)
.++||+|-.++|.....+.+.. .......+||++|.|.++.|+..+|||||||+|||||| |+.||.+ .+-.|
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae------IDPfE 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE------IDPFE 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc------cCHHH
Confidence 9999999999999888776643 34456789999999999999999999999999999998 8999864 44555
Q ss_pred HHhHhh-----------HHHHHHHHHHhhhcCC
Q 007351 583 WVNLID-----------AKILFKLVFLCQQNSN 604 (607)
Q Consensus 583 ~~~~~~-----------~~~~~~i~~~C~~~~~ 604 (607)
+..+++ .+.++.+...||..++
T Consensus 507 m~~ylkdGyRlaQP~NCPDeLf~vMacCWallp 539 (563)
T KOG1024|consen 507 MEHYLKDGYRLAQPFNCPDELFTVMACCWALLP 539 (563)
T ss_pred HHHHHhccceecCCCCCcHHHHHHHHHHHhcCc
Confidence 555554 3788999999997654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.01 Aligned_cols=200 Identities=27% Similarity=0.361 Sum_probs=172.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
+|++.++||+|+||.||+|+.. +++.||||+++... ......+.+|+++|+.++|+||+++++++.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 67899999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC-
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~- 522 (607)
||.+|+|..++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999887654 378888899999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeeccccCCCCCchhhhcCCCCCchhhHHHHHH
Q 007351 523 ---------------------------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557 (607)
Q Consensus 523 ---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGv 557 (607)
.......+|+..|||||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 007351 558 VLLELITGRKPVDAS 572 (607)
Q Consensus 558 ll~ELltg~~Pf~~~ 572 (607)
+||||++|+.||.+.
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.30 Aligned_cols=235 Identities=24% Similarity=0.394 Sum_probs=188.5
Q ss_pred hCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
.++|++++.||+|+||.||+|++ +++..||||+++... ....+.+.+|+++|+.+ +|+||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999973 245689999997443 33445688999999999 89999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCC-----------------------------------------------------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEG----------------------------------------------------------- 458 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 458 (607)
.++|||||.+|+|..+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988886432
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 459 --------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 459 --------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
...+++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12477888999999999999999998 9999999999999999999999999999865433221
Q ss_pred -eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHH
Q 007351 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFK 594 (607)
Q Consensus 525 -~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~ 594 (607)
......++..|||||++.+..++.++|||||||+||||++ |..||..... +..+.++.+. .....+.+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 1222345668999999999999999999999999999998 8889875421 2233333221 12356789
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.++.
T Consensus 349 li~~cl~~dP~ 359 (375)
T cd05104 349 IMKSCWDADPL 359 (375)
T ss_pred HHHHHccCChh
Confidence 99999987753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.80 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=175.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++..++..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 78899999997532 234456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+++|+|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999987652 2488999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeeccccCCCCCchhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYAS------SGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~------~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
........|+..|||||++. +..++.++|||||||+||||++|+.||.+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 33333456899999999987 456788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.19 Aligned_cols=233 Identities=28% Similarity=0.476 Sum_probs=193.0
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+++|++.+.||+|+||.||+|.+.+++.||||.++... ...+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688899999999999999998788899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.......+.+..+++++.||++||.|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999776555689999999999999999999998 99999999999999999999999999998765332221
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH-hH-------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV-NL-------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~-~~-------~~~~~~~~i~ 596 (607)
.....+...|+|||++.+..++.++|||||||++|||++ |+.||.+.. ...+.... +. .....+.+++
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 222223457999999998899999999999999999999 999997542 22222221 11 1247788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 238 ~~~l~~~P~ 246 (261)
T cd05068 238 LDCWKEDPD 246 (261)
T ss_pred HHHhhcCcc
Confidence 999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.64 Aligned_cols=223 Identities=27% Similarity=0.407 Sum_probs=181.2
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHH-ccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISR-IHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|++. +++.||||+++... ....+.+..|..++.. ++|+||+++++++.+++..+|||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997532 2233456778888876 4899999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++.... .+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 99999887644 388899999999999999999998 999999999999999999999999999875322221 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~i~~~C~ 600 (607)
...|+..|||||++.+..++.++|||||||++|||++|+.||.+.. ..++.+..+.. ....+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRMDNPCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHHHHHHHHh
Confidence 4568999999999999999999999999999999999999997642 22222222211 2345678888998
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~~P 235 (316)
T cd05619 232 VREP 235 (316)
T ss_pred ccCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.83 Aligned_cols=223 Identities=26% Similarity=0.413 Sum_probs=181.3
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+++ +|+.||||+++... ....+.+..|++++..+ +|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 68899999997532 22345567788888764 899999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 999988876543 88899999999999999999998 99999999999999999999999999987432221 1233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~i~~~C~ 600 (607)
...|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ...+.+..... ....+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRVDTPHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence 4568999999999999999999999999999999999999997542 22222221111 1245678888898
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~dP 235 (316)
T cd05620 232 ERDP 235 (316)
T ss_pred cCCH
Confidence 7664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=336.11 Aligned_cols=202 Identities=26% Similarity=0.366 Sum_probs=173.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|+.++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 68899999986322 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999987654 378888899999999999999998 99999999999999999999999999975321000
Q ss_pred ------------------------------------------cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHH
Q 007351 523 ------------------------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560 (607)
Q Consensus 523 ------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ 560 (607)
.......+|+..|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 007351 561 ELITGRKPVDASQ 573 (607)
Q Consensus 561 ELltg~~Pf~~~~ 573 (607)
||++|+.||.+..
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.07 Aligned_cols=231 Identities=28% Similarity=0.487 Sum_probs=190.4
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|+++++..||||.++... ....+|.+|++++++++|+||+++++++..++..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999987433 345679999999999999999999999998889999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|+|||++|||+++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999998876443 589999999999999999999998 999999999999999999999999999986544332222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~ 597 (607)
....++..|++||++.+..++.++|||||||+||||++ |+.||.... ..+..+... ......+.+++.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 22345678999999998889999999999999999998 999997532 112222111 112357889999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+||+.++.
T Consensus 236 ~cl~~~p~ 243 (256)
T cd05113 236 SCWHEKAE 243 (256)
T ss_pred HHcCCCcc
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.18 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=168.8
Q ss_pred CCCcccceecccCcEEEEEEEeC--CCcEEEEEEeecCCch--hHHHHHHHHHHHHHc---cCCCceeEEeEEEe-----
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIGGGQ--GEREFKAEVEIISRI---HHRHLVSLVGYCIS----- 434 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~----- 434 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|+++++.+ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 4678999998754322 234567788877766 69999999999863
Q ss_pred CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
+...++||||+. ++|..++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999996 5788888765555689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.+|.+..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9765432 22334568999999999998899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.84 Aligned_cols=223 Identities=28% Similarity=0.411 Sum_probs=181.7
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++..+ +|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999987432 23345677888888876 699999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++..... +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 999988876543 88999999999999999999998 99999999999999999999999999987543222 2233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C~ 600 (607)
...|+..|||||++.+..++.++|||||||++|||++|+.||.+.. ...+.+.... .....+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 4568999999999999899999999999999999999999997642 1222221110 11345678888888
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~dP 235 (320)
T cd05590 232 TKNP 235 (320)
T ss_pred ccCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.07 Aligned_cols=226 Identities=28% Similarity=0.360 Sum_probs=181.8
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||++... +|+.||||++...... ..+.+.+|+++|+.++|+||+++++++..++..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 7889999998643222 234578899999999999999999999999999999999999999
Q ss_pred hHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec
Q 007351 451 YFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (607)
Q Consensus 451 ~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 528 (607)
..++... ....+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 8777432 234588999999999999999999998 999999999999999999999999999976543322 2233
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHh-------HhhHHHHHHHHHHhh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVN-------LIDAKILFKLVFLCQ 600 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~-------~~~~~~~~~i~~~C~ 600 (607)
..|+..|||||++.+..++.++|||||||++|||++|+.||........ ..+.+... ......+.+++.+|+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 5688999999999999999999999999999999999999975432111 11111110 011356778899999
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 237 ~~~P 240 (280)
T cd05608 237 AKDP 240 (280)
T ss_pred cCCH
Confidence 7765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.18 Aligned_cols=230 Identities=24% Similarity=0.430 Sum_probs=193.6
Q ss_pred CCcccceecccCcEEEEEEEeC--CC--cEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~--~g--~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+++..++||+|.||.|++|.|. +| ..||||+++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3456689999999999999986 34 36999999865544 56789999999999999999999999887 7889999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|++..|+|.+.|++..+..|-...+..++.|||+||.||..+ ++|||||..+||||-....||||||||.|-+..+.
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999986666788899999999999999999999 99999999999999888899999999999776544
Q ss_pred cc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHH
Q 007351 523 TH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKI 591 (607)
Q Consensus 523 ~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~ 591 (607)
.+ +.......+.|.|||.|+...|+.++|||+|||+|||||+ |+.||.+.. ...+++.++.. ..+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---g~qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---GIQILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---HHHHHHhccccccCCCCCCChHH
Confidence 33 3334456778999999999999999999999999999998 888997643 23333333311 1478
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+++|+.+||.+..
T Consensus 344 IY~imk~cWah~p 356 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNP 356 (1039)
T ss_pred HHHHHHHhccCCc
Confidence 8999999998765
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.52 Aligned_cols=223 Identities=26% Similarity=0.373 Sum_probs=177.2
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHH-HHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEV-EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|+.. +++.||||+++... .....++.+|. .+++.++|+||+++++++..++..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57789999987432 22233444444 456788999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++..... +.+...+.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 999998876543 77888888999999999999998 999999999999999999999999999975433222 233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~ 600 (607)
..+|+..|||||++.+..++.++|||||||+||||++|+.||.+... ..+.++.. ......+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHHhCCcCCCCCCCHHHHHHHHHHc
Confidence 45689999999999999999999999999999999999999975421 12111111 012355677778887
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~~p 235 (325)
T cd05602 232 QKDR 235 (325)
T ss_pred ccCH
Confidence 6653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.61 Aligned_cols=199 Identities=24% Similarity=0.410 Sum_probs=168.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ceE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 439 (607)
+|++.+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++|++++|+||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999964 6899999998643 2233456889999999999999999999886433 469
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+|||||. ++|..++..... +.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 678888765543 89999999999999999999999 99999999999999999999999999997543
Q ss_pred cCCc--ceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANT--HITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.... ......+|+..|+|||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 2221 12234578999999999876 67889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.68 Aligned_cols=226 Identities=24% Similarity=0.343 Sum_probs=182.0
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++.++ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 678899999975422 2335588899999988 699999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++...+ .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence 99988887654 389999999999999999999998 999999999999999999999999999975332221 233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH--HhHh---------hHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW--VNLI---------DAKILFKLV 596 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~--~~~~---------~~~~~~~i~ 596 (607)
..+|+..|||||++.+..++.++|||||||+||||++|+.||.........+..++ .... ....+.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 45789999999999999999999999999999999999999964322211111111 1110 124567788
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 235 ~~~L~~dP 242 (327)
T cd05617 235 KGFLNKDP 242 (327)
T ss_pred HHHhccCH
Confidence 88887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.22 Aligned_cols=195 Identities=27% Similarity=0.367 Sum_probs=170.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++.++||+|+||.||+++.. +++.||||..+ ...+.+|+++|++|+|+||+++++++..++..++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999864 68899999653 24578999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. ++|+.++.... .+.+..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 95 67887776544 388999999999999999999998 9999999999999999999999999999754433322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......|+..|+|||++.+..++.++|||||||+||||++|+.+|...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 334457999999999999989999999999999999999999887543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=313.21 Aligned_cols=225 Identities=27% Similarity=0.365 Sum_probs=183.5
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||+++.+ +|+.||+|++.... ...+..+..|+++|++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999986432 22334567799999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
..++.......+++..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 8888766656689999999999999999999998 99999999999999999999999999997654332 223356
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHh--------HhhHHHHHHHHHHhhh
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVN--------LIDAKILFKLVFLCQQ 601 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~--------~~~~~~~~~i~~~C~~ 601 (607)
|+..|+|||++.+..++.++|||||||+||||++|+.||.+...... ..+.+... ......+.+++.+|++
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 88999999999988899999999999999999999999975432111 11111000 0123557889999998
Q ss_pred cCC
Q 007351 602 NSN 604 (607)
Q Consensus 602 ~~~ 604 (607)
.++
T Consensus 236 ~~P 238 (277)
T cd05607 236 KKP 238 (277)
T ss_pred cCH
Confidence 764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.62 Aligned_cols=194 Identities=31% Similarity=0.484 Sum_probs=165.5
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHH-HHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.. +|+.||||++.... ....+++.+|.. +++.++|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986432 222334555544 56789999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++..+. .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccc
Confidence 99998887654 388889999999999999999998 999999999999999999999999999875432222 233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...|+..|||||++.+..++.++|||||||+||||++|+.||...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.25 Aligned_cols=223 Identities=27% Similarity=0.388 Sum_probs=177.5
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHH-HHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.. +|+.||||++.... ....+++.+|+. +++.++|+||+++++++..++..+|||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 68899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|..++..+. .+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99988887644 378888899999999999999998 99999999999999999999999999987543222 2234
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~ 600 (607)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+... ......+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 4578999999999999899999999999999999999999997642 111111110 012345667777887
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.+.
T Consensus 232 ~~~p 235 (321)
T cd05603 232 HKDQ 235 (321)
T ss_pred cCCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.51 Aligned_cols=193 Identities=28% Similarity=0.452 Sum_probs=167.5
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+++.. +++.||||+++.. .......+++|+.++.++ +|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 6789999999753 223345678899998877 799999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99988886654 388999999999999999999998 999999999999999999999999999975432221 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 45689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.18 Aligned_cols=233 Identities=30% Similarity=0.537 Sum_probs=190.9
Q ss_pred CCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|.+.+ ++.||||.++.... ....+|.+|+++|++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368888999999999999998643 25799999875443 33456899999999999999999999999989999
Q ss_pred EEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC
Q 007351 440 LIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (607)
++|||+.+++|.+++..... ..+++..+++++.||++||+|||++ +|+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999988865321 3478889999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH
Q 007351 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~ 583 (607)
.+||+|||+++.....+. .......++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~---~~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS---NQEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence 999999999986543322 22334456788999999998899999999999999999998 999997643 2333333
Q ss_pred HhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 584 VNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 584 ~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.+.. ....+.+++.+||+.++.
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 268 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPA 268 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChh
Confidence 3211 136788999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.54 Aligned_cols=223 Identities=28% Similarity=0.380 Sum_probs=183.7
Q ss_pred ceecccCcEEEEEEEe----CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 373 NLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+.||+|+||.||+++. .+|+.||||+++... ......+.+|+++|++++|+||+++++++..++..+|||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 367899999997432 2233457889999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 999999887654 389999999999999999999998 999999999999999999999999999976543322 23
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHHh
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFLC 599 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~C 599 (607)
....|+..|||||++.+..++.++|||||||+||||++|+.||.+.. .....+.... .....+.+++.+|
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34568999999999998889999999999999999999999997542 1121111110 1235677888999
Q ss_pred hhcCC
Q 007351 600 QQNSN 604 (607)
Q Consensus 600 ~~~~~ 604 (607)
++.++
T Consensus 233 l~~~P 237 (318)
T cd05582 233 FKRNP 237 (318)
T ss_pred hhcCH
Confidence 88765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.86 Aligned_cols=234 Identities=25% Similarity=0.436 Sum_probs=186.3
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+++|+.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888999999999999998742 3457999999754333 345688999999999 899999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC------------------------------------------------------------
Q 007351 439 LLIYDYVPNNTLYFHLHGEG------------------------------------------------------------ 458 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 458 (607)
+||||||.+|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988875421
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-eeecc
Q 007351 459 --------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529 (607)
Q Consensus 459 --------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~ 529 (607)
...+++..+++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12367888899999999999999998 9999999999999999999999999999765432211 12223
Q ss_pred ccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhh
Q 007351 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQ 600 (607)
Q Consensus 530 ~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~ 600 (607)
.++..|||||++.+..++.++|||||||+||||++ |+.||..... +..+.+..+. .....+.+++.+||
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--cHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 35668999999998899999999999999999997 9999976432 1122222111 11366789999999
Q ss_pred hcCCC
Q 007351 601 QNSNS 605 (607)
Q Consensus 601 ~~~~~ 605 (607)
+.++.
T Consensus 353 ~~dp~ 357 (374)
T cd05106 353 NLEPT 357 (374)
T ss_pred CCChh
Confidence 87653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.28 Aligned_cols=228 Identities=25% Similarity=0.360 Sum_probs=183.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+|+..++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++++.++ |++|+++++++..++..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999864 68899999987432 223356778999998886 577888999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999998876543 88999999999999999999998 99999999999999999999999999987543222
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
. ......|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .......++
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~l 231 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYPKSLSKEAVSI 231 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 1 2233568999999999999899999999999999999999999997642 1222221110 113455678
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 232 i~~~l~~~p 240 (323)
T cd05615 232 CKGLMTKHP 240 (323)
T ss_pred HHHHcccCH
Confidence 888886653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=309.60 Aligned_cols=232 Identities=27% Similarity=0.419 Sum_probs=190.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|.+.+.||+|+||.||+|.++ +++.||+|+++.+ .....++.+|+++|++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999865 5889999998743 334567899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998776656689999999999999999999998 99999999999999999999999999998664433222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH-h-------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL-I-------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~-~-------~~~~~~~i~ 596 (607)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+.... . ....+.+++
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 222234567999999999999999999999999999998 999987532 1222121111 0 125788899
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 239 ~~cl~~~p~ 247 (263)
T cd05052 239 RACWQWNPS 247 (263)
T ss_pred HHHccCCcc
Confidence 999987653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.53 Aligned_cols=233 Identities=30% Similarity=0.529 Sum_probs=196.9
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.++||+|+||.||+|.+.+++.|++|+++........++.+|+++|+.++|+||+++++++..++..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999998889999999998766656778999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.++++......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999876666689999999999999999999998 9999999999999999999999999999866433222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~ 596 (607)
.....++..|++||++.+..++.++|||+|||++|||++ |+.||.... ..+..++... .....+.+++
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 223345668999999998899999999999999999998 899997543 2222222221 1136678999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 238 ~~~l~~~p~ 246 (261)
T cd05148 238 LECWAAEPE 246 (261)
T ss_pred HHHcCCCch
Confidence 999987653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=318.75 Aligned_cols=210 Identities=30% Similarity=0.483 Sum_probs=171.0
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-----eEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-----RLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-----~~lV 441 (607)
.|...++||.|+||.||+|.+. .++.||||++-.+ .+.-.+|+++|++++|+|||+|+.+|..... ..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677899999999999999965 5789999988632 3345679999999999999999998875432 2479
Q ss_pred EEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEeccccccc
Q 007351 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLA 518 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~~ 518 (607)
||||.. +|+.+++. ..+..++...++-+..||++||.|||+. +|+||||||.|||||.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 46666653 1233478888888999999999999998 99999999999999976 99999999999987
Q ss_pred ccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDA 589 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (607)
..+.... .+.-++.|+|||+|.|. .|+.+.||||.||+|.||+-|+.-|.++. +.+.|.+..+++..
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--SVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--HHHHHHHHHHHhCC
Confidence 6544332 22347889999999874 79999999999999999999999998853 44577777777764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.06 Aligned_cols=229 Identities=26% Similarity=0.385 Sum_probs=196.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-eEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-RLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~ 442 (607)
++|..++.||+|+||.++.++.+ +++.|++|++.... ....+...+|+.++++++|+|||.+++.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999998864 67899999997654 3334568999999999999999999999999988 89999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
+||+||+|.+.+...++..+.++.+++++.||+.|++|||++ +|+|||||..|||++.++.|||.|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999887777899999999999999999999998 99999999999999999999999999999876554
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----------hHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----------DAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----------~~~~ 591 (607)
......+||..||+||++.+..|+.|+|||||||++|||++-+..|.+.+ +...+..+ ....
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~~~~Plp~~ys~e 233 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRGLYSPLPSMYSSE 233 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhccCCCCCccccHH
Confidence 24555789999999999999999999999999999999999999998643 22222211 2356
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
++.|+..|++.++.
T Consensus 234 l~~lv~~~l~~~P~ 247 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPE 247 (426)
T ss_pred HHHHHHHHhhcCCc
Confidence 77788888877653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.50 Aligned_cols=200 Identities=25% Similarity=0.428 Sum_probs=171.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.++||+|+||.||+|+.+ +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999865 688999999875433 2345678999999999999999999999998899999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+ +|..++...+. .+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 78887765432 478889999999999999999998 999999999999999999999999999975432221
Q ss_pred eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|||||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233467889999999876 56889999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.24 Aligned_cols=194 Identities=30% Similarity=0.466 Sum_probs=165.5
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHH-HHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|+.. +|+.||||+++... .....++.+|.. +++.++|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 78999999986432 223344555554 56779999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 99988887654 388999999999999999999998 999999999999999999999999999875432221 233
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..+|+..|||||++.+..++.++|||||||+||||++|+.||...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.26 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=174.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+++|++++..++|+||+++++++..++..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68899999997432 233456888999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999876543 88999999999999999999998 99999999999999999999999999987442211
Q ss_pred c----------------------------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCC
Q 007351 523 T----------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 523 ~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~P 568 (607)
. ......+|+..|||||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234689999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007351 569 VDASQ 573 (607)
Q Consensus 569 f~~~~ 573 (607)
|.+..
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.97 Aligned_cols=230 Identities=27% Similarity=0.443 Sum_probs=184.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.+.||+|+||.||+|++. +|+ .||||+++... ....+++.+|+.+++.++|+||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999864 333 38999987543 33456789999999999999999999999764 5789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|+||+.+|+|.++++... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999887643 2478899999999999999999998 999999999999999999999999999986643
Q ss_pred CCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
..... .....++..||+||++.+..++.++|||||||+||||++ |+.||.+.. ..++.++.... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERLPQPPICTI 238 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhCCCCCCCCCCCCH
Confidence 33222 122234678999999999999999999999999999998 999997542 12222222111 135
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 239 ~~~~li~~cl~~~p 252 (316)
T cd05108 239 DVYMIMVKCWMIDA 252 (316)
T ss_pred HHHHHHHHHccCCh
Confidence 67889999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=313.66 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=188.2
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
|+..++||+|+||.||+|.+. +++.||||.++.... .....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677899999999999999864 688999999864432 2234578899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++...+...+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999998888765555699999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hhHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------IDAKILFK 594 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~~~~~~~ 594 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.+..... ....+... .....+.+
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhccccccCccCCHHHHH
Confidence 223468999999999998899999999999999999999999997643211 11111110 11245688
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 235 li~~~l~~~P 244 (285)
T cd05632 235 ICKMLLTKDP 244 (285)
T ss_pred HHHHHccCCH
Confidence 8999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.79 Aligned_cols=223 Identities=28% Similarity=0.415 Sum_probs=182.7
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|++. +++.||||+++... ......+.+|+++++.+ +|+||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997432 22345577899999888 699999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 999988876543 89999999999999999999998 999999999999999999999999999875332222 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhh
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQ 600 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~ 600 (607)
..+|+..|||||++.+..++.++|||||||++|||++|+.||.+.. ...+.+... ......+.+++.+|+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVRYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 3568999999999999999999999999999999999999997542 222222111 012356788999998
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 232 ~~dP 235 (318)
T cd05570 232 TKNP 235 (318)
T ss_pred cCCH
Confidence 7764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.67 Aligned_cols=230 Identities=31% Similarity=0.489 Sum_probs=189.6
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|.+.++..||+|.++.... ....+.+|+++|++++|+||+++++++. ++..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888899999999999999988888999999875333 3567999999999999999999999875 456899999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++......+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999875555689999999999999999999998 999999999999999999999999999986544322222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh-H-------hhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN-L-------IDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~-~-------~~~~~~~~i~~ 597 (607)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..+..++.. . .....+.+++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 23345678999999988899999999999999999999 899997542 222222221 1 12367889999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 238 ~~l~~~p 244 (260)
T cd05070 238 QCWKKDP 244 (260)
T ss_pred HHcccCc
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.13 Aligned_cols=233 Identities=27% Similarity=0.512 Sum_probs=191.1
Q ss_pred CCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|.+.+.||+|+||.||+|++.+ ++.||||.++..... ..+.+.+|+++|++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998633 478999998765444 4568999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 440 LIYDYVPNNTLYFHLHGEG------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
+||||+.+++|.++++..+ ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999987542 23478888999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh
Q 007351 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN 585 (607)
Q Consensus 508 kL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (607)
||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ...+.++..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence 9999999975433221 12233445678999999999999999999999999999998 999997542 223333322
Q ss_pred Hh--------hHHHHHHHHHHhhhcCCC
Q 007351 586 LI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.. ....+.+++.+||+.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~ 266 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQ 266 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 11 136788999999987753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.80 Aligned_cols=201 Identities=29% Similarity=0.414 Sum_probs=177.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHH---HHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGER---EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|..+++||+|.||+|.+++-+ .|+.+|||+++..-..... .-+.|-++|+..+|+.+..|.-.|..++++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888899999999999999854 7999999999865433333 346799999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.||.|+.+|..++. +.+...+.+...|+.||.|||++ +||+||||.+|.|||.||+|||.||||++.....
T Consensus 247 MeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999999877554 88888888999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++||..|+|||+|..+.|+..+|+|.+||+||||++|++||.+.
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 23455689999999999999999999999999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.92 Aligned_cols=229 Identities=26% Similarity=0.466 Sum_probs=188.0
Q ss_pred CCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+|++.+.||+|+||.||+|.+++++.+|||+++... ....++.+|+++++.++|+||+++++++..++..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998778899999886432 2345788999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|.++++.... .+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999998876443 589999999999999999999999 9999999999999999999999999999865433222122
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFL 598 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~ 598 (607)
...++..|++||++.+..++.++|||||||+||||++ |+.||.... +.+..+.... .....+.+++.+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS---NSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 2223457999999999999999999999999999999 899997542 2222222211 124668899999
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.++
T Consensus 237 cl~~~p 242 (256)
T cd05059 237 CWHEKP 242 (256)
T ss_pred HhcCCh
Confidence 997664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.23 Aligned_cols=232 Identities=29% Similarity=0.399 Sum_probs=188.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.|+..++||+|+||.||++... +++.||||.+..... .....+.+|+++|++++|+||+.+++++..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999865 688999999864332 223457789999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++...+...+.+..++.++.||+.||+|||+. +|+|||||++|||+++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999888665555689999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH-------hhHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~-------~~~~~~~~i 595 (607)
.....|+..|||||++.+..++.++|||||||++|||++|+.||........ +.+.+..+. .....+.++
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 1234689999999999999999999999999999999999999986432111 111111111 123456788
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 236 i~~~l~~~p 244 (285)
T cd05630 236 CKMLLCKDP 244 (285)
T ss_pred HHHHhhcCH
Confidence 889987764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=361.64 Aligned_cols=223 Identities=29% Similarity=0.567 Sum_probs=180.5
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
..|+..++||+|+||.||+|++ .+|+.||||+++.... ...+|+++|++++|+|||+++|+|.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577889999999999999996 4789999998864322 2235688999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|.++++. ++|..+.+|+.||++||+|||..+..+|+|||||++|||+++++..++. ||........
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 99999999863 8999999999999999999996656699999999999999999888875 6665433211
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------------------
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------------------ 587 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------------------ 587 (607)
....++..|||||++.+..++.++|||||||++|||++|+.||+.... ....+.+|.+..
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 223578899999999999999999999999999999999999964332 223444444321
Q ss_pred -----hHHHHHHHHHHhhhcCCC
Q 007351 588 -----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~ 936 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPT 936 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCch
Confidence 112456788899987753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.34 Aligned_cols=200 Identities=25% Similarity=0.346 Sum_probs=170.1
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ceE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 439 (607)
+|+..+.||+|+||.||+++. .+|+.||||++... .....+.+.+|+++|+.++|+||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 47899999998643 2234467889999999999999999999998776 789
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+. ++|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 56777665543 489999999999999999999998 99999999999999999999999999998654
Q ss_pred cCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
..........+++..|+|||++.+. .++.++|||||||++|||++|+.+|.+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 3333333445678899999998874 57899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.31 Aligned_cols=234 Identities=25% Similarity=0.410 Sum_probs=186.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIH-HRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 437 (607)
.++|.++++||+|+||.||+|++. .+..||||+++..... ..+.|.+|+++|++++ |+||++++++|.+++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467889999999999999999852 2347999999754333 3457999999999996 9999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCC-----------------------------------------------------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEG----------------------------------------------------------- 458 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 458 (607)
.+||||||.+|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988876421
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC
Q 007351 459 -----------------------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (607)
Q Consensus 459 -----------------------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (607)
...+.+..+++++.||++||+|||++ +|+|||||++|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12367788899999999999999998 9999999999999999
Q ss_pred CCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHH
Q 007351 504 NFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLV 581 (607)
Q Consensus 504 ~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~ 581 (607)
++.+||+|||+++........ ......++..|||||++.+..++.++|||||||+||||++ |+.||..... +..+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--DSTFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--hHHHH
Confidence 999999999999865433222 1223346778999999999899999999999999999997 9999975421 12222
Q ss_pred HHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 582 EWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 582 ~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
+..+. .....+.+++.+||+.++
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 381 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCH
Confidence 21111 113567889999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.81 Aligned_cols=232 Identities=30% Similarity=0.489 Sum_probs=192.0
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.++||+|+||.||+|..++++.||||.++... ....++.+|+++|++++|+||+++++++. ++..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45788999999999999999998899999999987443 33567899999999999999999999864 56789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.......+.+..++.++.||+.||+|||++ +++|||||++||++++++.++|+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998776666689999999999999999999998 99999999999999999999999999997655333222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
.....++..|++||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+..+.. ....+.+++
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 233345678999999998889999999999999999999 999997542 22222222111 125789999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 237 ~~~l~~~p~ 245 (260)
T cd05067 237 RLCWKEKPE 245 (260)
T ss_pred HHHccCChh
Confidence 999987653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=314.09 Aligned_cols=205 Identities=24% Similarity=0.397 Sum_probs=176.2
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEee--cCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe-----C
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-----D 435 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-----~ 435 (607)
....+|...+.||+|+||.|+.+... +|+.||||++. ..+....++..||+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456777899999999999999864 78999999987 5556667788999999999999999999998875 2
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+..|+|+|+| +.+|...++.+.. +..+....+++||++||.|+|+. +|+|||||+.|+|++.+..+||||||+|
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 4679999999 6788888877543 88888899999999999999999 9999999999999999999999999999
Q ss_pred cccccC-CcceeeccccCCCCCchhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 007351 516 KLALDA-NTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (607)
Q Consensus 516 ~~~~~~-~~~~~~~~~gt~~y~APE~l~-~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~ 574 (607)
|..... .....+.++.|+.|+|||++. ...|+...||||+||||.||++|+.-|.+.+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 976432 122345678899999999875 46899999999999999999999999988653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.44 Aligned_cols=230 Identities=31% Similarity=0.490 Sum_probs=187.4
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++.++..||||+++... ...++|++|++++++++|+||+++++++. ++..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4688999999999999999998777789999987433 23467899999999999999999999874 456799999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|.++++......+++..+++++.|+++||+|||+. +|+|||||++|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999765545688999999999999999999998 999999999999999999999999999976544332222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH-h-------HhhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV-N-------LIDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~-~-------~~~~~~~~~i~~ 597 (607)
....++..|++||++.+..++.++|||||||++|||++ |+.||.+.. ...+.+.. . ......+.+++.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 23345678999999998899999999999999999999 888886542 11111111 0 012366789999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 238 ~~l~~~p 244 (262)
T cd05071 238 QCWRKEP 244 (262)
T ss_pred HHccCCc
Confidence 9997765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.29 Aligned_cols=235 Identities=28% Similarity=0.431 Sum_probs=194.8
Q ss_pred hhCCCcccceecccCcEEEEEEEeCC---Cc--EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPD---GR--EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~---g~--~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++.+...++||+|.||.||+|.+.+ |+ -||||..|.+.. .+.+.|+.|..+|+.++|+||++|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34556677899999999999999643 33 489999987543 456679999999999999999999999964 678
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
|||||.+..|.|+.+|+.+.. .++...+..++.||..+|.|||+. ++|||||..+||||.....|||+|||++|.+
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999987654 588999999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCch-hHHH---HHh-HhhHHHH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDE-SLVE---WVN-LIDAKIL 592 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~-~l~~---~~~-~~~~~~~ 592 (607)
.+...+...+......|||||.+..++|+.++|||-|||+|||+|. |..||.+.++.+-. .+++ ... ....-.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 8888777777777889999999999999999999999999999886 99999876543221 1111 000 0113455
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
..+..+||.-++
T Consensus 622 YslmskcWayeP 633 (974)
T KOG4257|consen 622 YSLMSKCWAYEP 633 (974)
T ss_pred HHHHHHHhccCc
Confidence 678888887654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.09 Aligned_cols=232 Identities=28% Similarity=0.425 Sum_probs=190.2
Q ss_pred CcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+++.++||.|+||+||||.|- .|+ .||||++..... +...+|++|+-+|.+|+|+||++|+|+|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455689999999999999863 343 589998865543 44578999999999999999999999998766 78899
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
+||..|.|.++++.++. .+-...++.|..||++||.|||++ ++|||||..+||||..-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999987554 477788899999999999999999 99999999999999999999999999999765443
Q ss_pred cce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHhh-----HHHHHHH
Q 007351 523 THI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLID-----AKILFKL 595 (607)
Q Consensus 523 ~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~~-----~~~~~~i 595 (607)
... .........|||-|.++...|+.++|||+|||++||||| |..||++....+..+++|.-+-+. .-.++.+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 322 223345678999999999999999999999999999998 999998765443344444322221 3567788
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+||..|..
T Consensus 933 mvkCwmid~~ 942 (1177)
T KOG1025|consen 933 MVKCWMIDAD 942 (1177)
T ss_pred HHHHhccCcc
Confidence 9999988764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.84 Aligned_cols=233 Identities=29% Similarity=0.487 Sum_probs=188.6
Q ss_pred CCCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.+.||+|+||.||+|.+ .+++.|+||.++.... +...++.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 2567899999974433 334678999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC
Q 007351 441 IYDYVPNNTLYFHLHGEG---------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (607)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999998885322 23478888999999999999999998 999999999999999999
Q ss_pred cEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH
Q 007351 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~ 583 (607)
.+||+|||+++....... .......++..|++||++.+..++.++|||||||+||||++ |..||.+.. ..++.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence 999999999986543322 12223345678999999998889999999999999999998 999997542 2233333
Q ss_pred HhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 584 VNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 584 ~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.+.. ....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 268 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPS 268 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence 2211 135678899999987753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=319.51 Aligned_cols=203 Identities=32% Similarity=0.465 Sum_probs=182.5
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.+.|...++||+|+||.||-++.+ +|+.+|.|++..+ ..+.+...++|-.||.+++.+.||.|--.|++.+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888999999999999999854 7999999988533 234455678899999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|..|.||+|..+|.+.+...+++...+.++.+|+.||++||+. +||+||||++|||||++|+|+|+|+|||..+.+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999988888899999999999999999999999 9999999999999999999999999999987655
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.. ....+||.+|||||++.++.|+...|+|+|||+||||+.|+.||-..+
T Consensus 341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 43 223489999999999999999999999999999999999999996543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.00 Aligned_cols=231 Identities=28% Similarity=0.426 Sum_probs=192.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|.+.+.||+|+||.||+|..+ +|+.|++|.+... ......++.+|+++++.++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 6889999998643 234556789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.++++......+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999876555689999999999999999999998 9999999999999999999999999998865443222
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILFKLV 596 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~ 596 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.++... .....+.+++
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPPVSQMYSQQLAQLI 233 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 233457889999999999889999999999999999999999997543 2222221110 1235688999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 234 ~~~l~~~p~ 242 (256)
T cd08529 234 DQCLTKDYR 242 (256)
T ss_pred HHHccCCcc
Confidence 999977653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.06 Aligned_cols=231 Identities=31% Similarity=0.482 Sum_probs=189.0
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|.+.+.||+|+||.||+|.+.++..||||.++... ...+.+.+|++++++++|+||+++++++. ++..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4588889999999999999998777789999886433 33567899999999999999999999875 456889999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++......+.+..++.++.||+.||+|||+. +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999776555689999999999999999999998 999999999999999999999999999976543322222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
....++..|++||++.+..++.++|||||||++|||++ |+.||.+.. .....++.... ....+.+++.
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 22345678999999998899999999999999999999 999997642 22222222111 2367889999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+|++.++.
T Consensus 238 ~~l~~~p~ 245 (260)
T cd05069 238 LCWKKDPD 245 (260)
T ss_pred HHccCCcc
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.29 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=167.9
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 436 (607)
..++|++.+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999864 68899999986432 234457889999999999999999999986543
Q ss_pred -ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..++||||++++ |...++. .+++..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 468999999765 5554532 278888999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+...... ......|+..|||||++.+..++.++|||||||++|||++|+.+|.+.
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 7543321 223456889999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.09 Aligned_cols=233 Identities=31% Similarity=0.500 Sum_probs=192.4
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|.+.++||+|+||.||++.+++++.||||.++... ....++.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46789999999999999999998888899999987433 34567999999999999999999999999889999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++++|.+++.......+.+..++.++.||+.||+|||++ +|+|+|||++||||++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999876655689999999999999999999999 99999999999999999999999999997654322221
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh-------hHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI-------DAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~i~~ 597 (607)
.....++..|++||.+.+..++.++|||||||++|||++ |+.||.+... ...+.++.... ....+.+++.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 222234568999999998899999999999999999998 9999965321 11222222111 1357888999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 239 ~~l~~~p 245 (261)
T cd05034 239 QCWDKDP 245 (261)
T ss_pred HHcccCc
Confidence 9997764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.86 Aligned_cols=231 Identities=26% Similarity=0.417 Sum_probs=188.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-----hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 689999999864321 123468899999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+++|.+++.... .+.+..+++++.||+.||.|||+. +|+||||+++|||+++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999998887654 378888999999999999999998 999999999999999999999999999976533
Q ss_pred CCccee--eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHH
Q 007351 521 ANTHIT--TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAK 590 (607)
Q Consensus 521 ~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~ 590 (607)
...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.+..... ...+... .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AIFKIATQPTNPQLPSHVSP 234 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HHHHHhccCCCCCCCccCCH
Confidence 221111 23457789999999999889999999999999999999999997642211 1111000 11246
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 235 ~~~~li~~~l~~~p 248 (263)
T cd06625 235 DARNFLRRTFVENA 248 (263)
T ss_pred HHHHHHHHHhhcCc
Confidence 67889999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.63 Aligned_cols=203 Identities=22% Similarity=0.334 Sum_probs=165.9
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccC------CCceeEEeEE
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHH------RHLVSLVGYC 432 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g~~ 432 (607)
+++....++|++.++||+|+||.||+|++. +++.||||+++... ...+++..|+++++.++| .+|+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344445678999999999999999999864 67889999986432 234456778888877754 4588899988
Q ss_pred EeC-CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCC-----
Q 007351 433 ISD-DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNF----- 505 (607)
Q Consensus 433 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~----- 505 (607)
..+ +..+||||++ +++|.+++...+ .+.+..+++|+.||+.||+|||+ . +|||||||++||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 765 4678899988 667877776554 38999999999999999999997 5 899999999999998765
Q ss_pred -----------cEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 506 -----------EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 506 -----------~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.+||+|||+++.... .....+|+..|||||++.+..|+.++|||||||+||||++|+.||++..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864322 2334678999999999999999999999999999999999999997654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.18 Aligned_cols=235 Identities=24% Similarity=0.302 Sum_probs=188.3
Q ss_pred HhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC----
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD---- 436 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 436 (607)
...++|.+.++||+|+||.||+|+. .+|+.||||+++... ......+++|+.+|..++|.||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3446899999999999999999985 478999999987543 234456889999999999999999988765432
Q ss_pred ----ceEEEEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 437 ----RRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 437 ----~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
..++||||+.+|+|.++++.. ....+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 257999999999999888653 223588899999999999999999998 99999999999999999999999
Q ss_pred ecccccccccCC-cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh----
Q 007351 511 DFGLAKLALDAN-THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN---- 585 (607)
Q Consensus 511 DFGls~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~---- 585 (607)
|||+++...... ........|+..|||||++.+..++.++|||||||+||||++|+.||.+... .++.+...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~~~~~ 262 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLAGRY 262 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCC
Confidence 999998654322 1223345789999999999999999999999999999999999999975321 11111100
Q ss_pred ----HhhHHHHHHHHHHhhhcCC
Q 007351 586 ----LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 ----~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP 285 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDP 285 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccCh
Confidence 0113567889999997664
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.79 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=188.7
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|+. .+++.||||+++.........+++|+.++++++|+||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999996 478899999997665555667889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.++++..+ .+.+..+..++.|+++||+|||++ +|+|||||++|||+++++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999887654 378999999999999999999998 999999999999999999999999999986533221 1
Q ss_pred eeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhH--------HHHHh-HhhHHHHH
Q 007351 526 TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL--------VEWVN-LIDAKILF 593 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l--------~~~~~-~~~~~~~~ 593 (607)
.....++..|++||++. ...++.++|||||||++|||++|+.||........... ..+.. ......+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 22345788999999885 34577899999999999999999999964432111000 00100 01135678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 243 ~li~~~l~~~P~ 254 (267)
T cd06646 243 NFVKISLTKNPK 254 (267)
T ss_pred HHHHHHhhCChh
Confidence 899999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=303.34 Aligned_cols=234 Identities=21% Similarity=0.354 Sum_probs=189.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46889999999999999999864 78999999886432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+.+++|..++.. .....+.+..+++++.||++||+|||++ +|+|||||++||||++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999887753 2233478888999999999999999998 999999999999999999999999999886543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKI 591 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~ 591 (607)
... ......++..|+|||.+.+..++.++|||+||+++|||++|+.||..... ....+.+.... .....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCCChhhcCHH
Confidence 222 12234578899999999988899999999999999999999999965321 11122222111 12256
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 237 ~~~li~~cl~~~p~ 250 (267)
T cd08228 237 LRELVSMCIYPDPD 250 (267)
T ss_pred HHHHHHHHCCCCcc
Confidence 88999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.67 Aligned_cols=232 Identities=29% Similarity=0.470 Sum_probs=190.0
Q ss_pred CCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.+.||+|+||.||+|.+.. ...||||+++..... ...+|.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999998742 457999998754333 345789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++..... .+.+..+++++.|++.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876443 589999999999999999999998 9999999999999999999999999999876532
Q ss_pred Ccce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHH
Q 007351 522 NTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKI 591 (607)
Q Consensus 522 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~ 591 (607)
.... .....++..|++||.+.+..++.++|||+|||++|||++ |+.||.... ..++.++... .....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVEDGYRLPPPMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHH
Confidence 2221 222334678999999998899999999999999999998 999996532 2233332221 11367
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.++.
T Consensus 237 l~~li~~cl~~~p~ 250 (266)
T cd05033 237 LYQLMLDCWQKDRN 250 (266)
T ss_pred HHHHHHHHcCCCcc
Confidence 88999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=301.61 Aligned_cols=229 Identities=33% Similarity=0.486 Sum_probs=188.4
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHH--HHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGER--EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~--~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
|++++.||+|+||.||++... +++.||+|++......... ...+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999976 4668999999866544332 3466999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.... .+++..+++++.||++||+|||++ +|+|+|||++|||+++++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999998433 389999999999999999999999 99999999999999999999999999997542 22223
Q ss_pred eeccccCCCCCchhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------------hHHH
Q 007351 526 TTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------------DAKI 591 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~-~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------------~~~~ 591 (607)
.....++..|+|||++. +..++.++||||||+++|||++|+.+|...... .......+.. ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccccccccccccchhHHH
Confidence 44566888999999998 888999999999999999999999999865111 1111111111 0268
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.+++
T Consensus 233 l~~li~~~l~~~p~ 246 (260)
T PF00069_consen 233 LRDLIKKMLSKDPE 246 (260)
T ss_dssp HHHHHHHHSSSSGG
T ss_pred HHHHHHHHccCChh
Confidence 89999999987753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.33 Aligned_cols=233 Identities=28% Similarity=0.518 Sum_probs=189.7
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|.+.+.||+|+||.||++... ++..||||.++.........+.+|+++|++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999842 345699999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEE
Q 007351 441 IYDYVPNNTLYFHLHGEG-----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (607)
||||+.+++|.+++...+ ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999998886432 22489999999999999999999998 9999999999999999999999
Q ss_pred EecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH-
Q 007351 510 SDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL- 586 (607)
Q Consensus 510 ~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~- 586 (607)
+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..+....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~~~~~i~~~ 238 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQG 238 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC
Confidence 99999976533221 11223345678999999999899999999999999999998 899986542 1122221111
Q ss_pred -------hhHHHHHHHHHHhhhcCCC
Q 007351 587 -------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 -------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.+++
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~ 264 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPH 264 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChh
Confidence 1135678999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.07 Aligned_cols=225 Identities=29% Similarity=0.421 Sum_probs=182.8
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.|.+++.||.|+||.||-++. ++.+.||||+|.....+ ..+++++|+++|++|+|+|++.+.|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 477889999999999999995 47889999999765544 34578999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||-| +..++|....+ .+.+.++..|+.+.+.||.|||++ +.||||||..||||++.|.|||+|||.+......+
T Consensus 107 YClG-SAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred HHhc-cHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 9954 45555544332 488889999999999999999999 99999999999999999999999999998765543
Q ss_pred ceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~ 592 (607)
.++||.+|||||+|+ .+.|+.|+|||||||++.||...+.|+.+...++ .|+.... .-..+.+
T Consensus 181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIAQNesPtLqs~eWS~~F 254 (948)
T KOG0577|consen 181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNESPTLQSNEWSDYF 254 (948)
T ss_pred ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHHhcCCCCCCCchhHHHH
Confidence 478999999999986 4689999999999999999999999876543211 1111100 1112445
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
..++..|++..+
T Consensus 255 ~~Fvd~CLqKip 266 (948)
T KOG0577|consen 255 RNFVDSCLQKIP 266 (948)
T ss_pred HHHHHHHHhhCc
Confidence 568888887754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.77 Aligned_cols=231 Identities=26% Similarity=0.461 Sum_probs=191.0
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.+.||+|+||.||++.+.++..||||.++.. ......|.+|++++++++|+||+++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999999878888999988643 2334678999999999999999999999877 7789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.......+++..++.++.||+.||+|||+. +++|||||++||+|+.++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999776555688999999999999999999998 99999999999999999999999999997654433222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
.....+...|++||++.+..++.++|||||||++|||++ |+.||.+.. ...+.++.... ....+.+++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 223345678999999998889999999999999999998 999997532 22333332211 225678899
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 237 ~~~l~~~p 244 (260)
T cd05073 237 MRCWKNRP 244 (260)
T ss_pred HHHcccCc
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=299.20 Aligned_cols=226 Identities=29% Similarity=0.436 Sum_probs=184.2
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchh
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 451 (607)
++||+|+||.||+|.+.+++.||+|+++.... .....+.+|++++++++|+||+++++++..++..++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999875433 33456899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeecccc
Q 007351 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531 (607)
Q Consensus 452 ~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~g 531 (607)
+++.... ..+++..+++++.||+.+|.|||++ +++|||||++|||+++++.+||+|||+++..............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9887543 2478999999999999999999998 99999999999999999999999999997544332222222334
Q ss_pred CCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh-H-------hhHHHHHHHHHHhhhc
Q 007351 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN-L-------IDAKILFKLVFLCQQN 602 (607)
Q Consensus 532 t~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~-~-------~~~~~~~~i~~~C~~~ 602 (607)
...|+|||++.+..++.++|||||||++|||++ |+.||..... ....+... . .....+.+++.+|++.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccc
Confidence 567999999998899999999999999999998 9999975421 11111111 1 1136788899999977
Q ss_pred CCC
Q 007351 603 SNS 605 (607)
Q Consensus 603 ~~~ 605 (607)
++.
T Consensus 234 ~p~ 236 (250)
T cd05085 234 KPE 236 (250)
T ss_pred Ccc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.15 Aligned_cols=233 Identities=27% Similarity=0.509 Sum_probs=190.5
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.+|.+.+.||+|+||.||+|+.. ++..|++|.++.......+.+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35788899999999999999742 355799999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 441 IYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
||||+.+++|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999886532 13478999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 007351 507 AQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~ 584 (607)
+||+|||+++....... .......++..|||||++.+..++.++|||||||+||||++ |+.||.... ..+..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Confidence 99999999976543322 12233456788999999999999999999999999999998 999986542 12222211
Q ss_pred hH--------hhHHHHHHHHHHhhhcCCC
Q 007351 585 NL--------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~--------~~~~~~~~i~~~C~~~~~~ 605 (607)
.. .....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 267 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQ 267 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChh
Confidence 11 1135678999999987753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.90 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=179.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 440 (607)
.+.|+++++||+|.||.||+++.+ +|+.+|+|++...... ....+.+|+++|++|. |+|||+|+++++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888999999999999999976 5999999999654433 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC----CCcEEEEeccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDFGLAK 516 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DFGls~ 516 (607)
|||+|.||.|++.+... .+.+.....+++||+.+++|||+. ||||||||++|||+.. ++.+||+|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999988776 289999999999999999999998 9999999999999953 3579999999999
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+... .......+|+..|+|||++.+..|+..+||||+||++|.|++|..||.+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 8765 344566789999999999999999999999999999999999999998764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.01 Aligned_cols=234 Identities=28% Similarity=0.425 Sum_probs=186.6
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC------C
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISD------D 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~------~ 436 (607)
..+.|++.+.||+|+||.||+|... +++.||||++.... ....++.+|+++++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3456888899999999999999865 67889999987543 3456788999999998 699999999998753 3
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++||||+.+++|..++.......+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998875555689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccCCcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----- 586 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----- 586 (607)
....... ......|+..|+|||++. +..++.++|||||||+||||++|+.||.+......... .+...
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 237 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPAPRLK 237 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-HhcCCCCCCC
Confidence 6533221 233456888999999986 34578899999999999999999999975432111110 01000
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNH 257 (272)
T ss_pred CCCcCHHHHHHHHHHcCCCh
Confidence 112567889999997654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.62 Aligned_cols=221 Identities=28% Similarity=0.362 Sum_probs=176.1
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHc---cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI---HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
||+|+||.||+|+.. +|+.||||++..... .....+.+|.+++..+ +|+||+++++++.+++..+|||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 689999999864322 2223455677777665 699999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|..++...+. +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999988876543 88999999999999999999999 999999999999999999999999999875433222 233
Q ss_pred ccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------hHhhHHHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV--------NLIDAKILFKLVFL 598 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~--------~~~~~~~~~~i~~~ 598 (607)
...|+..|||||++.+. .++.++|||||||+||||++|+.||.+... ..+.+.. +......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 45689999999998764 478999999999999999999999976421 1111111 11124566788888
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.++
T Consensus 232 ~L~~~P 237 (330)
T cd05586 232 LLNRNP 237 (330)
T ss_pred HcCCCH
Confidence 887654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.67 Aligned_cols=233 Identities=26% Similarity=0.320 Sum_probs=190.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+++|+.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999975 5899999999754332 3456899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998765555689999999999999999999998 99999999999999999999999999987543211
Q ss_pred cc----------------------------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 007351 523 TH----------------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (607)
Q Consensus 523 ~~----------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~ 574 (607)
.. .....+|+..|++||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11234678899999999998899999999999999999999999975421
Q ss_pred CCchhHHHHHh-------H-hhHHHHHHHHHHhhhcCC
Q 007351 575 LGDESLVEWVN-------L-IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 575 ~~~~~l~~~~~-------~-~~~~~~~~i~~~C~~~~~ 604 (607)
. ..+.+... . .....+.+++.+|++.++
T Consensus 238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 238 D--ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred H--HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCH
Confidence 1 11111110 0 024678899999997664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.49 Aligned_cols=231 Identities=23% Similarity=0.347 Sum_probs=190.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999865 68899999986433 334567889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.......+.+..+++++.||+.||+|||++ +|+|+|||++|||++++++++|+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999888765555688899999999999999999998 999999999999999999999999999976543222 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-h-------HhhHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-N-------LIDAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~-------~~~~~~~~~i~~ 597 (607)
.....++..|+|||++.+..++.++||||||+++|||++|+.||..... ....... . ......+.+++.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQGSYKPLPSHYSYELRSLIK 233 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 3345688899999999988899999999999999999999999975421 1111110 0 011345678999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+||+.++.
T Consensus 234 ~~l~~~P~ 241 (255)
T cd08219 234 QMFKRNPR 241 (255)
T ss_pred HHHhCCcc
Confidence 99987764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.60 Aligned_cols=198 Identities=29% Similarity=0.424 Sum_probs=173.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||++... +++.||+|.++..... ...++.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999865 6788999988754333 345688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.++++..+ .+.+..+..++.||++||+|||+.+ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999997654 3788999999999999999999732 89999999999999999999999999987553321
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.....++..|++||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2335688899999999888899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=341.79 Aligned_cols=235 Identities=23% Similarity=0.321 Sum_probs=186.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|+.. +|+.||||+++.... ...+.|.+|++++++++|+||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999865 689999999874322 23457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 443 DYVPNNTLYFHLHGEG---------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
||+++++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998886421 12356677889999999999999998 99999999999999999999999999
Q ss_pred cccccccCCc-----------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 007351 514 LAKLALDANT-----------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (607)
Q Consensus 514 ls~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~ 576 (607)
+++....... ......+|+..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123569999999999999999999999999999999999999997643211
Q ss_pred chhHHHHHhH-------hhHHHHHHHHHHhhhcCC
Q 007351 577 DESLVEWVNL-------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 577 ~~~l~~~~~~-------~~~~~~~~i~~~C~~~~~ 604 (607)
.......... .....+.+++.+|++.++
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP 273 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDP 273 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCCh
Confidence 1000000000 012446788888987765
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=326.42 Aligned_cols=197 Identities=25% Similarity=0.403 Sum_probs=161.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-------- 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 436 (607)
.++|+++++||+|+||.||+|... +++.||||++... .....+|+.+|+.++|+||+++++++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999864 6889999988632 233567999999999999999999875421
Q ss_pred ceEEEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecc
Q 007351 437 RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFG 513 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFG 513 (607)
..++||||+.+ +|..++.. .....+.+..++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999976 45554432 2234588999999999999999999999 99999999999999865 479999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+++....... .....|+..|||||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9986543322 2234678999999998764 6899999999999999999999999764
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.56 Aligned_cols=232 Identities=25% Similarity=0.388 Sum_probs=191.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|... +++.++||++........+.+.+|++++++++|+||+++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999864 57889999998766566678999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+|+||+++||+|++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999998887642 2488999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred eeccccCCCCCchhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-----------HhhHHH
Q 007351 526 TTRVMGTFGYMAPEYASSG---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-----------LIDAKI 591 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~---~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-----------~~~~~~ 591 (607)
.....++..|++||++.+. .++.++|||||||++|||++|+.||.+..... ....... ......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCCCccccchhhhhHH
Confidence 2334678899999998877 88999999999999999999999997643111 1111110 011245
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.++.
T Consensus 236 ~~~li~~~l~~~p~ 249 (262)
T cd06613 236 FHDFIKKCLTKDPK 249 (262)
T ss_pred HHHHHHHHcCCChh
Confidence 78999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.73 Aligned_cols=194 Identities=25% Similarity=0.337 Sum_probs=167.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
..+|.+.+.||+|+||.||+|++. .++.||||... ...+.+|+++|++|+|+|||++++++..++..+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 356899999999999999999975 57889999643 23467899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. ++|+.++..... .+.+..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 678777765432 589999999999999999999998 9999999999999999999999999999865433221
Q ss_pred -eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 525 -~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
......|+..|||||++.+..++.++|||||||+||||++|..++.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2234569999999999999999999999999999999999886553
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=307.22 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=188.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+.|++.+.||+|+||.||+|+.. +++.|++|++........+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999975 58899999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|..++.... ..+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||++........ .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence 9999988776543 2489999999999999999999998 999999999999999999999999999875433221 1
Q ss_pred eeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------hHHH
Q 007351 526 TTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------DAKI 591 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~~ 591 (607)
.....++..|++||++. ...++.++|||||||++|||++|+.||..... ...+.++.+.. ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHhcCCCccCCCCcccCHH
Confidence 22345788999999885 34567899999999999999999999975431 11222222111 1245
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 245 ~~~li~~~l~~~p 257 (292)
T cd06644 245 FRDFLKTALDKHP 257 (292)
T ss_pred HHHHHHHHhcCCc
Confidence 7889999998765
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.58 Aligned_cols=197 Identities=25% Similarity=0.321 Sum_probs=170.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
..+|++.+.||+|+||.||++... .++.||||.+... +.+.+|+++|++|+|+||+++++++..++..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3578999987532 34578999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+. ++|..++.... .+.+..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9996 57777774433 489999999999999999999998 99999999999999999999999999997654433
Q ss_pred cc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 523 TH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 523 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.. .....+|+..|+|||++.+..++.++|||||||+||||++|+.||.+..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 2234578999999999999999999999999999999999999997654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.93 Aligned_cols=201 Identities=23% Similarity=0.436 Sum_probs=170.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|.+.+.||+|+||.||+|+.+ +++.||||+++..... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999865 6788999999754332 334678899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+ +|..++...+ ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 6777765543 3478889999999999999999998 999999999999999999999999999975433221
Q ss_pred eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|.+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999998865 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.21 Aligned_cols=233 Identities=30% Similarity=0.460 Sum_probs=186.0
Q ss_pred CCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|.+.++||+|+||.||+|.+.+ +..|++|.++.... ..+..|.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 568889999999999999998753 56799998864433 34457999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---cEEEEe
Q 007351 440 LIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSD 511 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~D 511 (607)
+||||+.+++|.++++..+. ..+.+..+++++.||++||+|||++ +++|||||++|||+++++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999998865432 2488999999999999999999998 999999999999998654 699999
Q ss_pred cccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--
Q 007351 512 FGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI-- 587 (607)
Q Consensus 512 FGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~-- 587 (607)
||+++......... .........|||||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---~~~~~~~~~~~~~ 239 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVMEFVTGGGR 239 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCc
Confidence 99998653322211 112233568999999998899999999999999999997 999997542 22222222110
Q ss_pred ------hHHHHHHHHHHhhhcCCC
Q 007351 588 ------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~ 263 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPE 263 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcc
Confidence 125677899999987653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=303.95 Aligned_cols=232 Identities=24% Similarity=0.379 Sum_probs=187.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|+.. +++.||||+++.........+++|+.+++.++|+||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45778899999999999999864 68899999998765555567889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.++++..+. +++..++.++.||+.||+|||++ +|+|+|||++|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 99999998876553 88999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred eeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH--------HHhH-hhHHHHH
Q 007351 526 TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE--------WVNL-IDAKILF 593 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~--------~~~~-~~~~~~~ 593 (607)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||............. +... .....+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 23356889999999875 4568889999999999999999999986543211110000 0000 0124567
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+|+..++
T Consensus 243 ~li~~~l~~~P 253 (267)
T cd06645 243 HFVKMALTKNP 253 (267)
T ss_pred HHHHHHccCCc
Confidence 88999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=316.27 Aligned_cols=198 Identities=24% Similarity=0.332 Sum_probs=167.8
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 436 (607)
..++|++.+.||+|+||.||++... .++.||||+++... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4468999999999999999999864 68899999986432 233457889999999999999999999886443
Q ss_pred -ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..++||||+++ +|...+.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 46899999976 45555543 378888999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+...... ......|+..|||||++.+..++.++|||||||+||||++|+.+|.+.
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8653321 223456899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.50 Aligned_cols=232 Identities=28% Similarity=0.452 Sum_probs=186.2
Q ss_pred CCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
+|++.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|++++..++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999863 2478999999754433 23568899999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 441 IYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
++||+.+++|..++..+. ...+.+..+++++.||++||+|||++ +|+|||||++|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999988875321 22478888899999999999999998 9999999999999999999
Q ss_pred EEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 007351 507 AQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~ 584 (607)
+||+|||+++....... .......++..|||||++.+..++.++|||||||+||||++ |..+|.+.. ..++.+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence 99999999886543322 12233446778999999998889999999999999999998 888886532 22233322
Q ss_pred hHh--------hHHHHHHHHHHhhhcCCC
Q 007351 585 NLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
... ....+.+++.+|++.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 268 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPS 268 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 111 135678999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.67 Aligned_cols=199 Identities=27% Similarity=0.431 Sum_probs=166.5
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHc---cCCCceeEEeEEEeC-----C
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRI---HHRHLVSLVGYCISD-----D 436 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~-----~ 436 (607)
+|++.+.||+|+||.||+|+.. +|+.||||.++..... ....+.+|+++++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 6889999998754322 234566777777765 699999999988642 3
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++||||+.+ +|..++.......+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 46899999974 788887765555689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.+|.+.
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 654322 123346788999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.81 Aligned_cols=226 Identities=24% Similarity=0.396 Sum_probs=184.7
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.++||+|+||.||+|.. .+++.||||++..+. ....+++.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 478899999986543 33446789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+++++|..+. .+.+..+.+++.||+.||+|||++ +|+|+|||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999886543 267888899999999999999998 99999999999999999999999999997653322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH------------hhHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL------------IDAKI 591 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~------------~~~~~ 591 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ....++.+. .....
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 2335688999999999998999999999999999999999999975322111 111122111 12245
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 229 ~~~li~~~l~~~P 241 (279)
T cd06619 229 FVHFITQCMRKQP 241 (279)
T ss_pred HHHHHHHHhhCCh
Confidence 7889999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.02 Aligned_cols=226 Identities=30% Similarity=0.483 Sum_probs=190.3
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|.. .|+.||||.++.... ..+.+.+|++++++++|+||+++++++..++..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4688899999999999999987 589999999976544 46679999999999999999999999999899999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++......+.+..++.++.|++.||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999876655689999999999999999999999 999999999999999999999999999986632221
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
...+...|++||++.+..++.++|||||||++|||++ |+.||.... ..++.+..... ....+.+++.
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence 2334668999999998889999999999999999997 999986542 22222221110 1367788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 234 ~~l~~~p 240 (256)
T cd05039 234 DCWELDP 240 (256)
T ss_pred HHhccCh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.23 Aligned_cols=233 Identities=29% Similarity=0.449 Sum_probs=184.4
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeC-Cc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD-DR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 437 (607)
++|++.++||+|+||.||+|.+. .++.||||+++..... ..+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999742 2478999998754333 345688899999999 799999999988754 46
Q ss_pred eEEEEEecCCCchhHhhhcCCC----------------------------------------------------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGR---------------------------------------------------------- 459 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 459 (607)
.+++|||+.+++|..++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999888754221
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce-eeccccCCCCCc
Q 007351 460 -PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMA 537 (607)
Q Consensus 460 -~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~A 537 (607)
..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......... .....++..|||
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999998 99999999999999999999999999998654332222 223456678999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 538 PEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 538 PE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
||++.+..++.++|||||||+||||++ |+.||.+... ++.+.+..+. .....+.+++.+|++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--cHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999997 9999975321 1222221111 113567889999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.56 Aligned_cols=234 Identities=26% Similarity=0.462 Sum_probs=187.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.+.||+|+||.||+|.+. .++.||||+++.... ....+|.+|+.+++.++|+||+++++++..++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 467999999999999999999753 346799998864332 3445689999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
++||||+.+++|.++++... ...+.+..+++++.||++||+|||+. +++|||||++||||++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 99999999999998886532 12357788899999999999999998 99999999999999999999999
Q ss_pred ecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--
Q 007351 511 DFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL-- 586 (607)
Q Consensus 511 DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~-- 586 (607)
|||+++......... .....++..|||||++.+..++.++|||||||+||||++ |+.||.+.. .....++...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~ 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVMEGG 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCC
Confidence 999997654332221 122345678999999998899999999999999999999 788886542 2222222111
Q ss_pred ------hhHHHHHHHHHHhhhcCCC
Q 007351 587 ------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~ 263 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPK 263 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChh
Confidence 1135678899999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.99 Aligned_cols=231 Identities=23% Similarity=0.374 Sum_probs=190.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|... +|+.||||.++... ......+.+|++++++++|.||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47889999999999999999976 78999999886432 223557899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+.+++|..++.. .....+.+..+++++.||++||+|||++ +|+||||+++|||+++++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999888864 2234578999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------------hh
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------------ID 588 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------------~~ 588 (607)
.... .....++..|+|||++.+..++.++|||+|||++|||++|+.||.... .++.++.+. ..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDYPPLPADHY 233 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCCCCCChhhc
Confidence 3221 223457888999999998899999999999999999999999996532 222222211 22
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 234 ~~~~~~~i~~cl~~~p~ 250 (267)
T cd08224 234 SEELRDLVSRCINPDPE 250 (267)
T ss_pred CHHHHHHHHHHcCCCcc
Confidence 34678899999977653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=308.23 Aligned_cols=230 Identities=23% Similarity=0.398 Sum_probs=191.3
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|++.+.||+|+||.||+|.. .+++.|+||.+........+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999985 478899999998766666677999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.++++.. .+.+.+++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999988653 378899999999999999999998 999999999999999999999999999876533221 1
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---------HhhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN---------LIDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~---------~~~~~~~~~i~ 596 (607)
.....++..|+|||.+.+..++.++|||+|||++|||++|+.||...... ..+..+.. ......+.+++
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 22346788999999999888999999999999999999999999764321 11111111 01135678899
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 251 ~~~l~~~p~ 259 (296)
T cd06654 251 NRCLDMDVE 259 (296)
T ss_pred HHHCcCCcc
Confidence 999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.27 Aligned_cols=233 Identities=27% Similarity=0.481 Sum_probs=189.2
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|...+.||+|+||.||+++.. ++..||+|.++.........|.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45778899999999999999742 356799999876666667789999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 441 IYDYVPNNTLYFHLHGEGR-------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
+|||+.+++|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998875431 2478899999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh
Q 007351 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN 585 (607)
Q Consensus 508 kL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (607)
||+|||+++....... .......++..|++||++.+..++.++|||||||++|||++ |+.||.... ..+..+...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---NTEAIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC---HHHHHHHHH
Confidence 9999999975533221 11223345678999999999999999999999999999998 999986532 122222111
Q ss_pred H--------hhHHHHHHHHHHhhhcCCC
Q 007351 586 L--------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~--------~~~~~~~~i~~~C~~~~~~ 605 (607)
. .....+.+++.+||+.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~ 266 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQ 266 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChh
Confidence 1 1135678999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=306.75 Aligned_cols=231 Identities=27% Similarity=0.455 Sum_probs=183.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.+.||+|+||.||+|.+. +|+ .|++|.+..... ....++.+|+.++++++|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35788899999999999999864 344 477887754332 23356888899999999999999999875 456788
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
++||+.+|+|.++++.... .+++..+++++.||+.||+|||++ +++|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999976443 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHH
Q 007351 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAK 590 (607)
Q Consensus 521 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~ 590 (607)
.... ......++..|++||++.+..++.++|||||||++|||++ |+.||.+... ..+.++... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLEKGERLAQPQICTI 238 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCcCCCCCCCCH
Confidence 3222 1223446778999999998899999999999999999998 9999976432 122222111 1234
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 239 ~~~~li~~c~~~~p~ 253 (279)
T cd05111 239 DVYMVMVKCWMIDEN 253 (279)
T ss_pred HHHHHHHHHcCCCcc
Confidence 567788999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.79 Aligned_cols=233 Identities=25% Similarity=0.409 Sum_probs=189.4
Q ss_pred hCCCcccceecccCcEEEEEEEeCC-----CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~-----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 438 (607)
.++|++.++||+|+||.||+|.+.+ ++.|++|+++.... ...+.+.+|+++|++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999765 68899999875433 345668999999999999999999998876 4678
Q ss_pred EEEEEecCCCchhHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 439 LLIYDYVPNNTLYFHLHGEGR------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
++++||+.+++|..++..... ..+.+..++.++.||+.||+|||++ +++|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999998865422 3588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh---
Q 007351 513 GLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--- 587 (607)
Q Consensus 513 Gls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--- 587 (607)
|+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+... .++.++.+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~ 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGYRL 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCCCC
Confidence 9998654433221 222345778999999998889999999999999999998 9999975421 2233322211
Q ss_pred -----hHHHHHHHHHHhhhcCC
Q 007351 588 -----DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+||+.++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p 260 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDP 260 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCCh
Confidence 13567899999997664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.97 Aligned_cols=231 Identities=30% Similarity=0.445 Sum_probs=182.9
Q ss_pred CcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ceEE
Q 007351 369 FADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLL 440 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~l 440 (607)
|++.++||+|+||.||++.+ .+++.||||+++.... .....|.+|+++|++++|+||+++++++...+ ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 3577899999875433 34567889999999999999999999887643 5789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+++|.+++... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999988754 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC---------chhHHHHHhHh--
Q 007351 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG---------DESLVEWVNLI-- 587 (607)
Q Consensus 521 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~---------~~~l~~~~~~~-- 587 (607)
.... ......++..|++||++.+..++.++|||||||++|||++|+.||......- ......+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 3221 1122335667999999998899999999999999999999999986432100 00111111111
Q ss_pred ---------hHHHHHHHHHHhhhcCCC
Q 007351 588 ---------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ---------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~ 266 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAK 266 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChh
Confidence 125788899999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.27 Aligned_cols=230 Identities=26% Similarity=0.461 Sum_probs=188.3
Q ss_pred CCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
+|++.+.||+|.||.||+|...+|+.+|||.++.... +....+.+|+++|++++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988899999999874421 2234588999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++.... .+.+..++.++.||+.||+|||+. +|+|+||+++|||+++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999987654 378899999999999999999998 9999999999999999999999999998754321
Q ss_pred C-----cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------h
Q 007351 522 N-----THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------I 587 (607)
Q Consensus 522 ~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~ 587 (607)
. ........++..|++||++.+..++.++|||+|||++|||++|+.||........ ....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFYIGAHRGLMPRLPDS 233 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHHhhhccCCCCCCCCC
Confidence 1 1112234688899999999988899999999999999999999999975432211 1111111 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 234 ~~~~~~~~i~~~l~~~p 250 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQ 250 (265)
T ss_pred CCHHHHHHHHHHhcCCc
Confidence 13567889999997764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.52 Aligned_cols=233 Identities=24% Similarity=0.410 Sum_probs=189.7
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
++|.+.+.||+|+||.||++... ++..||||+++.... ...+.+.+|+++++++ +|+||+++++++..++..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999741 355799999875433 3345689999999999 799999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+|+|..+++......+.+.++++++.||+.||+|||++ +|+|+|||++|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999765544589999999999999999999998 9999999999999999999999999999865
Q ss_pred ccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hh
Q 007351 519 LDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------ID 588 (607)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~ 588 (607)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+... +....++... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHHHHcCCcCCCCCCC
Confidence 433221 2222345678999999999999999999999999999998 9999975432 1222222211 12
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 270 ~~~~~~li~~cl~~~p 285 (302)
T cd05055 270 PAEIYDIMKTCWDADP 285 (302)
T ss_pred CHHHHHHHHHHcCCCc
Confidence 3677899999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.49 Aligned_cols=231 Identities=26% Similarity=0.434 Sum_probs=185.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.++||+|+||.||+|++. +|+ .||||+++.... ...+++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888999999999999999853 444 489999875433 345678999999999999999999999875 45789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
+|||+.+|+|.++++... ..+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999887643 2488999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
..... .....++..||+||++.+..++.++|||||||+||||++ |+.||.... ...+.++.... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCcCCCCccCCH
Confidence 32221 112234678999999998899999999999999999998 899987542 22333333221 125
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 239 ~~~~li~~~l~~dp~ 253 (279)
T cd05109 239 DVYMIMVKCWMIDSE 253 (279)
T ss_pred HHHHHHHHHcCCChh
Confidence 667899999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.90 Aligned_cols=197 Identities=24% Similarity=0.341 Sum_probs=167.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC------C
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------D 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 436 (607)
.++|++.+.||+|+||.||++... .++.||||+++... ......+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999864 68899999986432 33446788999999999999999999987643 2
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++||||+.+ +|..++.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 46999999976 56555542 278888999999999999999998 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... ......++..|+|||++.+..++.++|||||||+||||++|+.||.+.
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 653322 223356899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.48 Aligned_cols=222 Identities=27% Similarity=0.442 Sum_probs=178.4
Q ss_pred ecccCcEEEEEEEeC---CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||+|.+. ++..||||+++..... ..++|.+|+++|++++|+||+++++++. .+..++||||+.+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 4567999998755433 3456999999999999999999999885 4578999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeec--
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR-- 528 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~-- 528 (607)
.+++.... ..+++..+++++.||++||+|||++ +++|||||++|||+++++.+||+|||+++............
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99887543 3589999999999999999999998 99999999999999999999999999997554332221111
Q ss_pred cccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHHHh
Q 007351 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVFLC 599 (607)
Q Consensus 529 ~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~~C 599 (607)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+++... ....+.+++.+|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK---GPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 223568999999998889999999999999999996 999997542 22333322221 136778899999
Q ss_pred hhcCC
Q 007351 600 QQNSN 604 (607)
Q Consensus 600 ~~~~~ 604 (607)
|..+.
T Consensus 235 ~~~~~ 239 (257)
T cd05115 235 WIYKW 239 (257)
T ss_pred cCCCh
Confidence 97654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.07 Aligned_cols=231 Identities=27% Similarity=0.416 Sum_probs=180.8
Q ss_pred CcccceecccCcEEEEEEEeCCCc---EEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC------Cc
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGR---EVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~---~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 437 (607)
|.++++||+|+||.||+|.+.++. .||||.++... ....+.+.+|+++|+.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999975432 58999887542 33446789999999999999999999987542 24
Q ss_pred eEEEEEecCCCchhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 438 RLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
.+++|||+.+|+|..++... ....+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 58999999999998776422 223478999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh----
Q 007351 514 LAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI---- 587 (607)
Q Consensus 514 ls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~---- 587 (607)
+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.||.... ...+.+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLRQGNRLK 234 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCCCC
Confidence 998664332211 122235668999999999899999999999999999999 889997532 22222221111
Q ss_pred ----hHHHHHHHHHHhhhcCCC
Q 007351 588 ----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~ 256 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPK 256 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcc
Confidence 125688999999987753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.93 Aligned_cols=231 Identities=26% Similarity=0.408 Sum_probs=190.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|+..++||+|+||.||.++.. +++.|++|++.... ....+++.+|+++|++++|+||+++++++.+++..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999998854 68899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++.......+++..++.++.|+++||+|||++ +|+||||+++|||+++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999776445689999999999999999999998 999999999999999999999999999986644332
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVF 597 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~ 597 (607)
......++..|+|||++.+..++.++|||||||++|||++|+.+|...... +...+... ......+.+++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVKIVQGNYTPVVSVYSSELISLVH 234 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 233456889999999999888899999999999999999999999753211 11111110 011356788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 235 ~~l~~~p 241 (256)
T cd08221 235 SLLQQDP 241 (256)
T ss_pred HHcccCc
Confidence 9997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.34 Aligned_cols=223 Identities=26% Similarity=0.426 Sum_probs=180.3
Q ss_pred eecccCcEEEEEEEeC---CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 374 LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
.||+|+||.||+|.++ +++.||||+++.... ...+++.+|+++++.++|+||+++++++. ++..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899999875432 33467899999999999999999999885 45678999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee--
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-- 526 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~-- 526 (607)
+|..++.... .+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999887654 388999999999999999999998 999999999999999999999999999986544332211
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~ 597 (607)
....++..|||||++.+..++.++|||||||++|||++ |+.||.+.. ...+.++.+. .....+.+++.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQMIESGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 22234578999999988889999999999999999998 999997642 2222222221 12366789999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+||+.++.
T Consensus 233 ~~~~~~p~ 240 (257)
T cd05116 233 LCWTYGVD 240 (257)
T ss_pred HHhccCch
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.54 Aligned_cols=226 Identities=28% Similarity=0.358 Sum_probs=188.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||++... +++.||||+++... ......+.+|+++|++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 68899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++.... .+.+..++.++.||++||+|||++ +|+||||+++||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987664 488999999999999999999998 9999999999999999999999999999865443
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i 595 (607)
.....++..|++||.+.+..++.++|||+||+++|||++|+.||.... .....+... ......+.++
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l 228 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKVRFPSFFSPDAKDL 228 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCccCCccCCHHHHHH
Confidence 233467889999999988888999999999999999999999997543 111111110 0114677889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 229 i~~~l~~~p 237 (290)
T cd05580 229 IRNLLQVDL 237 (290)
T ss_pred HHHHccCCH
Confidence 999997764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.34 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=172.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 688999999864432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|++++.|..++.... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998887765543 389999999999999999999998 999999999999999999999999999986644332
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
......++..|++||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457788999999876 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.65 Aligned_cols=231 Identities=22% Similarity=0.369 Sum_probs=189.6
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||++.. .+++.||||.++... .....++.+|+++++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4578889999999999999995 488999999886432 233457889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+.+++|.+++.. .....+.+..+++++.||++||+|||++ +|+|+|||++|||++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999888763 2234588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------------hh
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------------ID 588 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------------~~ 588 (607)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||.+... +..++.+. ..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDYPPLPSDHY 233 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCCCCCCCcccc
Confidence 322 12234688899999999988899999999999999999999999965321 11122111 12
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 234 ~~~~~~li~~~l~~~p~ 250 (267)
T cd08229 234 SEELRQLVNMCINPDPE 250 (267)
T ss_pred cHHHHHHHHHhcCCCcc
Confidence 35788999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.72 Aligned_cols=233 Identities=25% Similarity=0.422 Sum_probs=185.4
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchh-HHHHHHHHHHHHHcc-CCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQG-EREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 438 (607)
++|.+++.||+|+||.||+|+++ .++.||||+++...... .+.+.+|+++|.+++ |+||++++++|..++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35778899999999999999863 24679999997543333 346889999999997 99999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCC-----------------------------------------------------------
Q 007351 439 LLIYDYVPNNTLYFHLHGEGR----------------------------------------------------------- 459 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 459 (607)
+|||||+.+|+|+++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999998865321
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc
Q 007351 460 -------------------------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (607)
Q Consensus 460 -------------------------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (607)
..+.+..+++|+.||++||+|||+. +|+|||||++|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 2366778889999999999999998 999999999999999
Q ss_pred CCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhH
Q 007351 503 NNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l 580 (607)
+++.+||+|||+++....... .......++..||+||++.+..++.++|||||||+||||++ |+.||..... .+.+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~~~~ 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--NEQF 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--hHHH
Confidence 999999999999986533221 11223456788999999998889999999999999999998 8999865321 1111
Q ss_pred HHHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 581 VEWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 581 ~~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
.+.... .....+.+++.+||+.++
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P 383 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 111110 113677899999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.65 Aligned_cols=230 Identities=28% Similarity=0.521 Sum_probs=188.9
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
.+|++.+.||+|+||.||++.+.+++.+|||.++... ....+|.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3577889999999999999998778899999886432 335678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++.... .+.+..+++++.|++.||+|||++ +++|||||++|||+++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998876433 378899999999999999999998 999999999999999999999999999976543322222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~ 597 (607)
....++.+|+|||++.++.++.++|||||||++|||++ |+.||.... ...+.+..+ .+....+.+++.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 22334578999999998899999999999999999998 999997532 122222211 113467889999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 236 ~~l~~~p 242 (256)
T cd05112 236 HCWKERP 242 (256)
T ss_pred HHcccCh
Confidence 9997765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.50 Aligned_cols=231 Identities=26% Similarity=0.421 Sum_probs=184.3
Q ss_pred CcccceecccCcEEEEEEEeCC----CcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-----
Q 007351 369 FADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 437 (607)
|++++.||+|+||.||+|.+.. ++.||||+++... ......+.+|+++|+.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 3679999987543 2334578999999999999999999998876554
Q ss_pred -eEEEEEecCCCchhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 438 -RLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 438 -~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
.+++|||+.+|+|..++... ....+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999998887542 223588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh---
Q 007351 513 GLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--- 587 (607)
Q Consensus 513 Gls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--- 587 (607)
|+++......... .....++..|++||++.+..++.++|||||||++|||++ |..||.+.. ..++.++....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~ 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRHGNRL 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCC
Confidence 9998664433221 112234668999999988899999999999999999999 889986532 22333332211
Q ss_pred -----hHHHHHHHHHHhhhcCCC
Q 007351 588 -----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~ 257 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPK 257 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChh
Confidence 135778899999987653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.85 Aligned_cols=232 Identities=26% Similarity=0.395 Sum_probs=191.2
Q ss_pred CCCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|+..+.||+|.||.||+|++.+ ++.|++|.++.... ..++.+|++++++++|+||+++++++..++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568889999999999999999764 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++...+ ..+++..++.++.||++||.|||+. +|+||||+++||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999886543 3589999999999999999999998 999999999999999999999999999986644332 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-H-----H-HhHhhHHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-E-----W-VNLIDAKILFKLVFL 598 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~-----~-~~~~~~~~~~~i~~~ 598 (607)
.....++..|++||++.+..++.++|||+|||++|||++|+.||............ . + ........+.+++.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 23345788999999999999999999999999999999999999764322111000 0 0 001112567889999
Q ss_pred hhhcCCC
Q 007351 599 CQQNSNS 605 (607)
Q Consensus 599 C~~~~~~ 605 (607)
|++.++.
T Consensus 236 ~l~~~P~ 242 (256)
T cd06612 236 CLVKDPE 242 (256)
T ss_pred HHhcChh
Confidence 9987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.72 Aligned_cols=225 Identities=28% Similarity=0.458 Sum_probs=185.2
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~ 445 (607)
++|++.++||+|+||.||++.. .|+.||+|.++.. ...+.|.+|+.++++++|+||+++++++.. ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999987 6888999998643 334678999999999999999999997654 45789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.++++......+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876665689999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
....+...|||||++.+..++.++|||||||++|||++ |+.||.... ..++.++.... ....+.+++
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKGYKMDAPDGCPPVVYDVM 232 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 12234567999999998899999999999999999997 999986431 12222222111 135678899
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 233 ~~~l~~~p 240 (256)
T cd05082 233 KQCWHLDA 240 (256)
T ss_pred HHHhcCCh
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.40 Aligned_cols=232 Identities=28% Similarity=0.451 Sum_probs=186.8
Q ss_pred CCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
+|++.++||+|+||.||+|... ..+.|++|.++.... ....++.+|+++|+.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235789998865433 334578999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCC
Q 007351 441 IYDYVPNNTLYFHLHGEG----------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (607)
+|||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999988875421 12478889999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 007351 499 ILLDNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (607)
Q Consensus 499 ILl~~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~ 576 (607)
|||++++.+||+|||+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999998654333221 222345678999999998899999999999999999998 999997532
Q ss_pred chhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 577 DESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 577 ~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
...+.++.+.. ....+.+++.+|++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~ 271 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPD 271 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 22333332211 125778999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.18 Aligned_cols=233 Identities=26% Similarity=0.443 Sum_probs=189.4
Q ss_pred hCCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|.+.+.||+|+||.||+|.+.+ ++.||||.+..... .....+.+|+++|+.++|+||+++++++..++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568889999999999999998642 36899999865433 3345788999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
++||||+.+|+|..++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999998886532 22367889999999999999999998 99999999999999999999999
Q ss_pred ecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh-
Q 007351 511 DFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI- 587 (607)
Q Consensus 511 DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~- 587 (607)
|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.+|.+.. ...+.++....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~ 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVIDGG 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHhcCC
Confidence 9999986544322 12233456788999999998889999999999999999998 999986532 22333333211
Q ss_pred -------hHHHHHHHHHHhhhcCC
Q 007351 588 -------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p 262 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNP 262 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCh
Confidence 13677899999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.36 Aligned_cols=229 Identities=22% Similarity=0.356 Sum_probs=186.4
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
|++.+.||+|+||.||+|.+. +++.+++|.+........+.+.+|+++++.++|+||+++++++..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999975 5778899988765555567789999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|..++.... ..+.+..++.++.||++||+|||+. +|+|||||++|||+++++++||+|||+++....... ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 99988776533 2489999999999999999999998 999999999999999999999999999976533221 223
Q ss_pred ccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHH
Q 007351 528 RVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILF 593 (607)
Q Consensus 528 ~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~ 593 (607)
...++..||+||++. +..++.++|||||||++|||++|+.||...... ....++.+. .....+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcCCCCCCCccccCHHHH
Confidence 356888999999984 345778999999999999999999999754311 111122111 1135688
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+||+.++
T Consensus 240 ~li~~~l~~~p 250 (282)
T cd06643 240 DFLKKCLEKNV 250 (282)
T ss_pred HHHHHHccCCh
Confidence 99999997764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.86 Aligned_cols=231 Identities=23% Similarity=0.385 Sum_probs=191.3
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|++.+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788999999999999999985 478999999998766666677899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++++|.+++... .+.+..+++++.|++.||+|||+. +|+|||||++||||++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999988653 378889999999999999999998 999999999999999999999999999876543322 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~ 597 (607)
.....++..|++||.+.+..++.++|||||||++|||++|+.||.......... ..+.. ......+.+++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccCCCCCCCCccccCHHHHHHHH
Confidence 233467889999999998889999999999999999999999997643211100 00000 112355678889
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+|++.++.
T Consensus 251 ~~l~~~p~ 258 (297)
T cd06656 251 RCLEMDVD 258 (297)
T ss_pred HHccCChh
Confidence 99977653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.12 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=174.4
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.|.+.+.||+|.|..|-++++- .|+.||||++..... .....+.+|++.|+.++|+|||+||.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4667788999999999998843 899999999964332 2345688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE-cCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL-DNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl-~~~~~vkL~DFGls~~~~~~~~ 523 (607)
-++|+|++|+.+.+. .+.++...++++||+.|+.|+|+. .|||||||++||.+ .+-|.|||.|||++..+..+..
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999876543 488999999999999999999998 89999999999877 5668999999999987755433
Q ss_pred ceeeccccCCCCCchhhhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTE-KSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~-~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
....+|.+.|-|||+|+|..|+. .+||||||||||.|++|+.||+...
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 45578999999999999999985 6899999999999999999998653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.69 Aligned_cols=234 Identities=29% Similarity=0.433 Sum_probs=187.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
.++|++.+.||+|+||.||++.+. +.+.||||.++... .+...++.+|+++++++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456888999999999999999864 23679999987543 23345688999999999 79999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC
Q 007351 438 RLLIYDYVPNNTLYFHLHGE--------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (607)
.+++|||+.+|+|..+++.. ....+++..+++++.||+.||+|||++ +|+|||||++|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999999999999988642 234588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHH
Q 007351 504 NFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLV 581 (607)
Q Consensus 504 ~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~ 581 (607)
++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..++.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEELF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---HHHHH
Confidence 9999999999998654432211 122234568999999998899999999999999999997 999987542 11222
Q ss_pred HHHhH--------hhHHHHHHHHHHhhhcCCC
Q 007351 582 EWVNL--------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 582 ~~~~~--------~~~~~~~~i~~~C~~~~~~ 605 (607)
+.... .....+.+++.+|++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 276 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS 276 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence 21111 1135678899999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.64 Aligned_cols=228 Identities=26% Similarity=0.448 Sum_probs=188.5
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
+|++.+.||+|+||.||+|... +++.|+||++.... .+..+.+.+|+++++.++|+||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999976 78999999986543 22446789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|..++.... .+++..++.++.||++||+|||+. +|+|+||+++||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999987654 378899999999999999999998 9999999999999999999999999998765433
Q ss_pred CcceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKIL 592 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~ 592 (607)
. ......++..|++||.+.... ++.++|||+|||++|||++|+.||...... ..+.++.. ......+
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHHhcccCCCcCCCcCHHH
Confidence 2 223456788999999988766 899999999999999999999999764311 11222222 0113567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 232 ~~li~~~l~~~p 243 (258)
T cd06632 232 KDFILKCLQRDP 243 (258)
T ss_pred HHHHHHHhhcCc
Confidence 889999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.32 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=169.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|+++++.++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 688999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+. ++|..++.... ...+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 57777775432 24588999999999999999999998 99999999999999999999999999997543221
Q ss_pred ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......++..|+|||++.+. .++.++|||||||++|||++|+.+|.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 222334578899999988764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.58 Aligned_cols=234 Identities=21% Similarity=0.368 Sum_probs=188.8
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 442 (607)
...|++++.||+|+.+.||++...+...+|+|++.... .+...-|+.|+++|.+|+ |.+|++||+|...++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35689999999999999999998888899999886443 334456999999999996 999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||- +.+|..+|+.......+| .++.+.+||+.++.++|++ ||||.|||+.|+||-++ ++||||||+|..+....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcccCccc
Confidence 986 568999998877765666 7888999999999999999 99999999999999875 89999999998776554
Q ss_pred cc-eeeccccCCCCCchhhhcCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------C-chhHHH
Q 007351 523 TH-ITTRVMGTFGYMAPEYASSGK-----------LTEKSDVFSFGVVLLELITGRKPVDASQPL-------G-DESLVE 582 (607)
Q Consensus 523 ~~-~~~~~~gt~~y~APE~l~~~~-----------~~~~~DVwSlGvll~ELltg~~Pf~~~~~~-------~-~~~l~~ 582 (607)
.. .....+||+.||+||.+.... ...++||||||||||+|+.|+.||...... . -+..++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 43 345678999999999986543 346799999999999999999999754310 0 011122
Q ss_pred HHhHhhHHHHHHHHHHhhhcCCC
Q 007351 583 WVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 583 ~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
|...-....+.++..+|+..++.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPk 616 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPK 616 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcc
Confidence 22222334488999999977653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.00 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=176.0
Q ss_pred ceecccCcEEEEEEEeCC-------------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 373 NLLGEGGFGSVYKGYLPD-------------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-------------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
+.||+|+||.||+|++.+ +..|+||++..........|.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555567899999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc-------EEEEec
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-------AQVSDF 512 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-------vkL~DF 512 (607)
+||||+.++.|..+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999888865432 489999999999999999999998 9999999999999987654 899999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCchhHHHHHhH----
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELI-TGRKPVDASQPLGDESLVEWVNL---- 586 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~DVwSlGvll~ELl-tg~~Pf~~~~~~~~~~l~~~~~~---- 586 (607)
|++...... ....++..|||||++. +..++.++|||||||+||||+ .|+.||...... +..+....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~ 228 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---EKERFYEGQCML 228 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---HHHHHHhcCccC
Confidence 998754322 2235778899999887 467889999999999999998 588888653211 11111110
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+||+.++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred CCCChHHHHHHHHHHcCCCh
Confidence 013567889999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.94 Aligned_cols=232 Identities=28% Similarity=0.391 Sum_probs=190.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999864 68899999887543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|..++...+ .+.+..+++++.+|+.||.|||+.. +|+|||||++|||+++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999998887644 3889999999999999999999732 89999999999999999999999999987543222
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-----chhHHHHHhHh------------
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG-----DESLVEWVNLI------------ 587 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~-----~~~l~~~~~~~------------ 587 (607)
....+|+..|++||++.+..++.++|||||||++|||++|+.||....... ...+.++.+.+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 223568999999999988899999999999999999999999998644321 11122222211
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 238 ~~~~~~~li~~~l~~dp~ 255 (284)
T cd06620 238 FPEDLRDFVDACLLKDPT 255 (284)
T ss_pred cCHHHHHHHHHHhcCCcc
Confidence 124578899999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.33 Aligned_cols=231 Identities=28% Similarity=0.455 Sum_probs=183.5
Q ss_pred CCCcccceecccCcEEEEEEEeCC-Cc--EEEEEEeecC-CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-GR--EVAIKQLKIG-GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|.+++ +. .+++|.++.. .....+.+.+|+++++++ +|+||+++++++..++..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 33 4788888743 233456789999999999 799999999999999999999
Q ss_pred EEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 442 YDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
|||+.+++|.++++.... ..+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999998865321 2478889999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH-h
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV-N 585 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~-~ 585 (607)
||+|||++........ ......+..|++||++.+..++.++|||||||+||||++ |+.||.+... .++.+.. .
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~~~ 233 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 233 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc
Confidence 9999999864321111 111223457999999998889999999999999999997 9999975421 1222211 1
Q ss_pred H-------hhHHHHHHHHHHhhhcCCC
Q 007351 586 L-------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~-------~~~~~~~~i~~~C~~~~~~ 605 (607)
. .....+.+++.+|++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~ 260 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPY 260 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 1 1235678999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.70 Aligned_cols=233 Identities=28% Similarity=0.413 Sum_probs=186.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++|.+.+.||+|+||.||+|++. ++..||||.++... ....+++.+|+++++.+ +|+||+++++++..+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356888899999999999999741 24579999886433 33456799999999999 799999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..++||||+.+|+|..++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999887532 13477888999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..+|.+.. ..+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHH
Confidence 999999999999998664332221 222335678999999998899999999999999999998 788886532 222
Q ss_pred HHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 580 LVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 580 l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
+.+..+.. ....+.+++.+||+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCh
Confidence 22222111 12578889999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.21 Aligned_cols=200 Identities=31% Similarity=0.465 Sum_probs=169.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-----CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 439 (607)
++|++.+.||+|+||.||++.++ +++.||||+++.......+.|.+|+++|++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999753 5789999998866666667899999999999999999999987643 4678
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+.+++|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999987543 2489999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 520 DANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
...... .....+...|++||++.+..++.++|||||||++|||++|..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 332221 112234456999999998899999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.78 Aligned_cols=234 Identities=28% Similarity=0.456 Sum_probs=189.4
Q ss_pred hCCCcccceecccCcEEEEEEEeCC-----------------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCcee
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD-----------------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~-----------------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~ 427 (607)
.++|++.+.||+|+||.||++++.+ +..||+|+++.... ....++.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999988642 24589999875543 34567899999999999999999
Q ss_pred EEeEEEeCCceEEEEEecCCCchhHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCC
Q 007351 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (607)
Q Consensus 428 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (607)
+++++..++..+++|||+.+++|..++.... ...+.+..+++++.||++||+|||++ +|+|||||++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999887643 12488999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 007351 499 ILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPL 575 (607)
Q Consensus 499 ILl~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt--g~~Pf~~~~~~ 575 (607)
||+++++.+||+|||+++....... .......++..|||||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543322 22334456778999999998899999999999999999998 777886432
Q ss_pred CchhHHHHHhHh---------------hHHHHHHHHHHhhhcCCC
Q 007351 576 GDESLVEWVNLI---------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 576 ~~~~l~~~~~~~---------------~~~~~~~i~~~C~~~~~~ 605 (607)
+....++.... ....+.+++.+|++.++.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 282 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282 (296)
T ss_pred -hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChh
Confidence 22222222211 125789999999987653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.59 Aligned_cols=198 Identities=17% Similarity=0.278 Sum_probs=166.8
Q ss_pred ccceeccc--CcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 371 DQNLLGEG--GFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 371 ~~~~IG~G--~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++++||+| +|+.||++..+ +|+.||||+++... ....+.+++|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999864 78999999997543 233456888999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~- 524 (607)
++|+|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.++|+|||...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999988765444589999999999999999999998 9999999999999999999999999876543221111
Q ss_pred -----eeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 525 -----ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 525 -----~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
......++..|||||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1122346778999999876 3588999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.32 Aligned_cols=200 Identities=25% Similarity=0.411 Sum_probs=175.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.+.|++.++||+|.|+.||++... .|+++|+|++..+ ...+.+++.+|++|.+.|+|+|||+|.+-+.+++..+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356788899999999999999754 7899999988533 3446788999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGls~~~~ 519 (607)
|+|+|++|.+-+-.+ ..+++......++||+++|.|+|.+ +|||||||+.|+||- ..--+||+|||++....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999996655443 3477888889999999999999999 999999999999993 44569999999999876
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
....-..++|+.+|||||++....|...+|||+-||+||-||.|+.||+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 344556678999999999999999999999999999999999999999984
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.24 Aligned_cols=230 Identities=23% Similarity=0.409 Sum_probs=191.6
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|++.+.||.|+||.||+|.. .+|+.|+||.+........+.+.+|+++++.++|+||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999985 478999999997666556677899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|..++... .+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999888653 389999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i~ 596 (607)
.....++..||+||.+.+..++.++|||||||++|||++|+.||....... .+..+... .....+.+++
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 233467889999999998889999999999999999999999997653211 11111100 0134677889
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+||+.++.
T Consensus 250 ~~~l~~dp~ 258 (296)
T cd06655 250 NRCLEMDVE 258 (296)
T ss_pred HHHhhcChh
Confidence 999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.39 Aligned_cols=230 Identities=26% Similarity=0.452 Sum_probs=186.9
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCc
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---------GEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 437 (607)
+|.+.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|++++++++|+||+++++++..++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999864 6789999988643221 12458899999999999999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.++||||+.+++|..++...+ .+++..++.++.||++||+|||++ +++||||+++||||++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997654 378888999999999999999998 999999999999999999999999999986
Q ss_pred cccCCcc-----eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------
Q 007351 518 ALDANTH-----ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------ 586 (607)
Q Consensus 518 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------ 586 (607)
....... ......|+..|++||++.+..++.++|||+|||++|||++|+.||.+.... ....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 233 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGENASPEIP 233 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHHhccCCCcCC
Confidence 6432111 112345788999999999888999999999999999999999999764321 111111111
Q ss_pred -hhHHHHHHHHHHhhhcCC
Q 007351 587 -IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 -~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+||+.++
T Consensus 234 ~~~~~~~~~li~~~l~~~p 252 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDH 252 (267)
T ss_pred cccCHHHHHHHHHHccCCc
Confidence 124667889999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.62 Aligned_cols=225 Identities=26% Similarity=0.455 Sum_probs=180.9
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
+.||+|+||.||+|++. +++.||||.++... ......+.+|+++|++++|+||++++++|..++..+|||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999874 78899999886433 23446799999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee-ecc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRV 529 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~-~~~ 529 (607)
.+++.... ..+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...+...... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99887543 3488999999999999999999998 999999999999999999999999999875433211111 111
Q ss_pred ccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhh
Q 007351 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQ 600 (607)
Q Consensus 530 ~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~ 600 (607)
.+...|+|||.+.+..++.++|||||||++|||++ |..||.... ..+..+.... .....+.+++.+|+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS---NQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC---HHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 23456999999998899999999999999999997 888886532 1222221111 12366788999999
Q ss_pred hcCC
Q 007351 601 QNSN 604 (607)
Q Consensus 601 ~~~~ 604 (607)
+.++
T Consensus 234 ~~~p 237 (252)
T cd05084 234 EYDP 237 (252)
T ss_pred CCCh
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=295.77 Aligned_cols=226 Identities=26% Similarity=0.458 Sum_probs=185.2
Q ss_pred ceecccCcEEEEEEEeCC--C--cEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD--G--REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~--g--~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++|+||+++++++.. ...++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3699999986665 556789999999999999999999999988 888999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc--e
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--I 525 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~--~ 525 (607)
++|..++.......+.+..++.++.||++||+|||++ +++|||||++|||+++++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999998775534589999999999999999999998 9999999999999999999999999999866443221 1
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL---------IDAKILFKL 595 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i 595 (607)
.....++..|++||++.+..++.++|||||||++|||++ |+.||.... ..++.+.... .....+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 123456788999999998899999999999999999998 999996532 2222221110 113678889
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 234 i~~~l~~~p~ 243 (257)
T cd05040 234 MLQCWAHNPA 243 (257)
T ss_pred HHHHCCCCcc
Confidence 9999987654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.05 Aligned_cols=234 Identities=25% Similarity=0.442 Sum_probs=186.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.++||+|+||.||+|..+ .+..||||.++.... ....++.+|+++++.++|+||+++++++..++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467899999999999999999753 245799998864432 3345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
++||||+.+|+|.++++... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999986532 23356778889999999999999998 99999999999999999999999
Q ss_pred ecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--
Q 007351 511 DFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL-- 586 (607)
Q Consensus 511 DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~-- 586 (607)
|||+++........ ......++..||+||.+.+..++.++|||||||++|||++ |+.||.+.. ..+..++...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~ 238 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKFVMDGG 238 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC
Confidence 99999865432221 1222345678999999998899999999999999999998 788886532 2233222211
Q ss_pred ------hhHHHHHHHHHHhhhcCCC
Q 007351 587 ------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~ 263 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPK 263 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChh
Confidence 1136789999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.33 Aligned_cols=231 Identities=24% Similarity=0.371 Sum_probs=190.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|.+. +++.||+|+++.......+.|.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999974 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|..++...+. .+.+..+++++.||+.||.|||++ +|+|+|||++|||+++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 85 DGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 99999988876432 488999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred eeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------hHHH
Q 007351 526 TTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------DAKI 591 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~~ 591 (607)
.....++..|++||++.. ..++.++|||||||++|||++|+.||...... ..+.++.+.. ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHhcCCCCCcCCcccCCHH
Confidence 233468889999999853 34677999999999999999999999764321 1222222211 1246
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 238 ~~~li~~~l~~~p 250 (280)
T cd06611 238 FNDFLKSCLVKDP 250 (280)
T ss_pred HHHHHHHHhccCh
Confidence 7788999997765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.30 Aligned_cols=221 Identities=27% Similarity=0.453 Sum_probs=177.2
Q ss_pred ceecccCcEEEEEEEeCCCc-----------EEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 373 NLLGEGGFGSVYKGYLPDGR-----------EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~-----------~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++||+|+||.||+|.+.+.. .|++|.++..... ...|.+|+++|+.++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 5788877654333 6789999999999999999999999988 788999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-------cEEEEeccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-------EAQVSDFGL 514 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-------~vkL~DFGl 514 (607)
|||+.+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999876543 588999999999999999999998 999999999999999887 799999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh---Hhh
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN---LID 588 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~---~~~ 588 (607)
++.... .....+...|++||++.+. .++.++|||||||++|||++ |..+|............++.. ...
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD 229 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence 986543 2223466789999999876 78899999999999999999 577886543211111111111 111
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 230 ~~~~~~li~~~l~~~p 245 (259)
T cd05037 230 CAELANLINQCWTYDP 245 (259)
T ss_pred chHHHHHHHHHhccCh
Confidence 3677899999997664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=293.15 Aligned_cols=232 Identities=23% Similarity=0.365 Sum_probs=188.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-ceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E 443 (607)
+|++.+.||+|+||.||++..+ +++.||||++.... ....+.+.+|++++++++|+||+++++.+..++ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999865 57889999986543 234456899999999999999999999876444 5789999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++.......+.+.++++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999988775555689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLV 596 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~ 596 (607)
.......++..|+|||++.+..++.++|||||||++|||++|+.+|...... .....+.. ......+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRIIEGKLPPMPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCCCCCccccCHHHHHHH
Confidence 2233456788999999999999999999999999999999999999753210 11111111 01236678899
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 235 ~~~l~~~p~ 243 (257)
T cd08223 235 ATMLSKRPE 243 (257)
T ss_pred HHHhccCcc
Confidence 999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=294.86 Aligned_cols=223 Identities=29% Similarity=0.479 Sum_probs=181.2
Q ss_pred ceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|.+.. ++.||||.++.... ..++++.+|+++|+.++|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899999875544 34567999999999999999999999876 4567999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|.+++.... .+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997655 489999999999999999999998 9999999999999999999999999999866443322211
Q ss_pred --ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 528 --RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 528 --~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
...++..|++||.+.+..++.++|||||||+||||++ |+.||.... ..++.++.... ....+.+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 1223467999999998899999999999999999998 999997542 22333333221 126678999
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 232 ~~cl~~~p 239 (257)
T cd05060 232 LSCWKYRP 239 (257)
T ss_pred HHHhcCCh
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.51 Aligned_cols=232 Identities=29% Similarity=0.475 Sum_probs=185.2
Q ss_pred CCCcccceecccCcEEEEEEEeCC---------------CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD---------------GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVG 430 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~---------------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g 430 (607)
++|++.+.||+|+||.||+++..+ ...||||+++..... ....|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468889999999999999987532 235899998754333 3456999999999999999999999
Q ss_pred EEEeCCceEEEEEecCCCchhHhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEE
Q 007351 431 YCISDDRRLLIYDYVPNNTLYFHLHGEG----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (607)
Q Consensus 431 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (607)
++..++..++||||+.+++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999998886432 12367888999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCCc
Q 007351 501 LDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLGD 577 (607)
Q Consensus 501 l~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt--g~~Pf~~~~~~~~ 577 (607)
|++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~ 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---D 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---h
Confidence 99999999999999976543322 12233445778999999998899999999999999999998 667876532 1
Q ss_pred hhHHH-HHhH--------------hhHHHHHHHHHHhhhcCC
Q 007351 578 ESLVE-WVNL--------------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 578 ~~l~~-~~~~--------------~~~~~~~~i~~~C~~~~~ 604 (607)
.+..+ .... .....+.+++.+|++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 280 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDI 280 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 22211 1110 112568899999998765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.73 Aligned_cols=232 Identities=29% Similarity=0.413 Sum_probs=185.0
Q ss_pred CCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 436 (607)
++|.+++.||+|+||.||+++.. ++..||||.++... .....++.+|+++++++ +|+||+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46899999999999999999752 23469999987543 33445788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (607)
..++||||+.+|+|.+++..... ..+.+.++++++.||+.||+|||++ +|+|||||++|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999875421 2478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhH
Q 007351 503 NNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l 580 (607)
+++.+||+|||+++......... .....++..|||||++.+..++.++|||||||++|||++ |+.||.+.. ..++
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHH
Confidence 99999999999997654322111 111224468999999999899999999999999999998 888886532 1122
Q ss_pred HHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 581 VEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 581 ~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
.+..+.. ....+.+++.+|++.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCh
Confidence 2111111 13577889999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.55 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=171.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|.++ +++.||||++...... ..+.+.+|+++|+.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 5889999988643322 34568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|++++.|..+...... +++..++.++.||++||+|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999988877665433 89999999999999999999998 999999999999999999999999999976544332
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 2233457889999999875 34678999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.97 Aligned_cols=232 Identities=27% Similarity=0.448 Sum_probs=186.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-C---CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-D---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~---g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.+.||+|+||.||+|++. + +..||||.++.... ...+.|.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999863 2 33699998875432 3346789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++..... .+.+.++++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999876543 478999999999999999999998 9999999999999999999999999999866443
Q ss_pred Cccee--eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHH
Q 007351 522 NTHIT--TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAK 590 (607)
Q Consensus 522 ~~~~~--~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~ 590 (607)
..... ....++..|++||++.+..++.++|||+|||++|||++ |+.||.+... .+..++... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCcCCCCCCCCH
Confidence 32221 11223568999999998899999999999999999886 9999975431 122222111 0134
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 237 ~~~~li~~~l~~~p~ 251 (267)
T cd05066 237 ALHQLMLDCWQKDRN 251 (267)
T ss_pred HHHHHHHHHcccCch
Confidence 678899999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.05 Aligned_cols=236 Identities=26% Similarity=0.437 Sum_probs=186.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-----------------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-----------------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSL 428 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-----------------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 428 (607)
++|++.+.||+|+||.||+++.. ++..||||+++.... ....+|.+|+++|+.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998632 234699999875433 334679999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCE
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 499 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NI 499 (607)
++++..++..++||||+.+++|..++..... ..+.+..+++++.||+.||+|||++ +|+|||||++||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999998875432 2367788999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCC
Q 007351 500 LLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLG 576 (607)
Q Consensus 500 Ll~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt--g~~Pf~~~~~~~ 576 (607)
||++++.+||+|||+++....... ....+..++..|++||++.++.++.++|||||||+||||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976543322 12233345678999999888889999999999999999998 778886532211
Q ss_pred ch-hHHHHHhH-----------hhHHHHHHHHHHhhhcCCC
Q 007351 577 DE-SLVEWVNL-----------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 577 ~~-~l~~~~~~-----------~~~~~~~~i~~~C~~~~~~ 605 (607)
.. ...++.+. .....+.+++.+||+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 11 11111111 1126778999999987754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=298.82 Aligned_cols=231 Identities=29% Similarity=0.480 Sum_probs=185.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CC---cEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DG---REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g---~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.+|++.+.||+|+||.||+|++. ++ ..||||+++... ....++|.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999999865 33 359999987543 33456799999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.++++.... .+.+..++.++.|++.||+|||++ +++|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998876433 488999999999999999999998 9999999999999999999999999998765432
Q ss_pred Ccce--eecc--ccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------h
Q 007351 522 NTHI--TTRV--MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------D 588 (607)
Q Consensus 522 ~~~~--~~~~--~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~ 588 (607)
.... .... ..+..|++||++.+..++.++|||||||++|||++ |+.||.... ..+..++.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYRLPPPMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCcCCCcccC
Confidence 2211 1111 12457999999999999999999999999999986 999997542 22333332211 1
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++..|++.++
T Consensus 237 ~~~~~~li~~~l~~~p 252 (269)
T cd05065 237 PTALHQLMLDCWQKDR 252 (269)
T ss_pred CHHHHHHHHHHcCCCh
Confidence 2457889999997764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.93 Aligned_cols=199 Identities=25% Similarity=0.389 Sum_probs=168.2
Q ss_pred HHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC----
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD---- 435 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~---- 435 (607)
....++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++|+.++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999864 67899999986432 22345678899999999999999999987543
Q ss_pred --CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 436 --DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 436 --~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
...++++|++ +++|..++... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 67887776542 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+++..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.+|.+.
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865432 233468999999999877 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.61 Aligned_cols=230 Identities=30% Similarity=0.478 Sum_probs=182.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc--EEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR--EVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~--~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.+.||+|+||.||+|+++ ++. .+++|.++... ......+.+|+++|.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999964 444 45777776433 23445789999999999 899999999999999999999
Q ss_pred EEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 442 YDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
|||+.+++|..+++... ...+.+..++.++.||++||+|||++ +|+|||||++||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999887542 22478899999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (607)
||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+... .++.+....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 238 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhc
Confidence 999999986432111 1111234567999999988889999999999999999998 9999975432 122221111
Q ss_pred --------hhHHHHHHHHHHhhhcCC
Q 007351 587 --------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p 264 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKP 264 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCh
Confidence 013567889999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=293.71 Aligned_cols=231 Identities=32% Similarity=0.539 Sum_probs=190.3
Q ss_pred CcccceecccCcEEEEEEEeCC-----CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~-----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
|++.+.||+|+||.||++++.+ ++.||+|+++..... ..+.+.+|+++++.++|+||+++++++..++..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 378999999765544 5668999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765544489999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILF 593 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~ 593 (607)
........++.+|++||.+.+..++.++|||+|||++|||++ |+.||.... ..++.+.... .....+.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKKGYRLPKPENCPPEIY 234 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 322222336789999999988889999999999999999998 788886531 2222222211 1246778
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 235 ~~i~~~l~~~p~ 246 (258)
T smart00219 235 KLMLQCWAEDPE 246 (258)
T ss_pred HHHHHHCcCChh
Confidence 899999987653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.32 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=174.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|.+. +++.||||+++... ......+.+|+++|++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 57899999987543 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.++.|..++.... .+.+..++.++.||++||+|||++ +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999887776655433 388999999999999999999999 999999999999999999999999999987655443
Q ss_pred ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......++..||+||++.+. .++.++||||||++||||++|+.+|.+.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 233445678899999999888 8899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.49 Aligned_cols=233 Identities=24% Similarity=0.362 Sum_probs=187.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++.+....+||+|+||.||+|++. ++..|+||.+.....+..+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4455666688999999999999854 677899999887766777889999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecccccccccC
Q 007351 444 YVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~~~~ 521 (607)
|+.+++|..+++.... ...++..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999998876422 1237788889999999999999998 9999999999999976 679999999998765432
Q ss_pred CcceeeccccCCCCCchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh----------HhhH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN----------LIDA 589 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~--~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~----------~~~~ 589 (607)
+. ......++..|++||++.+.. ++.++|||||||++|||++|+.||...... ....|.. ....
T Consensus 163 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 163 NP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred CC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhccCCCCCcccC
Confidence 22 122345788999999987643 788999999999999999999999753211 1111111 1123
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|++.++
T Consensus 239 ~~~~~li~~~l~~~p 253 (268)
T cd06624 239 AEAKNFILRCFEPDP 253 (268)
T ss_pred HHHHHHHHHHcCCCc
Confidence 567889999997764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=338.09 Aligned_cols=237 Identities=21% Similarity=0.334 Sum_probs=184.2
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--Cce
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 438 (607)
...++|.+++.||+|+||.||+++.. +++.||+|+++... ......|.+|+.+|+.|+|+|||+++++|... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34468999999999999999999965 56789999887542 23446789999999999999999999988654 467
Q ss_pred EEEEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCC----CCEEecCCCCCCEEEcCC--------
Q 007351 439 LLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCH----PRIIHRDIKSSNILLDNN-------- 504 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~----~~ivHrDLkp~NILl~~~-------- 504 (607)
||||||+.+|+|..+|... ....+.+..++.|+.||+.||+|||+... .+|||||||++||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999888652 12348999999999999999999998520 259999999999999643
Q ss_pred ---------CcEEEEecccccccccCCcceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 505 ---------FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 505 ---------~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+.+||+|||+++...... ......|+..|||||++.+ ..++.++||||||||||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998653322 2234578999999999864 458899999999999999999999997543
Q ss_pred CCCchhHHHHHh-------HhhHHHHHHHHHHhhhcCC
Q 007351 574 PLGDESLVEWVN-------LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 574 ~~~~~~l~~~~~-------~~~~~~~~~i~~~C~~~~~ 604 (607)
.. ..+..... ......+.+|+..||+.++
T Consensus 248 ~~--~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 248 NF--SQLISELKRGPDLPIKGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred cH--HHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCCh
Confidence 21 11111111 0113567889999997654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.08 Aligned_cols=230 Identities=23% Similarity=0.335 Sum_probs=186.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||++... +++.|+||.++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999865 578999999875432 23356889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+++++|.+++...+ .+.+..+.+++.|+++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997654 388899999999999999999998 99999999999999999999999999987421110
Q ss_pred c--------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH-
Q 007351 523 T--------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL- 586 (607)
Q Consensus 523 ~--------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~- 586 (607)
. .......++..|+|||.+.+..++.++|||||||++|||++|+.||.+... ..+. ++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence 0 011123567889999999888899999999999999999999999975421 1111 11110
Q ss_pred --------hhHHHHHHHHHHhhhcCC
Q 007351 587 --------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQNP 258 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhccCh
Confidence 113557899999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.13 Aligned_cols=230 Identities=28% Similarity=0.436 Sum_probs=189.3
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|+..+.||+|+||.||+|... +++.|+||.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 7889999999866543 567799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.++++... .+.+..+++++.||++||+|||++ +|+|+||+++|||+++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999987654 378889999999999999999998 9999999999999999999999999999876543332
Q ss_pred eee---ccccCCCCCchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hh
Q 007351 525 ITT---RVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------ID 588 (607)
Q Consensus 525 ~~~---~~~gt~~y~APE~l~~~~---~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~ 588 (607)
... ...++..|++||++.+.. ++.++|||+|||++|||++|+.||..... .......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQL 233 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCCCCCCCccccc
Confidence 211 245778999999998766 88999999999999999999999975421 1111111110 01
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 234 ~~~~~~li~~~l~~~p 249 (264)
T cd06626 234 SPEGKDFLDRCLESDP 249 (264)
T ss_pred CHHHHHHHHHHccCCc
Confidence 3556789999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=296.77 Aligned_cols=232 Identities=25% Similarity=0.438 Sum_probs=187.1
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
+|+.+++||+|+||.||++.. .+++.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 4789999999864331 124578999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEecccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLAL 519 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~ 519 (607)
||||+.+++|.+++...+ .+.+..+++++.||+.||+|||++ +|+|+||+++|||++.++ .+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999887654 378899999999999999999999 999999999999998765 69999999997664
Q ss_pred cCCcc---eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-h--------Hh
Q 007351 520 DANTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-N--------LI 587 (607)
Q Consensus 520 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~--------~~ 587 (607)
..... ......++..|++||++.+..++.++|||+|||++|||++|+.||............... . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence 33211 122346788999999999888999999999999999999999999754322211111111 0 01
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 236 ~~~~~~~~i~~~l~~~p 252 (268)
T cd06630 236 LSPGLRDVTLRCLELQP 252 (268)
T ss_pred hCHHHHHHHHHHcCCCc
Confidence 23567788899997664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.83 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=190.3
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEe-
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS- 434 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 434 (607)
++.++....+.|++.+.||+|+||.||+|++. +++.||+|++.... ....++.+|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556678999999999999999999964 67899999886543 3345688899999998 69999999999853
Q ss_pred -----CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEE
Q 007351 435 -----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (607)
Q Consensus 435 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (607)
++..+++|||+.+|+|..++.......+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 35679999999999999988765555688888999999999999999998 9999999999999999999999
Q ss_pred EecccccccccCCcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 510 ~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
+|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||.+...........+.
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence 99999875432221 123356888999999886 346788999999999999999999999764322111111111
Q ss_pred hH------hhHHHHHHHHHHhhhcCC
Q 007351 585 NL------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~~------~~~~~~~~i~~~C~~~~~ 604 (607)
.. .....+.+++.+||+.++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p 267 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNY 267 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCCh
Confidence 00 123577899999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.34 Aligned_cols=233 Identities=28% Similarity=0.427 Sum_probs=185.3
Q ss_pred CCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 436 (607)
++|++.+.||+|+||.||+++.. .+..||||+++.... ....++.+|+++++++ +|+||+++++++..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999742 245799999875432 3345788999999999 5999999999999989
Q ss_pred ceEEEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (607)
..++||||+.+|+|..++.... ...+.+.++++++.||+.||+|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999886532 13478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhH
Q 007351 503 NNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l 580 (607)
+++.+||+|||+++......... .....++..||+||++.+..++.++|||||||++|||++ |+.||.+.. ..++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 99999999999998654322211 112234467999999998899999999999999999999 899986532 2222
Q ss_pred HHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 581 VEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 581 ~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.+..... ....+.+++.+|++.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 278 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPT 278 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 2221111 124677899999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=293.32 Aligned_cols=226 Identities=31% Similarity=0.558 Sum_probs=187.9
Q ss_pred ceecccCcEEEEEEEeCC----CcEEEEEEeecCCchh-HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|...+ +..|+||+++...... .+.+.+|+++++.++|+||+++++++..++..++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7889999997654443 57799999999999999999999999999999999999999
Q ss_pred CchhHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 448 NTLYFHLHGEG-------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 448 gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999987752 24589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHH
Q 007351 521 ANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAK 590 (607)
Q Consensus 521 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~ 590 (607)
... .......++..|+|||.+....++.++|||||||++|||++ |+.||.+.. ..++.+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCccCCh
Confidence 332 12233457789999999998889999999999999999999 699997642 2233333221 1136
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 235 ~~~~li~~~l~~~p 248 (262)
T cd00192 235 ELYELMLSCWQLDP 248 (262)
T ss_pred HHHHHHHHHccCCc
Confidence 78889999997765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=298.53 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=172.8
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 78999999997654 23346799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+ +++|.+++.... ..+++..+++++.||++||+|||++ +|+|+|||++||++++++.+||+|||+++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999887644 3589999999999999999999998 9999999999999999999999999999866543322
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|+|||++.+. .++.++|||+|||++|||++|+.+|...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 23335688899999998754 4688999999999999999998877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.37 Aligned_cols=234 Identities=28% Similarity=0.426 Sum_probs=191.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|... +++.|+||++.... ......+.+|+++|+.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999954 67889999986543 23456799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|.++++.... ..+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876432 4589999999999999999999998 999999999999999999999999999976654432
Q ss_pred c---eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------------h
Q 007351 524 H---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------------I 587 (607)
Q Consensus 524 ~---~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------------~ 587 (607)
. ......|+..|++||++... .++.++|||+|||++|||++|+.||....... .+.++... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCCCCCcCCcccccc
Confidence 2 22345688899999998876 78899999999999999999999997543211 11111110 1
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 236 ~~~~~~~li~~~l~~~p~ 253 (267)
T cd06610 236 YSKSFRKMISLCLQKDPS 253 (267)
T ss_pred ccHHHHHHHHHHcCCChh
Confidence 125568899999987653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.55 Aligned_cols=228 Identities=24% Similarity=0.358 Sum_probs=186.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
.|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++++..++..++||||+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3445577999999999999864 688999999876555556678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.+++... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++........ ..
T Consensus 103 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 103 GGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 99998887543 378899999999999999999998 999999999999999999999999999875533222 22
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i~~ 597 (607)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..+.+. .....+.+++.
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCccccccccCHHHHHHHH
Confidence 33468889999999998889999999999999999999999997643211 11111111 12345677888
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 254 ~~l~~~P 260 (292)
T cd06658 254 LMLVREP 260 (292)
T ss_pred HHccCCh
Confidence 8887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.53 Aligned_cols=220 Identities=25% Similarity=0.391 Sum_probs=174.7
Q ss_pred eecccCcEEEEEEEeCC-------------------------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeE
Q 007351 374 LLGEGGFGSVYKGYLPD-------------------------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~~-------------------------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 428 (607)
.||+|+||.||+|.+.. +..|+||++........++|.+|+++++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13588998876555555678999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF--- 505 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~--- 505 (607)
+++|..+...+|||||+.+|+|..++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999988886543 2478999999999999999999998 999999999999997643
Q ss_pred ----cEEEEecccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCchh
Q 007351 506 ----EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELI-TGRKPVDASQPLGDES 579 (607)
Q Consensus 506 ----~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELl-tg~~Pf~~~~~~~~~~ 579 (607)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.+... ..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~ 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP---SE 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh---HH
Confidence 4899999998643222 12346788999998875 56889999999999999995 79999976432 22
Q ss_pred HHHHHhHh------hHHHHHHHHHHhhhcCCC
Q 007351 580 LVEWVNLI------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 580 l~~~~~~~------~~~~~~~i~~~C~~~~~~ 605 (607)
..++.... ....+.+++.+||+.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPT 261 (274)
T ss_pred HHHHHHhccCCCCCCChHHHHHHHHHcccChh
Confidence 22221111 124578899999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.28 Aligned_cols=199 Identities=28% Similarity=0.439 Sum_probs=178.1
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
-|.+++.||+|+||.|||+.++ .|+.||||.+-.. .+.+++.+|+.+|++++.++||++||.|..+..+|||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677889999999999999865 7999999988643 456789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
.|++.+.++.+++ .+.+.++..+++..++||+|||.. .-||||||..||||+.+|.+||+|||.+..+.+.-. .+
T Consensus 112 AGSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 9999998877544 689999999999999999999998 889999999999999999999999999987654332 34
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
..+.||..|||||+|....|+.++||||||+...||..|+.||.+.-
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 45679999999999999999999999999999999999999997643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=296.03 Aligned_cols=231 Identities=30% Similarity=0.502 Sum_probs=186.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc---EEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR---EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~---~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|+..++||+|+||.||+|++. +++ .||||.++... ....+++.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45788899999999999999975 333 69999887553 33456789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|..+++... ..+.+..+++++.|++.||+|||+. +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999887643 2488999999999999999999998 9999999999999999999999999999765433
Q ss_pred Ccceee--ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHH
Q 007351 522 NTHITT--RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAK 590 (607)
Q Consensus 522 ~~~~~~--~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~ 590 (607)
...... .......|++||++.+..++.++|||||||++|||++ |+.||.... ..++.+.... ....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhcCCCCCCCCCCCH
Confidence 221111 1223457999999998899999999999999999997 999997542 2222222111 0135
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 238 ~~~~li~~c~~~~p 251 (268)
T cd05063 238 AVYQLMLQCWQQDR 251 (268)
T ss_pred HHHHHHHHHcCCCc
Confidence 67899999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=310.01 Aligned_cols=191 Identities=25% Similarity=0.370 Sum_probs=163.5
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
..+|++.+.||+|+||.||+|+.. +++.||||+... ....+|+.+|++++|+||+++++++..++..++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999975 567899997542 2345699999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. ++|+.++.... ..+.+..+++|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred cC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 95 57777776533 3489999999999999999999998 99999999999999999999999999997543221
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
......|+..|||||++.+..++.++|||||||+||||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123356899999999999999999999999999999999865554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.59 Aligned_cols=198 Identities=30% Similarity=0.450 Sum_probs=171.2
Q ss_pred cccceecccCcEEEEEEEe-CCCcEEEEEEeecC-CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------ceEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------RRLLI 441 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~lV 441 (607)
...+.||+|+||.||+|+. ..|+.||||.++.. ..+..+.+.+|+++|++|+|+|||+++++-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3457899999999999994 58999999999754 3455567899999999999999999999876554 45899
Q ss_pred EEecCCCchhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc--CCCc--EEEEeccccc
Q 007351 442 YDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFE--AQVSDFGLAK 516 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~--vkL~DFGls~ 516 (607)
||||.+|+|+.+|.. ++..++.+.+.+.++.++..||.|||++ +|||||||+.||++- ++|. -||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999976 3445799999999999999999999999 999999999999983 3343 5999999999
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...++. ....++||..|++||+... +.|+..+|.|||||++||+.||.+||.-.
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 876544 4566899999999999984 88999999999999999999999999643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.93 Aligned_cols=233 Identities=25% Similarity=0.430 Sum_probs=189.4
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|+.+ +.+.|+||.+...... ...++.+|+++|++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999864 3467999988654433 4567999999999999999999999999989999
Q ss_pred EEEEecCCCchhHhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 440 LIYDYVPNNTLYFHLHGEGR-------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
+||||+.+|+|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999876541 1489999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH-----
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL----- 586 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~----- 586 (607)
|+++..............++..|++||.+.+..++.++|||||||++|||++ |..+|.+.. +..++.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~~~~~~~~~~ 238 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLNRLQAGKLEL 238 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHHHHHcCCcCC
Confidence 9987543332222233456678999999988888999999999999999998 888986532 2232322221
Q ss_pred ----hhHHHHHHHHHHhhhcCCC
Q 007351 587 ----IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ----~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~ 261 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPK 261 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcc
Confidence 1136788999999977653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=295.59 Aligned_cols=231 Identities=23% Similarity=0.374 Sum_probs=190.1
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.++||+|+||.||+++.. +|+.||||+++... ....+++.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999864 68899999987432 33446789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|..++.......+.+..+++++.||+.||+|||++ +++|+||+++|||+++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988765555578999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVF 597 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~ 597 (607)
......|+..|++||++.+..++.++|||+|||++|||++|+.+|..... .+...++.. ......+.+++.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKIIRGSYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 12234578889999999988999999999999999999999999975321 111111111 112356788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 235 ~~l~~~p 241 (256)
T cd08218 235 QLFKRNP 241 (256)
T ss_pred HHhhCCh
Confidence 9998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=298.15 Aligned_cols=229 Identities=27% Similarity=0.401 Sum_probs=189.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||.|+||.||+|.+. +++.||||++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999965 68899999987554 33446789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.++++.. .+.+..++.++.||+.||+|||++ +|+||||+++||||++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999988764 489999999999999999999998 999999999999999999999999999987654321
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFKLV 596 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~ 596 (607)
......++..|++||++.+..++.++|||+|||++|||++|+.||....... .+....+ ......+.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCCCcccccCHHHHHHH
Confidence 2233567888999999998889999999999999999999999997543211 1111000 00234578889
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|+..++
T Consensus 232 ~~~l~~~p 239 (274)
T cd06609 232 SLCLNKDP 239 (274)
T ss_pred HHHhhCCh
Confidence 99997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=300.70 Aligned_cols=233 Identities=25% Similarity=0.374 Sum_probs=184.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++++.||+|+||.||+++.. +|+.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999975 789999999875432 3345789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|..+++... ...+++..+++++.||++||+|||+.+ +|+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999988886531 235899999999999999999999632 89999999999999999999999999997653322
Q ss_pred ceeeccccCCCCCchhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHHh-------HhhH
Q 007351 524 HITTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWVN-------LIDA 589 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~------~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~~~~-------~~~~ 589 (607)
.....++..|++||++.+. .++.++|||||||+||||++|+.||.........+ +....+ ....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 2234577889999998654 34789999999999999999999997542111111 001111 0123
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|++.++
T Consensus 236 ~~~~~li~~~l~~~p 250 (286)
T cd06622 236 DDAQDFVAKCLNKIP 250 (286)
T ss_pred HHHHHHHHHHcccCc
Confidence 567788899997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=296.16 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=170.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--Cce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 438 (607)
++|++.++||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999864 68899999886432 12235688899999999999999999988764 356
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+++|.+++..... +++..+++++.||+.||+|||++ +|+|+|||++|||+++++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 789999999999998876543 78888999999999999999998 9999999999999999999999999999755
Q ss_pred ccCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 322111 122345888999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=303.51 Aligned_cols=195 Identities=26% Similarity=0.421 Sum_probs=158.8
Q ss_pred cceecccCcEEEEEEEeC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceEEEEEecC
Q 007351 372 QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLIYDYVP 446 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~Ey~~ 446 (607)
+++||+|+||.||+|+.. +++.||||.++... ....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 45789999886432 23567899999999999999999998864 345789999996
Q ss_pred CCchhHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----cCCCcEEEEecccc
Q 007351 447 NNTLYFHLHGE-------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLA 515 (607)
Q Consensus 447 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGls 515 (607)
+ +|++++... ....+.+..++.++.||+.||+|||++ +|+|||||++|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 676665432 122478888999999999999999999 99999999999999 45678999999999
Q ss_pred cccccCCcc--eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTH--ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+........ ......|+..|||||++.+. .++.++|||||||++|||++|+.+|...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865432211 12345689999999999874 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=296.21 Aligned_cols=230 Identities=26% Similarity=0.404 Sum_probs=185.6
Q ss_pred CCCcccceecccCcEEEEEEEeCCC----cEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDG----REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g----~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|.+.+.||+|+||.||+|.+.+. ..|+||...... ....+.+.+|+.++++++|+||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4588889999999999999986432 468999887554 3445679999999999999999999998875 567899
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++..... .+++..++.++.||+.||+|||++ +++|||||++||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999876432 489999999999999999999998 9999999999999999999999999999866544
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKIL 592 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~ 592 (607)
.........+...|+|||++.+..++.++|||||||++|||++ |+.||..... .+...+... .....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcCCCCCCCCHHH
Confidence 3322233334568999999988889999999999999999986 9999976432 222222211 113678
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|+..++
T Consensus 238 ~~li~~~l~~~P 249 (270)
T cd05056 238 YSLMTKCWAYDP 249 (270)
T ss_pred HHHHHHHcCCCh
Confidence 889999997664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=299.25 Aligned_cols=230 Identities=27% Similarity=0.367 Sum_probs=185.7
Q ss_pred CCcccceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
+|++.+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|+++|+++ +|+||+.+++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999987432 22345688999999999 599999999999998899
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+++|.+++.... .+.+..+..++.||++||+|||++ +|+||||+++||||++++++||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987654 378888999999999999999998 9999999999999999999999999999865
Q ss_pred ccCCcceeeccccCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------- 587 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------- 587 (607)
............|+..|++||++.+. .++.++|||+|||++|||++|+.||...... ....++.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCCCCCc
Confidence 44333333345688899999998753 4678899999999999999999999743221 1122222211
Q ss_pred -hHHHHHHHHHHhhhcCC
Q 007351 588 -DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 234 ~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 234 EMSALAKDIIQRLLMKDP 251 (290)
T ss_pred cCCHHHHHHHHHHhcCCH
Confidence 13567788999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=301.04 Aligned_cols=202 Identities=23% Similarity=0.388 Sum_probs=168.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|... +|+.||||+++...... ...+.+|+++|+.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 68899999987554332 3467899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+. ++|..++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++++||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 996 56655554332 2377888889999999999999998 999999999999999999999999999975433221
Q ss_pred ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
......++..|+|||++.+. .++.++|||||||+||||++|+.+|++..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 12234568899999998764 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.03 Aligned_cols=197 Identities=26% Similarity=0.430 Sum_probs=163.1
Q ss_pred ceecccCcEEEEEEEeCC---CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~---g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
+.||+|+||.||+|.+.+ +..+|+|.++.... ..+..+.+|+.++++++|+||+++++++.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 35799998875543 33457899999999999999999999999989999999999999
Q ss_pred chhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 449 TLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 449 sL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
+|.++++... ....++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999886532 22456777889999999999999998 99999999999999999999999999997543332221
Q ss_pred -eeccccCCCCCchhhhcCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 007351 526 -TTRVMGTFGYMAPEYASSG-------KLTEKSDVFSFGVVLLELIT-GRKPVDAS 572 (607)
Q Consensus 526 -~~~~~gt~~y~APE~l~~~-------~~~~~~DVwSlGvll~ELlt-g~~Pf~~~ 572 (607)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 2234567889999998642 35789999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=300.38 Aligned_cols=242 Identities=28% Similarity=0.389 Sum_probs=191.5
Q ss_pred CccHHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEE
Q 007351 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCI 433 (607)
Q Consensus 356 ~~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 433 (607)
++.++++.+..++|.+.+.||+|.||.||++... +++.+|||++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4566677777889999999999999999999964 68899999886432 2345678899999999 7999999999987
Q ss_pred eCC-----ceEEEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 434 SDD-----RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 434 ~~~-----~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
..+ ..++||||+.+++|.++++. .....+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 543 57999999999999888753 2233588999999999999999999998 9999999999999999999
Q ss_pred EEEEecccccccccCCcceeeccccCCCCCchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH
Q 007351 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~ 581 (607)
+||+|||+++........ .....|+..|++||++... .++.++|||||||++|||++|+.||...... ..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 999999999865432221 2234578899999998643 3678999999999999999999999754321 1222
Q ss_pred HHHhH---------hhHHHHHHHHHHhhhcCC
Q 007351 582 EWVNL---------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 582 ~~~~~---------~~~~~~~~i~~~C~~~~~ 604 (607)
++.+. .....+.+++.+|++.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 275 (291)
T cd06639 244 KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDF 275 (291)
T ss_pred HHhcCCCCCCCcccccCHHHHHHHHHHhhcCh
Confidence 22111 112457889999998765
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=299.38 Aligned_cols=234 Identities=27% Similarity=0.454 Sum_probs=187.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.+.||+|+||.||++.+. +++.||||+++.... ...++|.+|++++++++|+||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888999999999999999863 467899999875433 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCC
Q 007351 439 LLIYDYVPNNTLYFHLHGEG--------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (607)
++||||+.+++|.+++.... ...+.+..+++++.||+.||+|||++ +++|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999998886421 12467888899999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 007351 499 ILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (607)
Q Consensus 499 ILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~ 576 (607)
||+++++.+||+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999998754322211 1122234567999999998999999999999999999997 888886432
Q ss_pred chhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 577 DESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 577 ~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
..++.++.+.. ....+.+++.+|++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 12222222111 135688899999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=298.17 Aligned_cols=232 Identities=25% Similarity=0.401 Sum_probs=188.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+.|+..+.||+|+||.||+|.+. +++.||||+++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999865 58899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++... .+.+..+..++.|+++||+|||++ +++|+||+++|||++++++++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999988653 378888999999999999999998 999999999999999999999999999976543322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-----HHhHhhHHHHHHHHHHh
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-----WVNLIDAKILFKLVFLC 599 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-----~~~~~~~~~~~~i~~~C 599 (607)
......++..|++||++.+..++.++|||||||++|||++|+.||.+........... .........+.+++.+|
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence 2233457889999999998889999999999999999999999997543211111000 00011235577899999
Q ss_pred hhcCCC
Q 007351 600 QQNSNS 605 (607)
Q Consensus 600 ~~~~~~ 605 (607)
|+.++.
T Consensus 237 l~~~p~ 242 (277)
T cd06640 237 LNKDPS 242 (277)
T ss_pred cccCcc
Confidence 987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=323.74 Aligned_cols=201 Identities=21% Similarity=0.308 Sum_probs=160.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeCC--CcEEEEEEee-----------------cCCchhHHHHHHHHHHHHHccCCCc
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLK-----------------IGGGQGEREFKAEVEIISRIHHRHL 425 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~--g~~VAVK~l~-----------------~~~~~~~~~~~~Ei~il~~l~HpnI 425 (607)
..++|++.+.||+|+||.||+|.++. ++.+++|.+. .........+++|+++|++|+|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987542 2222222110 0112234568899999999999999
Q ss_pred eeEEeEEEeCCceEEEEEecCCCchhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc
Q 007351 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (607)
Q Consensus 426 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (607)
+++++++..++..++|+|++.+ +|+.++.... .........++|+.||++||+|||++ +|||||||++||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999954 5655554322 11233556778999999999999998 999999999999999
Q ss_pred CCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 007351 503 NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
+++.+||+|||+++.+...........+|+..|||||++.+..++.++|||||||+||||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876544433344467999999999999999999999999999999999988644
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.84 Aligned_cols=232 Identities=25% Similarity=0.380 Sum_probs=194.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||++... +++.|+||+++.... .....+.+|++++.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 589999999876554 4457799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|.+++.... .+.+..+++++.||++||+|||+ + +++||||+++||+|++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999997653 48999999999999999999999 8 999999999999999999999999999986643332
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------hHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------DAKILFK 594 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~~~~~ 594 (607)
. .....++..|++||.+.+..++.++|||+||+++|||++|+.||.........++.++.... ....+.+
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 2 22345788999999999888999999999999999999999999765432222333322211 2356888
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 235 li~~~l~~~p 244 (264)
T cd06623 235 FISACLQKDP 244 (264)
T ss_pred HHHHHccCCh
Confidence 9999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=292.19 Aligned_cols=225 Identities=27% Similarity=0.483 Sum_probs=183.7
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchh
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 451 (607)
++||+|+||.||++.+.+++.|+||+++..... ....+.+|++++++++|+||+++++++...+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765444 4567999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee-eccc
Q 007351 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRVM 530 (607)
Q Consensus 452 ~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~-~~~~ 530 (607)
+++..... .+.+..++.++.++++||+|||++ +|+|||||++||||++++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 98866433 478889999999999999999999 999999999999999999999999999976542221111 1123
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhhh
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQQ 601 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~~ 601 (607)
++..|++||++.+..++.++|||||||++|||++ |..+|..... ..+.++... .....+.+++.+|++
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 3567999999998899999999999999999999 8888865431 222222211 113678889999997
Q ss_pred cCC
Q 007351 602 NSN 604 (607)
Q Consensus 602 ~~~ 604 (607)
.++
T Consensus 234 ~~p 236 (251)
T cd05041 234 YDP 236 (251)
T ss_pred cCh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=295.09 Aligned_cols=230 Identities=27% Similarity=0.418 Sum_probs=190.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|+..+.||+|+||.||++.++ +++.||+|++..... ...+++.+|++++++++|+||+++++++..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999976 688999999876543 3456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|.+++.... ..+.+..+++++.||++||+|||+ . +++|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999887653 358889999999999999999999 7 999999999999999999999999999876543222
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------------hHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------------DAKI 591 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------------~~~~ 591 (607)
. ...++..|++||++.+..++.++|||||||++|||++|+.||....... ....++.+.+ ....
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 1 1567889999999999999999999999999999999999997543211 1222221111 2345
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|+..++
T Consensus 233 ~~~li~~~l~~~p 245 (265)
T cd06605 233 FQDFVNLCLIKDP 245 (265)
T ss_pred HHHHHHHHcCCCc
Confidence 7889999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.08 Aligned_cols=241 Identities=23% Similarity=0.371 Sum_probs=189.0
Q ss_pred ccHHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEe
Q 007351 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS 434 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 434 (607)
+.++.+....++|++.+.||+|+||.||+++.. +++.||||+++.. .....++.+|+++++.+ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666677789999999999999999999864 6789999987642 22345688999999999 69999999998853
Q ss_pred -----CCceEEEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 435 -----DDRRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 435 -----~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
++..++||||+++++|..+++. .....+.+..++.++.||++||.|||++ +|+|||||++|||+++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 3457999999999999887753 2233578888999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~ 582 (607)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.+..... .+.+
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh
Confidence 9999999976543222 2233468899999998753 447889999999999999999999997643211 1111
Q ss_pred HHh---------HhhHHHHHHHHHHhhhcCC
Q 007351 583 WVN---------LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 583 ~~~---------~~~~~~~~~i~~~C~~~~~ 604 (607)
+.+ ......+.+++.+|++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 271 (286)
T cd06638 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDY 271 (286)
T ss_pred ccccCCCcccCCCCcCHHHHHHHHHHccCCc
Confidence 100 0113457889999997665
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.39 Aligned_cols=226 Identities=23% Similarity=0.345 Sum_probs=185.5
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++++..++..++||||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999864 6899999999766555567789999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|..++... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++....... ....
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 9998877542 378999999999999999999998 99999999999999999999999999987543322 1223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hhHHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------IDAKILFKLVF 597 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~~~~~~~i~~ 597 (607)
...++..|+|||++.+..++.++|||||||+||||++|+.||..... ....+.... .....+.+++.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 35688999999999988999999999999999999999999975421 111111100 11345678888
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 253 ~~l~~~P 259 (297)
T cd06659 253 RMLTREP 259 (297)
T ss_pred HHhcCCc
Confidence 8887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=293.20 Aligned_cols=224 Identities=28% Similarity=0.498 Sum_probs=183.7
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.++||+|+||.||+|.. +++.||||.++.. .....+.+|+.++++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999986 7888999998643 2345789999999999999999999998654 5799999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|..++.......+.+..+++++.||++||+|||++ +++|||||++|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999876555689999999999999999999998 99999999999999999999999999987543221
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
........|++||++.+..++.++|||||||++|||++ |+.||..... .++.+..... ....+.+++.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence 12234567999999998899999999999999999997 9999975421 1222221110 1256788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 232 ~~l~~~p 238 (254)
T cd05083 232 SCWETEP 238 (254)
T ss_pred HHcCCCh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.59 Aligned_cols=199 Identities=27% Similarity=0.392 Sum_probs=170.4
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-----hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-----GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
+|++.+.||+|+||.||+|... +|+.||||+++..... ....+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 6899999999755432 334578899999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+ +++|..++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999987654 3589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..+|.+.
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 221 223356778999998865 46788999999999999999997777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.70 Aligned_cols=201 Identities=29% Similarity=0.471 Sum_probs=170.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-----hhHHHHHHHHHHHHHccCCCceeEEeEEEeC--Cce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 438 (607)
.+|+..+.||+|+||.||+|... +++.|++|+++.... +....+.+|+++++.++|+||+++++++..+ +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 688999998864321 2335688999999999999999999988764 466
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+++|||+.+++|.+++..... +.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999998876543 78889999999999999999998 9999999999999999999999999999755
Q ss_pred ccCCc--ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 32111 1112345788999999999988999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.07 Aligned_cols=233 Identities=28% Similarity=0.434 Sum_probs=182.1
Q ss_pred CCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC-Cc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD-DR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 437 (607)
++|++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+++|.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999973 2567899999975433 3345688999999999 689999999988654 45
Q ss_pred eEEEEEecCCCchhHhhhcCCC----------------------------------------------------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGR---------------------------------------------------------- 459 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 459 (607)
.++||||+.+|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999988864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-eeecccc
Q 007351 460 -------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMG 531 (607)
Q Consensus 460 -------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~g 531 (607)
..+.+..+.+++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2367788889999999999999998 9999999999999999999999999999865333221 1222345
Q ss_pred CCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHHHhhhc
Q 007351 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVFLCQQN 602 (607)
Q Consensus 532 t~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~~~ 602 (607)
+..||+||++.+..++.++|||||||+||||++ |..||..... ...+.+.... .....+.+++.+||+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--cHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 678999999999899999999999999999997 9999975321 1111111110 1124578889999876
Q ss_pred CC
Q 007351 603 SN 604 (607)
Q Consensus 603 ~~ 604 (607)
++
T Consensus 322 ~p 323 (343)
T cd05103 322 EP 323 (343)
T ss_pred Ch
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.31 Aligned_cols=230 Identities=28% Similarity=0.446 Sum_probs=185.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.+|++.+.||+|+||.||+|.++ +|+ .||+|.++.... ....++.+|+++|++++|+||++++++|.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45888899999999999999864 333 589998865543 344678999999999999999999999987 78899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+|+|.++++.... .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999876543 389999999999999999999998 999999999999999999999999999986543
Q ss_pred CCccee-eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
...... ....++..||+||.+....++.++|||||||++|||++ |+.||.+.. ..++.++.... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhCCCCCCCCCCCCH
Confidence 322211 11223568999999988899999999999999999998 999997642 12222222211 135
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||..++
T Consensus 239 ~~~~~~~~~l~~~p 252 (279)
T cd05057 239 DVYMVLVKCWMIDA 252 (279)
T ss_pred HHHHHHHHHcCCCh
Confidence 67888999987664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.08 Aligned_cols=200 Identities=24% Similarity=0.426 Sum_probs=169.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|.+.+.||+|+||.||+|+.+ +++.||||.++.... .....+.+|+++++.++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56899999999999999999865 678999999875433 2345678899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. ++|..++..... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 578777765432 478899999999999999999998 999999999999999999999999999975432221
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|++||++.+. .++.++|||||||+||||++|+.+|...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234568899999998754 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.60 Aligned_cols=224 Identities=29% Similarity=0.483 Sum_probs=177.6
Q ss_pred ceecccCcEEEEEEEeCC-Cc--EEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD-GR--EVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-g~--~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
++||+|+||.||+|++++ +. .+++|.++... ....+.+.+|++++.++ +|+||+++++++..++..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999753 43 47888887433 33456789999999999 799999999999999999999999999
Q ss_pred CchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 448 NTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 448 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
|+|.++++... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999886532 12478899999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH------
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL------ 586 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~------ 586 (607)
+++...... .......+..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~~~~~~~ 232 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLEK 232 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHHhCCCCCCC
Confidence 986322111 1111223567999999988889999999999999999997 999996532 1122221110
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred CCcCCHHHHHHHHHHcccCh
Confidence 113567899999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.77 Aligned_cols=230 Identities=25% Similarity=0.458 Sum_probs=184.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch----------hHHHHHHHHHHHHHccCCCceeEEeEEEeCC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ----------GEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 436 (607)
+|.+.+.||+|+||.||+|... +|+.||||.++..... ..+.+.+|+++++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 6889999988642111 1235788999999999999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++||||+.+++|.++++..+ .+.+..+..++.||+.||.|||++ +++||||+++||++++++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999987764 488889999999999999999998 99999999999999999999999999997
Q ss_pred ccccCCcc-eeeccccCCCCCchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------
Q 007351 517 LALDANTH-ITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------- 586 (607)
Q Consensus 517 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~--~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------- 586 (607)
...+.... ......++..|++||++.... ++.++||||||+++|||++|+.||...... ..+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhccccCCcCC
Confidence 65432211 122345788999999987654 788999999999999999999999643221 111111100
Q ss_pred -----hhHHHHHHHHHHhhhcCC
Q 007351 587 -----IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 -----~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINP 257 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCCh
Confidence 113567889999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.16 Aligned_cols=229 Identities=24% Similarity=0.380 Sum_probs=188.8
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|+..+.||+|+||.||++... +++.+|||++.... ....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 68899999986542 23456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|.+++.......+.+..+++++.|+++||+|||++ +|+|+||+++|||++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999876555689999999999999999999998 99999999999999854 468999999998654332
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-hH-------hhHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-NL-------IDAKILFKL 595 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~~-------~~~~~~~~i 595 (607)
......++..|+|||++.+..++.++|||||||++|||++|+.+|..... ..+..+. .. .....+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFAPISDRYSPDLRQL 232 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCCCCCCCcCHHHHHH
Confidence 12234678899999999988889999999999999999999999976431 1111111 10 013567889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+..|++.++
T Consensus 233 i~~~l~~~p 241 (256)
T cd08220 233 ILSMLNLDP 241 (256)
T ss_pred HHHHccCCh
Confidence 999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.26 Aligned_cols=233 Identities=25% Similarity=0.398 Sum_probs=189.3
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--------hHHHHHHHHHHHHHcc-CCCceeEEeEEE
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIH-HRHLVSLVGYCI 433 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 433 (607)
..-+.|...++||+|..+.|.++..+ +|+++|+|++...... ..+.-++|+.||+++. |+||++|.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456888899999999999988754 7899999998643221 1234577999999985 999999999999
Q ss_pred eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 434 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
.+...|+|+|.|..|.|+++|...- .+++.+.++|++|+++|++|||.+ +|||||||++|||+|++.+|||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999997654 488999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc----------
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPLGD---------- 577 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~---------- 577 (607)
+++.+..+.. ....+||.+|+|||.|... .|+..+|+|+.||+||-||.|..||+..+.+-.
T Consensus 169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 9997755433 3457899999999998754 467789999999999999999999985432100
Q ss_pred hhHHHHHhHhhHHHHHHHHHHhhhcCCC
Q 007351 578 ESLVEWVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 578 ~~l~~~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
-.-.+|.++. ...++++.+|++-|++
T Consensus 247 F~speWadis--~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 247 FRSPEWADIS--ATVKDLISRLLQVDPT 272 (411)
T ss_pred cCCcchhhcc--ccHHHHHHHHHeeCch
Confidence 0112455543 3456788888877654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.52 Aligned_cols=227 Identities=26% Similarity=0.418 Sum_probs=185.9
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.|++.+.||+|+||.||+|.+. +++.||||.++... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667788999999999999864 67889999987543 334457899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|..++... .+.+..++.++.||++||.|||++ +|+|+||+++||++++++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 999999888643 378899999999999999999998 999999999999999999999999999976543321 1
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~ 597 (607)
.....++..|++||++.+..++.++|||||||++|||++|+.||...... ....+... .....+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 22345788999999999989999999999999999999999999753211 11111110 12345778999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 235 ~~l~~~p 241 (277)
T cd06642 235 ACLNKDP 241 (277)
T ss_pred HHccCCc
Confidence 9997665
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.42 Aligned_cols=199 Identities=29% Similarity=0.469 Sum_probs=168.9
Q ss_pred CCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 439 (607)
.|++.+.||+|+||.||++++ .+++.||||.++... ......+.+|+++|++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999974 257889999987443 33446799999999999999999999998875 4678
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+.+++|..++..... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999998865432 489999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
..... ......++..|+|||++.+..++.++|||||||++|||++++.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 33221 1223456778999999998899999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.21 Aligned_cols=230 Identities=24% Similarity=0.312 Sum_probs=190.8
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
+|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999975 589999999974432 345678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|..++... ..+.+..+++++.||++||+|||++ +|+|+||+++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999988765 3488999999999999999999998 99999999999999999999999999998654432
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLV 596 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~ 596 (607)
......|+..|++||++.+..++.++|||+||+++|||++|+.||........+.+.+... ......+.+++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence 1233457889999999998889999999999999999999999998654221112111111 00136788899
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 234 ~~~l~~~p 241 (258)
T cd05578 234 NKLLERDP 241 (258)
T ss_pred HHHccCCh
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.28 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=158.4
Q ss_pred cceecccCcEEEEEEEeC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceEEEEEecC
Q 007351 372 QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLIYDYVP 446 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~Ey~~ 446 (607)
+++||+|+||.||+|+.. +++.||||.++.. .....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999965 3468999988643 233567899999999999999999998864 456789999997
Q ss_pred CCchhHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----cCCCcEEEEecccc
Q 007351 447 NNTLYFHLHGE-------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLA 515 (607)
Q Consensus 447 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGls 515 (607)
+ +|++++... ....+.+..+++++.||+.||+|||++ +|+|||||++|||+ ++++++||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 566555321 223478888999999999999999998 99999999999999 56679999999999
Q ss_pred cccccCCcc--eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+........ ......++..|||||++.+ ..++.++|||||||+||||++|+.+|...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1233568899999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.05 Aligned_cols=230 Identities=28% Similarity=0.477 Sum_probs=192.8
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+|...+.||+|+||.||++... +++.|+||+++........++.+|++++++++|+||+++++++..++..++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.+++.... ..+.+..+..++.||++||+|||++ +++||||+++||++++++.+||+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999887653 3489999999999999999999998 999999999999999999999999999987654332 3
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------Hh-hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LI-DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~-~~~~~~~i~~ 597 (607)
....++..|++||++.+..++.++|||+||++||||++|+.||...... ..+..... .. ....+.+++.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 3456788999999999888999999999999999999999999754211 11111110 00 1356788999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+|++.+++
T Consensus 233 ~~l~~~p~ 240 (253)
T cd05122 233 KCLQKNPE 240 (253)
T ss_pred HHccCChh
Confidence 99987753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.55 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=170.6
Q ss_pred cceecccCcEEEEEEEe-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 372 QNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
.++||.|.||+||-|+. ++|++||||++... ..+++..+++|+.||+.++|+.||+|...|++.++.|+|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999985 48999999998532 3455678999999999999999999999999999999999999665
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEecccccccccCCcce
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGls~~~~~~~~~~ 525 (607)
-|...|..+ ...+.+.....++.||+.||.|||.+ +|||+|||++||||.+. -.+||||||++|.+.+.. .
T Consensus 649 MLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 649 MLEMILSSE-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred HHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 555555544 33588888889999999999999999 99999999999999543 469999999999886543 3
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+..++||..|+|||+|+++.|+...|+||+|||+|--|+|.+||+...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 556789999999999999999999999999999999999999998643
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.50 Aligned_cols=232 Identities=28% Similarity=0.408 Sum_probs=184.0
Q ss_pred CCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 436 (607)
.+|++++.||+|+||.||+++.. .+..||||.++.... ...+++.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 123689998875432 3346789999999999 7999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (607)
..+++|||+.+|+|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999886532 22478889999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccccccccCCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhH
Q 007351 503 NNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l 580 (607)
+++.+||+|||+++......... .....++..|||||++.+..++.++|||||||+||||++ |+.+|.+.. ..++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence 99999999999998654332211 122234567999999999999999999999999999998 888886532 1222
Q ss_pred HHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 581 VEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 581 ~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
.+..... ....+.+++.+|++.++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVP 277 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 2221110 12467789999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.73 Aligned_cols=231 Identities=23% Similarity=0.386 Sum_probs=190.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|++.+.||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56888899999999999999854 68899999987655555677899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++++|.+++... .+.+..++.++.||+.||.|||++ +|+|||||++||++++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999988653 378889999999999999999999 999999999999999999999999999875543322 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHHh------HhhHHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWVN------LIDAKILFKLVFL 598 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~~~~------~~~~~~~~~i~~~ 598 (607)
.....++..|++||++.+..++.++|||+|||++|||++|+.||.......... +..+.. ......+.+++.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 233467889999999988889999999999999999999999997653221100 000000 0113467889999
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
||+.++
T Consensus 252 ~l~~~p 257 (293)
T cd06647 252 CLEMDV 257 (293)
T ss_pred HccCCh
Confidence 998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.56 Aligned_cols=200 Identities=24% Similarity=0.408 Sum_probs=170.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 688999999875432 2335788999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. ++|..++.......+.+..+++++.||++||+|||++ +++||||+++|||+++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6788888765555689999999999999999999998 999999999999999999999999999875533221
Q ss_pred eeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|++||++.+.. ++.++|||||||++|||++|+.+|...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 122335678899999887654 578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.08 Aligned_cols=230 Identities=22% Similarity=0.320 Sum_probs=188.4
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+|...+.||+|+||.||++.. .+++.|+||+++.......+.+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 466678999999999999985 4788999999876555556678999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.+++... .+++..++.++.||+.||+|||++ +|+||||+++|||+++++.+||+|||++........ ..
T Consensus 100 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 99999988762 388999999999999999999998 999999999999999999999999999875443221 22
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--H---h--hHHHHHHHHHHh
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--L---I--DAKILFKLVFLC 599 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--~---~--~~~~~~~i~~~C 599 (607)
....|+..|++||++.+..++.++|||||||++|||++|+.||................ . . ....+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 33458889999999998889999999999999999999999997643211111111000 0 0 125678899999
Q ss_pred hhcCC
Q 007351 600 QQNSN 604 (607)
Q Consensus 600 ~~~~~ 604 (607)
++.++
T Consensus 253 l~~~p 257 (285)
T cd06648 253 LVRDP 257 (285)
T ss_pred cccCh
Confidence 97664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.46 Aligned_cols=232 Identities=27% Similarity=0.376 Sum_probs=187.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 442 (607)
++|...+.||+|.||.||+|.+. +++.||+|.+..... ....++.+|++++++++|+||++++++|.... ..+|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888899999999999999975 678899999875433 34567899999999999999999999986543 679999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+++++|.+++.. .....+.+..+.+++.||+.||.|||+. +++|+||+++||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999877653 2233478888999999999999999998 999999999999999999999999999875533
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CCchhHHHHHhHh-----------
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP--LGDESLVEWVNLI----------- 587 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~--~~~~~l~~~~~~~----------- 587 (607)
.. .....++..|++||.+.+..++.++|||+|||++|||++|+.||..... ....++.+|....
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 22 1234577889999999988999999999999999999999999986532 1222333332221
Q ss_pred ---hHHHHHHHHHHhhhcCC
Q 007351 588 ---DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ---~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p 254 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDP 254 (287)
T ss_pred CCchHHHHHHHHHHHcCCCc
Confidence 12457899999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.04 Aligned_cols=225 Identities=30% Similarity=0.378 Sum_probs=183.2
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||++... +|+.||||++.... ....+.+.+|+++|+.++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999986432 22344578899999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
.+++.......+.+..++.++.||++||.|||++ +|+||||+++|||+++++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9998776655689999999999999999999998 99999999999999999999999999987654321 122345
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH-------hhHHHHHHHHHHhhhc
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL-------IDAKILFKLVFLCQQN 602 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~-------~~~~~~~~i~~~C~~~ 602 (607)
++..|++||++.+..++.++|||+|||++|||++|+.||........ ..+.+.... .....+.+++.+|++.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 77899999999988899999999999999999999999976543111 111111110 1135678899999977
Q ss_pred CC
Q 007351 603 SN 604 (607)
Q Consensus 603 ~~ 604 (607)
++
T Consensus 236 ~p 237 (277)
T cd05577 236 DP 237 (277)
T ss_pred Ch
Confidence 64
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.60 Aligned_cols=198 Identities=23% Similarity=0.368 Sum_probs=167.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|.||.||+|+.. +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 688999999875432 2235678899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+ +|..++.... ..+++..++.++.||++||+|||++ +|+|||||++|||+++++++||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 6766665432 2489999999999999999999998 999999999999999999999999999975533221
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 12334578899999998765 468999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.31 Aligned_cols=200 Identities=25% Similarity=0.433 Sum_probs=169.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|..+ +++.||||.++..... ....+.+|+++++.++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 6889999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+ +|..++..... .+.+...+.++.||++||+|||++ +|+|||||++|||+++++++||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 975 88887765443 588999999999999999999998 99999999999999999999999999987543211 1
Q ss_pred eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346788999999876 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.56 Aligned_cols=230 Identities=22% Similarity=0.353 Sum_probs=186.4
Q ss_pred CCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
.|.+...||.|+||+|||+..++ +...|.|++..+.....++|+-||+||..++|++||+||+.|+.++.+||++|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35566779999999999998654 45567888887777777889999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
||-...++..-+ ..+.+.++..+++|++.||.|||++ +|||||||..|||++-||.|+|+|||.+-.... ....+
T Consensus 113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 998876665443 3589999999999999999999999 999999999999999999999999999864332 22345
Q ss_pred eccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------h-hHHHH
Q 007351 527 TRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------I-DAKIL 592 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~-~~~~~ 592 (607)
..+.||.+|||||+++. ..|++++|||||||+|.||..+..|-.....+ ..|++..+. . ....+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHhhcCCCcccCcchhhhHH
Confidence 66889999999998764 46899999999999999999999887543221 122222111 0 12445
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|+..++
T Consensus 266 ~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 266 SDFLKRCLVKNP 277 (1187)
T ss_pred HHHHHHHHhcCC
Confidence 678899997764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=286.25 Aligned_cols=239 Identities=25% Similarity=0.314 Sum_probs=194.5
Q ss_pred hCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 439 (607)
.++|.+.+.||+|+|..||.++ +.+++.+|+|++.....++.+..++|++..++++|+||+++++++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999998 6689999999999888888899999999999999999999999876544 489
Q ss_pred EEEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 440 LIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
|++.|...|+|.+.+... ++..+++.+.++|+.+|.+||++||+. .+.++|||||+.|||+.+++.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999998887653 344689999999999999999999997 33499999999999999999999999999874
Q ss_pred cccCCc--c--e----eeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--------ch
Q 007351 518 ALDANT--H--I----TTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLG--------DE 578 (607)
Q Consensus 518 ~~~~~~--~--~----~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~--------~~ 578 (607)
..-... . . -....-+.-|+|||++.- ...+++.|||||||+||+||.|.-||+.....+ ..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 321100 0 0 011234778999998764 356889999999999999999999997543321 12
Q ss_pred hHHHHHhHhhHHHHHHHHHHhhhcCCC
Q 007351 579 SLVEWVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 579 ~l~~~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
++.-|.+....+.+.+++..|++.++.
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~ 285 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPN 285 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcc
Confidence 333345555678899999999987764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.36 Aligned_cols=197 Identities=25% Similarity=0.403 Sum_probs=160.9
Q ss_pred ceecccCcEEEEEEEeCC---CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~---g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
+.||+|+||.||+|...+ ...++||.++.... .....|.+|+++++.++|+||+++++++...+..+|||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997543 34688887764432 33457889999999999999999999999999999999999999
Q ss_pred chhHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-
Q 007351 449 TLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (607)
Q Consensus 449 sL~~~l~~~~~---~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~- 524 (607)
+|.+++..... ....+...++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99998876432 2346778889999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeccccCCCCCchhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~-------~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~ 572 (607)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1223345678999998753 356789999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.44 Aligned_cols=226 Identities=27% Similarity=0.448 Sum_probs=175.9
Q ss_pred ceecccCcEEEEEEEeC----CCcEEEEEEeecC-CchhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCceEEEEEecC
Q 007351 373 NLLGEGGFGSVYKGYLP----DGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYVP 446 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~~ 446 (607)
++||+|+||.||+|.+. ++..||||++... .....+.+.+|+.+++.++|+||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999853 2357999988533 23345678899999999999999999998764 556789999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc--
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-- 524 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~-- 524 (607)
+|+|..+++.... .+.+..+++++.||++||+|||+. +|+|||||++||||++++.+||+|||+++...+....
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999876433 367788889999999999999998 9999999999999999999999999999755432211
Q ss_pred -eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCchhHHHHHhH--------hhHHHHHH
Q 007351 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG-RKPVDASQPLGDESLVEWVNL--------IDAKILFK 594 (607)
Q Consensus 525 -~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg-~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~ 594 (607)
......++..|+|||++.+..++.++|||||||++|||++| ..+|.... ..++.++... .....+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 11223456789999999888999999999999999999995 45565432 2222222211 01356789
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+||+.+++
T Consensus 234 li~~cl~~~p~ 244 (262)
T cd05058 234 VMLSCWHPKPE 244 (262)
T ss_pred HHHHHcCCChh
Confidence 99999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.96 Aligned_cols=234 Identities=28% Similarity=0.436 Sum_probs=187.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-----CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEe--CCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-----~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 438 (607)
++|++.+.||+|+||.||++++. +++.||||+++..... ..++|.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999864 3678999999755443 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 489999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCcce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------------chhHHHHH
Q 007351 519 LDANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG------------DESLVEWV 584 (607)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~------------~~~l~~~~ 584 (607)
....... .....+...|++||.+.+..++.++|||||||++|||++|+.+|....... ...+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 112334567999999998889999999999999999999999986532111 11112221
Q ss_pred hHh--------hHHHHHHHHHHhhhcCC
Q 007351 585 NLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
+.. ....+.+++.+|++.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEP 267 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccCh
Confidence 111 12467899999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.49 Aligned_cols=229 Identities=24% Similarity=0.387 Sum_probs=183.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--Cce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 438 (607)
++|.+.++||+|+||.||+|++. +++.||||++.... .+....+++|++++++++|+||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999864 68999999875321 23345788999999999999999999998764 357
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+++|||+.+++|.+++...+. +.+...++++.||++||+|||++ +|+|+|||++|||+++++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999988876543 78888999999999999999998 9999999999999999999999999999865
Q ss_pred ccCC--cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------Hhh
Q 007351 519 LDAN--THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LID 588 (607)
Q Consensus 519 ~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~ 588 (607)
.... ........++..|++||++.+..++.++|||||||++|||++|+.||.+..... ...+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~p~~~ 234 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIATQPTKPMLPDGV 234 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHHcCCCCCCCCccc
Confidence 3211 111123457889999999998889999999999999999999999997542211 1111110 011
Q ss_pred HHHHHHHHHHhhhc
Q 007351 589 AKILFKLVFLCQQN 602 (607)
Q Consensus 589 ~~~~~~i~~~C~~~ 602 (607)
.+.+.+++..|++.
T Consensus 235 ~~~~~~~i~~~l~~ 248 (264)
T cd06653 235 SDACRDFLKQIFVE 248 (264)
T ss_pred CHHHHHHHHHHhcC
Confidence 35678888888864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.42 Aligned_cols=223 Identities=27% Similarity=0.342 Sum_probs=174.4
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHH---ccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISR---IHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~---l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+||+|+||.||++... +++.||||+++.... .....+.+|..+++. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 688999998864322 222334455544443 479999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.+++...+ .+.+..+..++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999998887654 389999999999999999999998 99999999999999999999999999987553322 2
Q ss_pred eccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFL 598 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~ 598 (607)
....|+..|||||++.+ ..++.++|||||||++|||++|+.||..........+.++... .....+.+++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 23468999999999864 5688999999999999999999999975432222222222110 113556788888
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.+.
T Consensus 233 ~l~~~p 238 (279)
T cd05633 233 LLQRDV 238 (279)
T ss_pred HhcCCH
Confidence 887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=329.22 Aligned_cols=235 Identities=28% Similarity=0.446 Sum_probs=193.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC----C----CcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP----D----GREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~----~----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.+++++.+.||+|.||.||+|.+. . ...||||.++..... +.+.+..|+++|+.+ +|+||+.|+|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345566679999999999999853 1 347999999865444 456799999999998 599999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEG------------R--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..++|+||+.+|+|..+|+.++ . ..+...+++.++.||+.||+||++. ++|||||..|||||
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998765 0 1378889999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcceeeccc--cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCch
Q 007351 502 DNNFEAQVSDFGLAKLALDANTHITTRVM--GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDE 578 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~ 578 (607)
+++..+||+|||+++.............. ...+|||||.|....|+.|+|||||||+||||++ |..||.+.. ...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~~ 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PTE 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cHH
Confidence 99999999999999976655544322222 3567999999999999999999999999999998 889997621 134
Q ss_pred hHHHHHhHhh--------HHHHHHHHHHhhhcCCC
Q 007351 579 SLVEWVNLID--------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 579 ~l~~~~~~~~--------~~~~~~i~~~C~~~~~~ 605 (607)
++.++.+... ...+.++...||+.++.
T Consensus 530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 5555544332 35666999999976653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.06 Aligned_cols=231 Identities=26% Similarity=0.449 Sum_probs=187.2
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.|++.+.||+|+||.||+|.+ .+++.||||+++... .....++.+|+++++.++ |+||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999999996 478999999987543 334467889999999997 999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.++++.. .+.+..++.++.||++||+|||+. +|+||||+++||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999888653 488999999999999999999998 99999999999999999999999999998765443
Q ss_pred cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH------HHHhHhhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV------EWVNLIDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~------~~~~~~~~~~~~~i 595 (607)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.+.......... .+........+.++
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHH
Confidence 2 22334688899999988754 4688999999999999999999999764322111110 00000123567889
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 235 i~~~l~~~p~ 244 (277)
T cd06917 235 VAACLDEEPK 244 (277)
T ss_pred HHHHcCCCcc
Confidence 9999987653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=288.08 Aligned_cols=204 Identities=26% Similarity=0.452 Sum_probs=173.4
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeC
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISD 435 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 435 (607)
+|+++.+.++ ++||+|+|+.|--+. +.+|+++|||++..........+.+|++++..++ |.||++|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4666666553 889999999998887 6689999999997666666778999999999996 99999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEec
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDF 512 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DF 512 (607)
...|||||.|.||.|..+++.+.. |++.+..++.++|+.||+|||++ ||.|||||++|||..+- .-||||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999987654 99999999999999999999999 99999999999999653 35899999
Q ss_pred ccccccccCCc------ceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 513 GLAKLALDANT------HITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 513 Gls~~~~~~~~------~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
+|...+...+. .....-+|.-.|||||++.- ..|+.++|.||||||||-||+|..||.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 99864332211 11233578889999998652 3589999999999999999999999975
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.93 Aligned_cols=221 Identities=23% Similarity=0.411 Sum_probs=175.8
Q ss_pred ceecccCcEEEEEEEeCC--------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+.||+|+||.||+|..+. ...|++|.+........+.+.+|+.+|+.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888655555566789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc--------EEEEeccccc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--------AQVSDFGLAK 516 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--------vkL~DFGls~ 516 (607)
+.+|+|..+++.++. .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++. +||+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999876543 588999999999999999999998 9999999999999987765 6999999987
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCchhHHHHHhH------hh
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGR-KPVDASQPLGDESLVEWVNL------ID 588 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~-~Pf~~~~~~~~~~l~~~~~~------~~ 588 (607)
..... ....++..|||||++.+ ..++.++|||||||++|||++|. .+|..... .....+... ..
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 228 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQFYEDRHQLPAPK 228 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHHHHHccccCCCCC
Confidence 54322 22457788999999886 45788999999999999999985 55543221 111111110 11
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 229 ~~~~~~li~~~l~~~p~ 245 (258)
T cd05078 229 WTELANLINQCMDYEPD 245 (258)
T ss_pred cHHHHHHHHHHhccChh
Confidence 25578999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=284.86 Aligned_cols=226 Identities=26% Similarity=0.424 Sum_probs=180.6
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-HHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++.+..||.|..|.||+++++ .|..+|||.++...+.. .+.+++.+.++.+.+ .++||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344577999999999999975 68999999997665544 456888888887765 899999999999999999999988
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.. -.+.|..+-...+.+..+-++...+++||.||.+++ +|+|||+|++|||+|+.|.|||||||++.++.+...
T Consensus 174 s~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 174 ST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 42 233333333345788888899999999999999875 999999999999999999999999999988766543
Q ss_pred eeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------------hHH
Q 007351 526 TTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------------DAK 590 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------------~~~ 590 (607)
.++..|-..|||||.|.- ..|+.++|||||||.|+||.||+.||.+.+ .+..-+-+++ ...
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdFe~ltkvln~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDFEVLTKVLNEEPPLLPGHMGFSP 323 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccHHHHHHHHhcCCCCCCcccCcCH
Confidence 455678899999999864 478999999999999999999999998642 2222222222 235
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.+.
T Consensus 324 ~F~~fv~~CL~kd~ 337 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDH 337 (391)
T ss_pred HHHHHHHHHhhcCc
Confidence 67889999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.39 Aligned_cols=199 Identities=24% Similarity=0.399 Sum_probs=169.6
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
|++.+.||+|.+|.||+|.+. +|+.||||++..... ...+.+.+|+++++.++|+||+++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567799999999999999864 789999999875432 23356889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
. ++|..++.......+++..+++++.||++||+|||++ +++||||+++|||+++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6888888765544689999999999999999999998 999999999999999999999999999975432211 1
Q ss_pred eeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++..|+|||++.+. .++.++|||||||++|||++|+.+|.+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2223467889999988764 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.97 Aligned_cols=230 Identities=30% Similarity=0.485 Sum_probs=182.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|+..+.||+|+||.||+|.+. +|+ .||+|.++.... ....++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45788899999999999999863 444 478888864433 2334689999999999999999999998754 5679
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
++||+.+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999998876432 478889999999999999999998 999999999999999999999999999986543
Q ss_pred CCcce-eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
..... .....++..||+||++.+..++.++|||||||++|||++ |+.||.+.. ..++.++.... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEKGERLPQPPICTI 238 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCCH
Confidence 32221 122345678999999999899999999999999999997 999997542 22233332211 134
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||..++
T Consensus 239 ~~~~li~~c~~~~p 252 (303)
T cd05110 239 DVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHHHHcCCCh
Confidence 56788899987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.74 Aligned_cols=232 Identities=25% Similarity=0.364 Sum_probs=179.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHH-HHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEI-ISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||++... +|+.||||+++... ...+.++.+|+++ ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 68999999987543 2334556667665 566789999999999999999999999
Q ss_pred ecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 444 YVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 444 y~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|++ |+|..++.. .....+++..+++++.||+.||+|||+++ +++|||||++|||+++++.+||+|||+++...+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 567666543 22345899999999999999999999853 7999999999999999999999999999865432
Q ss_pred CcceeeccccCCCCCchhhhcC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhH
Q 007351 522 NTHITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDA 589 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~ 589 (607)
. ......++..|++||++.+ ..++.++|||+|||++|||++|+.||...... ...+.+..+. ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHhcCCCCCCccccC
Confidence 2 1233467889999998865 34678999999999999999999999653211 1112121111 012
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|+..++
T Consensus 235 ~~l~~li~~~l~~~p 249 (283)
T cd06617 235 PEFQDFVNKCLKKNY 249 (283)
T ss_pred HHHHHHHHHHccCCh
Confidence 567889999997664
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=291.90 Aligned_cols=234 Identities=29% Similarity=0.426 Sum_probs=187.0
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC------
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~------ 436 (607)
..++|++.+.||+|+||.||+|..+ +++.|++|+++.... ...++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3568999999999999999999975 678899999875433 346799999999999 6999999999997654
Q ss_pred ceEEEEEecCCCchhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
..++||||+++++|.++++... ...+.+..++.++.||++||+|||++ +|+|+||+++||+|++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999988876533 34588999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-- 587 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-- 587 (607)
+....... .......++..|+|||++.. ..++.++|||+|||+||||++|+.||..... ...+.++.+..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~ 236 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFKIPRNPPP 236 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHHhhccCCC
Confidence 87654322 22233558889999998764 3467789999999999999999999975321 11222222110
Q ss_pred -------hHHHHHHHHHHhhhcCCC
Q 007351 588 -------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.+++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~ 261 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYE 261 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChh
Confidence 124678899999987654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.51 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=166.9
Q ss_pred CCcccceecccCcEEEEEEEeC---CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 439 (607)
+|++.+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++++++|+||+++++++..+ +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999975 47899999997633 33346688899999999999999999999988 7789
Q ss_pred EEEEecCCCchhHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC----CCcEEEEec
Q 007351 440 LIYDYVPNNTLYFHLHGE---GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDF 512 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DF 512 (607)
|||||+++ +|..++... ....+.+..+++++.||+.||+|||++ +|+|||||++|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 455544321 222578889999999999999999998 9999999999999999 999999999
Q ss_pred ccccccccCCc--ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 513 GLAKLALDANT--HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 513 Gls~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
|+++....... .......++..|+|||++.+. .++.++|||||||+||||++|+.+|....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543322 112234578889999988764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.36 Aligned_cols=233 Identities=26% Similarity=0.422 Sum_probs=185.0
Q ss_pred CCcccceecccCcEEEEEEEeCC--CcEEEEEEeecCC----------chhHHHHHHHHHHHHH-ccCCCceeEEeEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGG----------GQGEREFKAEVEIISR-IHHRHLVSLVGYCIS 434 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~--g~~VAVK~l~~~~----------~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 434 (607)
+|++.+.||+|+||.||+|.+++ ++.+|||.++... .....++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 6789999886432 1223457788888875 799999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
++..++||||+.+++|.+++.. .....+.+..+++++.|++.||+|||+ . +|+|+||+++|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999887743 223458889999999999999999996 4 799999999999999999999999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-H--HHh---
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-E--WVN--- 585 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~--~~~--- 585 (607)
||++....... ......++..|++||++.+..++.++||||||+++|||++|+.||............ + +..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc
Confidence 99998654432 233456888999999999888999999999999999999999999754321100000 0 000
Q ss_pred HhhHHHHHHHHHHhhhcCCC
Q 007351 586 LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~~~ 605 (607)
......+.+++.+|++.++.
T Consensus 236 ~~~~~~l~~li~~cl~~~p~ 255 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAE 255 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCc
Confidence 01236788899999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=293.04 Aligned_cols=227 Identities=27% Similarity=0.428 Sum_probs=186.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
-|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4777899999999999999864 688999998864432 33457899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|..++... .+.+..++.++.|++.||+|||++ +++|+||+++|||+++++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999888643 378999999999999999999998 999999999999999999999999999876543321 1
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~ 597 (607)
.....++..|++||.+.+..++.++|||||||++|||++|+.||..... ....+... ......+.+++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 2234578899999999888899999999999999999999999975321 11111110 011356788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 235 ~~l~~~p 241 (277)
T cd06641 235 ACLNKEP 241 (277)
T ss_pred HHccCCh
Confidence 9997665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=292.77 Aligned_cols=201 Identities=24% Similarity=0.396 Sum_probs=168.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|.||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999975 688999999865432 223568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecccccccccCC
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~~~~~ 522 (607)
|+. ++|..++.......+++..++.++.||+.||+|||++ +|+||||+++|||+++ ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5677776555444467888889999999999999998 9999999999999985 5679999999997543221
Q ss_pred cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.......++..|++||++.+. .++.++|||||||++|||++|+.+|...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112234567899999998764 5788999999999999999999999754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.82 Aligned_cols=231 Identities=25% Similarity=0.392 Sum_probs=191.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.+.|+..+.||+|.||.||+|.++ +++.|+||+++.... ....+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456888899999999999999976 688999999986544 566789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|+||+++||+|++++.+||+|||++........
T Consensus 97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999998765 3589999999999999999999998 999999999999999999999999999875543221
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i 595 (607)
......++..|++||++.+..++.++|||+|||+||||++|+.||.+.... .....+... .....+.++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 223345778899999999888999999999999999999999999764321 111111110 013557889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 250 i~~~l~~~p 258 (286)
T cd06614 250 LNKCLVKDP 258 (286)
T ss_pred HHHHhccCh
Confidence 999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.62 Aligned_cols=227 Identities=30% Similarity=0.543 Sum_probs=181.3
Q ss_pred ceecccCcEEEEEEEeCC-------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++||+|+||.||+|++.+ ++.||||.+..... ....++.+|+++|+.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 25799998865432 3456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-----cEEEEeccc
Q 007351 445 VPNNTLYFHLHGEG-----RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-----EAQVSDFGL 514 (607)
Q Consensus 445 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-----~vkL~DFGl 514 (607)
+.+++|.++++... ...+.+..++.++.||+.||+|||+. +++|+|||++|||+++++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999887532 23478899999999999999999998 999999999999999877 899999999
Q ss_pred ccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH------
Q 007351 515 AKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL------ 586 (607)
Q Consensus 515 s~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~------ 586 (607)
++....... .......++..|++||++.+..++.++|||||||++|||++ |+.||.... ..++..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHHhcCCccCC
Confidence 975533221 11222345678999999999999999999999999999998 999997532 1222222111
Q ss_pred --hhHHHHHHHHHHhhhcCCC
Q 007351 587 --IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~ 255 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPS 255 (269)
T ss_pred cccchHHHHHHHHHHcCCCcc
Confidence 1135678999999987653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=288.08 Aligned_cols=231 Identities=24% Similarity=0.385 Sum_probs=188.2
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999975 68899999986532 23445788999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~~~~ 523 (607)
+.+++|.+++.......+++..+++++.||++||+|||++ +|+|+|||++|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999988776555689999999999999999999998 999999999999998875 469999999976643322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLV 596 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~ 596 (607)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....+..+. .....+.+++
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--QLVLKICQGYFAPISPNFSRDLRSLI 234 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHhcccCCCCCCCCCHHHHHHH
Confidence 223345888999999998888999999999999999999999999753210 111111110 1135688899
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 235 ~~~l~~~p 242 (257)
T cd08225 235 SQLFKVSP 242 (257)
T ss_pred HHHhccCh
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=287.82 Aligned_cols=223 Identities=28% Similarity=0.327 Sum_probs=183.4
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||+++.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 488999999864432 3446799999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
.+++..... +.+..++.++.||++||+|||++ +++|+||+++||||++++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999976543 88899999999999999999998 99999999999999999999999999998664432 122346
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHHHhhhc
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVFLCQQN 602 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~~C~~~ 602 (607)
++..|++||++.+..++.++|||+||+++|||++|+.||..........+.+..+ ......+.+++.+|++.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 7889999999988889999999999999999999999997653211111111110 00136788999999976
Q ss_pred CC
Q 007351 603 SN 604 (607)
Q Consensus 603 ~~ 604 (607)
++
T Consensus 234 ~p 235 (262)
T cd05572 234 NP 235 (262)
T ss_pred Ch
Confidence 54
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=301.35 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=168.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 436 (607)
..++|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++|+||+++++++..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999864 7899999998643 2233456788999999999999999999886443
Q ss_pred -ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..++||||+.+ +|...+... +++..+..++.||++||+|||++ +|+|||||++|||+++++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 46899999964 677766532 78889999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+....... .....++..|+|||++.+..++.++|||||||++|||++|+.+|...
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 86543221 22345788999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.08 Aligned_cols=230 Identities=24% Similarity=0.356 Sum_probs=186.5
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 442 (607)
+|++.+.||+|+||.||++... +|+.||+|+++... ....+.+.+|++++++++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 67899999987543 23345688999999999999999999987643 4578999
Q ss_pred EecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 443 DYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLH-----EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH-----~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
||+.+++|..++... ....+++..++.++.||++||+||| +. +|+|+|||++|||+++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999998888653 2345889999999999999999999 66 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------- 587 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------- 587 (607)
......... .....++..|++||++.+..++.++|||+||+++|||++|+.||.... ...+.+.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKFRRIPYR 233 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCCCCCccc
Confidence 866443321 223468889999999998889999999999999999999999997643 22222222211
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 234 ~~~~~~~l~~~~l~~~p 250 (265)
T cd08217 234 YSSELNEVIKSMLNVDP 250 (265)
T ss_pred cCHHHHHHHHHHccCCc
Confidence 13667889999997664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=290.02 Aligned_cols=230 Identities=25% Similarity=0.396 Sum_probs=180.8
Q ss_pred CcccceecccCcEEEEEEEeC----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 369 FADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
|++.++||+|+||.||+|.+. +++.||||+++.+. ....+++.+|+++|++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987543 334567889999999999999999999886542
Q ss_pred ceEEEEEecCCCchhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 437 RRLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
..++++||+.+|+|..++... ....+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998776432 222478888999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh---
Q 007351 513 GLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--- 587 (607)
Q Consensus 513 Gls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--- 587 (607)
|+++........ ......+...|++||.+.+..++.++|||||||++|||++ |+.+|.+.. ..++.++....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCcC
Confidence 999865433221 1222345568999999998899999999999999999999 888886542 22333322111
Q ss_pred -----hHHHHHHHHHHhhhcCC
Q 007351 588 -----DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCCh
Confidence 12678899999997765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.19 Aligned_cols=200 Identities=27% Similarity=0.436 Sum_probs=177.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
..|.+.+.||+|.|+.|.++++. .+.+||||.+..... ...+.+.+|+++|+.|+|+|||+|+.+.+....+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 45888899999999999999854 789999999864432 223458999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+|.++++|.+.++ +.+.....++.|+..+++|||++ +|||||||.+||||+.+.++||+|||++.++...
T Consensus 136 ya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred eccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--
Confidence 9999999999998887 56688888999999999999999 9999999999999999999999999999887633
Q ss_pred ceeeccccCCCCCchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~-~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.+....+|+.-|.|||++.+..|+ .++|+|++|++||-|+.|.+||++..
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 345567899999999999998775 68999999999999999999999653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.55 Aligned_cols=201 Identities=22% Similarity=0.344 Sum_probs=166.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCc-----
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIH-HRHLVSLVGYCISDDR----- 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~----- 437 (607)
++|++.++||+|+||.||+|++. +|+.||||+++..... ....+.+|+++++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 6889999988654322 3357888999999995 6999999999887665
Q ss_pred eEEEEEecCCCchhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFG 513 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFG 513 (607)
.++||||+++ +|..++.... ...+.+..++.++.||++||+|||++ +|+|||||++|||+++ ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 6777665432 23579999999999999999999998 9999999999999998 8999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+++....... ......++..|+|||++.+ ..++.++|||+|||++|||++|+.+|.+.
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9875532211 1122346778999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=288.02 Aligned_cols=222 Identities=27% Similarity=0.372 Sum_probs=182.9
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||++++. +|+.|+||++..... ...+.+.+|++++++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc-------
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT------- 523 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~------- 523 (607)
.++++..+ .+.+..+++++.||++||+|||++ +|+||||+++|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987655 489999999999999999999998 999999999999999999999999999875543211
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------H-hhHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------L-IDAKILFK 594 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~-~~~~~~~~ 594 (607)
.......+...|++||++.+..++.++|||+||+++|||++|+.+|.... ...+.+... . .....+.+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWPEDVEVSDEAID 232 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCCccccCCHHHHH
Confidence 12233457889999999998889999999999999999999999997543 111111111 0 01467788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 233 ~i~~~l~~~p 242 (265)
T cd05579 233 LISKLLVPDP 242 (265)
T ss_pred HHHHHhcCCH
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.69 Aligned_cols=229 Identities=26% Similarity=0.376 Sum_probs=185.2
Q ss_pred CCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhH---HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
..|.+++.||-|+||+|++++ .++...+|+|.|+.++.... ..++.|..||...+..-||+||..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458889999999999999987 44567899999976543322 34788999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc--
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-- 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~-- 520 (607)
||+.||++-.+|-+.+- |.++..+.++..+.+|+++.|+. |+||||||++|||||.||+|||.|||||.-+..
T Consensus 709 dYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999888866553 77888888899999999999998 999999999999999999999999999852211
Q ss_pred ------CCcce---------------------------------eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHH
Q 007351 521 ------ANTHI---------------------------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLE 561 (607)
Q Consensus 521 ------~~~~~---------------------------------~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~E 561 (607)
.+.+. ....+||..|+|||+|....|+.-+|+|+.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 11100 012579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCch-hHHHHHhHhh--------HHHHHHHHHHhh
Q 007351 562 LITGRKPVDASQPLGDE-SLVEWVNLID--------AKILFKLVFLCQ 600 (607)
Q Consensus 562 Lltg~~Pf~~~~~~~~~-~l~~~~~~~~--------~~~~~~i~~~C~ 600 (607)
|+.|+.||-+....+.. .+..|.+.++ .+.+..|...|-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~ 911 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC 911 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc
Confidence 99999999876655433 4446666554 344444555554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=295.67 Aligned_cols=227 Identities=22% Similarity=0.334 Sum_probs=185.8
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
|+....||+|+||.||++..+ +|+.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+.+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334477999999999999874 7899999998765555566799999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|.+++... .+.+..++.++.||+.||+|||++ +|+||||+++||||++++.++|+|||++........ ...
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 102 GALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9998877543 378899999999999999999998 999999999999999999999999999875543221 223
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hhHHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------IDAKILFKLVF 597 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~~~~~~~i~~ 597 (607)
...++..|++||++.+..++.++|||||||++|||++|+.||...... ...+..+. .....+.+++.
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 345788999999998888999999999999999999999999754321 11111110 01345678899
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+|++.++.
T Consensus 252 ~~l~~~P~ 259 (292)
T cd06657 252 RLLVRDPA 259 (292)
T ss_pred HHHhCCcc
Confidence 99987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.43 Aligned_cols=203 Identities=29% Similarity=0.410 Sum_probs=169.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 436 (607)
..++|++.++||+|.||.||+|.++ +|+.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467899999999999999999975 688999999975432 23356788999999999999999999987654
Q ss_pred -----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 437 -----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 437 -----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
..+||+||+.+ +|..++... ...+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 566656543 23589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
||+++..............++..|++||++.+. .++.++|||+|||++|||++|+.+|...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999986654432222333467789999988653 5788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=330.67 Aligned_cols=209 Identities=26% Similarity=0.313 Sum_probs=183.5
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
..++.-..++|.++++||+|+||.|..++.+ .++.||+|++..... .+...|..|-.+|..-+..=|++|...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3344455689999999999999999999975 688899999864321 233468889999998888889999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
+..+|||||||.||+|..+|.+.+ .+.++..+.++..|+.||+-||+. |+|||||||+|||||.+|+|||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998877 488888999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYAS----S-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~----~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+-.+..+.......-|||.-|++||+|. + +.|+..+|+||+||++|||+.|..||+..
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 9877766665666779999999999986 3 67999999999999999999999999853
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.56 Aligned_cols=200 Identities=27% Similarity=0.481 Sum_probs=169.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+|++.+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||+++++++..++..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999975 6889999999765433 3456788999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 446 PNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 446 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
.+ +|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7777765433 23589999999999999999999998 999999999999999999999999999975433211
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|++||++.+. .++.++|||+|||++|||++|+.+|.+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234567889999988664 5688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=290.72 Aligned_cols=196 Identities=22% Similarity=0.403 Sum_probs=158.3
Q ss_pred ceecccCcEEEEEEEeCCCc---EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 373 NLLGEGGFGSVYKGYLPDGR---EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~---~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
++||+|+||.||+|++.++. .+++|.++.... ...+.|.+|+++++.++|+||++++++|......++||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999854443 456676654432 34567999999999999999999999999999999999999999
Q ss_pred chhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc-ce
Q 007351 449 TLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HI 525 (607)
Q Consensus 449 sL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~-~~ 525 (607)
+|..+++... ...+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999887642 23356677889999999999999998 999999999999999999999999999864322211 12
Q ss_pred eeccccCCCCCchhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~-------~~~~~~~DVwSlGvll~ELlt-g~~Pf~~ 571 (607)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 234567889999998753 245678999999999999997 5667764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.30 Aligned_cols=230 Identities=27% Similarity=0.342 Sum_probs=184.3
Q ss_pred CCcccceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 256789999987432 22335688999999999 599999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+++|..++.... .+.+..++.++.|+++||+|||+. +++|||||++|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998887643 378889999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------- 586 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------- 586 (607)
............|+..|++||.+.+.. .+.++|||+||+++|||++|+.||........ ..++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSKPPFPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccCCCCCc
Confidence 443332233345788999999987665 78899999999999999999999964322111 1111111
Q ss_pred hhHHHHHHHHHHhhhcCC
Q 007351 587 IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 234 ~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 234 TMSAEARDFIQKLLEKDP 251 (288)
T ss_pred ccCHHHHHHHHHHhcCCH
Confidence 113567888889987664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.20 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=167.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh--HHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 441 (607)
++|++.++||+|+||.||+|.+. +|+.||||+++...... ...+.+|++++++++|+||+++++++..+ +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 56899999999999999999975 68999999997543322 33567899999999999999999998765 457999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+ +|..++.... ..+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 87 MEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999975 6777666532 3589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
... .....++..|+|||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 222345778999999875 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=337.63 Aligned_cols=229 Identities=29% Similarity=0.451 Sum_probs=191.7
Q ss_pred hCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.-++..++.||.|.||.||-|. .++|+..|||.++..... ....+.+|+++|..|+|+|||+.||+-.+.++.+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3567788999999999999998 567999999999865444 2346899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||++|+|.+.++..+. +++.....+..|++.||.|||++ ||||||||+.||||+.+|.||++|||.|+.+....
T Consensus 1314 EyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999998876443 67777788899999999999999 99999999999999999999999999998776543
Q ss_pred cce---eeccccCCCCCchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh--------
Q 007351 523 THI---TTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID-------- 588 (607)
Q Consensus 523 ~~~---~~~~~gt~~y~APE~l~~~~---~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~-------- 588 (607)
..+ ....+||.-|||||+|.+.. ...++||||||||++||+||+.||...+ . +|.-+++
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----n---e~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----N---EWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----c---hhHHHhHHhccCCCC
Confidence 221 23468999999999998643 5568999999999999999999997542 2 2333332
Q ss_pred -----HHHHHHHHHHhhhcCCCC
Q 007351 589 -----AKILFKLVFLCQQNSNSI 606 (607)
Q Consensus 589 -----~~~~~~i~~~C~~~~~~~ 606 (607)
...-++++..|+++|+++
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchh
Confidence 355678999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.32 Aligned_cols=228 Identities=28% Similarity=0.389 Sum_probs=180.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|.||.||+|+.. +|+.||||++..... ...+++.+|+++++.++|+||++++++|..++..+|||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999865 688999999864432 23356889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+. |+|.+++.... ..+.+..+..++.||+.||.|||+. +|+||||+++||++++++.+||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 45655554332 2489999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH------HhHhhHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW------VNLIDAKILF 593 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~------~~~~~~~~~~ 593 (607)
....++..|+|||++. ...++.++|||+|||++|||++|+.||.+...........+ ........+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2245778899999874 35688899999999999999999999975421110000000 0001124578
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+||+.++
T Consensus 245 ~li~~~l~~~p 255 (307)
T cd06607 245 NFVDSCLQKIP 255 (307)
T ss_pred HHHHHHhcCCh
Confidence 88999997664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=292.71 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=169.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 441 (607)
++|++.+.||+|.||.||+|.+. +++.|+||.++..... ....+.+|++++++++|+||+++++++..+ +..+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 5889999999754332 234577899999999999999999998877 789999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+ +|..++..... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 78887765432 589999999999999999999998 9999999999999999999999999999866543
Q ss_pred CcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
... .....++..|||||++.+. .++.++|||||||++|||++|+.+|...
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 221 2234578889999998764 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=282.06 Aligned_cols=230 Identities=24% Similarity=0.367 Sum_probs=191.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|+||.||++... +++.|+||++..... ....++.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 688999999976543 4556789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
+++++|.++++... ...+.+..+++++.+|++||+|||++ +++|+||+++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 34589999999999999999999998 99999999999999999999999999998654433
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH-------hhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL-------IDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~-------~~~~~~~~ 594 (607)
.......|+..|++||.+.+..++.++|||+||+++|||++|+.+|.... ...+. ++.+. ...+.+.+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPPIPSQYSSELRN 233 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 22333567889999999998889999999999999999999999997542 11111 11110 12367788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 234 ~i~~~l~~~p 243 (258)
T cd08215 234 LVSSLLQKDP 243 (258)
T ss_pred HHHHHcCCCh
Confidence 9999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=281.39 Aligned_cols=229 Identities=30% Similarity=0.467 Sum_probs=190.0
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|.||.||+++.. +++.|+||.+..... .....+.+|++++++++|+||+++++++..++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999976544 3456799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||+++||+|++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999887653 489999999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVF 597 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~ 597 (607)
.....++..|++||.+.+..++.++|||+||+++|||++|+.||...... ..+.+... ......+.+++.
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 23345788999999998888899999999999999999999999754311 11111110 012367788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 233 ~~l~~~p 239 (254)
T cd06627 233 QCFQKDP 239 (254)
T ss_pred HHHhCCh
Confidence 9997664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.65 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=170.0
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIYD 443 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 443 (607)
|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++..+ +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999975 58899999998653 33345788999999999999999999999988 78999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+ +|..++.... ..+.+..++.++.||++||+|||++ +++|+||+++|||+++++.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7877776543 3589999999999999999999998 999999999999999999999999999986654432
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.......++..|++||.+.+ ..++.++|||+|||++|||++|+.+|....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22233456788999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.29 Aligned_cols=231 Identities=29% Similarity=0.406 Sum_probs=191.3
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 442 (607)
+|++.+.||+|+||.||+|... +++.|+||+++.... ...+.+.+|++++++++|+||+++++++... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 688999999875543 4456799999999999999999999999988 7899999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++.... .+.+..++.++.|+++||+|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987655 589999999999999999999998 99999999999999999999999999998765443
Q ss_pred cc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------hHhhHHHHH
Q 007351 523 TH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV--------NLIDAKILF 593 (607)
Q Consensus 523 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~--------~~~~~~~~~ 593 (607)
.. ......++..|++||.+.+..++.++|||+||++||||++|+.||...... ...+.+.. .......+.
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-MAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHhccccCCCcCCCcccCHHHH
Confidence 21 123356788999999999888999999999999999999999999765410 00111111 011146788
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+|++.++
T Consensus 235 ~~i~~~l~~~p 245 (260)
T cd06606 235 DFLRKCLRRDP 245 (260)
T ss_pred HHHHHhCcCCh
Confidence 89999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.73 Aligned_cols=226 Identities=27% Similarity=0.433 Sum_probs=182.3
Q ss_pred cccceecccCcEEEEEEEeC-CCcEEEEEEeecC----CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc--eEEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG----GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR--RLLIY 442 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~lV~ 442 (607)
+..++||+|+|-+||||.+. +|.+||=-.++.. ..+..+.|..|+.+|+.|+|+||++||.+|.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34478999999999999864 5777774433321 22334679999999999999999999999987665 66899
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEEEecccccccccC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGls~~~~~~ 521 (607)
|.+..|+|+.|+++.++ ++...++.|++||++||.|||.+ .+.|||||||-+||+|+ ..|.|||+|+|||......
T Consensus 123 EL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999988776 89999999999999999999996 77999999999999996 4689999999999876543
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------CCchhHHHHHhHhhHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP-------LGDESLVEWVNLIDAKILFK 594 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~-------~~~~~l~~~~~~~~~~~~~~ 594 (607)
. ...+.||..|||||+.. ..|++.+||||||++|+||+|+..||..=.. +..+..-.-...+++-..++
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 3 23368999999999877 7999999999999999999999999964211 11111112333445677888
Q ss_pred HHHHhhhc
Q 007351 595 LVFLCQQN 602 (607)
Q Consensus 595 i~~~C~~~ 602 (607)
++.+|+..
T Consensus 276 fIekCl~~ 283 (632)
T KOG0584|consen 276 FIEKCLAT 283 (632)
T ss_pred HHHHHhcC
Confidence 99999865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.52 Aligned_cols=223 Identities=29% Similarity=0.362 Sum_probs=174.0
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHH---HHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVE---IISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~---il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+||+|+||.||++... +++.||||++..... ..+..+.+|.. +++..+|+||+.+++++..++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 688999999864322 22223444444 3444579999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|..++...+ .+.+..++.++.|+++||+|||++ +|+|||||++|||+++++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999998886544 489999999999999999999998 99999999999999999999999999987553322 2
Q ss_pred eccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKLVFL 598 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i~~~ 598 (607)
....|+..||+||++.++ .++.++|||||||++|||++|+.||.+..........+.... .....+.+++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence 234688999999998754 688999999999999999999999986533222222111110 013567778888
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.++
T Consensus 233 ~l~~~p 238 (278)
T cd05606 233 LLQRDV 238 (278)
T ss_pred HhhcCH
Confidence 887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=289.17 Aligned_cols=200 Identities=27% Similarity=0.426 Sum_probs=165.5
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+++.+..||.|+||.|+|..++ .|+.+|||+++..+. +++++|+.|.+...+- +.+|||++||.+..++..||.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3455678999999999999865 799999999986655 5566788888776654 699999999999999999999999
Q ss_pred cCCC--chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 445 VPNN--TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~g--sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|+-. .|+.++..-....+.+..+-+|....++||+||.+.+ +|||||+|++||||+..|.|||||||++..+.+..
T Consensus 145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9532 2233443333345888888889999999999999875 89999999999999999999999999998765432
Q ss_pred cceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
..+...|-.-|||||.|.. ..|+.++|||||||+|||+.||++||..
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 3455678899999999864 3489999999999999999999999964
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.70 Aligned_cols=229 Identities=24% Similarity=0.279 Sum_probs=180.0
Q ss_pred HHHHHhhCCCccccee--cccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 360 EELVKATDGFADQNLL--GEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 360 eel~~~~~~y~~~~~I--G~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++....++|++.+.+ |+|+||.||+++.+ +++.+|+|+++...... .|+.++..+ +|+||+++++++..+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3445555677777776 99999999999864 67889999886432211 123233323 699999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEeccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGL 514 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGl 514 (607)
+..++||||+.+++|.+++..+. .+.+..++.++.||++||+|||+. +|+|||||++|||+++++ .+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999997664 589999999999999999999999 999999999999999988 999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------- 587 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------- 587 (607)
++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||...... +.++.+|....
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQKKLPFI 230 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhcccCCcc
Confidence 87653221 235788999999999989999999999999999999999999754221 11222332211
Q ss_pred --hHHHHHHHHHHhhhcCC
Q 007351 588 --DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 --~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 231 ~~~~~~~~~li~~~l~~~p 249 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNI 249 (267)
T ss_pred cccCHHHHHHHHHHhccCh
Confidence 23566778888887654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.94 Aligned_cols=198 Identities=28% Similarity=0.442 Sum_probs=167.6
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHc---cCCCceeEEeEEEeCCc-----
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRI---HHRHLVSLVGYCISDDR----- 437 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 437 (607)
|++.++||+|.||.||+|+++ +++.||||+++..... ....+.+|+++++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999986 4899999999754332 234567788887776 59999999999988776
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+++|||+.+ +|..++.......+.+..+++++.||++||+|||++ +|+|+||+++|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 788877665444589999999999999999999998 999999999999999999999999999976
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... .....++..|++||++.+..++.++|||||||++|||++|+.+|.+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 543221 12335788999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.64 Aligned_cols=200 Identities=18% Similarity=0.233 Sum_probs=167.8
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+.+++.+|+|+++.||++.. +++.||||+++.. .......+.+|+++|+.++|+||+++++++..++..+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34556677777777777766 7999999999754 23445679999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc--
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-- 524 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~-- 524 (607)
+++|.++++......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999875555688999999999999999999999 9999999999999999999999999998754322111
Q ss_pred ----eeeccccCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ----ITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ----~~~~~~gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223467789999998763 5788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.42 Aligned_cols=200 Identities=25% Similarity=0.420 Sum_probs=167.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC--ceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD--RRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~--~~~ 439 (607)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++++ +|+||++++++|...+ ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888999999999999999975 6789999988532 223345678899999999 9999999999987543 579
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+. ++|..++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5888877654 488999999999999999999998 99999999999999999999999999998654
Q ss_pred cCCc----ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANT----HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.... ......+|+..|++||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 12234568889999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.20 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=179.7
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|...+.||+|+||.||++... +|+.||||++..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4566788999999999999864 688999999875432 34567899999999996 99999999999999999999999
Q ss_pred cCCC--chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 445 VPNN--TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~g--sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
+... +|..++.......+.+..+.+++.|+++||+|||+.. +|+|||||++|||+++++.+||+|||+++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 8652 2333333333345889999999999999999999632 89999999999999999999999999997654332
Q ss_pred cceeeccccCCCCCchhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------H---hh
Q 007351 523 THITTRVMGTFGYMAPEYASSG---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------L---ID 588 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~---~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~---~~ 588 (607)
. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||...... ...+.+... . ..
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHHhhhcCCCCCcCCCcCCCcc
Confidence 2 2234578899999999876 6889999999999999999999999753210 011111100 0 02
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 240 ~~~l~~li~~~l~~~p~ 256 (288)
T cd06616 240 SPSFVNFINLCLIKDES 256 (288)
T ss_pred CHHHHHHHHHHccCChh
Confidence 24578899999987653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.57 Aligned_cols=200 Identities=26% Similarity=0.421 Sum_probs=166.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~ 438 (607)
.++|++.++||+|+||.||+|... +|+.||||+++... ......+.+|++++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 367999999999999999999854 78999999986432 234456888999999999999999999876543 47
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++|+||+.+ +|..++... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 899999964 677666543 388999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcc--eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... ......|+..|||||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 432221 1123467889999998765 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=288.77 Aligned_cols=230 Identities=26% Similarity=0.386 Sum_probs=190.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 441 (607)
++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 7899999998642 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++...+ .+.+..++.++.||+.||+|||++ +++|+||+++||+|+++++++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997754 489999999999999999999998 9999999999999999999999999999765443
Q ss_pred Cc-------------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 007351 522 NT-------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (607)
Q Consensus 522 ~~-------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~ 582 (607)
.. .......++..|++||++.+..++.++|||+|||++|||++|+.||.... .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHH
Confidence 22 12233457889999999988889999999999999999999999997643 111111
Q ss_pred HHhHh-------hHHHHHHHHHHhhhcCC
Q 007351 583 WVNLI-------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 583 ~~~~~-------~~~~~~~i~~~C~~~~~ 604 (607)
..... ....+.+++.+|++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 233 KILKLEYSFPPNFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred HHHhcCCCCCCccCHHHHHHHHHHhcCCH
Confidence 11111 13577899999997764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.22 Aligned_cols=219 Identities=27% Similarity=0.341 Sum_probs=175.9
Q ss_pred ceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHH-HccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIIS-RIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|... +|+.||||+++.... .....+..|..++. .++|+||+++++++..++..++||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 688999999864322 22233455555444 45899999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
++|..+++... .+.+..+.+++.||++||+|||++ +|+||||+++|||+++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999987654 378899999999999999999998 999999999999999999999999999875433 22
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHh-------H---hhHHHHHHHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVN-------L---IDAKILFKLV 596 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~-------~---~~~~~~~~i~ 596 (607)
...++..|++||.+.+..++.++|||+||+++|||++|+.||..... ..+.+ +.. . .....+.+++
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence 34578889999999988889999999999999999999999975421 11111 110 0 1246778999
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 229 ~~~l~~~p 236 (260)
T cd05611 229 NRLLCMDP 236 (260)
T ss_pred HHHccCCH
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.01 Aligned_cols=201 Identities=22% Similarity=0.371 Sum_probs=166.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCC-------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDD------- 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------- 436 (607)
++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46999999999999999999965 6889999998654322 2345678999999999999999999987654
Q ss_pred -ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..++||||+.+ +|..++.... ..+.+.++++++.||++||+|||++ +|+|+|||++||||++++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999965 6777665543 2489999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCcc---eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTH---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+........ ......++..|+|||++.+. .++.++||||||+++|||++|+.+|.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 765432211 12234578889999988764 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.59 Aligned_cols=226 Identities=30% Similarity=0.427 Sum_probs=181.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+.|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|++++++++|+||+++++++..++..+|||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999864 688999999864322 23356889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+ +|.+++.... ..+++..++.++.||+.||.|||++ +|+||||+++|||+++++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred eCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 99975 6666665433 2489999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHH
Q 007351 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~ 591 (607)
....++..|++||++. +..++.++|||||||++|||++|+.||...... ..+..+.+. .....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhccCCCCCCccccHH
Confidence 2345788999999874 456888999999999999999999999754211 111222111 12346
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 253 l~~li~~~l~~~p 265 (317)
T cd06635 253 FRNFVDSCLQKIP 265 (317)
T ss_pred HHHHHHHHccCCc
Confidence 7889999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=297.54 Aligned_cols=230 Identities=30% Similarity=0.474 Sum_probs=184.4
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhH-------HHHHHHHHHHHHccCCCceeEEeEEEeCC-c
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-------REFKAEVEIISRIHHRHLVSLVGYCISDD-R 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~-------~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~ 437 (607)
++|-.+++||+|+|+.|||+.+ ...+-||||+-..+..+.. +...+|.+|.+.|+|+.||++|+|+..+. .
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4577788999999999999984 4567899998765544322 23578999999999999999999987654 5
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGL 514 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGl 514 (607)
+|-|+|||+|++|.++|+..+. +.+.+.+.|+.||+.||.||.+. ++.|||.|||+.||||.+ -|.|||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 6789999999999999987654 89999999999999999999995 778999999999999954 47899999999
Q ss_pred ccccccCCcc------eeeccccCCCCCchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 515 AKLALDANTH------ITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 515 s~~~~~~~~~------~~~~~~gt~~y~APE~l~~~----~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
++.+.+.... ....+.||.+|+.||.+.-. .++.|+||||+|||+|.++.|+.||.... ...++++..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHhhh
Confidence 9977654332 34557899999999976533 57889999999999999999999997643 334444444
Q ss_pred hHhh------------HHHHHHHHHHhhh
Q 007351 585 NLID------------AKILFKLVFLCQQ 601 (607)
Q Consensus 585 ~~~~------------~~~~~~i~~~C~~ 601 (607)
.+++ ......++.+|+.
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLA 726 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHH
Confidence 4433 2445667777764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.62 Aligned_cols=232 Identities=20% Similarity=0.256 Sum_probs=167.3
Q ss_pred CCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCCchh--H---------HHHHHHHHHHHHccCCCceeEEeE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQG--E---------REFKAEVEIISRIHHRHLVSLVGY 431 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~~~--~---------~~~~~Ei~il~~l~HpnIv~l~g~ 431 (607)
++|++.++||+|+||.||+|.+.+ ++.+|+|+........ + ....+++..+..++|.||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999754 3566777644332211 1 112233344556689999999997
Q ss_pred EEeCC----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 432 CISDD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 432 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
+.... ..++++|++.. ++.+.+.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76544 34677777643 4555554322 256778889999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch---
Q 007351 508 QVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE--- 578 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~--- 578 (607)
||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.....+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999865432211 112246899999999999999999999999999999999999999865321110
Q ss_pred hHHHHHhHhh---------HHHHHHHHHHhhhcCC
Q 007351 579 SLVEWVNLID---------AKILFKLVFLCQQNSN 604 (607)
Q Consensus 579 ~l~~~~~~~~---------~~~~~~i~~~C~~~~~ 604 (607)
...++.+.+. .+.+.+++..|++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCC
Confidence 0111222111 3567889999986653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=285.30 Aligned_cols=199 Identities=24% Similarity=0.377 Sum_probs=170.5
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
|++.+.||+|++|.||+|... +|+.++||+++..... ....+.+|+++|++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 7889999998754333 4567889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+ +|..++.... ..+++..++.++.||++||+|||++ +|+|+|||++|||+++++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7777776543 3589999999999999999999998 99999999999999999999999999998665433 12
Q ss_pred eeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.....++..|++||++.+. .++.++|||+|||++|||++|+.+|....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2334577889999998876 78899999999999999999999997543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.37 Aligned_cols=206 Identities=27% Similarity=0.404 Sum_probs=169.3
Q ss_pred HHhhCCCcccceecccCcEEEEEEEeC---C--CcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEe-
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYLP---D--GREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCIS- 434 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~~---~--g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 434 (607)
+.....|+....||+|.||.|||+... + .+++|||+++..... -.....||+.+++.|+|+||+.|..++.+
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 344456889999999999999999643 2 347999998744222 12456789999999999999999999887
Q ss_pred CCceEEEEEecCCCchhHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC----CcE
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHG---EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEA 507 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~----~~v 507 (607)
+...+|++||.+. +|++.++- .....+....+..|+.||+.|+.|||++ =|+|||||+.||||..| |+|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 6788999999976 56666643 2234688888899999999999999999 79999999999999766 999
Q ss_pred EEEecccccccccCCcce--eeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 508 QVSDFGLAKLALDANTHI--TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~--~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
||+|||++|.+.+..... ...++.|+.|+|||+|+|. .|+.+.|||++|||+.||++-+.-|.+.
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999887654433 3456789999999999985 5888999999999999999988888654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.13 Aligned_cols=200 Identities=23% Similarity=0.386 Sum_probs=168.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----c
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----R 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~ 437 (607)
.++|.+.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+++++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999864 6899999998643 2333456788999999999999999999876543 4
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+|||||+. ++|..++...+ .+.+..++.++.||++||+|||++ +++|||||++|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 67887776544 389999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .......++..|+|||++.+ ..++.++|||+|||++|||++|+.+|.+.
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 54332 22233457889999998865 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=261.96 Aligned_cols=199 Identities=23% Similarity=0.381 Sum_probs=168.2
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhH--HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|.+.+.||+|.||+||||+. +.++.||+|.++.++..+. ...++||.+|+.|+|.|||+|+++...++...||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 467778999999999999995 4688899999987654432 4688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
|. .+|..+....++ .++.+..+.++.|+++||.|+|++ ++.|||||+.|.||+.+|++||+|||+++-+.-. ..
T Consensus 83 cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VR 156 (292)
T ss_pred hh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eE
Confidence 95 456555544332 388888999999999999999999 9999999999999999999999999999865432 22
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELIT-GRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELlt-g~~Pf~~~ 572 (607)
.....+.|+.|+.|+++.+. .|+...|+||-||++.||.. |+.-|.+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 34456789999999999875 58889999999999999997 66667654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=293.37 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=170.4
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
..+++....++|.+.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999985 478899999986432 2234568889999999999999999998864
Q ss_pred C------CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 435 D------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 435 ~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
. ...++++|++ +++|..++... .+.+..++.++.||++||+|||++ +|+|||||++||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 2357788876 77888777543 388999999999999999999998 999999999999999999999
Q ss_pred EEecccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 509 L~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.+|...
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998754322 223457889999999876 46788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.98 Aligned_cols=197 Identities=22% Similarity=0.292 Sum_probs=163.6
Q ss_pred ceeccc--CcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEG--GFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G--~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+| +||.||++++. +|+.||||+++..... ..+.+++|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999864 7899999998754322 335688999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce--
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-- 525 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~-- 525 (607)
++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988876555688999999999999999999998 99999999999999999999999998764332211110
Q ss_pred ----eeccccCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 526 ----TTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 526 ----~~~~~gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++..||+||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112345679999998764 4788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.84 Aligned_cols=201 Identities=27% Similarity=0.356 Sum_probs=166.2
Q ss_pred CCCc-ccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh--------------HHHHHHHHHHHHHccCCCceeEEe
Q 007351 367 DGFA-DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG--------------EREFKAEVEIISRIHHRHLVSLVG 430 (607)
Q Consensus 367 ~~y~-~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~l~g 430 (607)
++|. +.++||+|+||.||+|... +++.||||+++...... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4578999999999999864 68999999986543222 124788999999999999999999
Q ss_pred EEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 431 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
++..++..++||||+. |+|.+++.... .+.+.....++.||++||+|||++ +|+||||+++||||++++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 57888886544 388899999999999999999998 99999999999999999999999
Q ss_pred ecccccccccCC-------------cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 511 DFGLAKLALDAN-------------THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 511 DFGls~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
|||+++...... ........++..|++||++.+. .++.++|||||||++|||++|+.+|.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999997654110 0111223467789999998764 46889999999999999999999997653
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.71 Aligned_cols=196 Identities=24% Similarity=0.335 Sum_probs=163.6
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeC--CceEEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIH-HRHLVSLVGYCISD--DRRLLIYD 443 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E 443 (607)
|++.+.||+|.||.||+|+.. +++.||||+++... ........+|+.+++++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999864 68899999987542 223345567999999985 99999999999987 88999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+. ++|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++|||+++ +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 46777666533 3589999999999999999999998 9999999999999999 9999999999986543322
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++..|+|||++.. ..++.++|||||||++|||++|+.+|.+.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 123457889999997654 55788999999999999999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.59 Aligned_cols=229 Identities=26% Similarity=0.341 Sum_probs=196.8
Q ss_pred CCCcccceecccCcEEEEEEEeCCCc-EEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGR-EVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~-~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++++...||-|+||.|-++..+..+ .+|+|+++..+ .++++.+..|-+||..++.+.||+||.-|.+++..||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666777999999999999875433 38999887543 445566889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|-|-||.||..|++++. |+....+.++..+++|++|||++ +||+||||++|+||+.+|-+||.|||+++.+....
T Consensus 500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998776 88888899999999999999999 99999999999999999999999999999876544
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-------chhHHHHHhHhhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG-------DESLVEWVNLIDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~-------~~~l~~~~~~~~~~~~~~i 595 (607)
....++||..|.|||+++++-++..+|.|+|||++||||+|+.||.+.+.+. ..+.++|.+.+-......|
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 3566899999999999999999999999999999999999999999877643 3344566666666666667
Q ss_pred HHHhhhc
Q 007351 596 VFLCQQN 602 (607)
Q Consensus 596 ~~~C~~~ 602 (607)
...|-++
T Consensus 653 k~LCr~~ 659 (732)
T KOG0614|consen 653 KKLCRDN 659 (732)
T ss_pred HHHHhcC
Confidence 7777765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=281.45 Aligned_cols=228 Identities=28% Similarity=0.408 Sum_probs=187.0
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|++.+.||+|+||.||++... +++.++||+++... .....++.+|+++++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 78899999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
+.+++|..++... ....+++..+++++.||++||+|||++ +++|+||+++||++++++++||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999998887652 224588999999999999999999998 9999999999999999999999999999866543
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~ 594 (607)
......++..|++||.+.+..++.++|||+||+++|||++|+.||..... ..+.+... ......+.+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYPPIPPIYSQDLQN 231 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCCchhhCHHHHH
Confidence 12224578899999999998999999999999999999999999975421 11111111 012355788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|+..++
T Consensus 232 li~~~l~~~p 241 (256)
T cd08530 232 FIRSMLQVKP 241 (256)
T ss_pred HHHHHcCCCc
Confidence 9999996654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.91 Aligned_cols=198 Identities=27% Similarity=0.371 Sum_probs=169.2
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
|++.+.||+|+||.||+|+.. +++.|+||+++.... ..+....+|++.+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899999865433 23345667999999999 999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
+|+|.+++.......+.+..++.++.||+++|+|||++ +|+|+||+++||||++++.+||+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 78898888776545689999999999999999999998 999999999999999999999999999976543222
Q ss_pred eeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.+|...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 223457889999998754 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.15 Aligned_cols=200 Identities=24% Similarity=0.389 Sum_probs=168.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeC----CceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD----DRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~~~ 439 (607)
++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++|++++|+||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67889999999999999999864 689999999875432 3345678899999999999999999987643 4579
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+. ++|..++..... +.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 578888765443 89999999999999999999998 99999999999999999999999999997654
Q ss_pred cCCcc---eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....+++..|++||++.+ ..++.++|||+|||++|||++|+.+|.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 32221 1223468889999999865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=291.84 Aligned_cols=195 Identities=25% Similarity=0.376 Sum_probs=163.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ......+.+|+++++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 78999999986432 222356889999999999999999999987543
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++|+||+.. +|..++. ..+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 45899999964 5655542 2378899999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....++..|||||++.+ ..++.++|||||||+||||++|+.+|.+.
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54322 123456788999999876 46889999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.17 Aligned_cols=202 Identities=28% Similarity=0.403 Sum_probs=165.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 357999999999999999999965 6889999998654332 2346789999999999999999999875443
Q ss_pred --ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 437 --~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
..++||||+.+ +|...+.... ..+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 35899999975 5666555432 3489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcc----------eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 515 AKLALDANTH----------ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 515 s~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
++........ ......++..|+|||++.+. .++.++|||||||++|||++|+.+|.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9765432211 11223567889999988754 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.29 Aligned_cols=226 Identities=27% Similarity=0.399 Sum_probs=179.0
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
|...+.||+|+||.||+|+.. +|+.|+||++..... .....+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 688999999864332 2335688899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. |+|.+++.... ..+.+..++.++.||+.||+|||++ +|+||||+++|||+++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 56666665433 2488999999999999999999998 999999999999999999999999999864322
Q ss_pred eeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH------HHhHhhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE------WVNLIDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~------~~~~~~~~~~~~i 595 (607)
.....|+..|++||++. ...++.++|||||||++|||++|+.||............. +........+.++
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 22346788999999974 3568889999999999999999999997643211110000 0001112457889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 253 i~~~l~~~P 261 (313)
T cd06633 253 VDYCLQKIP 261 (313)
T ss_pred HHHHccCCh
Confidence 999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.17 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=171.4
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ceE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 439 (607)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999975 58999999987543 334567999999999999999999999988765 789
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+. ++|..+++... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888876544 589999999999999999999998 99999999999999999999999999998665
Q ss_pred cCCc--ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANT--HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.... .......++..|++||++.+. .++.++|||||||++|||++|+.+|.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 4321 112334678899999999887 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.28 Aligned_cols=194 Identities=30% Similarity=0.484 Sum_probs=170.9
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchhH
Q 007351 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 452 (607)
+||+|.||+||.|++. +...+|||.+-.++.+..+-+.+||.+.+.|+|.|||+++|.|.+++...|.||-+.||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 456799999988777777889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEEEecccccccccCCcceeeccc
Q 007351 453 HLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 453 ~l~~~~~~-~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
+|+..=+. .-++..+..+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-+++...-+ .....+-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 88764332 235667778999999999999999 999999999999996 46899999999999876543 3456678
Q ss_pred cCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 531 GTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 531 gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
||+.|||||+|..+ .|+..+|||||||++.||.||+.||..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 99999999999865 578899999999999999999999964
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=288.38 Aligned_cols=227 Identities=27% Similarity=0.413 Sum_probs=181.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+.|+..+.||+|+||.||+|+.. +++.||||.+.... ....+++.+|+++++.++|+||+++++++..++..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999964 67889999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+. |+|.+++.... ..+++..+++++.||+.||+|||++ +++||||+++|||+++++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 56766665433 2478899999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHH
Q 007351 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~ 591 (607)
....++..|+|||++. ...++.++|||||||++|||++|+.||.+.... ..+..+.+ ......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESPALQSGHWSEY 242 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhcCCCCcCcccccHH
Confidence 2345788999999975 356788999999999999999999998754211 11111111 123456
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 243 ~~~li~~cl~~~P~ 256 (308)
T cd06634 243 FRNFVDSCLQKIPQ 256 (308)
T ss_pred HHHHHHHHhhCCcc
Confidence 78899999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.46 Aligned_cols=200 Identities=30% Similarity=0.414 Sum_probs=172.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
.+|..+.+||+|+||+|.++..+ ..+.+|||+++.+-.. +.+.-+.|-++|... +-+.+++|..++.+-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999875 4677999999855322 222335677777766 467899999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.||+|-.++++-++ +.+..++.++..|+-||-|||++ |||+||||.+|||||.+|+|||+|||+++...-.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999888888776 77788889999999999999999 9999999999999999999999999999854333
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. .....++||.-|+|||+|....|...+|+|+|||+|||||.|+.||+++
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 2345588999999999999999999999999999999999999999985
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.14 Aligned_cols=231 Identities=27% Similarity=0.426 Sum_probs=179.7
Q ss_pred CCCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCc-hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|.+++ ++.||||.++.... ....++.+|++++.++. |+||+++++++..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999999864 88999999975433 23455777888777775 9999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|+.+ .|..++.... ..+++..+.+++.||++||+|||+ + +|+||||+++|||+++++.+||+|||+++...+..
T Consensus 95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 5555544322 258899999999999999999997 5 89999999999999999999999999997654332
Q ss_pred cceeeccccCCCCCchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhH
Q 007351 523 THITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDA 589 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~----~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~ 589 (607)
. .....++..|+|||++.+.. ++.++|||||||+||||++|+.||...... .+.+.++... ...
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCCCCCCCCCCCC
Confidence 2 22345778899999987654 788999999999999999999999653210 1111111111 123
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+|++.++.
T Consensus 247 ~~l~~li~~~l~~~p~ 262 (296)
T cd06618 247 PDFCSFVDLCLTKDHR 262 (296)
T ss_pred HHHHHHHHHHccCChh
Confidence 5578899999987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=287.88 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=168.3
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-- 436 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 436 (607)
+....++|++.+.||+|+||.||++... +|+.||||+++... ......+.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3345678999999999999999999854 78999999986432 223456889999999999999999999987654
Q ss_pred ----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 437 ----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 437 ----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
..++||||+ +++|..++... .+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 67888777542 388999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|+++..... .....++..|++||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999865332 123456889999999876 45888999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=274.06 Aligned_cols=221 Identities=31% Similarity=0.385 Sum_probs=183.6
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCch
Q 007351 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
||+|+||.||++... +++.|+||+++..... ....+.+|++++++++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999975 5889999998754322 345789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~ 530 (607)
.+++.... .+.+..+..++.||++||+|||+. +++|+||+++||++++++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence 99987654 389999999999999999999998 999999999999999999999999999986644321 233456
Q ss_pred cCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------HhhHHHHHHHHHHhhhcC
Q 007351 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-------LIDAKILFKLVFLCQQNS 603 (607)
Q Consensus 531 gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-------~~~~~~~~~i~~~C~~~~ 603 (607)
++..|++||.+.+..++.++|||+||+++|||++|+.||..... ..+.+... ....+.+.+++.+|++.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCC
Confidence 78899999999888889999999999999999999999975431 22222211 111467788999999766
Q ss_pred C
Q 007351 604 N 604 (607)
Q Consensus 604 ~ 604 (607)
+
T Consensus 232 p 232 (250)
T cd05123 232 P 232 (250)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=280.18 Aligned_cols=198 Identities=28% Similarity=0.419 Sum_probs=170.0
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
|+..+.||+|.||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999975 58999999997653 333467889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
. ++|.+++.... ..+++..+++++.||++||+|||++ +|+||||+++||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58988887653 2489999999999999999999999 999999999999999999999999999986543322 1
Q ss_pred eeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++..|+|||++.+. .++.++|||+|||++|||++|+.+|...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2223457789999998776 7889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.04 Aligned_cols=199 Identities=23% Similarity=0.388 Sum_probs=166.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC---------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--------- 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--------- 436 (607)
.+|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|+||+++++++..++
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57999999999999999999864 68899999998766666678999999999999999999998765542
Q ss_pred -----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEEE
Q 007351 437 -----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVS 510 (607)
Q Consensus 437 -----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~ 510 (607)
..++||||+. ++|..++... .+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 4689999997 5787777543 378899999999999999999998 999999999999997 55678999
Q ss_pred ecccccccccCCcc--eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 511 DFGLAKLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 511 DFGls~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999765332111 1122357889999998754 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.75 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=164.2
Q ss_pred CCcccceecccCcEEEEEEEeC-C--CcEEEEEEeecCC--chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC----Cc
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-D--GREVAIKQLKIGG--GQGEREFKAEVEIISRI-HHRHLVSLVGYCISD----DR 437 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~--g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 437 (607)
+|++.+.||+|+||.||+++.. + ++.||||+++... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 3 6789999986432 22345688899999999 599999999976533 35
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.++++||+. ++|..++.... .+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678888886 57888876544 489999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCcc---eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
....... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 5432211 1234568899999998776 46889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=264.44 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=163.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
+++..+..||+|+||.|-+.++. +|...|||.++..- .+.++++++|+.+..+. ..+++|.|||.+..++..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34455678999999999888754 78999999997543 44556788888887775 69999999999999999999999
Q ss_pred ecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 444 YVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 444 y~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
.|+ .+|..+.+. .....+.+..+-+|+..|++||+|||+++ .|+|||+|++||||+.+|++||||||++..+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 445333221 22335888889999999999999999886 8999999999999999999999999999877554
Q ss_pred CcceeeccccCCCCCchhhhcC----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~----~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.. .+--.|...|||||.+.. ..|+.|+||||||+.++||.++++||+.
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 32 222347788999998764 4688999999999999999999999974
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=286.24 Aligned_cols=201 Identities=26% Similarity=0.398 Sum_probs=168.6
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe-CC
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DD 436 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 436 (607)
++....++|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+++++.++|+||+++++++.. ++
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456678999999999999999999854 78999999885432 2334678899999999999999999998876 45
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++|+||+ +++|..+++.. .+.+.....++.||++||+|||++ +|+||||+++|||+++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 788999999 56788777643 367788889999999999999998 99999999999999999999999999997
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....++..|++||++.+ ..++.++|||+|||++|||++|+.+|...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54322 122456788999998766 56889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=312.03 Aligned_cols=145 Identities=29% Similarity=0.407 Sum_probs=130.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++++.++|+||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999975 688999999975432 23356889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
||+.+++|..+++..+ .+.+..+++|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987654 378888999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.98 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=167.9
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc---
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR--- 437 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--- 437 (607)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++..++.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34578999999999999999999975 57899999886432 2334567889999999999999999998776554
Q ss_pred ---eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 438 ---RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 438 ---~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
.++|+||+ +++|.+++... .+++..+++++.||++||+|||++ +|+|||||++|||+++++++||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 79999999 56888887652 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+...... .....++..|++||++.+ ..++.++|||||||++|||++|+.+|.+.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865332 223457888999999865 36788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.77 Aligned_cols=212 Identities=27% Similarity=0.436 Sum_probs=181.8
Q ss_pred CccHHHHHHhhCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEE
Q 007351 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCI 433 (607)
Q Consensus 356 ~~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 433 (607)
.+.++.+-...+.|++.++||+|.+|.||+++ .++|+.+|||++... ...+++++.|.++|+.+ +|+|++.+||++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34455555556779999999999999999998 457889999987643 33456788899999988 5999999999987
Q ss_pred e-----CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 434 S-----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 434 ~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
. ++.+|||||||.+|+.-+++++-....+.|..+..|++.++.||.|||++ .++|||||-.|||+++++.||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 4 35789999999999999999876677799999999999999999999999 999999999999999999999
Q ss_pred EEecccccccccCCcceeeccccCCCCCchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 509 L~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|+|||++..... ....+..++||..|||||+|... .|+.++|+|||||+..||.-|..|+.+.
T Consensus 164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 999999976543 33445668899999999998753 5788999999999999999999999754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=274.43 Aligned_cols=229 Identities=25% Similarity=0.350 Sum_probs=180.3
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC-----CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG-----GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
+|.+.++||+|+||.||+++.. .+..+++|+++.. ......++.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999864 3455666665421 122344677899999999999999999999999999999
Q ss_pred EEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||+.+++|..++.. .....+++..++.++.|+++||+|||++ +|+|+||+++|||++++ .+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999888764 2234589999999999999999999998 99999999999999864 69999999997654
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-h-------HhhHHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-N-------LIDAKI 591 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~-------~~~~~~ 591 (607)
.... ......|+..|++||.+.+..++.++|||+||+++|||++|+.+|..... ....... . ......
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcCCCCCCcchhcHH
Confidence 3322 22334578899999999888889999999999999999999999965321 1111111 0 012356
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 233 ~~~li~~~l~~~p 245 (260)
T cd08222 233 LNSIMQSMLNKDP 245 (260)
T ss_pred HHHHHHHHhcCCh
Confidence 7789999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=273.57 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=176.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|.++++||+|+|.+|..++++ +.+.+|+|++|.. ..++....+.|-.++... +|+.+|-|..+|.++.++|+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368999999999999999999865 6788999999743 333444567788888876 69999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|.||+.+|+|..+++..++ +.++..+.+...|..||.|||+. |||+||||.+|||||.+|+|||.|+|+++....
T Consensus 329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999888876654 88888899999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
. ......++||..|+|||+|++..|...+|+|+|||+|+||+.|+.||+.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 3 3346678999999999999999999999999999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=274.52 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=169.1
Q ss_pred hCCCcc-cceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEe----CCce
Q 007351 366 TDGFAD-QNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS----DDRR 438 (607)
Q Consensus 366 ~~~y~~-~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~----~~~~ 438 (607)
.++|.+ .++||-|-.|+|..+..+ +++++|+|++. +....++|+++.-..+ |+|||+++++|+. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 355654 368999999999999854 78999999986 3456788999887774 9999999998764 2356
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEecccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLA 515 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls 515 (607)
++|||+|+||.|+..++.++...+.+.+...|++||..|+.|||+. +|.|||||++|+|... |..+||+|||++
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 7899999999999999999998999999999999999999999999 9999999999999953 567999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+....... ...-+-|.+|.|||++...+|+..+|+||+||+||-||+|..||+..
T Consensus 212 K~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 212 KETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 87554332 22345689999999999999999999999999999999999999754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-34 Score=277.44 Aligned_cols=230 Identities=24% Similarity=0.365 Sum_probs=183.5
Q ss_pred CcccceecccCcEEEEEEEe-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----ceEE
Q 007351 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRLL 440 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~l 440 (607)
++-.+-||-|+||.||.+++ ++|+.||+|++-.- +-...+.+.+|+++|+.++|.||+..+++..-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457799999999999985 48999999988532 2223467889999999999999999998765433 4567
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|.|.|. .+|...+-.. +.+.-+.+.-+++||++||.|||+. +|.|||||+.|.||+.+..+||||||++|....
T Consensus 135 ~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 777773 3455544332 3367777788999999999999999 999999999999999999999999999997765
Q ss_pred CCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHHHHh
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFLC 599 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~~~C 599 (607)
.....++..+.|.+|+|||+|+|. .|+..+||||+|||+.||+.++.-|.....+ +.|+-..+.+..-.+..|...|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHh
Confidence 555556667889999999999985 6889999999999999999999999865432 3444455666677788888899
Q ss_pred hhcCCCC
Q 007351 600 QQNSNSI 606 (607)
Q Consensus 600 ~~~~~~~ 606 (607)
+...+++
T Consensus 287 EGAk~H~ 293 (449)
T KOG0664|consen 287 EGAKNHV 293 (449)
T ss_pred hhhHHHh
Confidence 8765554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=294.23 Aligned_cols=203 Identities=24% Similarity=0.337 Sum_probs=154.9
Q ss_pred hCCCcccceecccCcEEEEEEEe-----------------CCCcEEEEEEeecCCchhHHH--------------HHHHH
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-----------------PDGREVAIKQLKIGGGQGERE--------------FKAEV 414 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------~~~Ei 414 (607)
.++|++.++||+|+||.||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46799999999999999999964 235679999987544332233 33467
Q ss_pred HHHHHccCCCc-----eeEEeEEEe--------CCceEEEEEecCCCchhHhhhcCCC----------------------
Q 007351 415 EIISRIHHRHL-----VSLVGYCIS--------DDRRLLIYDYVPNNTLYFHLHGEGR---------------------- 459 (607)
Q Consensus 415 ~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------- 459 (607)
.++.+++|.|+ +++++||.. ++..+|||||+.+++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777876654 677888754 3567999999999999988864311
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchh
Q 007351 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539 (607)
Q Consensus 460 ~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE 539 (607)
..+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++..............++..|++||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1246777889999999999999998 9999999999999999999999999999765433222222234578999999
Q ss_pred hhcCCC--------------------CC--chhhHHHHHHHHHHHHcCCC-CCCC
Q 007351 540 YASSGK--------------------LT--EKSDVFSFGVVLLELITGRK-PVDA 571 (607)
Q Consensus 540 ~l~~~~--------------------~~--~~~DVwSlGvll~ELltg~~-Pf~~ 571 (607)
++.... |. .+.|||||||+||||++|.. +|.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 876432 11 24699999999999999986 7753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=271.24 Aligned_cols=212 Identities=23% Similarity=0.228 Sum_probs=168.3
Q ss_pred cCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhc
Q 007351 378 GGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456 (607)
Q Consensus 378 G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 456 (607)
|.||.||+++.. +++.||+|+++.. .++.+|...+....|+||+++++++..++..+|||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~-----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS-----SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch-----hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 7889999998643 2344566666667799999999999999999999999999999998876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCC
Q 007351 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536 (607)
Q Consensus 457 ~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~ 536 (607)
... +.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||++....... ....++..||
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 543 88999999999999999999998 99999999999999999999999999886543321 2234567799
Q ss_pred chhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHhHhhHHHHHHHHHHhhhcCC
Q 007351 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWVNLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 537 APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~i~~~C~~~~~ 604 (607)
+||.+.+..++.++|||||||++|||++|+.+|......... ...+.... ....+.+++.+|++.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp 217 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEW-VSEEARSLLQQLLQFNP 217 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCccc-CCHHHHHHHHHHccCCH
Confidence 999998888999999999999999999999887643211110 00011111 23456778888887764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=279.26 Aligned_cols=200 Identities=23% Similarity=0.355 Sum_probs=171.8
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc--CCC----ceeEEeEEEeCCc
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH--HRH----LVSLVGYCISDDR 437 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~--Hpn----Iv~l~g~~~~~~~ 437 (607)
..++|.+.+++|+|.||.|.++.++ .+..||||+++.- .+..+..+-|+++|.+|+ .+| +|++.+||.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999999864 4688999998732 233445677999999994 222 7888899999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------------- 503 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------------- 503 (607)
.+||+|.+ |-+++++|..++-..+....++.|++|++++++|||+. +++|-|||++|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 55899999998888899999999999999999999999 9999999999999831
Q ss_pred ------CCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 504 ------NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 504 ------~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+..|||+|||.+++..+.. ...+.|.+|+|||++++-.++..+||||+||||+||++|..-|+...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3468999999998754432 45678999999999999999999999999999999999999998654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=308.20 Aligned_cols=196 Identities=32% Similarity=0.474 Sum_probs=159.7
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeC-------
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD------- 435 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 435 (607)
-.++|+++++||+|+||.|||++.+ ||++||||++..... .....+.+|+++|++|+|+|||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467788899999999999999966 999999999976642 2335689999999999999999987521100
Q ss_pred --------------------------------------------------------------------------------
Q 007351 436 -------------------------------------------------------------------------------- 435 (607)
Q Consensus 436 -------------------------------------------------------------------------------- 435 (607)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007351 436 --------------------------------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483 (607)
Q Consensus 436 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~ 483 (607)
...||-||||+...|+++++.+... -.....++++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh
Confidence 0136779999998888888765431 1577889999999999999999
Q ss_pred cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc------c-----------CCcceeeccccCCCCCchhhhcCCC-
Q 007351 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL------D-----------ANTHITTRVMGTFGYMAPEYASSGK- 545 (607)
Q Consensus 484 ~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~------~-----------~~~~~~~~~~gt~~y~APE~l~~~~- 545 (607)
. |||||||||.||+|++++.|||+|||++.... + .+....+..+||..|+|||++.+..
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998621 0 1111235578999999999987654
Q ss_pred --CCchhhHHHHHHHHHHHHc
Q 007351 546 --LTEKSDVFSFGVVLLELIT 564 (607)
Q Consensus 546 --~~~~~DVwSlGvll~ELlt 564 (607)
|+.|+|||||||||+||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 9999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=295.08 Aligned_cols=229 Identities=26% Similarity=0.366 Sum_probs=176.5
Q ss_pred CCcccceecccCcE-EEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEec
Q 007351 368 GFADQNLLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 368 ~y~~~~~IG~G~fG-~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
-|...+++|.|+.| .||+|.+ +|++||||++-. ......++|+.+|+.-+ |+|||++|+...+....||.+|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35566889999998 5799999 889999998752 23345689999999885 999999999999999999999999
Q ss_pred CCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-----CCcEEEEeccccccc
Q 007351 446 PNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLA 518 (607)
Q Consensus 446 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGls~~~ 518 (607)
. .+|.+++... +.......+.+.++.|+++||+|||.. +||||||||.||||+. ..+++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 5698888773 222222245578899999999999997 9999999999999965 357899999999987
Q ss_pred ccCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC------CchhHHHHHhHhhH
Q 007351 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG-RKPVDASQPL------GDESLVEWVNLIDA 589 (607)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg-~~Pf~~~~~~------~~~~l~~~~~~~~~ 589 (607)
..+... ......|+.+|+|||+|.+..-+..+|||+|||++|+.++| .+||.+.... .+..+..+....++
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH
Confidence 654332 23456799999999999998888899999999999999985 9999754322 12222222222222
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
...+++.+.++.++.
T Consensus 742 -eA~dLI~~ml~~dP~ 756 (903)
T KOG1027|consen 742 -EAKDLISRMLNPDPQ 756 (903)
T ss_pred -HHHHHHHHhcCCCcc
Confidence 556677776666553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.80 Aligned_cols=199 Identities=32% Similarity=0.472 Sum_probs=173.5
Q ss_pred CcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
|.+.+.||+|+||.||++...+ ++.++||.+...... ..+.+.+|++.+++++|+||+++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999999865 889999999866554 56789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|..++...... +++..++.++.+++++|.|||++ +++|+||+++||++++++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999988765432 78899999999999999999998 999999999999999999999999999987654431122
Q ss_pred eccccCCCCCchhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 527 TRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 527 ~~~~gt~~y~APE~l-~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
....+...|++||++ ....++.++|||+||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334577889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=296.93 Aligned_cols=200 Identities=24% Similarity=0.294 Sum_probs=144.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-C----CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeE------EE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-D----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY------CI 433 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~----g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~------~~ 433 (607)
..++|++.++||+|+||.||+|++. + ++.||||+++..... +.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999975 4 689999987643211 111111 1112222222222211 24
Q ss_pred eCCceEEEEEecCCCchhHhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCC
Q 007351 434 SDDRRLLIYDYVPNNTLYFHLHGEGRP------------------VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495 (607)
Q Consensus 434 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk 495 (607)
.++..+|||||+.+++|.++++..... ......+..|+.||++||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566889999999999999888654311 011233567999999999999998 99999999
Q ss_pred CCCEEEcC-CCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC----------------------CCCchhhH
Q 007351 496 SSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG----------------------KLTEKSDV 552 (607)
Q Consensus 496 p~NILl~~-~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~~~~~DV 552 (607)
++||||++ ++.+||+|||+++..............++..|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986654444444556789999999976432 24456799
Q ss_pred HHHHHHHHHHHcCCCCCCC
Q 007351 553 FSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 553 wSlGvll~ELltg~~Pf~~ 571 (607)
|||||+||||+++.++++.
T Consensus 363 wSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHHHHhCcCCCch
Confidence 9999999999998877643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=285.30 Aligned_cols=224 Identities=23% Similarity=0.293 Sum_probs=181.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.+.|.....||+|+|+.|.++... +++..+||++... ..+..+|+.++... +|+||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 467888888999999999988854 7889999998643 34456788777766 69999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE-cCCCcEEEEecccccccccCC
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL-DNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl-~~~~~vkL~DFGls~~~~~~~ 522 (607)
++.++.|.+.+..... +. ..+..|+++|+.++.|||++ ||||||||++|||+ ++.+.++|+|||+++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988777765443 23 67778999999999999998 99999999999999 68999999999999876543
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----hHHHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----DAKILFKLVF 597 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----~~~~~~~i~~ 597 (607)
....+.|..|.|||++....|+.++||||||++|||||+|+.+|...... .++...+... -.+..++++.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccccccCHHHHHHHH
Confidence 22234688999999999999999999999999999999999999865322 2333333322 1356677888
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
.|++-+++
T Consensus 545 ~LL~~dP~ 552 (612)
T KOG0603|consen 545 QLLQVDPA 552 (612)
T ss_pred HhccCChh
Confidence 88877653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=256.57 Aligned_cols=218 Identities=30% Similarity=0.413 Sum_probs=182.1
Q ss_pred CcEEEEEEEeC-CCcEEEEEEeecCCchh-HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhc
Q 007351 379 GFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456 (607)
Q Consensus 379 ~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 456 (607)
+||.||+|... +|+.|++|++....... .+.+.+|++++++++|.||+++++++..+...++++||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997665544 67899999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCC
Q 007351 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536 (607)
Q Consensus 457 ~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~ 536 (607)
... +++..+++++.+++++|.|||+. +|+|+||+++||++++++.++|+|||++....... ......+...|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 544 88999999999999999999998 99999999999999999999999999998765432 233455788999
Q ss_pred chhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------hHHHHHHHHHHhhhcCCC
Q 007351 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 537 APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----------~~~~~~~i~~~C~~~~~~ 605 (607)
+||.+.+..++.++|||+||+++|||++|+.+|.... ....+.++.... ....+.+++.+|+..++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 9999998889999999999999999999999997531 112222222211 235678899999986643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-33 Score=264.64 Aligned_cols=202 Identities=23% Similarity=0.420 Sum_probs=166.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh--HHHHHHHHHHHHHccCCCceeEEeEEEeC--------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISD-------- 435 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 435 (607)
..|....+||+|.||.||+++.+ .|+.||+|++...+.+. -...++|+++|..|+|+|+++|+.+|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34667788999999999999865 57789998775433221 24578899999999999999999988643
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
...+|||+||+. +|.-+|.+.. ..+...++.+++++++.||.|+|+. .|+|||+|+.|+||+.||.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 236899999965 5777776542 3588999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcc---eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 516 KLALDANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
|.+...... ..++.+.|+.|+.||.|+| +.|+...|||.-||||.||++|..-|.+..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 765433222 2345677999999999887 568899999999999999999999887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.72 Aligned_cols=198 Identities=24% Similarity=0.371 Sum_probs=169.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc----h----hHHHHHHHHHHHHHcc---CCCceeEEeEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG----Q----GEREFKAEVEIISRIH---HRHLVSLVGYCI 433 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~----~----~~~~~~~Ei~il~~l~---HpnIv~l~g~~~ 433 (607)
..+|..++.||+|+||.|+.|.++ +..+|+||.+..... + .-..+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356888999999999999999976 566899998864321 1 1112456999999998 999999999999
Q ss_pred eCCceEEEEEecC-CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 434 SDDRRLLIYDYVP-NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 434 ~~~~~~lV~Ey~~-~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
+++.+||+||-.. +.+|++++....+ +++.+...|.+||+.|+++||++ +|||||||-+||.|+.+|.+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999999864 4588999876654 99999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCC
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE-KSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
|.+.+...+- ...++||..|.|||+|.|..|.- .-|||+|||+||-++...-||++
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9997664433 34478999999999999988864 57999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=277.68 Aligned_cols=231 Identities=23% Similarity=0.253 Sum_probs=185.5
Q ss_pred CccHHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc------CCCceeE
Q 007351 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH------HRHLVSL 428 (607)
Q Consensus 356 ~~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l 428 (607)
++.+...+....+|.+....|+|-|+.|.+|... .|.+||||+++.+ ....+.-++|++||++|+ .-|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3444444455678999999999999999999864 5789999999743 333455688999999995 4578999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-Cc
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FE 506 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~ 506 (607)
+..|...+++|||||-+. -+|.++|+..++ ..|....+..++.|+..||.+|.+. +|+|.|||++||||++. ..
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 999999999999999884 568888876543 4588889999999999999999997 99999999999999875 46
Q ss_pred EEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH
Q 007351 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~ 586 (607)
+||||||.|.+..++. .+-+.....|.|||+|+|..|+...|+||+||+||||+||+.-|.+.. +.+.+++..-
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T---NN~MLrl~me 649 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT---NNQMLRLFME 649 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC---cHHHHHHHHH
Confidence 7999999998765543 233445678999999999999999999999999999999999998863 5566665555
Q ss_pred hhHHHHHHHHH
Q 007351 587 IDAKILFKLVF 597 (607)
Q Consensus 587 ~~~~~~~~i~~ 597 (607)
++.++-.+|+.
T Consensus 650 ~KGk~p~KmlR 660 (752)
T KOG0670|consen 650 LKGKFPNKMLR 660 (752)
T ss_pred hcCCCcHHHhh
Confidence 55444444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=247.78 Aligned_cols=231 Identities=21% Similarity=0.354 Sum_probs=184.2
Q ss_pred CCCccHHHHHH---hhCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeE
Q 007351 354 RSMFTYEELVK---ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSL 428 (607)
Q Consensus 354 ~~~~~~eel~~---~~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 428 (607)
+..+.+|.... ..++|++.+.+|+|.|+.||.|. ..++++++||+++- ...+.+.+|++||..|. |+||+.|
T Consensus 22 ~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L 98 (338)
T KOG0668|consen 22 REYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKL 98 (338)
T ss_pred hhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeeh
Confidence 33455555432 34689999999999999999998 45788999999973 34567999999999997 9999999
Q ss_pred EeEEEeCC--ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CC
Q 007351 429 VGYCISDD--RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NF 505 (607)
Q Consensus 429 ~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~ 505 (607)
+++..+.. ...||+||+.+.+...+... +...+++.++.++++||.|+|+. ||.|||+|+.|+|||. ..
T Consensus 99 ~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~r 170 (338)
T KOG0668|consen 99 LDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELR 170 (338)
T ss_pred hhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhc
Confidence 99988655 44799999999887666543 66778889999999999999999 9999999999999985 45
Q ss_pred cEEEEecccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
.++|+|+||+.++...... ...+.++.|.-||+|.. ..|+...|+|||||+|.+|+..+.||-..... -+.|++.+
T Consensus 171 kLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIa 247 (338)
T KOG0668|consen 171 KLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIA 247 (338)
T ss_pred eeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHH
Confidence 7999999999987655432 23457788999998764 57899999999999999999999999654221 24566666
Q ss_pred hHhhHHHHHHHHHH
Q 007351 585 NLIDAKILFKLVFL 598 (607)
Q Consensus 585 ~~~~~~~~~~i~~~ 598 (607)
+.+..+.+.+-+.+
T Consensus 248 kVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 248 KVLGTDELYAYLNK 261 (338)
T ss_pred HHhChHHHHHHHHH
Confidence 66666655554443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=252.02 Aligned_cols=206 Identities=26% Similarity=0.386 Sum_probs=171.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeC------Cc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 437 (607)
.+|..++-+|.|.- .|..+.+. .++.||+|++... +....+...+|+.++..++|.||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788898888 56555432 5788999988532 233456788999999999999999999998643 35
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.|+|||||. .+|...++. .++.+.+.+|..|+++|++|||+. +|+|||||++||+|..++.+||.|||+++.
T Consensus 96 ~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 689999995 456666653 278899999999999999999999 999999999999999999999999999986
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (607)
.... ...+.++.++.|.|||++.+..|...+||||+||++.||++|+.-|.+ .+.+.+|.++++
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-----~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-----KDHIDQWNKIIE 231 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-----chHHHHHHHHHH
Confidence 4332 456677899999999999998899999999999999999999999985 467778877765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=248.56 Aligned_cols=210 Identities=21% Similarity=0.434 Sum_probs=164.6
Q ss_pred hCCCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeE-EEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY-CISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~-~~~~~~~~lV~ 442 (607)
.+.|.+.+.||+|.||.+.+++++. ...+++|.+.. .....++|.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999864 56788887742 233467888887765555 48999988875 56667788999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE--cCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL--DNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl--~~~~~vkL~DFGls~~~~~ 520 (607)
||+..|+|..-+...+ +-+....+++.|++.||+|||++ ++||||||.+|||| .+..+|||||||+.+....
T Consensus 102 E~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999988886644 77788889999999999999999 99999999999999 3456999999999975432
Q ss_pred CCcceeeccccCCCCCchhhhcC---CC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh
Q 007351 521 ANTHITTRVMGTFGYMAPEYASS---GK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~---~~--~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (607)
. ..+...+..|.+||++.. +. .+...|||.|||++|.+|+|+.||+ +....+..+.+|....
T Consensus 176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWL 242 (378)
T ss_pred e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHh
Confidence 1 222334667999998653 22 3456899999999999999999998 4445555555555443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=232.11 Aligned_cols=183 Identities=38% Similarity=0.595 Sum_probs=159.5
Q ss_pred ecccCcEEEEEEEeCC-CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchhH
Q 007351 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452 (607)
Q Consensus 375 IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 452 (607)
||+|.+|.||++...+ |+.++||++...... ....+.+|+++++.++|.+|+++++++......+++|||+.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998755433 34679999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecccccccccCCcceeecccc
Q 007351 453 HLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMG 531 (607)
Q Consensus 453 ~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~~~~~~~~~~~~~g 531 (607)
++.... ..+++..++.++.+++++|+|||++ +++|+||+++||++++ ++.++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 887652 2488999999999999999999999 9999999999999999 89999999999986654331 1223456
Q ss_pred CCCCCchhhhcCC-CCCchhhHHHHHHHHHHH
Q 007351 532 TFGYMAPEYASSG-KLTEKSDVFSFGVVLLEL 562 (607)
Q Consensus 532 t~~y~APE~l~~~-~~~~~~DVwSlGvll~EL 562 (607)
...|++||.+... .++.+.|+|+||++||||
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 7889999999887 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.24 Aligned_cols=131 Identities=24% Similarity=0.397 Sum_probs=111.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-----C---CCceeEEeEEEeCC-
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----H---RHLVSLVGYCISDD- 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~g~~~~~~- 436 (607)
.+|.++++||-|.|++||++.+. +.+.||+|++|.. ....+..+.||++|++++ | .+||+|+++|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57889999999999999999854 6778999998742 333456788999999984 2 35999999998643
Q ss_pred ---ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 437 ---RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 437 ---~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+.+||+|++ |.+|..++....-+.+....+++|++||+.||.|||+.| +|||.|||++||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 789999999 556777777777778999999999999999999999988 99999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=263.03 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=176.2
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
-.++|.....||.|.||.|||+++. .++..|||+++.....+...+++|+-+++..+|+|||.++|-+..++..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3467889999999999999999954 789999999999988888899999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|+|++..+.-+. +.+.++..+++..++||+|||.. +-+|||||-.|||+++.|++||+|||.+..+....
T Consensus 93 ycgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred ecCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999998887664 88899999999999999999999 88999999999999999999999999997664332
Q ss_pred ceeeccccCCCCCchhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYA---SSGKLTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l---~~~~~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
..+..+.||.+|||||+- +.+-|+.++|||++|+...||-.-+-|.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 234557899999999974 3457899999999999998876655444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=229.70 Aligned_cols=225 Identities=22% Similarity=0.318 Sum_probs=183.6
Q ss_pred CCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
-.|++++.||+|+||.+|.|+ +-+++.||||.--.+ .+.-++..|.+.++.|. ..+|.++|-|..++....||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 469999999999999999998 458999999965332 22346888999999886 78899999888888899999998
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-----CCcEEEEecccccccc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLAL 519 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGls~~~~ 519 (607)
+ |-+|.+++.-+++ .|.....+.||+||+.-|+|+|++ .+|+||||++|+||.. ...|.|+|||+++.+.
T Consensus 106 L-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 6788887766655 489999999999999999999999 9999999999999953 3468999999999887
Q ss_pred cCCcce------eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHH
Q 007351 520 DANTHI------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILF 593 (607)
Q Consensus 520 ~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (607)
+..... ....-||-+||+-...++++.+.+.|+-|||-+++++|.|.+||.+.+ .+.+.+++.++.+.+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK--A~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--ADTNKEKYEKIGETKRST 258 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc--CcchHHHHHHhccccccC
Confidence 754432 233569999999999999999999999999999999999999998864 344455555555555555
Q ss_pred HHHHHhh
Q 007351 594 KLVFLCQ 600 (607)
Q Consensus 594 ~i~~~C~ 600 (607)
.+-..|+
T Consensus 259 ~i~~Lc~ 265 (449)
T KOG1165|consen 259 PIEVLCE 265 (449)
T ss_pred CHHHHHh
Confidence 5555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=238.83 Aligned_cols=223 Identities=26% Similarity=0.359 Sum_probs=181.4
Q ss_pred HHhhCCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCc
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDR 437 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 437 (607)
....+.|...++||+|.|+.||++.+. .++.||+|.+... ..-..+.+|+++|..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344578999999999999999999853 4678999987643 33456899999999995 9999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEeccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAK 516 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~ 516 (607)
.++||||+++....+++.. ++..++..+++.+++||.|+|.+ ||||||||+.|||.+. -++-.|+|||++.
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 9999999999988888765 67889999999999999999999 9999999999999975 4678999999986
Q ss_pred ccccC-------------------------------------------CcceeeccccCCCCCchhhhcC-CCCCchhhH
Q 007351 517 LALDA-------------------------------------------NTHITTRVMGTFGYMAPEYASS-GKLTEKSDV 552 (607)
Q Consensus 517 ~~~~~-------------------------------------------~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DV 552 (607)
..... ....+....||.+|+|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21000 0001122469999999999864 567889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHH
Q 007351 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLV 596 (607)
Q Consensus 553 wSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~ 596 (607)
||.|||++-+++++.||.... .+.+.+.|.+.++.+..++++.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~-dd~~al~ei~tifG~~~mrk~A 304 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAK-DDADALAEIATIFGSAEMRKCA 304 (418)
T ss_pred eeccceeehhhccccccccCc-cccchHHHHHHHhChHHHHHHh
Confidence 999999999999999997543 2345777888887777666643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=220.06 Aligned_cols=226 Identities=23% Similarity=0.320 Sum_probs=183.2
Q ss_pred hCCCcccceecccCcEEEEEEE-eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC-CCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 443 (607)
...|++.+.||.|+||.+|.|. +.+|++||||+-+.+ ...-++..|.++++.|++ ..|..++.|..++....||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3579999999999999999998 568999999986533 223467889999999974 568888888888899999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGls~~~~~ 520 (607)
.+ |-+|.+++.-+.+ .+...+.+.++.||+.-++|+|.+ ++||||||++|+|+.-+ ..+.|||||+++.+.+
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 6788877765544 488889999999999999999999 99999999999999643 4688999999998766
Q ss_pred CCcce------eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHH
Q 007351 521 ANTHI------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFK 594 (607)
Q Consensus 521 ~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (607)
..... .....||-+|.+-....+.+...+.|+-|+|.+|.++..|.+||++.. ......++.++.+.++-.-
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk--a~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK--AATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc--hhhHHHHHHHHHHhhcCCC
Confidence 54332 234569999999888888888889999999999999999999999865 3345556666666655555
Q ss_pred HHHHhh
Q 007351 595 LVFLCQ 600 (607)
Q Consensus 595 i~~~C~ 600 (607)
+...|.
T Consensus 245 ie~LC~ 250 (341)
T KOG1163|consen 245 IEVLCK 250 (341)
T ss_pred HHHHhC
Confidence 555554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=237.20 Aligned_cols=164 Identities=20% Similarity=0.254 Sum_probs=128.5
Q ss_pred hhCCCcccceecccCcEEEEEEEeC--CCcEEEEEEeecC-----CchhHHHHHHHHHHHHHccCCCcee-EEeEEEeCC
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIG-----GGQGEREFKAEVEIISRIHHRHLVS-LVGYCISDD 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~--~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~~ 436 (607)
..++|.+.+.||+|+||.||+|+++ +++.||||++... .....+.|++|+++|++|+|.||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4467999999999999999999864 5777899986532 1223456999999999999999985 4432 4
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCC-CCCCEEEcCCCcEEEEecccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI-KSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFGls 515 (607)
..+||||||++++|... ... . ...++.|++++|+|||++ +|+|||| |++||||+.++.+||+|||++
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 68999999999999632 111 1 146788999999999998 9999999 999999999999999999999
Q ss_pred cccccCCcce-------eeccccCCCCCchhhhcCC
Q 007351 516 KLALDANTHI-------TTRVMGTFGYMAPEYASSG 544 (607)
Q Consensus 516 ~~~~~~~~~~-------~~~~~gt~~y~APE~l~~~ 544 (607)
+......... ....++++.|++||++..+
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8665432111 1345788899999988643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=231.21 Aligned_cols=202 Identities=24% Similarity=0.313 Sum_probs=168.0
Q ss_pred CCcccceecccCcEEEEEEEeCCC--cEEEEEEeecCCchhHHHHHHHHHHHHHccC----CCceeEEeEE-EeCCceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDG--REVAIKQLKIGGGQGEREFKAEVEIISRIHH----RHLVSLVGYC-ISDDRRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g--~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~~l 440 (607)
+|++.+.||+|+||.||++...+. +.+|+|............+..|+.+|..+.+ .++.++++.. ..+...||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4789998775543333378889999999873 5889999988 47778899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-----CcEEEEecccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-----FEAQVSDFGLA 515 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-----~~vkL~DFGls 515 (607)
||+.+ |.+|.++........+...+.++|+.|++.+|++||+. |++|||||+.|++++.. ..++|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 77888877665556799999999999999999999999 99999999999999764 46999999999
Q ss_pred c--ccccCCcc----e---eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 516 K--LALDANTH----I---TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 516 ~--~~~~~~~~----~---~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+ .+...... . ...+.||.+|.+.++..+...+.+.|+||++.++.||+.|.+||....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 8 43222211 1 123569999999999999999999999999999999999999996543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=213.66 Aligned_cols=200 Identities=35% Similarity=0.523 Sum_probs=170.6
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCC-CceeEEeEEEeCCceEEEEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHR-HLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey 444 (607)
|.+.+.||.|.||.||++.+. +.+++|.+...... ....+.+|+.+++.+.|. ||+++++++...+..++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999985 88999999755443 367799999999999988 799999999777778999999
Q ss_pred cCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~~~ 522 (607)
+.+++|..++..... ..+.......++.|++.+|+|+|+. +++|||||++|||++..+ .+||+|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966655432 1488889999999999999999999 899999999999999988 79999999998554433
Q ss_pred cc-----eeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 523 TH-----ITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 523 ~~-----~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.. ......|+..|++||.+.+ ..+....|+|++|++++++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2355679999999999987 578889999999999999999999986654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-25 Score=256.19 Aligned_cols=148 Identities=17% Similarity=0.193 Sum_probs=112.0
Q ss_pred HccC-CCceeEEeEEE-------eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 007351 419 RIHH-RHLVSLVGYCI-------SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490 (607)
Q Consensus 419 ~l~H-pnIv~l~g~~~-------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 490 (607)
.++| .||++++++|. +.+..+++|||+ +++|+++|.... ..+++..++.|++||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3444 57788888772 223456778887 668999997543 3489999999999999999999998 999
Q ss_pred ecCCCCCCEEEcCCC-------------------cEEEEecccccccccCC---------------cceeeccccCCCCC
Q 007351 491 HRDIKSSNILLDNNF-------------------EAQVSDFGLAKLALDAN---------------THITTRVMGTFGYM 536 (607)
Q Consensus 491 HrDLkp~NILl~~~~-------------------~vkL~DFGls~~~~~~~---------------~~~~~~~~gt~~y~ 536 (607)
|||||++||||+..+ .+||+|||+++...... .......+|+..||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 45555556554321100 00011245788899
Q ss_pred chhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 537 APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
|||++.+..|+.++|||||||+||||++|..+|..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999888754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=210.25 Aligned_cols=170 Identities=13% Similarity=0.135 Sum_probs=134.8
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHH---------HHHHHHHHHHccCCCceeEEeEEEeC-
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE---------FKAEVEIISRIHHRHLVSLVGYCISD- 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~---------~~~Ei~il~~l~HpnIv~l~g~~~~~- 435 (607)
.++|+..++||+|+||.||+... +++.+|||+++......++. +++|++.+.+|+|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 67799999997544333332 68999999999999999999886643
Q ss_pred -------CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 436 -------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 436 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
+..+|||||++|.+|.++.. ++. .+..+|+.+|..||++ ||+|||||++|||++++| ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999977632 222 3466999999999999 999999999999999988 99
Q ss_pred EEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHH
Q 007351 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 563 (607)
Q Consensus 509 L~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELl 563 (607)
|+|||..+........ . .+++...|+.++|+|+||+.+..+.
T Consensus 175 liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9999998754322110 0 1344556778999999999887655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=200.02 Aligned_cols=139 Identities=14% Similarity=0.164 Sum_probs=108.7
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCch--h------------------------HHHHHHHHHHHHHccCCCc
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--G------------------------EREFKAEVEIISRIHHRHL 425 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--~------------------------~~~~~~Ei~il~~l~HpnI 425 (607)
.+.||+|+||.||+|.+.+|+.||||+++..... . +....+|+++|.+|.+.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 0 1123459999999988776
Q ss_pred eeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCEEecCCCCCCEEEcCC
Q 007351 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 426 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivHrDLkp~NILl~~~ 504 (607)
.....+.. ...+|||||+.+++|...+.... .+++....+++.||+.+|+|| |+. +|+|||||++||||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 44333322 23489999999887755433222 478889999999999999999 687 9999999999999984
Q ss_pred CcEEEEeccccccc
Q 007351 505 FEAQVSDFGLAKLA 518 (607)
Q Consensus 505 ~~vkL~DFGls~~~ 518 (607)
++++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=193.35 Aligned_cols=140 Identities=15% Similarity=0.148 Sum_probs=110.8
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCch---------------------h-----HHHHHHHHHHHHHccCCCc
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---------------------G-----EREFKAEVEIISRIHHRHL 425 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~---------------------~-----~~~~~~Ei~il~~l~HpnI 425 (607)
.+.||+|+||.||+|++.+|+.||||+++..... . ...+++|++.+.+++|.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999999754211 0 1124679999999999987
Q ss_pred eeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCC
Q 007351 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 426 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~ 504 (607)
.....+... ..+|||||+.++++...+.... .++.....+++.|++.+|.+||+ + ||+|||||++||||+ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 544444332 3589999999885543322222 36778889999999999999999 8 999999999999999 7
Q ss_pred CcEEEEecccccccc
Q 007351 505 FEAQVSDFGLAKLAL 519 (607)
Q Consensus 505 ~~vkL~DFGls~~~~ 519 (607)
++++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=233.27 Aligned_cols=200 Identities=22% Similarity=0.237 Sum_probs=159.3
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCc
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDR 437 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~ 437 (607)
++....++|.+.+.||+|+||.||+|...+|+.||||+-+-.+.++..-+. +++.+|+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~---q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL---QVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH---HHHHhhchhhhcchHHHHHHHccCCc
Confidence 344456789999999999999999999888999999988765554332222 2333333 2334455555556778
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-------CCCcEEEE
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-------NNFEAQVS 510 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-------~~~~vkL~ 510 (607)
.+||+||...|+|.+++...+ .++|...+.|++||++.+++||.. +|||+|||++|+||. +..-++||
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999998544 599999999999999999999998 999999999999994 23458999
Q ss_pred ecccccccccC-CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCC
Q 007351 511 DFGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 511 DFGls~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~P 568 (607)
|||.+..+.-- +.......+++-.+-+.|++.|+.+++++|.|.|.-+++-||.|+.-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999755321 22233446788999999999999999999999999999999999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=191.48 Aligned_cols=139 Identities=24% Similarity=0.252 Sum_probs=109.6
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~ 527 (607)
|+|.++++.++ ..+++..+++|+.||++||+|||++ + |++|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 67888887643 3489999999999999999999998 5 999999999999999 99998654322
Q ss_pred ccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh--------------H-HHH
Q 007351 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID--------------A-KIL 592 (607)
Q Consensus 528 ~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~--------------~-~~~ 592 (607)
..|+..|||||++.+..++.++|||||||++|||++|+.||....... ..+..+.+... . ..+
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 257899999999999999999999999999999999999997643322 11112211110 1 158
Q ss_pred HHHHHHhhhcCCC
Q 007351 593 FKLVFLCQQNSNS 605 (607)
Q Consensus 593 ~~i~~~C~~~~~~ 605 (607)
.+++.+|++.++.
T Consensus 142 ~~~i~~cl~~~p~ 154 (176)
T smart00750 142 ADFMRVCASRLPQ 154 (176)
T ss_pred HHHHHHHHhcccc
Confidence 8999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=193.76 Aligned_cols=187 Identities=18% Similarity=0.123 Sum_probs=140.7
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCchh----HHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEe
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG----EREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~----~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.+...|++|.||+||.+.. ++..++.+.+....... ...+++|+++|++|+ |.+|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 78888888776433221 225789999999995 5889999987 457999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCC-CCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI-KSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
+.|.+|...+.. ....++.|++++|++||++ ||+|||| |+.|||+++++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999988654321 1135778999999999999 9999999 79999999999999999999985443221
Q ss_pred c----e--------eeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 H----I--------TTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~----~--------~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
. . ......+..|++|+.... ..--...++++.|+-+|.++|+++++....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 111235667788774322 222246799999999999999999886543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=201.64 Aligned_cols=224 Identities=24% Similarity=0.384 Sum_probs=174.6
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
...+|.+...|..|+|++ .|.++++|+++.. ..+..++|.+|+-.|+.+.|+||+.++|.|...-...++..||..|
T Consensus 194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345678889999999999 7778888888643 3345578999999999999999999999999998999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE--ecccccccccCCccee
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS--DFGLAKLALDANTHIT 526 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~--DFGls~~~~~~~~~~~ 526 (607)
+|+..||.......+..+.++++.+|++||+|||+. .+-|..--|+.+.|+||+|.+.+|. |--++.. ..
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---e~---- 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---EV---- 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---cc----
Confidence 999999998888899999999999999999999994 5556666799999999999887764 3333321 11
Q ss_pred eccccCCCCCchhhhcCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhH--HHHHh----HhhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKL---TEKSDVFSFGVVLLELITGRKPVDASQPLGDESL--VEWVN----LIDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~---~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l--~~~~~----~~~~~~~~~i~~ 597 (607)
.......||+||.|..+.- -..+|+|||.|+||||.|...||.+-.+.+-+-. +|=.+ ..-....-+++.
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN 423 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence 1224678999999986543 3468999999999999999999987554322211 11011 111355667888
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
.|.++|+
T Consensus 424 icmnedp 430 (448)
T KOG0195|consen 424 ICMNEDP 430 (448)
T ss_pred HHhcCCC
Confidence 8988875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-23 Score=230.69 Aligned_cols=197 Identities=26% Similarity=0.400 Sum_probs=160.1
Q ss_pred cccceecccCcEEEEEEEe-CCCcEEEEEEeecC--CchhHH----HHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGER----EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~--~~~~~~----~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
...+++|.|++|.|+.... ...+.++.|.++.. ....++ .+..|+.+-..|+|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997777663 24444555544311 111122 2666888888899999999888888777777779
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+ +|+.++...++ +...++..+++|++.|++|||+. ||.|||||.+|||++.+|.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 99999877643 78888899999999999999999 99999999999999999999999999997654332
Q ss_pred c---ceeeccccCCCCCchhhhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 T---HITTRVMGTFGYMAPEYASSGKLTEK-SDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~---~~~~~~~gt~~y~APE~l~~~~~~~~-~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. .....++|.-.|+|||++.+.+|+.. .||||.||++..|.+|+.+|...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 2 55667889999999999999999875 89999999999999999999644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=216.29 Aligned_cols=186 Identities=32% Similarity=0.401 Sum_probs=157.9
Q ss_pred eecccCcEEEEEEE----eCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEecC
Q 007351 374 LLGEGGFGSVYKGY----LPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~----~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
.+|+|.||.|++++ .+.|..+|+|+++.... ........|..++..++ |+.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998875 23467789998864432 11225667888888887 9999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|+..+..+.. +++.....+...++-+++++|+. +|+|||+|.+||+++.+|++|+.|||+++...+....
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999988876654 67777777888899999999998 9999999999999999999999999999876554432
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
+|+..|||||++. .+...+|+|+||++++||++|..+|..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999998 567789999999999999999999976
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=184.55 Aligned_cols=138 Identities=22% Similarity=0.275 Sum_probs=108.4
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-----cCCCceeEEeEEEeCC---c-eE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-----HHRHLVSLVGYCISDD---R-RL 439 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~-~~ 439 (607)
+...+.||+|+||.||+ .-+++.. +||++........+++.+|+++|+.| +|+||++++|+++++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45568999999999996 3334444 79988765555667899999999999 5799999999999874 2 23
Q ss_pred EEEEe--cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCCCCEEecCCCCCCEEEcC----CCcEEEEec
Q 007351 440 LIYDY--VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL-AYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDF 512 (607)
Q Consensus 440 lV~Ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL-~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DF 512 (607)
+|+|| +.+++|.+++.+.. +.+. ..+++|++.++ +|||++ +|||||||++|||++. +++++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 55799999996532 4444 35677888777 999999 9999999999999974 348999995
Q ss_pred cccc
Q 007351 513 GLAK 516 (607)
Q Consensus 513 Gls~ 516 (607)
+.++
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 4443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=187.21 Aligned_cols=149 Identities=15% Similarity=0.156 Sum_probs=116.0
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEE--eCCCcEEEEEEeecCCch------------------------hHHHHHHH
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQ------------------------GEREFKAE 413 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~--~~~g~~VAVK~l~~~~~~------------------------~~~~~~~E 413 (607)
..+.+.+..|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3444555678899999999999999998 568999999998743210 11236789
Q ss_pred HHHHHHccCCC--ceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-EE
Q 007351 414 VEIISRIHHRH--LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-II 490 (607)
Q Consensus 414 i~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-iv 490 (607)
++++.++++.+ +.+++++ ...+|||||+.+++|..++..+. .+......+++.||+.+|++||++ + |+
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~ii 171 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELV 171 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence 99999998633 4455543 24589999999988866543322 255566788999999999999999 8 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 491 HRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 491 HrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
|||||++||||+ +++++|+|||++...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 789999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=178.97 Aligned_cols=148 Identities=20% Similarity=0.246 Sum_probs=117.3
Q ss_pred ccHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch----------------------hHHHHHHHH
Q 007351 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ----------------------GEREFKAEV 414 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~----------------------~~~~~~~Ei 414 (607)
..++++......|.+.+.||+|+||.||++.+.+|+.||||+++..... ....+.+|+
T Consensus 5 ~~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 84 (198)
T cd05144 5 LALHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF 84 (198)
T ss_pred HHHHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence 3455666666678899999999999999999888999999987643210 112367899
Q ss_pred HHHHHccCCC--ceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEec
Q 007351 415 EIISRIHHRH--LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492 (607)
Q Consensus 415 ~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHr 492 (607)
.++..+.|.+ +..+++. +..++||||+.+++|..+... ....+++.+|+++|.+||+. +|+||
T Consensus 85 ~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~ 149 (198)
T cd05144 85 AALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHG 149 (198)
T ss_pred HHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence 9999998874 4555442 456899999999988654321 23467889999999999998 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecccccccc
Q 007351 493 DIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 493 DLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||++||||++++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=178.30 Aligned_cols=131 Identities=22% Similarity=0.361 Sum_probs=107.7
Q ss_pred eecccCcEEEEEEEeCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+||+|+||.||+|.+ +|..|+||+....... ....+.+|+++++.++|.+|.....++..++..+|||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 7789999986533211 1245788999999999887655555556677789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++++|.+++..... .++.+|+++|.+||+. +++||||+++|||++ ++.++|+|||+++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887754211 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=178.66 Aligned_cols=135 Identities=22% Similarity=0.357 Sum_probs=114.8
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+.||+|++|.||+|.+ +|..|+||+....... ....+.+|++++..++|.||.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999998 7888999986533211 123578899999999999988877777778889999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+++++|.+++.... . .+..++.+|+.+|.+||+. +|+||||+++|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999998886432 2 7789999999999999999 999999999999999 778999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=187.96 Aligned_cols=227 Identities=22% Similarity=0.296 Sum_probs=140.9
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHcc----------CCCceeEEeEE-
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIH----------HRHLVSLVGYC- 432 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~----------HpnIv~l~g~~- 432 (607)
.+.++++||.|+|+.||.+++. .|+++|||++..... ...+++++|...+..+. |-.++--++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4667899999999999999975 589999999865442 22345666654444322 21222222221
Q ss_pred --------EeCC--------ceEEEEEecCCCchhHhhh---cCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 007351 433 --------ISDD--------RRLLIYDYVPNNTLYFHLH---GEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (607)
Q Consensus 433 --------~~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (607)
.... ..+++|.-+ .++|..++. .... ..+....++.+..|+++.+++||.+ ||||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1111 235677766 566765543 2221 1244555677789999999999999 9999
Q ss_pred cCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC--------CCCchhhHHHHHHHHHHHH
Q 007351 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG--------KLTEKSDVFSFGVVLLELI 563 (607)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~DVwSlGvll~ELl 563 (607)
+||+++|||++++|.++|+||+......+. ... ...+..|.+||+.... .++.+.|.|+||++||+|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988754332 111 3345789999976442 4688899999999999999
Q ss_pred cCCCCCCCCCCCCchhHHHHHhHhhH-HHHHHHHHHhhhcC
Q 007351 564 TGRKPVDASQPLGDESLVEWVNLIDA-KILFKLVFLCQQNS 603 (607)
Q Consensus 564 tg~~Pf~~~~~~~~~~l~~~~~~~~~-~~~~~i~~~C~~~~ 603 (607)
+|+.||+......+.+. .|.+|.+. +.+..|+..-++.+
T Consensus 245 C~~lPf~~~~~~~~~~~-~f~~C~~~Pe~v~~LI~~lL~~~ 284 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-DFSRCRDMPEPVQFLIRGLLQRN 284 (288)
T ss_dssp HSS-STCCCGGGSTSGG-GGTTSS---HHHHHHHHHHT-SS
T ss_pred HccCCCCCCCccccccc-cchhcCCcCHHHHHHHHHHccCC
Confidence 99999986644333332 56666554 44444444444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-21 Score=212.08 Aligned_cols=231 Identities=26% Similarity=0.257 Sum_probs=170.8
Q ss_pred CCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC-chhHHHHHHHHHH--HHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG-GQGEREFKAEVEI--ISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~-~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
+|...+.||.+.|=+|++|+++.|. |+||++.... ...-+.|.++++- +..++|+|++.+..+.+.+.-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667788999999999999986666 9999986443 3333444444333 4455899999998887777888899899
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc--cccCC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL--ALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~--~~~~~ 522 (607)
+. .+|++.|..+ ..+...+++.|+.||++||..+|+. ||+|||||.+||||+.=.-+.|.||..-+- +.+++
T Consensus 103 vk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 85 4688888653 4588888999999999999999999 999999999999999877899999987542 11221
Q ss_pred cceeecc----ccCCCCCchhhhcCC-----------CCCchhhHHHHHHHHHHHHc-CCCCCCCC-----CCCCchhHH
Q 007351 523 THITTRV----MGTFGYMAPEYASSG-----------KLTEKSDVFSFGVVLLELIT-GRKPVDAS-----QPLGDESLV 581 (607)
Q Consensus 523 ~~~~~~~----~gt~~y~APE~l~~~-----------~~~~~~DVwSlGvll~ELlt-g~~Pf~~~-----~~~~~~~l~ 581 (607)
-.-...+ .....|+|||.+... ..+.+.||||+||++.||++ |+.+|+-. +.....+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 1111111 123469999987542 15567899999999999998 68888632 222345555
Q ss_pred HHHhHhhHHHHHHHHHHhhhcCCC
Q 007351 582 EWVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 582 ~~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
...+.+.+..++.|++..+|.+++
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs 280 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPS 280 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCch
Confidence 666677777888888888877653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=202.10 Aligned_cols=138 Identities=22% Similarity=0.335 Sum_probs=113.3
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecC--Cc------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~--~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 437 (607)
...|...++||+|+||.||+|.+. ++.+++|+...+ .. ...+.+.+|+++|+.++|.||+..+.++..++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999984 444555543211 11 123458899999999999999998888888888
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+|||||+++++|.+++. ...+++.+|+++|.|||++ +|+|||||++|||| +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999988775 3467899999999999999 99999999999999 567999999999976
Q ss_pred c
Q 007351 518 A 518 (607)
Q Consensus 518 ~ 518 (607)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-18 Score=155.89 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=115.0
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC--CCceeEEeEEEeCCceEEEEEecCCC
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
+.+.||+|.++.||++.. +++.++||.++.... ...+.+|+.+++.++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEe-cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 357899999999999998 458899998865433 5679999999999986 58999999988888899999999888
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+..+ +......++.+++++|++||.....+++|+||+++|||+++++.++|+|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4566678899999999999986444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-19 Score=201.17 Aligned_cols=165 Identities=25% Similarity=0.386 Sum_probs=122.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|+.+++|..|+||.||.++++ ..+.+|+|+=+ ++.+.|. +|.....+.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk------q~lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK------QNLILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc------cchhhhc--cccccCCccee------------------
Confidence 468999999999999999999875 34567775322 1222221 22222222222
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc-
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT- 523 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~- 523 (607)
|+-...+++.+.... +++.+++|||+. +|||||||++|.||+.-|++|+.|||++++......
T Consensus 136 ---gDc~tllk~~g~lPv----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPV----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCCcc----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 555555655443211 237899999999 999999999999999999999999999975432111
Q ss_pred -------------ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 -------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 -------------~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....++||..|+|||+++..-|..-+|||++|+|+||++-|+.||.++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 1123458999999999999999999999999999999999999999876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=177.12 Aligned_cols=144 Identities=26% Similarity=0.315 Sum_probs=107.4
Q ss_pred cCCCceeEEeEEEeC---------------------------CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHH
Q 007351 421 HHRHLVSLVGYCISD---------------------------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG 473 (607)
Q Consensus 421 ~HpnIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 473 (607)
+|+|||+++++|.+. ...||||.... .+|+.+|..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999876432 23578888774 46888887654 456667778999
Q ss_pred HHHHHHHHHHcCCCCEEecCCCCCCEEE--cCCC--cEEEEecccccccccCCcc-----eeeccccCCCCCchhhhcCC
Q 007351 474 AARGLAYLHEDCHPRIIHRDIKSSNILL--DNNF--EAQVSDFGLAKLALDANTH-----ITTRVMGTFGYMAPEYASSG 544 (607)
Q Consensus 474 ia~gL~~LH~~~~~~ivHrDLkp~NILl--~~~~--~vkL~DFGls~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~ 544 (607)
+++|+.|||++ ||.|||||++|||| |+|+ .+.|+|||++--....... ......|.-..||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 4443 4689999998422111111 11123467789999987532
Q ss_pred ------CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 545 ------KLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 545 ------~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
..-.|+|.|+.|.+.||++...-||+.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 223589999999999999999999986
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=185.55 Aligned_cols=186 Identities=25% Similarity=0.432 Sum_probs=145.0
Q ss_pred HHHccCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCC
Q 007351 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (607)
Q Consensus 417 l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (607)
|+.+.|.|+.+|+|.+..+...++|.+||..|+|.+.+.+. ...++|.....++++|++||+|||+- . ..+|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s-~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS-P-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC-c-ceeeeeecc
Confidence 45788999999999999999999999999999999999874 34699999999999999999999985 2 239999999
Q ss_pred CCEEEcCCCcEEEEecccccccccCC-cceeeccccCCCCCchhhhcCCC-------CCchhhHHHHHHHHHHHHcCCCC
Q 007351 497 SNILLDNNFEAQVSDFGLAKLALDAN-THITTRVMGTFGYMAPEYASSGK-------LTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 497 ~NILl~~~~~vkL~DFGls~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~-------~~~~~DVwSlGvll~ELltg~~P 568 (607)
.|+++|..+.+||.|||+.....+.. ............|.|||++.+.. .+.+.||||||++++|+++.+.+
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987664211 11111222456899999998642 35679999999999999999999
Q ss_pred CCCCCCCCc-hhHHHHHhH--------------hhHHHHHHHHHHhhhcCCC
Q 007351 569 VDASQPLGD-ESLVEWVNL--------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 569 f~~~~~~~~-~~l~~~~~~--------------~~~~~~~~i~~~C~~~~~~ 605 (607)
|.......+ +++..+++. .....+..++.+||..++.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE 209 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence 986543322 233333222 1123578899999987764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=161.50 Aligned_cols=136 Identities=18% Similarity=0.231 Sum_probs=100.8
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCch--hHH----------------------HHHHHHHHHHHccCCC--c
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--GER----------------------EFKAEVEIISRIHHRH--L 425 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--~~~----------------------~~~~Ei~il~~l~Hpn--I 425 (607)
.+.||+|+||.||+|.+.+|+.||||+++..... ... ....|++.+..+++.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999878999999998743211 111 1145677777775443 4
Q ss_pred eeEEeEEEeCCceEEEEEecCCCchhH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcC
Q 007351 426 VSLVGYCISDDRRLLIYDYVPNNTLYF-HLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDN 503 (607)
Q Consensus 426 v~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~ 503 (607)
.+++++ ...+|||||+.++.+.. .+.... .. ....+++.+++.+|++||. + +|+|||||++||||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 555543 24699999999865432 222111 11 5678899999999999999 7 999999999999999
Q ss_pred CCcEEEEecccccccc
Q 007351 504 NFEAQVSDFGLAKLAL 519 (607)
Q Consensus 504 ~~~vkL~DFGls~~~~ 519 (607)
++.++|+|||+++...
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=165.19 Aligned_cols=136 Identities=18% Similarity=0.237 Sum_probs=106.7
Q ss_pred cceec-ccCcEEEEEEEeCCCcEEEEEEeecCCc-------------hhHHHHHHHHHHHHHccCCCc--eeEEeEEEeC
Q 007351 372 QNLLG-EGGFGSVYKGYLPDGREVAIKQLKIGGG-------------QGEREFKAEVEIISRIHHRHL--VSLVGYCISD 435 (607)
Q Consensus 372 ~~~IG-~G~fG~Vyk~~~~~g~~VAVK~l~~~~~-------------~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~ 435 (607)
..+|| .|+.|.||++.. ++..++||.++.... .....+.+|++++.+|+|.+| ++.++++..+
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46787 889999999888 588999998854221 223457889999999998774 7788775543
Q ss_pred Cc----eEEEEEecCC-CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 436 DR----RLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 436 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
.. .+|||||+++ .+|.+++.... +.. ..+.+|+++|.+||++ ||+|||||++||||+.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~---l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP---LSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC---CCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 32 2599999997 68888775431 333 2367899999999999 99999999999999998899999
Q ss_pred eccccccc
Q 007351 511 DFGLAKLA 518 (607)
Q Consensus 511 DFGls~~~ 518 (607)
|||.++..
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.6e-19 Score=186.57 Aligned_cols=128 Identities=25% Similarity=0.387 Sum_probs=109.1
Q ss_pred ceEEEEEecCCCchhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..+|.|++|+.++|.++|.. +......+...+.+++|++.|++| + +.+|+|||+.||+..++..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 46789999999999999963 444457788889999999999999 5 8999999999999999989999999998
Q ss_pred cccccCC-----cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 007351 516 KLALDAN-----THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVD 570 (607)
Q Consensus 516 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~ 570 (607)
....... ...++..+|+..||+||.|.+..|+.|+|||+||+||+||+. -...|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 7654443 223456789999999999999999999999999999999998 444444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-16 Score=166.68 Aligned_cols=142 Identities=23% Similarity=0.260 Sum_probs=102.7
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCch----------------------------------------hHHHHH
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ----------------------------------------GEREFK 411 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~----------------------------------------~~~~~~ 411 (607)
.+-||.|++|.||+|++++|++||||+.+.+... .+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3569999999999999999999999998643110 011356
Q ss_pred HHHHHHHHcc----CCCceeEEeEEE-eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 007351 412 AEVEIISRIH----HRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR-GLAYLHEDC 485 (607)
Q Consensus 412 ~Ei~il~~l~----HpnIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~-gL~~LH~~~ 485 (607)
+|.+.+.+++ |.+-+.+-.++. .....+|||||++|++|.+++..... .+ .+.+++.++++ .+..+|+.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 6777776663 333333333332 24568999999999999776643211 12 23456666666 46888988
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|++|+|+|+.|||++++++++|+|||++.....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-16 Score=178.51 Aligned_cols=203 Identities=26% Similarity=0.363 Sum_probs=163.5
Q ss_pred CCcccceecccCcEEEEEEEeCC--CcEEEEEEeecCC--chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGG--GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~--g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.|.+.+-||+|.|+.|-.....+ ...+|+|.+.... .........|..+-+.+. |.|++.+++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46677789999999998887543 4456667665433 223344556888888887 999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCCEEecCCCCCCEEEcCCC-cEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-EDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~ 520 (607)
||..++++++.+.......+.......+..|+..+|.|+| +. ++.|||||++|.+++..+ .+|++|||++..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988883222224666777889999999999999 87 999999999999999999 999999999987665
Q ss_pred --CCcceeecccc-CCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 521 --ANTHITTRVMG-TFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 521 --~~~~~~~~~~g-t~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+........+| +.-|+|+|.+.+. ......|+|+.|+++.-+++|..+++...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 33334455667 9999999998884 45567899999999999999999997543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.4e-14 Score=135.70 Aligned_cols=135 Identities=15% Similarity=0.145 Sum_probs=101.7
Q ss_pred ceecccCcEEEEEEEeCC-------CcEEEEEEeecCC------------c----------hhHHHH----HHHHHHHHH
Q 007351 373 NLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGG------------G----------QGEREF----KAEVEIISR 419 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-------g~~VAVK~l~~~~------------~----------~~~~~~----~~Ei~il~~ 419 (607)
..||.|.-+.||.|...+ +..+|||+.+... . ...+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 569999999999998543 4799999886321 0 001122 389999999
Q ss_pred cc--CCCceeEEeEEEeCCceEEEEEecCCCchhH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCEEecCCC
Q 007351 420 IH--HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF-HLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDIK 495 (607)
Q Consensus 420 l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivHrDLk 495 (607)
+. .-++.+++++ ...+|||||+.++.+.. .|++. .+...+..+++.+++.+|.+| |+. +|||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 96 4677888865 57899999998764422 23221 244556678889999999999 787 99999999
Q ss_pred CCCEEEcCCCcEEEEeccccccc
Q 007351 496 SSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 496 p~NILl~~~~~vkL~DFGls~~~ 518 (607)
..|||+++ +.++|||||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999975 57999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-14 Score=135.93 Aligned_cols=131 Identities=17% Similarity=0.120 Sum_probs=98.2
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCCCch
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL 450 (607)
.+.|+.|.++.||+++. +++.|+||+...... ....+.+|+++++.+.+.++ .+++++. ....++||||+++..+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35689999999999997 588899998754321 23457889999999876554 4555543 3456899999999877
Q ss_pred hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC--HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.... .....++.+++++|+.||+.. ..+++|+||++.|||++ ++.++|+|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 111345788999999999872 12369999999999999 56899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-14 Score=153.78 Aligned_cols=166 Identities=18% Similarity=0.251 Sum_probs=130.1
Q ss_pred eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHH
Q 007351 388 LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467 (607)
Q Consensus 388 ~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~ 467 (607)
..++..|.|+..+..........++-++.|+.|+|+||+++++.+++++..|||.|.+. -|..+|...+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 34788899998887666445568889999999999999999999999999999999984 4555665533 4556
Q ss_pred HHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCC
Q 007351 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547 (607)
Q Consensus 468 ~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 547 (607)
...+.||++||.|||+.+ +++|++|.-.-|+|+.+|+.||++|.+++...+.+. ........-.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 677899999999999766 899999999999999999999999999876544332 111122233466666554333
Q ss_pred chhhHHHHHHHHHHHHcC
Q 007351 548 EKSDVFSFGVVLLELITG 565 (607)
Q Consensus 548 ~~~DVwSlGvll~ELltg 565 (607)
...|.|-|||++||++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.6e-14 Score=156.40 Aligned_cols=143 Identities=18% Similarity=0.212 Sum_probs=95.7
Q ss_pred CCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCch----------------------------------------h
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ----------------------------------------G 406 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~----------------------------------------~ 406 (607)
+|+. +-||.|++|.||+|++++ |++||||+++.+..+ .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4554 679999999999999987 999999999633100 0
Q ss_pred HHHHHHHHHHHHHcc----CCCceeEEeEEEe-CCceEEEEEecCCCchhHh--hhcCCCCCCCHHHHHHHHHHHHH-HH
Q 007351 407 EREFKAEVEIISRIH----HRHLVSLVGYCIS-DDRRLLIYDYVPNNTLYFH--LHGEGRPVLDWATRVKIAAGAAR-GL 478 (607)
Q Consensus 407 ~~~~~~Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~--l~~~~~~~l~~~~~~~i~~qia~-gL 478 (607)
+-+|.+|+..+.+++ +.+.+.+-.++.+ ....+||||||+|+.|.++ +...+ .+.. +++...++ -+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVFF 273 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHHH
Confidence 123555666666653 3333443333332 4578999999999999764 22221 2222 22222222 23
Q ss_pred HHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEeccccccccc
Q 007351 479 AYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGLAKLALD 520 (607)
Q Consensus 479 ~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGls~~~~~ 520 (607)
..+++. |++|+|+|+.||||+.++ +++++|||+......
T Consensus 274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344555 999999999999999888 999999999976643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.5e-13 Score=133.67 Aligned_cols=143 Identities=21% Similarity=0.276 Sum_probs=111.4
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccC--CCceeEEeEEEeCC---ceEEEEEec
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHH--RHLVSLVGYCISDD---RRLLIYDYV 445 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~---~~~lV~Ey~ 445 (607)
.+.|+.|.++.||+++..+|+.++||+...... .....+.+|+++++.+++ .++.+++.++..+. ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 366899999999999987778999998764332 234578999999999975 45678888876543 568999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED----------------------------------------- 484 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------- 484 (607)
++.+|...+.. ..++..++..++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888765532 1366777778888888888888842
Q ss_pred ------------CCCCEEecCCCCCCEEEcC--CCcEEEEecccccc
Q 007351 485 ------------CHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKL 517 (607)
Q Consensus 485 ------------~~~~ivHrDLkp~NILl~~--~~~vkL~DFGls~~ 517 (607)
....++|+|++++|||+++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-13 Score=124.50 Aligned_cols=144 Identities=19% Similarity=0.241 Sum_probs=110.3
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecCC--------chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--------GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
...+|.+|+-+.|+++.+ .|+..+||.--.+. .-.....++|+++|.+++--.|..-.-++.+....+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 568899999999999998 78888888542211 122356788999999998666665556677788899999
Q ss_pred EecCC-CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---cEEEEeccccccc
Q 007351 443 DYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKLA 518 (607)
Q Consensus 443 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGls~~~ 518 (607)
||+++ .++.+++...............++++|-+.|..||.+ +|||+||..+||||..++ .+.|+|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 3566666654433344444478899999999999999 999999999999996543 4589999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.6e-14 Score=152.22 Aligned_cols=198 Identities=25% Similarity=0.274 Sum_probs=157.8
Q ss_pred CCcccceecc--cCcEEEEEEEe---CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceE
Q 007351 368 GFADQNLLGE--GGFGSVYKGYL---PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 368 ~y~~~~~IG~--G~fG~Vyk~~~---~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 439 (607)
.|.+.+.+|+ |.+|.||++.. .+++.+|+|.-+.... .....-.+|+...++++ |.|.++.+..+++.+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4666788999 99999999986 3788899998543322 33334456677777775 999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEeccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGL 514 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~----gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGl 514 (607)
+-.|+|. .+|..+.+.... .+....++.+..++.+ ||.++|.. +++|.|+|+.||++.++ ..++++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 9999996 677777765443 3666777788888888 99999998 99999999999999998 8999999999
Q ss_pred ccccccCCcc----eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 515 AKLALDANTH----ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 515 s~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
...+.+.+.. ...+..|...|+++|++. ..++...|||+||.++.|-.++...+..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 9877665422 123336788999999876 4888899999999999998887666543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-12 Score=120.56 Aligned_cols=132 Identities=21% Similarity=0.328 Sum_probs=100.8
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.+|++|+-+.+|.+.+ -|..+++|.-..+.- -......+|+++|.+++.-.|..-+-|..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4689999999999987 444577775422211 1123467899999999755554444455567788999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++|..|.+.+... ...+++.|-..+.-||++ +|||+||..+||+|.+++ +.+|||||+.+.
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888654 246677788888899999 999999999999998874 999999999743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.7e-12 Score=126.42 Aligned_cols=142 Identities=17% Similarity=0.089 Sum_probs=105.9
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCch-----------hHHHHHHHHHHHHHcc--CCCceeEEeEEEe----
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-----------GEREFKAEVEIISRIH--HRHLVSLVGYCIS---- 434 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~---- 434 (607)
++++-+.....|+++.+ +|+.|.||........ ....+.+|++.+.+|. ...+..+++|.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35566555566888877 7889999977433211 1114789999999995 4445666767653
Q ss_pred -CCceEEEEEecCCC-chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-------CC
Q 007351 435 -DDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------NF 505 (607)
Q Consensus 435 -~~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------~~ 505 (607)
....+||+|++++. +|.+++............+..++.+|+..+..||++ ||+|+||++.||||+. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 788877532222355667789999999999999999 9999999999999975 57
Q ss_pred cEEEEecccccc
Q 007351 506 EAQVSDFGLAKL 517 (607)
Q Consensus 506 ~vkL~DFGls~~ 517 (607)
.+.||||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-13 Score=147.69 Aligned_cols=193 Identities=22% Similarity=0.212 Sum_probs=148.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC--CCcEEEEEEeecCCchhHH--HHHHHHHHHHHcc-CCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIGGGQGER--EFKAEVEIISRIH-HRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~--~g~~VAVK~l~~~~~~~~~--~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 440 (607)
..+|.....||.|.|+.||++..+ ++..+++|.++........ .-..|+.+...+. |.++++++..+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 357888899999999999998754 6889999998755433322 3356777777764 9999999888888888889
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLAL 519 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~~~ 519 (607)
-.|||+++++...+.. ...++...++++..|++.+|.++|+. .++|+|+|++||++.++ +..++.|||++..+.
T Consensus 344 p~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred chhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999987655522 23478888999999999999999998 99999999999999875 889999999986421
Q ss_pred cCCcceeeccccCCCCC--chhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 007351 520 DANTHITTRVMGTFGYM--APEYASSGKLTEKSDVFSFGVVLLELITGRK 567 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~--APE~l~~~~~~~~~DVwSlGvll~ELltg~~ 567 (607)
-. .......-+++ +++.+....+..+.|+|+||+-+.|.++|..
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ee----cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11 11122333444 4444555677889999999999999888765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-11 Score=118.02 Aligned_cols=126 Identities=25% Similarity=0.324 Sum_probs=85.3
Q ss_pred EEEEEEeCCCcEEEEEEeecCC-------------ch-------------hHHHHHHHHHHHHHccCC--CceeEEeEEE
Q 007351 382 SVYKGYLPDGREVAIKQLKIGG-------------GQ-------------GEREFKAEVEIISRIHHR--HLVSLVGYCI 433 (607)
Q Consensus 382 ~Vyk~~~~~g~~VAVK~l~~~~-------------~~-------------~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 433 (607)
.||.|...+|+.||||+.+... .+ .....++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999886321 00 012467899999999755 678887663
Q ss_pred eCCceEEEEEecC--CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 434 SDDRRLLIYDYVP--NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY-LHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 434 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~-LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
..+|||||++ +..+..+... . +.......++.+++..+.. ||+. ||||+||...|||++++ .+.||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 5789999998 5445433322 1 1234456778888886666 4677 99999999999999988 89999
Q ss_pred ecccccccc
Q 007351 511 DFGLAKLAL 519 (607)
Q Consensus 511 DFGls~~~~ 519 (607)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-12 Score=130.67 Aligned_cols=193 Identities=19% Similarity=0.295 Sum_probs=131.3
Q ss_pred HHHHHHHHHHccCCCceeEEeEEEeCC-----ceEEEEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 007351 410 FKAEVEIISRIHHRHLVSLVGYCISDD-----RRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLH 482 (607)
Q Consensus 410 ~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH 482 (607)
.+.-+..|-.+.|-|||++..|+.+.+ +..++.|||..|.|..+|++. ....+......+|+.||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 333445566677999999999986543 467899999999999888753 3344777888899999999999999
Q ss_pred HcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc---cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHH
Q 007351 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL---DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVL 559 (607)
Q Consensus 483 ~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~---~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll 559 (607)
. |.+.|+|++|.-+-|++..+|.|||.--....... ........+..+-.+|.++|.-..-..+..+|||+||.+.
T Consensus 194 s-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 S-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred c-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 9 78899999999999999999988874322211100 0011112223356789999976666667789999999999
Q ss_pred HHHHcCCCCC-CCCCC-CCchhHHHHHhHhhHHHHHHHHHHhhhcC
Q 007351 560 LELITGRKPV-DASQP-LGDESLVEWVNLIDAKILFKLVFLCQQNS 603 (607)
Q Consensus 560 ~ELltg~~Pf-~~~~~-~~~~~l~~~~~~~~~~~~~~i~~~C~~~~ 603 (607)
+||.-+..-- +.... ..+++...-.-.+...+-++++.+|++--
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~e 318 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGE 318 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCC
Confidence 9999877642 22111 11222222222333455556666666543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=121.47 Aligned_cols=148 Identities=23% Similarity=0.287 Sum_probs=110.7
Q ss_pred ccHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------h--------------hHHHHHHHH
Q 007351 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------Q--------------GEREFKAEV 414 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--------~--------------~~~~~~~Ei 414 (607)
+.+..+.+...-+.+++.||-|.-+.||.|....|.++|||.=+.... + .....++|+
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 344455555555678899999999999999998999999996643211 0 112467899
Q ss_pred HHHHHccCC--CceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEec
Q 007351 415 EIISRIHHR--HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492 (607)
Q Consensus 415 ~il~~l~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHr 492 (607)
++|.+|... .|.+-+++ +...+||||+++.-|...- ++..+...++..|++-+..+.+. ||||+
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHG 226 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHG 226 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 999999744 67777765 5679999999987664432 13344455666667666666666 99999
Q ss_pred CCCCCCEEEcCCCcEEEEeccccccc
Q 007351 493 DIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 493 DLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
||..-||||++||.++||||--+...
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-10 Score=111.06 Aligned_cols=156 Identities=12% Similarity=0.083 Sum_probs=114.4
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC------chhHHHHHHHHHHHHHcc--CCCceeEE
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG------GQGEREFKAEVEIISRIH--HRHLVSLV 429 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~------~~~~~~~~~Ei~il~~l~--HpnIv~l~ 429 (607)
+|+.+.....++.+.---|+|+.+.|++..+ +|+.+-||.-.... ...+..|.+|+..|++|. .-.+.+++
T Consensus 9 ~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 9 EFNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred hHHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 3555554444444333457788889999888 56689999775221 224567999999999996 34456666
Q ss_pred eEEEeCC----ceEEEEEecCC-CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC
Q 007351 430 GYCISDD----RRLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 430 g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (607)
.+..... ..+||+|-+.+ .+|.+++.+......+...+..++.+|++.|..||+. |+.|+|+.++|||++.+
T Consensus 88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~ 164 (216)
T PRK09902 88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTE 164 (216)
T ss_pred eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCC
Confidence 3322222 35899997764 5788887665444467778889999999999999999 99999999999999866
Q ss_pred Cc--EEEEecccccc
Q 007351 505 FE--AQVSDFGLAKL 517 (607)
Q Consensus 505 ~~--vkL~DFGls~~ 517 (607)
+. |++|||.-++.
T Consensus 165 g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 165 GKAEAGFLDLEKSRR 179 (216)
T ss_pred CCeeEEEEEhhccch
Confidence 66 99999998864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=113.21 Aligned_cols=107 Identities=26% Similarity=0.280 Sum_probs=87.8
Q ss_pred HHHHHHHHHHHHHcc--CCCceeEEeEEEeCC----ceEEEEEecCCC-chhHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 007351 407 EREFKAEVEIISRIH--HRHLVSLVGYCISDD----RRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479 (607)
Q Consensus 407 ~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~ 479 (607)
.....+|++.+..|. .-.+.+.+++.+... ..+||+|++++. +|.+++..... ++......++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 446888999999886 555677888776643 348999999874 78888876433 566778899999999999
Q ss_pred HHHHcCCCCEEecCCCCCCEEEcCCC---cEEEEeccccccc
Q 007351 480 YLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKLA 518 (607)
Q Consensus 480 ~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGls~~~ 518 (607)
.||++ ||+|+||++.||||+.++ ++.||||+.++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6e-12 Score=142.39 Aligned_cols=203 Identities=22% Similarity=0.254 Sum_probs=148.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.+++.+.+-+-+|.|+.++.+.-. .|...++|+.+..... +.+..+++-.++-..+++.+++..--+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666778899999999887632 4555666655433222 122334444444444455555554444456678999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
++|+.+++|...|++.+. .+.+..+.++..+...++|||.. .++|+|+++.|+|+..++..++.|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999988663 55555666777788999999997 6999999999999999999999999843211000
Q ss_pred ------------------------------CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 522 ------------------------------NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 522 ------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
+.......+++..|.+||.+.+......+|+|++|++++|.++|..+|+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00112345789999999999999999999999999999999999999986
Q ss_pred CC
Q 007351 572 SQ 573 (607)
Q Consensus 572 ~~ 573 (607)
..
T Consensus 1038 ~t 1039 (1205)
T KOG0606|consen 1038 ET 1039 (1205)
T ss_pred cc
Confidence 43
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-09 Score=114.71 Aligned_cols=168 Identities=21% Similarity=0.292 Sum_probs=127.1
Q ss_pred CcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe----CCceEEEEEecCC-CchhH
Q 007351 379 GFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIYDYVPN-NTLYF 452 (607)
Q Consensus 379 ~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~ 452 (607)
.-.+.||+.. .||..|++|++..+..+.......-++.++++.|.|||.|.+++.. +..++|||+|..+ ++|++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3356788874 3899999999954444444456667889999999999999998763 3467899999876 46655
Q ss_pred hhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 453 HLHGE-------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 453 ~l~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+.-.. ......+..+|.++.|+..||.+||+. |+.-+-|.+++||++.+.+|+|...|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 44221 122356788999999999999999999 99999999999999999999998888765443
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~ 567 (607)
.+.. |-|.+ ..+.|.-.||.+|+-|.+|+.
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3221 11111 235799999999999999965
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.9e-10 Score=122.42 Aligned_cols=140 Identities=21% Similarity=0.246 Sum_probs=96.4
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCc----------------------------------------hhHHHHHH
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG----------------------------------------QGEREFKA 412 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~----------------------------------------~~~~~~~~ 412 (607)
+-|+.++-|.||+|++++|++||||+.+-+-. ..+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45899999999999999999999999863210 11234567
Q ss_pred HHHHHHHcc-----CCCceeEEeE-EEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 007351 413 EVEIISRIH-----HRHLVSLVGY-CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG-LAYLHEDC 485 (607)
Q Consensus 413 Ei~il~~l~-----HpnIv~l~g~-~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~g-L~~LH~~~ 485 (607)
|...+.+++ .++ +.+=.+ +.-.+...|+|||++|..+.+....+. ..++. ..++..++++ ++.+-..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHhc-
Confidence 777777763 222 222222 333568899999999988876643222 23453 3344444433 3444445
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|++|.|.++.||+|+.+|++.+.|||+......
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-09 Score=105.12 Aligned_cols=151 Identities=19% Similarity=0.218 Sum_probs=105.5
Q ss_pred ccHHHHHHhhCCCcccce---ecccCcEEEEEEEeCCCcEEEEEEeecCCch-------------------hH-----HH
Q 007351 357 FTYEELVKATDGFADQNL---LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-------------------GE-----RE 409 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~---IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~-------------------~~-----~~ 409 (607)
.+++.+....++..+.++ |+.|.-+.||+|...++..||||+++..... .. ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345555555555554444 5667777899999878999999999743211 01 12
Q ss_pred HHHHHHHHHHcc--CCCceeEEeEEEeCCceEEEEEecCCCch-hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cC
Q 007351 410 FKAEVEIISRIH--HRHLVSLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DC 485 (607)
Q Consensus 410 ~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~ 485 (607)
..+|+..|+++. +-.+.+-+++. ...|||||+....+ .=.|.+-. +...+...+..++++.|.-|.. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHHhc-
Confidence 366888888874 56666666664 57899999965522 11222211 2223567788889999988887 5
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||+||.--|||+. ++.+.|||||-+...
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 999999999999999 678999999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=105.04 Aligned_cols=137 Identities=16% Similarity=0.191 Sum_probs=98.1
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHH---------HHHHHHHHHccCC---CceeEEeEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREF---------KAEVEIISRIHHR---HLVSLVGYCI 433 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~---------~~Ei~il~~l~Hp---nIv~l~g~~~ 433 (607)
..+|+..+++.......|.+-.. +|+.+++|..+......++.| .+++..+.+++.. .+..++.+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 36788889999988888888887 889999999886655544433 3455555555432 2333333333
Q ss_pred eC-----CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 434 SD-----DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 434 ~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
.. ...+|||||++|..|.++.. ++. .++..|+++|..||++ |++|+|.++.|++|++++ ++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EE
Confidence 22 24468999999988765542 221 3456677889999999 999999999999999765 99
Q ss_pred EEecccccc
Q 007351 509 VSDFGLAKL 517 (607)
Q Consensus 509 L~DFGls~~ 517 (607)
|+||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-09 Score=110.36 Aligned_cols=196 Identities=18% Similarity=0.247 Sum_probs=128.7
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeE------EEeCC-ceEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY------CISDD-RRLL 440 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~------~~~~~-~~~l 440 (607)
...+.-||+|+.+.+|-.. .-.+.+-|++..--.-.+ .+.++.|.+. .|+-+-.-+.| .-.++ ..-+
T Consensus 13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecc--hhhchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3456789999999999642 112334455542211111 1223333333 34432221221 11112 2456
Q ss_pred EEEecCCCc-hhHhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 441 IYDYVPNNT-LYFHLH----GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 441 V~Ey~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+|..+.+.. +..++. .+.-..++|..++++++.|+.+.+-||++ |.+-+|++.+||||.+++.+.|+|-+.-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 666665542 222221 12334589999999999999999999999 9999999999999999999999987654
Q ss_pred cccccCCcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITG-RKPVDASQP 574 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg-~~Pf~~~~~ 574 (607)
... .+.......+|...|..||.-. +...+...|.|.|||+|++||.| +.||.+...
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~ 227 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL 227 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence 322 3344455568999999999644 44566789999999999999986 999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.5e-09 Score=105.34 Aligned_cols=141 Identities=18% Similarity=0.201 Sum_probs=89.2
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC--ceeEEeEEEeCCceEEEEEecCCC
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
....||+|..+.||+. .|+.+++|..... ......++|.++++.+..-+ +.+.++++...+...+||||++|.
T Consensus 5 ~~~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 5 DWTQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred HheeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 3467999999999984 3556788987642 23455789999999997443 578888888778888999999986
Q ss_pred c-hhHh---------------------hhcCCCCCCCHHHHH-HHHH----------HHHHH-HHHHHHc-CCCCEEecC
Q 007351 449 T-LYFH---------------------LHGEGRPVLDWATRV-KIAA----------GAARG-LAYLHED-CHPRIIHRD 493 (607)
Q Consensus 449 s-L~~~---------------------l~~~~~~~l~~~~~~-~i~~----------qia~g-L~~LH~~-~~~~ivHrD 493 (607)
. +... ||.-.........+. ++.. .+.+. .++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 1111 121100011111110 1100 11111 1222211 133678999
Q ss_pred CCCCCEEEcCCCcEEEEecccccc
Q 007351 494 IKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 494 Lkp~NILl~~~~~vkL~DFGls~~ 517 (607)
+++.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999988 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.1e-09 Score=102.07 Aligned_cols=143 Identities=20% Similarity=0.221 Sum_probs=87.7
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC--CceeEEeEEEeC---CceEEEEEecC
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGYCISD---DRRLLIYDYVP 446 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~---~~~~lV~Ey~~ 446 (607)
.+.|+.|..+.||+....+ +.++||..... .....+.+|+++++.|... .+.+++.++... ...+++|+|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999866 79999986533 4567788999999998643 367788755433 34689999999
Q ss_pred CCchhH----------------hh---hcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHHH
Q 007351 447 NNTLYF----------------HL---HGE--GRPVLDWATR---------VKI------------AAGAAR-GLAYLHE 483 (607)
Q Consensus 447 ~gsL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~qia~-gL~~LH~ 483 (607)
+..+.. .+ +.. ....+.+... ... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987766 11 111 1111111110 000 111222 3333432
Q ss_pred c----CCCCEEecCCCCCCEEEc-CCCcEEEEecccccc
Q 007351 484 D----CHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKL 517 (607)
Q Consensus 484 ~----~~~~ivHrDLkp~NILl~-~~~~vkL~DFGls~~ 517 (607)
. ....++|+|++++|||++ +++++.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 344799999999999999 667778999998863
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.4e-09 Score=98.08 Aligned_cols=128 Identities=21% Similarity=0.270 Sum_probs=91.8
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCCC
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
.+.+.|++|.+|.||+|.+ .|..+|+|+-+. ......++.|+++|..++--++ .++|.|- +.++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 3457899999999999999 667999998653 3445779999999999987665 4566553 445569999988
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCC-C-CCEEEcCCCcEEEEecccccc
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK-S-SNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk-p-~NILl~~~~~vkL~DFGls~~ 517 (607)
.|....... + .+-+..+++..--|-.. ||-|+.|. + .||+++++ ++.||||..|.+
T Consensus 98 ~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 886655432 2 22334455554444454 89999986 3 45666554 899999999974
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.3e-09 Score=114.02 Aligned_cols=142 Identities=18% Similarity=0.207 Sum_probs=92.6
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCc-------------------------------------hhHHHHHHHH
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-------------------------------------QGEREFKAEV 414 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~-------------------------------------~~~~~~~~Ei 414 (607)
.+-||..+.|.||+|++++|+.||||+-+.+-. ..+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 356999999999999999999999998753210 0122456666
Q ss_pred HHHHHc----cCCC------ceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 007351 415 EIISRI----HHRH------LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484 (607)
Q Consensus 415 ~il~~l----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~ 484 (607)
+..+++ +|-+ |.++|-. -...+.|+||||+|..+.+...-.+ ..++...+.. .+.++ |++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~---~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILN---KLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHH---HHHHH--HHHHH
Confidence 665554 3545 3333322 2457899999999987754432211 1255444333 33332 22222
Q ss_pred CCCCEEecCCCCCCEEEc----CCCcEEEEecccccccccC
Q 007351 485 CHPRIIHRDIKSSNILLD----NNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 485 ~~~~ivHrDLkp~NILl~----~~~~vkL~DFGls~~~~~~ 521 (607)
+..|++|+|=++.||||+ .++++.|-|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 223899999999999998 3789999999999866543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.1e-08 Score=100.81 Aligned_cols=140 Identities=21% Similarity=0.178 Sum_probs=88.1
Q ss_pred eecccCc-EEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEecCCCchh
Q 007351 374 LLGEGGF-GSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (607)
Q Consensus 374 ~IG~G~f-G~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 451 (607)
.|..|.+ ..||+... +++.++||+..... ..++.+|+++++.+. +--+.+++++...++..+|||||++|..|.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 78999876 45788889765332 446788999999885 555778888887777789999999987664
Q ss_pred Hhh-------------------hcCC--CCCCC--HHHHHHHHH--------------------HHHHHHHHHHHc----
Q 007351 452 FHL-------------------HGEG--RPVLD--WATRVKIAA--------------------GAARGLAYLHED---- 484 (607)
Q Consensus 452 ~~l-------------------~~~~--~~~l~--~~~~~~i~~--------------------qia~gL~~LH~~---- 484 (607)
... |... ...+. ......... .+.+.++.|-+.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 321 1110 00011 000000000 011112222111
Q ss_pred CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 485 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
..+.++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234699999999999999987788999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.6e-07 Score=91.11 Aligned_cols=130 Identities=20% Similarity=0.330 Sum_probs=96.1
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCC----------------chhHHHHHHHHHHHHHcc------CCCcee
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----------------GQGEREFKAEVEIISRIH------HRHLVS 427 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~----------------~~~~~~~~~Ei~il~~l~------HpnIv~ 427 (607)
.....||+|+.-.||. +.++...+||+++... ....+++++|++-+..+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 4457899999999996 3456778899887554 122456777777777776 788999
Q ss_pred EEeEEEeCCceEEEEEecCCC------chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 428 LVGYCISDDRRLLIYDYVPNN------TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 428 l~g~~~~~~~~~lV~Ey~~~g------sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
++|+.+++....+|+|.+.+. +|.+++.... ++. .+...+-+-.+||.++ +|+.+||++.||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999999999999987543 4677775432 443 3344445556788888 89999999999999
Q ss_pred cCC---C-cEEEEe
Q 007351 502 DNN---F-EAQVSD 511 (607)
Q Consensus 502 ~~~---~-~vkL~D 511 (607)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-09 Score=118.62 Aligned_cols=184 Identities=16% Similarity=0.129 Sum_probs=134.9
Q ss_pred CCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC-ceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
.+..++.+++|++++++|.+-.-.+...+|.+.. ....+-++++|.+++|+| .+..++-+..+...+++++|+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3455677899999999998854444455666542 255677899999999999 7777777777788899999998
Q ss_pred CC-c-hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 447 NN-T-LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 447 ~g-s-L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
.+ + ....... ...+...+...+++.-+++|+|||+. .-+|+| |||..+ +..|+.||+....+....
T Consensus 318 ~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 318 TGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CCccccccCChh--hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 87 2 2111111 11244445556677778899999986 458998 888877 479999999987654432
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~P 568 (607)
......++..||+||++.++.++.+.|+|++|+--.+|--|..|
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 23445689999999999999999999999999866666655444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-07 Score=87.72 Aligned_cols=104 Identities=18% Similarity=0.213 Sum_probs=83.4
Q ss_pred HHHHHHHHHccC-CCceeEEeEEEeCCceEEEEEecCCCchhHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC
Q 007351 411 KAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488 (607)
Q Consensus 411 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 488 (607)
..|.-+|+.|.+ .++.+++|+| ..+++.||+..+.++.... ...-....|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999975 6999999999 5688999998776642110 001123689999999999999999999854446
Q ss_pred EEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 489 ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+...|++++||-|+++|++||+|.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-06 Score=93.63 Aligned_cols=76 Identities=13% Similarity=0.182 Sum_probs=55.3
Q ss_pred cceecccCcEEEEEEEeCCC-cEEEEEEeecC-----C--chhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDG-REVAIKQLKIG-----G--GQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g-~~VAVK~l~~~-----~--~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~l 440 (607)
.+.||.|.++.||++.+.+| +.|+||.-... . ......+..|.+.|+.+. -.++.+++++. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 36799999999999998776 58999975311 1 123345677888888763 35688888773 456899
Q ss_pred EEEecCCCc
Q 007351 441 IYDYVPNNT 449 (607)
Q Consensus 441 V~Ey~~~gs 449 (607)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.4e-07 Score=89.39 Aligned_cols=125 Identities=28% Similarity=0.463 Sum_probs=92.3
Q ss_pred CCCcccceecccCc-EEEEEEEeCCCcEEEEEEeecC---C--------c----------hhHHHHHHHHHHHHHcc---
Q 007351 367 DGFADQNLLGEGGF-GSVYKGYLPDGREVAIKQLKIG---G--------G----------QGEREFKAEVEIISRIH--- 421 (607)
Q Consensus 367 ~~y~~~~~IG~G~f-G~Vyk~~~~~g~~VAVK~l~~~---~--------~----------~~~~~~~~Ei~il~~l~--- 421 (607)
.+++.++.||+|.. |.|||+++ +|+.+|||+++.. . . ....-|..|++.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888999999999 99999999 8889999994321 0 0 11124788999999886
Q ss_pred CCCc--eeEEeEEEeCC------------------ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007351 422 HRHL--VSLVGYCISDD------------------RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481 (607)
Q Consensus 422 HpnI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~L 481 (607)
+.++ |+++||..-.. .+.||.||+.... .+. .+-+.+|++-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4455 99999875331 2357777776543 112 23456778888899
Q ss_pred HHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 482 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
|.. ||+-+|++.+|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999987 3589999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.9e-07 Score=93.52 Aligned_cols=72 Identities=11% Similarity=0.246 Sum_probs=47.2
Q ss_pred ceecccCcE-EEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC---CceeEEeEEEeCC---ceEEEEEec
Q 007351 373 NLLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR---HLVSLVGYCISDD---RRLLIYDYV 445 (607)
Q Consensus 373 ~~IG~G~fG-~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~~---~~~lV~Ey~ 445 (607)
+.|+.|+.. .||+. +..++||..+. .....++.+|+++|+.|... .+.++++.....+ ..+++|||+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58875 34677886543 22345789999999988632 4556665544322 348899999
Q ss_pred CCCch
Q 007351 446 PNNTL 450 (607)
Q Consensus 446 ~~gsL 450 (607)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 98665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.5e-07 Score=107.81 Aligned_cols=146 Identities=15% Similarity=0.275 Sum_probs=92.7
Q ss_pred cceecccCcEEEEEEEeCCC---cEEEEEEeecCCc-hhHHHHHHHHHHHHHcc-CCC--ceeEEeEEEeC---CceEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDG---REVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRH--LVSLVGYCISD---DRRLLI 441 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g---~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~---~~~~lV 441 (607)
.+.|+.|.++.+|+..+.++ ..+++|+...... .....+.+|+++|+.|. |.+ |.+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887554 4677776543221 23457899999999996 665 48888888764 467899
Q ss_pred EEecCCCchhH-----------------------hhhcCCCC---------CCCH--HHHHHHH---------------H
Q 007351 442 YDYVPNNTLYF-----------------------HLHGEGRP---------VLDW--ATRVKIA---------------A 472 (607)
Q Consensus 442 ~Ey~~~gsL~~-----------------------~l~~~~~~---------~l~~--~~~~~i~---------------~ 472 (607)
|||+++..+.+ .||.-... ...+ .++.++. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764311 11221100 0011 1111111 1
Q ss_pred HHHHHHHHHHHcCC--------CCEEecCCCCCCEEEcC-CCc-EEEEecccccc
Q 007351 473 GAARGLAYLHEDCH--------PRIIHRDIKSSNILLDN-NFE-AQVSDFGLAKL 517 (607)
Q Consensus 473 qia~gL~~LH~~~~--------~~ivHrDLkp~NILl~~-~~~-vkL~DFGls~~ 517 (607)
.+.+.+++|..+.. ..|||+|++..|||++. +++ +-|+||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 13334566754322 35999999999999974 334 57999999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.2e-07 Score=92.58 Aligned_cols=80 Identities=9% Similarity=0.117 Sum_probs=60.4
Q ss_pred CCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC---CCceeEEeEEEeC---CceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGYCISD---DRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~---~~~~lV 441 (607)
.....+.||+|..+.||+....++ .++||..+. ......|.+|.+.|+.|.. ..|.+++++|..+ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 455567899999999999876455 577787442 1234689999999999963 4689999888643 568999
Q ss_pred EEecCCCch
Q 007351 442 YDYVPNNTL 450 (607)
Q Consensus 442 ~Ey~~~gsL 450 (607)
|||++++.+
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-07 Score=95.47 Aligned_cols=142 Identities=18% Similarity=0.175 Sum_probs=89.3
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC--CceeEEeE------EEeCCceEEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGY------CISDDRRLLIYD 443 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~lV~E 443 (607)
.+.|..|....+|+... +++.++||+... .....+..|+++++.|.+. .+.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 55678888889999876 455788898753 3345677888888888643 35555542 233456789999
Q ss_pred ecCCCchhH--------------hhhcCC---------CCCCCHHHHH----------HHHHHHHHHHHHHHH----cCC
Q 007351 444 YVPNNTLYF--------------HLHGEG---------RPVLDWATRV----------KIAAGAARGLAYLHE----DCH 486 (607)
Q Consensus 444 y~~~gsL~~--------------~l~~~~---------~~~l~~~~~~----------~i~~qia~gL~~LH~----~~~ 486 (607)
|++|..+.. .||... .....|.... .....+.+++++|.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 112100 0111222211 011123334444443 233
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+++|+|+++.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999999864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.9e-07 Score=89.64 Aligned_cols=141 Identities=19% Similarity=0.185 Sum_probs=84.3
Q ss_pred cceecccCcEEEEEEEeCC--CcEEEEEEeecCCchhHHHHHHHHHHHHHccCC-CceeEEeEEEeCCceEEEEEecCCC
Q 007351 372 QNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGGGQGEREFKAEVEIISRIHHR-HLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~--g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
.+.|..|-...+|+....+ ++.|++|+..... ....+..+|+++++.+... -+.++++++. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567889999999998754 6789999765321 1123345789999988533 3455554432 34899999887
Q ss_pred chhHh-----------------hhcCCCC---------CCC-HHHHHHHHH----------------------HHHHHHH
Q 007351 449 TLYFH-----------------LHGEGRP---------VLD-WATRVKIAA----------------------GAARGLA 479 (607)
Q Consensus 449 sL~~~-----------------l~~~~~~---------~l~-~~~~~~i~~----------------------qia~gL~ 479 (607)
.+... +|..... ... +..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65211 1111110 111 112111111 1111122
Q ss_pred HHHHc-----CCCCEEecCCCCCCEEEcC-CCcEEEEecccccc
Q 007351 480 YLHED-----CHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKL 517 (607)
Q Consensus 480 ~LH~~-----~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~ 517 (607)
.|-+. ....++|+||++.|||+++ ++.+.|+||..+..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 22111 2347999999999999998 57899999998863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-08 Score=112.71 Aligned_cols=99 Identities=26% Similarity=0.465 Sum_probs=76.6
Q ss_pred HHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce--------eeccccCCCCCchhhhc
Q 007351 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI--------TTRVMGTFGYMAPEYAS 542 (607)
Q Consensus 471 ~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~--------~~~~~gt~~y~APE~l~ 542 (607)
+.+++.||.|+|+. .++||++|.+++|.++.++.+||+.|+++........+. ---..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 33455999999975 499999999999999999999999999987554422110 01122345799999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 007351 543 SGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (607)
Q Consensus 543 ~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~ 571 (607)
+...+.++|+|||||++|.++. |+.-|..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc
Confidence 9888999999999999999994 5544443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.6e-06 Score=85.69 Aligned_cols=155 Identities=17% Similarity=0.187 Sum_probs=87.3
Q ss_pred HHHHHHhhCCCcc-----cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC--CceeEEe-
Q 007351 359 YEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVG- 430 (607)
Q Consensus 359 ~eel~~~~~~y~~-----~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g- 430 (607)
.+++....+.|.+ .+.|+.|....+|+....+| .++||++. . .....+..|+++++.|... .+.+.+.
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 3444444344533 34567788889999887544 78889875 2 2334555667777776422 3445443
Q ss_pred -----EEEeCCceEEEEEecCCCchh--------------HhhhcCCC---------CCCCH-HHHHH------------
Q 007351 431 -----YCISDDRRLLIYDYVPNNTLY--------------FHLHGEGR---------PVLDW-ATRVK------------ 469 (607)
Q Consensus 431 -----~~~~~~~~~lV~Ey~~~gsL~--------------~~l~~~~~---------~~l~~-~~~~~------------ 469 (607)
+...++..++++||++|..+. ..+|.... ..+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 223355678999999886431 11121110 01112 11111
Q ss_pred HHHH-HHHHHHHHHH----cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 470 IAAG-AARGLAYLHE----DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 470 i~~q-ia~gL~~LH~----~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+.+ +...++.+.+ .+..++||+|+++.|||++++..+-|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 1112223221 1455899999999999999775568999999863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.2e-06 Score=85.09 Aligned_cols=156 Identities=19% Similarity=0.201 Sum_probs=91.8
Q ss_pred HHHHHHhhCCCcc-----cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC--CceeEEeE
Q 007351 359 YEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGY 431 (607)
Q Consensus 359 ~eel~~~~~~y~~-----~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~ 431 (607)
.+++....+.|.+ .+.|+.|....+|+.... +..+++|+.+... ...++..|+++++.|... +|.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 4455444444533 456778878899998764 4467788765321 234566778888887532 34555542
Q ss_pred E------EeCCceEEEEEecCCCchh--------------HhhhcCCC----------CCCCHHHHH------------H
Q 007351 432 C------ISDDRRLLIYDYVPNNTLY--------------FHLHGEGR----------PVLDWATRV------------K 469 (607)
Q Consensus 432 ~------~~~~~~~lV~Ey~~~gsL~--------------~~l~~~~~----------~~l~~~~~~------------~ 469 (607)
. ..++..+++|||++|..+. ..+|.... ....|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 1 2245678999999885431 11221100 001111110 0
Q ss_pred HHHHHHHHHHHHHH----cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 470 IAAGAARGLAYLHE----DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 470 i~~qia~gL~~LH~----~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
....+.+.+++|.. ....+++|+|++..|||+++++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11123344555542 2345899999999999999987778999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.5e-07 Score=91.28 Aligned_cols=138 Identities=13% Similarity=0.092 Sum_probs=82.4
Q ss_pred eecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCCCchhH
Q 007351 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTLYF 452 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 452 (607)
.+..|-.+.+|+... +++.++||...........+..+|.++++.+....+ .++++++ ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 356688889998875 677888997543322221246789999999875433 4555543 2478999998865431
Q ss_pred -----------------hhhcCCC--CCCCHHHH-HHHHHH---------HHHHHHHHHHc-----CCCCEEecCCCCCC
Q 007351 453 -----------------HLHGEGR--PVLDWATR-VKIAAG---------AARGLAYLHED-----CHPRIIHRDIKSSN 498 (607)
Q Consensus 453 -----------------~l~~~~~--~~l~~~~~-~~i~~q---------ia~gL~~LH~~-----~~~~ivHrDLkp~N 498 (607)
.||.... ..++...+ .++..+ +.+.++.+... ....++|+||.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1222111 11222211 111111 11222222221 13468999999999
Q ss_pred EEEcCCCcEEEEecccccc
Q 007351 499 ILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 499 ILl~~~~~vkL~DFGls~~ 517 (607)
||+++++ ++|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999999864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-07 Score=96.38 Aligned_cols=145 Identities=17% Similarity=0.181 Sum_probs=103.6
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--------ch--------------hHHHHHHHHH
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--------GQ--------------GEREFKAEVE 415 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--------~~--------------~~~~~~~Ei~ 415 (607)
.++.+.....-+.+++.||-|.-+.||++-..+|+..++|.-+... ++ ..-...+|+.
T Consensus 83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 83 ALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred HHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3444444445678899999999999999999899999999654221 11 0123467888
Q ss_pred HHHHccC--CCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecC
Q 007351 416 IISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493 (607)
Q Consensus 416 il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD 493 (607)
.|+.|.. --|.+.+++ ++.++|||++.+-.|....+.. + ...+...++.-+--|.++ |+||+|
T Consensus 163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHc---Cceecc
Confidence 8888853 235555554 4678999999887775544332 2 233444555556677777 999999
Q ss_pred CCCCCEEEcCCCcEEEEecccccc
Q 007351 494 IKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 494 Lkp~NILl~~~~~vkL~DFGls~~ 517 (607)
++--||||++++.+++|||--...
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred cchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999976543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.8e-06 Score=89.14 Aligned_cols=141 Identities=17% Similarity=0.242 Sum_probs=100.7
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCC------------------------chh--HHHHHHHHHHHHHccC
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG------------------------GQG--EREFKAEVEIISRIHH 422 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~------------------------~~~--~~~~~~Ei~il~~l~H 422 (607)
..+...|..|.-+.||.+.-.+|..+|||+++..- .+. ......|++.|++|+.
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34455688899999999998899999999886310 000 1124668888988876
Q ss_pred CCceeEEeEEEeCCceEEEEEecCCCc-hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 423 RHLVSLVGYCISDDRRLLIYDYVPNNT-LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 423 pnIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
-.|..---+.. ....|||+|+.... ..-.|++. .+....+..+..|++.-|.-|.+.| ++||.||.--|+|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 55433222221 24579999996322 12233322 2666778888889999999998877 89999999999999
Q ss_pred cCCCcEEEEecccccc
Q 007351 502 DNNFEAQVSDFGLAKL 517 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~ 517 (607)
.++ .+.|||.+-+..
T Consensus 299 hdG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HDG-KLYIIDVSQSVE 313 (520)
T ss_pred ECC-EEEEEEcccccc
Confidence 875 799999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.3e-06 Score=87.71 Aligned_cols=140 Identities=26% Similarity=0.320 Sum_probs=85.7
Q ss_pred ceecccCcEEEEEEEeCC-------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC-ceeEEeEEEeCCceEEEEEe
Q 007351 373 NLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~Ey 444 (607)
+.|..|-...||+....+ ++.+++|+..... ....+..+|+++++.+...+ ..++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456777788999988755 5789999865432 22346688888999886433 346666553 2458999
Q ss_pred cCCCchhH-----------------hhhcCCCC-------CCC--HHHHHH--------------------------HHH
Q 007351 445 VPNNTLYF-----------------HLHGEGRP-------VLD--WATRVK--------------------------IAA 472 (607)
Q Consensus 445 ~~~gsL~~-----------------~l~~~~~~-------~l~--~~~~~~--------------------------i~~ 472 (607)
++|..+.. .||..... .+. +..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 88765532 11221110 000 111100 111
Q ss_pred HHHHHHHHHHH------cCCCCEEecCCCCCCEEEcCC----CcEEEEecccccc
Q 007351 473 GAARGLAYLHE------DCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKL 517 (607)
Q Consensus 473 qia~gL~~LH~------~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGls~~ 517 (607)
++.+.+++|.. .....++|+||++.|||++++ +.++||||+.+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134589999999999999874 7899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.8e-06 Score=85.09 Aligned_cols=143 Identities=19% Similarity=0.258 Sum_probs=78.1
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+..+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. -..+.+++++...++..||||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 5566779999999999987 488899999765 233456888999998884 556889999998888889999999
Q ss_pred CCCc--------h---hHhhhc-C--CCCC-----------------CCHHHHH-----HHHHH-----------HHHHH
Q 007351 446 PNNT--------L---YFHLHG-E--GRPV-----------------LDWATRV-----KIAAG-----------AARGL 478 (607)
Q Consensus 446 ~~gs--------L---~~~l~~-~--~~~~-----------------l~~~~~~-----~i~~q-----------ia~gL 478 (607)
+.+. | ...||. . +... -+|.+.. +...+ +-+.+
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 8771 1 112333 1 1111 2232211 11111 11122
Q ss_pred HHHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 479 AYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 479 ~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+.|.+. .++.++|+||...||+++.+|+..|+|=...
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~y 216 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPACY 216 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---E
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccccc
Confidence 333322 2568999999999999999999999987643
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.5e-06 Score=83.26 Aligned_cols=47 Identities=15% Similarity=0.023 Sum_probs=32.5
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH 421 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~ 421 (607)
+.+++|....||.....+|+.++||.-+. ......+.+|+++|+.|+
T Consensus 17 ~~~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 17 SLNESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVR 63 (276)
T ss_pred eecCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHH
Confidence 33455555667766555788999997642 223456899999999996
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=81.53 Aligned_cols=149 Identities=17% Similarity=0.265 Sum_probs=86.8
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEee-cCCchhHHHHHHHHHHHHHccC--CCceeEEeEEEeCC--ceEEEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDD--RRLLIYD 443 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~-~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~lV~E 443 (607)
..+.+.+..|..-.+|.... +++.++|.+-. ...........+|+++|+.+.- .-+...+++|.++. ..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34445554444445555444 37778887221 1223345667889999998864 33455667776665 5599999
Q ss_pred ecCCCchhHhhhcCCC------------------------------------CCCCHHHHHHHHH--------HHHHHHH
Q 007351 444 YVPNNTLYFHLHGEGR------------------------------------PVLDWATRVKIAA--------GAARGLA 479 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~------------------------------------~~l~~~~~~~i~~--------qia~gL~ 479 (607)
|++|..+...+..... +...|...++.++ .+..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9998544322221110 0111111111000 1122234
Q ss_pred HHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 480 YLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 480 ~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+|+.+ ....+||+|++..||||++++.+-|+||+++...
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 44432 2357999999999999999988999999999754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.4e-05 Score=81.80 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=83.6
Q ss_pred ceecccCcEEEEEEEeCC-----CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecC
Q 007351 373 NLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~-----g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+.|..|-...+|+..+.+ ++.|+||+..... ....+..+|+++++.+...++ .++++++. ++ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence 445568888999987532 3678999775432 222234779999999875554 46666552 22 5799997
Q ss_pred CCchhHh-----------------hhcCC---CC-CCCHHHHHHHHHH-----------------HHHHHHHHHH-----
Q 007351 447 NNTLYFH-----------------LHGEG---RP-VLDWATRVKIAAG-----------------AARGLAYLHE----- 483 (607)
Q Consensus 447 ~gsL~~~-----------------l~~~~---~~-~l~~~~~~~i~~q-----------------ia~gL~~LH~----- 483 (607)
+..|... +|... .. ..-+..+.++..+ +...++.|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665211 12211 11 1112222222211 1112222221
Q ss_pred cCCCCEEecCCCCCCEEEcC-CCcEEEEeccccccc
Q 007351 484 DCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLA 518 (607)
Q Consensus 484 ~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~ 518 (607)
.....++|+||+..|||+++ ++.++|+||+.+...
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 12347899999999999986 468999999998643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00022 Score=76.43 Aligned_cols=73 Identities=16% Similarity=0.155 Sum_probs=51.2
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeec-----CCc--hhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKI-----GGG--QGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~-----~~~--~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 441 (607)
.+.||.|....||+... +++.|+||.-.. ... ........|++.|+.+. ..++.++|+++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999886 556799997641 111 12233344566666554 358899999886 567889
Q ss_pred EEecCC
Q 007351 442 YDYVPN 447 (607)
Q Consensus 442 ~Ey~~~ 447 (607)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.0002 Score=86.07 Aligned_cols=142 Identities=19% Similarity=0.233 Sum_probs=82.2
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC--CC--ceeEEe--------EEEe-CC--c
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RH--LVSLVG--------YCIS-DD--R 437 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pn--Iv~l~g--------~~~~-~~--~ 437 (607)
+.|+ |.+-.+|+.+..+|+.+++|+.+.. ....++..|.++|..|.. .. +.+++- .+.. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~--~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPS--EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCc--cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 4567889988878889999998753 234455556677766632 22 334332 1111 22 3
Q ss_pred eEEEEEecCCCchhHh-----------------hhc--------CCCCCCCHHH-----------------HHHHHHHHH
Q 007351 438 RLLIYDYVPNNTLYFH-----------------LHG--------EGRPVLDWAT-----------------RVKIAAGAA 475 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~-----------------l~~--------~~~~~l~~~~-----------------~~~i~~qia 475 (607)
.+.+|+|++|..|... |+. .....+.|.. .+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 4668999998766431 110 0111233321 122233333
Q ss_pred HHHHH----HHHcCCCCEEecCCCCCCEEEcCCC--cEE-EEecccccc
Q 007351 476 RGLAY----LHEDCHPRIIHRDIKSSNILLDNNF--EAQ-VSDFGLAKL 517 (607)
Q Consensus 476 ~gL~~----LH~~~~~~ivHrDLkp~NILl~~~~--~vk-L~DFGls~~ 517 (607)
+.++- ....+..++||+||+..|||+++++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 32221 1122455899999999999999875 565 999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00023 Score=74.99 Aligned_cols=73 Identities=15% Similarity=0.277 Sum_probs=49.0
Q ss_pred eecccCcEEEEEEEeCCC-cEEEEEEee----c-CC--chhHHHHHHHHHHHHHcc--CC-CceeEEeEEEeCCceEEEE
Q 007351 374 LLGEGGFGSVYKGYLPDG-REVAIKQLK----I-GG--GQGEREFKAEVEIISRIH--HR-HLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~~~~g-~~VAVK~l~----~-~~--~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~~lV~ 442 (607)
.||.|....||++...+| +.|+||.-. . .. .........|.+.|+.++ -+ .+.++|.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 689999763 1 11 122344556777777664 22 46666654 455677999
Q ss_pred EecCCC
Q 007351 443 DYVPNN 448 (607)
Q Consensus 443 Ey~~~g 448 (607)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00014 Score=76.50 Aligned_cols=158 Identities=18% Similarity=0.158 Sum_probs=88.1
Q ss_pred ccHHHHHHhhCCCcc---cc-eecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC--CCceeEE-
Q 007351 357 FTYEELVKATDGFAD---QN-LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLV- 429 (607)
Q Consensus 357 ~~~eel~~~~~~y~~---~~-~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~- 429 (607)
++-+.+..+.+.+.+ .+ .+=.+....||+...++|+.++||+.+.. .....++..|++++..|.. -.|+..+
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~ 89 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLA 89 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCcc
Confidence 444555555444322 11 22345567899998878889999987522 2355677888888888753 2233322
Q ss_pred --e--EEEeCCceEEEEEecCCCchh--------------Hhhhc--C-----CCCCCCHHHH-----H-----------
Q 007351 430 --G--YCISDDRRLLIYDYVPNNTLY--------------FHLHG--E-----GRPVLDWATR-----V----------- 468 (607)
Q Consensus 430 --g--~~~~~~~~~lV~Ey~~~gsL~--------------~~l~~--~-----~~~~l~~~~~-----~----------- 468 (607)
| +...++..+.|++|++|..+. ..||. . .+..++.... .
T Consensus 90 ~~G~~~~~~~g~~~~l~~~~~G~~~~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~ 169 (325)
T PRK11768 90 FNGQTLHEHQGFRFALFPRRGGRAPELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSD 169 (325)
T ss_pred CCCCEEEEECCEEEEEEeeeCCCCCCCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHH
Confidence 1 223355678899999876321 12222 1 0112221111 0
Q ss_pred ------HHHHHHHHHHHH-HHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 469 ------KIAAGAARGLAY-LHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 469 ------~i~~qia~gL~~-LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
+++.++...++. +.. ....++||+|+..+|||++ + .+.|+|||.++.
T Consensus 170 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 170 LRPAYLAAADQLLAAVEACWARGDVRLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 111122111111 111 1344789999999999995 4 588999999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.3e-05 Score=77.82 Aligned_cols=64 Identities=8% Similarity=0.171 Sum_probs=40.8
Q ss_pred EEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC--CceeEEeE------EEeCCceEEEEEecCCCch
Q 007351 382 SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGY------CISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 382 ~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~lV~Ey~~~gsL 450 (607)
.||+....+| .++||++.. ....+..|+.++..|... .|.+++.. ...++..++|+||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876444 688998742 234456677777777533 44555432 2335667899999988543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.3e-05 Score=91.20 Aligned_cols=183 Identities=21% Similarity=0.247 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHccCCCceeEEeEEEeCCceE----EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 007351 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRRL----LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484 (607)
Q Consensus 409 ~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~ 484 (607)
...-|++.+.++.|.|++.+++|..++...- +..|||...++...+..-.. +.....+.+..++++||+|+|++
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh
Confidence 3455777788889999999999977655433 45578888888777766544 77888888999999999999997
Q ss_pred CCCCEEecCCCCC---CEEEcCCCcEEEE--ecccccccccCCcceeeccccCCCCCchhhhcCCCCCch--hhHHHHHH
Q 007351 485 CHPRIIHRDIKSS---NILLDNNFEAQVS--DFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK--SDVFSFGV 557 (607)
Q Consensus 485 ~~~~ivHrDLkp~---NILl~~~~~vkL~--DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~--~DVwSlGv 557 (607)
.+.|.-|..+ +..++.++.+.+. ||+..+...+...... ..-...|.+.|.+..+.+..+ .|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 5666666555 5555666777777 9999887655433221 223445777887776666554 69999999
Q ss_pred HHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHHHHhhhcC
Q 007351 558 VLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFLCQQNS 603 (607)
Q Consensus 558 ll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~~~C~~~~ 603 (607)
++..+..|...-... .....+........+.+.+.+|.+++
T Consensus 381 l~~~~~~~~~i~~~~-----~~~~~~l~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS-----AVPVSLLDVLSTSELLDALPKCLDED 421 (1351)
T ss_pred HHhhhhhcCcccccc-----cchhhhhccccchhhhhhhhhhcchh
Confidence 999999876532211 11122222323335677777777654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00024 Score=75.66 Aligned_cols=75 Identities=11% Similarity=0.194 Sum_probs=51.0
Q ss_pred cceecccCcEEEEEEEeC-CCcEEEEEEee----cCC--chhHHHHHHHHHHHHHcc--C-CCceeEEeEEEeCCceEEE
Q 007351 372 QNLLGEGGFGSVYKGYLP-DGREVAIKQLK----IGG--GQGEREFKAEVEIISRIH--H-RHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~----~~~--~~~~~~~~~Ei~il~~l~--H-pnIv~l~g~~~~~~~~~lV 441 (607)
.+.||.|.-..||++.+. +++.|+||.-. ... .-.....+.|.+.|+.+. - .++.++|.| +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 467899999999999974 36789999653 211 122345666778887764 2 356777655 45566788
Q ss_pred EEecCCC
Q 007351 442 YDYVPNN 448 (607)
Q Consensus 442 ~Ey~~~g 448 (607)
||++...
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 8888543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00011 Score=77.12 Aligned_cols=141 Identities=26% Similarity=0.358 Sum_probs=87.0
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCce------eEEeE--EEeCC--ceEEEE
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV------SLVGY--CISDD--RRLLIY 442 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv------~l~g~--~~~~~--~~~lV~ 442 (607)
+.|.+ .-..||+....+|+. +||+.+.. +...++..|+++|..|...+|. .+=|- ....+ +.+.|+
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34554 567899998866666 88887654 5667788888888888533322 11111 11233 677899
Q ss_pred EecCCCchhH---------------hhhc--CCC--------CCCCHHH---H----------HHHHHHHHHHHHHHHHc
Q 007351 443 DYVPNNTLYF---------------HLHG--EGR--------PVLDWAT---R----------VKIAAGAARGLAYLHED 484 (607)
Q Consensus 443 Ey~~~gsL~~---------------~l~~--~~~--------~~l~~~~---~----------~~i~~qia~gL~~LH~~ 484 (607)
+|++|..+.. .||. ++. ....|.. + .....++...++.+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9998876652 1111 111 1233431 0 12333445555555543
Q ss_pred ----CCCC---EEecCCCCCCEEEcCCCc-EEEEecccccc
Q 007351 485 ----CHPR---IIHRDIKSSNILLDNNFE-AQVSDFGLAKL 517 (607)
Q Consensus 485 ----~~~~---ivHrDLkp~NILl~~~~~-vkL~DFGls~~ 517 (607)
.... |||+|+.+.|||++++.. +.|+|||.++.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 2223 999999999999999875 89999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.85 E-value=6.8e-05 Score=77.68 Aligned_cols=56 Identities=21% Similarity=0.269 Sum_probs=48.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 462 l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
..|++...|+.+.+..|+-|..++ .+-||||...||||+ +|.|-||||-++|....
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~ 373 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS 373 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccC
Confidence 578888999999888888877664 788999999999999 88999999999985433
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=74.96 Aligned_cols=33 Identities=21% Similarity=0.322 Sum_probs=29.5
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
..+++|+|+..+|||+++++.+.|+||..++..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 448999999999999999999999999998743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00016 Score=76.35 Aligned_cols=140 Identities=16% Similarity=0.183 Sum_probs=81.8
Q ss_pred ceecccCcEEEEEEEeCC----CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.|..|-...+|+....+ +..|+||+...... ...+-.+|+++++.+..-+| .++++++ .++ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 445557778899987643 23788997754322 22345778999999976555 5666665 222 58899876
Q ss_pred CchhH-----------------hhhcCCC---CCC-CHHHHHHHHHH----------------------HHHHHHHHHHc
Q 007351 448 NTLYF-----------------HLHGEGR---PVL-DWATRVKIAAG----------------------AARGLAYLHED 484 (607)
Q Consensus 448 gsL~~-----------------~l~~~~~---~~l-~~~~~~~i~~q----------------------ia~gL~~LH~~ 484 (607)
..|.. .||.... ... -|..+.++..+ +.+-+..+.+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65411 1122111 111 12222222221 11222222221
Q ss_pred -----CCCCEEecCCCCCCEEEcC-CCcEEEEecccccc
Q 007351 485 -----CHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKL 517 (607)
Q Consensus 485 -----~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~ 517 (607)
....++|+||.+.|||+++ ++.++||||+.+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1235799999999999974 57899999999864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00033 Score=68.49 Aligned_cols=78 Identities=14% Similarity=0.237 Sum_probs=56.3
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+..+.|..|.--..|+..+ +...+.||+ +.......|..|+.-|+.|. -.+|.+++.+...++..||||||+
T Consensus 18 i~er~~v~gG~inea~~v~d-g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 18 IKEREEVSGGDINEAWRLRD-GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred hhcccccCCccccceeEeec-CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 33445566666666666554 667899995 33344567888988887774 466888898888899999999999
Q ss_pred CCCch
Q 007351 446 PNNTL 450 (607)
Q Consensus 446 ~~gsL 450 (607)
+.|.+
T Consensus 94 ~~~~~ 98 (286)
T COG3001 94 PTGPL 98 (286)
T ss_pred cCCCC
Confidence 88654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=9e-05 Score=72.80 Aligned_cols=122 Identities=17% Similarity=0.194 Sum_probs=61.0
Q ss_pred CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCCCchhH-------h---------
Q 007351 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTLYF-------H--------- 453 (607)
Q Consensus 391 g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~-------~--------- 453 (607)
++.|+||+.... ........+|.++++.+..-++ .++++++. ..+|+||+++..|.. .
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~----~g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFE----NGRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEET----TEEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcC----CCcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888887654 2334567788999998864444 66666642 235779996665421 0
Q ss_pred -hhcC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHHHH---c--CCCCEEecCCCCCCEE
Q 007351 454 -LHGE-----GRPVLDWATRVKI----------------------AAGAARGLAYLHE---D--CHPRIIHRDIKSSNIL 500 (607)
Q Consensus 454 -l~~~-----~~~~l~~~~~~~i----------------------~~qia~gL~~LH~---~--~~~~ivHrDLkp~NIL 500 (607)
+|.. .....-|..+.++ ..++.+-+..|.+ . ....++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 1110 0000011111111 1112222222221 1 1136889999999999
Q ss_pred E-cCCCcEEEEecccccc
Q 007351 501 L-DNNFEAQVSDFGLAKL 517 (607)
Q Consensus 501 l-~~~~~vkL~DFGls~~ 517 (607)
+ +.++.++||||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8888999999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=1.7e-05 Score=93.90 Aligned_cols=158 Identities=13% Similarity=0.028 Sum_probs=109.4
Q ss_pred HHHHHHHHHccCCCceeEEeEEE--eCCceEEEEEecCCCchhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHc--
Q 007351 411 KAEVEIISRIHHRHLVSLVGYCI--SDDRRLLIYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHED-- 484 (607)
Q Consensus 411 ~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~-- 484 (607)
..|...++...|.++...+.-.. ++.+.+.+++|+..|+++..+-+... ..++..-.....++.+....-+|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 33444555567888766655443 34467899999999999888765322 2233333333333334444444432
Q ss_pred CCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc
Q 007351 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564 (607)
Q Consensus 485 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt 564 (607)
+..-.+|++||.-|.+|..+.++|+.|+|+.+... ......+..+++..|+.+++...-.++.+.|+|..|+.+|++..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 12246899999999999999999999999998332 22333455667888999998888889989999999999999888
Q ss_pred CCCCC
Q 007351 565 GRKPV 569 (607)
Q Consensus 565 g~~Pf 569 (607)
|...|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 76655
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00059 Score=70.50 Aligned_cols=71 Identities=11% Similarity=0.187 Sum_probs=44.2
Q ss_pred cccCcEEEEEEEeC-----CC----cEEEEEEeecCCc-----hhHHHHHHHHHHHHHcc---------C----CCceeE
Q 007351 376 GEGGFGSVYKGYLP-----DG----REVAIKQLKIGGG-----QGEREFKAEVEIISRIH---------H----RHLVSL 428 (607)
Q Consensus 376 G~G~fG~Vyk~~~~-----~g----~~VAVK~l~~~~~-----~~~~~~~~Ei~il~~l~---------H----pnIv~l 428 (607)
|+|..|.+|+.++. ++ ..++||....... +....|.+|+.+++.+- + ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 77888999998752 12 3588998752211 12345888998888652 1 223455
Q ss_pred EeEEEeCCceEEEEEecC
Q 007351 429 VGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~ 446 (607)
+....+.+..+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 555444446789988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=70.92 Aligned_cols=74 Identities=20% Similarity=0.254 Sum_probs=45.8
Q ss_pred cceecccCcEEEEEEEeCCC--cE-----EEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDG--RE-----VAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g--~~-----VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E 443 (607)
.+.|..|-...+|++...++ .. |.++... .......+-.+|+++++.|...++ .++++.+. .++|+|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 34565688889999986443 23 3333221 111112234678999999975554 66666653 369999
Q ss_pred ecCCCch
Q 007351 444 YVPNNTL 450 (607)
Q Consensus 444 y~~~gsL 450 (607)
|++|..|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 9988765
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0068 Score=73.01 Aligned_cols=229 Identities=18% Similarity=0.153 Sum_probs=0.0
Q ss_pred CCCCCCCCCccHHHHHHhh-CCCccc---ceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc--
Q 007351 348 GGLGHSRSMFTYEELVKAT-DGFADQ---NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-- 421 (607)
Q Consensus 348 ~~~~~s~~~~~~eel~~~~-~~y~~~---~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-- 421 (607)
......+..+..+++.... +.|.+. +.|+.+.- .+|+.+. ++..+++|+.+......+.+++.++...-.-+
T Consensus 8 ~~~~~~~p~ls~~~~~~ll~~~ygl~~~~~~L~s~~d-~nf~v~t-~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~ 85 (972)
T PRK06149 8 DRSSLPAPDVSEAQAERILAEHYGLSGTLTELGSQQD-RNFRVDS-DGGRFVLKICHAAYAAVELEAQHAALRHLAEREP 85 (972)
T ss_pred ccCCCCCCCCCHHHHHHHHHHhcCCceEEEecCCcCc-ceEEEEe-cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCC
Q ss_pred CCCceeEEe------EEEeC----CceEEEEEecCCCchhH-------------------------hhhcCCCCCCCHHH
Q 007351 422 HRHLVSLVG------YCISD----DRRLLIYDYVPNNTLYF-------------------------HLHGEGRPVLDWAT 466 (607)
Q Consensus 422 HpnIv~l~g------~~~~~----~~~~lV~Ey~~~gsL~~-------------------------~l~~~~~~~l~~~~ 466 (607)
.-.+.+++- +...+ ...+.+++|++|..+.. +-+......+.|..
T Consensus 86 glpvp~pi~t~~G~~~~~~~~~g~~~~vrL~~~l~G~~~~~~~~~~~~~~~~lG~~lArlh~al~~f~hp~~~r~~~Wdl 165 (972)
T PRK06149 86 ALRVPVVIPALDGEELLTLDVRGQGLRVRLLDYLPGQPLTRLGHLAPASVAGLGALCARVARALADFDHPGLDRTLQWDL 165 (972)
T ss_pred CCCCceeeECCCCCeEEEEecCCceEEEEEEEecCCccccccCCCCHHHHHHHHHHHHHHHHHHcCCCCCCCCCccccch
Q ss_pred ----------------------HHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-----CcEEEEecccccccc
Q 007351 467 ----------------------RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-----FEAQVSDFGLAKLAL 519 (607)
Q Consensus 467 ----------------------~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-----~~vkL~DFGls~~~~ 519 (607)
+.+++.++.+.+.-+-..+..++||+|++..|||++++ ...-|+|||.+...
T Consensus 166 ~~~~~~~~~ll~~i~d~~~r~~l~~~~~~~~~~l~~~~~~L~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~~- 244 (972)
T PRK06149 166 RHAGPVVAHLLSHITDPAQRARIAEATRDAARRLQPLAPALPLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVRT- 244 (972)
T ss_pred hhhHHHHHHHHhhcCCHHHHHHHHHHHHHHHHHhhhhhhhCcccccCCCCCcccEEEcCCCCCCcceeEEEEcccchhh-
Q ss_pred cCCcceeeccccCCCCCchhh---hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHH
Q 007351 520 DANTHITTRVMGTFGYMAPEY---ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLV 596 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~---l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~ 596 (607)
|..=|+ +.........|-+ .+..++.| |.....+.+.++..+...+.......++
T Consensus 245 ---------------~~i~DLAial~~~~~~~~~dp~----~~~~~l~G---Y~svrpLt~~E~~~L~~li~~R~~~~~~ 302 (972)
T PRK06149 245 ---------------WRVADLAVTCASLLHHAGGDPF----SILPAVRA---YHAVRPLSEAELKALWPLVVARAAVLVA 302 (972)
T ss_pred ---------------hHHHHHHHHHHHHhcccCCCHH----HHHHHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_pred HHhhh
Q 007351 597 FLCQQ 601 (607)
Q Consensus 597 ~~C~~ 601 (607)
+..++
T Consensus 303 ~~~~~ 307 (972)
T PRK06149 303 SSEQQ 307 (972)
T ss_pred HHHHH
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=70.99 Aligned_cols=134 Identities=17% Similarity=0.168 Sum_probs=0.0
Q ss_pred CCCcccceecccCcEEEEEEEeCCC---------cEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDG---------REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDD 436 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g---------~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~ 436 (607)
+++ ..+.|..|=...+|++...++ +.|+||+.......-. +-.+|+.+++.+...+| .++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC---
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC------------------------------- 485 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------------------------------- 485 (607)
.+.|.||+++..|...-.... .++.+|++.|..||+..
T Consensus 181 -gg~I~efi~g~~l~~~dl~~~----------~~~~~iA~~L~~lH~~~~~~~~~~~f~~~p~~f~~i~~~~~~~~~~~~ 249 (442)
T PTZ00296 181 -GGRIEEWLYGDPLRIDDLKNP----------SILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLSKYKN 249 (442)
T ss_pred -CCEEEEeeCCccCCHHHcCCH----------HHHHHHHHHHHHHhcccccccCchhccCCCcHHHHHHHHHHHHHhhcc
Q ss_pred ---------------------------------CCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 486 ---------------------------------HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 486 ---------------------------------~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
...++|+||...|||+++++ ++||||..|..
T Consensus 250 ~~~~~~~~~~l~~e~~~l~~~l~~~~~l~~~~~~~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 250 IEKYQRDIHKYIKESEKFIKFMKVYSKSDNLANDIVFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred chHhHhhHHHHHHHHHHHHHHHHhhcccccccCCeeEEeCCCCccceeecCCC-EEEEeeccccc
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 607 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-42 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 509 bits (1312), Expect = e-179
Identities = 132/263 (50%), Positives = 180/263 (68%), Gaps = 8/263 (3%)
Query: 341 VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQL 399
V + +DP LG + F+ EL A+D F+++N+LG GGFG VYKG L DG VA+K+L
Sbjct: 4 VPAEEDPEVHLGQLKR-FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 400 KIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG-- 456
K QG E +F+ EVE+IS HR+L+ L G+C++ RLL+Y Y+ N ++ L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
E +P LDW R +IA G+ARGLAYLH+ C P+IIHRD+K++NILLD FEA V DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
L +TH+TT V GT G++APEY S+GK +EK+DVF +GV+LLELITG++ D ++
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 577 DES--LVEWV-NLIDAKILFKLV 596
D+ L++WV L+ K L LV
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALV 265
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 476 bits (1227), Expect = e-166
Identities = 109/267 (40%), Positives = 152/267 (56%), Gaps = 7/267 (2%)
Query: 334 SGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE 393
S + ++ + +L +AT+ F + L+G G FG VYKG L DG +
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 394 VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
VA+K+ QG EF+ E+E +S H HLVSL+G+C + +LIY Y+ N L H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 454 LHGEGRPV--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
L+G P + W R++I GAARGL YLH IIHRD+KS NILLD NF +++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 512 FGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
FG++K + TH++T V GT GY+ PEY G+LTEKSDV+SFGVVL E++ R +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 571 ASQPLGDESLVEWV-NLIDAKILFKLV 596
S P +L EW + L ++V
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIV 269
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-158
Identities = 102/254 (40%), Positives = 153/254 (60%), Gaps = 21/254 (8%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQLKIG----GGQG 406
F++ EL T+ F ++ N +GEGGFG VYKGY+ + VA+K+L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWA 465
+++F E++++++ H +LV L+G+ D L+Y Y+PN +L L +G P L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTH 524
R KIA GAA G+ +LHE+ IHRDIKS+NILLD F A++SDFGLA+ + A T
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584
+T+R++GT YMAPE G++T KSD++SFGVVLLE+ITG VD + + L++
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 585 --NLIDAKILFKLV 596
+ K + +
Sbjct: 248 EEIEDEEKTIEDYI 261
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 9e-92
Identities = 71/249 (28%), Positives = 98/249 (39%), Gaps = 22/249 (8%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA 412
S E L + + G FG V+K VA+K I Q + +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67
Query: 413 EVEIISRIHHRHLVSLVGYCI----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EV + + H +++ +G D LI + +L L V+ W
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELC 124
Query: 469 KIAAGAARGLAYLHED-------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
IA ARGLAYLHED P I HRDIKS N+LL NN A ++DFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 522 NTHI-TTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ T +GT YMAPE + D+++ G+VL EL + D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 576 GDESLVEWV 584
E +
Sbjct: 245 YMLPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-67
Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI 416
E D L+G G +G+VYKG L D R VA+K + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNI 58
Query: 417 --ISRIHHRHLVSLVGYCI-----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
+ + H ++ + LL+ +Y PN +L +L DW + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 470 IAAGAARGLAYLHED------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL------ 517
+A RGLAYLH + P I HRD+ S N+L+ N+ +SDFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 518 -ALDANTHITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELITGRKPV 569
+ +GT YMAPE ++ D+++ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 570 DASQPLGD 577
+ + +
Sbjct: 236 FPGESVPE 243
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-65
Identities = 71/212 (33%), Positives = 120/212 (56%), Gaps = 23/212 (10%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE-------REFKAEVEIISRIHHR 423
+ +G+GGFG V+KG + D VAIK L +G +GE +EF+ EV I+S ++H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V L G + ++ ++VP LY L + P + W+ ++++ A G+ Y+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ- 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
+ +P I+HRD++S NI L + E A+V+DFGL++ + H + ++G F +MAP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAP 195
Query: 539 E--YASSGKLTEKSDVFSFGVVLLELITGRKP 568
E A TEK+D +SF ++L ++TG P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-65
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 6/197 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+V++ G +VA+K L + EF EV I+ R+ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++ +Y+ +LY LH R LD R+ +A A+G+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
R++KS N+L+D + +V DFGL++L + + GT +MAPE EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 552 VFSFGVVLLELITGRKP 568
V+SFGV+L EL T ++P
Sbjct: 222 VYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
L E G ++KG G ++ +K LK+ + R+F E + H +++ ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 430 GYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S LI ++P +LY LH V+D + VK A ARG+A+LH P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE---YASSG 544
I + S ++++D + A++S + + + M ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPED 186
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+D++SF V+L EL+T P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 7e-64
Identities = 70/196 (35%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V K ++VAIKQ++ + F E+ +SR++H ++V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ L+ +Y +LY LHG E P A + ++G+AYLH +IHRD
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 494 IKSSNILLDNNFE-AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
+K N+LL ++ DFG A D TH+T G+ +MAPE +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK-GSAAWMAPEVFEGSNYSEKCDV 186
Query: 553 FSFGVVLLELITGRKP 568
FS+G++L E+IT RKP
Sbjct: 187 FSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVG 430
+G GGFG VY+ + G EVA+K + Q + E ++ + + H ++++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C+ + L+ ++ L L G+ + V A ARG+ YLH++ II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 491 HRDIKSSNILLDNNFEAQ--------VSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
HRD+KSSNIL+ E ++DFGLA+ T + G + +MAPE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPEVIR 187
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ ++ SDV+S+GV+L EL+TG P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 7e-62
Identities = 67/200 (33%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ + ++ + ++LY HLH + + IA ARG+ YLH IIHR
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPE---YASSGKLTE 548
D+KS+NI L + ++ DFGLA + + +H ++ G+ +MAPE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 549 KSDVFSFGVVLLELITGRKP 568
+SDV++FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-60
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG K + G + +K+L + +R F EV+++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D R I +Y+ TL + W+ RV A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR-------------VMGTFGYMAPEY 540
+ S N L+ N V+DFGLA+L +D T V+G +MAPE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ EK DVFSFG+VL E+I
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-59
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLV 429
+G+G +G V++G G VA+K + E+ + E E+ + H +++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 430 GYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED- 484
++ LI Y +LY +L LD + ++I A GLA+LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 485 ----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL----ALDANTHITTRVMGTFGYM 536
P I HRD+KS NIL+ N + ++D GLA + + RV GT YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 537 APE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
APE ++ D+++FG+VL E+ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 9e-58
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVG 430
L+G+G FG VY G EVAI+ + I + + FK EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C+S +I TLY + + VLD +IA +G+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKL----ALDANTHITTRVMGTFGYMAPEYASSGKL 546
H+D+KS N+ DN + ++DFGL + G ++APE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 547 ---------TEKSDVFSFGVVLLELITGRKP 568
++ SDVF+ G + EL P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-57
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLV 429
+G+G +G V+ G G +VA+K E + E EI + H +++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 430 GYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED- 484
I LI DY N +LY +L LD + +K+A + GL +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 485 ----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI---TTRVMGTFGYMA 537
P I HRD+KS NIL+ N ++D GLA + + +GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 538 PE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
PE + + +D++SFG++L E+ +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 51/288 (17%)
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
+ P S TT I +++ GSG G + +V
Sbjct: 5 LDRPFISEGTTLKDLIYDMTTS---GSGSGLPLLVQRTIA------------RTIVL--- 46
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHL 425
Q +G+G FG V++G G EVA+K + ER + E EI + H ++
Sbjct: 47 ----QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 98
Query: 426 VSLVGYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+ + D+ L+ DY + +L+ +L+ R + +K+A A GLA+L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHL 155
Query: 482 HED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI----TTRVMGT 532
H + P I HRD+KS NIL+ N ++D GLA A I RV GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 214
Query: 533 FGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
YMAPE + +++D+++ G+V E+ +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ + V L EG L T +++ AA G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKS 550
D+ + N L+ ++SDFG+++ D + + + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+SFG++L E + G P
Sbjct: 297 DVWSFGILLWETFSLGASP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 375 LGEGGFGSVYKGY---LPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV L D VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S RR LI +Y+P +L +L + + +D ++ + +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R IHRD+ + NIL++N ++ DFGL K+ + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 546 LTEKSDVFSFGVVLLELIT 564
+ SDV+SFGVVL EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-44
Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G R+ L+ +Y+P+ L L R LD + + ++ +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R +HRD+ + NIL+++ +++DFGLAKL + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 546 LTEKSDVFSFGVVLLELIT-GRKP 568
+ +SDV+SFGVVL EL T K
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 375 LGEGGFGSVYKGY---LPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV L D VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S RR LI +Y+P +L +L + + +D ++ + +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R IHRD+ + NIL++N ++ DFGL K+ + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 546 LTEKSDVFSFGVVLLELIT 564
+ SDV+SFGVVL EL T
Sbjct: 225 FSVASDVWSFGVVLYELFT 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FGSV +G ++ VAIK LK G + + E E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +L+ + L+ L G+ + + ++ + G+ YL E+ + +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTE 548
HRD+ + N+LL N A++SDFGL+K +++ T R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
+SDV+S+GV + E ++ G+KP
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVG 430
+G G F +VYKG EVA +L+ + FK E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 431 YCIS---DDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
S + +++ + + + TL +L + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RT 149
Query: 487 PRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
P IIHRD+K NI + ++ D GLA L V+GT +MAPE
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEEK- 205
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
E DV++FG+ +LE+ T P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYP 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-42
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VA+K +K G E EF E + + ++ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ ++ +Y+ N L +L G+ L+ + +++ G+A+L E IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDL 130
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT---FGYMAPEYASSGKLTEKSD 551
+ N L+D + +VSDFG+ + LD +GT + APE K + KSD
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 552 VFSFGVVLLELIT-GRKP 568
V++FG+++ E+ + G+ P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-42
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
L+ +++ + L +L R + T + + G+AYL E+ +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDL 130
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+ N L+ N +VSDFG+ + LD T+ F +PE S + + KSDV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 553 FSFGVVLLELIT-GRKP 568
+SFGV++ E+ + G+ P
Sbjct: 189 WSFGVLMWEVFSEGKIP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 363 VKATDGFAD------------QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREF 410
V A D F +G+G FG V G G +VA+K +K + F
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAF 61
Query: 411 KAEVEIISRIHHRHLVSLVGYCISDDRRLLI-YDYVPNNTLYFHLHGEGRPVLDWATRVK 469
AE +++++ H +LV L+G + + L I +Y+ +L +L GR VL +K
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
+ + YL + +HRD+ + N+L+ + A+VSDFGL K +A++ T+
Sbjct: 122 FSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQD 172
Query: 530 MGTFGY--MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
G APE K + KSDV+SFG++L E+ + GR P
Sbjct: 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG ++P+G + VAIK+L+ E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C LI +P L ++ E + + + A+G+ YL + R
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
++HRD+ + N+L+ +++DFGLAKL L A G +MA E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T +SDV+S+GV + EL+T G KP
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 375 LGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG V G +VA+K LK G + K E+EI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C D LI +++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSG 544
+ +HRD+ + N+L+++ + ++ DFGL K + T + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 545 KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDE 578
K SDV+SFGV L EL+T
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
LG GG +VY D +VAIK + I + E + F+ EV S++ H+++VS
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ DD L+ +Y+ TL ++ G L T + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM--- 130
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
RI+HRDIK NIL+D+N ++ DFG+AK + + T V+GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPL 575
E +D++S G+VL E++ G P + +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-41
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 432 CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + L ++ +Y+ +L +L GR VL +K + + YL + +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTE 548
HRD+ + N+L+ + A+VSDFGL K +A++ T+ G APE K +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFST 365
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
KSDV+SFG++L E+ + GR P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G + F AE ++ ++ H+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +Y+ N +L L L + +AA A G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+++NIL+ + +++DFGLA+L D T R F APE + G T KSDV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T GR P
Sbjct: 194 WSFGILLTEIVTHGRIP 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-41
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL T GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-41
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG+G FG+VY +A+K L ++ E + + EVEI S + H +++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
GY D R+ LI +Y P T+Y L + D A L+Y H
Sbjct: 75 YGY-FHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK--- 128
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
R+IHRDIK N+LL + E +++DFG + A ++ GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL--CGTLDYLPPEMIEGRMHD 185
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQP 574
EK D++S GV+ E + G+ P +A+
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTY 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-41
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+I +Y+ N L +L E R +++ + YL E +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDL 146
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+ N L+++ +VSDFGL++ LD T+ V F PE K + KSD+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 553 FSFGVVLLELIT-GRKP 568
++FGV++ E+ + G+ P
Sbjct: 205 WAFGVLMWEIYSLGKMP 221
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
LGEG FG VY+G G + VA+K K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G ++ +I + P L +L + L T V + + +AYL E +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--C 134
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRDI NIL+ + ++ DFGL++ D + + + +M+PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+ F V + E+++ G++P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-41
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG G FG V+ +VA+K +K G F AE ++ + H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ + +I +++ +L L + + +A A G+A++ + IH
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEK 549
RD++++NIL+ + +++DFGLA++ D T R F APE + G T K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+SFG++L+E++T GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G P+ VAIK K R +F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G +++ +I + L L + LD A+ + A + LAYL R
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRDI + N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+ FGV + E++ G KP
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 375 LGEGGFGSVYKGYLPDGR---EVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + VA+K LK + E AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G C + +L+ + L +L + +++ + G+ YL E+ +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-EESN--F 138
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLT 547
+HRD+ + N+LL A++SDFGL+K + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
KSDV+SFGV++ E + G+KP
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
++G G FG VY G L DG++ A+K L GE +F E I+ H +++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
SL+G C+ S+ L++ Y+ + L + E + A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG------YMAPE 539
+ +HRD+ + N +LD F +V+DFGLA+ D V G +MA E
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T KSDV+SFGV+L EL+T G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGG-GQGEREF-KAEVEIISRIHHRHLVSLVG 430
+G G +G K DG+ + K+L G + E++ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 431 -YCISDDRRLLIY-DYVPNNTLYFHL---HGEGRP-----VLDWATRVKIAAGAARGLAY 480
+ L I +Y L + E + VL T++ L
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------TLALKE 126
Query: 481 LHE--DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H D ++HRD+K +N+ LD ++ DFGLA++ L+ +T +GT YM+P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSP 185
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
E + EKSD++S G +L EL P A
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V +G P G+ VA+K LK + +F EV + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L G ++ + P +L L + + T + A A G+ YL
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGK 545
R IHRD+ + N+LL ++ DFGL + + H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 546 LTEKSDVFSFGVVLLELIT-GRKP 568
+ SD + FGV L E+ T G++P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 17/219 (7%)
Query: 375 LGEGGFGSVYKGYL---PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG V DG VA+K LK G R +K E++I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C L+ +YVP +L +L R + A + A G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSG 544
IHRD+ + N+LLDN+ ++ DFGLAK + + + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 545 KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582
K SDV+SFGV L EL+T + +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 24/314 (7%)
Query: 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKT 325
G + + IA ++ L+ R S + +
Sbjct: 292 GAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEK 351
Query: 326 QSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNL-----LGEGGF 380
Q S +D D TY + + +GEG F
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEED--------TYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 381 GSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYCISD 435
G V++G P+ VAIK K R +F E + + H H+V L+G ++
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 462
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
+ +I + L L + LD A+ + A + LAYL R +HRDI
Sbjct: 463 NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIA 518
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSF 555
+ N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T SDV+ F
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 556 GVVLLELIT-GRKP 568
GV + E++ G KP
Sbjct: 579 GVCMWEILMHGVKP 592
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 372 QNLLGEGGFGSVYKGYLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
++G+G FG VY G D + AIK L + F E ++ ++H +++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 427 SLVGYCISDD-RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+L+G + + ++ Y+ + L + + + ARG+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG-----YMAPEY 540
+ +HRD+ + N +LD +F +V+DFGLA+ LD + + A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALES 199
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ + T KSDV+SFGV+L EL+T G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 375 LGEGGFGSVYKGYLPDGR-EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ +I +++ L +L R + + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSD 551
+ + N L+ N +V+DFGL++L +T+ T F APE + K + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 552 VFSFGVVLLELIT-GRKP 568
V++FGV+L E+ T G P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + L+G GGFG V+K DG+ IK++K + + EV+ ++++ H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVH 68
Query: 428 LVGY---------------CISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
G S + L I ++ TL + LD +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
+G+ Y+H ++I+RD+K SNI L + + ++ DFGL +L + T G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSK-G 183
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T YM+PE SS ++ D+++ G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGR----EVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHL 425
+LG G FG+V+KG ++P+G V IK ++ G+ + I + H H+
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V L+G C L+ Y+P +L H+ + R L + A+G+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASS 543
++HR++ + N+LL + + QV+DFG+A L L + +MA E
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 544 GKLTEKSDVFSFGVVLLELIT-GRKP 568
GK T +SDV+S+GV + EL+T G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 357 FTYEELVKATDGFAD---------QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGG 403
TYEE +A F + ++G G G V G L P R+ VAIK LK G
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 404 GQGER-EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
+ +R +F +E I+ + H +++ L G +++ +Y+ N +L L
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQF 148
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
V + G G+ YL D +HRD+ + N+L+D+N +VSDFGL+++ D
Sbjct: 149 TIMQLVGMLRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 523 THITTRVMGTFGY--MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
T G APE + + SDV+SFGVV+ E++ G +P
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 7/225 (3%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGG-GQGEREF-K 411
+ T ++ + + +GEG FG DGR+ IK++ I ERE +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 412 AEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
EV +++ + H ++V + ++ DY L+ ++ + + +
Sbjct: 72 REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
L ++H+ +I+HRDIKS NI L + Q+ DFG+A++ L++ + +G
Sbjct: 132 VQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVELARACIG 187
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
T Y++PE + KSD+++ G VL EL T + +A
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
+G G FG V G L P +E VAIK LK+G + +R +F E I+ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G +++ +Y+ N +L L + V + G A G+ YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLT 547
+HRD+ + NIL+++N +VSDFGL ++ D T G +PE + K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
SDV+S+G+VL E+++ G +P
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHH 422
F + +G G F VY+ L DG VA+K+++I + E++++ +++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 423 RHLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRP--------VLDWATRVKIAAG 473
+++ I D+ L I + L + + V + ++
Sbjct: 92 PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL----- 145
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
L ++H R++HRDIK +N+ + ++ D GL + + T ++GT
Sbjct: 146 -CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTP 200
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
YM+PE KSD++S G +L E+ + P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 375 LGEGGFGSVYKGYL--PDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
+G G FG VYKG L G++ VAIK LK G + +R +F E I+ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G ++I +Y+ N L L E V + G A G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKL 546
+HRD+ + NIL+++N +VSDFGL+++ D T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T SDV+SFG+V+ E++T G +P
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 31/289 (10%)
Query: 292 LRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLG 351
+ R + G+ + + + L + +++ Y + ++ + S + V + Q +G
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVV-IG 85
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGE 407
S + + E+ +G G FG VY G L DG++ A+K L GE
Sbjct: 86 PSSLIVHFNEV------------IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 408 R-EFKAEVEIISRIHHRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
+F E I+ H +++SL+G C+ S+ L++ Y+ + L + E
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK 192
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A+G+ +L + +HRD+ + N +LD F +V+DFGLA+ D
Sbjct: 193 DLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 526 TTRVMGTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
T +MA E + K T KSDV+SFGV+L EL+T G P
Sbjct: 250 VHN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 39/237 (16%)
Query: 354 RSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FK 411
R + +E + LG GGFG V++ D AIK++++ + RE
Sbjct: 2 RYLTDFEPI----------QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM 51
Query: 412 AEVEIISRIHHRHLVSLVGYCISDD---------RRLLIY---DYVPNNTLYFHLHG-EG 458
EV+ ++++ H +V + + ++ +Y L ++G
Sbjct: 52 REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-- 516
+ + + I A + +LH ++HRD+K SNI + +V DFGL
Sbjct: 112 IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 517 ---------LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
L T +GT YM+PE + K D+FS G++L EL+
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 4e-38
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FGSV +G ++ VAIK LK G + + E E +I+ ++ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +L+ + L+ L G+ + + ++ + G+ YL E +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTE 548
HR++ + N+LL N A++SDFGL+K +++ T R G + APE + K +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
+SDV+S+GV + E ++ G+KP
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP 539
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-38
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
++ LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +I +++ L +L R + + +A + + YL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HR++ + N L+ N +V+DFGL++L + APE + K + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV++FGV+L E+ T G P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
+LG GG V+ D R+VA+K L+ + F+ E + + ++H +V+
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 428 LVGYCISDDRRLLIY----DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+ ++ + +YV TL +H EG + +++ A A + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT--RVMGTFGYMAPEYA 541
+ IIHRD+K +NI++ +V DFG+A+ D+ +T V+GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ +SDV+S G VL E++TG P P+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 58/222 (26%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LGEGGF V L DG A+K++ Q E + E ++ +H +++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 433 ISDDRR----LLIYDYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+ + L+ + TL+ + + L + + G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM--------GTFGYMAP 538
HRD+K +NILL + + + D G A + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 539 E---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
E S + E++DV+S G VL ++ G P D GD
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG ++P+G + VAIK+L+ E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C LI +P L ++ E + + + A+G+ YL + R
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
++HRD+ + N+L+ +++DFGLAKL L A G +MA E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T +SDV+S+GV + EL+T G KP
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + +LG+G FG V K D R AIK+++ + +EV +++ ++H+++V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 428 LVGYCISDDRRLL----------IY---DYVPNNTLYFHLHGEGRP-----VLDWATRVK 469
+ + ++ +Y N TLY +H E ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI- 125
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL------------ 517
L+Y+H IIHRD+K NI +D + ++ DFGLAK
Sbjct: 126 -----LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 518 --ALDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITG 565
++ ++T+ + GT Y+A E +G EK D++S G++ E+I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 59/237 (24%), Positives = 87/237 (36%), Gaps = 16/237 (6%)
Query: 344 PQDPGGLGHSRSMFTYEELVKATDGFAD---QNLLGEGGFGSVYKGYLPD---GREVAIK 397
GL S + F + L+G GG G VY+ D R VA+K
Sbjct: 8 HHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAE--DTVRERIVALK 65
Query: 398 QLK--IGGGQGERE-FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
+ + R + E R+ H+V + + D + + + L L
Sbjct: 66 LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML 125
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
+G L V I L H HRD+K NIL+ + A + DFG+
Sbjct: 126 RRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGI 180
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
A D +GT YMAPE S T ++D+++ VL E +TG P
Sbjct: 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 375 LGEGGFGSVYKGYL--------PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C+ D +L+ ++V +L +L + + ++ ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 487 PRIIHRDIKSSNILLDNNFEAQ--------VSDFGLAKLALDANTHITTRVMGTFGY--- 535
+IH ++ + NILL + + +SD G++ L +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQER 180
Query: 536 ---MAPEYASSGKL-TEKSDVFSFGVVLLELIT-GRKP 568
+ PE + K +D +SFG L E+ + G KP
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LLG+G F VY+ + G EVAIK + + + + EV+I ++ H ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y D + L+ + N + +L +P + R G+ YLH
Sbjct: 78 NY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---G 132
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
I+HRD+ SN+LL N +++DFGLA +L + H T GT Y++PE A+
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHG 190
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+SDV+S G + L+ GR P D
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FG+VY + +A+K L ++ E + + E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y D +R+ L+ ++ P LY L GR D A L Y HE +
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---K 134
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+IHRDIK N+L+ E +++DFG + A T GT Y+ PE E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEGKTHDE 191
Query: 549 KSDVFSFGVVLLELITGRKPVDASQP 574
K D++ GV+ E + G P D+
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSH 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGRE----VAIKQLKIGG-GQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FGSV +G L VA+K +K+ Q E EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 429 VGYCISDD-----RRLLIYDYVPN----NTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+G CI + ++I ++ L + G + T +K A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG----- 534
YL +HRD+ + N +L ++ V+DFGL+K + + G
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T KSDV++FGV + E+ T G P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG+G +G VY G L + +AIK++ + + E+ + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 433 ISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRII 490
S++ + I+ + VP +L L + P+ D + GL YLH++ +I+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 491 HRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--YASSGKLT 547
HRDIK N+L++ + ++SDFG +K N T GT YMAPE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 548 EKSDVFSFGVVLLELITGRKP 568
+ +D++S G ++E+ TG+ P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGRE----VAIKQLKIGGGQGER--EFKAEVEIISRIHHRHL 425
+LG+G FGSV + L VA+K LK EF E + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 426 VSLVGYCISDDRR------LLIYDYVPNNTLYFHL----HGEGRPVLDWATRVKIAAGAA 475
LVG + + ++I ++ + L+ L GE L T V+ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG- 534
G+ YL IHRD+ + N +L + V+DFGL++ + + G
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 535 ----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T SDV++FGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 61/266 (22%), Positives = 93/266 (34%), Gaps = 25/266 (9%)
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
LG+ + S + Q + DP S +++ L
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSR-PESFFQQSFQRL----- 62
Query: 368 GFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHR 423
+ LG G +G V+K DGR A+K+ G + AEV ++ H
Sbjct: 63 -----SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 424 HLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
V L + L + + +L H G L A LA+LH
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELC-GPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLH 174
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
++H D+K +NI L ++ DFGL L + G YMAPE
Sbjct: 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LL 228
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
G +DVFS G+ +LE+ +
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQL-----------------KIGGGQGEREFKAEVEII 417
L +G F + D + A+K+ KI +FK E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 418 SRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRV------KI 470
+ I + + ++ G I++ + +IY+Y+ N+++ ++ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
+Y+H I HRD+K SNIL+D N ++SDFG ++ +D +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--R 211
Query: 531 GTFGYMAPEYASSGKLT---EKSDVFSFGVVLLELITGRKPVDAS 572
GT+ +M PE S + + K D++S G+ L + P
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ + VA+K LK ++F+ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 429 VGYCISDDRRLLIYDYVPN--------------NTLYFHLHGEGRPVLDWATRVKIAAGA 474
G C D +++++Y+ + L + + L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
A G+ YL +HRD+ + N L+ N ++ DFG+++ + + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 535 -----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G + VAIK + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL--------HGEGRPVLDWATRVKIAAGAARGLA 479
L+G L+I + + L +L + + +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY---- 535
YL+ + + +HRD+ + N ++ +F ++ DFG+ + D R G G
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR-KGGKGLLPVR 205
Query: 536 -MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M+PE G T SDV+SFGVVL E+ T +P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRI--HHRHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +GT YM PE
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRI--HHRHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +GT YM PE
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ + VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 429 VGYCISDDRRLLIYDYV-------------PNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
G C L++++Y+ P+ L L + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG- 534
G+ YL +HRD+ + N L+ ++ DFG+++ D + RV G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRVGGR-TM 221
Query: 535 ----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL T GR P
Sbjct: 447 VWSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+N S P ++ P V + P T S P S P+++ PA
Sbjct: 2 SNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQ-----TPSKPASADGHRGPSAAFAPA 56
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
++ P S+ +SP + P + T
Sbjct: 57 AAEPKLFGGFNSSDTVTSPQRAGPLAGGVTT 87
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 14/80 (17%), Positives = 22/80 (27%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P ++ S PA + + T S P S P+ + P + P
Sbjct: 6 KPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGG 65
Query: 116 PPPSSTPPPNSPPSPPSDPP 135
S T P +
Sbjct: 66 FNSSDTVTSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 14/89 (15%), Positives = 24/89 (26%), Gaps = 6/89 (6%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
KS P + PA N + + T S P +++ PA+
Sbjct: 4 KSKPKD------ASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAA 57
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ P + S+ T
Sbjct: 58 AEPKLFGGFNSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 13/83 (15%), Positives = 20/83 (24%), Gaps = 1/83 (1%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPS 154
S P + S P + P S PS P+ + P + P
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLF 63
Query: 155 SVEPPKRSPPSVPPQNPPPPPSS 177
+ S P +
Sbjct: 64 GGFNSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 17/88 (19%), Positives = 25/88 (28%), Gaps = 7/88 (7%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S P S +S P V + P S S P ++ P A P
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHR-------GPSAAFAPAA 57
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P +S T++ P
Sbjct: 58 AEPKLFGGFNSSDTVTSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 17/82 (20%), Positives = 22/82 (26%), Gaps = 3/82 (3%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSS---PPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
S P +S S PA N + P S S P + S + P
Sbjct: 3 NKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKL 62
Query: 121 TPPPNSPPSPPSDPPANSPPPS 142
NS + S A
Sbjct: 63 FGGFNSSDTVTSPQRAGPLAGG 84
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 17/87 (19%), Positives = 23/87 (26%), Gaps = 4/87 (4%)
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
S P S + P N P+S P K P+ + P + +P P
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSK---PASADGHRGPSAAFAPAAAEP 60
Query: 185 PAPIAVPPS-NVPPPPTQTPPTPASPI 210
S V P P
Sbjct: 61 KLFGGFNSSDTVTSPQRAGPLAGGVTT 87
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 50/229 (21%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L VAIK LK R EF+ E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 428 LVGYCISDDRRLLIYDYVPN--------------NTLYFHLHGEGRPVLDWATRVKIAAG 473
L+G D +I+ Y + + + L+ V + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
A G+ YL ++H+D+ + N+L+ + ++SD GL R +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF------------REVYAA 181
Query: 534 GY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE GK + SD++S+GVVL E+ + G +P
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 372 QNLLGEGGFGSVYKGYL-PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG AIK++K + + +F E+E++ ++ HH +++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKIAA 472
+L+G C L +Y P+ L F + L + AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ ++ MG
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT-MGR 202
Query: 533 F--GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MA E + T SDV+S+GV+L E+++ G P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV--- 429
LG GGFG V + G +VAIKQ + RE + E++I+ +++H ++VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 430 ---GYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDC 485
+D LL +Y L +L+ L + + + L YLHE+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 486 HPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
RIIHRD+K NI+L + + D G AK LD T V GT Y+APE
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTLQYLAPELLE 196
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
K T D +SFG + E ITG +P +
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGR------EVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + +VA+K L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-----HGEGRPVLDWATRVKIAAGAARGLAYLH 482
+G + R ++ + + L L L + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 483 EDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTHITTRVMGTFGY---- 535
E+ IHRDI + N LL A++ DFG+A+ D R G
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYR-KGGCAMLPVK 210
Query: 536 -MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE G T K+D +SFGV+L E+ + G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LG G FG V + + VA+K LK E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL------------YFHLHGEGRPVLDWATRVKIAA 472
+V+L+G C L+I +Y L + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMG 531
A+G+A+L IHRD+ + N+LL N A++ DFGLA + D+N +
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+S+G++L E+ + G P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGEG FG V K + VA+K LK E + +E ++ +++H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 428 LVGYCISDDRRLLIYDYVPN----------------------NTLYFHLHGEGRPVLDWA 465
L G C D LLI +Y + L L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A ++G+ YL E +++HRD+ + NIL+ + ++SDFGL++ + +++
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 526 TTRVMGTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
V + G +MA E T +SDV+SFGV+L E++T G P
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE--------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L + ++ + + V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
ARG+ YL + IHRD+ + N+L+ N +++DFGLA R +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA------------RDI 207
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + + VA+K LK ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 427 SLVGYCISDDRRLLIYDYVPN----------------NTLYFHLHGEGRPVLDWATRVKI 470
+L+G C L+I +Y + + + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
+ A+G+A+L IHRD+ + NILL + ++ DFGLA R +
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA------------RDI 195
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
MAPE + T +SDV+S+G+ L EL + G P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 69/303 (22%), Positives = 109/303 (35%), Gaps = 41/303 (13%)
Query: 288 VVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDP 347
++ +Y + + + K ++S + P F
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSI 62
Query: 348 GGLGH-SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGR------EVAIKQLK 400
L R T LG G FG VY+G + +VA+K L
Sbjct: 63 SDLKEVPRKNITLIRG------------LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110
Query: 401 IGGGQGER-EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL----- 454
+ + +F E IIS+ +H+++V +G + R ++ + + L L
Sbjct: 111 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSD 511
L + +A A G YL E+ IHRDI + N LL A++ D
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 512 FGLAKLALDANTHITTRVMGTFGY-----MAPEYASSGKLTEKSDVFSFGVVLLELIT-G 565
FG+A+ D R G M PE G T K+D +SFGV+L E+ + G
Sbjct: 228 FGMAR---DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283
Query: 566 RKP 568
P
Sbjct: 284 YMP 286
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 32/217 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+LG+G +V++G G AIK I + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 432 CISDDRRLLIY---DYVPNNTLYFHLHGEGRPVL---DWATRV--KIAAGAARGLAYLHE 483
+ ++ P +LY L V + G + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG----MNHLRE 130
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ I+HR+IK NI+ + Q ++DFG A+ L+ + + GT Y+ P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPD 185
Query: 540 --------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
K D++S GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE--------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V + VA+K LK + + + +E+E++ I H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L + ++ + + V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
ARG+ YL + IHRD+ + N+L+ N +++DFGLA R +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA------------RDI 253
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
+GEG FG V++ P VA+K LK + +F+ E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 428 LVGYCISDDRRLLIYDYVPN----------------------NTLYFHLHGEGRPVLDWA 465
L+G C L+++Y+ + + G P L A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
++ IA A G+AYL E + +HRD+ + N L+ N +++DFGL++ A+ +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 526 TTRVMGTFGY-----MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE + T +SDV+++GVVL E+ + G +P
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 52/231 (22%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYCISDDR-RLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKIA 471
+L+G C ++I ++ L + L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
A+G+ +L + IHRD+ + NILL ++ DFGLA R +
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA------------RDIY 199
Query: 532 TFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 57/291 (19%), Positives = 105/291 (36%), Gaps = 31/291 (10%)
Query: 313 GSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKA-TDGFAD 371
GS S+ + + + + GS +D G+ + + + +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
Q +G G FG V++ G + A+K++++ E E+ + + +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYG 117
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + + +L + G L + A GL YLH RI+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 491 HRDIKSSNILLDNN-FEAQVSDFGLAKLALDANTHITTR----VMGTFGYMAPEYASSGK 545
H D+K+ N+LL ++ A + DFG A + + GT +MAPE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLV 596
K D++S ++L ++ G P W + K+
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP--------------WTQYFRGPLCLKIA 269
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 58/237 (24%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + VA+K LK ER +E+++++++ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 427 SLVGYCISDDRRLLIYDYVPN---------------------NTLYFHLHGEGRPVLDWA 465
+L+G C LI++Y E VL +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A A+G+ +L +HRD+ + N+L+ + ++ DFGLA
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA---------- 219
Query: 526 TTRVMGTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
R + + MAPE G T KSDV+S+G++L E+ + G P
Sbjct: 220 --RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V +VA+K LK + + + +E+E++ I H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L ++ L V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA R +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA------------RDI 241
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV+L E+ T G P
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 45/213 (21%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHH--RHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +G YM PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+GGF ++ A K + + + E+ I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G+ D+ + ++ + +L LH + + + R G YLH + R
Sbjct: 82 GF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+IHRD+K N+ L+ + E ++ DFGLA K+ D GT Y+APE S +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 193
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+ DV+S G ++ L+ G+ P + S
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 42/250 (16%), Positives = 78/250 (31%), Gaps = 35/250 (14%)
Query: 347 PGGLGHSRSMFTYE---ELVKATDGFADQNLLGEGGFGSVYKGY------LPDGREVAIK 397
P + + E + +LLGEG F VY+ + ++ +K
Sbjct: 42 PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101
Query: 398 QLKIGGGQGEREFKAEVEIISRI---HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
K EF +++ R+ + + + +L+ + TL +
Sbjct: 102 VQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 455 HGEGRP---VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---- 507
+ V+ + A + +H+ IIH DIK N +L N F
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215
Query: 508 -------QVSDFGLAK--LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVV 558
+ D G + T T + T G+ E S+ + D F
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 559 LLELITGRKP 568
+ ++ G
Sbjct: 275 VYCMLFGTYM 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 47/240 (19%), Positives = 77/240 (32%), Gaps = 48/240 (20%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHRH 424
F + +G G FGSV+K DG AIK+ K G E+ EV + + H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 425 LVSLVGYCISDDRRLLIY-DYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYL 481
+V ++D +LI +Y +L + + A + RGL Y+
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVS-------------------DFGLAKLALDAN 522
H ++H DIK SNI + + D G
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 523 THITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
G ++A E + K+D+F+ + ++
Sbjct: 189 VEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNGDQW 237
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 33/232 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+LG+G +V++G G AIK I + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 432 CISDDRRLLIY---DYVPNNTLYFHLHGEGRPVL---DWATRV--KIAAGAARGLAYLHE 483
+ ++ P +LY L V + G + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG----MNHLRE 130
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ I+HR+IK NI+ + Q ++DFG A+ L+ + + GT Y+ P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPD 185
Query: 540 --------YASSGKLTEKSDVFSFGVVLLELITGRKP-VDASQPLGDESLVE 582
K D++S GV TG P P ++ ++
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 27/248 (10%)
Query: 333 GSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD---GFADQNLLGEGGFGSVYKGY-L 388
SG N G + H + +V D +GEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
GR+VA+K + + Q EV I+ H ++V + + + ++ +++
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL--- 124
Query: 449 TLYFHLHGEGRPVLDWATRVK-----IAA---GAARGLAYLHEDCHPRIIHRDIKSSNIL 500
+G + D ++V+ IA + LAYLH +IHRDIKS +IL
Sbjct: 125 --------QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173
Query: 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560
L + ++SDFG + V GT +MAPE S + D++S G++++
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 561 ELITGRKP 568
E++ G P
Sbjct: 233 EMVDGEPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 25/226 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+L EGGF VY+ + GRE A+K+L + R EV + ++ H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 432 CISDDRR--------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
LL+ + + F E R L T +KI R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----------GT 532
P IIHRD+K N+LL N ++ DFG A + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 533 FGYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
Y PE S+ + EK D+++ G +L L + P + L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 28/240 (11%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVS 427
F +++LG G G++ + D R+VA+K++ + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ + + TL Y L+ + + GLA+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL- 137
Query: 486 HPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLALDANTHITTR--VMGTFGYMAP 538
I+HRD+K NIL+ A +SDFGL K + R V GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 539 EY---ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKL 595
E T D+FS G V +I+ P G + L+ A L L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLGACSLDCL 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 18/238 (7%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL- 399
+ G L + MF + ++ + LG G +G V E AIK +
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 400 --KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE 457
+ + EV ++ + H +++ L + L+ + L+ +
Sbjct: 72 KTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 458 GR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFG 513
+ +D A +K + YLH+ I+HRD+K N+LL++ + ++ DFG
Sbjct: 131 MKFNEVDAAVIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
L+ + + + R+ GT Y+APE K EK DV+S GV+L L+ G P
Sbjct: 185 LSAV-FENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 22/209 (10%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL-- 428
+ GG G +Y +GR V +K L G + AE + ++ + H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 429 VGYCISDDRRLLIY---DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ Y +YV +L + L A + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
+++ D+K NI+L + ++ D G +++ + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINS----FGYLYGTPGFQAPEIVR-TG 252
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQP 574
T +D+++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 17/159 (10%), Positives = 29/159 (18%), Gaps = 10/159 (6%)
Query: 29 PPPVSNPPKSSPPPPPVSKPP---------TTSPPPSP-PASNPPTSSSPPASSPPTSSP 78
P P PV K P P + S+ +
Sbjct: 274 PTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
P S SP S+ T
Sbjct: 334 DTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTD 393
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S + + P +++ + + + S
Sbjct: 394 VAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSES 432
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 17/162 (10%), Positives = 28/162 (17%), Gaps = 19/162 (11%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISP-------PPPVSNPPT-----------RSPP 116
P P P + + P P T
Sbjct: 271 LDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
T P S P ++ ++ V K + + P
Sbjct: 331 VAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVD 390
Query: 177 SSPPK-NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
+ + A + P S S
Sbjct: 391 PTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSES 432
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 9/105 (8%), Positives = 15/105 (14%), Gaps = 3/105 (2%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ P SP ++ +
Sbjct: 332 AQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQ---VHAEKLTANEIVTALSVPL 388
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
P + S P S + SV
Sbjct: 389 VDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESV 433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ +G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-----IAA---GAARGLA 479
+ + D ++ +Y+ G + D T IAA + L
Sbjct: 82 YLDSYLVGDELWVVMEYL-----------AGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+LH + ++IHRDIKS NILL + +++DFG + +T V GT +MAPE
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 186
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ K D++S G++ +E+I G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREF-KAEVEIISRIHHRH 424
D F + LG G G V+K + P G +A K + + R E++++ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYL 481
+V G SD + +++ +L L GR +L K++ +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYL 147
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPE 539
E I+HRD+K SNIL+++ E ++ DFG++ +D AN+ + GT YM+PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 200
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDA 589
+ +SD++S G+ L+E+ GR P+ E + DA
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 335 GPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGRE 393
GPGS + PG MF +D + Q +LG+G FG V G+E
Sbjct: 1 GPGSMMDHLHATPG-------MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQE 53
Query: 394 VAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNT 449
A+K + ++ + EV+++ ++ H +++ L + D L+ +
Sbjct: 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGE 112
Query: 450 LYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NF 505
L+ + R +D A ++ + Y+H++ +I+HRD+K N+LL++ +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDA 166
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
++ DFGL+ +A+ + ++ GT Y+APE G EK DV+S GV+L L++G
Sbjct: 167 NIRIIDFGLSTH-FEASKKMKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
Query: 566 RKP 568
P
Sbjct: 224 CPP 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+GGF ++ A K + + + E+ I + H+H+V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G+ D+ + ++ + +L LH + + + R G YLH + R
Sbjct: 108 GF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 161
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+IHRD+K N+ L+ + E ++ DFGLA K+ D GT Y+APE S +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+ DV+S G ++ L+ G+ P + S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
F +G+G FG V+KG + VAIK + + + E E + E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR-----VKIAA---GAARGL 478
G + D + +I +Y+ G LD +IA +GL
Sbjct: 84 KYYGSYLKDTKLWIIMEYL-----------GGGSALDLLEPGPLDETQIATILREILKGL 132
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
YLH + + IHRDIK++N+LL + E +++DFG+A D T +GT +MAP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 188
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K+D++S G+ +EL G P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 60/254 (23%), Positives = 98/254 (38%), Gaps = 57/254 (22%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LG G G+V GR VA+K++ I E+++++ H +++ Y
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRY--Y 75
Query: 432 CISDDRRLL----------IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
C R L + D V + + E + + + A G+A+L
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVESKNVS----DENLKLQKEYNPISLLRQIASGVAHL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDN-------------NFEAQVSDFGLAKLALDANTHITTR 528
H +IIHRD+K NIL+ N +SDFGL K + T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 529 VM---GTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
+ GT G+ APE + +LT D+FS G V +++ K P GD+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----PFGDK 243
Query: 579 SLVEWVNLIDAKIL 592
++ I+
Sbjct: 244 ------YSRESNII 251
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 69/243 (28%), Positives = 109/243 (44%), Gaps = 22/243 (9%)
Query: 336 PGSDFVNSPQDPGGLGHSRSM-FTYEELVKAT-DGFADQNLLGEGGFGSVYKGYLPDGRE 393
P +F++S R + + + E D F D +LG GGFG V+ + +
Sbjct: 158 PFQEFLDSLY------FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 394 V-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNN 448
+ A K+L + +G + E +I++++H R +VSL Y L L+ +
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG 270
Query: 449 TLYFHLH--GEGRPVLDWATRVKI-AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505
+ +H++ E P R A GL +LH+ II+RD+K N+LLD++
Sbjct: 271 DIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDG 326
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
++SD GLA T GT G+MAPE + D F+ GV L E+I
Sbjct: 327 NVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 566 RKP 568
R P
Sbjct: 386 RGP 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIH--- 421
F+ ++G GGFG VY D G+ A+K L I QGE E ++S +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 422 HRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLA 479
+V + Y +L I D + L++HL G ++ AA GL
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILGLE 306
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H +++RD+K +NILLD + ++SD GLA H V GT GYMAPE
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPE 360
Query: 540 YASSGKLTEKS-DVFSFGVVLLELITGRKP 568
G + S D FS G +L +L+ G P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 359 YEELVKATD---GFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEV 414
YE + + D + LG+G FG VYK G A K ++ + ++ E+
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA-- 472
EI++ H ++V L+G D + ++ ++ P + + R + T +I
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVC 123
Query: 473 -GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG----LAKLALDANTHITT 527
L +LH RIIHRD+K+ N+L+ + +++DFG K ++ I
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178
Query: 528 RVMGTFGYMAPEYASSGKLTE-----KSDVFSFGVVLLELITGRKP 568
GT +MAPE + + K+D++S G+ L+E+ P
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+LG+GGFG V + ++ A K+L+ I +GE E +I+ +++ R +VSL
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y L L+ + L FH++ G+ A V AA GL LH + R
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---R 306
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD++ ++SD GLA + T I RV GT GYMAPE + + T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 364
Query: 549 KSDVFSFGVVLLELITGRKP 568
D ++ G +L E+I G+ P
Sbjct: 365 SPDWWALGCLLYEMIAGQSP 384
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 352 HSRSMFTYEELVKATDG---FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
R + +E F LGEG +GSVYK G+ VAIKQ+ +
Sbjct: 11 PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDL 68
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
+E E+ I+ + H+V G + ++ +Y ++ + + + T
Sbjct: 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TE 124
Query: 468 VKIAA---GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
+IA +GL YLH R IHRDIK+ NILL+ A+++DFG+A D
Sbjct: 125 DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T + GT +MAPE +D++S G+ +E+ G+ P
Sbjct: 182 RNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-29
Identities = 58/245 (23%), Positives = 97/245 (39%), Gaps = 27/245 (11%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK 400
G+ + M+ ++ K + + LG G +G V E AIK +K
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 401 -------------IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447
+ E E+ ++ + H +++ L L+ ++
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 448 NTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--- 503
L+ + + D A +K + YLH+ I+HRDIK NILL+N
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQILSG---ICYLHKH---NIVHRDIKPENILLENKNS 184
Query: 504 NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 563
++ DFGL+ + + R+ GT Y+APE K EK DV+S GV++ L+
Sbjct: 185 LLNIKIVDFGLSSF-FSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
Query: 564 TGRKP 568
G P
Sbjct: 242 CGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG V K +E A+K + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLFE 88
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
++ + L+ + R D A +K + Y+H+ I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKH---NI 142
Query: 490 IHRDIKSSNILLDN---NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
+HRD+K NILL++ + + ++ DFGL+ NT + R+ GT Y+APE G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRI-GTAYYIAPE-VLRGTY 199
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
EK DV+S GV+L L++G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
D + Q ++G G V Y P +VAIK++ + Q + E++ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 425 LVSLVGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+VS + D L+ + + H+ +G IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF-G--- 534
YLH++ IHRD+K+ NILL + Q++DFG++ +V TF G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 535 YMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKP 568
+MAPE + K+D++SFG+ +EL TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
+LGEG F +V L RE AIK L+ I + E +++SR+ H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHPFFVKL 95
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDCH 486
+ DD +L Y N L ++ G + A L YLH
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSALEYLHGK-- 149
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGK 545
IIHRD+K NILL+ + Q++DFG AK+ + GT Y++PE +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
+ SD+++ G ++ +L+ G P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 15/221 (6%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
+ D +G G +GSV K P G+ +A+K+++ + E++ +++++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 424 HLVSLVGYCISDDRRLLIYDYVPN--NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
++V G + + + + + Y +++ V+ KI + L +L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPE- 539
E+ IIHRDIK SNILLD + ++ DFG+ +L ++ TR G YMAPE
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPER 196
Query: 540 ---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
AS +SDV+S G+ L EL TGR P + D
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 23/242 (9%), Positives = 47/242 (19%), Gaps = 43/242 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
L G V+ + + A+K +R+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 430 GYC--------------------------ISDDRRLLIYDYVPNNTLY----FHLHGEGR 459
+ LL+ + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
+ A R A L ++H N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 520 DANTHITTRVMGTFGYMAPEYASSGKL--TEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
Y E+ ++ T + + G+ + + P P
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 578 ES 579
S
Sbjct: 302 GS 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
D LG G +G V K ++P G+ +A+K+++ E++ +++I R +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 424 HLVSLVG-------------YC-ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
V+ G S D+ Y V + E +L K
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDK---FYKQVIDKGQTI---PE--DIL-----GK 113
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR 528
IA + L +LH +IHRD+K SN+L++ + ++ DFG+ L +
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDI 168
Query: 529 VMGTFGYMAPE----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
G YMAPE + + KSD++S G+ ++EL R P
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG G F V+ G+ A+K +K + + E+ ++ +I H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHE 483
S L+ V G + D K A+ + + YLHE
Sbjct: 76 ESTTHYYLVMQLV-----------SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
+ I+HRD+K N+L E ++DFGL+K+ + N ++T GT GY+APE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC-GTPGYVAPEV 178
Query: 541 ASSGKLTEKSDVFSFGVVL 559
+ ++ D +S GV+
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLV 426
F L+G G +G VYKG + G+ AIK + + G E E K E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 427 S-----LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARG 477
+ + D +L L+ ++ ++ + L IA RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRG 141
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L++LH+ ++IHRDIK N+LL N E ++ DFG++ T +GT +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 197
Query: 538 PEYASSGKLTE-----KSDVFSFGVVLLELITGRKP 568
PE + + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F+D +G G FG+VY + + VAIK++ G Q +++ EV + ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----KIAA---GAARG 477
+ G + + L+ +Y G +L+ + +IAA GA +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLH +IHRD+K+ NILL ++ DFG A + AN+ +GT +MA
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMA 218
Query: 538 PEYASSGKLTE---KSDVFSFGVVLLELITGRKP 568
PE + + K DV+S G+ +EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 31/243 (12%), Positives = 62/243 (25%), Gaps = 43/243 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG+ + + G + K E + R+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 433 ISDDRRLLIYD--------------------YVPNNTLYFHL--------------HGEG 458
R + +D +V + + H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
L R+++ R LA LH H ++H ++ +I+LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 519 LDANTHITTRVMGTFGYMAPE-----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 574 PLG 576
LG
Sbjct: 322 ALG 324
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 35/254 (13%), Positives = 72/254 (28%), Gaps = 54/254 (21%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRI--------- 420
+LG+ + + G + + ++ K EV + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 421 --HHRHLVSLVGYCISDDR---RLLIYDYVPNNTLYFHL-----------------HGEG 458
H R + + R+ + + F L H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
L R+++ R LA LH H ++H ++ +I+LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 519 LDANTHITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRK 567
+ G+ PE + +T D ++ G+V+ +
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 568 PVDASQPLGDESLV 581
P+ LG +
Sbjct: 312 PITKDAALGGSEWI 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 36/234 (15%), Positives = 82/234 (35%), Gaps = 19/234 (8%)
Query: 351 GHSRSMFTYEELVKATDG---FADQNLLGEG--GFGSVYKGY-LPDGREVAIKQLKIGGG 404
H ++ + + ++G+G +V P G V ++++ +
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 405 QGER--EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
E + E+ + +H ++V I+D+ ++ ++ + + +
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
+ I G + L Y+H +HR +K+S+IL+ + + +S +
Sbjct: 126 NELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 523 THITTRVM------GTFGYMAPEYASSGKL--TEKSDVFSFGVVLLELITGRKP 568
+++PE KSD++S G+ EL G P
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
+ + +G G G V+K + G +A+KQ++ G + E + +++++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAY 480
++V G I++ + + + +G +L K+ + L Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYY 139
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPE 539
L E +IHRD+K SNILLD + ++ DFG+ +L + R G YMAPE
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPE 194
Query: 540 -----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ ++DV+S G+ L+EL TG+ P +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLV 426
+G+G FG V + A+K + R E++I+ + H LV
Sbjct: 22 AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L Y D+ + ++ D + L +HL + VK+ L YL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMALDYLQNQ 134
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RIIHRD+K NILLD + ++DF +A + T + GT YMAPE SS
Sbjct: 135 ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSR 189
Query: 545 KLTE--KS-DVFSFGVVLLELITGRKP 568
K + D +S GV EL+ GR+P
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 66/254 (25%), Positives = 88/254 (34%), Gaps = 20/254 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ SP + ++ P P S
Sbjct: 1479 LVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVS 1538
Query: 61 NPPTSSSPPASSP--PTSSPPPASNPPTS------SPPPSP--PASSP------PTISPP 104
+P S + P SP P SP S PTS SP SP P+ SP PT
Sbjct: 1539 SPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1598
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P S + + P S T P SP SP P + S P++P + P P S P SP
Sbjct: 1599 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPT 1657
Query: 165 SVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV--PPPPTQTPPTPA-SPIAPRPSNSSPNS 221
S P S + P SP +P P S P P +P +P+ SP +P S SP
Sbjct: 1658 SPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAY 1717
Query: 222 PPPPSTKRLSPPPG 235
P ++ +
Sbjct: 1718 SPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 69/263 (26%), Positives = 100/263 (38%), Gaps = 12/263 (4%)
Query: 2 SAPSPGPPAANSSSPPP---PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
S S A P+ + + + S P+ P
Sbjct: 1474 SNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSP 1533
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP--PTISPPPPVSNPPTRSPP 116
+S +SP S PA +P + S P+ P+ SP P+ SP P +P + S
Sbjct: 1534 -GFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1592
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P S + P SP P+ P + PS P++ P S P + PS P +P P+
Sbjct: 1593 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP--TSPSYSPTSPSYSPT 1650
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPN-SPPPPSTKRLSPP- 233
S + PA PS P P+ +P +P+ SP +P S +SPN SP PS SP
Sbjct: 1651 SPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGY 1710
Query: 234 -PGIPVPSTENTPGNGTNPSSPE 255
PG P S + +
Sbjct: 1711 SPGSPAYSPKQDEQKHNENENSR 1733
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 1e-21
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 10/241 (4%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P + SP + + + + + P +
Sbjct: 1468 GGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYG 1527
Query: 91 PSPPASSPPTISPPP-PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+P + SP P S + + P S T P SP SP P + S P++P + P
Sbjct: 1528 EAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-P 1586
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSP--PKNSPPAPIAVPPSNVPPP--PTQTPPT 205
P S P SP S P P PS SP P SP +P P S P P+ +P +
Sbjct: 1587 TSPSYSPTSPSYSPTS--PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1644
Query: 206 PA-SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPSNN 263
P+ SP +P S +SP P + + P P + + +P+SP S +SPS +
Sbjct: 1645 PSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYS 1704
Query: 264 G 264
Sbjct: 1705 P 1705
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 97.5 bits (242), Expect = 4e-21
Identities = 59/245 (24%), Positives = 82/245 (33%), Gaps = 17/245 (6%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
+ P ++ + SP S +
Sbjct: 1457 QKITEIEDGQDGGVTPYSNESGLVNADLDVK---DELMFSPLVDSGSNDAMAGGFTA--Y 1511
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
A+SP P S S P S T P SP SP P + S P PS
Sbjct: 1512 GGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSP-TSPSY 1570
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--PSNVPPPPTQTPPT 205
P P S P SP S P S + P SP +P P PS P P+ +P +
Sbjct: 1571 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1630
Query: 206 PASPIAPRPSNSSPNSPP-PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPSNN 263
P+ P + SP SP P++ SP P++ +P+SP S +SPS +
Sbjct: 1631 PSYS--PTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSP-----SYSPTSPSYSPTSPSYS 1683
Query: 264 GIGTA 268
+
Sbjct: 1684 PTSPS 1688
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 9e-21
Identities = 63/228 (27%), Positives = 88/228 (38%), Gaps = 7/228 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS--SPPPPPVSKPPTTSPPPSPP 58
+ G ++ P SP VS+P S SP P S + + P P
Sbjct: 1506 GGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSP 1565
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
S P S + P+ SP + S P S + + P P S + + P P+ SP P
Sbjct: 1566 TS-PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1624
Query: 119 SSTPP-PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S +P P+ P+ PS P + PS P P S P SP S P S
Sbjct: 1625 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSP 1684
Query: 178 SPPKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSP 222
+ P SP +P P PS P P +P +PA SP ++ +
Sbjct: 1685 TSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 22/143 (15%), Positives = 35/143 (24%), Gaps = 9/143 (6%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P +P + + SP N +
Sbjct: 1455 PEQKITEIEDGQDGGVTPYSNESGL--VNADLDVKDELMFSPLVDSGSNDAMAGGFTAYG 1512
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASP-IAPRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
+ P PT +SP +P SP SP SP P+
Sbjct: 1513 GADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAY------SPTSPSYSPT 1566
Query: 241 TENTPGNGTNPSSPESSSSPSNN 263
+ + + S S SP++
Sbjct: 1567 SPSYSPTSPSYSPTSPSYSPTSP 1589
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 50/246 (20%), Positives = 81/246 (32%), Gaps = 56/246 (22%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+G+G +G V AIK +++ + K EV ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG--------------- 473
+ L+ + L L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 474 ----------------AAR-------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV- 509
+ L YLH I HRDIK N L N ++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 510 -SDFGLAKL----ALDANTHITTRVMGTFGYMAPE--YASSGKLTEKSDVFSFGVVLLEL 562
DFGL+K +TT+ GT ++APE ++ K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 563 ITGRKP 568
+ G P
Sbjct: 270 LMGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGERE-----FKAEVEIISRIHHRHL 425
LG G G V + ++VAI+ + K G + E+EI+ +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDW-ATRVKIAAGAAR------- 476
+ + + D ++ + + GE + D ++ +
Sbjct: 203 IKIKNFF--DAEDYYIVLELMEG--------GE---LFDKVVGNKRLKEATCKLYFYQML 249
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
+ YLHE+ IIHRD+K N+LL + + +++DFG +K+ L + + T GT
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GT 304
Query: 533 FGYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y+APE + D +S GV+L ++G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 61/249 (24%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKA-------------- 412
+G+G +G V Y D A+K L + G +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 413 ------EVEIISRIHHRHLVSL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDW 464
E+ I+ ++ H ++V L V ++D ++++ V PV++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV-----------NQGPVMEV 128
Query: 465 ATRVKIAAGAAR--------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
T ++ AR G+ YLH +IIHRDIK SN+L+ + +++DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 517 LALDANTHITTRVMGTFGYMAPEYASSGKLT---EKSDVFSFGVVLLELITGRKPVDASQ 573
++ ++ V GT +MAPE S + + DV++ GV L + G+ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM--- 241
Query: 574 PLGDESLVE 582
DE ++
Sbjct: 242 ---DERIMC 247
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLV 426
+LG+G FG V+ K D R++ A+K LK + K E +I+ ++H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIV 89
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
L Y + +L LI D++ L+ L E + VK A A L +LH
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALALDHLHSL 145
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASS 543
II+RD+K NILLD +++DFGL+K ++D GT YMAPE +
Sbjct: 146 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNR 200
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
T+ +D +SFGV++ E++TG P
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G+G F V + GREVAIK + ++ ++ F+ EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 431 Y-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLAY 480
+ I ++ L LI +Y ++ +L GR + AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR----------MKEKEARSKFRQIVSAVQY 129
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
H+ I+HRD+K+ N+LLD + +++DFG + + G Y APE
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPEL 184
Query: 541 ASSGKLTE--KSDVFSFGVVLLELITGRKPVDAS 572
GK + + DV+S GV+L L++G P D
Sbjct: 185 F-QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREF-KAEVEIISRIHHRHL 425
+LG+GG+G V+ K + ++ A+K LK I + KAE I+ + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
V L+ Y +L LI +Y+ L+ L EG + D A + L +LH+
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMALGHLHQ 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K NI+L++ +++DFGL K ++ T T GT YMAPE
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILM 194
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D +S G ++ +++TG P
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 35/172 (20%), Positives = 60/172 (34%), Gaps = 17/172 (9%)
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWA 465
++ + ++ V + + L + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-------- 517
+ I A + +LH ++HRD+K SNI + +V DFGL
Sbjct: 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 518 ----ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
+ A T +V GT YM+PE + K D+FS G++L EL+
Sbjct: 222 TVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 12/86 (13%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-F 410
SR + +E + +G GGFG V++ D AIK++++ + RE
Sbjct: 2 SRYLTDFEPI----------QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV 51
Query: 411 KAEVEIISRIHHRHLVSLVGYCISDD 436
EV+ ++++ H +V +
Sbjct: 52 MREVKALAKLEHPGIVRYFNAWLETP 77
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+G+G F V + G++ A+K + G + K E I + H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR----GLAYLHED 484
+ SD ++++++ L F + ++ V A+ R L Y H++
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYCHDN 149
Query: 485 CHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
IIHRD+K +LL +N+ ++ FG+A ++ RV GT +MAPE
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ DV+ GV+L L++G P ++
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 35/210 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G FG V++ GR K + + K E+ I++++HH L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR----GLAY 480
+LI +++ G + D R+ R GL +
Sbjct: 119 DKYEMVLILEFL-----------SGGELFD---RIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAP 538
+HE I+H DIK NI+ + + V DFGLA L+ + + T + AP
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAP 219
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E + +D+++ GV+ L++G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LLGEG +G V + A+K LK GE K E++++ R+ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 429 --VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GL 478
V Y + ++ +Y + +LD + A GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCV---------CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-ANTHITTRVMGTFGYMA 537
YLH I+H+DIK N+LL ++S G+A+ A G+ +
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 538 PEYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
PE A+ K D++S GV L + TG P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 72/241 (29%), Positives = 99/241 (41%), Gaps = 22/241 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP--P 58
A+ P P S P +SP P S +TSP P P
Sbjct: 1519 FGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGL--TSPSYSPSSPGYSTSPAYMPSSP 1576
Query: 59 ASNP------PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP--PTISPPPPVSNP 110
+ +P PTS S +SP S P+ + + S P+ P+ SP P+ SP P +P
Sbjct: 1577 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSP 1636
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS---NLPPPPPSSVEPPKRSPPSVP 167
+ S P S + P SP P+ P + PS P+ P P S P SP S
Sbjct: 1637 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1696
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPN-SPPPP 225
P S + P SP +P P S P+ +P +P+ SP +P S +SP+ SP P
Sbjct: 1697 YSPTSPSYSPTSPSYSPTSPSYSPTS-----PSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
Query: 226 S 226
S
Sbjct: 1752 S 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 1e-22
Identities = 72/241 (29%), Positives = 94/241 (39%), Gaps = 17/241 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P P P SS P + P SP S
Sbjct: 1508 LVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYST 1567
Query: 62 -PPTSSSPPASSP--PTSSPPPASNPPTSSPP-PSPPASSP--PTISPPPPVSNPPTRSP 115
P S P+ SP P+ SP S PTS P+ P+ S P+ SP P +P +
Sbjct: 1568 SPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSP---TS 1624
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S T P SP SP P + S P++P + P P S P SP S P
Sbjct: 1625 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPTSPSYSPTSPSY 1683
Query: 176 SSSPPKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPP-PPSTKRLS 231
S + P SP +P P PS P P+ +P +P+ SP +P SP SP P++ S
Sbjct: 1684 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY---SPTSPSYSPTSPSYS 1740
Query: 232 P 232
P
Sbjct: 1741 P 1741
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 77/279 (27%), Positives = 104/279 (37%), Gaps = 24/279 (8%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
M A P V + SP +P AS
Sbjct: 1473 MGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGR---EGFGDYGLLGAAS 1529
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP-PTISPPPPVSNP--PTRSPPP 117
SP +SP +S+ P + S PS P S P P P +P P+ SP
Sbjct: 1530 PYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTS 1589
Query: 118 P--SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S T P SP SP + S P++P + P P S P SP S P P P
Sbjct: 1590 PSYSPTSPSYSPTSPSYSATSPSYSPTSPSYS-PTSPSYSPTSPSYSPTS--PSYSPTSP 1646
Query: 176 SSSP--PKNSPPAPIAVPPSNVPPP--PTQTPPTPA--------SPIAPRPSNSSPNSPP 223
S SP P SP +P P S P P+ +P +P+ SP +P S +SP+ P
Sbjct: 1647 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1706
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPS 261
+ + P P + + +P+SP S +SPS
Sbjct: 1707 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1745
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 8e-19
Identities = 54/234 (23%), Positives = 81/234 (34%), Gaps = 13/234 (5%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSS--SPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P P SP P ++ SP + P SP
Sbjct: 1478 LPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSP 1537
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
SP +P S + P+SP S S P +P S P P+S
Sbjct: 1538 GYTSPFSSAMSP---GYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTS--PSYSPTS--- 1589
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSP--PAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPS 215
P SP S P S++ P SP P+ PS P P+ +P +P+ SP +P S
Sbjct: 1590 PSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1649
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAG 269
+SP+ P + + P P + + +P+SP S + + +
Sbjct: 1650 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1703
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 55/233 (23%), Positives = 79/233 (33%), Gaps = 11/233 (4%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
S P P + P SP S SP A+ P
Sbjct: 1460 SLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGF 1519
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA--NSPPPSNPPSNLPPPPPSS 155
+SP S SP + P +SP S P+ +P P S
Sbjct: 1520 GDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYS 1579
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPIAP 212
P SP S P S + P S +P P PS P P+ +P +P+ SP +P
Sbjct: 1580 PTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1639
Query: 213 RPSNSSPNSPPP-PSTKRLSPPPGIPVPSTENTPGNGT--NPSSPESSSSPSN 262
+ SP SP P++ SP P++ + +P+SP S + +
Sbjct: 1640 ---SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1689
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 65/257 (25%), Positives = 110/257 (42%), Gaps = 44/257 (17%)
Query: 332 IGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDG 391
+ + P + +P D + + + + ++G G FG V++ L +
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 392 REVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLVSLVGYCISDDRRL------LIYDY 444
EVAIK++ ++ FK E++I+ + H ++V L + S+ + L+ +Y
Sbjct: 65 DEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAA----------RGLAYLHEDCHPRIIHRDI 494
VP T+Y ++K R LAY+H I HRDI
Sbjct: 120 VPE-TVY--------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDI 167
Query: 495 KSSNILLD-NNFEAQVSDFGLAK--LALDANTH-ITTRVMGTFGYMAPE-YASSGKLTEK 549
K N+LLD + ++ DFG AK +A + N I +R Y APE + T
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTN 222
Query: 550 SDVFSFGVVLLELITGR 566
D++S G V+ EL+ G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG V K +E A+K + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLFE 88
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYL 481
++ + G + D + AA + G+ Y+
Sbjct: 89 ILEDSSSFYIVGELY-----------TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H+ I+HRD+K NILL++ + + DFGL+ NT + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRI-GTAYYIAP 192
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E G EK DV+S GV+L L++G P
Sbjct: 193 EVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V+ G E IK + Q E +AE+E++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG------AAR-------GLA 479
++ + GE +L+ + A LA
Sbjct: 90 EDYHNMYIVMETCEG--------GE---LLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYM 536
Y H ++H+D+K NIL + + DFGLA+L ++ H T GT YM
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYM 193
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
APE +T K D++S GVV+ L+TG P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 46/235 (19%)
Query: 364 KATDGFADQ----NLLGEGGFGSVYKG-YLPDGREVAIK---------QLKIGGGQGERE 409
+T GF + +LG G V + + P +E A+K +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 410 FKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EV+I+ ++ H +++ L ++ L++D + GE + D+ T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK--------GE---LFDYLTEK 118
Query: 469 -----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
K R + LH+ I+HRD+K NILLD++ +++DFG + L
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-L 174
Query: 520 DANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
D + GT Y+APE + ++ D++S GV++ L+ G P
Sbjct: 175 DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREF-KAEVEIISRI-HHRH 424
+LG G +G V+ K D ++ A+K LK I E + E +++ I
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV+L Y + +L LI DY+ L+ HL R V+I L +LH
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLH 176
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--- 539
+ II+RDIK NILLD+N ++DFGL+K + T GT YMAP+
Sbjct: 177 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 540 YASSGKLTEKS-DVFSFGVVLLELITGRKP 568
SG +K+ D +S GV++ EL+TG P
Sbjct: 234 GGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G FG V K + A+K L + + F+ E +++ + +
Sbjct: 81 VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWI 136
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLH-GEGRPVLDWATRVKI-AAGAARGLAYLH 482
+L Y DD L L+ DY L L E R + A + A + +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA---RFYLAEMVIAIDSVH 192
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--- 539
+ +HRDIK NIL+D N +++DFG ++ T ++ +GT Y++PE
Sbjct: 193 QL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 540 --YASSGKLTEKSDVFSFGVVLLELITGRKP 568
G+ + D +S GV + E++ G P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 36/210 (17%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G FG V++ + K +K+ G + K E+ I++ HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR----GLAY 480
S + ++I++++ G + + R+ + L +
Sbjct: 72 SMEELVMIFEFI-----------SGLDIFE---RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAP 538
LH I H DI+ NI+ + + +FG A+ L + Y AP
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAP 172
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E ++ +D++S G ++ L++G P
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-23
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 30/200 (15%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL--KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
LG+G F V + + G+E A + K + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLH 482
+ LI+D V G + + A+ + + + H
Sbjct: 79 ISEEGHHYLIFDLV-----------TGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFE-AQV--SDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ ++HR++K N+LL + + A V +DFGLA GT GY++PE
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
Query: 540 YASSGKLTEKSDVFSFGVVL 559
+ D+++ GV+L
Sbjct: 184 VLRKDPYGKPVDLWACGVIL 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 41/218 (18%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGERE-----FKAEVEIISRIHHRHL 425
LG G G V + ++VAIK + K G + E+EI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR---- 476
+ + + + ++ + + GE + D
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEG--------GE---LFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTF 533
+ YLHE+ IIHRD+K N+LL + E ++DFG +K+ L + + T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTP 180
Query: 534 GYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y+APE + D +S GV+L ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLKIGGGQGEREF---KAEVEIISRIHHRHLV 426
LLG+G FG V K GR A+K LK + E E ++ H L
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L Y RL + +Y L+FHL E D R + A L YLH +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLHSE 267
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASS 543
+ +++RD+K N++LD + +++DFGL K + T + GT Y+APE
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLED 323
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 30/207 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G V A K++ + FK E+EI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHED 484
+ L+ + G + + AA + +AY H+
Sbjct: 77 DNTDIYLVMELC-----------TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
+ HRD+K N L + + DFGLA + T+V GT Y++P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKV-GTPYYVSPQ-V 179
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
G + D +S GV++ L+ G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDG 368
+ + S P+ + V+ P P H +
Sbjct: 32 SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT- 90
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ +LG G FG V+K G ++A K +K G + + E K E+ +++++ H +L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR-- 476
L S + +L+ +YV +G + D R+ +
Sbjct: 151 LYDAFESKNDIVLVMEYV-----------DGGELFD---RIIDESYNLTELDTILFMKQI 196
Query: 477 --GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGT 532
G+ ++H+ I+H D+K NIL N Q+ DFGLA+ + GT
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GT 251
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + ++ +D++S GV+ L++G P
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 58/259 (22%), Positives = 102/259 (39%), Gaps = 35/259 (13%)
Query: 327 SSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQ----NLLGEGGFGS 382
S L ++S G + + Y D +D + LG G
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 383 VYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441
VY+ + A+K LK ++ + E+ ++ R+ H +++ L + L+
Sbjct: 69 VYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 442 YDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHR 492
+ V G + D + AA A + +AYLHE+ I+HR
Sbjct: 127 LELV-----------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHR 172
Query: 493 DIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
D+K N+L ++DFGL+K+ ++ + T GT GY APE +
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAPEILRGCAYGPE 230
Query: 550 SDVFSFGVVLLELITGRKP 568
D++S G++ L+ G +P
Sbjct: 231 VDMWSVGIITYILLCGFEP 249
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G F V + G E A K + K+ ++ + E I ++ H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHD 72
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYL 481
+ L++D V GE + + A+ + +AY
Sbjct: 73 SIQEESFHYLVFDLVTG--------GE---LFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H + I+HR++K N+LL + + ++DFGLA ++ + GT GY++P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSP 176
Query: 539 EYASSGKLTEKSDVFSFGVVL 559
E ++ D+++ GV+L
Sbjct: 177 EVLKKDPYSKPVDIWACGVIL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G E A K Q + RE + EV I+ ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GL 478
L + +LI + V GE + D+ + + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GE---LFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFG 534
YLH +I H D+K NI+L + + DFGLA ++ GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPE 183
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 28/209 (13%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKI--GGGQGEREFKAEVEIISRI-HHRHLVSLVG 430
LG G F V + G+E A K LK G E E+ ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRV--KIAAGAAR----GLAYLH 482
+ +LI +Y GE + + A V + G+ YLH
Sbjct: 97 VYENTSEIILILEYAA--------GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++ I+H D+K NILL + + + DFG+++ + + + GT Y+APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPE 203
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ +T +D+++ G++ L+T P
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 367 DGFADQNLLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIIS 418
D F LG G FG V K G A+K L + Q E E I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQ 96
Query: 419 RIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAAR 476
++ LV L + D+ L ++ +YV ++ HL GR A + AA
Sbjct: 97 AVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVL 152
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
YLH +I+RD+K N+L+D QV+DFG AK T + GT +
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEAL 205
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
APE S + D ++ GV++ E+ G P A QP+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 40/238 (16%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAI 396
+ GG R E ++ A+ F+D LG+G F V + G E A
Sbjct: 3 HMASMTGGQQMGRGS---EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 397 KQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
K + K+ ++ + E I ++ H ++V L + L++D V
Sbjct: 60 KIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG------ 112
Query: 454 LHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNN 504
GE + + A+ + +AY H + I+HR++K N+LL +
Sbjct: 113 --GE---LFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK 164
Query: 505 FEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVL 559
+ ++DFGLA ++ + GT GY++PE ++ D+++ GV+L
Sbjct: 165 AKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
LLG+G FG V K GR A+K L+ I + E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFL 67
Query: 426 VSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
+L Y + DR + +Y L+FHL E + R + A L YLH
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHS 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
+++RDIK N++LD + +++DFGL K + T + GT Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV-- 176
Query: 543 SGKLTEKS-----DVFSFGVVLLELITGRKP 568
L + D + GVV+ E++ GR P
Sbjct: 177 ---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG V G G +VA+K L KI + K E++ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y IS ++ +YV L+ ++ GR + AR +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAVD 125
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH ++HRD+K N+LLD + A+++DFGL+ + D T+ G+ Y AP
Sbjct: 126 Y----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 179
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E SG+L + D++S GV+L L+ G P D
Sbjct: 180 EVI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 38/228 (16%)
Query: 360 EELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEV 414
++L + + F D +G G + + E A+K + E +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 415 EIISR-IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----- 468
EI+ R H ++++L ++ + + GE +LD R
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG--------GE---LLDKILRQKFFSE 115
Query: 469 KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALD 520
+ A+ + YLH ++HRD+K SNIL + + DFG AK
Sbjct: 116 REASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
N + T T ++APE D++S GV+L ++TG P
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G F V K G+ A+K + + G+ F+ E +++ R +
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWI 123
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
L + D+ L L+ +Y L L G + + A + +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--EMARFYLAEIVMAIDSVHR 180
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPE--- 539
+HRDIK NILLD +++DFG L A+ + + V GT Y++PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+G + D ++ GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G FG V K + A+K L I F E +I++ + +
Sbjct: 76 VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
V L Y DDR L ++ +Y+P L + WA + A L +H
Sbjct: 132 VQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWA---RFYTAEVVLALDAIHS 186
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPE--- 539
IHRD+K N+LLD + +++DFG ++ + GT Y++PE
Sbjct: 187 M---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 540 -YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
G + D +S GV L E++ G P A
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LGEG F K + A+K + + E + E+ + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR----GLAY 480
L+ + + G + + R+ A+ R +++
Sbjct: 76 HDQLHTFLVMELL-----------NGGELFE---RIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 481 LHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+H+ ++HRD+K N+L ++N E ++ DFG A+L N + T T Y A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE + E D++S GV+L +++G+ P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G + A K + K RE + EV I+ I H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR--- 476
L + +LI + V G + D + + A +
Sbjct: 79 LHEVYENKTDVILILELV-----------AGGELFD---FLAEKESLTEEEATEFLKQIL 124
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMG 531
G+ YLH +I H D+K NI+L + + + DFGLA +D G
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-G 179
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T ++APE + L ++D++S GV+ L++G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 8e-22
Identities = 55/282 (19%), Positives = 98/282 (34%), Gaps = 41/282 (14%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHS--RSMFTYEELVKAT 366
P + K + + G + + + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 367 DGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH 421
D D LG G FG V++ G A K + + + E++ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAA 472
H LV+L D+ ++IY+++ G + + +V A
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFM-----------SGGELFE---KVADEHNKMSEDEAV 258
Query: 473 GAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHIT 526
R GL ++HE+ +H D+K NI+ ++ DFGL LD +
Sbjct: 259 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVK 314
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
GT + APE A + +D++S GV+ L++G P
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 42/219 (19%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKA-----EVEIISRIHHRHL 425
LG G FG V+ +EV +K + K+ + K E+ I+SR+ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYF---HLHGEGRPVLDW-ATRVKIAAGAAR----- 476
+ + D N + HG G + + ++ A
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 477 ---GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
+ YL IIHRDIK NI++ +F ++ DFG A L+ T GT
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-GTI 193
Query: 534 GYMAPEYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
Y APE G + +++S GV L L+ P
Sbjct: 194 EYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG V+ + +GR A+K LK + Q E E ++S + H +
Sbjct: 13 TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFI 68
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
+ + D +++ +I DY+ L+ L R K AA L YLH
Sbjct: 69 IRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLALEYLHS 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K NILLD N +++DFG AK D T + GT Y+APE S
Sbjct: 125 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVS 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ + D +SFG+++ E++ G P S +
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 39/216 (18%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGG--GQGEREFKAEVEIISRIHHRHLVS 427
LGEG +G V VA+K + + ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
G+ + + L +Y L+ + + + A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVV 119
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--HITTRVMGTFGYM 536
Y H I HRDIK N+LLD ++SDFGLA + N + GT Y+
Sbjct: 120 Y----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 537 APEYASSGKL--TEKSDVFSFGVVLLELITGRKPVD 570
APE + E DV+S G+VL ++ G P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGER------EFKAEVEIISRIHHRHLVS 427
LG G F V K G E A K +K + R E + EV I+ ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GL 478
L + +LI + V GE + D+ + + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GE---LFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFG 534
YLH +I H D+K NI+L + + DFGLA ++ GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPE 183
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-- 409
YE+L LGEG F +VYK + VAIK++K+G ++
Sbjct: 6 KSRAKRYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI 55
Query: 410 -FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT 466
A E++++ + H +++ L+ L++D++ + L + L +
Sbjct: 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV-LTPSH 113
Query: 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526
+GL YLH+ I+HRD+K +N+LLD N +++DFGLAK N T
Sbjct: 114 IKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 527 TRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
+V+ T Y APE Y D+++ G +L EL+
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVG------VDMWAVGCILAELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 48/215 (22%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRI 420
+ +GEG +G+V+K VA+K++++ + E A E+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H+++V L SD + L++++ + L + LD +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD-LDPEIVKSFLFQLLKGLGF 116
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H ++HRD+K N+L++ N E ++++FGLA+ + V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y++S D++S G + EL +P
Sbjct: 173 LFGAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 42/217 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G+E A K +L RE + EV I+ I H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR--- 476
L + +LI + V GE + D + A +
Sbjct: 73 LHDIFENKTDVVLILELVSG--------GE---LFD---FLAEKESLTEDEATQFLKQIL 118
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMG 531
G+ YLH RI H D+K NI+L + + DFG+A ++A G
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-G 173
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T ++APE + L ++D++S GV+ L++G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 37/237 (15%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
+ L M Y++L K +GEG +G VYK GR VA+K++++
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRL 55
Query: 402 GGGQGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
E E A E+ ++ +HH ++VSL+ S+ L+++++ + L L
Sbjct: 56 DA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDE 111
Query: 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
L + RG+A+ H+ RI+HRD+K N+L++++ +++DFGLA+
Sbjct: 112 NKTG-LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
Query: 517 LALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T V+ T Y AP+ Y++S D++S G + E+ITG+
Sbjct: 168 AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 48/241 (19%)
Query: 349 GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
G S + YE + + +G G +G+VYK G VA+K +++
Sbjct: 1 GPLGSMATSRYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPN---G 47
Query: 408 REFKAEV------EI-----ISRIHHRHLVSL----VGYCISDDRRL-LIYDYVPNNTLY 451
+ E+ + H ++V L + ++ L++++V + L
Sbjct: 48 GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LR 106
Query: 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
+L P L T + RGL +LH + I+HRD+K NIL+ + +++D
Sbjct: 107 TYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163
Query: 512 FGLAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITG 565
FGLA+ +T V+ T Y APE YA+ D++S G + E+
Sbjct: 164 FGLAR-IYSYQMALTPVVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRR 215
Query: 566 R 566
+
Sbjct: 216 K 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRIH 421
+ + +GEG +G VYK G A+K++++ E E E+ I+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK 58
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H ++V L + R +L+++++ + + G L+ T G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAY 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H+ R++HRD+K N+L++ E +++DFGLA+ T ++ T Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDV 171
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y+++ D++S G + E++ G
Sbjct: 172 LMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LGEG FG V ++VA+K + + + E+ + + H H++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y I+ + ++ +Y L+ ++ + R + R +
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKR----------MTEDEGRRFFQQIICAIE 122
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH I+HRD+K N+LLD+N +++DFGL+ + D N T+ G+ Y AP
Sbjct: 123 Y----CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 176
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E +GKL + DV+S G+VL ++ GR P D
Sbjct: 177 EVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-F 410
+SM YE L +GEG +G V K GR VAIK+ + +
Sbjct: 21 FQSMEKYENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMV 67
Query: 411 KA----EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT 466
K E++++ ++ H +LV+L+ C R L++++V + + L LD+
Sbjct: 68 KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNG-LDYQV 125
Query: 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526
K G+ + H H IIHRDIK NIL+ + ++ DFG A+
Sbjct: 126 VQKYLFQIINGIGFCHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 527 TRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
V T Y APE Y + DV++ G ++ E+ G
Sbjct: 183 DEVA-TRWYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 39/216 (18%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGG--GQGEREFKAEVEIISRIHHRHLVS 427
LGEG +G V VA+K + + ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
G+ + + L +Y L+ + + + A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVV 119
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--HITTRVMGTFGYM 536
Y H I HRDIK N+LLD ++SDFGLA + N + GT Y+
Sbjct: 120 Y----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 537 APEYASSGKL--TEKSDVFSFGVVLLELITGRKPVD 570
APE + E DV+S G+VL ++ G P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 41/292 (14%)
Query: 293 RRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGH 352
RR ++E+ L + S D A +G
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIK-------QLKIGGG 404
+ + + + ++++G G V + + G E A+K +L
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 405 QGERE-FKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
+ RE + E I+ ++ H H+++L+ S L++D + GE +
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK--------GE---LF 188
Query: 463 DWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
D+ T K R +++LH + I+HRD+K NILLD+N + ++SDFG
Sbjct: 189 DYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 514 LAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVL 559
+ L+ + GT GY+APE + ++ D+++ GV+L
Sbjct: 246 FSCH-LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 58/250 (23%), Positives = 92/250 (36%), Gaps = 56/250 (22%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL- 399
P + Y+ VK +G G FG VA+K +
Sbjct: 5 PVTTGPLDMPIMHDSDRYD-FVK---------DIGSGNFGVARLMRDKLTKELVAVKYIE 54
Query: 400 --KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE 457
+RE + + H ++V ++ +I +Y LY +
Sbjct: 55 RGAAIDENVQRE----IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110
Query: 458 GRPVLDWATRVKIAAGAAR--------GLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQ 508
GR + AR G++Y CH I HRD+K N LLD + +
Sbjct: 111 GR----------FSEDEARFFFQQLLSGVSY----CHSMQICHRDLKLENTLLDGSPAPR 156
Query: 509 --VSDFGLAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLL 560
+ DFG +K ++ + +T +GT Y+APE Y GK +DV+S GV L
Sbjct: 157 LKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLY 209
Query: 561 ELITGRKPVD 570
++ G P +
Sbjct: 210 VMLVGAYPFE 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG V G G +VA+K L KI + + E++ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y IS + ++ +YV L+ ++ GR + +R G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGR----------LDEKESRRLFQQILSGVD 130
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH ++HRD+K N+LLD + A+++DFGL+ + D T+ G+ Y AP
Sbjct: 131 Y----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 184
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E SG+L + D++S GV+L L+ G P D
Sbjct: 185 EVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKA-EVEII---S 418
K D F + + G+G FG+V G G VAIK K+ + F+ E++I+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KV---IQDPRFRNRELQIMQDLA 74
Query: 419 RIHHRHLVSLVGYCISDDRR-------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
+HH ++V L Y + R ++ +YVP+ TL+ R ++A
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH--------RCCRNYYRRQVA 125
Query: 472 AGAA----------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLA-- 518
R + LH + HRDIK N+L++ + ++ DFG AK
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 519 LDANTH-ITTRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELITGR 566
+ N I +R Y APE + T D++S G + E++ G
Sbjct: 185 SEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 54/254 (21%), Positives = 95/254 (37%), Gaps = 51/254 (20%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LGEG V L +E A+K ++ G EVE++ + HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI----------AAGAAR----G 477
+DR L+++ + G +L I A+ +
Sbjct: 80 FEEEDRFYLVFEKM-----------RGGSILS-----HIHKRRHFNELEASVVVQDVASA 123
Query: 478 LAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAK-------LALDANTHITT 527
L +LH I HRD+K NIL + ++ DF L + + + T
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 528 RVMGTFGYMAPE-----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
G+ YMAPE + ++ D++S GV+L L++G P
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 583 WVNLIDAKILFKLV 596
+LF+ +
Sbjct: 240 EACPACQNMLFESI 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIISRIHHR--H 424
LLG GGFGSVY G + D VAIK + G EV ++ ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 425 LVSLVGYCISDDRRLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++ L+ + D +LI + P L+ + G L + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH--- 164
Query: 484 DCHPR-IIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
CH ++HRDIK NIL+D N E ++ DFG AL +T T GT Y PE+
Sbjct: 165 -CHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYSPPEWI 220
Query: 542 SSGKLT-EKSDVFSFGVVLLELITGRKPVD 570
+ + V+S G++L +++ G P +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
+LG+G FG V KG A+K LK I E E +++
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPGKPPF 82
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L C + DR + +YV L +H+ GR A V AA A GL +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQS 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K N++LD+ +++DFG+ K + TT+ GT Y+APE +
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIA 194
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ D ++FGV+L E++ G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 46/237 (19%)
Query: 351 GHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG--YLPDGREVAIKQLKIGGGQGER 408
G R+ YE + + +GEG +G V+K GR VA+K++++ Q
Sbjct: 5 GLCRADQQYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGE 51
Query: 409 E---FKAEVEI-----ISRIHHRHLVSL----VGYCISDDRRL-LIYDYVPNNTLYFHLH 455
E E+ + H ++V L + +L L++++V + L +L
Sbjct: 52 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLD 110
Query: 456 GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
P + T + RGL +LH R++HRD+K NIL+ ++ + +++DFGLA
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 516 KLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGR 566
+ +T+ V+ T Y APE YA+ D++S G + E+ +
Sbjct: 168 R-IYSFQMALTSVVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 48/254 (18%)
Query: 333 GSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDG 391
G+ + S+ Y + K LGEG +G VYK
Sbjct: 10 GTLEAQTQGPGSMSVSAAPSATSIDRYRRITK----------LGEGTYGEVYKAIDTVTN 59
Query: 392 REVAIKQLKIGGGQGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446
VAIK++++ E E A EV ++ + HR+++ L + R LI++Y
Sbjct: 60 ETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 447 NNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504
N+ L + P + G+ + H R +HRD+K N+LL +
Sbjct: 117 ND-----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168
Query: 505 FEAQ-----VSDFGLAKLALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDV 552
++ + DFGLA+ T ++ T Y PE Y++S D+
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS------VDI 221
Query: 553 FSFGVVLLELITGR 566
+S + E++
Sbjct: 222 WSIACIWAEMLMKT 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKA- 412
M YE++ K +GEG +G V+K G+ VAIK+ + K
Sbjct: 2 MEKYEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKI 48
Query: 413 ---EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
E+ ++ ++ H +LV+L+ R L+++Y + + L R +
Sbjct: 49 ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRG-VPEHLVKS 106
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
I + + + H+ H IHRD+K NIL+ + ++ DFG A+L + + V
Sbjct: 107 ITWQTLQAVNFCHK--H-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 530 MGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y +PE Y DV++ G V EL++G
Sbjct: 164 A-TRWYRSPELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-----R 408
S +++L K LG G + +VYKG G VA+K++K+ +G R
Sbjct: 3 SSSQFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR 52
Query: 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN--TLYFHLHGEGRPVLDWAT 466
E + ++ + H ++V L ++++ L+++++ N+ P
Sbjct: 53 E----ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108
Query: 467 RVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
VK +GLA+ HE+ +I+HRD+K N+L++ + ++ DFGLA+
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 526 TTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
++ V+ T Y AP+ Y++S D++S G +L E+ITG+
Sbjct: 166 SSEVV-TLWYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISR-IHHRH 424
++G+G FG V K + A+K L+ + + + +E ++ + + H
Sbjct: 45 VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLKNVKHPF 100
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L + +L + DY+ L++HL E + R + AA A L YLH
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLH 156
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
I++RD+K NILLD+ ++DFGL K ++ N+ TT GT Y+APE
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 46/220 (20%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSL 428
+ +LG G G V + + G++ A+K L + + EV+ + H+V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCI 87
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRV----------KIAAGAA 475
+ +Y+ + + + E G + R+ + AA
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFS---RIQERGDQAFTEREAAEIM 134
Query: 476 R----GLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTR 528
R + +LH I HRD+K N+L + + +++DFG AK + T
Sbjct: 135 RDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTP 189
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T Y+APE K + D++S GV++ L+ G P
Sbjct: 190 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
+ D ++G G FG VY+ L G VAIK++ ++ FK E++I+ ++ H ++V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA----- 475
L + S + L+ DYVP T+Y V +R K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY--------RVARHYSRAKQTLPVIYVKLY 161
Query: 476 -----RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLAL--DANTH-IT 526
R LAY+H I HRDIK N+LLD + ++ DFG AK + + N I
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 527 TRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELITGR 566
+R Y APE + T DV+S G VL EL+ G+
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
++G G + V K R A+K +K + + E + + +H
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQASNHPF 71
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L C ++ R + +YV L FH+ + + + + +A + L YLH
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
E II+RD+K N+LLD+ +++D+G+ K L TT GT Y+APE
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 182
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV++ E++ GR P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIISRIH----H 422
LLG+GGFG+V+ G+ L D +VAIK + EV ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 423 RHLVSLVGYCISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
++ L+ + + + +L+ + +P L+ ++ +G L + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQH- 154
Query: 482 HEDCHPR-IIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
CH R ++HRDIK NIL+D A++ DFG AL + T GT Y PE
Sbjct: 155 ---CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GTRVYSPPE 208
Query: 540 YASSGKLT-EKSDVFSFGVVLLELITGRKPVD 570
+ S + + V+S G++L +++ G P +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 90.3 bits (223), Expect = 6e-19
Identities = 29/168 (17%), Positives = 46/168 (27%), Gaps = 6/168 (3%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP 78
P + P+ P + PP P + + PP P+ +P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
+ T+S + P P P P P P + P
Sbjct: 70 HQQIDQATTSMNDMHLHNVPL---VDPNAYMQP---QVPVQMGTPLQQQQQPMAAPAYGQ 123
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
P + + P ++ PP + PPPP PP+
Sbjct: 124 PSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVP 171
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 87.2 bits (215), Expect = 6e-18
Identities = 32/190 (16%), Positives = 48/190 (25%), Gaps = 6/190 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ P ++ P PA P P + PP + P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
+++ + P P P P P P+A
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHN--VPLVDPN--AYMQPQVPVQMGTPLQQQQQPMA 117
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
P P P + P + PPP + L PPP + P P +
Sbjct: 118 APAYGQPSAAMGQNMRPMNQ--LYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELS 175
Query: 250 NPSSPESSSS 259
N S S+
Sbjct: 176 NASPDYIRST 185
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 85.6 bits (211), Expect = 2e-17
Identities = 32/206 (15%), Positives = 53/206 (25%), Gaps = 7/206 (3%)
Query: 1 MSAPSPG---PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
MS P+ P PP P + + PP + P
Sbjct: 1 MSHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQD---PAAAGMSYGQMGMPPQGAVPSMG 57
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+ ++ + P P A P + + P
Sbjct: 58 QQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMA 117
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
+ P++ P N P + + LPPP PP P S+
Sbjct: 118 APAYGQPSAAMGQNMRPM-NQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 176
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P AVP ++ ++ P
Sbjct: 177 ASPDYIRSTLNAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 85.6 bits (211), Expect = 2e-17
Identities = 23/185 (12%), Positives = 35/185 (18%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S + P + PP S P P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P + + + P P P+ + P
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
P A N P + P PP I + P S + +
Sbjct: 122 GQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDY 181
Query: 267 TAGTV 271
T+
Sbjct: 182 IRSTL 186
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 7e-17
Identities = 26/188 (13%), Positives = 48/188 (25%), Gaps = 5/188 (2%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P + + P PP P + P P + +P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQD-PAAAGMSYGQMGMPPQ--GAVPSMGQQQFLTPAQ 66
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP--KRSPPSVPPQNPPPPP 175
+ + +D ++ P +P + + P P + P ++ P P P
Sbjct: 67 EQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
+ + PPP P P+ P S ++
Sbjct: 127 AMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTL 186
Query: 236 IPVPSTEN 243
VP +
Sbjct: 187 NAVPKNSS 194
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 6e-15
Identities = 32/210 (15%), Positives = 46/210 (21%), Gaps = 5/210 (2%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS- 60
+A PA P + P S ++ A+
Sbjct: 19 NATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATT 78
Query: 61 --NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
N + P P P + + P P R
Sbjct: 79 SMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQL 138
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS--VPPQNPPPPPS 176
P P +D PP PP + P S P + P+N
Sbjct: 139 YPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVPKNSSLLKK 198
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
S P P ++ PPP
Sbjct: 199 SKLPFGLVIRPYQHLYDDIDPPPLNEDGLI 228
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 15/153 (9%), Positives = 25/153 (16%), Gaps = 26/153 (16%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
S P N+ P P +PP P++ Q PP
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAA-------AGMSYGQMGMPPQG--- 51
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P + + P P
Sbjct: 52 ----------------AVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNA 95
Query: 240 STENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
+ + + G +
Sbjct: 96 YMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 6e-19
Identities = 79/415 (19%), Positives = 140/415 (33%), Gaps = 32/415 (7%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PS+ + + + + P S +
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFS 283
+ P + + S + + + + +++ GI
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 284 LIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNS 343
G+ W ++E N +P P S + K + + G+ + +
Sbjct: 269 KAGVDGWFKLLSQEEGEYFN----VPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 344 PQDPGGLGHSRSMFTYE--ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQLK 400
+R + +LG+G FG V E+ A+K LK
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLM---------VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 401 ----IGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHL 454
I E E +++ L L C + DR + +YV L +H+
Sbjct: 376 KDVVIQDDDVECT-MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
GR A V AA A GL +L II+RD+K N++LD+ +++DFG+
Sbjct: 434 QQVGRFKEPHA--VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 515 AKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
K + TT+ GT Y+APE + + D ++FGV+L E++ G+ P
Sbjct: 489 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISR-IHHRH 424
+LG+G FG V +K + AIK LK + E E ++S H
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPF 79
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L + L + +Y+ L +H+ + L A AA GL +LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILGLQFLHS 136
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
I++RD+K NILLD + +++DFG+ K + + T GT Y+APE
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 191
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
K D +SFGV+L E++ G+ P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
+LG+G FG V K G A+K LK + E E I+S +H
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPF 85
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L C + DR + ++V L FH+ R A AA L +LH+
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--RFYAAEIISALMFLHD 142
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K N+LLD+ +++DFG+ K + TT GT Y+APE
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQ 197
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV+L E++ G P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE-----REFKAEVEIISRI 420
+ + + LGEG + +VYKG VA+K++++ +G RE ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H ++V+L ++ L+++Y+ + L +L G ++ RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H +++HRD+K N+L++ E +++DFGLA+ V+ T Y P+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y++ D++ G + E+ TGR
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
++G G + V K R A++ +K + + E + + +H
Sbjct: 59 VIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQASNHPF 114
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L C ++ R + +YV L FH+ + + + + +A + L YLH
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 170
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
E II+RD+K N+LLD+ +++D+G+ K L TT GT Y+APE
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 225
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV++ E++ GR P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 56/246 (22%), Positives = 106/246 (43%), Gaps = 50/246 (20%)
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG 404
D + YE+L K +G+G FG V+K G++VA+K++ +
Sbjct: 6 DSVECPFCDEVSKYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLM--- 52
Query: 405 QGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRL--------LIYDYVPNNTLY 451
+ E+E A E++I+ + H ++V+L+ C + L++D+ ++ L
Sbjct: 53 ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LA 111
Query: 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
L + ++ GL Y+H + +I+HRD+K++N+L+ + +++D
Sbjct: 112 GLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167
Query: 512 FGLAKL----ALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLL 560
FGLA+ T RV+ T Y PE Y D++ G ++
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMA 220
Query: 561 ELITGR 566
E+ T
Sbjct: 221 EMWTRS 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 28/207 (13%), Positives = 56/207 (27%), Gaps = 43/207 (20%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
G ++ D R+VA+ + G + +E + +SRI +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ + L++ +++ +L P ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+ S + VS G LA M
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVLA-------------YPATMPDA-------N 180
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQP 574
+ D+ G L L+ R P+ +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGV 207
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 5/167 (2%)
Query: 404 GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLD 463
G R+ K V I R L S+ S + + + + L
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523
+ + A+G+ +L + IHRD+ + NILL ++ DFGLA+
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 524 HI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++ +MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 54/252 (21%), Positives = 91/252 (36%), Gaps = 55/252 (21%)
Query: 349 GLGHSRSMFTYE---ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
G+ + EL + Q + G +G+V G +G VAIK ++
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIK--RVFNTV 58
Query: 406 GEREFKA-------------EVEIISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTL 450
+ E+ +++ HH +++ L + + + +Y L
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-------L 111
Query: 451 YFHLHGEGRPVLDWATRVKIAAGAA---------------RGLAYLHEDCHPRIIHRDIK 495
L D A +V I GL LHE ++HRD+
Sbjct: 112 VTELMRT-----DLA-QV-IHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLH 161
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY-ASSGKLTEKSDVFS 554
NILL +N + + DF LA+ A+ + T V Y APE T+ D++S
Sbjct: 162 PGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWS 219
Query: 555 FGVVLLELITGR 566
G V+ E+ +
Sbjct: 220 AGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 50/244 (20%), Positives = 90/244 (36%), Gaps = 59/244 (24%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
++ LG G FG V + + + G+ A+K++ + +K E++I+ + H +++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63
Query: 427 SL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------------- 468
L Y D+ +N L +G
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 469 --KIAAGAA-------------------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFE 506
K+ R + ++H I HRDIK N+L++ +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 507 AQVSDFGLAKLAL--DANTH-ITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLEL 562
++ DFG AK + + + I +R Y APE + + T D++S G V EL
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 563 ITGR 566
I G+
Sbjct: 236 ILGK 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 58/297 (19%), Positives = 102/297 (34%), Gaps = 60/297 (20%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFT--YEELVKAT 366
P P + + P P GL ++ Y+ +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ-- 68
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRH 424
+LG G G V + + + A+K L+ + + EVE+ R H
Sbjct: 69 -------VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPH 116
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRVKI----------- 470
+V +V +Y+ + + E G + +I
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTER 161
Query: 471 -AAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDAN 522
A+ + + YLH I HRD+K N+L + +++DFG AK ++
Sbjct: 162 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 217
Query: 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
+TT T Y+APE K + D++S GV++ L+ G P ++ L
Sbjct: 218 NSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 375 LGEGGFGSVYKG---YLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLV 429
+G G +G VYK D ++ A+KQ++ G A E+ ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQ 84
Query: 430 GYCISD-DRRL-LIYDYVPNN-TLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYL 481
+S DR++ L++DY ++ H + L + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKL---ALDANTHITTRVMGTFG 534
H + ++HRD+K +NIL+ + ++D G A+L L + V+ TF
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 535 YMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE Y T+ D+++ G + EL+T
Sbjct: 201 YRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.8 bits (193), Expect = 4e-16
Identities = 50/311 (16%), Positives = 89/311 (28%), Gaps = 73/311 (23%)
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG-------- 403
+ + + T+ +GEG FG V++ D VAIK + I G
Sbjct: 6 SQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 404 GQGEREFKAEVEIISRIH---------HRHLVSLVGYCISDDRR----LLIYDYV----- 445
+ E E+ I + + L L +D+
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 446 ---------PNNTLYFH---------LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ L+ L + AT I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR- 182
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP--EYASSGK 545
HRD+ N+LL ++ K + + + G +Y S
Sbjct: 183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLSRL 231
Query: 546 LTEKSDVFSFGVVLLELITG------------RKPV-DASQPLGDESLVEWVNLIDAKIL 592
+ VF + +L TG +K + S V W++ + K+L
Sbjct: 232 ERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML 291
Query: 593 FKLVFLCQQNS 603
++ F + N+
Sbjct: 292 KQMTFKTKCNT 302
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 80.8 bits (198), Expect = 5e-16
Identities = 21/215 (9%), Positives = 38/215 (17%), Gaps = 3/215 (1%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
++ P +N +S S ++ ++SP
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVAT--ASETASPA 78
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
++ T+ A++ S + P+ P P +
Sbjct: 79 SNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAE 138
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP-PPPPSSSPPKNSPPAPI 188
P P + P S S
Sbjct: 139 ANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGH 198
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
V Q S S
Sbjct: 199 LVNEKASKEAKVQALSNTNSKAKDHASVGGEEFKA 233
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 76.2 bits (186), Expect = 2e-14
Identities = 17/194 (8%), Positives = 41/194 (21%), Gaps = 3/194 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+ S N + + S+ + + +
Sbjct: 29 NSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAATT--- 85
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
T+ + A+ P + + P++ P + + +
Sbjct: 86 ETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANKTEKE 145
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P N L P + E + SV + + +
Sbjct: 146 VQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVNEKAS 205
Query: 183 SPPAPIAVPPSNVP 196
A+ +N
Sbjct: 206 KEAKVQALSNTNSK 219
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 74.6 bits (182), Expect = 5e-14
Identities = 21/213 (9%), Positives = 49/213 (23%), Gaps = 10/213 (4%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P++S + + + + A+ T+SP +
Sbjct: 26 VPENSGANTELVSGESEHSTNEAD---KQNEGEHARENKLEKAEGVATASETASPASNEA 82
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
A++ + P ++ + TP + P + A +
Sbjct: 83 ATTETA--EAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQ-----GDESKP 135
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
+ E K P + P + + + + +A R
Sbjct: 136 AAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRR 195
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGN 247
+ N K + + G
Sbjct: 196 TGHLVNEKASKEAKVQALSNTNSKAKDHASVGG 228
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 6e-13
Identities = 17/208 (8%), Positives = 46/208 (22%), Gaps = 2/208 (0%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ + T+ P + S +++ +
Sbjct: 8 HGHHHQLENLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEG 67
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
+T + P+ + ++ E P + P
Sbjct: 68 VATASETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEAT 127
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ ++ P A V P + P + ++ P +
Sbjct: 128 NQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRG 187
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNG 264
V G+ N + + + + +
Sbjct: 188 SVVLASRRTGHLVNEKASKEAKVQALSN 215
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 69.2 bits (168), Expect = 2e-12
Identities = 22/206 (10%), Positives = 44/206 (21%), Gaps = 2/206 (0%)
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
+ P +S S + + + S + +
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASN 80
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
++T S S + PS P K + ++ P +
Sbjct: 81 EAATTETAE-AASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEA 139
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ K P P + + P ++ S S G
Sbjct: 140 NKTEKEVQPDV-PKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGH 198
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSN 262
V + S+ S +
Sbjct: 199 LVNEKASKEAKVQALSNTNSKAKDHA 224
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 61.9 bits (149), Expect = 4e-10
Identities = 17/172 (9%), Positives = 32/172 (18%), Gaps = 3/172 (1%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P ++ S N A S P +
Sbjct: 24 TAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAE---GVATASETASPASN 80
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
+ + K S P +T P + S + +
Sbjct: 81 EAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEAN 140
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIA 274
+ P + + + G+VV+A
Sbjct: 141 KTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 57/248 (22%), Positives = 92/248 (37%), Gaps = 40/248 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQ--LKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+GEG FG +++G L + ++VAIK + Q E++ + + V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR----TYKLLAGCTGIPNVYY 73
Query: 432 CISDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ +L+ D + P+ L G T A + +HE +
Sbjct: 74 FGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 490 IHRDIKSSNILLDNNFEAQ-----VSDFGLAKLALDANT--HITTR----VMGTFGYMAP 538
++RDIK N L+ V DFG+ K D T HI R + GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----A 182
Query: 539 EYAS----SGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-DAKIL 592
Y S G+ + + D+ + G V + + G P Q L + + I + K
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATNKQKYERIGEKKQS 239
Query: 593 FKLVFLCQ 600
L LC
Sbjct: 240 TPLRELCA 247
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 61/246 (24%), Positives = 97/246 (39%), Gaps = 38/246 (15%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG +Y G + G EVAIK + + E +I + + + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 434 SDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++ +++ + + P+ F+ T + +A + Y+H IH
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 492 RDIKSSNILL---DNNFEAQVSDFGLAKLALDANT--HITTR----VMGTFGYMAPEYAS 542
RD+K N L+ + DFGLAK DA T HI R + GT YAS
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT-----ARYAS 183
Query: 543 ----SGKLTEKS---DVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-DAKILFK 594
G E+S D+ S G VL+ G P Q L + + I + K+
Sbjct: 184 INTHLGI--EQSRRDDLESLGYVLMYFNLGSLPW---QGLKAATKRQKYERISEKKMSTP 238
Query: 595 LVFLCQ 600
+ LC+
Sbjct: 239 IEVLCK 244
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ + +T V+ T Y
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV-TRYY 192
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 42/228 (18%), Positives = 88/228 (38%), Gaps = 44/228 (19%)
Query: 375 LGEGGFGSVYKGY---------LPDGREVAIK------QLKIGGGQGEREFKA-EVEIIS 418
G +Y+ P ++ ++K +L +R K +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 419 RIHHRHLV---SLVGYCISDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+++ L+ + +G+ + D+ R L+ + + L L + VL + +++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVACR 167
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTR--- 528
L +LHE+ +H ++ + NI +D ++QV + +G A + H+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 529 ---VMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ +G G +GSV G +VAIK K+ R F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLS-----RPFQSEIFAKRAYRELL 75
Query: 416 IISRIHHRHLVSLVGYCISDDRRL------LIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
++ + H +++ L+ L+ ++ + L
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEEKIQY 130
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTR 528
+ +GL Y+H ++HRD+K N+ ++ + E ++ DFGLA+ A T + TR
Sbjct: 131 LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
Query: 529 VMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE S + D++S G ++ E++TG+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 50/261 (19%), Positives = 90/261 (34%), Gaps = 46/261 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKI---GGGQGEREFK-----AEVEIISRIHHRH 424
+G GGFG +Y + + A +K+ G E K A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 425 LVSLVG-----YCISDDRRLLIYDYV------PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+ +G + + Y ++ + +G +T +++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIR 159
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHI------ 525
L Y+HE+ +H DIK++N+LL QV +D+GL+ H
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 526 TTRVMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580
GT E+ S G L+ +SDV G +L + G+ P + +
Sbjct: 217 RKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271
Query: 581 VEWVNLI-DAKILFKLVFLCQ 600
NL+ +
Sbjct: 272 TAKTNLLDELPQSVLKWAPSG 292
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 44/205 (21%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LG G + V++ + + +V +K LK +++ K E++I+ + ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITL--AD 98
Query: 433 I----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---KIAAGAARGLAYLHEDC 485
I L++++V N + + D+ R +I + L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEIL----KALDYCHSM- 149
Query: 486 HPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
I+HRD+K N+++D + + ++ D+GLA+ + RV + + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDY 205
Query: 545 KLTEKS-DVFSFGVVLLELITGRKP 568
++ + S D++S G +L +I ++P
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 44/229 (19%), Positives = 86/229 (37%), Gaps = 58/229 (25%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIH-------- 421
LG G F +V+ + + VA+K ++ + +A E++++ R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 422 ---HRHLVSLVGY-----------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLD 463
H++ L+ + + + +L + + L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-------- 131
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ------VSDFGLAKL 517
+ +I+ GL Y+H C IIH DIK N+L++ + ++D G
Sbjct: 132 -YVK-QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG---N 184
Query: 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
A + H T + Y +PE +D++S ++ ELITG
Sbjct: 185 ACWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
+L+G+G FG V K Y + VAIK +K + EV ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
++V L + C+ + +L +YD + N L+ TR K A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLN---------LTR-KFA 163
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ--VSDFGLAKLALDANTHITTRV 529
L +L IIH D+K NILL N + + DFG + I +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYI 219
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
F Y +PE D++S G +L+E+ TG
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 24/124 (19%), Positives = 36/124 (29%), Gaps = 3/124 (2%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
S + + P P +S PP + P PP +P A +PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS---TPPPNSPPSPP 131
+ + P P +S P + PP++ P P P
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 132 SDPP 135
DP
Sbjct: 123 PDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 25/130 (19%), Positives = 36/130 (27%), Gaps = 3/130 (2%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
SS + P P S + AS + PP + P + PPP PA+
Sbjct: 3 SSHHHHH---HSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAG 59
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P + P T P +P + P + P
Sbjct: 60 NPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
Query: 158 PPKRSPPSVP 167
P+ P V
Sbjct: 120 VPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 26/140 (18%), Positives = 36/140 (25%), Gaps = 11/140 (7%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS-NPPTSSPPPSPPASSPPTISP 103
+ S P AS +S A+ +PP + P P+PP P
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN 60
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP S P+ P S P+ P P + PP
Sbjct: 61 PPD--------TVTGDSVLQR--ILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGR 110
Query: 164 PSVPPQNPPPPPSSSPPKNS 183
+ P P
Sbjct: 111 AVPGLYHHPVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 3e-12
Identities = 28/134 (20%), Positives = 43/134 (32%), Gaps = 3/134 (2%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ SS P S S + AS+ + PP + P + PPP + + P
Sbjct: 6 HHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTV 65
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
S I P + P T + P+ P P+ P + + P P
Sbjct: 66 TGDSVLQRILRGP--TGPGT-TSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 153 PSSVEPPKRSPPSV 166
P V + S
Sbjct: 123 PDPVRVEEVSRRIK 136
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 4e-12
Identities = 24/131 (18%), Positives = 37/131 (28%), Gaps = 5/131 (3%)
Query: 80 PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP--SDPPAN 137
+ +S P P+ S S+ PP + P PP P +PP
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 138 SPPPSNPPSNLPPP---PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
S L P +S+ P R P+ P P ++ VP +
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPD 124
Query: 195 VPPPPTQTPPT 205
+
Sbjct: 125 PVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 4e-11
Identities = 26/129 (20%), Positives = 35/129 (27%), Gaps = 7/129 (5%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
SS + P S+ S + AS PP P PPP P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDP---APPPPPAPAAG 59
Query: 126 SPPSPPSDPPANSPPPSNP-PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS-SPPKNS 183
+P P + + P+ + R P P + PP P
Sbjct: 60 NP--PDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYH 117
Query: 184 PPAPIAVPP 192
P P P
Sbjct: 118 HPVPEPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 27/132 (20%), Positives = 40/132 (30%), Gaps = 6/132 (4%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
S+ V + P AS +S A+ P + P + PP +P
Sbjct: 3 SSHHHHHHSSGLVPRGS---HMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAG 59
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP--PSNLPP 150
P + S + PT P S P P + PA++PP + P
Sbjct: 60 NPPDTVTGDSVLQRILRGPTG-PGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHH 118
Query: 151 PPPSSVEPPKRS 162
P P
Sbjct: 119 PVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 22/124 (17%), Positives = 32/124 (25%), Gaps = 2/124 (1%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP--PNSPPSPPSDPPANSPPPS 142
S + P P P+ P PP P A +PP +
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
++ P + + + P +P P A AVP P P
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPD 124
Query: 203 PPTP 206
P
Sbjct: 125 PVRV 128
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 1e-10
Identities = 21/127 (16%), Positives = 29/127 (22%), Gaps = 1/127 (0%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPPPSNPPSNLPPPPPSS 155
S P PS++ + PP P P+ PP P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
S + P P ++S P + PP P P P
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 216 NSSPNSP 222
Sbjct: 123 PDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 24/140 (17%), Positives = 37/140 (26%), Gaps = 11/140 (7%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S P S PS + + S+ + L PP P P P
Sbjct: 7 HHHHSSGLVPRGSHMVIPS--ASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
S + P + PA +P +P S PP + + +
Sbjct: 65 VTGDSVLQRILRGPTGPGTT---------SLAPAVRYGRQPGPEAPASAPPAAGRAVPGL 115
Query: 234 PGIPVPSTENTPGNGTNPSS 253
PVP + +
Sbjct: 116 YHHPVPEPDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 8e-10
Identities = 24/123 (19%), Positives = 29/123 (23%), Gaps = 2/123 (1%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
S + P P S S SD A PP P P PPP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD--PAPPPPPAPAAGN 60
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P +V + P + P P P + P
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
Query: 222 PPP 224
P P
Sbjct: 121 PEP 123
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 5e-08
Identities = 20/112 (17%), Positives = 27/112 (24%), Gaps = 2/112 (1%)
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP--PPPTQTPPTPAS 208
SS P+ S +P + S PP + P P P P T
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTG 67
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
+ P P S P P + + P P
Sbjct: 68 DSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 23/112 (20%), Positives = 31/112 (27%), Gaps = 8/112 (7%)
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ---NPPPPPSSSPPKNSPPAPIAVPPS 193
+S + S L P V P + PP P PPAP A P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 194 NVPPPPTQTPPTPASPI-----APRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
+ + P + P+ P P + P G VP
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPG 114
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 12/98 (12%), Positives = 21/98 (21%), Gaps = 1/98 (1%)
Query: 165 SVPPQNPPP-PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
S + P+ ++ P T P P P + +PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
T + P+ T +
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEA 100
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 19/102 (18%), Positives = 29/102 (28%), Gaps = 2/102 (1%)
Query: 161 RSPPSVP-PQNPPPP-PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
S P P S + + + + PP T P P P AP N
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
+R+ P P ++ PE+ +S
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASA 104
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 45/230 (19%), Positives = 80/230 (34%), Gaps = 46/230 (20%)
Query: 374 LLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFK-----AEVEIISRIHH 422
+G+GGFG +Y + +K G E K A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 423 RHLVSLVG-----YCISDDRRLLIYDYV------PNNTLYFHLHGEGRPVLDWATRVKIA 471
+ +G D+ Y ++ + + + + T ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK---RFSRKTVLQLS 158
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANT--HITT 527
L Y+HE +H DIK+SN+LL+ QV D+GLA
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 528 R----VMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
GT E+ S +G + + D+ G +++ +TG P
Sbjct: 216 DPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 40/248 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG + G L VAIK + + E ++ + V Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 434 SDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ ++ + + P+ F L T + IA + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 492 RDIKSSNILL---DNNFEAQV--SDFGLAKLALDANT--HITTR----VMGTFGYMAPEY 540
RD+K N L+ N + + DF LAK +D T HI R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 541 AS----SGKLTEKS---DVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-DAKIL 592
S GK E+S D+ + G + + + G P Q L ++L E I D K
Sbjct: 184 MSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPW---QGLKADTLKERYQKIGDTKRA 238
Query: 593 FKLVFLCQ 600
+ LC+
Sbjct: 239 TPIEVLCE 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ + +G G G V Y R VAIK K+ R F+ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLS-----RPFQNQTHAKRAYRELV 113
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLIYD-YVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
++ ++H++++SL+ D Y+ + +L + LD +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + +T V+ T
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRY 228
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE E D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
+GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ A T ++ TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE + + T+ D++S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 61/230 (26%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-------REFKAEVEIISRI 420
+ + + +GEG +G V Y + VAIK KI + + RE K I+ R
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIK----ILLRF 82
Query: 421 HHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRVKIAAG 473
H +++ + + + +Y + L+ ++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVY-------IVQDLMETDLY-----------KL-LKTQ 123
Query: 474 A-------------ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-- 518
RGL Y+H ++HRD+K SN+LL+ + ++ DFGLA++A
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 519 -LDANTHITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
D +T V T Y APE +S T+ D++S G +L E+++ R
Sbjct: 181 DHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 24/137 (17%), Positives = 37/137 (27%), Gaps = 2/137 (1%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+ S+ SS + + + P+ P P SP + P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 111 PTR--SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P PP + P P +P + P P SS E K
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 169 QNPPPPPSSSPPKNSPP 185
P PS + +
Sbjct: 122 LKVPAHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 27/137 (19%), Positives = 39/137 (28%), Gaps = 3/137 (2%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
+ S PT + P+ +P + S S+P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
PP SSP P +S P T + + +P +SP +P S PP
Sbjct: 66 MGPPFSVISSP---MGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVL 122
Query: 148 LPPPPPSSVEPPKRSPP 164
P PS
Sbjct: 123 KVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 28/138 (20%), Positives = 34/138 (24%), Gaps = 3/138 (2%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ V + PT A+ S P P P SS
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P PP SP P S P +P S P NP S+ P
Sbjct: 62 PINGMGPPF---SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 158 PPKRSPPSVPPQNPPPPP 175
P+ P N
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 22/135 (16%), Positives = 32/135 (23%), Gaps = 1/135 (0%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+ + + S + + P S P P + SS
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
PP S P + S P +P SP P S N
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTG-SPQLSSPMNPVSSSEDIKPPLGLNGVLKV 124
Query: 131 PSDPPANSPPPSNPP 145
P+ P N +
Sbjct: 125 PAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 23/132 (17%), Positives = 32/132 (24%)
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
+ +S SP P P SP S S P
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
PP + P ++ P ++ SP P NP P + VP
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 193 SNVPPPPTQTPP 204
+ T
Sbjct: 127 HPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 24/139 (17%), Positives = 40/139 (28%), Gaps = 4/139 (2%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSS--PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
++ + +SS P ++P + P S T+S
Sbjct: 1 MAHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLS 60
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P PP P + P +P SP S+P + P ++PP
Sbjct: 61 SPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMN--PVSSSEDIKPPLGL 118
Query: 163 PPSVPPQNPPPPPSSSPPK 181
+ P +S K
Sbjct: 119 NGVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 4e-11
Identities = 29/142 (20%), Positives = 41/142 (28%), Gaps = 7/142 (4%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP--PA 70
+ S N +SP P+ P P +P SP
Sbjct: 3 HHHHHHVDDDDKMFSTQV---NSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTL 59
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
SSP PP S + P S + PT+ +P SP P S+ PP
Sbjct: 60 SSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTG--SPQLSSPMNPVSSSEDIKPPLG 117
Query: 131 PSDPPANSPPPSNPPSNLPPPP 152
+ PS ++
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 21/138 (15%), Positives = 35/138 (25%), Gaps = 2/138 (1%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ ++ +S P ++P P P I P + +P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLG--PGIGSPGQLHSPISTL 59
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + PP S S P P + S P + P S S
Sbjct: 60 SSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLN 119
Query: 175 PSSSPPKNSPPAPIAVPP 192
P + +
Sbjct: 120 GVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 23/131 (17%), Positives = 31/131 (23%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ +SS P +P S P P S T S P +
Sbjct: 9 VDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGP 68
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
SSP + P T SP S P + + P P
Sbjct: 69 PFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHP 128
Query: 121 TPPPNSPPSPP 131
+ S
Sbjct: 129 SGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 19/128 (14%), Positives = 32/128 (25%), Gaps = 1/128 (0%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
S S P+ +P P P SP + P + P + + PP
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPF 70
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
S + P++ S +P P N P +
Sbjct: 71 SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSG 130
Query: 221 SPPPPSTK 228
+ +
Sbjct: 131 NMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 24/142 (16%), Positives = 33/142 (23%), Gaps = 4/142 (2%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A + S+ S P +P S P P P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P N PP S + P P P S+ P+ S P ++ PP
Sbjct: 62 PINGMG----PPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLG 117
Query: 201 QTPPTPASPIAPRPSNSSPNSP 222
S
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 17/133 (12%), Positives = 34/133 (25%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
+ NS + P+ + + P +P P + P + S
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
PP S P + P+ + +P +P++ P
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVP 125
Query: 230 LSPPPGIPVPSTE 242
P + +
Sbjct: 126 AHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 24/136 (17%), Positives = 38/136 (27%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ + P+ S+ P P Q P + S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P N P +V S + P P TP + S P S++ + PP G+
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 240 STENTPGNGTNPSSPE 255
+G S +
Sbjct: 122 LKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 22/137 (16%), Positives = 36/137 (26%), Gaps = 5/137 (3%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSP--PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
+ S SS P + PS P+ P P L P + P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIG-SPGQLHSPISTLSSPIN 64
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
P + P P S +P + + P P + + I P +
Sbjct: 65 GMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPM--NPVSSSEDIKPPLGLNGVL 122
Query: 221 SPPPPSTKRLSPPPGIP 237
P + ++
Sbjct: 123 KVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 20/130 (15%), Positives = 31/130 (23%), Gaps = 1/130 (0%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-SSPPKNSPPAPIAVPPSNVP 196
+ S P R + P +P P SP + P P N
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPES 256
PP +P P + + S + SP + P +
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 257 SSSPSNNGIG 266
S +
Sbjct: 127 HPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 21/99 (21%), Positives = 35/99 (35%)
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
V + + SP ++ ++ P +P +P + SSP +
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P +S P G S TP G + SP+ SS +
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMN 104
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 46/216 (21%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR------ 423
++G+G FG V K Y + VA+K ++ +R + E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 424 HLVSLVGY-------CISDDRRLL---IYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAA 472
+++ ++ C++ + LL +Y+ + N F L R K A
Sbjct: 160 NVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLP---------LVR-KFAH 207
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ--VSDFGLAKLALDANTHITTRVM 530
+ L LH+ RIIH D+K NILL + V DFG + + + T +
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ 261
Query: 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
F Y APE + D++S G +L EL+TG
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 72/242 (29%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ F ++LLGEG +G V P G VAIK KI F E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KI------EPFDKPLFALRTLREIK 61
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRV 468
I+ H +++++ D +Y + LH RV
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVY-------IIQELMQTDLH-----------RV 103
Query: 469 KIAAGAA-------------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
I+ R + LH +IHRD+K SN+L+++N + +V DFGLA
Sbjct: 104 -ISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 516 KLALDANTHITTRVMGTFGYM----------APEY-ASSGKLTEKSDVFSFGVVLLELIT 564
+ +D + + G M APE +S K + DV+S G +L EL
Sbjct: 160 R-IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 565 GR 566
R
Sbjct: 219 RR 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 58/242 (23%), Positives = 90/242 (37%), Gaps = 82/242 (33%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
LGEG FG V + GR VA+K +K +R +A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
V ++ + CI + LL YD++ N L F L R K+A
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLD---------HIR-KMA 124
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS-------------------DF 512
+ + +LH ++ H D+K NIL + + DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 513 GLAKLALDANTHIT---TRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELI 563
G A D H T TR Y APE + ++ DV+S G +L+E
Sbjct: 182 GSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEYY 228
Query: 564 TG 565
G
Sbjct: 229 LG 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 48/231 (20%), Positives = 91/231 (39%), Gaps = 54/231 (23%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA-----EVEIISRIHH 422
+ D LG GG G V+ + VAIK++ + E++II R+ H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDH 67
Query: 423 RHLVSL--VGYCISDDRRLLIYDYVPNNTLYF-------HLHGEGRPVLDWATRVKIAAG 473
++V + + + N++Y L V + G
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-----------NV-LEQG 115
Query: 474 AA-------------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLA- 518
RGL Y+H ++HRD+K +N+ ++ + ++ DFGLA++
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 519 --LDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
H++ ++ T Y +P S T+ D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 44/230 (19%), Positives = 79/230 (34%), Gaps = 72/230 (31%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LG G G V + + + A+K L+ + + EVE+ R H+V +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD-- 78
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT------RV----------KIAAGAAR 476
+Y+ + + V++ R+ + A+ +
Sbjct: 79 --------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 477 ----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDANTHITTRV 529
+ YLH I HRD+K N+L + +++DFG AK
Sbjct: 125 SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ET 170
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
G Y + D++S GV++ L+ G P ++ L
Sbjct: 171 TGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 5e-12
Identities = 46/336 (13%), Positives = 99/336 (29%), Gaps = 90/336 (26%)
Query: 287 LVVWCLRRRKKEV------SGLNGVY------IMPSPLGSSSTTDSSYIKTQSSAPLIGS 334
+ W L +++E+ L Y I S T YI+ + L
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MYIEQRD--RLYND 122
Query: 335 GP--GSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLL---GEGGFGSVYKGYLP 389
V+ Q Y +L +A + G G G K ++
Sbjct: 123 NQVFAKYNVSRLQ------------PYLKLRQALLELRPAKNVLIDGVLGSG---KTWV- 166
Query: 390 DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNT 449
A+ +K + ++ +I ++ + C S + L +
Sbjct: 167 -----ALDVC--------LSYKVQCKMDFKI---FWLN-LKNCNSPETVLEML-----QK 204
Query: 450 LYFHLHGEGRPVLDWATRVKIAAGAARG--LAYLHEDCHPR--IIHRDIKSSNILLDNNF 505
L + + D ++ +K+ + + L + ++ +++++ N F
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF 262
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSF--GVVLLELI 563
+ K+ L +TTR +++ + L S + LL
Sbjct: 263 -----NLS-CKI-L-----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 564 TGRK----PVDASQ--PL-----GDESLVEWVNLID 588
+ P + P ES+ + + D
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATWD 345
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 86/246 (34%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRI-----HHRH 424
+G+G FG V + + + A+K ++ ++ ++ E +I+ +I ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 425 LVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+V G C+ + L +Y+ + NN FH+ +
Sbjct: 98 IVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIE---------DIK-LYCIE 145
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS----------------------- 510
+ L YL + + H D+K NILLD+ + +
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 511 --DFGLAKLALDANTH---ITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVL 559
DFG A ++ H I TR Y APE + SD++SFG VL
Sbjct: 203 LIDFGCA--TFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVL 249
Query: 560 LELITG 565
EL TG
Sbjct: 250 AELYTG 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 53/262 (20%), Positives = 90/262 (34%), Gaps = 82/262 (31%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
D + ++L+G G +G VY Y + VAIK K+ R F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KV-----NRMFEDLIDCKRILREIT 77
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRV 468
I++R+ +++ L I DD +Y + L ++
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELY-------IVLEIADSDLK-----------KL 119
Query: 469 KIAAGAA--------------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
G ++HE IIHRD+K +N LL+ + +V DFGL
Sbjct: 120 -FKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 515 A-KLALDANTHITTRVMGTFGYMAPEYASSGKLTE--------------------KS-DV 552
A + + +T+I + +LT KS D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 553 FSFGVVLLELITGRKPVDASQP 574
+S G + EL+ +
Sbjct: 236 WSTGCIFAELLNMLQSHINDPT 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 82/242 (33%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
LGEG FG V + +VA+K ++ + +A E+ ++ +I +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENK 81
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
V + + CI+ + LL ++++ NN + L R +A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLP---------HVR-HMA 129
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ-------------------VSDF 512
L +LHE ++ H D+K NIL N+ V+DF
Sbjct: 130 YQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 513 GLAKLALDANTH---ITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELI 563
G A D H + TR Y PE + + DV+S G +L E
Sbjct: 187 GSA--TFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYY 233
Query: 564 TG 565
G
Sbjct: 234 RG 235
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 24/157 (15%), Positives = 40/157 (25%), Gaps = 4/157 (2%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
V + + S N ++S + P P + P S
Sbjct: 5 EAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHG 64
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
++ + P+R+ P +SP S +S S+P S P +E
Sbjct: 65 SLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPAS----IPHLILELL 120
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
K P Q N +
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMC 157
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 18/154 (11%), Positives = 34/154 (22%), Gaps = 12/154 (7%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP--PTSSSPPASSPPTSSP 78
+ I P + SK + PP P +SP + + P
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS----------PP 128
P + + P + P + +S+P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P + + S+ +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKM 159
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 21/142 (14%), Positives = 36/142 (25%), Gaps = 7/142 (4%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
P SS + + P + PP P V+ P + + PP T
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQT 71
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP-------VSNPPTRSPPP 117
P+ + + P P ++ P S S S + P P
Sbjct: 72 YGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQA 131
Query: 118 PSSTPPPNSPPSPPSDPPANSP 139
+ ++
Sbjct: 132 KIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 23/150 (15%), Positives = 32/150 (21%), Gaps = 4/150 (2%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS---TPPPNSPPSPPSDPPANS 138
+ PS S + P P + P + P + PP S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 139 PPPSNPPSNLPPPPPSSVEP-PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ P S P P S P + S P I P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P A + + S
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 16/150 (10%), Positives = 27/150 (18%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+ S S+ + S PP P + P + PP S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
+ S + + P S+ P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 187 PIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
V + +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 27/181 (14%), Positives = 41/181 (22%), Gaps = 7/181 (3%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ S + S P N PP+ + + PP
Sbjct: 3 KLEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPP 62
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL-- 230
P S P P T +P + +S + P L
Sbjct: 63 HGSLQGYQTY-GHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLK 121
Query: 231 --SPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAV--AVGIIAFSLIG 286
P + N S E S+ T+ V A I F +
Sbjct: 122 CEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELK 181
Query: 287 L 287
+
Sbjct: 182 V 182
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 24/133 (18%), Positives = 35/133 (26%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S+ +A+ P + PPT P P S PP S + P +
Sbjct: 21 SSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAI 80
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P SSP + + +S P S P + P +
Sbjct: 81 KSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQE 140
Query: 122 PPPNSPPSPPSDP 134
S S
Sbjct: 141 QANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 21/153 (13%), Positives = 35/153 (22%), Gaps = 15/153 (9%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD---PPANSPPPSNPPSN 147
+ P + ++ S P N PP+D P + P S
Sbjct: 5 EAMSQVIQAM--PSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMP- 61
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT----- 202
P + P P P +SSP + + ++ P
Sbjct: 62 -PHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 203 ---PPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P P + K +
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 46/226 (20%), Positives = 84/226 (37%), Gaps = 50/226 (22%)
Query: 316 STTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLL 375
S+ +++ + +S + + SM + D + ++L+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 376 GEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVEIISRIHHRHL 425
G G +G V + Y + R VAIK KI R F+ E+ I++R++H H+
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIK--KIL-----RVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 426 VSLVGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA-------- 475
V ++ I D +Y + + D +
Sbjct: 115 VKVLDIVIPKDVEKFDELY-------VVLEI-------ADSDFKKLFRTPVYLTELHIKT 160
Query: 476 ------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
G+ Y+H I+HRD+K +N L++ + +V DFGLA
Sbjct: 161 LLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 62.3 bits (150), Expect = 3e-10
Identities = 23/171 (13%), Positives = 43/171 (25%), Gaps = 4/171 (2%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+++ A++ T + S A+ P +S P V P P
Sbjct: 7 AAAAAAAAAAAATGTEAGPGTAGGSENGSE-VAAQPAGLSGPAEVGPGAVGERTPRKKEP 65
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P SPP ++PP ++ P + P P + + +
Sbjct: 66 PRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEY---RE 122
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
+ + + P P +P S
Sbjct: 123 MDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSG 173
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 61.5 bits (148), Expect = 6e-10
Identities = 27/163 (16%), Positives = 44/163 (26%), Gaps = 7/163 (4%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
A+ +++ + S + S P + P P + PP
Sbjct: 7 AAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPP 66
Query: 118 PSSTPPPNSPP---SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP----PQN 170
+S P + P + P P P + P P +R V ++
Sbjct: 67 RASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDES 126
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
A +PPPP Q PP + P
Sbjct: 127 LANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPE 169
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 7e-10
Identities = 24/176 (13%), Positives = 42/176 (23%), Gaps = 3/176 (1%)
Query: 39 SPPPPPVSKPPTTSPPPSPPAS--NPPTSSSPPASSP-PTSSPPPASNPPTSSPPPSPPA 95
S + + A S + + P PA P + +P
Sbjct: 3 SGKKAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRK 62
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
PP SPP ++ PP + P T P S +
Sbjct: 63 KEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYRE 122
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
++ + + + + + P P P P+ A
Sbjct: 123 MDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAA 178
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 59.2 bits (142), Expect = 3e-09
Identities = 27/173 (15%), Positives = 43/173 (24%), Gaps = 11/173 (6%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKP----PTTSPPPSPPASNP 62
AA +++ N + + P +S P P +P P
Sbjct: 6 KAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEP 65
Query: 63 PTSSSPPASSPPTSSPPPASNP--PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P +S P + P S P + P S P + P R
Sbjct: 66 PRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGI-----AETPEGRRTSRRKRAKVEY 120
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S + D + + PP + P P+ P
Sbjct: 121 REMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSG 173
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 1e-08
Identities = 32/205 (15%), Positives = 52/205 (25%), Gaps = 13/205 (6%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ T + P + + + P S P P + P EPP+ SPP
Sbjct: 15 AAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPG-- 72
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR---PSNSSPNSPPP 224
PP S+ P+ P V P + P T TP R
Sbjct: 73 --GLAEPPGSAGPQAGPT----VVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDES 126
Query: 225 PSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG--TAGTVVIAVAVGIIAF 282
+ + + P P++ N +G A +
Sbjct: 127 LANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPHD 186
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYI 307
+ C V++
Sbjct: 187 RMTSQEAACFPDIISGPQQTQKVFL 211
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 5e-08
Identities = 19/161 (11%), Positives = 37/161 (22%), Gaps = 5/161 (3%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
++ A+ T + + P ++ + + + P S P +
Sbjct: 7 AAAAAAAAAAAATGTE--AGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKE 64
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
PP SPP P + S + P + V
Sbjct: 65 PPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRA---KVEYR 121
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ R + + PP + P
Sbjct: 122 EMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEE 162
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 20/131 (15%), Positives = 35/131 (26%), Gaps = 7/131 (5%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPP-------PPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+P +SPP ++ PP + P P + P ++ P + +
Sbjct: 58 RTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAK 117
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S + + S + P PP +PP P
Sbjct: 118 VEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGA 177
Query: 117 PPSSTPPPNSP 127
S P +
Sbjct: 178 AFQSRLPHDRM 188
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ + YLH ++HRD+K SNILL+ +V+DFGL++ ++ +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 536 MAPEYASSGKLTE--------------------KS-DVFSFGVVLLELITGR 566
LT+ K D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.9 bits (146), Expect = 5e-10
Identities = 29/174 (16%), Positives = 45/174 (25%), Gaps = 4/174 (2%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS----NPPTSSSPPASSPPTSSPPPASN 83
P PP PPK + P ++P +P + S PP + + PP S
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
SSP P SP + + PP T +
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
P+ P + + + A +P +P
Sbjct: 135 ARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.9 bits (146), Expect = 6e-10
Identities = 30/176 (17%), Positives = 48/176 (27%), Gaps = 3/176 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P A +P + P +P A + S + P ++P PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASA---TSGSRKRARPPAAPGRDQARPPAR 67
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S SS P +P P P S P + PP S+ + S +
Sbjct: 68 RRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCL 127
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPP 224
Q + + + + P +P R + P
Sbjct: 128 QRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.9 bits (146), Expect = 7e-10
Identities = 29/177 (16%), Positives = 42/177 (23%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
+ P PP ++ P PSP +S + S + PP A + PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
P P P S P+ P S + S L +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
E R + + P P P + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLP 187
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.4 bits (142), Expect = 2e-09
Identities = 24/173 (13%), Positives = 37/173 (21%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP +PP + S + P+ S + PP PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
S PS P A P P + P + S
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
A + ++ P +P + + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.0 bits (141), Expect = 2e-09
Identities = 28/180 (15%), Positives = 42/180 (23%), Gaps = 3/180 (1%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
P PP PP ++ P P P S + PPA+ + PPA
Sbjct: 13 RRPGPPRIAPPKLACRTP---SPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRR 69
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
S S+P T P P SP + + S
Sbjct: 70 LRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
++ S + P + P + +P
Sbjct: 130 ARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.0 bits (141), Expect = 2e-09
Identities = 21/179 (11%), Positives = 37/179 (20%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ P P P +P + P + A+S P + P P
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
++ S P P S +P + P + + +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
+ + S P+ P P P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.0 bits (141), Expect = 3e-09
Identities = 23/174 (13%), Positives = 35/174 (20%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
P PP T SP + +S + P ++P P +
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ S P P SP P + P + S S L
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
+ P + P+ P
Sbjct: 135 ARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.4 bits (137), Expect = 7e-09
Identities = 24/169 (14%), Positives = 40/169 (23%), Gaps = 7/169 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPT-------TSPPP 55
+P A + SP P P + + P ++PP
Sbjct: 19 RIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVS 78
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
SP P + P+ PA+ P + S R
Sbjct: 79 SPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVR 138
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
+S +P ++ P P+ + P P
Sbjct: 139 ALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLP 187
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 56.7 bits (135), Expect = 2e-08
Identities = 18/179 (10%), Positives = 33/179 (18%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
PP +P P + S P +P D
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
S PS+ E P P Q ++ + + Q
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
+ + +++ P + + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 55.5 bits (132), Expect = 3e-08
Identities = 22/171 (12%), Positives = 31/171 (18%), Gaps = 2/171 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P P + P P P ++ + PP PP
Sbjct: 15 PGPPRIAPPKLACRTPSPARPAL--RAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S P++ P S P S + S +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
S A P +R P P
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 47.8 bits (112), Expect = 8e-06
Identities = 17/151 (11%), Positives = 27/151 (17%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
AP+ + + PP PP P + P P
Sbjct: 38 RAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQK 97
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S+ P +S + + + S P +
Sbjct: 98 IKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEG 157
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P L P
Sbjct: 158 RPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 41.3 bits (95), Expect = 9e-04
Identities = 20/129 (15%), Positives = 28/129 (21%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P + P P S S + PP + + PPA + S
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
TP P P P P S P +E
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 255 ESSSSPSNN 263
+ +
Sbjct: 135 ARVRALKAS 143
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 19/93 (20%), Positives = 27/93 (29%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P P P + P T + P + PT P P N +P P PA
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
T++ R ++ P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 20/110 (18%), Positives = 27/110 (24%), Gaps = 7/110 (6%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
+ P SP ++ P T +PP PT P P P P N
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPS-------NPPSNLPPPPPS 154
+ + PPP+ P P P
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEG 112
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 15/94 (15%), Positives = 22/94 (23%), Gaps = 1/94 (1%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
+P + P P T + P PP + P P NP P
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 94 -PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
++ + PPP
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/110 (19%), Positives = 34/110 (30%), Gaps = 5/110 (4%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P P ++ +N ++P PP + PT P P + PA T +
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVS-----NPPTRSPPPPSSTP 122
A+ + + + PPP + P R P P
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 25/112 (22%), Positives = 35/112 (31%), Gaps = 6/112 (5%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP-PTISPPPPVSNPPTRSPPPPSST 121
PTS P + T + P T +PP A + P NP P ++T
Sbjct: 5 PTSPGTPGVAAATQAANGG--PATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV---EPPKRSPPSVPPQN 170
+ PPP ++V E P+R P QN
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 19/115 (16%), Positives = 32/115 (27%), Gaps = 2/115 (1%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P A + P + A+ + P +P + + P P P + P P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALG--AAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+ + A V PP V + P P+ +N
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 16/113 (14%), Positives = 27/113 (23%), Gaps = 5/113 (4%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P P S + +P P + P P + P + PP +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST-----PPPNSPPSPPSDPP 135
+ ++ PPP+ P P+ P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 18/114 (15%), Positives = 30/114 (26%), Gaps = 1/114 (0%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
P +P + P ++ +N +P PP+ P P P + +P P P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ PP + P P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFE-QPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 16/93 (17%), Positives = 28/93 (30%), Gaps = 2/93 (2%)
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV--PPQNPPPPP 175
P++ P +P + AN P + P L P +P K P PP+
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ + + + + P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 18/111 (16%), Positives = 29/111 (26%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
+P P + +N +P PP + P P +K P PP P N
Sbjct: 4 APTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATV 63
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
++ + P P ++ P P
Sbjct: 64 AAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 20/107 (18%), Positives = 29/107 (27%), Gaps = 16/107 (14%)
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
P+ P+ P + +N P P+ P P P + PKN P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAP------PALGAAPTGDPKPKKNKKPKNPTP-- 53
Query: 188 IAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P P A R + + + PPP
Sbjct: 54 --------PRPAGDNATVAAGHATLREHLRDIKAENTDANFYVCPPP 92
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 16/81 (19%), Positives = 28/81 (34%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A + ++ PP + PT P P + PK+ PP P T + + +
Sbjct: 14 AAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAAGHATLREH 73
Query: 62 PPTSSSPPASSPPTSSPPPAS 82
+ + PPP
Sbjct: 74 LRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 15/95 (15%), Positives = 22/95 (23%)
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+P P S P + A P PP P + +PP P+
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 230 LSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNG 264
+ G N + P
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 17/105 (16%), Positives = 25/105 (23%), Gaps = 6/105 (5%)
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
DP A P P ++ P +PP++ P K P P
Sbjct: 1 DPAA--PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNS--PPPPSTK--RLSPP 233
N + + PPP + P
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQP 103
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 13/79 (16%), Positives = 24/79 (30%)
Query: 157 EPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
+P + P P ++ P P + P+ P P P +P P N
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 217 SSPNSPPPPSTKRLSPPPG 235
++ + + L
Sbjct: 61 ATVAAGHATLREHLRDIKA 79
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 15/96 (15%), Positives = 27/96 (28%)
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
++P P A + P T PP + P P P+ R +
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
+ + + + ++ T TVV
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVV 98
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 25/160 (15%), Positives = 39/160 (24%), Gaps = 8/160 (5%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
N S P T + + + + P V + + P +
Sbjct: 10 RKKVMGNRRSDEPAK----TKKGLSSILDAARWNRGEPQVPDF---RHLKAEVDAEKPGA 62
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ S P +P S S + P P P P
Sbjct: 63 TDRKGGVGMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQG-PMSL 121
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
+PP + S P + P S +E PP
Sbjct: 122 ESLAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 27/158 (17%), Positives = 43/158 (27%), Gaps = 6/158 (3%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
K +P T S + P A P +
Sbjct: 10 RKKVMGNRRSDEPAKTKKGLSSIL--DAARWNRGEPQVPDFRHLKAE-VDAEKPGATDRK 66
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
S + P + P + P S SP +P A++P S P S
Sbjct: 67 GGVGMPSRDRNIGAPGQDT---PGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLES 123
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ PP+ + ++P P P ++ PP
Sbjct: 124 LAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 22/163 (13%), Positives = 35/163 (21%), Gaps = 11/163 (6%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP---------PPPSSTPPPNSPPSPP 131
N + P + S + P P +T P
Sbjct: 14 MGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPS 73
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP--PPSSSPPKNSPPAPIA 189
D +P P +L P S + + + + P P S
Sbjct: 74 RDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEG 133
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ P P + P PP + L
Sbjct: 134 AETESPEPGDEGEPGRSGLELEPEEPPGWRELVPPDTLHSLPK 176
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 23/146 (15%), Positives = 32/146 (21%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
SS N P + P + PS +
Sbjct: 23 AKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAPG 82
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P S S P + P SSP ++ P + + +P P
Sbjct: 83 QDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEPG 142
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPP 151
P P L PP
Sbjct: 143 DEGEPGRSGLELEPEEPPGWRELVPP 168
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 26/152 (17%), Positives = 34/152 (22%), Gaps = 12/152 (7%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
R P+ T S + P + E P + +
Sbjct: 17 RRSDEPAKTKKGLSSILDAARWNRGEPQVPDFR-------HLKAEVDAEKPGATDRKGGV 69
Query: 173 PPPSSSPPKNSPP--APIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN---SPPPPST 227
PS +P P P + P A S P S PP +
Sbjct: 70 GMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPES 129
Query: 228 KRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
P P E PG PE
Sbjct: 130 TDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG +Y G + EVAIK + + E +I + + V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 434 SDDR-RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ +L+ D + + L + R L T + +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLLGPS-LEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 493 DIKSSNILLDNNFEAQ---VSDFGLAKLALDANT--HITTR----VMGTFGYMAPEYASS 543
DIK N L+ A + DFGLAK D +T HI R + GT Y A
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186
Query: 544 GK-LTEKSDVFSFGVVLLELITGRKP 568
G + + D+ S G VL+ + G P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 27/187 (14%), Positives = 51/187 (27%), Gaps = 13/187 (6%)
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+ S+PP + + P+ PP + N ++ + P A+
Sbjct: 293 LKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIAS 352
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ + + S EP + S P +S S
Sbjct: 353 VGTLAKQKAPVGNDASFSKEP---VISASNFLGRSSGSSRRPAVSS---------SRDVM 400
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESS 257
P + P+ P S P S+ S P S ++ S+ +
Sbjct: 401 PIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPK-HSSSARHSSNVKNYESALKGI 459
Query: 258 SSPSNNG 264
+ +G
Sbjct: 460 EGLNFDG 466
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 32/153 (20%), Positives = 39/153 (25%), Gaps = 2/153 (1%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
VS + PP + P PA P +P + P P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
S +P + T S + PP PP PP P P
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRP 197
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
P P P P PPP PP
Sbjct: 198 PMGP--PMGIPPGRGTPMGMPPPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 25/151 (16%), Positives = 34/151 (22%), Gaps = 2/151 (1%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S + P + P P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ T + A+ + + P+ PP PP PP P
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRP 197
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
P P PP P PP + PPPP
Sbjct: 198 P--MGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 28/147 (19%), Positives = 38/147 (25%), Gaps = 3/147 (2%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP---ASSPPTISPPPP 106
T P P + A+ P P P P P A + P
Sbjct: 80 MTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQ 139
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
P ++ + + PP PPP + PP P +
Sbjct: 140 QVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPM 199
Query: 167 PPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P PP +P PP PP
Sbjct: 200 GPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 24/144 (16%), Positives = 34/144 (23%)
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
A P + P P ++ P P
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQ 140
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P + + A + + P+ PP P R P PPP
Sbjct: 141 VMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMG 200
Query: 181 KNSPPAPIAVPPSNVPPPPTQTPP 204
P P +PPP + PP
Sbjct: 201 PPMGIPPGRGTPMGMPPPGMRPPP 224
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 27/149 (18%), Positives = 37/149 (24%), Gaps = 3/149 (2%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
S PP + P P+ P + P +
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVP-MPQAPAGLAGPVRGVGG 136
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P + P R + + +P + P PP PP P P
Sbjct: 137 PSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPP--PG 194
Query: 211 APRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P PP T PPPG+ P
Sbjct: 195 MRPPMGPPMGIPPGRGTPMGMPPPGMRPP 223
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 28/155 (18%), Positives = 41/155 (26%), Gaps = 2/155 (1%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
N + + PP + P + P P P P+
Sbjct: 76 NLVSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVG 135
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P + P + + P PP PP + PP
Sbjct: 136 GPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGM 195
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIP 237
P P+ P +P PPP + PPPG+
Sbjct: 196 RPPMGPPMGIPPGRGTPMGMPPPGMR--PPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 26/111 (23%), Positives = 33/111 (29%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A P P A + P P+ P ++ + P
Sbjct: 114 IPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRG 173
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PP A P PPP PP P PP P PPP + PP
Sbjct: 174 GPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPP 224
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 26/119 (21%), Positives = 32/119 (26%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+A P P ++ P P + T+ P
Sbjct: 108 RAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQ 167
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
PP PP + PP PP PP P P P PP PPPP
Sbjct: 168 YPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 31/141 (21%), Positives = 44/141 (31%), Gaps = 11/141 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A + G P ++ + P P ++ P + P P + A+
Sbjct: 97 LAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAA 156
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S + + P P PPP + PP + PPP PP PP
Sbjct: 157 ATASIAGAPTQYPPGRGGP--------PPPMGRGAPPPGMMGPPPGMRPP---MGPPMGI 205
Query: 122 PPPNSPPSPPSDPPANSPPPS 142
PP P P PPP
Sbjct: 206 PPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 29/148 (19%), Positives = 42/148 (28%), Gaps = 2/148 (1%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
T+ PPP R P ++ P + P P P+ L P P
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAG--VPMPQAPAGLAGPVRGVGGPS 138
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
++ +++ + P PPPP P + P P P
Sbjct: 139 QQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPP 198
Query: 220 NSPPPPSTKRLSPPPGIPVPSTENTPGN 247
PP P G+P P P
Sbjct: 199 MGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 25/136 (18%), Positives = 36/136 (26%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ PP ++ P + P + P VP P + P+
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQ 140
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
+ P AS PPP R +PPPG+ P P G
Sbjct: 141 VMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMG 200
Query: 249 TNPSSPESSSSPSNNG 264
P +P
Sbjct: 201 PPMGIPPGRGTPMGMP 216
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 25/154 (16%), Positives = 36/154 (23%), Gaps = 8/154 (5%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
S + P + + P A+ + P P + P P
Sbjct: 79 SMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPS 138
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+P + + S P P P PP PP
Sbjct: 139 QQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGP------PPPMGRGAPPPGMMGPP 192
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P PP +PP P + P P
Sbjct: 193 PGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 53/277 (19%), Positives = 82/277 (29%), Gaps = 94/277 (33%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G F +V+ + + + VA+K +K E E+ ++ + + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGE------------GRPVLDWATR----------VK-I 470
+LL D F + G G +L W + VK I
Sbjct: 103 V--VQLL--DD-------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILL----------------------------- 501
+GL YLH C IIH DIK NILL
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 502 --------------------DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEY 540
+ +++D G A T I TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
+D++S + EL TG +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 21/99 (21%), Positives = 33/99 (33%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ ++ ++ P + P+++ A A P +PPP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
PP PP PPPP PP +PP+ P
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAP 437
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 14/116 (12%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ + + +S P+++ + + PP +
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP------Q 391
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
PP PP P P PP PP PPPP + PP+ +PP+ PPQ
Sbjct: 392 GYAPPPQGYPPQGYP------PQGYPPQGYPPQGYPPPPQGA--PPQGAPPAAPPQ 439
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 22/108 (20%), Positives = 32/108 (29%), Gaps = 10/108 (9%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP--SPPAS 96
+ P+ +S+ S+ + + PP +PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P PP PP PP PP P PP +PP + P
Sbjct: 399 GYPPQGYPPQ--------GYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 25/114 (21%), Positives = 33/114 (28%), Gaps = 6/114 (5%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P + T P SS P++ + + A +
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQA---A 387
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP PP + P PP PP+ PP P PP PP PP
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPP---AAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 17/99 (17%), Positives = 25/99 (25%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A + P S+ + + PP
Sbjct: 340 DDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQG 399
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP P P P PP +PP P ++PP
Sbjct: 400 YPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 27/120 (22%), Positives = 34/120 (28%), Gaps = 12/120 (10%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P + T P S+ S+ A+ PP
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP 390
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+PP P PP PP PP PPPP PP +PP + PP
Sbjct: 391 QGYAPPPQGYPPQGYPPQGYPPQGYPPQG---------YPPPPQGAPPQGAPP---AAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 25/107 (23%), Positives = 33/107 (30%), Gaps = 5/107 (4%)
Query: 7 GPPAANSSSPPPPVSNPPTI--SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
+ + P S P ++ + + K P PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPS--PPASSPPTISPPPPVSN 109
PP PP PP P PPP PP +PP +PP V N
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPA-APPQGVDN 443
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 19/103 (18%), Positives = 23/103 (22%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P SS P + PP A PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
PP P P+ P PP +PP G+
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQGV 441
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 9/111 (8%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ ++ P+ +++ P ++ + ++ ++ + PPQ
Sbjct: 337 CQFDDKETEDDKDAETEIPAGESSDAAPSADAAQM--KEMMAMMQKMQQQQAAYPPQGYA 394
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PPP PP+ PP PP PP PP A P + P +PP
Sbjct: 395 PPPQGYPPQGYPPQG--YPPQGYPPQGYPPPPQGAP-----PQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 21/84 (25%), Positives = 30/84 (35%), Gaps = 5/84 (5%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPPA 59
+ + + + PP + PP+ PP PP PP PP P
Sbjct: 363 APSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYP- 421
Query: 60 SNPPTSSSPPASSPPTSSPPPASN 83
PP +PP +PP + P N
Sbjct: 422 --PPPQGAPPQGAPPAAPPQGVDN 443
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 7e-08
Identities = 21/121 (17%), Positives = 28/121 (23%), Gaps = 3/121 (2%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
S N P +D PPP P + P P S P P++
Sbjct: 11 DSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERAS---TAAPVASPAAP 67
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPV 238
P +S SN T S S + + P
Sbjct: 68 SPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDW 127
Query: 239 P 239
Sbjct: 128 A 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 1e-07
Identities = 17/115 (14%), Positives = 32/115 (27%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
P PP P P ++ + AS +SP A SP +S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+ +++ + A++ S R + P + +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAKYFKG 133
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 5e-07
Identities = 13/105 (12%), Positives = 23/105 (21%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S ++ P P P PP S + P + + P +P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
S SN ++ +
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 2e-06
Identities = 18/117 (15%), Positives = 35/117 (29%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
SN + P P PPPP + P +P +++ S +P + P A SP
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGS 71
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
S + + + + Q + + + + +
Sbjct: 72 SGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 12/100 (12%), Positives = 23/100 (23%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P+ PPPP + + P + P P S
Sbjct: 17 NLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGG 76
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+S S ++ S + + +
Sbjct: 77 FFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 15/103 (14%), Positives = 26/103 (25%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPAS 71
N + P P PP P +SP P S + + P + SP +S
Sbjct: 13 NFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSS 72
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
++ ++ + S
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 14/116 (12%), Positives = 26/116 (22%), Gaps = 3/116 (2%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+N P P PPP++ P ++P + ++ P P S
Sbjct: 16 ANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERA---STAAPVASPAAPSPGSS 72
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
S S + + + V +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 17/102 (16%), Positives = 29/102 (28%), Gaps = 3/102 (2%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+N P +PP P + P T S AS+ S+ P ++P SP S
Sbjct: 16 ANLPNGYMTDLQRPQPPPPPPSAASP---GATPGSAAASAERASTAAPVASPAAPSPGSS 72
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
++S + + +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 14/124 (11%), Positives = 24/124 (19%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
S + P P PP P S + ++ + PSP
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAV 190
S + ++ + S + P A
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAK 129
Query: 191 PPSN 194
Sbjct: 130 YFKG 133
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-06
Identities = 20/113 (17%), Positives = 30/113 (26%), Gaps = 2/113 (1%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P P PP S+ + P S+ A T++P SP A SP +
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
S+ ++ S A L + K
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGA--GRGGAAARVLLVIDEPHTDWAK 129
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-06
Identities = 16/104 (15%), Positives = 27/104 (25%), Gaps = 3/104 (2%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A P + P PP PP S P + P ++ S + P +P
Sbjct: 14 FMANLPNGYMTDLQRPQPP---PPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPG 70
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
+ + S A+ S + +
Sbjct: 71 SSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 6e-06
Identities = 14/97 (14%), Positives = 28/97 (28%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PPPP S + P + + + PV+ P SP S +
Sbjct: 21 GYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSS 80
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
S+ + ++ + S ++ +
Sbjct: 81 LSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVL 117
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 6e-06
Identities = 13/102 (12%), Positives = 25/102 (24%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
++ P PPP S P + + P ++P S +
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
S + T++ + + S R
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 9e-06
Identities = 14/114 (12%), Positives = 31/114 (27%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
++ P PPPP S + P ++ + + P PA P S+
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPP 199
++V+ + + + + + + V
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 9e-06
Identities = 11/97 (11%), Positives = 21/97 (21%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P R PPP + +P S + + P P P
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
S+ +++ + +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 14/114 (12%), Positives = 31/114 (27%), Gaps = 3/114 (2%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
++ P P P PP+++ P + P S+ + + + + P P S+
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 124 PNSPPSPPS---DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
S + A + + R + +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 15/106 (14%), Positives = 25/106 (23%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
S+ ++ P P PPP + A+ +S A ++P P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
S+ A T + S
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 12/102 (11%), Positives = 23/102 (22%), Gaps = 2/102 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P PP S+ + P ++ + P +SP +P P S
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPA--APSPGSS 72
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
++ + +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 9e-05
Identities = 21/116 (18%), Positives = 35/116 (30%), Gaps = 15/116 (12%)
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
SN +NLP + ++ P+ PP +P P S+
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAA---------------SAERAS 56
Query: 202 TPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESS 257
T ASP AP P +S + + + G G+ + +
Sbjct: 57 TAAPVASPAAPSPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 12/106 (11%), Positives = 22/106 (20%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P S ++P P + P +S +S
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
A++ T S + + P +
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 53.9 bits (128), Expect = 9e-08
Identities = 24/236 (10%), Positives = 42/236 (17%), Gaps = 15/236 (6%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS------------- 67
S + P S + +T P SN
Sbjct: 87 SPRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINC 146
Query: 68 --PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P SS ++ ++ P + + I P +N P PN
Sbjct: 147 GVPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPN 206
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
+ N + S + S K+
Sbjct: 207 ASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGV 266
Query: 186 APIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ T+ + + P S
Sbjct: 267 LFSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSR 322
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 47.7 bits (112), Expect = 9e-06
Identities = 25/240 (10%), Positives = 47/240 (19%), Gaps = 22/240 (9%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP--SST 121
P + S S+ S +S P P +
Sbjct: 88 PRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINCG 147
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS-------VEPPKRSPPSVPPQNPPPP 174
P + + S +N+ P+ P N + P+ + P
Sbjct: 148 VPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPNA 207
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
N + + + S ++ S S S ++
Sbjct: 208 SKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGVL 267
Query: 235 GIPV-------------PSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIA 281
N N +S +GI +
Sbjct: 268 FSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSRIGISS 327
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-07
Identities = 21/174 (12%), Positives = 36/174 (20%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P KSS ++ N + A S
Sbjct: 5 PRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQR 64
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
+ A P + + + A S
Sbjct: 65 ATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSD 124
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
++ RS P S+ + A ++ P+ V PPT +
Sbjct: 125 TGINNANELSRSGNVDNEGGSNQKPMSTRIAEATSAIVSKHPARVGLPPTASSG 178
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 7e-06
Identities = 20/180 (11%), Positives = 41/180 (22%), Gaps = 6/180 (3%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P + S+ + S S +S N P S+ P +++
Sbjct: 4 IPRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQ 63
Query: 112 TRSPP--PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
+ P +P + S + +S V
Sbjct: 64 RATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYS 123
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+ ++ ++ P T A+ + PP S+
Sbjct: 124 DTGINNANELSRSGNVD----NEGGSNQKPMSTRIAEATSAIVSKHPARVGLPPTASSGH 179
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 24/135 (17%), Positives = 36/135 (26%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
S P S ++P + PP P P P P P A
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
P P P P + P ++ P P + + A ++ P
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 199 PTQTPPTPASPIAPR 213
+ P S P+
Sbjct: 138 SVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 27/143 (18%), Positives = 34/143 (23%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P + PA P S + + P P P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P V P P P P S P S + P SS S
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 164 PSVPPQNPPPPPSSSPPKNSPPA 186
P + P S + P+ A
Sbjct: 135 PVTSVASGPRALSRNQPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 24/128 (18%), Positives = 33/128 (25%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ AP+ + P P V P+ P P P + P P P
Sbjct: 28 LPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPK 87
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P P P S P + +P + T + S P S
Sbjct: 88 PKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALS 147
Query: 121 TPPPNSPP 128
P P
Sbjct: 148 RNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 18/134 (13%), Positives = 32/134 (23%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
+ + P + P +++ P P + PPP P P
Sbjct: 19 HMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVV 78
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P P P SP + S ++T P +
Sbjct: 79 IEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTS 138
Query: 128 PSPPSDPPANSPPP 141
+ + + P
Sbjct: 139 VASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 23/136 (16%), Positives = 32/136 (23%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S P + P + + ++ PP P P+ PP
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+P P P P P P P P P R S
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 174 PPSSSPPKNSPPAPIA 189
P +S +
Sbjct: 135 PVTSVASGPRALSRNQ 150
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 19/128 (14%), Positives = 28/128 (21%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
+P P+S + P P +P P P + P P
Sbjct: 30 APAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPK 89
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P + P + P T + S P S
Sbjct: 90 PKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRN 149
Query: 135 PANSPPPS 142
P +
Sbjct: 150 QPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 26/133 (19%), Positives = 32/133 (24%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
V + P + P S P P A PP P P P A
Sbjct: 23 HQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKP 82
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P P P S P+ P N+ P S V
Sbjct: 83 KPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
Query: 163 PPSVPPQNPPPPP 175
P ++ P P
Sbjct: 143 PRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 27/141 (19%), Positives = 36/141 (25%), Gaps = 3/141 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P S P + P V+ PP + PP P P P P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
P PK P V P P ++ P +P T T
Sbjct: 75 A---PVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAA 131
Query: 205 TPASPIAPRPSNSSPNSPPPP 225
T + + + P
Sbjct: 132 TSKPVTSVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 21/135 (15%), Positives = 30/135 (22%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
+S I P P + P + P PPP P P P
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P P PV + P + +S + + P
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 138 SPPPSNPPSNLPPPP 152
S + P
Sbjct: 138 SVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 28/150 (18%), Positives = 38/150 (25%), Gaps = 4/150 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
+ P S I P P P PP P P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP + V K P P P P ++ P P +
Sbjct: 70 E----PPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTS 125
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ A+ +P S + P S + P
Sbjct: 126 STATAATSKPVTSVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 22/125 (17%), Positives = 32/125 (25%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + P + +P P + P P P P P + P + P V + P P
Sbjct: 27 ELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKP 86
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P V P A + ++ S P S
Sbjct: 87 KPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRAL 146
Query: 235 GIPVP 239
P
Sbjct: 147 SRNQP 151
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 26/142 (18%), Positives = 30/142 (21%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S P + S + P P P PP V PP P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
P P P P + P T SST
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 124 PNSPPSPPSDPPANSPPPSNPP 145
+ S N P
Sbjct: 130 AATSKPVTSVASGPRALSRNQP 151
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 48.0 bits (112), Expect = 6e-06
Identities = 19/110 (17%), Positives = 31/110 (28%), Gaps = 8/110 (7%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
S P + A++ +S P V P+ N + P
Sbjct: 391 MSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPK----- 445
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAV 190
P PP P K + + P P P + + +PP +
Sbjct: 446 ---VTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEH 492
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 47.6 bits (111), Expect = 9e-06
Identities = 14/114 (12%), Positives = 29/114 (25%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+P + + + + ++ T P +
Sbjct: 377 SDAPNSWYGAGAIKMSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNG 436
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ P+PP P A + P L P P + + +PP+
Sbjct: 437 KIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRL 490
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 46.4 bits (108), Expect = 2e-05
Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 1/113 (0%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+P + +N T ++ P + P P + P+ S
Sbjct: 377 SDAPNSWYGAGAIKMSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNG 436
Query: 150 PPPPSSVEPPKRSPPSVPPQ-NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
+V + P+ P + P P+ K PAP+A P PPT+
Sbjct: 437 KIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTR 489
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 44.1 bits (102), Expect = 1e-04
Identities = 15/96 (15%), Positives = 20/96 (20%), Gaps = 4/96 (4%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+T N P N+ + P V + P PP +
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVN--VPKVTKEKPTPPVKPTA 459
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P P P P P P
Sbjct: 460 PT--KPTYETEKPLKPAPVAPNYEKEPTPPTRLEHH 493
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 43.0 bits (99), Expect = 2e-04
Identities = 13/86 (15%), Positives = 22/86 (25%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
++ + P + + + P +PP P A +
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPT 461
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPP 123
PT P+ P TPP
Sbjct: 462 KPTYETEKPLKPAPVAPNYEKEPTPP 487
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 42.2 bits (97), Expect = 4e-04
Identities = 14/104 (13%), Positives = 24/104 (23%), Gaps = 4/104 (3%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ S+ P + +++ N P
Sbjct: 393 GPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPK--VTKEK 450
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
TPP P+ P+ P + P P P P +
Sbjct: 451 PTPPV--KPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEH 492
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 41.4 bits (95), Expect = 7e-04
Identities = 13/96 (13%), Positives = 21/96 (21%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++ + S P V P + T P P
Sbjct: 398 VTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKP 457
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
PT + P +P + +PP
Sbjct: 458 TAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEHH 493
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 41.0 bits (94), Expect = 9e-04
Identities = 12/86 (13%), Positives = 22/86 (25%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ + P + P + + + + PP P+
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPT 461
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPP 118
P P PV+ + P PP
Sbjct: 462 KPTYETEKPLKPAPVAPNYEKEPTPP 487
|
| >2kr0_A Proteasomal ubiquitin receptor ADRM1; proteasome, 19S regulator, protein binding; NMR {Homo sapiens} Length = 411 | Back alignment and structure |
|---|
Score = 47.1 bits (110), Expect = 1e-05
Identities = 31/164 (18%), Positives = 50/164 (30%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ G + P +++ S PP S+ S V+ TTS + PA
Sbjct: 176 IGPAGLGGLGGLGALTGPGLASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAP 235
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ P ++S + SP SS AS + + P + P + S
Sbjct: 236 SAPAAASATSPSPAPSSGNGASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASV 295
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P P + P P P ++ SP
Sbjct: 296 LTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQ 339
|
| >2kr0_A Proteasomal ubiquitin receptor ADRM1; proteasome, 19S regulator, protein binding; NMR {Homo sapiens} Length = 411 | Back alignment and structure |
|---|
Score = 41.7 bits (96), Expect = 6e-04
Identities = 28/205 (13%), Positives = 41/205 (20%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP 78
P + S S P T
Sbjct: 135 PPMPGALGASGSSGHELSALGGEGGLQSLLGNMSHSQLMQLIGPAGLGGLGGLGALTGPG 194
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
+ + P S +SS + P S + P S P S SP P + +
Sbjct: 195 LASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAPSAPAAASATSPSPAPSSGN 254
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ P P +S API
Sbjct: 255 GASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERL 314
Query: 199 PTQTPPTPASPIAPRPSNSSPNSPP 223
P + P ++ SP
Sbjct: 315 LPYLPSGESLPQTADEIQNTLTSPQ 339
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 15/144 (10%), Positives = 32/144 (22%), Gaps = 3/144 (2%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S P + S + S PS PP P
Sbjct: 12 SGLVPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPI-TTD 70
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
++ K++ P + + A + + ++
Sbjct: 71 ATSATVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIW- 129
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRL 230
S + P ++ + P +
Sbjct: 130 -SDVVPFVRRTTDSDFDPSRMYKF 152
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 16/135 (11%), Positives = 35/135 (25%), Gaps = 8/135 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A + S+ S P+ PP + + V+ T + + A+
Sbjct: 22 ASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSATVTAAGG 81
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+ ++ PA +++ + A + N S
Sbjct: 82 AKKKA--------TTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVV 133
Query: 123 PPNSPPSPPSDPPAN 137
P + P+
Sbjct: 134 PFVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 14/140 (10%), Positives = 29/140 (20%), Gaps = 6/140 (4%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
P + + +S+S P+ PP + T +
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSS---LSPSELPPSKKAAGGQRVTAEVEVAPITTDA 71
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
V+ + +P + + ++ + K
Sbjct: 72 TSATVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAE---ALAALNAKKSEKEI 128
Query: 163 PPSVPPQNPPPPPSSSPPKN 182
V P S P
Sbjct: 129 WSDVVPFVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 14/134 (10%), Positives = 31/134 (23%), Gaps = 3/134 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT---SSPPPASNPPT 86
P + S ++S P+ PP+ + +P
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSA 74
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
+ T SP S+ + + + + S+
Sbjct: 75 TVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVP 134
Query: 147 NLPPPPPSSVEPPK 160
+ S +P +
Sbjct: 135 FVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 15/133 (11%), Positives = 27/133 (20%), Gaps = 2/133 (1%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA--SNPPTSSPPPS 92
P+ S + + S +S P+ P + P T+ +
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSA 74
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
++ S S + A + S P
Sbjct: 75 TVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVP 134
Query: 153 PSSVEPPKRSPPS 165
PS
Sbjct: 135 FVRRTTDSDFDPS 147
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 13/74 (17%), Positives = 21/74 (28%), Gaps = 2/74 (2%)
Query: 109 NPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+PP++ + +P P + P E P R VP
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAE-VP 68
Query: 168 PQNPPPPPSSSPPK 181
+ P PP +
Sbjct: 69 TKPPLPPARTQGTP 82
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 13/72 (18%), Positives = 20/72 (27%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
PP + + + P P S P + P+ +
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPT 69
Query: 89 PPPSPPASSPPT 100
PP PPA + T
Sbjct: 70 KPPLPPARTQGT 81
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 14/76 (18%), Positives = 22/76 (28%), Gaps = 1/76 (1%)
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
PP+ + + +P P P V + P T P+ P+
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDP-RPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPT 69
Query: 133 DPPANSPPPSNPPSNL 148
PP P +L
Sbjct: 70 KPPLPPARTQGTPVHL 85
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 15/82 (18%), Positives = 22/82 (26%), Gaps = 8/82 (9%)
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
PPS + + P P + S + P+
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTE--------LPS 62
Query: 187 PIAVPPSNVPPPPTQTPPTPAS 208
A P+ P PP +T TP
Sbjct: 63 RRAEVPTKPPLPPARTQGTPVH 84
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 8e-05
Identities = 23/112 (20%), Positives = 30/112 (26%), Gaps = 2/112 (1%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV 156
+ P P R P P +D PP PP + P S
Sbjct: 1 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 60
Query: 157 EPPK--RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P RS + P+N S P P ++ PPP
Sbjct: 61 ASPDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPPLNEDGLI 112
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 15/88 (17%), Positives = 23/88 (26%)
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P P + P P P PS + +
Sbjct: 5 PTQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQK 64
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
PK++PP P + P + K+ P
Sbjct: 65 KPKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 1e-04
Identities = 15/138 (10%), Positives = 29/138 (21%), Gaps = 2/138 (1%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P+ P ++ + P + PP
Sbjct: 84 EVRQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPL 143
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
+++P + Q+ +PP P + N
Sbjct: 144 EYTTDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPP--QLPPQLENVILNKYYATQDQ 201
Query: 203 PPTPASPIAPRPSNSSPN 220
S P P++ N
Sbjct: 202 FNENNSGALPIPNHVVLN 219
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 7e-04
Identities = 17/129 (13%), Positives = 30/129 (23%)
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
+ P +P S S PP S + + +P + P
Sbjct: 86 RQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPLEY 145
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
++ P P + S+ + P P L + +
Sbjct: 146 TTDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPPQLPPQLENVILNKYYATQDQFNEN 205
Query: 167 PPQNPPPPP 175
P P
Sbjct: 206 NSGALPIPN 214
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 15/72 (20%), Positives = 23/72 (31%)
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P + PP P+ P+ ++ S PP +P S+ S+
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 148 LPPPPPSSVEPP 159
P E P
Sbjct: 61 FAVPTIHFKESP 72
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 15/92 (16%), Positives = 28/92 (30%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ P ++ + + P + + + SP S+ + S PP +NP S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
+ P + SP P
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 7e-04
Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 2/92 (2%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
S P + PP+ +P P TS+ S P + P + +SS
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 99 PTISPPPPVSNP--PTRSPPPPSSTPPPNSPP 128
+ +P + P +
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 9e-04
Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 2/97 (2%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S P + +S PP V + + SP +++S + +PP ++P +S+ +
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 87 SSPPPSPPASSP--PTISPPPPVSNPPTRSPPPPSST 121
+ P SP P + + +
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3vf0_A Vinculin, metavinculin; cytoskeletal F-actin binding protein, CEL adhesion-protein binding complex; HET: EPE; 2.54A {Homo sapiens} Length = 283 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 3e-04
Identities = 23/115 (20%), Positives = 32/115 (27%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
S+ + P P PPP PP P + I+ P ++
Sbjct: 1 GSHMDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQKAGEVINQPMMMAARQLHDEARK 60
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S+ P A + +PP EP PS P N P
Sbjct: 61 WSSKPGIPAAEVGIGVVAEADAADAAGFPVPPDMEDDYEPELLLMPSNQPVNQPI 115
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 11/89 (12%), Positives = 18/89 (20%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
S S P +S T + V + P +P +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
S + + P S
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3q2s_C Cleavage and polyadenylation specificity factor S; CFIM, CFIM25, CFIM68, CPSF5, CPSF6, CPSF, 3' END processing, processing, cleavage factor; 2.90A {Homo sapiens} PDB: 3q2t_C Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 10/83 (12%), Positives = 17/83 (20%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
P + S + + + P P + P +
Sbjct: 146 PVNKQFLSQFEMQSRKTTQSGQMSGEGKAGPPGGSSRAAFPQGGRGRGRFPGAVPGGDRF 205
Query: 150 PPPPSSVEPPKRSPPSVPPQNPP 172
P P PP P +
Sbjct: 206 PGPAGPGGPPPPFPAGQTHHHHH 228
|
| >1zvo_C Myeloma immunoglobulin D delta; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 512 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 17/203 (8%), Positives = 35/203 (17%), Gaps = 6/203 (2%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP------PVSKPPTTSPPPSPP 58
S P A P P + P ++ P ++ P
Sbjct: 128 SSAPTKAPDVFPIISGCRHPKDNSPVVLACLITGYHPTSVTVTWYMGTQSQPQRTFPEIQ 187
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ +S S+P P ++ + P
Sbjct: 188 RRDSYYMTSSQLSTPLQQWRQGEYKCVVQHTASKSKKEIFRWPESPKAQASSVPTAQPQA 247
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
+ + + + P+ + P P+
Sbjct: 248 EGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEERETKTPECPSHTQPLGVYLLTPAVQ 307
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQ 201
A
Sbjct: 308 DLWLRDKATFTCFVVGSDLKDAH 330
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 6e-04
Identities = 14/95 (14%), Positives = 18/95 (18%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
K P P P +S + SP PA SS
Sbjct: 90 DRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASS 149
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
S + + S P
Sbjct: 150 DTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNIS 184
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 11/55 (20%), Positives = 21/55 (38%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
++ P + P +P S PA + A++P ++ A P +S
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKAS 148
|
| >2j89_A Methionine sulfoxide reductase A; MSRA, poplar, oxidoreductase; 1.7A {Populus trichocarpa} Length = 261 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 18/86 (20%), Positives = 34/86 (39%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+ +S ++++P P A + + S P + P + P PP++N ++
Sbjct: 7 THLSSTSTSTTTPLLLLSKPFLSPSAKSQLSHSKPFNFPRTLKPISYYKPPMANILSKLG 66
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPP 141
S P P+ P P + P P
Sbjct: 67 FGTRSPDPSTMDPTIPQGPDDDLPAP 92
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.61 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 99.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 99.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 99.0 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 98.24 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 98.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 98.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 98.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.69 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.3 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.17 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.22 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.85 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.31 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.13 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 94.51 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.26 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 94.05 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.99 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 93.18 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 93.16 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 93.11 | |
| 3hhm_A | 1091 | Phosphatidylinositol-4,5-bisphosphate 3-kinase cat | 91.43 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 91.2 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.16 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 89.84 | |
| 1zza_A | 90 | Stannin, AG8_1; helix, membrane protein; NMR {Homo | 89.29 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.42 | |
| 2wxf_A | 940 | Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca | 88.21 | |
| 2y3a_A | 1092 | Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca | 88.19 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 88.13 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 85.41 | |
| 3eps_A | 578 | Isocitrate dehydrogenase kinase/phosphatase; ATP-b | 84.93 | |
| 1e7u_A | 961 | Phosphatidylinositol 3-kinase catalytic subunit; p | 82.67 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=427.45 Aligned_cols=233 Identities=27% Similarity=0.507 Sum_probs=197.1
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|.+.+.||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|+|||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999864 467899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEE
Q 007351 441 IYDYVPNNTLYFHLHGEG-----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (607)
|||||++|+|.++|+..+ ...++|.++++|+.||++||+|||++ +|||||||++||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 34599999999999999999999998 9999999999999999999999
Q ss_pred EecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh
Q 007351 510 SDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI 587 (607)
Q Consensus 510 ~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~ 587 (607)
+|||+++........ ......||.+|||||++.+..|+.++|||||||+||||+| |+.||.+.. ..++.+.+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcC
Confidence 999999876544332 2234568999999999999999999999999999999998 899998642 33343333221
Q ss_pred --------hHHHHHHHHHHhhhcCCC
Q 007351 588 --------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 --------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~ 272 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPH 272 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCCCccchHHHHHHHHHHcCCChh
Confidence 126788999999988763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=428.49 Aligned_cols=233 Identities=27% Similarity=0.473 Sum_probs=190.9
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|.+.+.||+|+||.||+|+++ +++.||||+++.......++|++|+++|++|+|+|||+|+|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999864 477899999987666667789999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 441 IYDYVPNNTLYFHLHGEGR-------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
|||||++|+|.++|+.... ..+.|.++++|+.||++||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 3489999999999999999999998 99999999999999999999
Q ss_pred EEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHh
Q 007351 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVN 585 (607)
Q Consensus 508 kL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (607)
||+|||+++.....+. ......+||.+|||||++.+..|+.++|||||||+||||+| |+.||.+.. ..++.+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence 9999999987654332 23445679999999999999999999999999999999999 899997642 333333332
Q ss_pred Hh--------hHHHHHHHHHHhhhcCCC
Q 007351 586 LI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.. ....+.+++.+||+.++.
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~ 302 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQ 302 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTT
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChh
Confidence 21 136788999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=429.92 Aligned_cols=233 Identities=24% Similarity=0.373 Sum_probs=191.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++++.||+|+||.||+|+.. +|+.||||+++... ....+.|++|+++|++|+|+|||++++++++++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999964 79999999997543 234467999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||++|+|+++|+.++...+++..++.|++||+.||+|||++ +|||||||++||||+++|.+||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999877666789999999999999999999999 99999999999999999999999999998664322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~ 594 (607)
......+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+.+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 22344679999999999999999999999999999999999999997642 1222211110 01256789
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+||+.++.
T Consensus 256 li~~~L~~dP~ 266 (350)
T 4b9d_A 256 LVSQLFKRNPR 266 (350)
T ss_dssp HHHHHTCSSGG
T ss_pred HHHHHccCChh
Confidence 99999987753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=426.85 Aligned_cols=229 Identities=21% Similarity=0.301 Sum_probs=197.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++++.||+|+||.||+|++. +|+.||||+++.......+.+.+|+++|+.|+|+|||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999998665566677899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|+++++.. .+.+.+++.|++||++||+|||++ +|||||||++||||+++|.+||+|||+|+....... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999998764 389999999999999999999999 999999999999999999999999999987654332 3
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------hHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----------DAKILFKL 595 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----------~~~~~~~i 595 (607)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+..... ....+.++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 445789999999999999999999999999999999999999997642 22222221110 12567899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 304 i~~~L~~dP~ 313 (346)
T 4fih_A 304 LDRLLVRDPA 313 (346)
T ss_dssp HHHHSCSSTT
T ss_pred HHHHcCCChh
Confidence 9999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=422.81 Aligned_cols=233 Identities=28% Similarity=0.462 Sum_probs=195.4
Q ss_pred CCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
+++++.+.||+|+||.||+|++. +++.||||+++.... ...++|++|+++|++|+|+|||+|+|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667789999999999999863 467899999975433 34578999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC
Q 007351 440 LIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (607)
||||||++|+|.++|+.+. ...++|.++++|+.||++||+|||++ +|||||||++||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 13489999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH
Q 007351 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~ 583 (607)
.+||+|||+++.....+. ......+||.+|||||++.++.|+.++|||||||+||||+| |+.||.+.. ..++.++
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 999999999987654332 23455679999999999999999999999999999999998 899998642 3444444
Q ss_pred HhHhh--------HHHHHHHHHHhhhcCCC
Q 007351 584 VNLID--------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 584 ~~~~~--------~~~~~~i~~~C~~~~~~ 605 (607)
+.... ...+.+++.+||+.++.
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~ 289 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPS 289 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChh
Confidence 33211 36688999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=431.90 Aligned_cols=229 Identities=21% Similarity=0.302 Sum_probs=198.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++++.||+|+||.||+|++. +|+.||||+++.......+.+.+|+++|+.|+|+|||+|+++|.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999998766666677999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|+++++... +.+..++.|++||++||+|||++ +|||||||++||||+++|.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 9999999987543 89999999999999999999999 999999999999999999999999999987654332 3
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------hHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----------DAKILFKL 595 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----------~~~~~~~i 595 (607)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++++..... ....+.++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 455789999999999999999999999999999999999999997642 22222221110 12567899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+||+.++.
T Consensus 381 i~~~L~~dP~ 390 (423)
T 4fie_A 381 LDRLLVRDPA 390 (423)
T ss_dssp HHHHSCSSTT
T ss_pred HHHHcCCChh
Confidence 9999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=416.75 Aligned_cols=231 Identities=26% Similarity=0.356 Sum_probs=196.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|+++++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++|+|+|||++++++++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999964 78999999996432 234567999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||++|+|+++++..+. +++..++.|++||+.||+|||++ +|||||||++||||++++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999987654 89999999999999999999999 99999999999999999999999999998765433
Q ss_pred -cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHH
Q 007351 523 -THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFK 594 (607)
Q Consensus 523 -~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~ 594 (607)
.......+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+..... ....+.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~d 263 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIKLEYDFPEKFFPKARD 263 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTCCHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCcccCHHHHH
Confidence 223455789999999999999999999999999999999999999997642 22222211110 1356788
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.+++
T Consensus 264 li~~lL~~dp~ 274 (311)
T 4aw0_A 264 LVEKLLVLDAT 274 (311)
T ss_dssp HHHHHSCSSGG
T ss_pred HHHHHccCCHh
Confidence 99999987753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=416.11 Aligned_cols=231 Identities=30% Similarity=0.510 Sum_probs=185.4
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++++.||+|+||.||+|+++ ..||||+++... .+..+.|++|+++|++|+|+|||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 356888899999999999999974 369999997543 2344679999999999999999999999864 56899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC-
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~- 522 (607)
||++|+|+++|+..+. .+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999976543 499999999999999999999998 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------------
Q 007351 523 THITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------------ 587 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------------ 587 (607)
.......+||..|||||++.+ ..|+.++|||||||+||||+||+.||.+.... ..+...+...
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCSTTSCTT
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCccccccc
Confidence 223445689999999999974 35899999999999999999999999764311 1122221110
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 266 ~~~~l~~li~~cl~~dP~ 283 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKE 283 (307)
T ss_dssp SCHHHHHHHHHHTCSSST
T ss_pred chHHHHHHHHHHcCCCHh
Confidence 125688999999988764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=413.41 Aligned_cols=229 Identities=21% Similarity=0.209 Sum_probs=188.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+.|++.+.||+|+||.||+|++. +|+.||||+++.... +.+|+++|+.|+|+|||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46888899999999999999965 689999999975422 357999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEecccccccccCCcc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~~~~~ 524 (607)
++|+|+++|+..+. +.+..++.|+.||++||+|||++ +|||||||++||||+.+| ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999987654 89999999999999999999999 999999999999999887 6999999999876543211
Q ss_pred ----eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-----h--HhhHHHHH
Q 007351 525 ----ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-----N--LIDAKILF 593 (607)
Q Consensus 525 ----~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-----~--~~~~~~~~ 593 (607)
....++||..|||||++.+..|+.++|||||||+||||++|+.||.+.........+.-. . ......+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 123457999999999999999999999999999999999999999875433221111100 0 01135678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+||+.++.
T Consensus 288 ~li~~~L~~dP~ 299 (336)
T 4g3f_A 288 QAIQEGLRKEPV 299 (336)
T ss_dssp HHHHHHTCSSGG
T ss_pred HHHHHHccCCHh
Confidence 899999987753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=399.85 Aligned_cols=226 Identities=26% Similarity=0.395 Sum_probs=184.4
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe----CCceEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLI 441 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV 441 (607)
|++.++||+|+||.||+|++. +++.||||++.... ....+.|++|+++|++|+|+|||+++++|.. ++..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999965 68899999996432 3344679999999999999999999999875 2357899
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcC-CCcEEEEeccccccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDN-NFEAQVSDFGLAKLA 518 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~-~~~vkL~DFGls~~~ 518 (607)
||||++|+|.++++..+. +.+..++.|++||++||+|||++ + |||||||++||||++ +|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999987554 89999999999999999999998 6 999999999999974 789999999999864
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDA 589 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~ 589 (607)
... .....+||..|||||++.+ .|+.++|||||||+||||++|+.||.+... ...+.+.+.. ...
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCCCCCCccCC
Confidence 332 2345689999999998875 699999999999999999999999975421 1122221111 112
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+||+.++.
T Consensus 257 ~~~~~li~~~L~~dP~ 272 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKD 272 (290)
T ss_dssp HHHHHHHHHHSCSSGG
T ss_pred HHHHHHHHHHccCChh
Confidence 4678999999988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=395.37 Aligned_cols=228 Identities=24% Similarity=0.384 Sum_probs=178.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+++|+++|++|+|+|||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 79999999996432 233467999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||| +|+|.+++..++. +++.+++.+++||+.||+|||++ +|+|||||++||||++++++||+|||+|+...+..
T Consensus 93 Ey~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 6899998877654 99999999999999999999999 99999999999999999999999999998654432
Q ss_pred cceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~ 594 (607)
.....+||..|||||++.+..| +.++|||||||+||||++|+.||.+.. ...+.+..... ....+.+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNGVYTLPKFLSPGAAG 241 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 2344689999999999998876 579999999999999999999997632 12222211110 1356788
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.++.
T Consensus 242 li~~~L~~dP~ 252 (275)
T 3hyh_A 242 LIKRMLIVNPL 252 (275)
T ss_dssp HHHHHSCSSGG
T ss_pred HHHHHccCChh
Confidence 99999987753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=408.91 Aligned_cols=230 Identities=27% Similarity=0.356 Sum_probs=186.2
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++++.||+|+||.||+|+.. .++.||||+++... ......+++|+++|++|+|+|||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999852 46789999996432 2233468899999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||++|+|+++++..+. +++.+++.++.||+.||+|||++ +|||||||++||||+++|.+||+|||+|+...+
T Consensus 104 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999987654 89999999999999999999999 999999999999999999999999999986544
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILF 593 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~ 593 (607)
... .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILKAKLGMPQFLSPEAQ 254 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCCCcCCHHHH
Confidence 332 2345689999999999999999999999999999999999999997642 1222221110 0135678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.+++
T Consensus 255 ~li~~~L~~dP~ 266 (304)
T 3ubd_A 255 SLLRMLFKRNPA 266 (304)
T ss_dssp HHHHHHTCSSGG
T ss_pred HHHHHHcccCHH
Confidence 899999987753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=412.09 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=199.0
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCch-hHHHHHHHHHHHHHccC-CCceeEE
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHH-RHLVSLV 429 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H-pnIv~l~ 429 (607)
..++.+...++|++++.||+|+||.||+|++.+ ++.||||+++..... ..++|.+|+++|.+++| +|||+|+
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344555556889999999999999999998642 357999999765443 34679999999999965 8999999
Q ss_pred eEEEeC-CceEEEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCC
Q 007351 430 GYCISD-DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494 (607)
Q Consensus 430 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL 494 (607)
|+|.+. +..+||||||++|+|.++|+... ...+++..+++|+.||++||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999765 56899999999999999997532 23489999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 007351 495 KSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDAS 572 (607)
Q Consensus 495 kp~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~ 572 (607)
|++||||++++.+||+|||+|+........ ......||.+|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 3445679999999999999999999999999999999998 99999864
Q ss_pred CCCCchhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 573 QPLGDESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 573 ~~~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.. +..+.+.+... ....+.+++.+||+.++.
T Consensus 292 ~~--~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~ 330 (353)
T 4ase_A 292 KI--DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 330 (353)
T ss_dssp CC--SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CH--HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChh
Confidence 32 22333322211 135788999999988763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=400.18 Aligned_cols=234 Identities=26% Similarity=0.398 Sum_probs=180.8
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC----ceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----RRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV~ 442 (607)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .....+++|+..+.+|+|+|||+++|+|.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 78999999986432 11223345666667889999999999998765 468999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
|||++|+|+++|+... +.|..+++|+.||++||+|||++ +.++|||||||++||||++++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999998653 89999999999999999999975 245899999999999999999999999999987
Q ss_pred cccCCcce---eeccccCCCCCchhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------Cchh
Q 007351 518 ALDANTHI---TTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPL---------GDES 579 (607)
Q Consensus 518 ~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~---------~~~~ 579 (607)
........ ....+||.+|||||++.+. .++.++|||||||+||||++|+.+|...... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65443322 2345799999999999764 3567899999999999999998766432211 1112
Q ss_pred HHHHHhHh-----------------hHHHHHHHHHHhhhcCCC
Q 007351 580 LVEWVNLI-----------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 580 l~~~~~~~-----------------~~~~~~~i~~~C~~~~~~ 605 (607)
..++.+.+ ....+.+++.+||+.++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence 22222211 124678899999988763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=389.50 Aligned_cols=229 Identities=23% Similarity=0.373 Sum_probs=175.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDR------- 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------- 437 (607)
++|++.+.||+|+||.||+|+.+ +|+.||||+++..... ..+.+++|+++|++|+|+|||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999964 7899999999765443 34579999999999999999999999876543
Q ss_pred -----eEEEEEecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 438 -----RLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 438 -----~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
.|||||||.+|+|.++++.... ....+..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999986543 2345667889999999999999999 999999999999999999999999
Q ss_pred cccccccccCCcc-----------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 007351 512 FGLAKLALDANTH-----------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580 (607)
Q Consensus 512 FGls~~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l 580 (607)
||+|+........ .....+||..|||||++.+..|+.++|||||||+||||++ ||.... +..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 9999876443221 1233579999999999999999999999999999999996 775421 111
Q ss_pred HHHHhHh----------hHHHHHHHHHHhhhcCCC
Q 007351 581 VEWVNLI----------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 581 ~~~~~~~----------~~~~~~~i~~~C~~~~~~ 605 (607)
..+.+.. ......+++.+|++.++.
T Consensus 235 ~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~ 269 (299)
T 4g31_A 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPM 269 (299)
T ss_dssp HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChh
Confidence 1111111 113346789999987753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=395.12 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=172.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeC------Cc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 437 (607)
++|++++.||+|+||.||+|+.. +|+.||||+++.... ...+.+++|+++|+.|+|+|||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 799999999964432 3345688999999999999999999997643 56
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.|||||||+ |+|+.++...+ .+.+..++.|++||+.||+|||++ +|||||||++||||++++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 799999995 77999887655 499999999999999999999999 999999999999999999999999999986
Q ss_pred cccCC---cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDAN---THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~---~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+.... .......+||..|||||++.+. .|+.++|||||||+||||++|+.||.+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 64322 2234457899999999998875 5689999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=381.58 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=171.3
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCce
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 438 (607)
...++|++.+.||+|+||.||+|+.+ .++.||||++... .....+.+|+++|+.+ +|+|||++++++.+++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999853 4678999988643 3456788999999998 699999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKL 517 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~ 517 (607)
|||||||++|+|.++++ .+.+.+++.+++||++||+|||++ ||||||||++||||+.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999884 288999999999999999999999 99999999999999876 7999999999976
Q ss_pred cccCCc---------------------------ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCC
Q 007351 518 ALDANT---------------------------HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 518 ~~~~~~---------------------------~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
..+... ......+||..|||||++.+. .|+.++||||+||+||||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543211 112335799999999999875 5899999999999999999999999
Q ss_pred CCC
Q 007351 570 DAS 572 (607)
Q Consensus 570 ~~~ 572 (607)
...
T Consensus 248 ~~~ 250 (361)
T 4f9c_A 248 YKA 250 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=406.17 Aligned_cols=231 Identities=27% Similarity=0.362 Sum_probs=188.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHH---HHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAE---VEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~E---i~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|+++++||+|+||.||+|+.. +|+.||||+++... ......+++| +++++.++|+|||+|++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999965 68999999996321 1222334444 55666678999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
||||||.||+|+.+|...+. +.+..++.|+.||+.||+|||++ +|||||||++||||+++|.|||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999987654 89999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKI 591 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~ 591 (607)
... ....+||..|||||++.+ ..|+.++|||||||+||||++|+.||.+........+.+..... ....
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 432 334689999999999974 57999999999999999999999999764332222222211110 1356
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
..+++.+|++.+++
T Consensus 421 a~dLI~~lL~~dP~ 434 (689)
T 3v5w_A 421 LRSLLEGLLQRDVN 434 (689)
T ss_dssp HHHHHHHHTCSCGG
T ss_pred HHHHHHHHccCCHh
Confidence 78899999987653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=402.77 Aligned_cols=229 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++++.||+|+||.||+|+.+ +|+.||||+++.......+.+++|+++|+.|+|+|||+|++++.+++..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 67999999999999999999965 78999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC--CcEEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN--FEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DFGls~~~~~~~~ 523 (607)
++|+|+++|..+.. .+.+.+++.|++||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 237 SGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 99999998865432 489999999999999999999999 99999999999999754 899999999998765433
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----------hHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----------DAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----------~~~~~ 592 (607)
.....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++++..... .....
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2344579999999999999999999999999999999999999998642 22222211110 12556
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 388 ~dli~~~L~~dp 399 (573)
T 3uto_A 388 KDFIRKLLLADP 399 (573)
T ss_dssp HHHHHTTSCSSG
T ss_pred HHHHHHHccCCh
Confidence 788999988765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.94 Aligned_cols=242 Identities=44% Similarity=0.737 Sum_probs=205.5
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++....++|++.++||+|+||.||+|++++|+.||||++........+.+.+|+++|+.++|+||+++++++..++..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 44456688999999999999999999988899999999887666667889999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
||||+++|+|.+++..... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999876542 3489999999999999999999998 9999999999999999999999999999865
Q ss_pred ccCC-cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh------------
Q 007351 519 LDAN-THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN------------ 585 (607)
Q Consensus 519 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~------------ 585 (607)
.... ........|+..|+|||++.+..++.++|||||||+||||++|+.||.........++.+|..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 4322 222334568999999999998999999999999999999999999998765544445555432
Q ss_pred ---------HhhHHHHHHHHHHhhhcCCC
Q 007351 586 ---------LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ---------~~~~~~~~~i~~~C~~~~~~ 605 (607)
......+.+++.+|++.++.
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 298 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSE 298 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcc
Confidence 11235677899999987753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.33 Aligned_cols=231 Identities=23% Similarity=0.398 Sum_probs=196.5
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|+||+++++++..++..+|||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999985 47899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+|+|.+++... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999765 389999999999999999999999 999999999999999999999999999986654332
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---------HhhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN---------LIDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~---------~~~~~~~~~i 595 (607)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+..... ......+.++
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 234467999999999999999999999999999999999999999764211 11111111 0113567899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 250 i~~~l~~dp~ 259 (297)
T 3fxz_A 250 LNRCLEMDVE 259 (297)
T ss_dssp HHHHSCSSTT
T ss_pred HHHHccCChh
Confidence 9999988764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=352.99 Aligned_cols=234 Identities=30% Similarity=0.454 Sum_probs=194.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|+++++||+|+||.||+|++. +++.||||++........+.|.+|+++|++++|+||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56899999999999999999975 68999999987666667788999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++++|.++++.... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999987433 489999999999999999999999 99999999999999999999999999998664432211
Q ss_pred -------------eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc---hhHHHHHhH---
Q 007351 526 -------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD---ESLVEWVNL--- 586 (607)
Q Consensus 526 -------------~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~---~~l~~~~~~--- 586 (607)
.....|+..|+|||++.+..++.++|||||||+||||++|+.+|........ .....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 1145789999999999999999999999999999999999999875432211 122222211
Q ss_pred -hhHHHHHHHHHHhhhcCC
Q 007351 587 -IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 -~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 246 ~~~~~~l~~li~~~l~~dP 264 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDP 264 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSG
T ss_pred CCCCHHHHHHHHHHccCCh
Confidence 112467889999998775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.47 Aligned_cols=250 Identities=50% Similarity=0.861 Sum_probs=209.1
Q ss_pred CccHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 356 ~~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
.+.++++....++|++.++||+|+||.||+|++.+|+.||||+++..... ....+++|+++|+.++|+||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 47788999999999999999999999999999888999999999754322 23468999999999999999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
++..++||||+.+|+|.++++.... ..+.+..+++|+.||++||+|||+++..+|+|||||++||||++++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 9999999999999999999976533 34899999999999999999999986678999999999999999999999999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCCchhHHHHHhH----
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ--PLGDESLVEWVNL---- 586 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~--~~~~~~l~~~~~~---- 586 (607)
|+++..............|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+..+.+|...
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9998776555555556679999999999998899999999999999999999999996211 1112233333321
Q ss_pred -----------------hhHHHHHHHHHHhhhcCCC
Q 007351 587 -----------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 -----------------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 294 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM 294 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGG
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCc
Confidence 1236688899999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.86 Aligned_cols=210 Identities=24% Similarity=0.325 Sum_probs=182.5
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
++++....++|++.++||+|+||.||+|+++ +++.||||+++.... .....+++|+++|..++|+||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455688999999999999999999976 478899999974221 122348899999999999999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
++..+||||||.+|+|.++++... ..+.+..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999997632 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
++.............+||..|||||++. ...++.++|||||||+||||++|+.||.+.
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 9876555444445568999999999987 467899999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=354.73 Aligned_cols=230 Identities=26% Similarity=0.377 Sum_probs=193.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+++|+.++|+||+++++++..++..+|||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6899999999743 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.+|.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999876543 89999999999999999999999 99999999999999999999999999998643322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
. .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.++
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2 2344679999999999999999999999999999999999999997532 1222221110 113667889
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 236 i~~lL~~dP~ 245 (337)
T 1o6l_A 236 LAGLLKKDPK 245 (337)
T ss_dssp HHHHTCSSTT
T ss_pred HHHHhhcCHH
Confidence 9999987764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=352.61 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=194.0
Q ss_pred hhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
..++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++|+.++|+||+++++++..++..+||
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999997 589999999996542 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|.+++...+. +.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999877654 89999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILF 593 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~ 593 (607)
. .....+|+..|+|||++.+..+. .++|||||||+||||++|+.||.+.. ...+.+..... ....+.
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYRIPFYMSTDCE 242 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 23446799999999999988876 78999999999999999999997642 12222211110 135678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 243 ~li~~~L~~dP~ 254 (328)
T 3fe3_A 243 NLLKRFLVLNPI 254 (328)
T ss_dssp HHHHHHCCSSTT
T ss_pred HHHHHHCCCChh
Confidence 899999987764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=348.13 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=201.5
Q ss_pred CccHHHHHHhhCC----------CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC
Q 007351 356 MFTYEELVKATDG----------FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH 424 (607)
Q Consensus 356 ~~~~eel~~~~~~----------y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn 424 (607)
.+.++++..+.+. |+..+.||+|+||.||+|++. +|+.||||+++.......+.+.+|+++|++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4667777666543 677789999999999999976 79999999998776666778999999999999999
Q ss_pred ceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC
Q 007351 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 425 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (607)
|+++++++..++..+|||||+.+++|.+++... .+++..+++++.||++||+|||++ +|+|||||++||||+++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 999999999999999999999999999988653 389999999999999999999998 99999999999999999
Q ss_pred CcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 505 FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 505 ~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
+.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... .....+..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Confidence 9999999999986644322 2344679999999999999999999999999999999999999997542 11222211
Q ss_pred hH----------hhHHHHHHHHHHhhhcCCC
Q 007351 585 NL----------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~----------~~~~~~~~i~~~C~~~~~~ 605 (607)
.. .....+.+++.+|++.++.
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred hcCCCCCcCccccCCHHHHHHHHHHccCChh
Confidence 11 1135678999999987764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.44 Aligned_cols=232 Identities=28% Similarity=0.445 Sum_probs=187.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.|.+|++++++++|+||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999964 688999999864332 2345789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++++|.+++...+. +.+..+++++.||++||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999977653 89999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-----------hHhhHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-----------NLIDAK 590 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-----------~~~~~~ 590 (607)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||.+.... ....+.. ......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhccCCCcchhcccCCCH
Confidence 433444567999999999999999999999999999999999999999764211 0001100 011136
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 243 ~l~~li~~~l~~dp 256 (294)
T 4eqm_A 243 SLSNVILRATEKDK 256 (294)
T ss_dssp HHHHHHHHHSCSSG
T ss_pred HHHHHHHHHhcCCH
Confidence 68889999998765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=357.11 Aligned_cols=234 Identities=28% Similarity=0.412 Sum_probs=193.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++|++++.||+|+||.||+|++. ++..||||+++..... ..+++.+|+++|+++ +|+||++++++|..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367899999999999999999852 3457999999765433 346799999999999 899999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..+|||||+.+|+|.++++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999976532 3478999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++........ ......++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~---~~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC---HHH
Confidence 99999999999999866543322 2233456788999999999999999999999999999999 999997643 233
Q ss_pred HHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 580 LVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 580 l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
+.+..... ....+.+++.+||+.++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 347 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 347 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 33322211 135788999999987653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.37 Aligned_cols=236 Identities=22% Similarity=0.264 Sum_probs=193.4
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeC
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 435 (607)
+++....++|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|+++|+.++|+||++++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445678999999999999999999975 58899999996421 12234588999999999999999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+..+||||||.+|+|.++++.. .+.+..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999998764 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---h-
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---I- 587 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---~- 587 (607)
+.............+||..|||||++.+.. ++.++|||||||+||||++|+.||.+.... ..+.+..+. +
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNSLT 293 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHCC
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhcccccc
Confidence 876554433444678999999999998765 788999999999999999999999764211 111111111 0
Q ss_pred ------hHHHHHHHHHHhhhcC
Q 007351 588 ------DAKILFKLVFLCQQNS 603 (607)
Q Consensus 588 ------~~~~~~~i~~~C~~~~ 603 (607)
....+.+++.+|++.+
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~ 315 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDR 315 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCG
T ss_pred CCCcccccHHHHHHHHHHccCh
Confidence 1356788888998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.82 Aligned_cols=230 Identities=27% Similarity=0.377 Sum_probs=188.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.++||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|+++|+.+ +|+||+++++++..++..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999975 68999999997432 23345688999999998 69999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||.+|+|..+++..+. +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999977554 89999999999999999999999 999999999999999999999999999985432
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILF 593 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~ 593 (607)
.. ......+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..++.+..... ....+.
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYPTWLHEDAT 252 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHH
Confidence 22 23345679999999999999899999999999999999999999997642 12222111110 135678
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+|++.++
T Consensus 253 ~li~~lL~~dP 263 (353)
T 3txo_A 253 GILKSFMTKNP 263 (353)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHhhhCH
Confidence 89999987765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.82 Aligned_cols=234 Identities=25% Similarity=0.378 Sum_probs=192.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|++. +++.||||+++..... ..+.+++|+++++.++|+||+++++++.+++..+||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 7899999999754433 34568999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|+|.+++.... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999987654 389999999999999999999999 999999999999999999999999999986543322
Q ss_pred -ceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAKILF 593 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~ 593 (607)
.......|+..|+|||++.+..+ +.++|||||||+||||++|+.||...... ...+.+|.... ....+.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcccccCCccccCCHHHH
Confidence 22345679999999999988775 67899999999999999999999765322 22333333211 235677
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 240 ~li~~~L~~dP~ 251 (323)
T 3tki_A 240 ALLHKILVENPS 251 (323)
T ss_dssp HHHHHHSCSSTT
T ss_pred HHHHHHccCChh
Confidence 899999987764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=349.71 Aligned_cols=229 Identities=26% Similarity=0.408 Sum_probs=182.5
Q ss_pred CCCcccceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
++|++.++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|+.++|+||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5799999999999999999986 478999999997542 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+|||||+.+++|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999976543 88999999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhH------hhHHH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNL------IDAKI 591 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~------~~~~~ 591 (607)
.... .......|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+. .+. .....
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCCCCCHH
Confidence 3322 22344679999999999999999999999999999999999999997642 1111111 110 11367
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 248 ~~~li~~~L~~dp 260 (327)
T 3a62_A 248 ARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHSCSCG
T ss_pred HHHHHHHHHhcCH
Confidence 7889999997765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=364.74 Aligned_cols=239 Identities=21% Similarity=0.239 Sum_probs=193.8
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
++++....++|++.++||+|+||.||+|+.+ +|+.||||+++.... ...+.+++|+++|..++|+||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455688999999999999999999975 789999999974321 122358899999999999999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
++..|||||||.+|+|..++...+ ..+.+..++.++.||+.||+|||++ +|||||||++||||++++++||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999997643 2489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYAS-------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL 586 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~ 586 (607)
++.............+||..|||||++. +..|+.++|||||||+||||++|+.||.+...... ..+.++...
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 9876554433344568999999999987 35689999999999999999999999976421100 011111110
Q ss_pred --------hhHHHHHHHHHHhhh
Q 007351 587 --------IDAKILFKLVFLCQQ 601 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~ 601 (607)
.....+.+++.+|++
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~ 311 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC 311 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS
T ss_pred cCCCccccCCCHHHHHHHHHHcC
Confidence 113567888888886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=347.97 Aligned_cols=225 Identities=28% Similarity=0.391 Sum_probs=191.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|+.++|+||+++++++.+++..+|||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999975 78999999997432 233466889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +|+|||||++||||+.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999987554 89999999999999999999998 9999999999999999999999999999865432
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------hHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------DAKILF 593 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~~~~ 593 (607)
....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ....+.+++ ....+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~p~~~~~~~~ 231 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRFPPFFNEDVK 231 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 234578999999999999999999999999999999999999997632 111222221 135678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 232 ~li~~lL~~dp~ 243 (318)
T 1fot_A 232 DLLSRLITRDLS 243 (318)
T ss_dssp HHHHHHTCSCTT
T ss_pred HHHHHHhccCHH
Confidence 899999977653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=359.71 Aligned_cols=234 Identities=24% Similarity=0.354 Sum_probs=191.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.++||+|+||.||+|+++ +++.||||+++... ....+.+++|+.+|.++ +|+||+++++++.+++..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367999999999999999999975 57889999997542 22234588999999887 89999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||.+|+|..++...+. +.+..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999887554 89999999999999999999999 999999999999999999999999999986433
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc---hhHHHHHhHh----------
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD---ESLVEWVNLI---------- 587 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~---~~l~~~~~~~---------- 587 (607)
.. ......+||..|||||++.+..++.++|||||||+||||++|+.||.......+ .....+.+.+
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 22 224456799999999999999999999999999999999999999975321111 1111111111
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 285 ~s~~~~~li~~lL~~dP~ 302 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPK 302 (396)
T ss_dssp SCHHHHHHHHHHTCSCTT
T ss_pred CCHHHHHHHHHHhcCCHh
Confidence 135678899999987754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.09 Aligned_cols=233 Identities=16% Similarity=0.192 Sum_probs=191.9
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+++|++| +|+||+++++++..++..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999996 4789999999875432 34688999999999 89999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc-----EEEEeccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLA 518 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGls~~~ 518 (607)
|+ +++|.+++.... ..+++..+++|+.||++||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999987642 3589999999999999999999999 9999999999999998887 999999999876
Q ss_pred ccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh----
Q 007351 519 LDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID---- 588 (607)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~---- 588 (607)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.......+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 443321 1235679999999999999999999999999999999999999998754322222222111000
Q ss_pred -------HHHHHHHHHHhhhcCCC
Q 007351 589 -------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 -------~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++..||+.++.
T Consensus 241 ~~~~~~~~p~~~~li~~~l~~~p~ 264 (330)
T 2izr_A 241 IEVLCENFPEMATYLRYVRRLDFF 264 (330)
T ss_dssp HHHHTTTCHHHHHHHHHHHHCCTT
T ss_pred HHHHhccChHHHHHHHHHHhCCCC
Confidence 12788899999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.99 Aligned_cols=231 Identities=26% Similarity=0.358 Sum_probs=193.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|+.++|+||+++++++..++..+|||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56999999999999999999965 58899999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++..... +.+..++.++.||+.||+|||++ +|+|||||++||||+++|.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999987544 89999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKIL 592 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~ 592 (607)
.....+|+..|||||++.+ ..++.++|||||||+||||++|+.||..........+.+..... ....+
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~ 247 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence 2345679999999999874 45889999999999999999999999865433333333222111 13677
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 248 ~~li~~lL~~dP 259 (384)
T 4fr4_A 248 VSLLKKLLEPNP 259 (384)
T ss_dssp HHHHHHHSCSSG
T ss_pred HHHHHHHhcCCH
Confidence 889999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.48 Aligned_cols=231 Identities=26% Similarity=0.407 Sum_probs=192.5
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 439 (607)
..++|++.++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|.++|..+ +|+||+++++++.+++..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3478999999999999999999975 68899999997432 23345678899999987 8999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||||+.+|+|..++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.+|.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999976543 89999999999999999999999 99999999999999999999999999998543
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKIL 592 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~ 592 (607)
.... .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+..... ....+
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYPRWLEKEA 245 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCCCCcccCHHH
Confidence 2222 2345679999999999999999999999999999999999999997642 22222211110 13667
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 246 ~~li~~lL~~dp 257 (345)
T 1xjd_A 246 KDLLVKLFVREP 257 (345)
T ss_dssp HHHHHHHSCSSG
T ss_pred HHHHHHHhcCCH
Confidence 889999997664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.85 Aligned_cols=233 Identities=24% Similarity=0.359 Sum_probs=191.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|+++ +|+.||||+++... ....+.+++|+++|+++ +|+||+++++++..++..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56999999999999999999975 68899999997542 23345688999999988 899999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999876543 89999999999999999999999 9999999999999999999999999999864332
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc---hhHHHHHhHh----------h
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD---ESLVEWVNLI----------D 588 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~---~~l~~~~~~~----------~ 588 (607)
. ......+|+..|+|||++.+..++.++|||||||+||||++|+.||.......+ .......+.+ .
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 2 223456799999999999999999999999999999999999999975321111 1111111111 1
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 243 s~~~~~li~~lL~~dP~ 259 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPK 259 (345)
T ss_dssp CHHHHHHHHHHTCSSTT
T ss_pred CHHHHHHHHHHhcCCHh
Confidence 35678899999987764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.36 Aligned_cols=232 Identities=31% Similarity=0.477 Sum_probs=185.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
..++|++.+.||+|+||.||+|++ +|+.||||+++.... ...+++.+|+++|++++|+||+++++++..++..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346799999999999999999988 789999999875443 33457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
||+.+|+|.++++.... ..+++..+++++.||++||+|||++ + |+|||||++||||++++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999976432 2388999999999999999999998 8 9999999999999999999999999997544
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAK 590 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~ 590 (607)
... .......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+....... ....
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHHSCCCCCCCTTSCH
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCccCCH
Confidence 322 22334568999999999999999999999999999999999999997642 2222222211 1135
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 267 ~l~~li~~~l~~dP 280 (309)
T 3p86_A 267 QVAAIIEGCWTNEP 280 (309)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHccCCh
Confidence 67889999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.58 Aligned_cols=200 Identities=20% Similarity=0.231 Sum_probs=174.3
Q ss_pred hCCCcccceecccCcEEEEEEE------eCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDD 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~------~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~ 436 (607)
.++|.+.++||+|+||.||+|. ..+++.||||+++.. ...++.+|+++++.++ |+||+++++++..++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999994 446889999998743 3557888888888886 999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC----------
Q 007351 437 RRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---------- 503 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---------- 503 (607)
..+||||||++|+|.++++.. ....+++..+++|+.||++||+|||++ +|||||||++||||++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999998642 234599999999999999999999998 9999999999999988
Q ss_pred -CCcEEEEeccccccccc-CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 504 -NFEAQVSDFGLAKLALD-ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 504 -~~~vkL~DFGls~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
++.+||+|||+++.... .........+||..|||||++.+..++.++|||||||+||||++|+.||..
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976542 223344556799999999999999999999999999999999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.89 Aligned_cols=230 Identities=23% Similarity=0.323 Sum_probs=193.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++++.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|+.++|+||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999975 6899999999754322 346799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEeccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 514 (607)
+|||||+.+|+|.+++...+ .+++..++.++.||++||+|||++ +|+|||||++||||++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997654 489999999999999999999999 999999999999998776 799999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------- 586 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------- 586 (607)
++...... .....+|+..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..++.+....
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITAVSYDFDEE 240 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCCHH
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCch
Confidence 98765432 2334579999999999999999999999999999999999999997642 1222211110
Q ss_pred ---hhHHHHHHHHHHhhhcCCC
Q 007351 587 ---IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ---~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~ 262 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETR 262 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTT
T ss_pred hccCCCHHHHHHHHHHCCCChh
Confidence 0134578899999987764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.48 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=172.7
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|++.+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++..++..+||||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4679999999999999999999988999999999754322 34678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+++ +|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9985 6777666543 3489999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+..
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2334568999999999876 568999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=337.85 Aligned_cols=230 Identities=27% Similarity=0.487 Sum_probs=194.1
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++.+++.||||+++... ...+++.+|+++|++++|+||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5689999999999999999999889999999997543 345679999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999976443 589999999999999999999999 999999999999999999999999999986644332233
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++.+..... ....+.+++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 33456778999999999999999999999999999999 999997642 22222221111 2467889999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 242 ~~l~~~p 248 (269)
T 4hcu_A 242 HCWRERP 248 (269)
T ss_dssp HHTCSSG
T ss_pred HHccCCc
Confidence 9998775
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.90 Aligned_cols=230 Identities=22% Similarity=0.335 Sum_probs=192.3
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
..++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+++|+++|+.|+|+||+++++++.+++..+||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999975 689999999975432 3446789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEeccccccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKLA 518 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DFGls~~~ 518 (607)
|||+.+|+|.+++.... .+.+..++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999887654 489999999999999999999999 99999999999999764 45999999999866
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------h
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------I 587 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~ 587 (607)
..... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.+.. ...+.+.... .
T Consensus 182 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 182 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp TTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTGGGG
T ss_pred cCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCcccccC
Confidence 53322 334679999999999999999999999999999999999999997642 1222221111 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 257 ~~~~~~~li~~~L~~dP 273 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNP 273 (362)
T ss_dssp SCHHHHHHHHHHSCSSG
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 13567889999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=369.26 Aligned_cols=233 Identities=26% Similarity=0.410 Sum_probs=198.0
Q ss_pred hhCCCcccceecccCcEEEEEEEeCC-CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
..++|++.+.||+|+||.||+|++++ ++.||||+++... ...++|.+|+++|++|+|+||++++++|..++..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568889999999999999999864 8899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|+|.++++......+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999876666799999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFK 594 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~ 594 (607)
.......++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ...+.++.... ....+.+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 33333456778999999999999999999999999999999 999997643 23333332211 1367889
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+||+.++
T Consensus 451 li~~cl~~dP 460 (495)
T 1opk_A 451 LMRACWQWNP 460 (495)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcCcCh
Confidence 9999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=367.55 Aligned_cols=233 Identities=25% Similarity=0.455 Sum_probs=194.8
Q ss_pred HhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
...++|++.+.||+|+||.||+|.+++++.||||+++... ...++|++|+++|++|+|+||+++++++. ++..+||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456788999999999999999999888999999997543 44678999999999999999999999986 667899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|+|.++++......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999865444588899999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFK 594 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~ 594 (607)
.......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....+.+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22233446778999999999999999999999999999999 999997642 22333322211 1267889
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+||+.++
T Consensus 417 li~~cl~~dp 426 (454)
T 1qcf_A 417 IMMRCWKNRP 426 (454)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 9999998775
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.90 Aligned_cols=232 Identities=28% Similarity=0.426 Sum_probs=183.7
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCce---
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR--- 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~--- 438 (607)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... ....+++|++++++++|+||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36799999999999999999996 47889999999754332 235689999999999999999999998876544
Q ss_pred -EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 439 -LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 439 -~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
+|||||+++++|.++++..+. +.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999986553 89999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------
Q 007351 518 ALDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------- 586 (607)
Q Consensus 518 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------- 586 (607)
....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.... ....++.+.
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCCCccccc
Confidence 5443221 223456899999999999999999999999999999999999999764211 111111110
Q ss_pred -hhHHHHHHHHHHhhhcCC
Q 007351 587 -IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 -~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 244 ~~~~~~l~~li~~~l~~dP 262 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNP 262 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSG
T ss_pred CCCCHHHHHHHHHHHhcCH
Confidence 023567889999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=341.99 Aligned_cols=228 Identities=24% Similarity=0.323 Sum_probs=191.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|+.|+|+||+++++++..++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45899999999999999999975 6899999999754322 3567999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEecccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGLA 515 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGls 515 (607)
|||||+.+++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999997654 489999999999999999999999 999999999999998887 8999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------- 586 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------- 586 (607)
+....... .....|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..+.......
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCCCCCHHH
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCCCcCccc
Confidence 87643322 234568999999999999999999999999999999999999997542 1111111110
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 241 ~~~~~~~~~~li~~~L~~dP 260 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDP 260 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSG
T ss_pred cccCCHHHHHHHHHHccCCh
Confidence 113567889999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.61 Aligned_cols=232 Identities=24% Similarity=0.356 Sum_probs=191.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+++|+++|+.++|+||+++++++..++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999864 68999999986321 224577999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc---EEEEeccc
Q 007351 440 LIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGL 514 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGl 514 (607)
||||||++++|.+++... ....+.+..+++++.||++||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777542 233488999999999999999999999 9999999999999976554 99999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------- 586 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------- 586 (607)
++....... .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..+.+....
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCCCCCHH
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCCCCCcc
Confidence 987654322 2344579999999999999999999999999999999999999997631 222211110
Q ss_pred ---hhHHHHHHHHHHhhhcCCC
Q 007351 587 ---IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ---~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~ 276 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPA 276 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTT
T ss_pred ccccCCHHHHHHHHHHCCCChh
Confidence 0135678899999987764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.35 Aligned_cols=231 Identities=27% Similarity=0.440 Sum_probs=189.5
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|++. .+..||||+++.... ...+.|.+|+++|+.|+|+||+++++++..++..+||
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56899999999999999999974 344699999976533 3456799999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++++|.++++.... .+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 999999999999976532 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+..... ...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCCCCCCCCcCH
Confidence 222 2223345778999999999999999999999999999999 999997642 22222222111 136
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 282 ~l~~li~~~l~~dp 295 (325)
T 3kul_A 282 ALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHccCCh
Confidence 78889999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.48 Aligned_cols=227 Identities=27% Similarity=0.298 Sum_probs=192.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|+.++|+||+++++++.+++..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999975 68999999996432 233467889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999987554 89999999999999999999999 9999999999999999999999999999865432
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.++
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 234568999999999999999999999999999999999999997532 1122111110 113677899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 269 i~~lL~~dp~ 278 (350)
T 1rdq_E 269 LRNLLQVDLT 278 (350)
T ss_dssp HHHHSCSCTT
T ss_pred HHHHhhcCHH
Confidence 9999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.61 Aligned_cols=227 Identities=27% Similarity=0.379 Sum_probs=182.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHH-HHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEI-ISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|+.+ +++.||||+++.... ...+.+.+|..+ ++.++|+||+++++++..++..|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57999999999999999999975 578899999975432 233456677776 5678999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.+|++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999976543 88999999999999999999999 9999999999999999999999999999864333
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------hHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI---------DAKIL 592 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~~~ 592 (607)
.. .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ....+.+++ ....+
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 NS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKPLQLKPNITNSA 266 (373)
T ss_dssp CC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHSCCCCCSSSCHHH
T ss_pred CC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcccCCCCCCCHHH
Confidence 22 2445679999999999999999999999999999999999999997532 111122221 13567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 267 ~~li~~lL~~dp 278 (373)
T 2r5t_A 267 RHLLEGLLQKDR 278 (373)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHcccCH
Confidence 888999987664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.75 Aligned_cols=231 Identities=25% Similarity=0.346 Sum_probs=192.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.++||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|.++|..+ +|+||+++++++..++..+|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999976 47889999997432 23345688899999987 79999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+|+|..++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.+|.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999986554 89999999999999999999999 999999999999999999999999999986432
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILF 593 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~ 593 (607)
.. ......+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22 22345679999999999999999999999999999999999999997632 1222221110 0136678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 250 ~li~~lL~~dP~ 261 (353)
T 2i0e_A 250 AICKGLMTKHPG 261 (353)
T ss_dssp HHHHHHTCSCTT
T ss_pred HHHHHHhhcCHH
Confidence 899999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.60 Aligned_cols=231 Identities=26% Similarity=0.466 Sum_probs=194.6
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.+.||+|+||.||+|+++++..||||+++.... ..+++.+|+++|++++|+||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357999999999999999999998888999999975433 3567999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++++|.+++...+ ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999887643 2489999999999999999999999 99999999999999999999999999998765544433
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~ 596 (607)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....... .....+.+++
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 344456678999999998899999999999999999999 999997542 2222211111 1246688999
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 239 ~~~l~~~p 246 (268)
T 3sxs_A 239 YSCWHELP 246 (268)
T ss_dssp HHTTCSSG
T ss_pred HHHcCCCh
Confidence 99998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.92 Aligned_cols=205 Identities=16% Similarity=0.270 Sum_probs=179.0
Q ss_pred hCCCcccceeccc--CcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEG--GFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G--~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.++||+| +||.||+|+.. +|+.||||+++... ....+.+++|+++|+.++|+||+++++++..++..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3579999999999 99999999976 68999999997543 2334668899999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||++|+|.+++.......+.+..+++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876555699999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcc------eeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 521 ANTH------ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 521 ~~~~------~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
.... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2111 1122468889999999987 578999999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.83 Aligned_cols=231 Identities=28% Similarity=0.479 Sum_probs=181.0
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|++. +++.||||+++.... ...++|.+|+++|++++|+||+++++++..++..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999864 567899999976533 3456799999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++|+|.++++..+ ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997653 3489999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+..... ...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHHHTTEECCCCTTCBH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCccccH
Confidence 2221 122345678999999999999999999999999999998 999997542 23333322211 136
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 278 ~l~~li~~cl~~dp 291 (373)
T 2qol_A 278 ALYQLMLDCWQKDR 291 (373)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHhCcCh
Confidence 78899999998765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=335.29 Aligned_cols=199 Identities=22% Similarity=0.368 Sum_probs=170.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++..++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 688999999975443 234678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.++ |..++.... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEE-HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCCC-HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 99865 544444322 2489999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
.......|+..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 2234457899999999998765 79999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.68 Aligned_cols=235 Identities=27% Similarity=0.457 Sum_probs=193.5
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 436 (607)
...++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.|++|+++|++++|+||+++++++..++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999974 347899999975543 33567999999999999999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCC
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGR----------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL 494 (607)
..+|||||+++|+|.+++..... ..+++.++++|+.||++||+|||++ +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999999999999999876421 4589999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 007351 495 KSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDAS 572 (607)
Q Consensus 495 kp~NILl~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~ 572 (607)
|++||||++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986543322 22334567889999999999999999999999999999999 99999754
Q ss_pred CCCCchhHHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 573 QPLGDESLVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 573 ~~~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
. ..++.+..... ....+.+++.+||+.++
T Consensus 281 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 281 A---HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp C---HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred C---hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 2 22222222111 13578899999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.68 Aligned_cols=231 Identities=25% Similarity=0.454 Sum_probs=190.9
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.+.||+|+||.||+|.+.+++.||||+++... ...+++.+|+++|++++|+||+++++++..++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 35799999999999999999999888899999997543 34567999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 99999999976332 489999999999999999999999 99999999999999999999999999998664433222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~ 596 (607)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..+.... .....+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLRLYRPHLASEKVYTIM 254 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence 333456778999999998899999999999999999998 999997642 2222221111 1246788999
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 255 ~~~l~~~p 262 (283)
T 3gen_A 255 YSCWHEKA 262 (283)
T ss_dssp HHTTCSSG
T ss_pred HHHccCCh
Confidence 99998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=341.05 Aligned_cols=229 Identities=20% Similarity=0.308 Sum_probs=192.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|... +++.||+|+++.. ......+++|+++|+.++|+||+++++++.+++..+|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999975 6889999998754 34456789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--CCcEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGls~~~~~~~ 522 (607)
|++++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999987643 2489999999999999999999999 9999999999999987 7899999999998765433
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-hH----------hhHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-NL----------IDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~~----------~~~~~ 591 (607)
. .....|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. +..+.+.. +. .....
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCChhhhccCCHH
Confidence 2 334568999999999998889999999999999999999999997642 12221111 10 01356
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 234 ~~~li~~~L~~dp 246 (321)
T 1tki_A 234 AMDFVDRLLVKER 246 (321)
T ss_dssp HHHHHHTTSCSSG
T ss_pred HHHHHHHHcCCCh
Confidence 7889999998765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=336.79 Aligned_cols=230 Identities=23% Similarity=0.321 Sum_probs=184.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--------------------------hHHHHHHHHHHHH
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------------------------GEREFKAEVEIIS 418 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--------------------------~~~~~~~Ei~il~ 418 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999864 6889999999654311 1246889999999
Q ss_pred HccCCCceeEEeEEEe--CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCC
Q 007351 419 RIHHRHLVSLVGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (607)
Q Consensus 419 ~l~HpnIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (607)
+++|+||+++++++.. ++..+|||||+++++|.+++.. ..+++..++.++.||++||+|||++ +|+|||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 5578999999999999876543 2489999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 497 SNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 497 ~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+||||++++.+||+|||+++....... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.+..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987654332 234467999999999998765 3678999999999999999999997542
Q ss_pred CCCchhHHHHHhH---------hhHHHHHHHHHHhhhcCCC
Q 007351 574 PLGDESLVEWVNL---------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 574 ~~~~~~l~~~~~~---------~~~~~~~~i~~~C~~~~~~ 605 (607)
...+.+.... .....+.+++.+|++.++.
T Consensus 245 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 282 (298)
T 2zv2_A 245 ---IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282 (298)
T ss_dssp ---HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTT
T ss_pred ---HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChh
Confidence 1111111110 1136788999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.33 Aligned_cols=245 Identities=40% Similarity=0.715 Sum_probs=201.2
Q ss_pred CccHHHHHHhhCCCccc------ceecccCcEEEEEEEeCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHccCCCc
Q 007351 356 MFTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHL 425 (607)
Q Consensus 356 ~~~~eel~~~~~~y~~~------~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnI 425 (607)
.|.++++.++.++|... +.||+|+||.||+|++ +++.||||++.... ....+.+.+|+++|+.++|+||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 47889999998888766 8999999999999997 78999999986432 2345679999999999999999
Q ss_pred eeEEeEEEeCCceEEEEEecCCCchhHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC
Q 007351 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 426 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (607)
+++++++..++..++||||+.+++|.+++... ....+.+..+++++.||++||+|||++ +|+|||||++||||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999988643 234589999999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch-hH--
Q 007351 505 FEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SL-- 580 (607)
Q Consensus 505 ~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l-- 580 (607)
+.+||+|||+++....... .......|+..|+|||++.+ .++.++|||||||++|||++|+.||......... .+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 9999999999986544322 22344578999999998875 5889999999999999999999999865432211 11
Q ss_pred ---------HHHHh-------HhhHHHHHHHHHHhhhcCCC
Q 007351 581 ---------VEWVN-------LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 581 ---------~~~~~-------~~~~~~~~~i~~~C~~~~~~ 605 (607)
.+|.. ......+.+++.+|++.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp HHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred HhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcc
Confidence 11111 11235678899999988764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=349.90 Aligned_cols=229 Identities=23% Similarity=0.304 Sum_probs=193.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|... +|+.||+|+++.........+++|+++|+.|+|+||+++++++.+++..+||||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999975 68899999998666566678999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--CCcEEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGls~~~~~~~~ 523 (607)
.+|+|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++.......
T Consensus 131 ~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 131 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999887643 3489999999999999999999999 9999999999999974 57899999999987654322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~~~~ 592 (607)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. +.+..+.... .....+
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccccccCCHHH
Confidence 233468999999999999999999999999999999999999997642 1222221111 113567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 282 ~~li~~~L~~dP 293 (387)
T 1kob_A 282 KDFIKNLLQKEP 293 (387)
T ss_dssp HHHHHTTSCSSG
T ss_pred HHHHHHHcCCCh
Confidence 899999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.21 Aligned_cols=200 Identities=25% Similarity=0.395 Sum_probs=171.2
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|+..+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999999754332 236788999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+ +|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 8888876543 2488999999999999999999999 999999999999999999999999999986543221
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......|+..|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22345689999999999764 5899999999999999999999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=373.02 Aligned_cols=231 Identities=31% Similarity=0.486 Sum_probs=192.8
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.+.||+|+||.||+|++++++.||||+++... ...++|++|+++|++|+|+||+++++++.+ +..+||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688889999999999999999888899999997544 345689999999999999999999999875 6789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+|+|.++|+......+.+..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++...+.....
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999764444589999999999999999999999 99999999999999999999999999998664322222
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
.....++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....+.+++
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYRMPCPPECPESLHDLM 497 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 233456788999999999999999999999999999999 999997642 22333322111 135688999
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+||+.++
T Consensus 498 ~~cl~~dP 505 (535)
T 2h8h_A 498 CQCWRKEP 505 (535)
T ss_dssp HHHTCSSG
T ss_pred HHHcCCCh
Confidence 99998775
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.64 Aligned_cols=228 Identities=23% Similarity=0.340 Sum_probs=185.7
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
|...++||+|+||.||+|+.. +|+.||||+++.......+++++|+++|++|+|+||+++++++..++..+|||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 344678999999999999864 6899999999876666677899999999999999999999999999999999999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE--cCCCcEEEEecccccccccCCcce
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL--DNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl--~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 171 GELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp CEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988886543 2489999999999999999999999 99999999999999 5678999999999987644332
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hhHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------IDAKILFKL 595 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~~~~~~~i 595 (607)
....+|+..|||||++.+..++.++|||||||+||||++|+.||.+... ...+.++.+. .....+.++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 2334689999999999998999999999999999999999999976421 1111222211 113677899
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 323 i~~~L~~dp 331 (373)
T 2x4f_A 323 ISKLLIKEK 331 (373)
T ss_dssp HHTTSCSSG
T ss_pred HHHHcCCCh
Confidence 999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.47 Aligned_cols=201 Identities=24% Similarity=0.375 Sum_probs=174.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 442 (607)
++|++.++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56999999999999999999975 58999999997543 234567889999999999999999999998765 679999
Q ss_pred EecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----cCCCcEEEEecccccc
Q 007351 443 DYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKL 517 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGls~~ 517 (607)
||+.+++|.+++..... ..+.+..++.++.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976433 2389999999999999999999999 99999999999999 7788899999999987
Q ss_pred cccCCcceeeccccCCCCCchhhhc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYAS--------SGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... .....|+..|+|||++. +..++.++|||||||+||||++|+.||...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654332 23456899999999986 577899999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=359.22 Aligned_cols=227 Identities=27% Similarity=0.452 Sum_probs=191.0
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-ceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+++|++++|+||+++++++..++ ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 35788899999999999999998 58899999997543 4578999999999999999999999988765 78999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
|.+|+|.++++..+...+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 9999999999877666689999999999999999999999 9999999999999999999999999999854322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i 595 (607)
.....++..|||||++.+..++.++|||||||+||||++ |+.||.+... .++.+.+... ....+.++
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 122356889999999999999999999999999999998 9999986532 2222222111 13678899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+||+.++.
T Consensus 419 i~~cl~~dp~ 428 (450)
T 1k9a_A 419 MKNCWHLDAA 428 (450)
T ss_dssp HHHHTCSSGG
T ss_pred HHHHcCCChh
Confidence 9999987753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=345.60 Aligned_cols=206 Identities=25% Similarity=0.342 Sum_probs=180.8
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-----CCCceeEEeE
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----HRHLVSLVGY 431 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~g~ 431 (607)
.+++.....++|++.++||+|+||.||+|++. +++.||||+++. .....+.+.+|+++|+.++ |+||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33444455678999999999999999999974 788999999863 2344567888999999996 9999999999
Q ss_pred EEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--------
Q 007351 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------- 503 (607)
Q Consensus 432 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------- 503 (607)
+...+..+|||||+ +++|.+++.......+.+..++.++.||++||+|||++ +|||||||++||||++
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 99999999999999 89999999877666699999999999999999999999 9999999999999975
Q ss_pred -----------------CCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCC
Q 007351 504 -----------------NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566 (607)
Q Consensus 504 -----------------~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~ 566 (607)
++.+||+|||+++..... .....|+..|||||++.+..++.++|||||||+||||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999864432 23456899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 007351 567 KPVDAS 572 (607)
Q Consensus 567 ~Pf~~~ 572 (607)
.||...
T Consensus 257 ~pf~~~ 262 (360)
T 3llt_A 257 LLFRTH 262 (360)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=336.06 Aligned_cols=229 Identities=28% Similarity=0.440 Sum_probs=185.1
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHH--ccCCCceeEEeEEEeC----CceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISD----DRRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~----~~~~ 439 (607)
.++|++.+.||+|+||.||+|++ +|+.||||+++. .....+.+|.+++.. ++|+||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999998 799999999864 345667778888887 7899999999987653 3578
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH--------EDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
|||||+++|+|.++++.. .+++..+++++.||++||+||| ++ +|+|||||++||||++++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999643 4899999999999999999999 77 999999999999999999999999
Q ss_pred cccccccccCCcce---eeccccCCCCCchhhhcCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCC
Q 007351 512 FGLAKLALDANTHI---TTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITG----------RKPVDAS 572 (607)
Q Consensus 512 FGls~~~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~~~~~DVwSlGvll~ELltg----------~~Pf~~~ 572 (607)
||+++......... .....|+..|+|||++.+. .++.++|||||||+||||++| +.||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998665443322 2234789999999999876 344689999999999999999 8888654
Q ss_pred CCCCchhHHHHHhH-----------------hhHHHHHHHHHHhhhcCCC
Q 007351 573 QPLGDESLVEWVNL-----------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 573 ~~~~~~~l~~~~~~-----------------~~~~~~~~i~~~C~~~~~~ 605 (607)
..... ...++.+. .....+.+++.+||+.++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 237 VPNDP-SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp SCSSC-CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred CCCCc-chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChh
Confidence 32221 11222111 1236688999999987753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.13 Aligned_cols=201 Identities=31% Similarity=0.487 Sum_probs=171.8
Q ss_pred CCCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 439 (607)
++|++.+.||+|+||.||+|++ .+++.||||+++.......+.+.+|+++|++++|+||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5799999999999999999984 26889999999876666667899999999999999999999998654 4589
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||||+.+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++++||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999976532 489999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
..... ......++..|+|||++.+..++.++|||||||+||||++|+.+|..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 43221 22334567789999999999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.83 Aligned_cols=232 Identities=26% Similarity=0.428 Sum_probs=191.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|++. +++.||||+++..... ..++|.+|+++|++++|+||++++++|..++..+||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457889999999999999999986 7899999998754332 33468999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+++|+|.++++..+ ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...+...
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999987643 2488999999999999999999999 999999999999999999999999999986443221
Q ss_pred cee-eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHH
Q 007351 524 HIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILF 593 (607)
Q Consensus 524 ~~~-~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~ 593 (607)
... ....++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. .....+++... ....+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFVEKGGRLPCPELCPDAVF 345 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 11234678999999998899999999999999999998 999997642 23333333221 135778
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+||+.++
T Consensus 346 ~li~~cl~~dP 356 (377)
T 3cbl_A 346 RLMEQCWAYEP 356 (377)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHcCCCc
Confidence 99999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.66 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=197.0
Q ss_pred ccHHHHHHhhCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeE
Q 007351 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSL 428 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l 428 (607)
+...++....++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|+++ +|+||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45556666678899999999999999999974 24578999999765433 346799999999999 79999999
Q ss_pred EeEEEeCCc-eEEEEEecCCCchhHhhhcCCC------------------------------------------------
Q 007351 429 VGYCISDDR-RLLIYDYVPNNTLYFHLHGEGR------------------------------------------------ 459 (607)
Q Consensus 429 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 459 (607)
+++|..++. .++|||||.+|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 460 ----------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 460 ----------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
..+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1288999999999999999999999 999999999999999999999999999986543322
Q ss_pred -ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILF 593 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~ 593 (607)
.......|+..|||||++.+..++.++|||||||+||||++ |+.||.+... +..+.+..... ....+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 326 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGTRMRAPDYTTPEMY 326 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--SHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--hHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 23344568889999999999999999999999999999998 9999976432 12222222211 135688
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+|++.++
T Consensus 327 ~li~~~l~~dP 337 (359)
T 3vhe_A 327 QTMLDCWHGEP 337 (359)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHccCCh
Confidence 89999998765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.61 Aligned_cols=231 Identities=27% Similarity=0.367 Sum_probs=190.4
Q ss_pred CCCcccceecccCcEEEEEEEe----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
++|++.++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|+.+ +|+||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999997 378999999986432 23345678899999999 59999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+|||||+.+++|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++++||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999976543 89999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCcceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------- 587 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------- 587 (607)
............+|+..|||||++.+ ..++.++|||||||+||||++|+.||........ ..++.+.+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccCCCCC
Confidence 65443333445679999999999986 3478899999999999999999999975432222 22222211
Q ss_pred --hHHHHHHHHHHhhhcCC
Q 007351 588 --DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 --~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 287 ~~~~~~~~~li~~~L~~dP 305 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDP 305 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSG
T ss_pred cccCHHHHHHHHHHhhhCH
Confidence 13567889999998765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=364.66 Aligned_cols=234 Identities=29% Similarity=0.406 Sum_probs=197.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.++||+|+||.||+|+.. +|+.||||+++... ......+++|+++|+.++|+||+++++++.+++..+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356899999999999999999975 78999999996432 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|.+++...+...+++..++.++.||+.||+|||++ +|||||||++||||+++|.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876666699999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhHh-------hHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNLI-------DAKILF 593 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~~-------~~~~~~ 593 (607)
.. ....+|+..|||||++.+..++.++|||||||+||||++|+.||.+...... ..+.+..... ....+.
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 22 3345799999999999998999999999999999999999999987543222 2222222111 135678
Q ss_pred HHHHHhhhcCC
Q 007351 594 KLVFLCQQNSN 604 (607)
Q Consensus 594 ~i~~~C~~~~~ 604 (607)
+++.+|++.++
T Consensus 418 dLI~~lL~~dP 428 (576)
T 2acx_A 418 SLCSQLLCKDP 428 (576)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHhccCCH
Confidence 89999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=351.87 Aligned_cols=228 Identities=23% Similarity=0.323 Sum_probs=179.4
Q ss_pred CCCccc-ceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHH-ccCCCceeEEeEEEe----CCceE
Q 007351 367 DGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISR-IHHRHLVSLVGYCIS----DDRRL 439 (607)
Q Consensus 367 ~~y~~~-~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~----~~~~~ 439 (607)
++|.+. ++||+|+||.||+|++. +|+.||||+++. ...+.+|++++.+ ++|+||+++++++.. ++..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 346555 78999999999999975 688999999863 3467888988755 589999999999875 55689
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~ 516 (607)
||||||.+|+|.+++.......+++..+++|+.||++||+|||++ +|||||||++||||++ ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876656699999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHhH---------
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWVNL--------- 586 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l~~~~~~--------- 586 (607)
...... .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+....... .+.+....
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 654322 233457899999999999999999999999999999999999999865433211 12111111
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 291 ~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSG
T ss_pred cccCCHHHHHHHHHHCCCCh
Confidence 123567889999998765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.23 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=172.7
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-----hhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-----QGEREFKAEVEIISRIH---HRHLVSLVGYCISDD 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~-----~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~ 436 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++ |+||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 46899999999999999999996 4789999999974321 22356778888887775 999999999998765
Q ss_pred -----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 437 -----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 437 -----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
..++||||+. ++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999997 5899999877666699999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
||+++...... ......|+..|||||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998654322 234457899999999999999999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.34 Aligned_cols=234 Identities=28% Similarity=0.429 Sum_probs=191.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....++.+|+++|++++|+||+++++++..++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357899999999999999999953 46689999996543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---cEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~ 510 (607)
+||||||.+|+|.++++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999876432 3489999999999999999999999 999999999999998544 59999
Q ss_pred ecccccccccCC-cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh-
Q 007351 511 DFGLAKLALDAN-THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI- 587 (607)
Q Consensus 511 DFGls~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~- 587 (607)
|||+++...... ........|+..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.++....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~~~~ 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGG 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC
Confidence 999998553322 222334567889999999999999999999999999999998 999997642 23333332221
Q ss_pred -------hHHHHHHHHHHhhhcCCC
Q 007351 588 -------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~ 328 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPE 328 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHh
Confidence 135678999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.74 Aligned_cols=201 Identities=25% Similarity=0.423 Sum_probs=161.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++..++..+|||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 57899999999999999999864 689999999975543 2346789999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 445 VPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 445 ~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
++ |+|.+++... ....+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 5888777542 223488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222 23345689999999999864 6899999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.00 Aligned_cols=231 Identities=21% Similarity=0.283 Sum_probs=192.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+++|+++|+.|+|+||+++++++.+++..+|||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 457999999999999999999864 789999999975543 33456899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGls~~~~ 519 (607)
|||.+|+|.+++...+. +.+..+.+++.||++||+|||++ +|+|||||++||||+ +++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999998887654 89999999999999999999999 999999999999998 56789999999998665
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hh
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------ID 588 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~ 588 (607)
.... ......|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... ..
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCTTTTTTS
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCCccccccC
Confidence 4332 2344679999999999999999999999999999999999999997642 2222221111 11
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 241 s~~~~~li~~~L~~dP~ 257 (444)
T 3soa_A 241 TPEAKDLINKMLTINPS 257 (444)
T ss_dssp CHHHHHHHHHHSCSSTT
T ss_pred CHHHHHHHHHHcCCChh
Confidence 35678999999988764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.18 Aligned_cols=233 Identities=29% Similarity=0.408 Sum_probs=193.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++|.+++.||+|+||.||+|++. +++.||||+++..... ..+.+.+|+++|+++ +|+||++++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357899999999999999999852 2357999999765433 346799999999999 899999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..+|||||+.+|+|.+++..... ..+.+..+++|+.||++||+|||++ +|+|||||++||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999976542 3489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHH
Confidence 9999999999999986644322 22333456788999999999999999999999999999999 999997542 223
Q ss_pred HHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 580 LVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 580 l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
+.++.... ....+.+++.+||+.++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCh
Confidence 33332221 13678889999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.01 Aligned_cols=232 Identities=30% Similarity=0.503 Sum_probs=193.2
Q ss_pred hhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
..++|++.+.||+|+||.||+|++.+++.||||+++... ...+.+.+|+++|+.++|+||+++++++. ++..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346799999999999999999999888899999987543 34578999999999999999999999986 4568999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999999764433589999999999999999999999 9999999999999999999999999999876554433
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i 595 (607)
......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.... .....+.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHHHHhcccCCCCcccccHHHHHH
Confidence 3344456788999999998889999999999999999999 999997532 2222222211 113677889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 243 i~~~l~~~p 251 (279)
T 1qpc_A 243 MRLCWKERP 251 (279)
T ss_dssp HHHHTCSSG
T ss_pred HHHHhccCh
Confidence 999998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=340.35 Aligned_cols=230 Identities=22% Similarity=0.313 Sum_probs=183.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR------- 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------- 437 (607)
++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+++|+++|++|+|+||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56999999999999999999976 789999999975443 345679999999999999999999999866432
Q ss_pred --------------------------------------------------eEEEEEecCCCchhHhhhcCCC-CCCCHHH
Q 007351 438 --------------------------------------------------RLLIYDYVPNNTLYFHLHGEGR-PVLDWAT 466 (607)
Q Consensus 438 --------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~ 466 (607)
.++|||||++++|.++++.... ....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 7899999999999999976533 2355667
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc-----------ceeeccccCCCC
Q 007351 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-----------HITTRVMGTFGY 535 (607)
Q Consensus 467 ~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~-----------~~~~~~~gt~~y 535 (607)
+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... .......|+..|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999999 999999999999999999999999999987654321 122345689999
Q ss_pred CchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHHHHHHhhhcCC
Q 007351 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 536 ~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~i~~~C~~~~~ 604 (607)
+|||++.+..++.++|||||||+||||++|..++... ..+..... ......+.+++.+|++.++
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence 9999999999999999999999999999987765321 11111110 0112445789999998775
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.90 Aligned_cols=231 Identities=26% Similarity=0.377 Sum_probs=184.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++|+.++|+||++++++|..++..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999964 6899999999743 233345678999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||.+|+|.+++.... .+.+..++.++.||++||+|||+ + +|||||||++||||++++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999987654 38999999999999999999998 7 999999999999999999999999999986433
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILF 593 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~ 593 (607)
... .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....+.
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~ 377 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFPRTLGPEAK 377 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHH
Confidence 322 2344679999999999999999999999999999999999999997642 2222222111 1235678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 378 ~li~~~L~~dP~ 389 (446)
T 4ejn_A 378 SLLSGLLKKDPK 389 (446)
T ss_dssp HHHHHHTCSSTT
T ss_pred HHHHHHcccCHH
Confidence 899999988764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=361.30 Aligned_cols=232 Identities=31% Similarity=0.485 Sum_probs=187.8
Q ss_pred hhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
..++|++.+.||+|+||.||+|.++++..||||+++... ...++|++|+++|++|+|+||+++++++.. +..+|||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346688899999999999999999888889999997543 345689999999999999999999999876 678999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+|+|.++++......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999764444589999999999999999999999 9999999999999999999999999999876543333
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i 595 (607)
......++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....+.++
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 3333456788999999999999999999999999999999 999997642 22222222111 13567899
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+||+.++
T Consensus 414 i~~cl~~dP 422 (452)
T 1fmk_A 414 MCQCWRKEP 422 (452)
T ss_dssp HHHHTCSSG
T ss_pred HHHHccCCh
Confidence 999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.06 Aligned_cols=203 Identities=32% Similarity=0.447 Sum_probs=171.8
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc----eEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----RLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----~~lV 441 (607)
.++|++.++||+|+||.||+|++ .++.||||+++.. ......+.+|+.+|++++|+||+++++++..... .+||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 35799999999999999999998 5899999998643 2334456779999999999999999999987553 6999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------CCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-------HPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-------~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
|||+++|+|.++++... +.+..+++++.||++||+|||+++ ..+|+|||||++||||++++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999997643 899999999999999999999751 33799999999999999999999999999
Q ss_pred ccccccCCcc-eeeccccCCCCCchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 515 AKLALDANTH-ITTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 515 s~~~~~~~~~-~~~~~~gt~~y~APE~l~~~-----~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
++........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||.+..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9866543322 22335789999999999874 44567899999999999999999997643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.27 Aligned_cols=233 Identities=19% Similarity=0.253 Sum_probs=193.6
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+|+++++.+ +|+||+++++++..++..+||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999995 478999999986432 334688999999999 79999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc-----EEEEeccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLA 518 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DFGls~~~ 518 (607)
|+ +++|.+++...+. .+++..+++++.||++||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986543 489999999999999999999998 9999999999999987766 999999999876
Q ss_pred ccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----
Q 007351 519 LDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----- 587 (607)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----- 587 (607)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+..........+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543321 234457999999999999999999999999999999999999999876543333322211111
Q ss_pred -------hHHHHHHHHHHhhhcCCC
Q 007351 588 -------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~ 266 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFD 266 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTT
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcc
Confidence 135688999999987764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.34 Aligned_cols=229 Identities=24% Similarity=0.343 Sum_probs=176.3
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
..++|++.+.||+|+||.||+|++. +++.||||+++.. ...+.+++|+++|++++|+||+++++++..++..+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999976 5788999999753 234678899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~~~~~ 520 (607)
|+.+++|.+++...+ .+.+..+++++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999987654 389999999999999999999999 9999999999999975 88999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH----------hhH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL----------IDA 589 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~----------~~~ 589 (607)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+... +..+. ++.+. ...
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCccCCchhhhCC
Confidence 22 23345689999999999999999999999999999999999999975421 11111 11111 113
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|++.++
T Consensus 280 ~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDP 294 (349)
T ss_dssp HHHHHHHHTTSCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 567889999998765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.30 Aligned_cols=234 Identities=28% Similarity=0.375 Sum_probs=195.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|++. +|+.||||+++... ......+.+|+++|++++|+||+++++++..++..+|||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888999999999999999975 68999999996432 223467889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+.+|+|..++.... ...+.+..++.++.||+.||+|||++ +|+|||||++||||+++|.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999887643 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHhH-------hhHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWVNL-------IDAKIL 592 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~-~~l~~~~~~-------~~~~~~ 592 (607)
... .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+...... ..+.+.... .....+
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 332 23345799999999999999999999999999999999999999986543222 122221110 113677
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 421 ~~li~~lL~~dP 432 (543)
T 3c4z_A 421 KDFCEALLQKDP 432 (543)
T ss_dssp HHHHHHHSCSSG
T ss_pred HHHHHHhccCCH
Confidence 889999997765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.42 Aligned_cols=231 Identities=20% Similarity=0.298 Sum_probs=189.3
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++.... .+.+|+++|.++ +|+||+++++++.+++..+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3457999999999999999999975 688999999975432 345788888888 7999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC----CcEEEEeccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKLA 518 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGls~~~ 518 (607)
|||++|+|.+++...+ .+.+..++.++.||++||+|||++ +|+|||||++||||.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999987654 389999999999999999999999 99999999999998443 35999999999876
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------h
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------I 587 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~ 587 (607)
..... .....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.......++.+.... .
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 54332 23345789999999999888889999999999999999999999986432222233222111 1
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 250 ~s~~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPH 267 (342)
T ss_dssp SCHHHHHHHHHHTCSSTT
T ss_pred CCHHHHHHHHHHCCCChh
Confidence 236678899999987764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.26 Aligned_cols=197 Identities=25% Similarity=0.349 Sum_probs=165.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
.++|++++.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+++|+.++|+||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999864 6889999999743 3344567899999999999999999999997553
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..+|||||++++ |...+.. .+++..++.+++||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 469999999765 5555543 288999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... .....+|+..|+|||++.+..|+.++|||||||+||||++|+.||.+.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 234467999999999999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.73 Aligned_cols=229 Identities=20% Similarity=0.263 Sum_probs=192.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356999999999999999999975 5778999999866556677899999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccccC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~~~ 521 (607)
+.+++|.+++..... +.+..+++++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999988876544 89999999999999999999999 99999999999999 78899999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHhH----------hhHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVNL----------IDAK 590 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~~----------~~~~ 590 (607)
. ......|+..|+|||++.+. ++.++|||||||++|||++|+.||.... +.+..+ +.+. ....
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred c--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2 23345689999999998764 8999999999999999999999997642 112111 1110 1235
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 237 ~~~~li~~~l~~dp~ 251 (277)
T 3f3z_A 237 QAESLIRRLLTKSPK 251 (277)
T ss_dssp HHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHccCChh
Confidence 778999999987764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.02 Aligned_cols=229 Identities=22% Similarity=0.366 Sum_probs=184.3
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccC--CCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||++...+++.||||+++.... ...+.+++|+++|+.|+| +||+++++++..++..+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 457999999999999999999988899999999975433 334678999999999986 9999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|| +.+++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 568899999987553 89999999999999999999999 999999999999997 568999999999866543
Q ss_pred Ccc-eeeccccCCCCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh-
Q 007351 522 NTH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID- 588 (607)
Q Consensus 522 ~~~-~~~~~~gt~~y~APE~l~~-----------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~- 588 (607)
... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.. .....+...++
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~ 236 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAIIDP 236 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHHCT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh----hHHHHHHHHhcC
Confidence 322 2345679999999999875 678889999999999999999999997532 12222222211
Q ss_pred ----------HHHHHHHHHHhhhcCCC
Q 007351 589 ----------AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ----------~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~ 263 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPK 263 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChh
Confidence 25678999999988764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.45 Aligned_cols=230 Identities=22% Similarity=0.325 Sum_probs=192.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|.+.++||+|+||.||++++. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++.+++..+||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357999999999999999999975 57889999986442 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++++|.+++.... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999887654 389999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH------hhHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL------IDAKILFK 594 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~------~~~~~~~~ 594 (607)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..+.. ++.+. .....+.+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYSIPKHINPVAAS 270 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCCCCccCCHHHHH
Confidence 22 2334568999999999999999999999999999999999999997532 11111 11110 11356788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 271 li~~~l~~dp 280 (335)
T 2owb_A 271 LIQKMLQTDP 280 (335)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 9999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.84 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=198.6
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
..++|++.+.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|+++|+.++|+||+++++++..++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3467999999999999999999976 4788999998743 3445779999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999876666799999999999999999999999 999999999999999999999999999987665544
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFK 594 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~ 594 (607)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ...+.+..... ....+.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 44444567788999999999999999999999999999999 999997643 22333322211 1356788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 244 li~~~l~~dp 253 (288)
T 3kfa_A 244 LMRACWQWNP 253 (288)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHhCCCh
Confidence 9999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.54 Aligned_cols=239 Identities=23% Similarity=0.278 Sum_probs=188.1
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC-----CchhHHHHHHHHHHHHHccCCCceeEEeEEEeC
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG-----GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 435 (607)
+....++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+++|++++|+||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4555678999999999999999999974 6889999998643 234456799999999999999999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEG--------------------------------------RPVLDWATRVKIAAGAARG 477 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qia~g 477 (607)
+..+||||||++|+|.+++.... ...+.+..+++|+.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 1123566778899999999
Q ss_pred HHHHHHcCCCCEEecCCCCCCEEEcCCC--cEEEEecccccccccCCc---ceeeccccCCCCCchhhhcC--CCCCchh
Q 007351 478 LAYLHEDCHPRIIHRDIKSSNILLDNNF--EAQVSDFGLAKLALDANT---HITTRVMGTFGYMAPEYASS--GKLTEKS 550 (607)
Q Consensus 478 L~~LH~~~~~~ivHrDLkp~NILl~~~~--~vkL~DFGls~~~~~~~~---~~~~~~~gt~~y~APE~l~~--~~~~~~~ 550 (607)
|+|||++ +|+|||||++||||+.++ .+||+|||+++....... .......|+..|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 899999999986543222 12344578999999999975 6788999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------hHHHHHHHHHHhhhcCCC
Q 007351 551 DVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 551 DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----------~~~~~~~i~~~C~~~~~~ 605 (607)
|||||||+||||++|+.||.+.... +.+.+..+.. ....+.+++.+|++.++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999764211 1111111110 236788999999987764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.39 Aligned_cols=201 Identities=27% Similarity=0.446 Sum_probs=163.5
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCC--ce
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDD--RR 438 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~~ 438 (607)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++ |+||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3478999999999999999999864 7899999998543 3344567889999999997 999999999998654 67
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+||||||+ ++|..+++.. .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 6888888763 488999999999999999999999 9999999999999999999999999999865
Q ss_pred ccC--------------------CcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDA--------------------NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~--------------------~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
... ........+||..|||||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 1112344679999999999987 67899999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.01 Aligned_cols=231 Identities=22% Similarity=0.314 Sum_probs=181.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+++.. +++.||||+++... ...+.+++|+.+++.++|+||+++++++..++..+|||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 57999999999999999999976 78999999997543 33467889999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc--EEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--AQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGls~~~~~~~~ 523 (607)
.+|+|..++...+. +.+..++++++||++||+|||++ +|+|||||++||||+.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 99999999876554 89999999999999999999999 9999999999999987765 9999999997433221
Q ss_pred ceeeccccCCCCCchhhhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHH-HhH--------hhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEK-SDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEW-VNL--------IDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~-~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l~~~-~~~--------~~~~~~ 592 (607)
.....+|+..|||||++.+..++.+ +|||||||+||||++|+.||.+....... ...+. ... .....+
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 2234568999999999998888766 89999999999999999999865432221 11111 110 013567
Q ss_pred HHHHHHhhhcCCC
Q 007351 593 FKLVFLCQQNSNS 605 (607)
Q Consensus 593 ~~i~~~C~~~~~~ 605 (607)
.+++.+|++.++.
T Consensus 252 ~~li~~~L~~dP~ 264 (361)
T 3uc3_A 252 CHLISRIFVADPA 264 (361)
T ss_dssp HHHHHHHSCSCTT
T ss_pred HHHHHHHccCChh
Confidence 8899999987764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.08 Aligned_cols=231 Identities=26% Similarity=0.393 Sum_probs=179.2
Q ss_pred hCCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.+.||+|+||.||+|++.. +..||||+++.... ...+.+.+|+++|++++|+||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4579999999999999999998743 45699999875433 33467999999999999999999999984 567899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997653 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKI 591 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~ 591 (607)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+..... ....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC---HHHHHHHHHcCCCCCCCCCCCHH
Confidence 43333344456788999999999999999999999999999996 999997643 22333322211 1366
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 246 l~~li~~~l~~~p 258 (281)
T 1mp8_A 246 LYSLMTKCWAYDP 258 (281)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHccCCh
Confidence 7889999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.45 Aligned_cols=233 Identities=27% Similarity=0.444 Sum_probs=194.0
Q ss_pred hCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++|+.++|+||+++++++..++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999985 2457899999975543 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCC
Q 007351 439 LLIYDYVPNNTLYFHLHGEGR----------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (607)
++||||+.+++|.+++..... ..+.+..+++++.||++||+|||++ +|+|||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976533 3488999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 007351 497 SNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP 574 (607)
Q Consensus 497 ~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~ 574 (607)
+||||++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~- 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999999866543322 2233456788999999999889999999999999999999 999997643
Q ss_pred CCchhHHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 575 LGDESLVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 575 ~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
...+.+..... ....+.+++.+|++.++
T Consensus 258 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 258 --PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp --GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred --HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCCh
Confidence 23333332221 13678899999998765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.95 Aligned_cols=226 Identities=19% Similarity=0.298 Sum_probs=168.4
Q ss_pred ccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 371 DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
..+.||+|+||.||+|++. +|+.||||++.. .....+.+|+++|+.++ |+||+++++++.+++..+|||||+++|
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp TSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 3588999999999999975 689999999864 34567889999999997 999999999999999999999999999
Q ss_pred chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---cEEEEecccccccccCCcce
Q 007351 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DFGls~~~~~~~~~~ 525 (607)
+|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||++++ .+||+|||+++....... .
T Consensus 92 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 92 ELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp BHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 9999998764 389999999999999999999999 999999999999997765 899999999986543322 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----CchhHHHHHhH-----------hhHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL----GDESLVEWVNL-----------IDAK 590 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~----~~~~l~~~~~~-----------~~~~ 590 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...++.+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 33456899999999999999999999999999999999999999764321 11112221111 0135
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 246 ~~~~li~~~L~~dP~ 260 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPN 260 (325)
T ss_dssp HHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHCCCChh
Confidence 678899999987754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.59 Aligned_cols=235 Identities=24% Similarity=0.417 Sum_probs=192.0
Q ss_pred hhCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 436 (607)
..++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++|+++ +|+||+++++++..++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346799999999999999999985 245689999997543 23446799999999999 8999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCC
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGR---------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk 495 (607)
..+|||||+++|+|.+++..... ..+.+..+++++.||++||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999976543 2378999999999999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 007351 496 SSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573 (607)
Q Consensus 496 p~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~ 573 (607)
++||||++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866543322 2334557889999999999999999999999999999998 999997653
Q ss_pred CCCchhHHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 574 PLGDESLVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 574 ~~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
. ...+.++.... ....+.+++.+||+.++
T Consensus 280 ~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 316 (344)
T 1rjb_A 280 V--DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 316 (344)
T ss_dssp C--SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred c--HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 2 22222222211 14678889999998765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.26 Aligned_cols=233 Identities=19% Similarity=0.237 Sum_probs=182.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCchhH-----------HHHHHHHHHHHHccCCCceeE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGE-----------REFKAEVEIISRIHHRHLVSL 428 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~l 428 (607)
.++|++.+.||+|+||.||+|.+.+ ++.||||++........ ..+.+|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3579999999999999999998754 47899999875542211 123445566677789999999
Q ss_pred EeEEEeC----CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc--
Q 007351 429 VGYCISD----DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-- 502 (607)
Q Consensus 429 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-- 502 (607)
++++..+ ...+|||||+ +++|.+++.... ..+++..+++|+.||++||+|||++ +|+|||||++||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9998875 3479999999 999999997653 3489999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccccccccCCcce------eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 007351 503 NNFEAQVSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (607)
Q Consensus 503 ~~~~vkL~DFGls~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~ 576 (607)
+++.+||+|||+++......... .....|+..|||||++.+..++.++|||||||+||||++|+.||.+...
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-- 266 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-- 266 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 88999999999998654332211 1334599999999999999999999999999999999999999985321
Q ss_pred chhHHHHHhHh-----------------hHHHHHHHHHHhhhcCCC
Q 007351 577 DESLVEWVNLI-----------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 577 ~~~l~~~~~~~-----------------~~~~~~~i~~~C~~~~~~ 605 (607)
+..+..+.... ....+.+++..||+.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 312 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYT 312 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTT
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCC
Confidence 22222221111 134577888889877653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.68 Aligned_cols=230 Identities=27% Similarity=0.483 Sum_probs=193.2
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++.+++.||||+++.... ..+++.+|+++++.++|+||+++++++..++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56899999999999999999998889999999975433 35679999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+++|.++++... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999997653 3488999999999999999999999 999999999999999999999999999986543322222
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i~~ 597 (607)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ...+.+.... .....+.+++.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 33456778999999998899999999999999999999 899997532 2222222111 11467889999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 240 ~~l~~~p 246 (267)
T 3t9t_A 240 HCWRERP 246 (267)
T ss_dssp HHTCSSG
T ss_pred HHccCCh
Confidence 9998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=333.39 Aligned_cols=234 Identities=25% Similarity=0.410 Sum_probs=194.4
Q ss_pred hCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 2567899999975544 3446799999999999 89999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRP----------------VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~----------------~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
.++||||+.+|+|.+++...... .+++..+++++.||++||+|||++ +|+|||||++||||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999999999998765432 489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+... ...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSK 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc--hhH
Confidence 99999999999999876544322 2334457788999999999999999999999999999999 9999976432 122
Q ss_pred HHHHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 580 LVEWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 580 l~~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
+.+..+. .....+.+++.+|++.++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 2222221 123678899999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=341.30 Aligned_cols=230 Identities=27% Similarity=0.440 Sum_probs=183.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.++||+|+||.||+|++. +|+ .||||.++... ....++|++|+++|++++|+||++++++|..+ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56999999999999999999964 444 36888875433 34457899999999999999999999999865 4789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|+||+.+|+|.++++.... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999877543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ...+.++.... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTCCCCCCTTBCH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC---HHHHHHHHHcCCCCCCCccCCH
Confidence 3322 2233456789999999999999999999999999999999 999997643 23333333221 235
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 247 ~~~~li~~~l~~~p 260 (327)
T 3poz_A 247 DVYMIMVKCWMIDA 260 (327)
T ss_dssp HHHHHHHHHTCSCG
T ss_pred HHHHHHHHHcCCCh
Confidence 67889999998765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.87 Aligned_cols=230 Identities=23% Similarity=0.340 Sum_probs=188.1
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++ .+|+.||||+++... ......+.+|+++|+.++|+||+++++++..++..+|||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999996 478999999986432 223457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+ +|+|.+++...+. +.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 7888888876544 89999999999999999999999 99999999999999999999999999998654432
Q ss_pred cceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH----HHhHhhHHHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE----WVNLIDAKILFKLVF 597 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~----~~~~~~~~~~~~i~~ 597 (607)
.....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||.+........... .........+.+++.
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 2334579999999999988776 679999999999999999999997643211100000 000112355678889
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 241 ~~L~~dP 247 (336)
T 3h4j_B 241 RMIVADP 247 (336)
T ss_dssp TTSCSSG
T ss_pred HHcCCCh
Confidence 9987765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.04 Aligned_cols=202 Identities=25% Similarity=0.402 Sum_probs=170.4
Q ss_pred CCCccc-ceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~-~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++. ++||+|+||.||+|+.. +++.||||+++.......+.+.+|+++|.++ +|+||+++++++..++..+||||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999954 7899999999876666677899999999995 79999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc---EEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGls~~~~~ 520 (607)
|+++++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997754 389999999999999999999999 9999999999999988766 99999999975532
Q ss_pred CCc------ceeeccccCCCCCchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 521 ANT------HITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 521 ~~~------~~~~~~~gt~~y~APE~l~~-----~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 211 11223468999999999875 457889999999999999999999997653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.47 Aligned_cols=202 Identities=23% Similarity=0.361 Sum_probs=165.6
Q ss_pred HhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
...++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++..++..+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34467999999999999999999854 7889999999754433 23567899999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE-----cCCCcEEEEecccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL-----DNNFEAQVSDFGLA 515 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl-----~~~~~vkL~DFGls 515 (607)
||||++ |+|.+++..... +.+..+++|++||++||+|||++ +|+|||||++|||| ++++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999997 589888877654 89999999999999999999999 99999999999999 45556999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+....... ......|+..|+|||++.+. .++.++|||||||+||||++|+.+|.+.
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 86643322 23345689999999999874 4899999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.98 Aligned_cols=192 Identities=27% Similarity=0.399 Sum_probs=153.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC-----Cce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 438 (607)
++|+++++||+|+||.||+|++. +|+.||||++.... ....+.+++|+++|+.|+|+||+++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999865 78999999986432 33456789999999999999999999998543 468
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
||||||+ +++|..+++... .+.+..++.|++||++||+|||++ +|||||||++||||++++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 578888887654 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCc--------------------------ceeeccccCCCCCchhhh-cCCCCCchhhHHHHHHHHHHHHc
Q 007351 519 LDANT--------------------------HITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELIT 564 (607)
Q Consensus 519 ~~~~~--------------------------~~~~~~~gt~~y~APE~l-~~~~~~~~~DVwSlGvll~ELlt 564 (607)
..... ......+||..|||||++ .+..|+.++|||||||+||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 42211 123345789999999986 45679999999999999999999
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.34 Aligned_cols=231 Identities=21% Similarity=0.332 Sum_probs=184.8
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHcc--CCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIH--HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|...+++.||||+++... ....+.+++|+++|++|+ |+||+++++++..++..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4699999999999999999998889999999997543 234467999999999996 599999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
| +.+++|.+++.... .+.+..+++|+.||++||+|||++ +|+|||||++||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999998755 488999999999999999999998 999999999999996 5789999999998764432
Q ss_pred cc-eeeccccCCCCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---
Q 007351 523 TH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--- 587 (607)
Q Consensus 523 ~~-~~~~~~gt~~y~APE~l~~-----------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--- 587 (607)
.. .....+|+..|||||++.+ ..++.++|||||||+||||++|+.||...... ...+.+..+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEI 287 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHCTTSCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHHHHHHhCccccC
Confidence 22 2345679999999999875 36888999999999999999999999753210 01111111110
Q ss_pred -----hHHHHHHHHHHhhhcCCC
Q 007351 588 -----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~ 310 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPK 310 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTT
T ss_pred CCCccchHHHHHHHHHHcccChh
Confidence 135678999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.37 Aligned_cols=226 Identities=24% Similarity=0.249 Sum_probs=181.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|++. +|+.||||+++.... ....++.+|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46999999999999999999976 789999999864332 3334556666666665 8999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+ +++|.+++...+ ..+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 667877776543 3489999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh--------HhhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------LIDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~~ 594 (607)
......|+..|+|||++.+ .++.++|||||||+||||++|+.+|.+. ..+.++.+ ......+.+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHhccCCCcccccCCCHHHHH
Confidence 2334568999999999886 7899999999999999999997766532 22222211 112367889
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.++.
T Consensus 284 li~~~L~~dP~ 294 (311)
T 3p1a_A 284 VLVMMLEPDPK 294 (311)
T ss_dssp HHHHHSCSSTT
T ss_pred HHHHHcCCChh
Confidence 99999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.99 Aligned_cols=230 Identities=22% Similarity=0.343 Sum_probs=192.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999965 68899999997543 234467899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc---EEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGls~~~~ 519 (607)
||+.+++|.+++..... +.+..+++++.||++||+|||++ +|+|||||++||||+.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999888876543 89999999999999999999999 9999999999999976655 9999999997654
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hh
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------ID 588 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~ 588 (607)
.... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... ..
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCchhhccc
Confidence 4322 234568999999999999999999999999999999999999997642 2222221111 11
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 235 ~~~~~~li~~~l~~dp~ 251 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPK 251 (284)
T ss_dssp CHHHHHHHHHHSCSSTT
T ss_pred CHHHHHHHHHHcccChh
Confidence 35678999999987764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=327.63 Aligned_cols=230 Identities=23% Similarity=0.339 Sum_probs=191.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56999999999999999999976 57889999986442 234567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+++++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999887654 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------hhHHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------IDAKILFKLV 596 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------~~~~~~~~i~ 596 (607)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+.+.++.+. .....+.+++
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKNEYSIPKHINPVAASLI 246 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhhccCCCccccCHHHHHHH
Confidence 2 23345689999999999998999999999999999999999999975421 0111111110 1135678899
Q ss_pred HHhhhcCC
Q 007351 597 FLCQQNSN 604 (607)
Q Consensus 597 ~~C~~~~~ 604 (607)
.+|++.++
T Consensus 247 ~~~l~~~p 254 (294)
T 2rku_A 247 QKMLQTDP 254 (294)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCh
Confidence 99998765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=333.30 Aligned_cols=229 Identities=24% Similarity=0.330 Sum_probs=192.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+++.+|+++|+.++|+||+++++++..++..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46999999999999999999975 6899999999754322 3567999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEecccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGLA 515 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGls 515 (607)
+||||+.+++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999997654 489999999999999999999999 999999999999999887 7999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHh---------
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVN--------- 585 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~--------- 585 (607)
+....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+..+ +.+
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITSVSYDFDEEF 241 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCCHHH
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcccccChhh
Confidence 86654322 234568999999999999999999999999999999999999997542 111111 111
Q ss_pred -HhhHHHHHHHHHHhhhcCCC
Q 007351 586 -LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 -~~~~~~~~~i~~~C~~~~~~ 605 (607)
......+.+++.+|++.++.
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~ 262 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETR 262 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTT
T ss_pred hcccCHHHHHHHHHHcCCChh
Confidence 01135678999999987764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=325.30 Aligned_cols=234 Identities=25% Similarity=0.376 Sum_probs=194.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357999999999999999999975 78999999997543 3345679999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+++++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999987543 489999999999999999999999 999999999999999999999999999986543321
Q ss_pred -ceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILF 593 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~ 593 (607)
.......|+..|+|||++.+..+ +.++|||||||++|||++|+.||...... ...+.+|... .....+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhhcccccCchhhcCHHHH
Confidence 12334568999999999987665 67899999999999999999999764322 2233334321 1246678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 240 ~li~~~l~~~p~ 251 (276)
T 2yex_A 240 ALLHKILVENPS 251 (276)
T ss_dssp HHHHHHSCSSTT
T ss_pred HHHHHHCCCCch
Confidence 899999987764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=329.94 Aligned_cols=200 Identities=23% Similarity=0.349 Sum_probs=170.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+++|++++|+||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 5899999998654332 34568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|..+++.... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999888876543 89999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 2334568999999999986 56899999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=340.46 Aligned_cols=234 Identities=25% Similarity=0.410 Sum_probs=176.4
Q ss_pred hhCCCcccceecccCcEEEEEEEeCCCc----EEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPDGR----EVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~g~----~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
..++|++.+.||+|+||.||+|++..+. .||||+++.. .....+.+.+|+++|++++|+||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3467999999999999999999965432 7999999754 334557799999999999999999999999877655
Q ss_pred ------EEEEEecCCCchhHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 439 ------LLIYDYVPNNTLYFHLHGEG----RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 439 ------~lV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
++||||+.+|+|.+++.... ...+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999998886432 22489999999999999999999999 999999999999999999999
Q ss_pred EEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH
Q 007351 509 VSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 509 L~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (607)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~~ 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---NAEIYNYLIG 254 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC---hHHHHHHHhc
Confidence 9999999866443322 2223456778999999999999999999999999999999 999997643 2222222111
Q ss_pred --------hhHHHHHHHHHHhhhcCC
Q 007351 587 --------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp 280 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADP 280 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred CCCCCCCCccCHHHHHHHHHHccCCh
Confidence 113678899999998765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.37 Aligned_cols=236 Identities=25% Similarity=0.407 Sum_probs=193.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeCC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCC
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 436 (607)
..++|++.+.||+|+||.||+|.+.. ++.||||+++.... ...+.+.+|+++|+.+ +|+||+++++++..++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34679999999999999999999642 24799999975543 3446799999999999 8999999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEG------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (607)
..+|||||+.+|+|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||+++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999886532 23478999999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHH
Q 007351 505 FEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582 (607)
Q Consensus 505 ~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~ 582 (607)
+.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+... ...+.+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV--NSKFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS--SHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch--hHHHHH
Confidence 99999999999865443322 2334456788999999999999999999999999999998 9999976432 222222
Q ss_pred HHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 583 WVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 583 ~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
+.+.. ....+.+++.+|++.++.
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 309 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPT 309 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChh
Confidence 22211 236788999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.68 Aligned_cols=231 Identities=24% Similarity=0.293 Sum_probs=180.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++|+||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 688999999975432 2246789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++++|.+++...+ .+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998654 389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----------hhHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL----------IDAKI 591 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~----------~~~~~ 591 (607)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ...+.+.... .....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCccccCCCCCHH
Confidence 3333445578999999999999999999999999999999999999997532 1111111110 01245
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 265 l~~li~~~l~~dP 277 (309)
T 2h34_A 265 FDAVIARGMAKNP 277 (309)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHhccCCH
Confidence 7889999998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=334.76 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=171.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++.++||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++|++++|+||+++++++..++..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999975 5899999998654332 3456889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|..++..... +++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999887765543 89999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
. ......|+..|+|||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 23345689999999999875 7899999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.77 Aligned_cols=230 Identities=14% Similarity=0.159 Sum_probs=177.2
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecC---CchhHHHHHHHHH---HHHHccCCCceeEE-------eE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVE---IISRIHHRHLVSLV-------GY 431 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------g~ 431 (607)
.++|++.+.||+|+||.||+|++ .+|+.||||+++.. .....+.|++|++ +|++++|+||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688999999999999999996 47999999999743 3344577999995 55555799999998 66
Q ss_pred EEeCCc-----------------eEEEEEecCCCchhHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCE
Q 007351 432 CISDDR-----------------RLLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRI 489 (607)
Q Consensus 432 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~i 489 (607)
+..++. .+|||||+ +|+|.+++...+. ..+.+..+++|+.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 655432 78999999 6899998876432 1133578888999999999999999 99
Q ss_pred EecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC-----------CCCchhhHHHHHHH
Q 007351 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-----------KLTEKSDVFSFGVV 558 (607)
Q Consensus 490 vHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~DVwSlGvl 558 (607)
+|||||++||||++++.+||+|||+++.... ......| ..|||||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2344567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHHHHhhhcCC
Q 007351 559 LLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 559 l~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~~~C~~~~~ 604 (607)
||||++|+.||.+...........-........+.+++.+||+.++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCc
Confidence 9999999999976443221111100001123667889999998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.74 Aligned_cols=228 Identities=29% Similarity=0.444 Sum_probs=187.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+++|++++++++|+||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357999999999999999999865 57789999986432 12345789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999998876543 89999999999999999999998 9999999999999999999999999998654332
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFK 594 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~ 594 (607)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+.... .....+.+
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFPDFVTEGARD 236 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 2 234568999999999999999999999999999999999999997532 1111111111 02356788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 237 li~~~l~~~p 246 (279)
T 3fdn_A 237 LISRLLKHNP 246 (279)
T ss_dssp HHHHHCCSSG
T ss_pred HHHHHhccCh
Confidence 9999997765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=335.18 Aligned_cols=233 Identities=28% Similarity=0.414 Sum_probs=191.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++|+++ +|+||+++++++..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999863 467899999975543 3446799999999999 899999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..+|||||+.+|+|.+++..... ..+.+..+++++.||++||+|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999976532 2488999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence 99999999999999866543322 2233456788999999998899999999999999999999 999997542 222
Q ss_pred HHHHHhHh--------hHHHHHHHHHHhhhcCC
Q 007351 580 LVEWVNLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 580 l~~~~~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
+.+..... ....+.+++.+|++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCCh
Confidence 22222111 13568889999998765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.17 Aligned_cols=235 Identities=20% Similarity=0.303 Sum_probs=190.4
Q ss_pred HHHhhCCCccc-ceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCC
Q 007351 362 LVKATDGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDD 436 (607)
Q Consensus 362 l~~~~~~y~~~-~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 436 (607)
.....++|.+. ++||+|+||.||+|+.. +|+.||||+++... .....++.+|+++|+.++ |+||+++++++..++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445567776 89999999999999975 68999999997432 334578999999999995 699999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEecc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFG 513 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFG 513 (607)
..+|||||+.+|+|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||+. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999998776556799999999999999999999999 9999999999999987 7899999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHhH------
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVNL------ 586 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~~------ 586 (607)
+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...... ..+.
T Consensus 180 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 180 MSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDYSE 254 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT
T ss_pred cccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhcccccCc
Confidence 9986643322 234568999999999999999999999999999999999999997642 111111 1110
Q ss_pred ----hhHHHHHHHHHHhhhcCC
Q 007351 587 ----IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ----~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP 276 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNP 276 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSG
T ss_pred hhhcccCHHHHHHHHHHcCCCh
Confidence 113567889999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.73 Aligned_cols=228 Identities=30% Similarity=0.492 Sum_probs=177.8
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG----QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++ .|+.||||+++.... ...+.+++|+++++.++|+||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5789999999999999999998 589999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--------CCcEEEEeccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--------NFEAQVSDFGL 514 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--------~~~vkL~DFGl 514 (607)
||+++++|.+++... .+++..+++++.||++||+|||++...+|+|||||++||||++ ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999988643 4899999999999999999999982112999999999999986 77899999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---------
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--------- 585 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--------- 585 (607)
++...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.+.. +........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHTSCCCCCCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHhhhcCCCCCCCC
Confidence 98654332 223468999999999999999999999999999999999999997642 111111111
Q ss_pred HhhHHHHHHHHHHhhhcCC
Q 007351 586 LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 237 ~~~~~~~~~li~~~l~~~p 255 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDP 255 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSG
T ss_pred cccCHHHHHHHHHHhcCCc
Confidence 0113668899999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=352.31 Aligned_cols=229 Identities=25% Similarity=0.397 Sum_probs=192.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|.+++.||+|+||.||+|++. +|+.||||+++... ......+++|+++|+.++|+||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999975 79999999996432 123457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|.+++...+. +++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999976543 89999999999999999999998 99999999999999999999999999998764432
Q ss_pred cceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-H------hhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-L------IDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-~------~~~~~~~~ 594 (607)
.....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||.+.. ...+.+... . .....+.+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCcCCCccCCHHHHH
Confidence 2334579999999999998766 679999999999999999999997642 122222111 1 12356788
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+|++.++.
T Consensus 246 Li~~~L~~dP~ 256 (476)
T 2y94_A 246 LLKHMLQVDPM 256 (476)
T ss_dssp HHHHHTCSSTT
T ss_pred HHHHHcCCCch
Confidence 99999987764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.55 Aligned_cols=233 Identities=22% Similarity=0.298 Sum_probs=189.9
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC-CCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|+++++||+|+||.||+|++ .+++.||||+++.... ..++++|+++|+.|+| .+|..+..++..++..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999996 4789999998875433 2358899999999986 556666777777888899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~~ 520 (607)
|+ +++|.+++..... .+.+..+++|+.||++||+|||++ +|||||||++|||| ++++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999875433 489999999999999999999999 99999999999999 6889999999999987655
Q ss_pred CCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------
Q 007351 521 ANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------- 587 (607)
Q Consensus 521 ~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------- 587 (607)
.... ......|+..|||||++.+..++.++|||||||+||||++|+.||.+.........++.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 4322 122567999999999999999999999999999999999999999876543322222211111
Q ss_pred -----hHHHHHHHHHHhhhcCCC
Q 007351 588 -----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~ 261 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFD 261 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTT
T ss_pred HHhcCCcHHHHHHHHHHhcCChh
Confidence 125678999999987753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.76 Aligned_cols=234 Identities=27% Similarity=0.432 Sum_probs=188.2
Q ss_pred CCCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--Cce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 438 (607)
++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++|+.++|+||+++++++..+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999984 368899999997443 33456799999999999999999999999877 567
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+.+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999865432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------CCCchhHHHHHhHh
Q 007351 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ---------PLGDESLVEWVNLI 587 (607)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~---------~~~~~~l~~~~~~~ 587 (607)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.+|.... ........++.+.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 544322 2334567888999999999999999999999999999999998864210 11112222222222
Q ss_pred h-----------HHHHHHHHHHhhhcCC
Q 007351 588 D-----------AKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~-----------~~~~~~i~~~C~~~~~ 604 (607)
. ...+.+++.+|++.++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp 284 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQP 284 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCC
Confidence 1 2568899999998765
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.68 Aligned_cols=196 Identities=32% Similarity=0.441 Sum_probs=162.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------ceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------RRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~ 439 (607)
.+|++.++||+|+||.||+|++. +|+.||||++.... +.+.+|+++|+.|+|+||++++++|...+ ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 68999999986432 23457999999999999999999986532 257
Q ss_pred EEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~ 516 (607)
|||||+.+ +|..++.. .....+.+..++.|+.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 45444432 2234589999999999999999999998 99999999999999954 678999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
....... ....+|+..|||||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 6543322 2345789999999999765 7899999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=340.92 Aligned_cols=231 Identities=26% Similarity=0.430 Sum_probs=185.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcE----EEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGRE----VAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~----VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.++||+|+||.||+|++. +++. ||+|++.... ....+.+.+|+++++.++|+||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56899999999999999999964 4443 7888775433 233356889999999999999999999986 567899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+|+|.+++.... ..+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999987642 2488899999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+... .++.++.... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHHHHTTCBCCCCTTBCT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHHHHcCCCCCCCCcCcH
Confidence 3322 2344567889999999999999999999999999999999 9999986532 2222222211 124
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 245 ~~~~li~~~l~~dp~ 259 (325)
T 3kex_A 245 DVYMVMVKCWMIDEN 259 (325)
T ss_dssp TTTHHHHHHTCSCTT
T ss_pred HHHHHHHHHcCCChh
Confidence 567889999987764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.89 Aligned_cols=232 Identities=16% Similarity=0.237 Sum_probs=181.3
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCCchh-----------HHHHHHHHHHHHHccCCCceeEEeE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQG-----------EREFKAEVEIISRIHHRHLVSLVGY 431 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~~~~-----------~~~~~~Ei~il~~l~HpnIv~l~g~ 431 (607)
++|++.+.||+|+||.||+|++. +++.||||++....... ...+.+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999975 56789999987554321 1346678899999999999999999
Q ss_pred EEe----CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC--
Q 007351 432 CIS----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-- 505 (607)
Q Consensus 432 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-- 505 (607)
+.. ++..+|||||+ +++|.+++...+ .+++..+++|+.||++||+|||++ +|+|||||++||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 66789999999 999999997655 589999999999999999999999 999999999999999887
Q ss_pred cEEEEecccccccccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 007351 506 EAQVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~ 579 (607)
.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-PVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-HHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-cHH
Confidence 9999999999865432211 113457899999999999999999999999999999999999999643211 111
Q ss_pred HHHHHhH----------------hhHHHHHHHHHHhhhcCCC
Q 007351 580 LVEWVNL----------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 580 l~~~~~~----------------~~~~~~~~i~~~C~~~~~~ 605 (607)
+..+... .....+.+++..||+.++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 311 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYD 311 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTT
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcc
Confidence 1111111 1123688999999987754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.94 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=167.9
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-----HHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
..++|++.+.||+|+||.||+|++. +|+.||||+++...... .+.+.+|+++|+.++|+||+++++++..++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467999999999999999999975 68999999997533221 24688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+++ +|..++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999986 7877776543 3588889999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ......|+..|+|||++.+. .++.++|||||||+||||++|+.+|.+.
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 43332 23345789999999999764 5889999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=366.49 Aligned_cols=231 Identities=25% Similarity=0.349 Sum_probs=193.5
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|+++++||+|+||.||+|++. +++.||||+++.. .....+.+.+|.++|..+ +|+||+++++++.+++..||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999975 6788999999743 223345688899999987 69999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+|+|..+++..+. +.+..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999987654 89999999999999999999999 999999999999999999999999999986433
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILF 593 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~ 593 (607)
.. ......+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+.
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMSKEAV 570 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHH
Confidence 22 22445679999999999999999999999999999999999999998642 2222221111 0136678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 571 ~li~~lL~~dP~ 582 (674)
T 3pfq_A 571 AICKGLMTKHPG 582 (674)
T ss_dssp HHHHHHSCSSST
T ss_pred HHHHHHccCCHH
Confidence 899999987764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=324.45 Aligned_cols=234 Identities=22% Similarity=0.306 Sum_probs=186.3
Q ss_pred hhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEE-EeCCceEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC-ISDDRRLLIY 442 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~ 442 (607)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++.++|.|++..++++ ..++..+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999996 478899999876432 224588999999999988877776665 5566779999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~ 519 (607)
||+ +++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999998875433 489999999999999999999999 99999999999999 789999999999998765
Q ss_pred cCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhHh-----
Q 007351 520 DANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNLI----- 587 (607)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~~----- 587 (607)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+..........+. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 44321 22345789999999999999999999999999999999999999987554333322221 1110
Q ss_pred ------hHHHHHHHHHHhhhcCCC
Q 007351 588 ------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~ 263 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFD 263 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred hhhhccCCHHHHHHHHHHHhcCCC
Confidence 135788999999987764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=331.03 Aligned_cols=233 Identities=22% Similarity=0.357 Sum_probs=180.2
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||+++++++..++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5699999999999999999996 478999999997532 334567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+++++|.+++.. .....+.+..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999988864 2234589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKI 591 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~ 591 (607)
... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.... ...+.+.... .....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcccCCCCcccccCHH
Confidence 322 223456899999999999999999999999999999999999999754211 1122222111 12357
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 267 l~~li~~~l~~dp 279 (310)
T 2wqm_A 267 LRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHcCCCh
Confidence 8899999998775
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.10 Aligned_cols=226 Identities=24% Similarity=0.357 Sum_probs=188.2
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++ +|+.||||+++... ....+.|.+|+++|++++|+||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5689999999999999999998 58999999997653 23446799999999999999999999999887 6789999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||+++|+|.++++......+++..+++++.||++||+|||++ + |+|||||++||||++++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999887665689999999999999999999998 7 99999999999999999999999998764322
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHhH--------hh
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTE---KSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVNL--------ID 588 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~---~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~~--------~~ 588 (607)
....|+..|+|||++.+..++. ++|||||||++|||++|+.||.+.. ...... .... ..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEIGMKVALEGLRPTIPPGI 236 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHHHHHHHHHSCCCCCCCTTC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHHHHHHHHhcCCCCCCCCCC
Confidence 2245789999999998765554 7999999999999999999997542 111111 1110 12
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 237 ~~~~~~li~~~l~~~p~ 253 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPA 253 (271)
T ss_dssp CHHHHHHHHHHTCSSGG
T ss_pred CHHHHHHHHHHcCCChh
Confidence 35788999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.60 Aligned_cols=237 Identities=22% Similarity=0.370 Sum_probs=193.9
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--------hHHHHHHHHHHHHHc-cCCCceeE
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------GEREFKAEVEIISRI-HHRHLVSL 428 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l-~HpnIv~l 428 (607)
++......++|++.+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|+++ +|+||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444455678999999999999999999975 7999999999754321 134578999999999 79999999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
++++...+..+|||||+++++|.+++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999987654 389999999999999999999998 999999999999999999999
Q ss_pred EEecccccccccCCcceeeccccCCCCCchhhhcC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 007351 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (607)
Q Consensus 509 L~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~ 582 (607)
|+|||+++....... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.. .....+
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLR 315 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHH
Confidence 999999986654322 334678999999999864 357889999999999999999999997632 112221
Q ss_pred HHhH-----------hhHHHHHHHHHHhhhcCCC
Q 007351 583 WVNL-----------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 583 ~~~~-----------~~~~~~~~i~~~C~~~~~~ 605 (607)
.... .....+.+++.+|++.++.
T Consensus 316 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 349 (365)
T 2y7j_A 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPE 349 (365)
T ss_dssp HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence 1111 0123478899999987764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.22 Aligned_cols=228 Identities=24% Similarity=0.339 Sum_probs=188.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+++|+++|++++|+||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999976 689999999975432 23577999999999999999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEecccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGLA 515 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGls 515 (607)
+||||+.+++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999987644 389999999999999999999999 999999999999998877 8999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHh---------
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVN--------- 585 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~--------- 585 (607)
+....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+..+ +..
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNYDFDEEY 234 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCCHHH
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcccCCcchh
Confidence 86543322 233568999999999999999999999999999999999999997642 111111 111
Q ss_pred -HhhHHHHHHHHHHhhhcCC
Q 007351 586 -LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 -~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp 254 (283)
T 3bhy_A 235 FSNTSELAKDFIRRLLVKDP 254 (283)
T ss_dssp HTTCCHHHHHHHHTTSCSSG
T ss_pred cccCCHHHHHHHHHHccCCH
Confidence 0113567889999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.43 Aligned_cols=200 Identities=25% Similarity=0.451 Sum_probs=165.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhH-HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|+.. +++.||||+++....... ..+.+|+++|+.++|+||+++++++..++..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 788999999975432222 2466899999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+. |+|.+++...+. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 588887776543 589999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2334568999999999886 56899999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=343.55 Aligned_cols=230 Identities=23% Similarity=0.329 Sum_probs=189.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch--------hHHHHHHHHHHHHHccCCCceeEEeEEEeCC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 436 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++..++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999854 7889999999754321 2345788999999999999999999999999
Q ss_pred ceEEEEEecCCC-chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 RRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 ~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..+|||||+.+| +|..++..... +.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 99998876554 89999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHH
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFK 594 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (607)
+....... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||..........+ .........+.+
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~l~~ 253 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI--HPPYLVSKELMS 253 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCC--CCSSCCCHHHHH
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhcc--CCCcccCHHHHH
Confidence 87654332 233568999999999998876 7889999999999999999999975321111000 000112356778
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 254 li~~~L~~dP 263 (335)
T 3dls_A 254 LVSGLLQPVP 263 (335)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 8888887765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.88 Aligned_cols=232 Identities=25% Similarity=0.394 Sum_probs=186.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++.+.||+|+||.||+|++.+ +..||||+++... ....+.+.+|+++|++++|+||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3579999999999999999998643 2359999987553 3345679999999999999999999999764 56789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999987643 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKI 591 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~ 591 (607)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++.+..... ....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---GGGHHHHHHHTCCCCCCTTCCHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC---hHHHHHHHhcCCCCCCCCCCCHH
Confidence 43333344557788999999998999999999999999999998 999997543 22333222211 1366
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.++.
T Consensus 243 l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 243 LYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHHHHTCSSGG
T ss_pred HHHHHHHHccCCch
Confidence 88999999987653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.76 Aligned_cols=232 Identities=30% Similarity=0.477 Sum_probs=185.0
Q ss_pred CCCcccceecccCcEEEEEEEeCC-----CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~-----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.++||+|+||.||+|++.. +..||||+++.... .....+.+|+++|++++|+||+++++++...+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 568889999999999999998642 23599999975543 344579999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+++++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997643 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hH
Q 007351 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DA 589 (607)
Q Consensus 521 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~ 589 (607)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+..... ..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHCCCcCCCcccCC
Confidence 3221 1222345778999999999999999999999999999999 999997542 22333222111 13
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+||+.++.
T Consensus 277 ~~l~~li~~~l~~~p~ 292 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERA 292 (333)
T ss_dssp HHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHcCCChh
Confidence 6788999999988764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.17 Aligned_cols=234 Identities=27% Similarity=0.427 Sum_probs=183.1
Q ss_pred HhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc--cCCCceeEEeEEEeC----Cc
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI--HHRHLVSLVGYCISD----DR 437 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~~----~~ 437 (607)
...++|++.+.||+|+||.||+|++ .|+.||||++... ....+.+|.+++..+ +|+||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3446799999999999999999998 5899999998632 344556666666654 899999999999887 67
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-----HPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
.+|||||+++|+|.++++.. .+.+..+++++.||++||+|||+++ ..+|+|||||++||||++++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 89999999999999999764 3899999999999999999999751 348999999999999999999999999
Q ss_pred ccccccccCCcce---eeccccCCCCCchhhhcCCCCCch------hhHHHHHHHHHHHHcC----------CCCCCCCC
Q 007351 513 GLAKLALDANTHI---TTRVMGTFGYMAPEYASSGKLTEK------SDVFSFGVVLLELITG----------RKPVDASQ 573 (607)
Q Consensus 513 Gls~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~------~DVwSlGvll~ELltg----------~~Pf~~~~ 573 (607)
|+++......... .....|+..|+|||++.+..+..+ +|||||||+||||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997654433221 124578999999999988776654 9999999999999999 67775433
Q ss_pred CCCchhHHHHHhH-----------------hhHHHHHHHHHHhhhcCCC
Q 007351 574 PLGDESLVEWVNL-----------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 574 ~~~~~~l~~~~~~-----------------~~~~~~~~i~~~C~~~~~~ 605 (607)
... ....++... .....+.+++.+||+.++.
T Consensus 267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 267 PSD-PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp CSS-CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred CCC-CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence 221 111122111 2235588999999988753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=329.98 Aligned_cols=229 Identities=23% Similarity=0.383 Sum_probs=189.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|+.++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356999999999999999999975 7899999999866555566799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccccC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~~~ 521 (607)
+++++|.+++...+. +.+..++.++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999988876543 89999999999999999999999 99999999999999 78899999999999754332
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDAK 590 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~~ 590 (607)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.... ....
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 163 I---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp T---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred c---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCccccccCCH
Confidence 1 233468999999999999999999999999999999999999997642 2222221111 1136
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 237 ~~~~li~~~l~~dp~ 251 (304)
T 2jam_A 237 SAKDFICHLLEKDPN 251 (304)
T ss_dssp HHHHHHHHHHCSSTT
T ss_pred HHHHHHHHHcCCChh
Confidence 788999999987754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=331.27 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=196.9
Q ss_pred ccHHHHHHhhCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeE
Q 007351 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSL 428 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l 428 (607)
+...++....++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|+++ +|+||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44555555668899999999999999999984 25688999999765443 345799999999999 69999999
Q ss_pred EeEEEeCC-ceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecC
Q 007351 429 VGYCISDD-RRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493 (607)
Q Consensus 429 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD 493 (607)
++++...+ ..++||||+.+++|.+++..... ..+.+..+++++.||++||+|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988765 48999999999999999976543 2278899999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 007351 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (607)
Q Consensus 494 Lkp~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~ 571 (607)
||++||||++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866443322 2334567889999999999999999999999999999998 9999976
Q ss_pred CCCCCchhHHHHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 572 SQPLGDESLVEWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 572 ~~~~~~~~l~~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
... +..+.+.... .....+.+++.+|++.++
T Consensus 254 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 292 (316)
T 2xir_A 254 VKI--DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292 (316)
T ss_dssp CCC--SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cch--hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCCh
Confidence 432 1222222111 123578889999998765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=321.68 Aligned_cols=234 Identities=22% Similarity=0.302 Sum_probs=189.6
Q ss_pred hhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEE-EeCCceEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC-ISDDRRLLIY 442 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~ 442 (607)
..++|++.+.||+|+||.||+|+. .+|+.||||++..... ..++.+|+++++.++|.|++..++++ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 346899999999999999999996 5789999999875432 34689999999999988866666655 5566779999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~ 519 (607)
||+ +++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 9999999875432 489999999999999999999999 99999999999999 588999999999998765
Q ss_pred cCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhH------
Q 007351 520 DANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNL------ 586 (607)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~------ 586 (607)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+..........+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 44321 12445789999999999999999999999999999999999999987544333222221 111
Q ss_pred -----hhHHHHHHHHHHhhhcCCC
Q 007351 587 -----IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 -----~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~ 263 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFD 263 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcC
Confidence 1135678999999987764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=332.76 Aligned_cols=225 Identities=25% Similarity=0.407 Sum_probs=187.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe----------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS---------- 434 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---------- 434 (607)
.++|++.++||+|+||.||+|++. +|+.||||+++... ..+.+|+++|++++|+||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356999999999999999999976 78999999997543 357789999999999999999998864
Q ss_pred ------CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 435 ------DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 435 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
....++||||+++++|.+++.......+++..+++++.||++||+|||++ +|+|||||++||||++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 34578999999999999999765545689999999999999999999999 999999999999999999999
Q ss_pred EEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHh--
Q 007351 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVN-- 585 (607)
Q Consensus 509 L~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~-- 585 (607)
|+|||+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.+|... ..+.+ ..+
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRDGI 235 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHTTC
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhccc
Confidence 999999986644322 23456899999999999999999999999999999999999887421 11111 111
Q ss_pred --HhhHHHHHHHHHHhhhcCC
Q 007351 586 --LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 --~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp 256 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKP 256 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSG
T ss_pred ccccCCHHHHHHHHHHccCCh
Confidence 1123567889999998765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.74 Aligned_cols=227 Identities=28% Similarity=0.424 Sum_probs=190.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999975 57789999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++...+. +++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999876543 89999999999999999999998 99999999999999999999999999997654322
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHh------HhhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVN------LIDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~------~~~~~~~~~i 595 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+ ..+ ......+.++
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccccCCCCcCCHHHHHH
Confidence 234568999999999999999999999999999999999999997532 111111 111 0123667889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 243 i~~~l~~~p 251 (284)
T 2vgo_A 243 ISKLLRYHP 251 (284)
T ss_dssp HHHHSCSSG
T ss_pred HHHHhhcCH
Confidence 999997765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.18 Aligned_cols=230 Identities=27% Similarity=0.432 Sum_probs=189.3
Q ss_pred CCCcccc-eecccCcEEEEEEEeC---CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQN-LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~-~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|+.++|+||+++++++ .++..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 9999999999999864 577899999986543 3456799999999999999999999999 56678999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999987543 3489999999999999999999999 9999999999999999999999999999876443
Q ss_pred Ccce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++.++.... ...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHHTTCCCCCCTTCCH
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHhcCCcCCCCCCcCH
Confidence 3221 223346788999999998889999999999999999998 999997643 23333332221 136
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 241 ~l~~li~~~l~~~p 254 (287)
T 1u59_A 241 ELYALMSDCWIYKW 254 (287)
T ss_dssp HHHHHHHHTTCSSG
T ss_pred HHHHHHHHHcCCCh
Confidence 78889999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.60 Aligned_cols=237 Identities=26% Similarity=0.449 Sum_probs=193.5
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
+....++|++.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++|+.++|+||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3344577999999999999999999864 367899999975433 344578999999999999999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
++..++||||+.+|+|.++++... ...+.+..+++++.||++||+|||++ +|+|||||++||||++++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence 999999999999999999886522 13468899999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 007351 507 AQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~ 584 (607)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ...+.+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHHHHHH
Confidence 999999999865443222 2233456888999999999999999999999999999999 899997532 22332222
Q ss_pred hH--------hhHHHHHHHHHHhhhcCC
Q 007351 585 NL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
.. .....+.+++.+|++.++
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (322)
T 1p4o_A 254 MEGGLLDKPDNCPDMLFELMRMCWQYNP 281 (322)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCc
Confidence 11 113567889999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=326.37 Aligned_cols=227 Identities=32% Similarity=0.580 Sum_probs=184.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhH-------HHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGE-------REFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~-------~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
++|++.+.||+|+||.||+|++. +++.||||++........ +.+.+|+++|++++|+||+++++++.+. .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--P 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--T
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--C
Confidence 57999999999999999999974 789999999865432211 6789999999999999999999998554 3
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcCCCc-----EEEEe
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFE-----AQVSD 511 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~-----vkL~D 511 (607)
++||||+.+++|.+++.... ..+.+..+++++.||++||+|||++ + |+|||||++||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999988887644 3589999999999999999999998 8 999999999999988776 99999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYAS--SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--- 586 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--- 586 (607)
||+++.... ......|+..|+|||++. ...++.++|||||||+||||++|+.||...... ...+.++...
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-HHHHHHHHHHSCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-HHHHHHHHhccCC
Confidence 999975432 234467899999999984 456788999999999999999999999764322 1111221111
Q ss_pred ------hhHHHHHHHHHHhhhcCC
Q 007351 587 ------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp 271 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDP 271 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCCCCcccCHHHHHHHHHHhcCCh
Confidence 113568899999998765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.66 Aligned_cols=227 Identities=31% Similarity=0.494 Sum_probs=179.6
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++ .++.||||+++.. ...+.|.+|+++|++++|+||+++++++. +..+|||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4688999999999999999998 5889999998632 34567999999999999999999999886 45899999999
Q ss_pred CCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc-EEEEecccccccccCCcc
Q 007351 447 NNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-AQVSDFGLAKLALDANTH 524 (607)
Q Consensus 447 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-vkL~DFGls~~~~~~~~~ 524 (607)
+++|.++++.... ..+.+..+++++.||++||+|||+.+..+|+|||||++||||++++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986543 24788899999999999999999932128999999999999988876 799999999755332
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i 595 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....|... .....+.++
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 22345899999999999999999999999999999999999999754211 111111111 113567889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 237 i~~~l~~dp 245 (307)
T 2eva_A 237 MTRCWSKDP 245 (307)
T ss_dssp HHHHTCSSG
T ss_pred HHHHhcCCh
Confidence 999998765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.16 Aligned_cols=229 Identities=17% Similarity=0.260 Sum_probs=187.9
Q ss_pred CCCcccceecccCcEEEEEEEeCC---------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCcee----------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS---------- 427 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~---------- 427 (607)
++|++.+.||+|+||.||+|++.. ++.||||+++.. +.+.+|+++|++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 579999999999999999999763 789999998743 46889999999999999887
Q ss_pred -----EEeEEEe-CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 428 -----LVGYCIS-DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 428 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+++++.. ++..+|||||+ +++|.+++.......+++..+++|+.||++||+|||++ +|+|||||++||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6777776 66789999999 99999999876444599999999999999999999999 99999999999999
Q ss_pred cCCC--cEEEEecccccccccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 502 DNNF--EAQVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 502 ~~~~--~vkL~DFGls~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
++++ .+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999865433221 1233478999999999999999999999999999999999999998643
Q ss_pred CCCchhHHHHHhHh----------------hHHHHHHHHHHhhhcCCC
Q 007351 574 PLGDESLVEWVNLI----------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 574 ~~~~~~l~~~~~~~----------------~~~~~~~i~~~C~~~~~~ 605 (607)
.. ...+.++...+ ....+.+++.+|++.++.
T Consensus 273 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 319 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYE 319 (352)
T ss_dssp TC-HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTT
T ss_pred cC-HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChh
Confidence 21 12222222211 147788999999987764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=335.95 Aligned_cols=234 Identities=29% Similarity=0.430 Sum_probs=191.3
Q ss_pred CCCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~ 439 (607)
++|++.+.||+|+||.||+|++ .+++.||||+++.......+.+++|+++|++++|+||+++++++.. ++..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5699999999999999999984 3678999999987766667789999999999999999999999874 45678
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||||+++++|.+++..... .+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999876332 489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCchhHHHHHhHhh
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP---------LGDESLVEWVNLID 588 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~---------~~~~~l~~~~~~~~ 588 (607)
..... ......++..|+|||++.+..++.++|||||||+||||++|+.||..... .....+.++...+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 43322 22334578889999999998999999999999999999999999864210 00011111111111
Q ss_pred -----------HHHHHHHHHHhhhcCC
Q 007351 589 -----------AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 -----------~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCCh
Confidence 2568899999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.40 Aligned_cols=230 Identities=31% Similarity=0.551 Sum_probs=177.3
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|++. +.||||+++.... ...+.|.+|+++|+.++|+||+++++++ .++..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 357999999999999999999863 4699999975543 3346799999999999999999999965 4567899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC-
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~- 522 (607)
|+.+++|.++++... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999986543 3589999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH------------h
Q 007351 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL------------I 587 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~------------~ 587 (607)
........|+..|+|||++. +..++.++|||||||++|||++|+.||.+... ...+.++... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCcchhhcccc
Confidence 22233456899999999987 56788899999999999999999999976431 1222222211 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 254 ~~~~l~~li~~~l~~~p 270 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKR 270 (289)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHccCCh
Confidence 12668899999998765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.56 Aligned_cols=196 Identities=27% Similarity=0.394 Sum_probs=166.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|+.++|+||+++++++..++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999974 78999999985432 233467899999999999999999999998663
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..+|||||+ +++|..+++.. .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88999888763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ....+++..|+|||++.+ ..++.++|||||||+||||++|+.+|.+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432 234578999999999887 67999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.00 Aligned_cols=228 Identities=23% Similarity=0.383 Sum_probs=186.6
Q ss_pred hCCCcccceecccCcEEEEEEEeCC-C-------cEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD-G-------REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~-g-------~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 437 (607)
.++|++.+.||+|+||.||+|++.. + +.||||+++.......+.+.+|+++|++++|+||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3579999999999999999998642 3 4799999976666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc--------EEE
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--------AQV 509 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--------vkL 509 (607)
.+|||||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997653 2489999999999999999999999 9999999999999998887 999
Q ss_pred EecccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-
Q 007351 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI- 587 (607)
Q Consensus 510 ~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~- 587 (607)
+|||+++..... ....++..|+|||++.+ ..++.++|||||||+||||++|..++.... ......++....
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~~~~~~ 235 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQFYEDRH 235 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTC
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHHHHhhccC
Confidence 999999754322 22457889999999987 678999999999999999999665554321 111211211111
Q ss_pred -----hHHHHHHHHHHhhhcCC
Q 007351 588 -----DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp 257 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEP 257 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSG
T ss_pred CCCCCCCHHHHHHHHHHcCCCh
Confidence 12457789999998765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=362.56 Aligned_cols=230 Identities=26% Similarity=0.421 Sum_probs=185.2
Q ss_pred CCcccc-eecccCcEEEEEEEeC---CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 368 GFADQN-LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 368 ~y~~~~-~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
+|.+.+ .||+|+||.||+|.++ ++..||||+++.... ...++|.+|+++|++|+|+||++++++|.. +..+|||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999864 456799999976533 356789999999999999999999999976 5689999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+|+|.+++.... ..+.+..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999987543 3589999999999999999999999 99999999999999999999999999998764332
Q ss_pred cce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHH
Q 007351 523 THI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKI 591 (607)
Q Consensus 523 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~ 591 (607)
... .....++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+++... ....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i~~~~~~~~p~~~~~~ 567 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRMECPPECPPE 567 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---SHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCCHH
Confidence 221 222345688999999999999999999999999999998 999998643 33344433221 1377
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 568 l~~li~~cl~~dP~ 581 (613)
T 2ozo_A 568 LYALMSDCWIYKWE 581 (613)
T ss_dssp HHHHHHHTTCSSTT
T ss_pred HHHHHHHHcCCChh
Confidence 88999999987754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.38 Aligned_cols=201 Identities=23% Similarity=0.380 Sum_probs=170.5
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeC--------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD-------- 435 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 435 (607)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++|+.++|+||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999997 4789999999865433 2345788999999999999999999998873
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+..+|||||+++ +|...+..... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 467999999975 66666655432 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCC---cceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDAN---THITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+...... ........|+..|+|||++.+ ..++.++|||||||+||||++|+.+|.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 8654221 122344568999999999876 45899999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.75 Aligned_cols=198 Identities=23% Similarity=0.338 Sum_probs=174.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc------cCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI------HHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~~~~~~ 438 (607)
..+|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++|+.+ +|+||+++++++..++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999865 5889999998742 33456788899999988 466999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc--EEEEeccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--AQVSDFGLAK 516 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DFGls~ 516 (607)
+|||||+. ++|.+++.......+.+..+++|+.||++||+|||++ +|||||||++||||++++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6898888877666699999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ....+|+..|||||++.+..++.++|||||||+||||++|+.||.+.
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64332 23356899999999999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.81 Aligned_cols=227 Identities=28% Similarity=0.416 Sum_probs=186.3
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++..++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999996 47899999999754332 2356899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+. |+|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 67777665432 2489999999999999999999999 9999999999999999999999999999865432
Q ss_pred cceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHH
Q 007351 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~ 591 (607)
....|+..|||||++. +..++.++|||||||+||||++|+.||.+.... ..+.+.... .....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESPALQSGHWSEY 281 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCCCTTSCHH
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCCHH
Confidence 2356899999999985 567899999999999999999999999754211 111111111 12356
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 282 l~~li~~~l~~dP~ 295 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQ 295 (348)
T ss_dssp HHHHHHHHTCSSGG
T ss_pred HHHHHHHHcccChh
Confidence 78999999987753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=343.99 Aligned_cols=201 Identities=24% Similarity=0.371 Sum_probs=173.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 442 (607)
++|++.++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56999999999999999999975 58999999997543 234567889999999999999999999998765 679999
Q ss_pred EecCCCchhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----cCCCcEEEEecccccc
Q 007351 443 DYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKL 517 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DFGls~~ 517 (607)
|||.+|+|.++++.... ..+.+..+++++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 2389999999999999999999999 99999999999999 7788899999999986
Q ss_pred cccCCcceeeccccCCCCCchhhhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASS--------GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 54432 2234568999999999875 45678999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.06 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=169.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc--------CCCceeEEeEEE---
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH--------HRHLVSLVGYCI--- 433 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~g~~~--- 433 (607)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++|+.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999864 6889999998743 334567899999999996 788999999987
Q ss_pred -eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-------
Q 007351 434 -SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF------- 505 (607)
Q Consensus 434 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~------- 505 (607)
.+...+|||||+ +++|..++.......+.+..+++|+.||++||+|||+++ +|||||||++||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 445789999999 555655555544456999999999999999999999853 799999999999998775
Q ss_pred ------------------------------------------cEEEEecccccccccCCcceeeccccCCCCCchhhhcC
Q 007351 506 ------------------------------------------EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543 (607)
Q Consensus 506 ------------------------------------------~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~ 543 (607)
.+||+|||+++..... ....+|+..|||||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999865432 233568999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 544 ~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
..++.++|||||||+||||++|+.||....
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.77 Aligned_cols=234 Identities=26% Similarity=0.380 Sum_probs=170.9
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+++|++++++++|+||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999996 4789999999964321 2246789999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+++++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999987643 3489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH---HH-HhHhhHHHHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV---EW-VNLIDAKILFKLVF 597 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~---~~-~~~~~~~~~~~i~~ 597 (607)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ++ ........+.+++.
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence 22 123356899999999999888999999999999999999999999764321110000 00 00112356788999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+|++.++
T Consensus 245 ~~l~~dp 251 (278)
T 3cok_A 245 QLLRRNP 251 (278)
T ss_dssp HHSCSSG
T ss_pred HHcccCH
Confidence 9998765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.95 Aligned_cols=197 Identities=24% Similarity=0.340 Sum_probs=162.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|+.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999864 68899999997532 233467889999999999999999999998665
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..+|||||+++ +|.+++.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 67999999975 67777753 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 233457899999999999999999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.74 Aligned_cols=229 Identities=26% Similarity=0.417 Sum_probs=193.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.+.|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|+.++|+||+++++++..++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999864 68899999997554 3345779999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999988653 489999999999999999999999 999999999999999999999999999986644322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILFKL 595 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i 595 (607)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ......+... .....+.++
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 2334568999999999999999999999999999999999999997532 2222222111 113567899
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 251 i~~~l~~dp 259 (303)
T 3a7i_A 251 VEACLNKEP 259 (303)
T ss_dssp HHHHCCSSG
T ss_pred HHHHcCCCh
Confidence 999998765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.95 Aligned_cols=208 Identities=24% Similarity=0.334 Sum_probs=170.3
Q ss_pred cHHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCch-----------hHHHHHHHHHHHHHccCCCce
Q 007351 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-----------GEREFKAEVEIISRIHHRHLV 426 (607)
Q Consensus 358 ~~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv 426 (607)
.++++....++|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+++|++++|+||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456777788999999999999999999999888999999998543221 236799999999999999999
Q ss_pred eEEeEEEeCC-----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 427 SLVGYCISDD-----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 427 ~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
++++++...+ ..+|||||+. |+|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 9999986533 5699999998 67777776543 3589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 502 DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
++++.+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999997543322 2334568899999999887 67899999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.72 Aligned_cols=199 Identities=26% Similarity=0.360 Sum_probs=167.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC-----Cc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 437 (607)
.++|++.++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|+.|+|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 67889999997432 33456789999999999999999999999876 56
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.||||||++ ++|..+++... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 58999887654 389999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCc---------------------ceeeccccCCCCCchhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 518 ALDANT---------------------HITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 518 ~~~~~~---------------------~~~~~~~gt~~y~APE~l-~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
...... ......+||..|+|||++ .+..++.++|||||||+||||++|..+|.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 643321 123456799999999986 45679999999999999999998655553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=323.20 Aligned_cols=231 Identities=24% Similarity=0.396 Sum_probs=187.1
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
+|....+||+|+||.||+|+. .+++.||||+++.......+.+.+|+++++.++|+||+++++++..++..++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 456667999999999999996 4688999999987666667789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecccccccccCCcc
Q 007351 447 NNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 447 ~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls~~~~~~~~~ 524 (607)
+++|.+++.... ...+.+..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999987653 33467888999999999999999999 9999999999999987 89999999999986543322
Q ss_pred eeeccccCCCCCchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-H---------hhHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN-L---------IDAKIL 592 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~--~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~-~---------~~~~~~ 592 (607)
......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.... ......+.. . .....+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG---EPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS---SHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC---chhHHHHhhccccccccccccCCHHH
Confidence 233456899999999987643 8899999999999999999999997532 111111111 0 113677
Q ss_pred HHHHHHhhhcCCC
Q 007351 593 FKLVFLCQQNSNS 605 (607)
Q Consensus 593 ~~i~~~C~~~~~~ 605 (607)
.+++.+|++.++.
T Consensus 256 ~~li~~~l~~dp~ 268 (295)
T 2clq_A 256 KAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHHTTCSSTT
T ss_pred HHHHHHHccCChh
Confidence 8999999988764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=327.54 Aligned_cols=231 Identities=26% Similarity=0.423 Sum_probs=188.1
Q ss_pred hCCCcccc-eecccCcEEEEEEEeC---CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 366 TDGFADQN-LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 366 ~~~y~~~~-~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
.++|++.+ .||+|+||.||+|.+. +++.||||+++.... ...+++.+|+++++.++|+||+++++++ .++..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45688877 9999999999999642 467899999975432 3356799999999999999999999999 667889
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+.+++|.+++..... +.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999987543 89999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------h
Q 007351 520 DANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------D 588 (607)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~ 588 (607)
...... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.++.... .
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGERMGCPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC
Confidence 443322 222345688999999998889999999999999999999 999997642 23333332221 1
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 246 ~~~l~~li~~~l~~dp~ 262 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVE 262 (291)
T ss_dssp CHHHHHHHHHHTCSSTT
T ss_pred CHHHHHHHHHHcCCChh
Confidence 36788999999987764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.90 Aligned_cols=230 Identities=24% Similarity=0.323 Sum_probs=185.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46899999999999999999964 68899999997543 33457899999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccc
Q 007351 445 VPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 445 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~ 519 (607)
+.+|+|.+++... ....+.+..+++++.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887542 223589999999999999999999999 99999999999999 456889999999998654
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh----------hH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----------DA 589 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----------~~ 589 (607)
... ......|+..|+|||++. ..++.++|||||||+||||++|+.||.+.. ..++.+..... ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCC--CCCC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhhccCCcccccccCcCC
Confidence 332 233456899999999886 578899999999999999999999997642 22222221111 13
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+|++.++.
T Consensus 253 ~~~~~li~~~L~~dP~ 268 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPE 268 (285)
T ss_dssp HHHHHHHHHHTCSCTT
T ss_pred HHHHHHHHHHccCChh
Confidence 5678899999987764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.88 Aligned_cols=230 Identities=30% Similarity=0.465 Sum_probs=187.2
Q ss_pred CcccceecccCcEEEEEEEeC-----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeC--CceEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLL 440 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-----~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 440 (607)
|++.+.||+|+||.||++.++ +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++... ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 678899999986543 3456799999999999999999999999885 46789
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+++++|.+++.... +.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997654 89999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCchhHHHHHhHh--
Q 007351 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP---------LGDESLVEWVNLI-- 587 (607)
Q Consensus 521 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~---------~~~~~l~~~~~~~-- 587 (607)
.... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .......++.+.+
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4322 23345678889999999998999999999999999999999999964210 0001111122211
Q ss_pred ---------hHHHHHHHHHHhhhcCC
Q 007351 588 ---------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ---------~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP 292 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEA 292 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCc
Confidence 12568899999998765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.38 Aligned_cols=193 Identities=20% Similarity=0.338 Sum_probs=170.1
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEe--CCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS--DDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+. .+++.||||+++. ...+.+.+|+++|++|+ |+||+++++++.. ....+|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5799999999999999999986 4789999999873 33567999999999997 9999999999987 56789999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEecccccccccC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDA 521 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~~~~ 521 (607)
||+.+++|..+++. +.+..++.++.||++||+|||++ +|+|||||++||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999988853 78899999999999999999999 999999999999999766 8999999999865443
Q ss_pred CcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 32 334568899999999887 67899999999999999999999999643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=337.70 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=175.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|+.++|+||+++++++..++..+|||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57999999999999999999975 689999999976533 3346799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+++++|.++++..+. +.+..+++++.||++||+|||+.+ +|+|||||++||||++++.+||+|||+++......
T Consensus 113 ~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999999987554 899999999999999999999831 79999999999999999999999999997653322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23456899999999999999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=326.03 Aligned_cols=232 Identities=22% Similarity=0.357 Sum_probs=188.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~l 440 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. ++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999975 78999999997543 2344679999999999999999999998854 567899
Q ss_pred EEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-----EEecCCCCCCEEEcCCCcEEEEecc
Q 007351 441 IYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPR-----IIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-----ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
||||+++++|.+++... ....+++..+++++.||++||+|||++ + |+|||||++||||++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999988653 233489999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------ 587 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------ 587 (607)
+++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..++.+.....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIP 237 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHhhcccccCC
Confidence 9986543322 2223468999999999999999999999999999999999999997642 22222222111
Q ss_pred --hHHHHHHHHHHhhhcCC
Q 007351 588 --DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 --~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 238 ~~~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKD 256 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSG
T ss_pred cccCHHHHHHHHHHcCCCc
Confidence 13678899999998775
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.98 Aligned_cols=233 Identities=23% Similarity=0.305 Sum_probs=186.1
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC----chhHHHHHHHHHHHHHccCCCceeEEeEEE--eCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCI--SDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 438 (607)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+++|+++|++++|+||+++++++. +++..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 68899999997432 234567999999999999999999999985 44578
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+|||||+.++ |.+++.......+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 66666665555699999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCC-cceeeccccCCCCCchhhhcCCCC--CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hh
Q 007351 519 LDAN-THITTRVMGTFGYMAPEYASSGKL--TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------ID 588 (607)
Q Consensus 519 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~--~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~ 588 (607)
.... ........|+..|+|||++.+... +.++|||||||++|||++|+.||.+.. ...+.+.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~ 236 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSYAIPGDC 236 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCCSSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCCCCCCcc
Confidence 4322 222334568999999999986543 779999999999999999999997532 1121111111 01
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+|++.++.
T Consensus 237 ~~~l~~li~~~l~~dp~ 253 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPA 253 (305)
T ss_dssp CHHHHHHHHHHTCSSTT
T ss_pred CHHHHHHHHHHccCChh
Confidence 35678999999987764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.03 Aligned_cols=232 Identities=28% Similarity=0.420 Sum_probs=189.3
Q ss_pred HHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHH--ccCCCceeEEeEEEeCC----
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD---- 436 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~---- 436 (607)
....++|++.+.||+|+||.||+|++ +|+.||||+++. ...+.+.+|+++++. ++|+||+++++++..++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34456799999999999999999998 689999999863 345678889999998 78999999999998876
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCEEecCCCCCCEEEcCCCcEE
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH--------EDCHPRIIHRDIKSSNILLDNNFEAQ 508 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivHrDLkp~NILl~~~~~vk 508 (607)
..++||||+.+|+|.+++... .+.+..+++++.||++||+||| ++ +|+|||||++||||++++++|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999764 3899999999999999999999 76 999999999999999999999
Q ss_pred EEecccccccccCCcc---eeeccccCCCCCchhhhcCCC------CCchhhHHHHHHHHHHHHcC----------CCCC
Q 007351 509 VSDFGLAKLALDANTH---ITTRVMGTFGYMAPEYASSGK------LTEKSDVFSFGVVLLELITG----------RKPV 569 (607)
Q Consensus 509 L~DFGls~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~------~~~~~DVwSlGvll~ELltg----------~~Pf 569 (607)
|+|||+++........ ......|+..|+|||++.+.. ++.++|||||||+||||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999876544332 124457899999999998753 23689999999999999999 7888
Q ss_pred CCCCCCCchhHHHHHhH-----------------hhHHHHHHHHHHhhhcCCC
Q 007351 570 DASQPLGDESLVEWVNL-----------------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 570 ~~~~~~~~~~l~~~~~~-----------------~~~~~~~~i~~~C~~~~~~ 605 (607)
....... ....++.+. .....+.+++.+||+.++.
T Consensus 268 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (342)
T 1b6c_B 268 YDLVPSD-PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319 (342)
T ss_dssp TTTSCSS-CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred cccCcCc-ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChh
Confidence 7643221 122222221 1235788999999987653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.74 Aligned_cols=235 Identities=27% Similarity=0.417 Sum_probs=185.7
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEe-----
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS----- 434 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----- 434 (607)
+....++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+|+++|+++ +|+||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3344578999999999999999999974 78999999987543 3456789999999999 79999999999987
Q ss_pred -CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 435 -DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 435 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
++..+|||||+++++|.+++.......+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 45789999999999999999876545689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH-
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL- 586 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~- 586 (607)
+++....... ......|+..|+|||++. +..++.++|||||||+||||++|+.||.+.. ..... .+.+.
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~ 250 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPRNP 250 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSC
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCc
Confidence 9986543221 223456899999999987 5678899999999999999999999997542 11111 11110
Q ss_pred -------hhHHHHHHHHHHhhhcCC
Q 007351 587 -------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 -------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp 275 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNH 275 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSG
T ss_pred cccCCccccCHHHHHHHHHHhccCh
Confidence 113678899999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.12 Aligned_cols=225 Identities=22% Similarity=0.293 Sum_probs=186.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++..+ +|+||+++++++.+++..+|||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56999999999999999999975 7899999999754 234556789999999999 8999999999999999999999
Q ss_pred EecCCCchhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-----------------
Q 007351 443 DYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN----------------- 503 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~----------------- 503 (607)
||+++++|.+++..... ..+++..+++|+.||++||+|||++ +|+|||||++||||+.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999998876421 3489999999999999999999999 9999999999999984
Q ss_pred --CCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 007351 504 --NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580 (607)
Q Consensus 504 --~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l 580 (607)
++.+||+|||+++...... ...|+..|+|||++.+. .++.++|||||||+||||++|+.+|... ..+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~ 237 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQW 237 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----HHH
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----hHH
Confidence 4489999999998664432 23588999999999876 5667999999999999999998776432 222
Q ss_pred HHHHhH-------hhHHHHHHHHHHhhhcCC
Q 007351 581 VEWVNL-------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 581 ~~~~~~-------~~~~~~~~i~~~C~~~~~ 604 (607)
.++.+. .....+.+++.+|++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSG
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCc
Confidence 222221 124678899999998775
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.09 Aligned_cols=227 Identities=26% Similarity=0.375 Sum_probs=184.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC----CceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD----DRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~~~ 439 (607)
+.|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++|+.++|+||+++++++... ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999864 67889999987432 33456789999999999999999999998753 4578
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEc-CCCcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLD-NNFEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGls~ 516 (607)
+||||+++++|.+++..... +.+..+++++.||++||+|||++ + |+|||||++||||+ +++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999976543 89999999999999999999998 7 99999999999997 78999999999997
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------h
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------I 587 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~ 587 (607)
...... .....|+..|+|||++.+ .++.++|||||||++|||++|+.||..... ...+.+.... .
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGGGC
T ss_pred cccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCccccCCC
Confidence 544322 234568999999998874 589999999999999999999999976421 1111111111 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 255 ~~~~l~~li~~~l~~dp 271 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNK 271 (290)
T ss_dssp CCHHHHHHHHHHSCSSG
T ss_pred CCHHHHHHHHHHccCCh
Confidence 12568899999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.83 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=173.6
Q ss_pred HhhCCCcccceecccCcEEEEEEEe--CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHc---cCCCceeEEeEEE---
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYL--PDGREVAIKQLKIGGG--QGEREFKAEVEIISRI---HHRHLVSLVGYCI--- 433 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~--~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~--- 433 (607)
...++|++.+.||+|+||.||+|++ .+|+.||||+++.... .....+.+|+++++.+ +|+||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 3678999999974332 2234567788877776 7999999999987
Q ss_pred --eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 434 --SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 434 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
.+...++||||+. |+|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4557899999998 6899988876655689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 512 FGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
||+++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.+.
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99997654322 233456899999999999999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.21 Aligned_cols=230 Identities=24% Similarity=0.366 Sum_probs=184.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--------QGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 436 (607)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++|++++|+||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357999999999999999999975 678999999864321 12245889999999999999999999987654
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc---EEEEecc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFG 513 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFG 513 (607)
.++||||+.+++|.+++.... .+.+..++.++.||++||+|||++ +|+|||||++||||+.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999887654 489999999999999999999999 9999999999999987654 9999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH----
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---- 586 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---- 586 (607)
+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||....... .+.+....
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHTCCC
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhCccc
Confidence 998654321 223356899999999974 4678899999999999999999999997654321 22221111
Q ss_pred -------hhHHHHHHHHHHhhhcCCC
Q 007351 587 -------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 -------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~~li~~~l~~dP~ 264 (322)
T 2ycf_A 239 FIPEVWAEVSEKALDLVKKLLVVDPK 264 (322)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred cCchhhhhcCHHHHHHHHHHcccCHh
Confidence 1246678999999987764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.09 Aligned_cols=202 Identities=31% Similarity=0.474 Sum_probs=175.6
Q ss_pred hCCCcccceecccCcEEEEEEEe-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC--ce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 438 (607)
.++|++.+.||+|+||.||+|++ .+|+.||||+++.......+.+++|+++|++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999984 368899999998766666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+++++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997754 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcce--eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 519 LDANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
....... .....++..|+|||++.+..++.++|||||||+||||++|+.+|..
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 5443321 2234567789999999988899999999999999999999998863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.63 Aligned_cols=233 Identities=29% Similarity=0.447 Sum_probs=187.7
Q ss_pred hCCCcccceecccCcEEEEEEEe------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++.+.||+|+||.||+|++ .+++.||||+++... .....++.+|+++|++++|+||+++++++..++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35799999999999999999984 256789999997443 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~ 510 (607)
+|||||+++++|.+++..... ..+.+..+++++.||++||+|||++ +|+|||||++||||+ +++.+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 3488999999999999999999999 999999999999998 44569999
Q ss_pred ecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh-
Q 007351 511 DFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI- 587 (607)
Q Consensus 511 DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~- 587 (607)
|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ..++.++....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGG 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHHHhcCC
Confidence 9999986543322 22334567889999999999999999999999999999998 999997542 23333333221
Q ss_pred -------hHHHHHHHHHHhhhcCC
Q 007351 588 -------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp 286 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQP 286 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCh
Confidence 23667889999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=331.83 Aligned_cols=237 Identities=26% Similarity=0.423 Sum_probs=180.3
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 435 (607)
+....++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|+++|++++|+||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3334567999999999999999999864 34579999997543 23346799999999999999999999999876
Q ss_pred Cc-----eEEEEEecCCCchhHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc
Q 007351 436 DR-----RLLIYDYVPNNTLYFHLHG----EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (607)
Q Consensus 436 ~~-----~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (607)
+. .++||||+.+++|.+++.. .....+.+..+++++.||++||+|||++ +|+|||||++||||++++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 53 4999999999999988843 2334589999999999999999999998 9999999999999999999
Q ss_pred EEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 007351 507 AQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 507 vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~ 584 (607)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ...+.+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~ 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ---NHEMYDYL 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHHH
Confidence 999999999866443222 2233456788999999999999999999999999999999 899997643 22322222
Q ss_pred hHh--------hHHHHHHHHHHhhhcCC
Q 007351 585 NLI--------DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~~~--------~~~~~~~i~~~C~~~~~ 604 (607)
... ....+.+++.+|++.++
T Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp 290 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYEIMYSCWRTDP 290 (313)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHTTCSSG
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCCh
Confidence 111 12678899999998765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.00 Aligned_cols=228 Identities=25% Similarity=0.396 Sum_probs=183.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999976 78999999986432 223457899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++..... +.+..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999976543 89999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFK 594 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~ 594 (607)
......|+..|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+.+.... .....+.+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCcccCchhcCHHHHH
Confidence 2233468899999999988765 578999999999999999999997532 1222221111 11466788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 241 li~~~l~~~p 250 (276)
T 2h6d_A 241 LLMHMLQVDP 250 (276)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 9999998765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=336.13 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=164.8
Q ss_pred HhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------
Q 007351 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (607)
Q Consensus 364 ~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 436 (607)
...++|++.+.||+|+||.||+|+. .+|+.||||++.... +.+.+|+++|+.++|+||+++++++...+
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3457899999999999999999986 478999999987432 23357999999999999999999985432
Q ss_pred --------------------------------ceEEEEEecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007351 437 --------------------------------RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLH 482 (607)
Q Consensus 437 --------------------------------~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH 482 (607)
..+|||||+. |+|...+.. .....+.+..++.++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3789999998 577665543 22345899999999999999999999
Q ss_pred HcCCCCEEecCCCCCCEEEc-CCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHH
Q 007351 483 EDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLL 560 (607)
Q Consensus 483 ~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ 560 (607)
++ +|+|||||++||||+ +++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||+||
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 98 999999999999997 688999999999986644332 2345689999999998875 4899999999999999
Q ss_pred HHHcCCCCCCCC
Q 007351 561 ELITGRKPVDAS 572 (607)
Q Consensus 561 ELltg~~Pf~~~ 572 (607)
||++|+.||.+.
T Consensus 234 ell~g~~pf~~~ 245 (383)
T 3eb0_A 234 ELILGKPLFSGE 245 (383)
T ss_dssp HHHHSSCSSCCS
T ss_pred HHHhCCCCCCCC
Confidence 999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.17 Aligned_cols=230 Identities=23% Similarity=0.337 Sum_probs=190.4
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---------hhHHHHHHHHHHHHHcc-CCCceeEEeEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---------QGEREFKAEVEIISRIH-HRHLVSLVGYCI 433 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---------~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 433 (607)
..++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|+++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999975 688999999975431 22356889999999996 999999999999
Q ss_pred eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 434 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
.++..+|||||+++++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999997654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYAS------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL- 586 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~- 586 (607)
+++....... .....|+..|+|||++. ...++.++|||||||+||||++|+.||.... .....+....
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHhcC
Confidence 9986543322 23456899999999985 4567889999999999999999999997542 1222211110
Q ss_pred ----------hhHHHHHHHHHHhhhcCC
Q 007351 587 ----------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ----------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSG
T ss_pred CcccCcccccccCHHHHHHHHHHccCCc
Confidence 123568899999998765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.61 Aligned_cols=231 Identities=28% Similarity=0.405 Sum_probs=187.7
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
..++|++.+.||+|+||.||+|.+. +|+.||||+++... ..+++.+|+++|+.++|+||+++++++..++..+||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467999999999999999999975 58999999997542 34678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999886432 2489999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH-h---------HhhHHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV-N---------LIDAKILF 593 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~-~---------~~~~~~~~ 593 (607)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.+... ....... . ......+.
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcccCCcccCCHHHH
Confidence 23345689999999999998999999999999999999999999975421 1111111 0 01136678
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 257 ~li~~~l~~dp~ 268 (314)
T 3com_A 257 DFVKQCLVKSPE 268 (314)
T ss_dssp HHHHHHTCSCTT
T ss_pred HHHHHHccCChh
Confidence 999999987764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.68 Aligned_cols=224 Identities=27% Similarity=0.432 Sum_probs=181.9
Q ss_pred ceecccCcEEEEEEEeC---CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|.+. +++.||||+++.... ...++|++|+++|++|+|+|||+++++|. ++..+||||||.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999753 467899999975432 34578999999999999999999999996 4568899999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc--e
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--I 525 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~--~ 525 (607)
|+|.++++... .+.+..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 389999999999999999999999 9999999999999999999999999999876543321 2
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
.....++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....+.+++
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 233456788999999999999999999999999999998 999997642 22333332221 135788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+||+.++.
T Consensus 606 ~~cl~~dP~ 614 (635)
T 4fl3_A 606 NLCWTYDVE 614 (635)
T ss_dssp HHHTCSSTT
T ss_pred HHHcCCCHh
Confidence 999988764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=332.89 Aligned_cols=236 Identities=25% Similarity=0.334 Sum_probs=187.0
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe----CCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 440 (607)
.++|++.+.||+|+||.||+++. .+|+.||||++........+.+++|+++++.++|+||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999996 5789999999987666667789999999999999999999999873 346789
Q ss_pred EEEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 441 IYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
||||+.+|+|.+++... ....+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999888652 234589999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCcc--------eeeccccCCCCCchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-
Q 007351 519 LDANTH--------ITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL- 586 (607)
Q Consensus 519 ~~~~~~--------~~~~~~gt~~y~APE~l~~~~---~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~- 586 (607)
...... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.......+.....+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321110 011235789999999987654 68899999999999999999999964211111111111111
Q ss_pred ------hhHHHHHHHHHHhhhcCC
Q 007351 587 ------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 ------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCCccccCCHHHHHHHHHHhhcCh
Confidence 123578889999998765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.16 Aligned_cols=231 Identities=23% Similarity=0.367 Sum_probs=179.8
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--------chhHHHHHHHHHHHHHccCCCceeEEeEEEeC
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--------GQGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 435 (607)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++|+||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999865 68899999986432 111234889999999999999999999975 4
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC---CcEEEEec
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDF 512 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DF 512 (607)
+..+||||||.+|+|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 568999999999999998876544 89999999999999999999999 99999999999999654 45999999
Q ss_pred ccccccccCCcceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---
Q 007351 513 GLAKLALDANTHITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--- 586 (607)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--- 586 (607)
|+++...... ......|+..|||||++.+ ..++.++|||||||+||||++|+.||....... .+.+....
T Consensus 287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGKY 362 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHTTCC
T ss_pred ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhcCCC
Confidence 9998754322 2344678999999999864 567889999999999999999999997643221 22211111
Q ss_pred --------hhHHHHHHHHHHhhhcCCC
Q 007351 587 --------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 363 ~~~~~~~~~~~~~~~~li~~~L~~dP~ 389 (419)
T 3i6u_A 363 NFIPEVWAEVSEKALDLVKKLLVVDPK 389 (419)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred CCCchhhcccCHHHHHHHHHHccCChh
Confidence 1235678899999987764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=325.75 Aligned_cols=198 Identities=23% Similarity=0.373 Sum_probs=174.1
Q ss_pred hCCCcccceecccCcEEEEEEEe--CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC------ceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL--PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH------LVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~--~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~ 437 (607)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+++++.++|.| |+++++++..++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35799999999999999999986 36889999998643 344567899999999997654 9999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------------- 503 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------------- 503 (607)
.+|||||+ +++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999988877666689999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 504 -----NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 504 -----~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864332 23456899999999999999999999999999999999999999764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.55 Aligned_cols=197 Identities=27% Similarity=0.405 Sum_probs=165.1
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc------eEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR------RLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------~~l 440 (607)
.+|++.++||+|+||.||+|++.+++.||||++..... ...+|+++|+.++|+||+++++++...+. .+|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46999999999999999999988777899998864322 23479999999999999999999876543 689
Q ss_pred EEEecCCCchhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEEEeccccccc
Q 007351 441 IYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLA 518 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DFGls~~~ 518 (607)
||||+.++.+....+. .....+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655433321 2233589999999999999999999999 999999999999999 7999999999999876
Q ss_pred ccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....++..|+|||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43332 2345689999999999765 5899999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.98 Aligned_cols=196 Identities=26% Similarity=0.406 Sum_probs=154.5
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC------C
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------D 436 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 436 (607)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|+.++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999985 478899999986532 23456788999999999999999999998754 4
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..++|+||+ +++|..+++.. .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 579999999 78898888652 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432 234578999999999887 67899999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.92 Aligned_cols=200 Identities=24% Similarity=0.370 Sum_probs=165.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEE-----------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI----------- 433 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----------- 433 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.......+++.+|+++|++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999976 48999999998766666678999999999999999999999874
Q ss_pred ---eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEE
Q 007351 434 ---SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQV 509 (607)
Q Consensus 434 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL 509 (607)
..+..++||||++ |+|.+++... .+.+..+++++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3356789999997 6898888643 388999999999999999999999 999999999999997 5779999
Q ss_pred EecccccccccCCc--ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 510 SDFGLAKLALDANT--HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 510 ~DFGls~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+|||+++....... .......++..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999986543211 11233457889999998875 67899999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.14 Aligned_cols=230 Identities=27% Similarity=0.440 Sum_probs=181.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcE----EEEEEeecC-CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGRE----VAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~----VAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.+.||+|+||.||+|++. +++. ||+|.++.. .....+.+++|+++|+.++|+||+++++++..+ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence 57999999999999999999964 4444 577777533 334567899999999999999999999999865 4889
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|+||+.+|+|.+++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999876543 489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ...+.++.... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTCCCCCCTTBCH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCCCCCCCccCCH
Confidence 3221 2233456778999999999999999999999999999999 999997643 23333332221 235
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+||+.++
T Consensus 247 ~l~~li~~~l~~dp 260 (327)
T 3lzb_A 247 DVYMIMRKCWMIDA 260 (327)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHcCCCh
Confidence 67889999998765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.99 Aligned_cols=230 Identities=23% Similarity=0.351 Sum_probs=192.3
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchh-----------------HHHHHHHHHHHHHccCCCceeE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----------------EREFKAEVEIISRIHHRHLVSL 428 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~-----------------~~~~~~Ei~il~~l~HpnIv~l 428 (607)
.++|++.+.||+|+||.||+|++ +|+.||||+++...... .+.+.+|+++|++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36799999999999999999999 99999999996432111 1789999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCchhHh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEE
Q 007351 429 VGYCISDDRRLLIYDYVPNNTLYFH------LHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 429 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl 501 (607)
++++..++..++||||+++++|.++ +.......+.+..+++++.||++||+|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999988 655445569999999999999999999999 8 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTE-KSDVFSFGVVLLELITGRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~ 579 (607)
++++.+||+|||+++..... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||...... .+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999865433 33446789999999999887 6666 999999999999999999999764321 22
Q ss_pred HHHHHh--------------------------HhhHHHHHHHHHHhhhcCC
Q 007351 580 LVEWVN--------------------------LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 580 l~~~~~--------------------------~~~~~~~~~i~~~C~~~~~ 604 (607)
+.+... ......+.+++.+|++.++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 311 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCCh
Confidence 222211 1124667899999998765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.67 Aligned_cols=207 Identities=23% Similarity=0.307 Sum_probs=160.8
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR- 437 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~- 437 (607)
++.....++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+|++.++.++|+||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455666789999999999999999999975 68999999986432 333456778899999999999999999976543
Q ss_pred ------eEEEEEecCCCchhHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCCCEEecCCCCCCEEEcC-CCcE
Q 007351 438 ------RLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLH--EDCHPRIIHRDIKSSNILLDN-NFEA 507 (607)
Q Consensus 438 ------~~lV~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qia~gL~~LH--~~~~~~ivHrDLkp~NILl~~-~~~v 507 (607)
.+|||||+.++.+..+.. ......+.+..++.++.||+.||+||| ++ +|+|||||++||||++ ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998764332221 123345889999999999999999999 77 9999999999999996 8999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
||+|||+++....... .....|+..|+|||++.+.. ++.++|||||||+||||++|+.||.+.
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 9999999986654332 33456899999999987654 899999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.06 Aligned_cols=227 Identities=27% Similarity=0.450 Sum_probs=182.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeC-CceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|++ +|+.||||+++.. ...+.+.+|+++|++++|+||+++++++.++ +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35799999999999999999998 6899999998743 3456799999999999999999999997655 478999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|.+++.......+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999998765444478899999999999999999999 99999999999999999999999999997554322
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDAKILFKL 595 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~~i 595 (607)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++.+.... .....+.++
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKGYKMDAPDGCPPAVYEV 246 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 22356889999999999999999999999999999998 999997642 2233222211 113678899
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 247 i~~~l~~~p~ 256 (278)
T 1byg_A 247 MKNCWHLDAA 256 (278)
T ss_dssp HHHHTCSSGG
T ss_pred HHHHhcCChh
Confidence 9999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=340.27 Aligned_cols=230 Identities=28% Similarity=0.456 Sum_probs=176.7
Q ss_pred CCcccceecccCcEEEEEEEeC--CC--cEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCceEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~--~g--~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV 441 (607)
.|++.++||+|+||.||+|++. ++ ..||||.++... ....++|++|+++|++++|+||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677899999999999999863 22 358999986433 3445679999999999999999999998765 4578999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+|+|.++++.... .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999976443 478999999999999999999999 9999999999999999999999999999865433
Q ss_pred Ccc---eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH--------hhH
Q 007351 522 NTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL--------IDA 589 (607)
Q Consensus 522 ~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~--------~~~ 589 (607)
... ......++..|||||++.+..++.++|||||||+||||++ |+.||.+.... ++.++... ...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~~~~~~~~p~~~~ 322 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRRLLQPEYCP 322 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHHcCCCCCCCCCCC
Confidence 221 1233456778999999999999999999999999999999 67777654322 22222211 123
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+||+.++
T Consensus 323 ~~l~~li~~cl~~dp 337 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKA 337 (373)
T ss_dssp HHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHcCCCh
Confidence 678899999998765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.12 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=172.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeC-----Cce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 438 (607)
.++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+++|++++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999865 688899999975433 3346789999999999999999999998765 367
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+. ++|..++... .+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5898888764 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcc--eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 519 LDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
...... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 433221 1234578999999998765 458999999999999999999999997653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.89 Aligned_cols=230 Identities=30% Similarity=0.475 Sum_probs=185.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcE--EEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGRE--VAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~--VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.+.||+|+||.||+|++. +|+. ||||+++... ....+.+.+|+++|+++ +|+||+++++++..++..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56899999999999999999864 5554 4999887433 33445789999999999 899999999999999999999
Q ss_pred EEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 442 YDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
|||+++++|.+++.... ...+.+..+++++.||++||+|||++ +|+|||||++||||++++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987643 23589999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (607)
||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQ 256 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGGG
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHHHHHHhhc
Confidence 999999997433221 1223456789999999998889999999999999999998 999997642 1222222111
Q ss_pred --------hhHHHHHHHHHHhhhcCC
Q 007351 587 --------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --------~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 113567889999997765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=321.38 Aligned_cols=231 Identities=26% Similarity=0.391 Sum_probs=186.1
Q ss_pred CCcccceecccCcEEEEEEEeC-CC---cEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce-EEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DG---REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR-LLI 441 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g---~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~lV 441 (607)
.|+..++||+|+||.||+|++. ++ ..||||+++.... ...+.+.+|+++|++++|+||+++++++..++.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566799999999999999853 22 3699999875443 3446789999999999999999999999876665 999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
|||+.+++|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 3588999999999999999999999 9999999999999999999999999999865432
Q ss_pred Cc---ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NT---HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.. .......++..|+|||++.+..++.++|||||||++|||++|..+|.... ...++.++.... ...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCCCCCCccchH
Confidence 21 12233457889999999999999999999999999999999766654332 223333332222 135
Q ss_pred HHHHHHHHhhhcCC
Q 007351 591 ILFKLVFLCQQNSN 604 (607)
Q Consensus 591 ~~~~i~~~C~~~~~ 604 (607)
.+.+++.+|++.++
T Consensus 256 ~l~~li~~~l~~~p 269 (298)
T 3pls_A 256 SLYQVMQQCWEADP 269 (298)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHccCCh
Confidence 68899999998765
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.75 Aligned_cols=230 Identities=11% Similarity=0.046 Sum_probs=169.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHc--cCCCceeEE-------eEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI--HHRHLVSLV-------GYCI 433 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l--~HpnIv~l~-------g~~~ 433 (607)
.+|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+++|+++++.| +|+||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35889999999999999999965 789999999986543 3345678887666666 599988755 4444
Q ss_pred eCC-----------------ceEEEEEecCCCchhHhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCCCCEE
Q 007351 434 SDD-----------------RRLLIYDYVPNNTLYFHLHGEGRPVLDWATR------VKIAAGAARGLAYLHEDCHPRII 490 (607)
Q Consensus 434 ~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qia~gL~~LH~~~~~~iv 490 (607)
..+ ..+||||||+ |+|.++++..+. .+.+..+ +.++.||++||+|||++ +||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 332 3799999998 899999976432 2455555 77889999999999999 999
Q ss_pred ecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCC
Q 007351 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKP 568 (607)
Q Consensus 491 HrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~P 568 (607)
|||||++||||++++.+||+|||+++..... .....++..|||||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865321 223456799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCchhHH------------HHHh-HhhHHHHHHHHHHhhhcCCC
Q 007351 569 VDASQPLGDESLV------------EWVN-LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 569 f~~~~~~~~~~l~------------~~~~-~~~~~~~~~i~~~C~~~~~~ 605 (607)
|.+........+. .+.. ......+.+++.+|++.++.
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 342 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChh
Confidence 9865321111000 0000 01246778899999987764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=345.69 Aligned_cols=228 Identities=24% Similarity=0.372 Sum_probs=185.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+++|+++|+.++|+||++++++|..++..+||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999975 68899999997543 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~~~~~ 520 (607)
||.+|+|.+++..... +.+..++.|++||++||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 117 ~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999888876543 89999999999999999999999 9999999999999975 45599999999987643
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDA 589 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~ 589 (607)
.. .....+|+..|+|||++. ..++.++|||||||++|||++|+.||.+.. ..++.+.... ...
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCchhcccCC
Confidence 32 234457999999999886 469999999999999999999999997642 2222221111 013
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+|++.++.
T Consensus 266 ~~~~~li~~~L~~dp~ 281 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQ 281 (494)
T ss_dssp HHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHCCCChh
Confidence 5678899999987764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.85 Aligned_cols=233 Identities=22% Similarity=0.361 Sum_probs=186.5
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|+.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999975 5889999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.+++|..++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999998886533 2489999999999999999999999 99999999999999999999999999986432211 1
Q ss_pred eeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHH
Q 007351 525 ITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAK 590 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~ 590 (607)
......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ..+.++.+. ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhccCCcccCCccccCH
Confidence 123346889999999984 567889999999999999999999999764211 111111111 1135
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 251 ~l~~li~~~l~~dp~ 265 (302)
T 2j7t_A 251 EFRDFLKIALDKNPE 265 (302)
T ss_dssp HHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHcccChh
Confidence 678999999987754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.59 Aligned_cols=230 Identities=25% Similarity=0.387 Sum_probs=188.1
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-------------hhHHHHHHHHHHHHHccCCCceeEEe
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-------------QGEREFKAEVEIISRIHHRHLVSLVG 430 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~g 430 (607)
..++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+++|+.|+|+||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467999999999999999999975 678999999974321 23467899999999999999999999
Q ss_pred EEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC---cE
Q 007351 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EA 507 (607)
Q Consensus 431 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~v 507 (607)
++..++..+||||||.+|+|.+++..... +++..++.|++||+.||+|||++ +|+|||||++||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999988876544 89999999999999999999999 999999999999998775 69
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL- 586 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~- 586 (607)
||+|||+++...... .....+|+..|+|||++.+ .++.++|||||||++|||++|+.||.+.. ..++.+....
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKKVEKG 262 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcC
Confidence 999999998664432 2334579999999999874 68999999999999999999999998642 2222221111
Q ss_pred ----------hhHHHHHHHHHHhhhcCCC
Q 007351 587 ----------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ----------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 263 KYYFDFNDWKNISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCCccccCCCCHHHHHHHHHHcCCChh
Confidence 0135678899999987754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.03 Aligned_cols=227 Identities=24% Similarity=0.403 Sum_probs=191.1
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+||+++++++..++..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 78999999996442 344677999999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE---cCCCcEEEEecccccccc
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DFGls~~~~ 519 (607)
|||.+|+|.+++..... +.+..++++++||++||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 106 e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999998876554 89999999999999999999999 99999999999999 567899999999998764
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hh
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------ID 588 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~ 588 (607)
.... .....|+..|||||++.+ .++.++|||||||++|||++|+.||.+.. ..++.+.+.. ..
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCCcccccC
Confidence 4332 233568999999999876 69999999999999999999999998642 2222222111 11
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 255 s~~~~~li~~~L~~dp 270 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVP 270 (484)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHCCCCh
Confidence 3567889999998765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.02 Aligned_cols=199 Identities=25% Similarity=0.397 Sum_probs=153.5
Q ss_pred CCcc-cceecccCcEEEEEEEeC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceEEE
Q 007351 368 GFAD-QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLI 441 (607)
Q Consensus 368 ~y~~-~~~IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 441 (607)
.|.+ +++||+|+||.||+|+++ +++.||||+++.. .....+.+|+++|+.|+|+||+++++++.. +...+||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4554 568999999999999965 5788999998643 233568899999999999999999999965 5678999
Q ss_pred EEecCCCchhHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----cCCCcEEEE
Q 007351 442 YDYVPNNTLYFHLHGE-------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVS 510 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~ 510 (607)
|||+.+ +|.+++... ....+.+..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999974 676666421 222488999999999999999999999 99999999999999 778999999
Q ss_pred ecccccccccCCc--ceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 511 DFGLAKLALDANT--HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 511 DFGls~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|||+++....... ......+|+..|+|||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999987643221 223446789999999999874 5899999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.13 Aligned_cols=231 Identities=27% Similarity=0.426 Sum_probs=182.4
Q ss_pred CCCcccceecccCcEEEEEEEeCCC----cEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDG----REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g----~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~l 440 (607)
.+|++.++||+|+||.||+|++.++ ..||||.++.... ...+.+.+|+++|++++|+||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688889999999999999986432 3589998875433 344679999999999999999999998654 557799
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||||+.+|+|.++++... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 3578999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcc---eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCchhHHHH-HhH-------hh
Q 007351 521 ANTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG-RKPVDASQPLGDESLVEW-VNL-------ID 588 (607)
Q Consensus 521 ~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg-~~Pf~~~~~~~~~~l~~~-~~~-------~~ 588 (607)
.... ......++..|+|||++.+..++.++|||||||++|||++| ..+|.+... .++... ... ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHHHTTCCCCCCTTC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhcCCCCCCCccC
Confidence 3211 12334567789999999999999999999999999999995 555554322 122211 111 11
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 258 ~~~l~~li~~~l~~~p 273 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKA 273 (298)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHcCCCh
Confidence 4668889999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.83 Aligned_cols=232 Identities=26% Similarity=0.330 Sum_probs=168.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEe--------C
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS--------D 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--------~ 435 (607)
..+|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+++|+++. |+||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999964 78999999997766666778999999999996 9999999999853 2
Q ss_pred CceEEEEEecCCCchhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEcCCCcEEEEec
Q 007351 436 DRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
...++||||+. |+|.+++.. .....+.+..+++|+.||++||+|||++ + |+|||||++||||++++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 34789999996 788777754 2233589999999999999999999998 8 999999999999999999999999
Q ss_pred ccccccccCCcce-----------eeccccCCCCCchhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 007351 513 GLAKLALDANTHI-----------TTRVMGTFGYMAPEYA---SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (607)
Q Consensus 513 Gls~~~~~~~~~~-----------~~~~~gt~~y~APE~l---~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~ 578 (607)
|+++......... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||.+.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998664432211 1134588999999998 56678899999999999999999999997543211
Q ss_pred hHHHHH-----hHhhHHHHHHHHHHhhhcCC
Q 007351 579 SLVEWV-----NLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 579 ~l~~~~-----~~~~~~~~~~i~~~C~~~~~ 604 (607)
+.+.. .......+.+++.+|++.++
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 290 (337)
T 3ll6_A 261 -IVNGKYSIPPHDTQYTVFHSLIRAMLQVNP 290 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSG
T ss_pred -hhcCcccCCcccccchHHHHHHHHHccCCh
Confidence 11000 00112346678888887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.75 Aligned_cols=228 Identities=24% Similarity=0.371 Sum_probs=188.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.++||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++|++++|+||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 56999999999999999999975 7899999998632 23345779999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGls~~~~~ 520 (607)
||.+|+|.+++..... +.+..+++|++||++||+|||++ +|+|||||++||||+ +++.+||+|||+++....
T Consensus 102 ~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999988876543 89999999999999999999999 999999999999994 566899999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----------hH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----------DA 589 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----------~~ 589 (607)
.. .....+|+..|+|||++.+ .++.++|||||||+||||++|+.||.+.. ..++.+.+... ..
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCcccCCCC
Confidence 32 2334579999999999886 59999999999999999999999997642 22222211110 12
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+|++.++.
T Consensus 251 ~~~~~li~~~L~~dp~ 266 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPS 266 (486)
T ss_dssp HHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHcCCChh
Confidence 5678999999987764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.98 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=172.7
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CC-----CceeEEeEEEeCCc
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HR-----HLVSLVGYCISDDR 437 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g~~~~~~~ 437 (607)
..++|++.++||+|+||.||+|+.. +++.||||+++.. ....+++.+|+++++.++ |. +|+++++++..++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999865 6788999998742 334567888999999885 55 39999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc--CCCcEEEEecccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLA 515 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGls 515 (607)
.+|||||+. ++|.+++.......+.+..+++++.||+.||+|||.+ ..+|||||||++||||+ +++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5899988876655699999999999999999999942 22899999999999994 4788999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+..... .....|+..|||||++.+..++.++|||||||+||||++|+.||.+.
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 23456899999999999999999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.72 Aligned_cols=200 Identities=30% Similarity=0.518 Sum_probs=161.8
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHH--HHHccCCCceeEEeEEEe-----CCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLVGYCIS-----DDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~-----~~~~ 438 (607)
.++|++.+.||+|+||.||+|++ +++.||||+++.. ....+.+|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36799999999999999999988 7899999998743 23344444444 445899999999986543 2245
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC------CCCEEecCCCCCCEEEcCCCcEEEEec
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC------HPRIIHRDIKSSNILLDNNFEAQVSDF 512 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------~~~ivHrDLkp~NILl~~~~~vkL~DF 512 (607)
+|||||+++|+|.+++.... +.+..+++|+.||++||+|||+++ ..+|+|||||++||||++++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997654 588999999999999999999862 338999999999999999999999999
Q ss_pred ccccccccCCc-------ceeeccccCCCCCchhhhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 513 GLAKLALDANT-------HITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 513 Gls~~~~~~~~-------~~~~~~~gt~~y~APE~l~~-------~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
|+++....... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.+|...
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99986643221 12234569999999999987 34567899999999999999998877543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.40 Aligned_cols=195 Identities=23% Similarity=0.368 Sum_probs=167.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce----
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR---- 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~---- 438 (607)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|+.++|+||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 689999999975432 3346789999999999999999999999877654
Q ss_pred --EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 439 --LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 439 --~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
++||||+. ++|..++.. .+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 678777643 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 65332 234568999999999987 67899999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.21 Aligned_cols=198 Identities=23% Similarity=0.366 Sum_probs=171.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CC-cEEEEEEeecCCchhHHHHHHHHHHHHHccCCC------ceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DG-REVAIKQLKIGGGQGEREFKAEVEIISRIHHRH------LVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g-~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~ 437 (607)
.++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+++|+++|+.++|.| |+.+++++..++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367999999999999999999964 34 68999998632 344567889999999997665 9999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE----------------
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---------------- 501 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---------------- 501 (607)
.+|||||+ +++|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56666666665545689999999999999999999998 99999999999999
Q ss_pred ---cCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 502 ---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 502 ---~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
++++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864332 23456899999999999999999999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.06 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=185.6
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHcc--CCCceeEEeEEEeCC
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIH--HRHLVSLVGYCISDD 436 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~ 436 (607)
.+....++|++.+.||+|+||.||+++..+++.||||+++... ....+.+++|+++|++++ |+||+++++++..++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3344457799999999999999999998889999999997543 234467899999999997 599999999999999
Q ss_pred ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 437 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..+|||| +.+++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++ +.+||+|||+++
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 9999999 56889999998754 489999999999999999999999 9999999999999975 799999999998
Q ss_pred ccccCCcc-eeeccccCCCCCchhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 007351 517 LALDANTH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584 (607)
Q Consensus 517 ~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~ 584 (607)
........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...+.++.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~ 253 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAII 253 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHHHHHHH
Confidence 65443221 2234568999999999875 46888999999999999999999999753210 01111111
Q ss_pred hH--------hhHHHHHHHHHHhhhcCCC
Q 007351 585 NL--------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~--------~~~~~~~~i~~~C~~~~~~ 605 (607)
+. .....+.+++.+|++.++.
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred hcccccCCcccchHHHHHHHHHHccCCcc
Confidence 11 0135688999999987764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.22 Aligned_cols=235 Identities=28% Similarity=0.437 Sum_probs=172.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+++|++++|+||+++++++..++..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999854 78999999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 444 YVPNNTLYFHLHG------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 444 y~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
|+.+++|.+++.. .....+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999888864 1233589999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCc----ceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh-------
Q 007351 518 ALDANT----HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN------- 585 (607)
Q Consensus 518 ~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~------- 585 (607)
...... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPPSLE 248 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCCCTT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCCccc
Confidence 543221 11234568999999999876 568999999999999999999999997643211 1111000
Q ss_pred ---------HhhHHHHHHHHHHhhhcCCC
Q 007351 586 ---------LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ---------~~~~~~~~~i~~~C~~~~~~ 605 (607)
......+.+++.+|++.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 277 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPE 277 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChh
Confidence 00124578899999987753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.29 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=169.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeC-----Cce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 438 (607)
.++|++.+.||+|+||.||+|++. +|+.||||+++.... .....+.+|+++|+.++|+||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367999999999999999999975 688999999964433 3345788999999999999999999998764 578
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
++||||+. ++|..++... .+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6898888763 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcc---------eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTH---------ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~---------~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
...... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 432211 1123468999999998765 67899999999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.29 Aligned_cols=230 Identities=24% Similarity=0.360 Sum_probs=180.3
Q ss_pred HHhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch------hHHHHHHHHHHHHHc----cCCCceeEEeE
Q 007351 363 VKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ------GEREFKAEVEIISRI----HHRHLVSLVGY 431 (607)
Q Consensus 363 ~~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l----~HpnIv~l~g~ 431 (607)
....++|++.+.||+|+||.||+|++ .+|+.||||+++..... ....+.+|+++++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999986 47889999999754322 223467899999999 89999999999
Q ss_pred EEeCCceEEEEEe-cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEE
Q 007351 432 CISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQV 509 (607)
Q Consensus 432 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL 509 (607)
+..++..++|||| +.+++|.+++...+. +.+..+++++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 789999999987543 89999999999999999999999 999999999999999 8899999
Q ss_pred EecccccccccCCcceeeccccCCCCCchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---
Q 007351 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN--- 585 (607)
Q Consensus 510 ~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~--- 585 (607)
+|||+++...... .....|+..|+|||++.+..+. .++|||||||+||||++|+.||... .+..+...
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~ 253 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEILEAELHFP 253 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHTCCCCC
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHHhhhccCCc
Confidence 9999998765432 2345689999999999877665 4899999999999999999999642 11111100
Q ss_pred HhhHHHHHHHHHHhhhcCCC
Q 007351 586 LIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~~~ 605 (607)
......+.+++.+|++.++.
T Consensus 254 ~~~~~~~~~li~~~l~~~p~ 273 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPS 273 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTT
T ss_pred ccCCHHHHHHHHHHccCChh
Confidence 11235678899999987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=319.13 Aligned_cols=230 Identities=25% Similarity=0.432 Sum_probs=178.6
Q ss_pred CCCcccceecccCcEEEEEEEeC--CCc--EEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--DGR--EVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--~g~--~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++++++|+||+++++++..++ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57999999999999999999853 333 6899998744 2334567999999999999999999999998654 88
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+||||+.+++|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999887643 2488999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhH---------h
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNL---------I 587 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~---------~ 587 (607)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.... .
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCCCCCTT
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHccCCCCCCCcC
Confidence 44322 1233457778999999998889999999999999999999 999997642 2222222211 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 250 ~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp CCHHHHHHHHHHTCSSG
T ss_pred cCHHHHHHHHHHccCCc
Confidence 13668889999998765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.03 Aligned_cols=233 Identities=22% Similarity=0.305 Sum_probs=171.8
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch-hH-HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ-GE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~-~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... .. +.+.++..+++.++|+||+++++++..++..+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36799999999999999999996 47889999999754332 22 33455555677889999999999999999999999
Q ss_pred EecCCCchhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 443 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
||++ |+|.+++.. .....+.+..+++++.||++||+|||+++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 477666543 22345899999999999999999999853 799999999999999999999999999986544
Q ss_pred CCcceeeccccCCCCCchhhh----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hh
Q 007351 521 ANTHITTRVMGTFGYMAPEYA----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------ID 588 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~ 588 (607)
... .....|+..|+|||++ .+..++.++|||||||++|||++|+.||..... ....+.++... ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-PFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-HHHHHHHHHHSCCCCCCTTTS
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-hHHHHHHHhccCCCCcccccC
Confidence 322 2334689999999996 456788999999999999999999999975321 01111111111 12
Q ss_pred HHHHHHHHHHhhhcCC
Q 007351 589 AKILFKLVFLCQQNSN 604 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~ 604 (607)
...+.+++.+|++.++
T Consensus 240 ~~~~~~li~~~l~~~p 255 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNS 255 (290)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHhhcCh
Confidence 3567889999998765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.15 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=169.6
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-----------CCCceeEEeEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----------HRHLVSLVGYCIS 434 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~ 434 (607)
++|++.+.||+|+||.||+|+. .+|+.||||+++. .......+.+|+++|++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999996 4788999999863 2334567889999999886 7899999999886
Q ss_pred CC----ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc------CC
Q 007351 435 DD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD------NN 504 (607)
Q Consensus 435 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~------~~ 504 (607)
.+ ..+|||||+ +++|.+++.......+.+..+++++.||+.||+|||+++ +|+|||||++||||+ ++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 678999999 899999998765556999999999999999999999953 799999999999994 44
Q ss_pred CcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 007351 505 FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (607)
Q Consensus 505 ~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~ 573 (607)
+.+||+|||+++..... .....|+..|||||++.+..++.++|||||||+||||++|+.||....
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 58999999999865432 233468999999999999999999999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.04 Aligned_cols=195 Identities=23% Similarity=0.365 Sum_probs=166.4
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-----
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 437 (607)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|+.++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999964 689999999965432 234678999999999999999999999987654
Q ss_pred -eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 438 -RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 438 -~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
.++||||+. ++|..++.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688777643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.||.+.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 64322 233568999999999887 67899999999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.40 Aligned_cols=231 Identities=25% Similarity=0.363 Sum_probs=187.6
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch------hHHHHHHHHHHHHHcc--CCCceeEEeE
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ------GEREFKAEVEIISRIH--HRHLVSLVGY 431 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~g~ 431 (607)
+.....++|++.++||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 4444567899999999999999999985 47889999999754321 2345788999999996 5999999999
Q ss_pred EEeCCceEEEEEecCC-CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc-CCCcEEE
Q 007351 432 CISDDRRLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQV 509 (607)
Q Consensus 432 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL 509 (607)
+..++..++||||+.+ ++|.+++...+ .+.+..+++++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999999999999986 89999887654 389999999999999999999999 999999999999999 7899999
Q ss_pred EecccccccccCCcceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH---Hh
Q 007351 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW---VN 585 (607)
Q Consensus 510 ~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~---~~ 585 (607)
+|||+++...... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||... ....+. ..
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~~~~~~~~~~ 263 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIRGQVFFR 263 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHCCCCCS
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----hhhhccccccc
Confidence 9999998765332 234568999999999987666 67899999999999999999999642 111110 00
Q ss_pred HhhHHHHHHHHHHhhhcCC
Q 007351 586 LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 264 ~~~~~~~~~li~~~l~~dp 282 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRP 282 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSG
T ss_pred ccCCHHHHHHHHHHccCCh
Confidence 1123567889999998765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.77 Aligned_cols=227 Identities=26% Similarity=0.428 Sum_probs=177.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe----------
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS---------- 434 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---------- 434 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|+||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999964 7899999998642 2345678999999999999999999998865
Q ss_pred ---CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 007351 435 ---DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (607)
Q Consensus 435 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (607)
++..++||||+++++|.++++... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 345789999999999999997643 3478889999999999999999999 999999999999999999999999
Q ss_pred cccccccccCC-------------cceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 007351 512 FGLAKLALDAN-------------THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577 (607)
Q Consensus 512 FGls~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~ 577 (607)
||+++...... ........|+..|+|||++.+. .++.++|||||||++|||++ +|...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----- 231 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----- 231 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----
Confidence 99998654321 1122345689999999999865 68999999999999999998 45321
Q ss_pred hhHHHHHhHh--------------hHHHHHHHHHHhhhcCCC
Q 007351 578 ESLVEWVNLI--------------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 578 ~~l~~~~~~~--------------~~~~~~~i~~~C~~~~~~ 605 (607)
.+..++...+ ....+.+++.+|++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcc
Confidence 1111111111 124578899999987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.76 Aligned_cols=229 Identities=21% Similarity=0.291 Sum_probs=160.6
Q ss_pred hCCCccc-ceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe----CCceE
Q 007351 366 TDGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRL 439 (607)
Q Consensus 366 ~~~y~~~-~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 439 (607)
.++|.+. ++||+|+||.||+|++. +|+.||||+++.. .....+....++.++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3568874 57999999999999976 6899999998642 2223333445667799999999999876 34578
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~ 516 (607)
|||||+++|+|.+++.......+++..+++++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999877666799999999999999999999999 9999999999999975 4569999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHh----------
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWVN---------- 585 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~-~l~~~~~---------- 585 (607)
...... .....|+..|+|||++.+..++.++|||||||+||||++|+.||......... ...+...
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 654322 23356799999999998888999999999999999999999999754321110 0011000
Q ss_pred -HhhHHHHHHHHHHhhhcCC
Q 007351 586 -LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 -~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP 276 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDP 276 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSG
T ss_pred hccCCHHHHHHHHHHCCCCh
Confidence 0123567889999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.11 Aligned_cols=229 Identities=23% Similarity=0.375 Sum_probs=188.6
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|++++|+||+++++++..++..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999975 78999999986432 33457799999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAKLA 518 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~~~ 518 (607)
|||+.+++|.+++..... +++..+++++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999888876543 89999999999999999999999 9999999999999965 447999999999865
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------h
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------I 587 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~ 587 (607)
..... .....|+..|+|||++.+ .++.++|||||||+||||++|+.||.+.. ..++.+.... .
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSGGGTT
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCchhhhh
Confidence 43322 223457889999999876 48999999999999999999999997642 2222221110 1
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 249 ~~~~~~~li~~~l~~dp 265 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHP 265 (287)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred cCHHHHHHHHHHcccCh
Confidence 13567889999998765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=350.20 Aligned_cols=233 Identities=27% Similarity=0.393 Sum_probs=187.6
Q ss_pred hhCCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
..++|++.+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|+.+|++++|+||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34679999999999999999998742 45799999875433 33467999999999999999999999984 56789
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
|||||+.+|+|.++++... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997653 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
...........++..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+..... ...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHHTCCCCCCTTCCH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCccccH
Confidence 544333344557789999999999999999999999999999997 999997642 22332222111 126
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 620 ~l~~li~~~l~~dP~ 634 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPS 634 (656)
T ss_dssp HHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHcCCChh
Confidence 788999999987653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=315.48 Aligned_cols=229 Identities=23% Similarity=0.359 Sum_probs=167.3
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-H-HHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-E-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.++|++.+.||+|+||.||+|++. +|+.||||+++...... . +.+.++..+++.++|+||+++++++..++..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357899999999999999999975 78999999997654332 2 33455556788889999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||+ ++.+..++... ...+.+..+++++.||++||+|||+ + +|+|||||++||||++++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 45554444332 2348999999999999999999998 6 8999999999999999999999999999765433
Q ss_pred CcceeeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh---------
Q 007351 522 NTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------- 587 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------- 587 (607)
. ......|+..|+|||++. +..++.++|||||||+||||++|+.||.... .....+.+.+
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----TDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHHHSCCCCCCS
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----ccHHHHHHHhccCCCCCCc
Confidence 2 223456899999999984 4568889999999999999999999997532 1111222211
Q ss_pred ---hHHHHHHHHHHhhhcCCC
Q 007351 588 ---DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ---~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+|++.++.
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTT
T ss_pred cCCCCHHHHHHHHHHccCChh
Confidence 136688999999987764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.55 Aligned_cols=231 Identities=22% Similarity=0.290 Sum_probs=173.0
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+.|...++||+|+||.||.+...+|+.||||++... ..+.+.+|+++|+++ +|+||+++++++..++..+||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 446667899999999998766668999999998742 345678999999987 8999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-------------CcE
Q 007351 446 PNNTLYFHLHGEGRPV-----LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-------------FEA 507 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-------------~~v 507 (607)
. |+|.+++....... ..+..+++++.||++||+|||++ +|+|||||++||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999987654321 12234578999999999999999 99999999999999754 489
Q ss_pred EEEecccccccccCCcc---eeeccccCCCCCchhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 007351 508 QVSDFGLAKLALDANTH---ITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~---~~~~~~gt~~y~APE~l~~-------~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~ 576 (607)
||+|||+++........ ......|+..|||||++.+ ..++.++|||||||+||||++ |+.||.+....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999876543222 1234579999999999976 578999999999999999999 99999754211
Q ss_pred chhHHHHH----------hHhhHHHHHHHHHHhhhcCCC
Q 007351 577 DESLVEWV----------NLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 577 ~~~l~~~~----------~~~~~~~~~~i~~~C~~~~~~ 605 (607)
..++.+.. .......+.+++.+|++.++.
T Consensus 247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (434)
T 2rio_A 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285 (434)
T ss_dssp HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGG
T ss_pred HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChh
Confidence 01111100 001125678899999987653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=317.83 Aligned_cols=232 Identities=27% Similarity=0.383 Sum_probs=163.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHH-HHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|... +|+.||||+++.... ....++.+|+. +++.++|+||+++++++..++..+||||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57889999999999999999975 689999999976533 33345666666 6677899999999999999999999999
Q ss_pred ecCCCchhHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHG---EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|+.+ +|.+++.. .....+.+..+++++.||++||+|||++. +|+|||||++||||++++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 66655542 22345899999999999999999999852 799999999999999999999999999986543
Q ss_pred CCcceeeccccCCCCCchhhh----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH--------HHh---
Q 007351 521 ANTHITTRVMGTFGYMAPEYA----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE--------WVN--- 585 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~--------~~~--- 585 (607)
... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||.+.....+ .+.+ +..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSCCCCCCCCSS
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HHHHHhcCCCCCCCCccc
Confidence 322 2334689999999998 456789999999999999999999999975321100 0000 000
Q ss_pred HhhHHHHHHHHHHhhhcCC
Q 007351 586 LIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 586 ~~~~~~~~~i~~~C~~~~~ 604 (607)
......+.+++.+|++.++
T Consensus 256 ~~~~~~l~~li~~~l~~dp 274 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDE 274 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSG
T ss_pred ccCCHHHHHHHHHHhhCCh
Confidence 0124567889999998765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=319.68 Aligned_cols=231 Identities=27% Similarity=0.420 Sum_probs=182.5
Q ss_pred hhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
..++|++.++||+|+||.||+|++++ .||||+++.... ...+.+.+|++++++++|+||+++++++..++..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34679999999999999999999743 599999875432 23356889999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+++|.+++...+ ..+++..+++++.||++||+|||++ +|+|||||++||||+ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999997654 3588999999999999999999999 999999999999998 5799999999987543211
Q ss_pred ----cceeeccccCCCCCchhhhcC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---
Q 007351 523 ----THITTRVMGTFGYMAPEYASS---------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--- 586 (607)
Q Consensus 523 ----~~~~~~~~gt~~y~APE~l~~---------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--- 586 (607)
........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAIIWQMGTGMK 260 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHHHHHHTTCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhccCCC
Confidence 112233458899999999874 357889999999999999999999997542 1122111110
Q ss_pred ------hhHHHHHHHHHHhhhcCCC
Q 007351 587 ------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTT
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChh
Confidence 0124678899999987754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.88 Aligned_cols=192 Identities=21% Similarity=0.249 Sum_probs=162.7
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------hhHHHHHHHHHHHHHcc---------CCCceeE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------QGEREFKAEVEIISRIH---------HRHLVSL 428 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~il~~l~---------HpnIv~l 428 (607)
.++|++.+.||+|+||.||+|++ +|+.||||+++.... ...+.+.+|+++|+.|+ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999998 789999999975532 23377899999999986 8888888
Q ss_pred EeEEE------------------------------eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 007351 429 VGYCI------------------------------SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL 478 (607)
Q Consensus 429 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL 478 (607)
++++. .++..+||||||.+|++.+.+.. ..+++..++.|++||++||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87653 15788999999999977666643 2489999999999999999
Q ss_pred HHHH-HcCCCCEEecCCCCCCEEEcCCC--------------------cEEEEecccccccccCCcceeeccccCCCCCc
Q 007351 479 AYLH-EDCHPRIIHRDIKSSNILLDNNF--------------------EAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537 (607)
Q Consensus 479 ~~LH-~~~~~~ivHrDLkp~NILl~~~~--------------------~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~A 537 (607)
+||| ++ +|||||||++||||+.++ .+||+|||+++..... ..+||..|||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999887 9999999999876432 2368999999
Q ss_pred hhhhcCCCCCchhhHHHHHHH-HHHHHcCCCCCCC
Q 007351 538 PEYASSGKLTEKSDVFSFGVV-LLELITGRKPVDA 571 (607)
Q Consensus 538 PE~l~~~~~~~~~DVwSlGvl-l~ELltg~~Pf~~ 571 (607)
||++.+.. +.++||||||++ +++++.|..||.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99998766 889999998776 7889999999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.36 Aligned_cols=222 Identities=21% Similarity=0.293 Sum_probs=180.5
Q ss_pred CCCcccceecccCcEEEEEEEeC--CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc-----e
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-----R 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-----~ 438 (607)
++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+++|++++|+||+++++++..++. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999975 689999999865433 344578999999999999999999999988766 6
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
|||||||++++|.+++.. .+++..+++|+.||++||+|||++ +|||||||++||||+++ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999887754 489999999999999999999999 99999999999999986 8999999999865
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhhHHHHHHHHHH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFL 598 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~i~~~ 598 (607)
... ....|+..|||||++.+. ++.++|||||||+||||++|..+|.+...........+. .....+.+++.+
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~ 303 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL--KTYDSYGRLLRR 303 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHH--HHCHHHHHHHHH
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccccccccc--ccCHHHHHHHhh
Confidence 432 345689999999998765 488999999999999999999988753211111111111 123567788999
Q ss_pred hhhcCC
Q 007351 599 CQQNSN 604 (607)
Q Consensus 599 C~~~~~ 604 (607)
|++.++
T Consensus 304 ~l~~dP 309 (681)
T 2pzi_A 304 AIDPDP 309 (681)
T ss_dssp HTCSSG
T ss_pred hccCCh
Confidence 998765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.01 Aligned_cols=203 Identities=11% Similarity=0.032 Sum_probs=167.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++.+.||+|+||.||+|++. +|+.||||+++..... ..+.|.+|++++++++|+||+++++++..++..||||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56999999999999999999975 5899999999755332 3367899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+++++|.++++.. ....++++|+.||++||+|||++ +|+|||||++||||++++.+||+++|.
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-------- 175 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence 999999999998542 35567889999999999999999 999999999999999999999985542
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCch------------hHHHHHhHhhHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE------------SLVEWVNLIDAK 590 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~------------~l~~~~~~~~~~ 590 (607)
++ .++.++|||||||+||||++|+.||.+....... ...++. .....
T Consensus 176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (286)
T 3uqc_A 176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID-RDIPF 234 (286)
T ss_dssp -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC-TTSCH
T ss_pred -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc-cCCCH
Confidence 22 3688999999999999999999999865432110 011111 11235
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+|++.++.
T Consensus 235 ~l~~li~~~l~~dP~ 249 (286)
T 3uqc_A 235 QISAVAARSVQGDGG 249 (286)
T ss_dssp HHHHHHHHHHCTTSS
T ss_pred HHHHHHHHHcccCCc
Confidence 678999999988764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=323.31 Aligned_cols=227 Identities=24% Similarity=0.290 Sum_probs=172.5
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.+|.+.++||+|+||.||.....+|+.||||++..... ..+.+|+++|+.+ +|+||+++++++..++..+||||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46889999999999986555555899999999864322 2367899999999 7999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-----CCcEEEEeccccccccc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLALD 520 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGls~~~~~ 520 (607)
. |+|.+++..... .+.+..++.++.||++||+|||++ +|+|||||++||||+. +..+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 689988876543 244445678999999999999999 9999999999999942 34688999999986643
Q ss_pred CCc--ceeeccccCCCCCchhhhc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH----------
Q 007351 521 ANT--HITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWV---------- 584 (607)
Q Consensus 521 ~~~--~~~~~~~gt~~y~APE~l~---~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~---------- 584 (607)
... .......|+..|||||++. +..++.++|||||||+||||++ |+.||.... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~---~~~~~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL---QRQANILLGACSLDCLHP 252 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT---THHHHHHTTCCCCTTSCT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh---HHHHHHHhccCCccccCc
Confidence 321 2234467999999999997 4567789999999999999999 999996432 11111111
Q ss_pred hHhhHHHHHHHHHHhhhcCC
Q 007351 585 NLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 585 ~~~~~~~~~~i~~~C~~~~~ 604 (607)
.......+.+++.+|++.++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSG
T ss_pred cccccHHHHHHHHHHHhCCH
Confidence 01123456789999998775
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=326.58 Aligned_cols=227 Identities=14% Similarity=0.167 Sum_probs=167.5
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHHccC-CCce---------------
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHH-RHLV--------------- 426 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~H-pnIv--------------- 426 (607)
..|+..++||+|+||.||+|++ .+|+.||||+++..... ..+.|++|+.+++.|+| .|+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3477889999999999999995 47999999998744332 35679999999999987 2211
Q ss_pred e------EEeEEEe-----CCceEEEEEecCCCchhHhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 007351 427 S------LVGYCIS-----DDRRLLIYDYVPNNTLYFHLH-----GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490 (607)
Q Consensus 427 ~------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 490 (607)
. ++.++.. ....+++|+++ +++|.++++ ......+.+..++.|+.||++||+|||++ +||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1 1111111 12345666655 688888774 22233477888999999999999999999 999
Q ss_pred ecCCCCCCEEEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhh----------cCCCCCchhhHHHHHHHHH
Q 007351 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA----------SSGKLTEKSDVFSFGVVLL 560 (607)
Q Consensus 491 HrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~~DVwSlGvll~ 560 (607)
|||||++||||++++.+||+|||+++..... ....+| ..|||||++ .+..++.++|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865332 344567 999999999 5556888999999999999
Q ss_pred HHHcCCCCCCCCCCCCchhHH--HHHhHhhHHHHHHHHHHhhhcCC
Q 007351 561 ELITGRKPVDASQPLGDESLV--EWVNLIDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 561 ELltg~~Pf~~~~~~~~~~l~--~~~~~~~~~~~~~i~~~C~~~~~ 604 (607)
||++|+.||.+.......... .+. .....+.+++.+||+.++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFRSCK--NIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGSSCC--CCCHHHHHHHHHHTCSSG
T ss_pred HHHHCCCCCCCcchhhhHHHHHhhcc--cCCHHHHHHHHHHccCCh
Confidence 999999999765322111100 011 123668889999998765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=336.60 Aligned_cols=200 Identities=31% Similarity=0.437 Sum_probs=172.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEe------CCce
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCIS------DDRR 438 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~~ 438 (607)
++|++.+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999864 68999999987543 3345679999999999999999999998765 6677
Q ss_pred EEEEEecCCCchhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCc---EEEEeccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGL 514 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DFGl 514 (607)
+||||||.+|+|.+++.... ...+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 23588899999999999999999998 9999999999999987664 99999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 98764432 23446789999999999999999999999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.47 Aligned_cols=206 Identities=23% Similarity=0.339 Sum_probs=167.1
Q ss_pred CCCccc-ceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHH-HHccCCCceeEEeEEEe----CCceE
Q 007351 367 DGFADQ-NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEII-SRIHHRHLVSLVGYCIS----DDRRL 439 (607)
Q Consensus 367 ~~y~~~-~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~~ 439 (607)
++|.+. ++||+|+||.||+|.. .+++.||||+++. ...+.+|++++ +.++|+||+++++++.. ++..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 8899999999999996 4789999999863 35678899888 55689999999999887 66789
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~ 516 (607)
|||||+++|+|.+++.......+.+..+++++.||++||+|||++ +|+|||||++||||+. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999887666799999999999999999999999 9999999999999988 7899999999986
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc--------------hhHHH
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD--------------ESLVE 582 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~--------------~~l~~ 582 (607)
... +..++.++|||||||+||||++|+.||.+...... .....
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 432 23467799999999999999999999965421100 00111
Q ss_pred HHhHhhHHHHHHHHHHhhhcCCC
Q 007351 583 WVNLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 583 ~~~~~~~~~~~~i~~~C~~~~~~ 605 (607)
| ......+.+++.+|++.++.
T Consensus 226 ~--~~~~~~~~~li~~~l~~dP~ 246 (299)
T 3m2w_A 226 W--SEVSEEVKMLIRNLLKTEPT 246 (299)
T ss_dssp H--TTSCHHHHHHHHHHTCSSTT
T ss_pred c--ccCCHHHHHHHHHHcccChh
Confidence 1 11245678899999987764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=303.51 Aligned_cols=184 Identities=16% Similarity=0.125 Sum_probs=129.4
Q ss_pred eecccCcEEEEEEE-eCCCcEEEEEEeecCC----------chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGG----------GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 374 ~IG~G~fG~Vyk~~-~~~g~~VAVK~l~~~~----------~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
.++.|.+|.+..++ +-.|+.||||++.... ....++|++|+++|+++ +|.||++|++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35556666555543 2258999999996432 12335699999999999 699999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||+|++|.++|...+. ++.. +|+.||++||+|||++ ||||||||++||||+++|++||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999987654 5543 5899999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~ 567 (607)
.. .....+||..|||||++.+ .+..++|+|++|+++++|+++..
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 2344679999999999876 56778999999999887765533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=279.77 Aligned_cols=184 Identities=17% Similarity=0.227 Sum_probs=146.3
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
...++||+|+||.||+|++ .++.+++|++..+... ..+.|++|+++|++++|+||+++..++..++..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 7889999987533211 124589999999999999999777777778888999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||++++|.++++. +++|+.||++||+|||++ +|+|||||++||||++ ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 458999999999999999 9999999999999999 9999999999876443
Q ss_pred Ccc------eeeccccCCCCCchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 007351 522 NTH------ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 522 ~~~------~~~~~~gt~~y~APE~l~~--~~~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
... ......||..|||||++.+ ..|+...|+|+.++-.+|.+.++-.|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 221 1234679999999999986 56778889999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=233.98 Aligned_cols=154 Identities=17% Similarity=0.179 Sum_probs=124.8
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc------------------hhHHHHHHHHHHHHHc
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG------------------QGEREFKAEVEIISRI 420 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~il~~l 420 (607)
+..+......|.+++.||+|+||.||+|++.+|+.||||+++.... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3455556677888999999999999999997799999999964321 1245689999999999
Q ss_pred cCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEE
Q 007351 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (607)
Q Consensus 421 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (607)
+ | +++++++.. +..++|||||++++|.+ +.. .....++.||++||+|||++ +|+|||||++|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 9 5 666665543 56699999999999988 422 22457999999999999999 9999999999999
Q ss_pred EcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcC
Q 007351 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543 (607)
Q Consensus 501 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~ 543 (607)
|+ ++.+||+|||+++. +..|+|+|++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999963 345889998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.8e-22 Score=199.77 Aligned_cols=145 Identities=18% Similarity=0.155 Sum_probs=111.0
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEe-CCCcE--EEEEEeecCCch------------------------hHHHHHH
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYL-PDGRE--VAIKQLKIGGGQ------------------------GEREFKA 412 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~--VAVK~l~~~~~~------------------------~~~~~~~ 412 (607)
.++......|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 34444444577889999999999999997 68889 999987543111 1136889
Q ss_pred HHHHHHHccCCC--ceeEEeEEEeCCceEEEEEecCC-C----chhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-Hc
Q 007351 413 EVEIISRIHHRH--LVSLVGYCISDDRRLLIYDYVPN-N----TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-ED 484 (607)
Q Consensus 413 Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~ 484 (607)
|+++|++|+|.| +..++++ +..+|||||+.+ | .|.+++.. +.+..+..++.||+.||+||| ++
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 999999998875 4455543 367999999942 4 55554432 224456789999999999999 87
Q ss_pred CCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 485 ~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+|||||||++||||++ .+||+|||++...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=185.75 Aligned_cols=145 Identities=12% Similarity=0.116 Sum_probs=108.6
Q ss_pred HHHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------------hhHH--------HHHHHHHH
Q 007351 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------------QGER--------EFKAEVEI 416 (607)
Q Consensus 359 ~eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--------------~~~~--------~~~~Ei~i 416 (607)
+..+.+...-|.+++.||+|+||.||+|...+|+.||||+++.... .... ...+|+..
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 3455555667999999999999999999988999999998763210 0011 12457778
Q ss_pred HHHccCCCc--eeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCC
Q 007351 417 ISRIHHRHL--VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494 (607)
Q Consensus 417 l~~l~HpnI--v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL 494 (607)
|.+|.+.+| ...+++ ...+|||||++++.|..++.. ....+++.||+.+|.|||++ |||||||
T Consensus 167 L~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp HHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred HHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 888865443 333332 235899999999888655422 12357889999999999998 9999999
Q ss_pred CCCCEEEcCCC----------cEEEEeccccccc
Q 007351 495 KSSNILLDNNF----------EAQVSDFGLAKLA 518 (607)
Q Consensus 495 kp~NILl~~~~----------~vkL~DFGls~~~ 518 (607)
|+.||||++++ .+.||||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998876 4899999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-15 Score=149.88 Aligned_cols=148 Identities=14% Similarity=0.056 Sum_probs=117.5
Q ss_pred HHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEE
Q 007351 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 362 l~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 440 (607)
+.....+|++...++.|+++.||++.. +|+.++||+...........+.+|+++|+.|. +.++.++++++..++..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344456788888999999999999986 57899999986432223346899999999995 6788899999998889999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED------------------------------------ 484 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------ 484 (607)
||||++|.+|...+.. ......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999776421 122347888999999999981
Q ss_pred --------------------CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 485 --------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 485 --------------------~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
....++|+||++.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013699999999999998876667999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=142.10 Aligned_cols=138 Identities=17% Similarity=0.124 Sum_probs=103.6
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC--ceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey 444 (607)
.+|.+..+.+.|.++.||++...+|+.++||+.... ....+.+|+++|+.|++.+ +.++++++..++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345544444567779999998877888999987543 2346889999999997544 66799988888888999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------------
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC--------------------------------------- 485 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--------------------------------------- 485 (607)
++|..|. +.. .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 221 11 2356777777788887631
Q ss_pred ----------------CCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 486 ----------------HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 486 ----------------~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
...++|+||+++|||+++++.++|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.9e-13 Score=139.46 Aligned_cols=145 Identities=17% Similarity=0.261 Sum_probs=109.5
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEee--cCCc-hhHHHHHHHHHHHHHcc--CCCceeEEeEEEeC---CceEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLK--IGGG-QGEREFKAEVEIISRIH--HRHLVSLVGYCISD---DRRLL 440 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~--~~~~-~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~l 440 (607)
....+.|+.|.++.||+.... ++.++||+.. .... .....+.+|+++|+.|+ +.++.++++++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 345677999999999999874 5788888765 3221 23456889999999997 45689999998776 45899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC----------------------------------- 485 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~----------------------------------- 485 (607)
||||++|..|.+... ..++..++..++.++++.|..||+..
T Consensus 119 vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999887744221 12677888899999999999999730
Q ss_pred --------------------CCCEEecCCCCCCEEEcCCCc--EEEEeccccccc
Q 007351 486 --------------------HPRIIHRDIKSSNILLDNNFE--AQVSDFGLAKLA 518 (607)
Q Consensus 486 --------------------~~~ivHrDLkp~NILl~~~~~--vkL~DFGls~~~ 518 (607)
...++|+|+++.|||+++++. +.|+||+++...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987653 689999998743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=134.93 Aligned_cols=184 Identities=23% Similarity=0.251 Sum_probs=123.4
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CC--CceeEEeEEEeCC---ceEEEEEe
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HR--HLVSLVGYCISDD---RRLLIYDY 444 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hp--nIv~l~g~~~~~~---~~~lV~Ey 444 (607)
..+.|+.|.+..||+.. +.++||+... ......+.+|+++|+.|. +. .+.++++++..++ ..|+||||
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 34668999999999853 5789998642 234567899999999984 33 2556666554433 34889999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED---------------------------------------- 484 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------------------------------------- 484 (607)
++|..|...... .++..++..++.++++.|..||+.
T Consensus 98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999888653322 256777788888888888888861
Q ss_pred ---------------CCCCEEecCCCCCCEEEcC--CCcEEEEecccccccccCCcceeeccccCCCC---CchhhhcC-
Q 007351 485 ---------------CHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDANTHITTRVMGTFGY---MAPEYASS- 543 (607)
Q Consensus 485 ---------------~~~~ivHrDLkp~NILl~~--~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y---~APE~l~~- 543 (607)
....++|+||++.|||+++ +..+.|+||+.+...... ..... ...+ ..++.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~----~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFIS----LMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHT----TCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHH----HHhhccccCHHHHHHH
Confidence 1246899999999999998 556789999998754221 11100 0011 12221110
Q ss_pred ----CC---------CCchhhHHHHHHHHHHHHcCCCCC
Q 007351 544 ----GK---------LTEKSDVFSFGVVLLELITGRKPV 569 (607)
Q Consensus 544 ----~~---------~~~~~DVwSlGvll~ELltg~~Pf 569 (607)
.. .....+.|+||.++|++.+|+..|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 112358999999999999997655
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=2.1e-09 Score=107.81 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=101.2
Q ss_pred ceecccCcE-EEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEEEecCCCc
Q 007351 373 NLLGEGGFG-SVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNT 449 (607)
Q Consensus 373 ~~IG~G~fG-~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 449 (607)
+.+..|..| .||+.... ++..++||+... ....++.+|..+|+.|. +--|.++++++..++..||||||+++..
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 445556665 68987754 567899997653 23557899999999985 5568899999999999999999999988
Q ss_pred hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 007351 450 LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED--------------------------------------------- 484 (607)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~--------------------------------------------- 484 (607)
+...+... ......++.++++.|..||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 86655421 122345666677777777742
Q ss_pred ----------CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 485 ----------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 485 ----------~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112489999999999999887778999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=4.5e-09 Score=107.96 Aligned_cols=138 Identities=22% Similarity=0.217 Sum_probs=96.2
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCC---CceeEEeEEE-eCCceEEEEEecC
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR---HLVSLVGYCI-SDDRRLLIYDYVP 446 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~ 446 (607)
..+.++.|....||+. |+.++||+.+ .......+.+|+++|+.|++. .|.+++.++. .++..|+||||++
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 4567899999999987 6778899753 223456789999999999753 3677787775 4556789999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED------------------------------------------ 484 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------------ 484 (607)
|..|...... .+...++..++.++++.|..||+.
T Consensus 97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9887653211 123344444444444444444431
Q ss_pred ---------------CCCCEEecCCCCCCEEEcC---CCc-EEEEeccccccc
Q 007351 485 ---------------CHPRIIHRDIKSSNILLDN---NFE-AQVSDFGLAKLA 518 (607)
Q Consensus 485 ---------------~~~~ivHrDLkp~NILl~~---~~~-vkL~DFGls~~~ 518 (607)
....++|+|+++.|||+++ +++ +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 455 489999988654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.5e-09 Score=113.66 Aligned_cols=81 Identities=7% Similarity=-0.027 Sum_probs=58.3
Q ss_pred cccee-cccCcEEEEEEEeC-------CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccC---CCceeEEeEEEeC-
Q 007351 371 DQNLL-GEGGFGSVYKGYLP-------DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHH---RHLVSLVGYCISD- 435 (607)
Q Consensus 371 ~~~~I-G~G~fG~Vyk~~~~-------~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~- 435 (607)
..+.| +.|..+.+|+.... +++.++||+..... ......+.+|+++|+.|.. ..+.++++++..+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88999999998764 26789999764322 1112467889999998852 4678899887665
Q ss_pred --CceEEEEEecCCCchh
Q 007351 436 --DRRLLIYDYVPNNTLY 451 (607)
Q Consensus 436 --~~~~lV~Ey~~~gsL~ 451 (607)
+..|+||||++|..|.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=2.5e-08 Score=105.95 Aligned_cols=76 Identities=13% Similarity=0.123 Sum_probs=51.9
Q ss_pred ccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHccC---CCceeEEeEEEeCCceE
Q 007351 371 DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-------QGEREFKAEVEIISRIHH---RHLVSLVGYCISDDRRL 439 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-------~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~~~~~ 439 (607)
..+.||.|.++.||++.+. +++.|+||....... .....+.+|+++|+.+++ ..+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567999999999999754 568899998643211 123456789999998853 345566654 355678
Q ss_pred EEEEecCCC
Q 007351 440 LIYDYVPNN 448 (607)
Q Consensus 440 lV~Ey~~~g 448 (607)
|||||+.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.8e-08 Score=102.75 Aligned_cols=141 Identities=16% Similarity=0.238 Sum_probs=84.0
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc--CCCceeEEe------EEEeCCceEEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH--HRHLVSLVG------YCISDDRRLLIYD 443 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g------~~~~~~~~~lV~E 443 (607)
.+.|+.|..+.||+....+ ..++||+... ...++..|+++++.|. .-+|.+++. +...++..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~-~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS-GAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETT-EEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCC-CCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3456767889999998744 4599998864 2234556667777664 224555554 2234567789999
Q ss_pred ecCCCchh--------------HhhhcC--C---C-------CCCCHHHH------------------------------
Q 007351 444 YVPNNTLY--------------FHLHGE--G---R-------PVLDWATR------------------------------ 467 (607)
Q Consensus 444 y~~~gsL~--------------~~l~~~--~---~-------~~l~~~~~------------------------------ 467 (607)
|++|..+. ..+|.. . . ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986431 112211 0 0 01123211
Q ss_pred -HHHHHHHHHHHHHHHH----------cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 468 -VKIAAGAARGLAYLHE----------DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 468 -~~i~~qia~gL~~LH~----------~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
..+..++.+++++|++ .....++|+|++..|||+++++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 1244899999999999998778899999999864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.5e-08 Score=108.74 Aligned_cols=74 Identities=18% Similarity=0.203 Sum_probs=48.5
Q ss_pred ccceecccCcEEEEEEEeCCCcEEEEEEeec-----CCc----hhHHHHHHHHHHHHH-ccCCCceeEEeEEEeCCceEE
Q 007351 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKI-----GGG----QGEREFKAEVEIISR-IHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~-----~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~l 440 (607)
..+.||.|..+.||++.. +++.++||.... ... .....+..|+..+.. .....+.+++++. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999975 678899994321 111 122334444433332 2345677888776 567899
Q ss_pred EEEec-CC
Q 007351 441 IYDYV-PN 447 (607)
Q Consensus 441 V~Ey~-~~ 447 (607)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.62 E-value=9.1e-08 Score=97.07 Aligned_cols=79 Identities=19% Similarity=0.213 Sum_probs=61.3
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC---CCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~~~~~lV~E 443 (607)
..+...+.+|.|..+.||+.++.||+.|+||+...........|.+|++.|+.|.. ..+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45666788999999999999999999999998764444444568999999999853 3456666652 4589999
Q ss_pred ecCCCc
Q 007351 444 YVPNNT 449 (607)
Q Consensus 444 y~~~gs 449 (607)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.60 E-value=3.4e-07 Score=94.18 Aligned_cols=140 Identities=15% Similarity=0.148 Sum_probs=95.9
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc---CCCceeEEeEEEeCCceEEEEEec
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
....+.|+.|.+..+|+... +++.++||+... .....+.+|++.|+.|. ...|.++++++..++..++||||+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34556799999999999887 678899998653 23567899999999985 366899999988888899999999
Q ss_pred CCCchh-----------HhhhcCCC---C-----------------CCCHHHHH---HHHHH-------------HHHHH
Q 007351 446 PNNTLY-----------FHLHGEGR---P-----------------VLDWATRV---KIAAG-------------AARGL 478 (607)
Q Consensus 446 ~~gsL~-----------~~l~~~~~---~-----------------~l~~~~~~---~i~~q-------------ia~gL 478 (607)
++..+. ..||.... . .-+|.+.. ++..+ +.+.+
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987541 12333211 0 12444321 11111 11122
Q ss_pred H----HHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 479 A----YLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 479 ~----~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
+ .|.. ...+.+||+||...|||+++++ +.|+||+
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 2321 1256899999999999999887 8999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.45 E-value=9.1e-07 Score=90.83 Aligned_cols=158 Identities=13% Similarity=0.105 Sum_probs=91.9
Q ss_pred ccHHHHHHhhCCCcc-----cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC--ceeEE
Q 007351 357 FTYEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLV 429 (607)
Q Consensus 357 ~~~eel~~~~~~y~~-----~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~ 429 (607)
+..+++....+.|.. .+.|+.|....+|+....+| .+++|+.... ....++..|+++++.|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345556555555654 34577788899999987555 6889987642 12345677888888875322 34444
Q ss_pred eE------EEeCCceEEEEEecCCCchh--------------HhhhcC--C--CC---C---CCHHHHHH----------
Q 007351 430 GY------CISDDRRLLIYDYVPNNTLY--------------FHLHGE--G--RP---V---LDWATRVK---------- 469 (607)
Q Consensus 430 g~------~~~~~~~~lV~Ey~~~gsL~--------------~~l~~~--~--~~---~---l~~~~~~~---------- 469 (607)
.. ...++..++||+|++|..+. ..+|.. . .. . ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 32 12345678999999876431 112211 0 00 0 11222110
Q ss_pred --HHHHHHHHHHHHHHc----CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 470 --IAAGAARGLAYLHED----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 470 --i~~qia~gL~~LH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
+...+.+.+++|++. ...+++|+|++.+|||+++++.+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666542 234799999999999999876668999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.34 E-value=3.4e-06 Score=86.74 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=86.0
Q ss_pred ceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC--CCceeEEeE-----EEeCCceEEEEEec
Q 007351 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGY-----CISDDRRLLIYDYV 445 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~-----~~~~~~~~lV~Ey~ 445 (607)
+.|+ |....||+....+|+.++||+..... .....+.+|+++++.|.. -.+.+++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887677789999886321 234567789999888853 234555543 22345568899999
Q ss_pred CCCchh--------------Hhhhc--C-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHHc-
Q 007351 446 PNNTLY--------------FHLHG--E-----GRPVLDWATR----VKI---------------AAGAARGLAYLHED- 484 (607)
Q Consensus 446 ~~gsL~--------------~~l~~--~-----~~~~l~~~~~----~~i---------------~~qia~gL~~LH~~- 484 (607)
+|..+. ..+|. . .+..+++... ..+ ...+.+.++.|.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 01121 0 0111222211 011 11111223333322
Q ss_pred ---CCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 485 ---CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 485 ---~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
....++|+|++++|||++ + .+.|+||+.++..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234789999999999999 4 8999999988643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.33 E-value=1.6e-06 Score=88.39 Aligned_cols=141 Identities=13% Similarity=0.107 Sum_probs=81.1
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEec-C
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYV-P 446 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~-~ 446 (607)
+...+.|+.|....+|+. +.++||+...... ...+..+|+++++.+...++ .++++++ .+..++|+||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 334678999999999998 6788998753211 11234678888888863333 4666543 44568999999 6
Q ss_pred CCchhH------------------hhhcCCCC---CCCH-HHHHHHHH--------------HHHHHHHHHHH-----cC
Q 007351 447 NNTLYF------------------HLHGEGRP---VLDW-ATRVKIAA--------------GAARGLAYLHE-----DC 485 (607)
Q Consensus 447 ~gsL~~------------------~l~~~~~~---~l~~-~~~~~i~~--------------qia~gL~~LH~-----~~ 485 (607)
+..|.. .||..... .++. ..+.++.. .+.+.++.|.+ ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 544421 11221110 0111 11111111 11112222211 12
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
...++|+|+.++||| .+++.+.|+||+.+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 346899999999999 55667899999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.32 E-value=4.3e-06 Score=86.33 Aligned_cols=142 Identities=15% Similarity=0.125 Sum_probs=77.0
Q ss_pred cceecccCcEE-EEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc--CCCceeEEeEEEeCCceEEEEEecCCC
Q 007351 372 QNLLGEGGFGS-VYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH--HRHLVSLVGYCISDDRRLLIYDYVPNN 448 (607)
Q Consensus 372 ~~~IG~G~fG~-Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~g 448 (607)
.+.|+.|.... +|+....+|+.+++|...... ..++..|+++++.|. .-.+.+++.+... ..+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence 34566665554 677765447788888654221 134566777777775 2346778877433 338899999766
Q ss_pred chhHhhh---------------------cCC---CCCCCHHHHH-------H-H------------HHHHHHHHHHHHH-
Q 007351 449 TLYFHLH---------------------GEG---RPVLDWATRV-------K-I------------AAGAARGLAYLHE- 483 (607)
Q Consensus 449 sL~~~l~---------------------~~~---~~~l~~~~~~-------~-i------------~~qia~gL~~LH~- 483 (607)
.+..++. ... ...++..... . + ...+.+.++.|.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 5543221 110 0112211110 0 0 0112222333321
Q ss_pred --cCCCCEEecCCCCCCEEEcCC----CcEEEEeccccccc
Q 007351 484 --DCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKLA 518 (607)
Q Consensus 484 --~~~~~ivHrDLkp~NILl~~~----~~vkL~DFGls~~~ 518 (607)
.....++|||++++|||++++ +.+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124489999999999999874 68999999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=98.24 E-value=2e-06 Score=92.56 Aligned_cols=73 Identities=19% Similarity=0.229 Sum_probs=51.1
Q ss_pred cceecccCcEEEEEEEeCC--------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC-ceeEEeEEEeCCceEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 442 (607)
.+.|+.|....||++...+ ++.++||+.... .....+.+|+.+++.|...+ ..++++++.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568889999999998753 578999987421 11245668999999986434 4677776532 3899
Q ss_pred EecCCCch
Q 007351 443 DYVPNNTL 450 (607)
Q Consensus 443 Ey~~~gsL 450 (607)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=98.16 E-value=8.5e-06 Score=88.19 Aligned_cols=74 Identities=9% Similarity=0.029 Sum_probs=49.0
Q ss_pred cceecccCcEEEEEEEeCC-CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc-eeEEeEEEeCCceEEEEEecCCCc
Q 007351 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNT 449 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs 449 (607)
.+.|+.|-...+|++...+ ++.++||+..... ....+..+|+.+|+.|...+| .++++++. + .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888899999998854 4788899764321 111123689999999975554 67777762 2 35999998754
Q ss_pred h
Q 007351 450 L 450 (607)
Q Consensus 450 L 450 (607)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=7.3e-06 Score=86.49 Aligned_cols=141 Identities=19% Similarity=0.199 Sum_probs=85.5
Q ss_pred cceecccCcEEEEEEEeC--------CCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~--------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.+.|..|-...+|++... +++.++||+.... ......+.+|.++|+.|. +.-..++++++.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345777888899999874 2478999986321 123456779999999986 3334677766542 3999
Q ss_pred EecCCCchhH-----------------hhhcCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 007351 443 DYVPNNTLYF-----------------HLHGEG---RPVLD--WATRVKIAAGAA-------------------RGLAYL 481 (607)
Q Consensus 443 Ey~~~gsL~~-----------------~l~~~~---~~~l~--~~~~~~i~~qia-------------------~gL~~L 481 (607)
||++|..|.. .||... ..... |.++.++..++. +.++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865421 112211 11122 344444544432 223444
Q ss_pred HHc-----CCCCEEecCCCCCCEEEcCC----CcEEEEecccccc
Q 007351 482 HED-----CHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKL 517 (607)
Q Consensus 482 H~~-----~~~~ivHrDLkp~NILl~~~----~~vkL~DFGls~~ 517 (607)
.+. ....++|+|+...|||++++ +.++|+||+.+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 23478999999999999876 7899999999864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=4.5e-06 Score=87.61 Aligned_cols=140 Identities=13% Similarity=0.130 Sum_probs=78.7
Q ss_pred cceecccCcEEEEEEEeCC---------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC-ceeEEeEEEeCCceEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLI 441 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV 441 (607)
.+.|+.|....+|+....+ ++.+++|+..... ....+..+|+++|+.|...+ +.++++.. ..++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4567888889999998754 2688888765321 11123467888888886434 45777654 24789
Q ss_pred EEecCCCchhH-----------------hhhc----C-CCCCCC-----HHHHHHHHH--------------------HH
Q 007351 442 YDYVPNNTLYF-----------------HLHG----E-GRPVLD-----WATRVKIAA--------------------GA 474 (607)
Q Consensus 442 ~Ey~~~gsL~~-----------------~l~~----~-~~~~l~-----~~~~~~i~~--------------------qi 474 (607)
|||++|..|.. .||. . ....+. +..+.++.. .+
T Consensus 113 ~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (369)
T 3c5i_A 113 EEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKES 192 (369)
T ss_dssp EECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHH
T ss_pred EEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHH
Confidence 99998754310 1121 0 000111 111111111 11
Q ss_pred HHHHHHHHH-------cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 475 ARGLAYLHE-------DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 475 a~gL~~LH~-------~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
...+++|.+ .....++|+|++..|||+++++ +.|+||+.+..
T Consensus 193 ~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 193 DKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp HHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred HHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 222334432 1234799999999999998764 89999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.2e-05 Score=83.51 Aligned_cols=140 Identities=14% Similarity=0.194 Sum_probs=81.7
Q ss_pred ccee--cccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC---CCceeEEeE------EEeCCceEE
Q 007351 372 QNLL--GEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGY------CISDDRRLL 440 (607)
Q Consensus 372 ~~~I--G~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~------~~~~~~~~l 440 (607)
.+.| |.|....||+....+| .++||+...... .+|+++|+.|.. ++|.+++.. +..++..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 3445 3344689999987666 999998764332 456666666642 225555542 233566789
Q ss_pred EEEecCCCchh----------------HhhhcCCC----------CCCC--HHH-HHHH---------------------
Q 007351 441 IYDYVPNNTLY----------------FHLHGEGR----------PVLD--WAT-RVKI--------------------- 470 (607)
Q Consensus 441 V~Ey~~~gsL~----------------~~l~~~~~----------~~l~--~~~-~~~i--------------------- 470 (607)
||||++|..+. ..||.... ..+. |.. ..++
T Consensus 99 l~~~i~G~~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 178 (339)
T 3i1a_A 99 AYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFF 178 (339)
T ss_dssp EEECCCCCBTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHH
T ss_pred EEeccCCCcCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHH
Confidence 99999887551 11122111 0011 111 1111
Q ss_pred ------HHHHHHHHHHHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEeccccccc
Q 007351 471 ------AAGAARGLAYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (607)
Q Consensus 471 ------~~qia~gL~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~ 518 (607)
+..++..++.|.+. ....++|+|+...|||+++++.+.|+||+.+...
T Consensus 179 ~~~~~~l~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 179 NQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp HHTHHHHHHHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred HHhHHHHHHHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 11222222222221 2347999999999999998888999999988643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0001 Score=78.74 Aligned_cols=140 Identities=11% Similarity=0.103 Sum_probs=86.0
Q ss_pred cceecccCcEEEEEEEeCC--------CcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCceEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 442 (607)
.+.|..|-...+|+....+ ++.++||+..... ....+..+|.++++.|. +.-..++++.+ ..++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 4567778889999998753 5789999864321 11223467888888885 33346667543 247899
Q ss_pred EecCCCchhH-----------------hhhc--------C---CCCCCCHHHHHHHHHHH-------------------H
Q 007351 443 DYVPNNTLYF-----------------HLHG--------E---GRPVLDWATRVKIAAGA-------------------A 475 (607)
Q Consensus 443 Ey~~~gsL~~-----------------~l~~--------~---~~~~l~~~~~~~i~~qi-------------------a 475 (607)
||++|..|.. .||. . ++...-|..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865411 0111 0 11111233333333222 2
Q ss_pred HHHHHHHHc---------------------CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 476 RGLAYLHED---------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 476 ~gL~~LH~~---------------------~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
+.+++|.+. ....++|+|++..||| ++++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233333321 1246899999999999 7788999999999864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00013 Score=51.06 Aligned_cols=31 Identities=13% Similarity=0.255 Sum_probs=20.0
Q ss_pred ceeehhHHHHHHHHHHHHHHHHhheeccccc
Q 007351 269 GTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (607)
Q Consensus 269 ~~ivi~v~v~~~~l~li~~~~~~~~rrkk~~ 299 (607)
..|+++|+.+++++++|++++|+++|||+++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3466777777777777777666666555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00015 Score=50.63 Aligned_cols=31 Identities=23% Similarity=0.315 Sum_probs=19.8
Q ss_pred ceeehhHHHHHHHHHHHHHHHHhheeccccc
Q 007351 269 GTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (607)
Q Consensus 269 ~~ivi~v~v~~~~l~li~~~~~~~~rrkk~~ 299 (607)
+.|+.+|+.+++++++|++++|+++|||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3466677777777777777666665555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0014 Score=69.36 Aligned_cols=30 Identities=27% Similarity=0.406 Sum_probs=25.6
Q ss_pred CEEecCCCCCCEEE------cCCCcEEEEecccccc
Q 007351 488 RIIHRDIKSSNILL------DNNFEAQVSDFGLAKL 517 (607)
Q Consensus 488 ~ivHrDLkp~NILl------~~~~~vkL~DFGls~~ 517 (607)
.++|+||...|||+ +++..++|+||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999999864
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0023 Score=44.64 Aligned_cols=25 Identities=32% Similarity=0.616 Sum_probs=11.0
Q ss_pred ehhHHHHHHHHHHHHHHHHhheecc
Q 007351 272 VIAVAVGIIAFSLIGLVVWCLRRRK 296 (607)
Q Consensus 272 vi~v~v~~~~l~li~~~~~~~~rrk 296 (607)
+++.++++++++++++++++|.|||
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHhheehh
Confidence 3444444444444444444443333
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0036 Score=43.42 Aligned_cols=29 Identities=28% Similarity=0.440 Sum_probs=15.8
Q ss_pred cceeehhHHHHHHHHHHHHHHHHhheecc
Q 007351 268 AGTVVIAVAVGIIAFSLIGLVVWCLRRRK 296 (607)
Q Consensus 268 ~~~ivi~v~v~~~~l~li~~~~~~~~rrk 296 (607)
.+.|++++++++++++++++++|++||||
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 34456666666666553444455555544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.31 E-value=0.066 Score=51.34 Aligned_cols=110 Identities=9% Similarity=0.020 Sum_probs=70.4
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecC-CCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD-IKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD-Lkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
-+|.+.|+..+. .++++++|.++.|.+++|.-+-... . -|.. +.+..|+|..+|.|.+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~--~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------~--- 98 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR--Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------A--- 98 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT--C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc--c-CCceecCCcceEEecCCceeccc-cccc------c---
Confidence 368888877654 5999999999999999987763210 1 1233 345889999999998764 2211 0
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~ 576 (607)
....+.+||.+. ...+.+.-||+||++||.-+--.++=+....++
T Consensus 99 ----~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS 143 (229)
T 2yle_A 99 ----GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELS 143 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCC
T ss_pred ----cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhC
Confidence 112355777653 345678899999999999887666655444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.28 E-value=0.01 Score=40.22 Aligned_cols=9 Identities=22% Similarity=0.154 Sum_probs=3.6
Q ss_pred HHHHhheec
Q 007351 287 LVVWCLRRR 295 (607)
Q Consensus 287 ~~~~~~~rr 295 (607)
+++||++||
T Consensus 29 ~l~~~~~rr 37 (38)
T 2k1k_A 29 GILVFRSRR 37 (38)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHeec
Confidence 333444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.077 Score=50.74 Aligned_cols=116 Identities=9% Similarity=0.072 Sum_probs=78.8
Q ss_pred cCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEE
Q 007351 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (607)
Q Consensus 421 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (607)
.|++++.. .+...++...+.|+.-.++.=+..++. ++...+++++.+|+...++++. -+|--|+|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 47777765 455555555555554443322333433 7789999999999988866654 378889999999
Q ss_pred EcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 501 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
++.++.++|.-.|+-..+.. ..++...=+-.+-|++..+++++.-|+
T Consensus 112 f~~~~~p~i~~RGik~~l~P-----------------------~~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDP-----------------------LPVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTBSC-----------------------CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCCCC-----------------------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987776432211 122333344567789999999988885
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=94.51 E-value=0.091 Score=53.45 Aligned_cols=139 Identities=14% Similarity=0.091 Sum_probs=73.0
Q ss_pred cccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEE-----------------
Q 007351 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC----------------- 432 (607)
Q Consensus 370 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~----------------- 432 (607)
+..+.+-.|.. .||.+.. ++..|+||... ....+.|..++...-.+.-++ .+++.+.
T Consensus 72 ~~I~~s~~Gst-gvff~~t-d~~~~VVK~s~---~l~~E~l~s~LA~~LGlpiP~-~Riv~~~~~E~~e~~~~L~~~~~~ 145 (342)
T 1cja_A 72 KGIERSEKGTE-GLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPK-VRVVSSNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp EEEEECCSTTS-CEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCC-EEEEESSSHHHHHHHHHHHHHCSS
T ss_pred eEEEeccCCCC-CeEEEEe-CCCEEEEeCcH---HHHHHHHHHHHHHHhCCCCCC-eeEEeeCcHHHHHHHHHHHHhhhh
Confidence 33455566654 4555555 68899999542 223333444444444444444 2222211
Q ss_pred ------EeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHH--HHHHHHHHHcCC-CCEEe-cCCCCCCEEEc
Q 007351 433 ------ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA--ARGLAYLHEDCH-PRIIH-RDIKSSNILLD 502 (607)
Q Consensus 433 ------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi--a~gL~~LH~~~~-~~ivH-rDLkp~NILl~ 502 (607)
..++..+++|||+.|..|...-+......+.. +.++++ +-+++.+.++.. ..+++ ..-+..|||++
T Consensus 146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~ 221 (342)
T 1cja_A 146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLS 221 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCcccccCCCChhheEEe
Confidence 01224679999998766654322110001222 223333 345667766532 11111 12478899997
Q ss_pred CCC-cEEEEeccccccc
Q 007351 503 NNF-EAQVSDFGLAKLA 518 (607)
Q Consensus 503 ~~~-~vkL~DFGls~~~ 518 (607)
+++ .+.+||-+++...
T Consensus 222 ~~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 222 ERGATVVPIDSKIIPLD 238 (342)
T ss_dssp SBTTCEEECSCCCCCCC
T ss_pred CCCCeEEEEcCCccccC
Confidence 654 5999999999753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.37 E-value=0.025 Score=39.55 Aligned_cols=33 Identities=9% Similarity=-0.008 Sum_probs=21.7
Q ss_pred ccceeehhHHHHHHHHHHHHHHHHhheeccccc
Q 007351 267 TAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (607)
Q Consensus 267 ~~~~ivi~v~v~~~~l~li~~~~~~~~rrkk~~ 299 (607)
.++.-+|+.++++++++++.+++|.+||+++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 344445555555666667888888888777653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.15 Score=48.84 Aligned_cols=115 Identities=10% Similarity=0.128 Sum_probs=76.0
Q ss_pred cCCCceeEEeEEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCCCCEEecCCCCCCE
Q 007351 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA-YLHEDCHPRIIHRDIKSSNI 499 (607)
Q Consensus 421 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~-~LH~~~~~~ivHrDLkp~NI 499 (607)
.|+++ -..+..+++...+.++.-+++.=+..++. ++...+++++.+|+...+ +++. -+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 46666 33344556666666665544433444433 788899999999888776 5554 47888999999
Q ss_pred EEcCCCcEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 500 LLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 500 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
+++.++.++|.-.|+-..+. |. .++...=+-.+-|++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lp------------------P~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLP------------------PD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBS------------------SC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998877643221 11 12222233466778888888877774
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=94.05 E-value=0.99 Score=50.61 Aligned_cols=45 Identities=24% Similarity=0.180 Sum_probs=34.2
Q ss_pred HHHHHHHHHHH--HHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 465 ATRVKIAAGAA--RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 465 ~~~~~i~~qia--~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
..+..+++.+| ..+.|+-.. +|-+.+||||+++|++.=||||++.
T Consensus 529 ~ar~nF~~SlA~~Svv~YILGl-------GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLGV-------GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC-------CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHccC-------CCCCCcceEEeCCCCEEEEeehhhh
Confidence 34555665554 445666554 6999999999999999999999975
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.99 E-value=0.024 Score=39.58 Aligned_cols=34 Identities=18% Similarity=-0.030 Sum_probs=23.0
Q ss_pred cccceeehhHHHHHHHHHHHHHHHHhheeccccc
Q 007351 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (607)
Q Consensus 266 ~~~~~ivi~v~v~~~~l~li~~~~~~~~rrkk~~ 299 (607)
..++.-+++.++++++++++.+++|.+||+++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 3455556665566666668888888888877665
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=93.18 E-value=1.5 Score=48.38 Aligned_cols=117 Identities=14% Similarity=0.140 Sum_probs=67.1
Q ss_pred CCcE--EEEEEeecCCchhHHHHHHHHHHHHHc-c--CCC-ceeEEeEEEeCCceEEEEEecCCCchhHhhhcCC-----
Q 007351 390 DGRE--VAIKQLKIGGGQGEREFKAEVEIISRI-H--HRH-LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG----- 458 (607)
Q Consensus 390 ~g~~--VAVK~l~~~~~~~~~~~~~Ei~il~~l-~--Hpn-Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----- 458 (607)
||+. +++|. .++-+.+..+.+-+.++..+ + ..+ -++.|.+.-..... =++||+.+.++.+.+...+
T Consensus 362 DG~~y~~i~K~--gDDLRQD~~~~Ql~~l~n~il~~~~ldL~i~~Y~Vipls~~~-GlIE~V~~~tl~~il~~~~~l~~~ 438 (614)
T 3ls8_A 362 DGGKYPVIFKH--GDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKH-GFMQFIQSVPVAEVLDTEGSIQNF 438 (614)
T ss_dssp TSCEEEEEEEE--SSCCHHHHHHHHHHHHHHHHHHHTTCCCCCCCCCEEESSSSE-EEEECCCCEEHHHHHHHTSSHHHH
T ss_pred CCCEEEEEEec--CCcchHHHHHHHHHHHHHHHHHhcCCCceeeccEEEEecCCC-ceEEEeCCccHHHHHHccChHHHH
Confidence 5654 55564 23334444455555555554 2 222 13444444443333 3467887665555443211
Q ss_pred -----C-----CCCCHHHHHHHHHHHH--HHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 459 -----R-----PVLDWATRVKIAAGAA--RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 459 -----~-----~~l~~~~~~~i~~qia--~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
. ....+..+..+++.+| ..+.|+-.. +|=+.+||||+.+|++.=||||.+.
T Consensus 439 f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi-------gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 439 FRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV-------GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp HHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC-------CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred HHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec-------cCCCCcceeEcCCCCEeeeehHHhh
Confidence 0 0122455566666554 355666654 5889999999999999999999984
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.16 E-value=0.049 Score=39.61 Aligned_cols=21 Identities=19% Similarity=0.646 Sum_probs=14.6
Q ss_pred eeehhHHHHHHHHHHHHHHHH
Q 007351 270 TVVIAVAVGIIAFSLIGLVVW 290 (607)
Q Consensus 270 ~ivi~v~v~~~~l~li~~~~~ 290 (607)
+|++++++|+++++++.+++|
T Consensus 11 iIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 11 VILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHH
Confidence 456666777777777777666
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.11 E-value=0.053 Score=39.57 Aligned_cols=21 Identities=24% Similarity=0.650 Sum_probs=14.4
Q ss_pred eeehhHHHHHHHHHHHHHHHH
Q 007351 270 TVVIAVAVGIIAFSLIGLVVW 290 (607)
Q Consensus 270 ~ivi~v~v~~~~l~li~~~~~ 290 (607)
+|++++++|+++++++.+++|
T Consensus 14 iIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 14 WVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHH
Confidence 456666677777777777666
|
| >3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A | Back alignment and structure |
|---|
Probab=91.43 E-value=1.3 Score=51.97 Aligned_cols=47 Identities=17% Similarity=0.116 Sum_probs=34.5
Q ss_pred CHHH-HHHHHHHHH--HHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 463 DWAT-RVKIAAGAA--RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 463 ~~~~-~~~i~~qia--~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
.|.. +..+++.+| ..+.|+-.. +|=+.+||||+++|++.=+|||.+.
T Consensus 912 ~~~~ar~nF~~S~A~ysvv~YiLgi-------gDRH~~NILid~tG~v~HIDFG~~f 961 (1091)
T 3hhm_A 912 IYDAAIDLFTRSCAGYCVATFILGI-------GDRHNSNIMVKDDGQLFHIDFGHFL 961 (1091)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHTC-------CCCCTTTEEEETTSCEEECCCCCCS
T ss_pred HHHHHHHHHHHHhhhhhheEEEEee-------cCCCCcceEEeCCCCEEEEeehhhh
Confidence 4443 345555544 355666654 6889999999999999999999985
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=91.20 E-value=0.048 Score=35.92 Aligned_cols=23 Identities=35% Similarity=0.574 Sum_probs=10.8
Q ss_pred hHHHHHHHHHHHHHHHHhheecc
Q 007351 274 AVAVGIIAFSLIGLVVWCLRRRK 296 (607)
Q Consensus 274 ~v~v~~~~l~li~~~~~~~~rrk 296 (607)
+.++++++++++++.+.++.|||
T Consensus 12 agVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 12 ATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHTTTTTHHHHHC
T ss_pred HHHHHHHHHHHHHHHhheEEeec
Confidence 33344555555555444444444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.16 E-value=0.08 Score=36.87 Aligned_cols=32 Identities=9% Similarity=0.123 Sum_probs=21.9
Q ss_pred cccceeehhHHHHHHHHHHHHHHHHhheecccc
Q 007351 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKE 298 (607)
Q Consensus 266 ~~~~~ivi~v~v~~~~l~li~~~~~~~~rrkk~ 298 (607)
..++..+++ ++.++++++++++++.+||.+++
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~~k 43 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQQKIR 43 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHCSCCC
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhhhhcc
Confidence 345566667 45666677777888888877754
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=89.84 E-value=0.16 Score=35.07 Aligned_cols=21 Identities=24% Similarity=0.650 Sum_probs=14.1
Q ss_pred eeehhHHHHHHHHHHHHHHHH
Q 007351 270 TVVIAVAVGIIAFSLIGLVVW 290 (607)
Q Consensus 270 ~ivi~v~v~~~~l~li~~~~~ 290 (607)
+|++++++|+++++++.+++|
T Consensus 12 iIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 12 WVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHH
Confidence 456666667777777666666
|
| >1zza_A Stannin, AG8_1; helix, membrane protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.29 E-value=0.19 Score=38.37 Aligned_cols=26 Identities=31% Similarity=0.629 Sum_probs=16.0
Q ss_pred ehhHHHHHHHHHHHHHHHHhheeccc
Q 007351 272 VIAVAVGIIAFSLIGLVVWCLRRRKK 297 (607)
Q Consensus 272 vi~v~v~~~~l~li~~~~~~~~rrkk 297 (607)
++.++++++++.++++.+||+.|..|
T Consensus 17 v~viliavaalg~li~gcwcylrlqr 42 (90)
T 1zza_A 17 VIVILIAIAALGALILGCWCYLRLQR 42 (90)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTSSCS
T ss_pred ehhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34444555666667777787766544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.42 E-value=0.035 Score=59.86 Aligned_cols=61 Identities=5% Similarity=-0.005 Sum_probs=18.4
Q ss_pred ccceecccCcEEEEEEEeCC-CcEEEE------EEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEe
Q 007351 371 DQNLLGEGGFGSVYKGYLPD-GREVAI------KQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~~-g~~VAV------K~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 434 (607)
+.+.|| ||.||+|.+.. ...||| |.++.... +....|.+|..+++.++|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 446676 99999999854 357888 76654322 223468889999999999999999887653
|
| >2wxf_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit delta isoform; transferase, phosphoprotein, isoform-specific inhibitors; HET: 039; 1.90A {Mus musculus} PDB: 2wxg_A* 2wxh_A* 2wxi_A* 2wxj_A* 2wxk_A* 2wxl_A* 2wxm_A* 2wxn_A* 2wxo_A* 2wxp_A* 2wxq_A* 2wxr_A 2x38_A* | Back alignment and structure |
|---|
Probab=88.21 E-value=2.9 Score=48.57 Aligned_cols=41 Identities=22% Similarity=0.183 Sum_probs=30.9
Q ss_pred HHHHHHH--HHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccc
Q 007351 469 KIAAGAA--RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 469 ~i~~qia--~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
.+++.+| ..+.|+-.. +|-+.+||||+++|++.=+|||.+.
T Consensus 770 ~F~~S~A~~Svv~YILGl-------gDRH~~NILid~tG~v~HIDFG~~f 812 (940)
T 2wxf_A 770 EFTLSCAGYCVATYVLGI-------GDRHSDNIMIRESGQLFHIDFGHFL 812 (940)
T ss_dssp HHHHHHHHHHHHHHHHTC-------CCCCGGGEEEETTSCEEECCCCCCT
T ss_pred HHHHHHHHHHHHHHHhcc-------CCCCcccEEEecCCCEEEEeehhhh
Confidence 3555443 345565543 6899999999999999999999875
|
| >2y3a_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit beta isoform; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=88.19 E-value=2.9 Score=49.28 Aligned_cols=25 Identities=28% Similarity=0.284 Sum_probs=23.4
Q ss_pred cCCCCCCEEEcCCCcEEEEeccccc
Q 007351 492 RDIKSSNILLDNNFEAQVSDFGLAK 516 (607)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DFGls~ 516 (607)
+|-+.+||||+++|++.=+|||++.
T Consensus 940 GDRH~~NILid~tG~v~HIDFG~~f 964 (1092)
T 2y3a_A 940 GDRHSDNIMVKKTGQLFHIDFGHIL 964 (1092)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCCS
T ss_pred CCCCCccEEEecCCCEEEEeehhhh
Confidence 6999999999999999999999875
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.13 E-value=0.3 Score=36.67 Aligned_cols=7 Identities=43% Similarity=0.952 Sum_probs=3.0
Q ss_pred HHHHHHH
Q 007351 284 LIGLVVW 290 (607)
Q Consensus 284 li~~~~~ 290 (607)
++++.+|
T Consensus 23 ~~glcI~ 29 (70)
T 2klu_A 23 FIGLGIF 29 (70)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3444444
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.41 E-value=0.19 Score=39.98 Aligned_cols=24 Identities=25% Similarity=0.484 Sum_probs=15.2
Q ss_pred cceeehhHHHHHHHHHHHHHHHHh
Q 007351 268 AGTVVIAVAVGIIAFSLIGLVVWC 291 (607)
Q Consensus 268 ~~~ivi~v~v~~~~l~li~~~~~~ 291 (607)
+..|+++++++++++.|+++++|.
T Consensus 10 ~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 10 ILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHHHHHH
Confidence 344566677777766666666664
|
| >3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A* | Back alignment and structure |
|---|
Probab=84.93 E-value=4.9 Score=43.17 Aligned_cols=140 Identities=11% Similarity=0.035 Sum_probs=92.8
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHccCCCceeEEe-----------------
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVG----------------- 430 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g----------------- 430 (607)
.=+|.-|--|.|-.+-.--+-.++.|++|..- .......++..++.++. ..|=++.+
T Consensus 311 ~Fi~APGikGmVM~VFTLPSf~~VFKvIKD~F~p~K~~tr~~Vk~KY~LVK~h--DRVGRMADT~Efsn~~fp~~Rfs~e 388 (578)
T 3eps_A 311 QFIEAPGIRGMVMLVFTLPGFDRVFKVIKDKFAPQKEMSAAHVRACYQLVKEH--DRVGRMADTQEFENFVLEKRHISPA 388 (578)
T ss_dssp CBEECSSCCCSSEEEEECTTCSEEEEEECSSCCTTCCCCHHHHHHHHHHHHTS--CCTTTBCCCEEEEEEEEEGGGBCHH
T ss_pred hEEECCCCCceEEEEEcCCCCceEEEEEccCCCCccccCHHHHHHHHHHHHhh--hhhhhhhhhhhhhcccCchhhCCHH
Confidence 34577888888877764467788999998542 12233445444444433 22222211
Q ss_pred ------------EEEeCCceEEEEEecC--CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCC
Q 007351 431 ------------YCISDDRRLLIYDYVP--NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (607)
Q Consensus 431 ------------~~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (607)
+..+++...|--=|++ ..-|..+|+.. +..++...+.+.-.||..|-.. +|.-||+=-
T Consensus 389 LL~EL~~~~ps~le~~gd~liIkHlYiERRMtPLNLYL~~a-----~~~~~~~av~eYG~AIKqLAaA---NIFPGDML~ 460 (578)
T 3eps_A 389 LMELLLQEAAEKITDLGEQIVIRHLYIERRMVPLNIWLEQV-----EGQQLRDAIEEYGNAIRQLAAA---NIFPGDMLF 460 (578)
T ss_dssp HHHHHHHHSGGGEEEETTEEEEEEEEEEECCEEHHHHHHHC-----CTHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred HHHHHHHhCCccEEEcCCeeEeeeeeeeccccchhHHHhhC-----CHHHHHHHHHHHHHHHHHHHHh---cCCCccccc
Confidence 1112333332222333 34577777664 4467788888999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecccccccccC
Q 007351 497 SNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 497 ~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
+|+=|+..|+|..-|++-.+.+.+-
T Consensus 461 KNFGVTRhgRVVFYDYDEI~ylTdc 485 (578)
T 3eps_A 461 KNFGVTRHGRVVFYDYDEICYMTEV 485 (578)
T ss_dssp GGEEECTTCCEEECCGGGCEESTTC
T ss_pred ccCCccccceEEEecccceeeeccc
Confidence 9999999999999999988776543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 607 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-74 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-71 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-31 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 1e-74
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 9/226 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHH 422
D F + LG G G V+K P G +A K + + R E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
++V G SD + +++ +L L GR + K++ +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
E +I+HRD+K SNIL+++ E ++ DFG++ +D + +GT YM+PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
+ +SD++S G+ L+E+ GR P+ E + D
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-71
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 13/208 (6%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +G
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
Y + + ++ + ++LY HLH + + IA A+G+ YLH II
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPEYA---SSGKL 546
HRD+KS+NI L + ++ DFGLA + + + +H ++ G+ +MAPE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQP 574
+ +SDV++FG+VL EL+TG+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINN 214
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 7e-71
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 10/216 (4%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ +I +Y+ N +L L L + +AA A G+A++ E IHR
Sbjct: 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D++++NIL+ + +++DFGLA+L D + APE + G T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
+SFG++L E++T + P + E + ++
Sbjct: 194 WSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLE 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 4e-68
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 16/224 (7%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 433 ISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ + L ++ +Y+ +L +L GR VL +K + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD+ + N+L+ + A+VSDFGL K A + + APE K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 552 VFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKL 595
V+SFG++L E+ + + P L + V ++
Sbjct: 183 VWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDA 221
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 4e-68
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ L+++++ + L +L + T + + G+AYL +IHR
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYL---EEACVIHR 125
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D+ + N L+ N +VSDFG+ + LD +T + +PE S + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
+SFGV++ E+ + K P + S E V I
Sbjct: 186 WSFGVLMWEVFSEGKI-----PYENRSNSEVVEDI 215
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-67
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 10/216 (4%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+I +Y+ N L +L +++ + YL + +HR
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D+ + N L+++ +VSDFGL++ LD + + PE K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
++FGV++ E+ + K P + E I
Sbjct: 185 WAFGVLMWEIYSLGKM-----PYERFTNSETAEHIA 215
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 1e-66
Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 27/250 (10%)
Query: 357 FTYEELVKATDGFAD---------QNLLGEGGFGSVYKGYLP----DGREVAIKQLKIG- 402
FT+E+ +A FA + ++G G FG V G+L VAIK LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 403 GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
+ R+F +E I+ + H +++ L G ++I +++ N +L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
V + G A G+ YL +HRD+ + NIL+++N +VSDFGL++ D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 523 THITTR----VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
+ T + APE K T SDV+S+G+V+ E+++ + P D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWDM 237
Query: 579 SLVEWVNLID 588
+ + +N I+
Sbjct: 238 TNQDVINAIE 247
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-65
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 23/243 (9%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+K + +AE+ + H +++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 432 CISDD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-- 485
D+ + L+ DY + +L+ +L+ + +K+A A GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 486 ---HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL---ALDANTHITTRVMGTFGYMAPE 539
P I HRD+KS NIL+ N ++D GLA A D +GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 540 YASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILF 593
+ +++D+++ G+V E+ + + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 594 KLV 596
K+V
Sbjct: 243 KVV 245
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-64
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 371 DQNLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHL 425
+ LG G FG+V KGY + VA+K LK E AE ++ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V ++G C + +L+ + L +L + +++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPEYASS 543
+HRD+ + N+LL A++SDFGL+K + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
K + KSDV+SFGV++ E + + P E +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTAMLE 224
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-64
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 10/211 (4%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
+G G +G K DG+ + K+L G ++ +EV ++ + H ++V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 430 GYCI--SDDRRLLIYDYVPNNTLYFHLH--GEGRPVLDWATRVKIAAGAARGLAYLHE-- 483
I ++ ++ +Y L + + R LD +++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
D ++HRD+K +N+ LD ++ DFGLA++ L+ +T +GT YM+PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
EKSD++S G +L EL P A
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 1e-64
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLK---IGGGQGEREFKAEVEIISRIHH 422
+ F LG+G FG+VY +A+K L + E + + EVEI S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+++ L GY R LI +Y P T+Y L + D A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
R+IHRDIK N+LL + E +++DFG + A + + GT Y+ PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
EK D++S GV+ E + G+ P +A+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-64
Identities = 61/236 (25%), Positives = 111/236 (47%), Gaps = 17/236 (7%)
Query: 360 EELVKATDGFADQNL-LGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQGERE-FKAEV 414
++L D ++ LG G FGSV +G +VAIK LK G + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+I+ ++ + ++V L+G C + +L+ + L+ L G+ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGT 532
+ G+ YL +HRD+ + N+LL N A++SDFGL+K +++ T R
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
+ APE + K + +SDV+S+GV + E ++ + P E + I+
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIE 226
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 8e-63
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 14/226 (6%)
Query: 359 YEEL---VKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEV 414
YE + + D + LG+G FG VYK + A K + + ++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+I++ H ++V L+ ++ ++ ++ + + RP L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
L YLH+ +IIHRD+K+ NIL + + +++DFG++ + + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 535 YMAPEYA-----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+MAPE K+DV+S G+ L+E+ P P+
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-63
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G F +VYKG + EVA +L+ + FK E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 432 CISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
S + +L+ + + + TL +L + +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 488 RIIHRDIKSSNILL-DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
IIHRD+K NI + ++ D GLA L V+GT +MAPE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKY 189
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQP 574
E DV++FG+ +LE+ T P Q
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQN 217
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-62
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 18/225 (8%)
Query: 372 QNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLV 426
++G G FG VY G L D A+K L GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
SL+G C+ S+ L++ Y+ + L + E + A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KFLA 147
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN---THITTRVMGTFGYMAPEYAS 542
+ +HRD+ + N +LD F +V+DFGLA+ D H T +MA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
+ K T KSDV+SFGV+L EL+T P P D + + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYL 247
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 6e-62
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE---REFKAEVEIISRIH 421
F+D +G G FG+VY + + VAIK++ G Q ++ EV + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H + + G + + L+ +Y + + L + GA +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H +IHRD+K+ NILL ++ DFG A + AN+ +GT +MAPE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 183
Query: 542 SS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ G+ K DV+S G+ +EL + P+ +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 1e-61
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 10/238 (4%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEII 417
Y++ ++ LG G +G VY+G VA+K LK + E EF E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 418 SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
I H +LV L+G C + +I +++ L +L R + + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+ YL + IHRD+ + N L+ N +V+DFGL++L + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKL 595
PE + K + KSDV++FGV+L E+ T P L + L++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMER 237
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-61
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 552 VFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
V+SFG++L EL T + P E ++ ++
Sbjct: 197 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVE 228
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-61
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 13/226 (5%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVG 430
LGEG +G V VA+K + + E K E+ I ++H ++V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + + L +Y L+ + + + + G+ YLH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKL-TE 548
HRDIK N+LLD ++SDFGLA + + ++ GT Y+APE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFK 594
DV+S G+VL ++ G P D +S E+ + + K
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQP----SDSCQEYSDWKEKKTYLN 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 8e-61
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 374 LLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
+GEG FG V++G VAIK K RE F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G +++ +I + L L LD A+ + A + LAYL R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRDI + N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
SDV+ FGV + E++ P + + I
Sbjct: 189 ASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRI 222
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-60
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGERE-FKAEVEIISRI-HHRH 424
LG G FG V + VA+K LK ERE +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG----------------EGRPVLDWATRV 468
+V+L+G C L+I +Y L L + LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITT 527
+ A+G+A+L IHRD+ + NILL + ++ DFGLA+ + D+N +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN 585
+MAPE + T +SDV+S+G+ L EL + P+ D + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKFYKMIK 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 8e-60
Identities = 58/259 (22%), Positives = 102/259 (39%), Gaps = 38/259 (14%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGER-EFK 411
L + +GEG FG V++ P VA+K LK + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 412 AEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR------------ 459
E +++ + ++V L+G C L+++Y+ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 460 ----------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509
P L A ++ IA A G+AYL + +HRD+ + N L+ N ++
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 510 SDFGLAKLALDAN-THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+DFGL++ A+ +M PE + T +SDV+++GVVL E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 569 VDASQPLGDESLVEWVNLI 587
P + E + +
Sbjct: 242 -----PYYGMAHEEVIYYV 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-59
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 374 LLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGERE-FKAEVEIISRI-HHRHL 425
+LG G FG V +VA+K LK ERE +E+++++++ H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHG---------------------EGRPVLDW 464
V+L+G C LI++Y L +L E VL +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANT 523
+ A A+G+ +L +HRD+ + N+L+ + ++ DFGLA+ + D+N
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
+ +MAPE G T KSDV+S+G++L E+ + P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGIPVDAN 275
Query: 584 VNLI 587
+
Sbjct: 276 FYKL 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-59
Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 17/228 (7%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQGER-EFKAEVEIISRIHH 422
Q ++G G FG VYKG L VAIK LK G + +R +F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+++ L G ++I +Y+ N E V + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL+++ D T+ T+ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
S K T SDV+SFG+V+ E++T + P + S E + I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER-----PYWELSNHEVMKAIN 227
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ D ++ +Y+ +L + + + L +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RDIKS NILL + +++DFG + +T V GT +MAPE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 552 VFSFGVVLLELITGRKPVDASQPL 575
++S G++ +E+I G P PL
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPL 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-58
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 19/225 (8%)
Query: 375 LGEGGFGSVYKGYLP----DGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V +G VA+K LK + + +F EV + + HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L G ++ + ++ + P +L L T + A A G+ YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES---K 130
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--ITTRVMGTFGYMAPEYASSGK 545
R IHRD+ + N+LL ++ DFGL + + H + F + APE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAK 590
+ SD + FGV L E+ T + P + + ++ ID +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKE 230
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 18/235 (7%)
Query: 361 ELVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGG-GQGEREFKAEV 414
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+++ + + H+ L+G C++ +L I +P L ++ + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQI 120
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
A+G+ YL R++HRD+ + N+L+ +++DFGLAK L + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
+MA E T +SDV+S+GV + EL+T P E ++++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILE 227
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-57
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 372 QNLLGEGGFGSVYKGYLPDG---REVAIKQLK-IGGGQGEREFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + + AIK++K R+F E+E++ ++ HH +++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG--------------EGRPVLDWATRVKIAA 472
+L+G C L +Y P+ L L L + AA
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ T
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLP 189
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID 588
+MA E + T SDV+S+GV+L E+++ P + E +
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLP 240
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-54
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 10/216 (4%)
Query: 364 KATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISR 419
K + F +LGEG F +V L RE AIK L+ I E +++SR
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+ H V L D++ Y N L ++ G D A L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALE 122
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAP 538
YLH IIHRD+K NILL+ + Q++DFG AK+ + ++ +GT Y++P
Sbjct: 123 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
E + + SD+++ G ++ +L+ G P A
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (468), Expect = 1e-53
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 9/205 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ GR K + + K E+ I++++HH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+LI +++ L+ + E + A + A GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 493 DIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
DIK NI+ + + V DFGLA I T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 551 DVFSFGVVLLELITGRKPVDASQPL 575
D+++ GV+ L++G P L
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDL 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 180 bits (458), Expect = 5e-53
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 24/226 (10%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG---------QGEREFKAEVEI 416
+ + + +LG G V + P +E A+K + + GG + EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 417 ISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
+ ++ H +++ L ++ L++D + L+ +L + L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ LH+ I+HRD+K NILLD++ +++DFG + V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175
Query: 536 MAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+APE ++ D++S GV++ L+ G P + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 180 bits (458), Expect = 5e-53
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE---REFKAEVEIISRIH 421
+D + +LG GG V+ L R+VA+K L+ + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 422 HRHLVSLVGYCISDDRRL----LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
H +V++ ++ ++ +YV TL +H EG + +++ A A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI--TTRVMGTFGY 535
L + H+ IIHRD+K +NI++ +V DFG+A+ D+ + T V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
++PE A + +SDV+S G VL E++TG P P+
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-53
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 32/239 (13%)
Query: 373 NLLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LG G FG V + R VA+K LK G E R +E++I+ I HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 425 LVSLVGYCISDDRRLLI-YDYVPNNTLYFHLHGEG--------------RPVLDWATRVK 469
+V+L+G C L++ ++ L +L + + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTR 528
+ A+G+ +L + IHRD+ + NILL ++ DFGLA+ ++
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
+MAPE T +SDV+SFGV+L E+ + P + E
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRR 249
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 180 bits (456), Expect = 1e-52
Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 18/223 (8%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+GEG FG +++G L + ++VAIK + + E + + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ ++ + +L L GR T A + +HE +++R
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 493 DIKSSNILLDNNFEAQ-----VSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYA 541
DIK N L+ V DFG+ K D T + GT YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWV 584
+ + + D+ + G V + + G P + ++ E +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 1e-52
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHR 423
D + +++LG G F V + VAIK + +G+ + E+ ++ +I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V+L S LI V L+ + +G ++ + YLH+
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD 125
Query: 484 DCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
I+HRD+K N+L D + + +SDFGL+K+ D + ++T GT GY+APE
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC-GTPGYVAPEV 180
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ ++ D +S GV+ L+ G P
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (461), Expect = 2e-52
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIH- 421
+ F+ ++G GGFG VY D G+ A+K L I QGE E ++S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 422 --HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+V + + D+ I D + L++HL G A AA GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLE 121
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H +++RD+K +NILLD + ++SD GLA D + +GT GYMAPE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPE 175
Query: 540 YASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
G +D FS G +L +L+ G P + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 2e-52
Identities = 51/243 (20%), Positives = 90/243 (37%), Gaps = 18/243 (7%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG +Y G + G EVAIK + + E +I + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ ++ + +L + R T + +A + Y+H IHR
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNFIHR 127
Query: 493 DIKSSNIL---LDNNFEAQVSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYASS 543
D+K N L + DFGLAK DA TH + GT Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLVFLCQQNS 603
+ + + D+ S G VL+ G P + ++ + + K+ + LC+
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 604 NSI 606
+
Sbjct: 246 SEF 248
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (458), Expect = 4e-52
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 9/204 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ G A K + + + E++ +S + H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
D+ ++IY+++ L+ + E + V+ +GL ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 493 DIKSSNILL--DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
D+K NI+ + E ++ DFGL + T GT + APE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 551 DVFSFGVVLLELITGRKPVDASQP 574
D++S GV+ L++G P
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGEND 230
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-51
Identities = 63/248 (25%), Positives = 101/248 (40%), Gaps = 33/248 (13%)
Query: 373 NLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HH 422
LGEG FG V +VA+K LK + + + +E+E++ I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP--------------VLDWATRV 468
+++++L+G C D +I +Y L +L P L V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 529 VM-GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI 587
+MAPE T +SDV+SFGV+L E+ T P + E L+
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEELFKLL 250
Query: 588 DAKILFKL 595
Sbjct: 251 KEGHRMDK 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 42/204 (20%), Positives = 83/204 (40%), Gaps = 10/204 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ + K +K+ G + K E+ I++ HR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF 70
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
S + ++I++++ ++ ++ L+ V L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 493 DIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
DI+ NI+ + + +FG A+ + Y APE ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTAT 184
Query: 551 DVFSFGVVLLELITGRKPVDASQP 574
D++S G ++ L++G P A
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETN 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (444), Expect = 5e-51
Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 7/204 (3%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVG 430
+GEG +G VYK G A+K++++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ R +L+++++ + EG L+ T G+AY H+ R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRD+K N+L++ E +++DFGLA+ T ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 551 DVFSFGVVLLELITGRKPVDASQP 574
D++S G + E++ G
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSE 206
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 26/235 (11%)
Query: 351 GHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQG-- 406
G R+ YE + +GEG +G V+K GR VA+K++++ G+
Sbjct: 1 GLCRADQQYECV----------AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM 50
Query: 407 EREFKAEVEIISRI---HHRHLVSLVGYCISDDRRLLIYDYVPNNTL----YFHLHGEGR 459
EV ++ + H ++V L C + + +L
Sbjct: 51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 110
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
P + T + RGL +LH ++HRD+K NIL+ ++ + +++DFGLA++
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 167
Query: 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
T V+ T Y APE D++S G + E+ + S
Sbjct: 168 FQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-49
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 11/213 (5%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE---FKAEVEIISR-IH 421
+ F +LG+G FG V+ + + AIK LK + + E ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H L + + + + +Y+ L +H+ + D + AA GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H I++RD+K NILLD + +++DFG+ K + + T GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
K D +SFGV+L E++ G+ P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-49
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 24/243 (9%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHL 425
LG+G FG VY+G VAIK + ER EF E ++ + H+
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR--------PVLDWATRVKIAAGAARG 477
V L+G L+I + + L +L + +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN-THITTRVMGTFGYM 536
+AYL + +HRD+ + N ++ +F ++ DFG+ + + + + + +M
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLIDAKILFKLV 596
+PE G T SDV+SFGVVL E+ T + P S + + + L
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVMEGGLLDKP 257
Query: 597 FLC 599
C
Sbjct: 258 DNC 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 8e-48
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG G FG V+ +GR A+K LK + + E ++S + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G + +I DY+ L+ L R A AA L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYLHSKD 124
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K NILLD N +++DFG AK D + GT Y+APE S+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNK 180
Query: 549 KSDVFSFGVVLLELITGRKPVDASQP 574
D +SFG+++ E++ G P S
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNT 206
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 19/211 (9%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LG G G V + + + A+K L+ + + EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 432 C----ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L++ + + L+ + G +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 488 RIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
I HRD+K N+L + +++DFG AK N+ T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K + D++S GV++ L+ G P ++ L
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-47
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 13/217 (5%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHR 423
+ + + +GEG +G V Y + VAIK++ Q + E++I+ R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 424 HLVSLVGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+++ + + + Y+ + L L RGL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMAP 538
+H ++HRD+K SN+LL+ + ++ DFGLA++A + H T + T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 539 EYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQP 574
E + K T+ D++S G +L E+++ R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 21/231 (9%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGER----- 408
++F E + D + LG G F V K G + A K +K + R
Sbjct: 1 TVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
+ + EV I+ I H ++++L + +LI + V L+ L + + AT
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKLALDANT 523
+ L ++ +I H D+K NI+L + ++ DFGLA N
Sbjct: 118 F-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ GT ++APE + L ++D++S GV+ L++G P
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 41/212 (19%), Positives = 90/212 (42%), Gaps = 7/212 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V L+ ++++ L+++++ + L + + +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++HRD+K N+L++ +++DFGLA+ T V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G + E++T R +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-45
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 18/213 (8%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE------FKAEVEIISRIHHRH-- 424
LLG GGFGSVY G + D VAIK ++ E EV ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
++ L+ + D +LI + F E L + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 485 CHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++HRDIK NIL+D N E ++ DFG L + T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 544 GKL-TEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ + V+S G++L +++ G P + + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 428 LVGYCISDDRR------LLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAY 480
L + S + L+ DYVP H + L R LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 481 LHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+H I HRDIK N+LLD + ++ DFG AK L + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPEL 193
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ T DV+S G VL EL+ G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-43
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLV 426
+ LGEG F +VYK + VAIK++K+G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
L+ L++D++ + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI--KAYMLMTLQGLEYLHQHW- 120
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRD+K +N+LLD N +++DFGLAK + + T + T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 547 -TEKSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G +L EL+ + L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 38/199 (19%), Positives = 83/199 (41%), Gaps = 8/199 (4%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLV 429
+GEG +G+V+K VA+K++++ E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
SD + L++++ + + G + + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRD+K N+L++ N E ++++FGLA+ + V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 550 SDVFSFGVVLLELITGRKP 568
D++S G + EL +P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 10/206 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHH 422
+ F LLG+G FG V GR A+K L+ I E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
L +L + DR + +Y L+FHL E + A A ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
+++RDIK N++LD + +++DFGL K + GT Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 50/235 (21%), Positives = 97/235 (41%), Gaps = 23/235 (9%)
Query: 354 RSMFTYEELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQG 406
RS F +E+ K +G G +G+V G +VAIK+L
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRR------LLIYDYVPNNTLYFHLHGEGRP 460
+ E+ ++ + H +++ L+ D+ L+ ++ + H +
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520
L + +GL Y+H HRD+K N+ ++ + E ++ DFGLA+ A
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-- 171
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
++ +T V+ + + + T+ D++S G ++ E+ITG+ S L
Sbjct: 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 46/215 (21%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLV 429
+G+G FG V+K G++VA+K++ + + E++I+ + H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 430 GYCISDDRR--------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
C + L++D+ ++ + + L RV L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAP 538
+ +I+HRD+K++N+L+ + +++DFGLA+ LA ++ + T + T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 539 EYASSGKL-TEKSDVFSFGVVLLELITGRKPVDAS 572
E + D++ G ++ E+ T + +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-40
Identities = 59/213 (27%), Positives = 86/213 (40%), Gaps = 13/213 (6%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHH 422
D F LG G FG V G A+K L K+ + E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
LV L + ++ +YV ++ HL GR AA YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
+I+RD+K N+L+D QV+DFG AK T + GT +APE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIIL 211
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
S + D ++ GV++ E+ G P A QP+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLK----IGGGQGEREFKAEVEIIS 418
+ F +LG G +G V+ G+ A+K LK + + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 419 RI-HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
I LV+L ++ + LI DY+ L+ HL R
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEI 138
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+ L II+RDIK NILLD+N ++DFGL+K + T GT YMA
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 538 PEYASSGK--LTEKSDVFSFGVVLLELITGRKP 568
P+ G + D +S GV++ EL+TG P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 19/210 (9%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G G V Y R VAIK+L + E+ ++ ++H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 431 YCISDDRR------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L+ + + N D + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
IHRD+K SNI++ ++ ++ DFGLA+ + + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQP 574
E D++S G ++ E++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-35
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 22/226 (9%)
Query: 352 HSRSMFTYEELVKAT---DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
R + YE V D + LG G + V++ + + +V +K LK +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKK 73
Query: 408 REFKAEVEIISRI-HHRHLVSLVGYCISDDRRL--LIYDYVPNNTLYFHLHGEGRPVLDW 464
++ K E++I+ + ++++L R L++++V N L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTD 128
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANT 523
+ L Y H I+HRD+K N+++D+ + + ++ D+GLA+
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 524 HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKP 568
+ + + + PE ++ D++S G +L +I ++P
Sbjct: 186 Y--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (320), Expect = 5e-33
Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 25/247 (10%)
Query: 363 VKATDGFAD-----QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEI 416
+ + D LG G F +V+ + + VA+K ++ E + E+++
Sbjct: 4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKL 62
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGE-------------GRPVL 462
+ R++ + +LL + ++ N ++ + E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDA 521
+I+ GL Y+H IIH DIK N+L++ + + +A L
Sbjct: 123 PLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 522 NTHITTR-VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580
+ T Y +PE +D++S ++ ELITG + +
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 581 VEWVNLI 587
+ + I
Sbjct: 241 DDHIAQI 247
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 122 bits (307), Expect = 7e-33
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 19/154 (12%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----------GQGEREFKAEVEIISRIHH 422
L+GEG +V+ Y E +K K+G G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
R L L G + Y + N L + + + ++ +A +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
I+H D+ N+L+ + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-31
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 19/223 (8%)
Query: 357 FTYEELVKA----TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQGERE 409
F +EL K + + + + +G G +GSV + G VA+K+L +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV----PNNTLYFHLHGEGRPVLDWA 465
E+ ++ + H +++ L+ D ++ + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDD 121
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ RGL Y+H HRD+K SN+ ++ + E ++ DFGLA+ + +
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM 175
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T V + + + D++S G ++ EL+TGR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.01 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 92.78 | |
| d1e7ua4 | 369 | Phoshoinositide 3-kinase (PI3K), catalytic domain | 85.89 | |
| d1bo1a_ | 383 | Phosphatidylinositol phosphate kinase IIbeta, PIPK | 83.7 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=398.61 Aligned_cols=230 Identities=23% Similarity=0.398 Sum_probs=196.8
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|+|||++++++.+++..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 479999999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
.+|+|..++... .+++.+++.|++||+.||+|||++ +|||||||++||||++++++||+|||+++....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999887654 389999999999999999999999 999999999999999999999999999987654332 3
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~~~~i~ 596 (607)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.... ..+....+. .....+.+++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 44567999999999999999999999999999999999999999764211 111111111 0136788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+|++.++.
T Consensus 251 ~~~L~~dP~ 259 (293)
T d1yhwa1 251 NRCLDMDVE 259 (293)
T ss_dssp HHHTCSSTT
T ss_pred HHHccCChh
Confidence 999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=397.10 Aligned_cols=234 Identities=25% Similarity=0.382 Sum_probs=192.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|++. +|+.||||+++.... +..+.+++|+++|++|+|+|||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999974 789999999975443 234568999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||++|+|+++++..+ .+++.+++.++.||++||+|||++ +|+|||||++||||++++++||+|||+++.....+.
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997654 489999999999999999999999 999999999999999999999999999987654432
Q ss_pred -ceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhHHHHH
Q 007351 524 -HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDAKILF 593 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~~~~~ 593 (607)
......+||..|||||++.+..+ +.++|||||||+||||++|+.||...... ...+..+... .....+.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-SHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCccccCCHHHH
Confidence 23445689999999999998876 46799999999999999999999764322 1122222111 1135667
Q ss_pred HHHHHhhhcCCC
Q 007351 594 KLVFLCQQNSNS 605 (607)
Q Consensus 594 ~i~~~C~~~~~~ 605 (607)
+++.+|++.++.
T Consensus 238 ~li~~~L~~dP~ 249 (271)
T d1nvra_ 238 ALLHKILVENPS 249 (271)
T ss_dssp HHHHHHSCSSTT
T ss_pred HHHHHHcCCChh
Confidence 899999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=393.76 Aligned_cols=232 Identities=27% Similarity=0.455 Sum_probs=184.8
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|+++|++++|+|||+++|+|..++..+||||||.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 568899999999999999999988899999999753 3446789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|.++++... ..+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999887653 3588999999999999999999999 999999999999999999999999999987765544444
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVFL 598 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~~ 598 (607)
....|+..|||||++.+..|+.++|||||||+||||+++..+|.... ...++.+..... ....+.+++.+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 45678999999999999999999999999999999999655443321 223333332211 13678899999
Q ss_pred hhhcCCC
Q 007351 599 CQQNSNS 605 (607)
Q Consensus 599 C~~~~~~ 605 (607)
||+.++.
T Consensus 238 cl~~~p~ 244 (263)
T d1sm2a_ 238 CWKERPE 244 (263)
T ss_dssp HTCSSGG
T ss_pred HccCCHh
Confidence 9988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=395.04 Aligned_cols=232 Identities=28% Similarity=0.468 Sum_probs=194.9
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....++|.+|+++|++++|+|||+++|++. ++..+||||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 3578899999999999999999988899999999754 344567999999999999999999999875 45679999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|.+++.......+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999888765555589999999999999999999998 99999999999999999999999999999876555444
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
.....|+..|||||++.++.++.++|||||||+||||+||..+|.... ...++.+.+... ....+.+++.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 555678999999999999999999999999999999999766654432 222333322211 1356889999
Q ss_pred HhhhcCC
Q 007351 598 LCQQNSN 604 (607)
Q Consensus 598 ~C~~~~~ 604 (607)
+||+.++
T Consensus 245 ~cl~~~P 251 (272)
T d1qpca_ 245 LCWKERP 251 (272)
T ss_dssp HHTCSSG
T ss_pred HHcCCCH
Confidence 9998765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-49 Score=401.20 Aligned_cols=234 Identities=26% Similarity=0.379 Sum_probs=199.6
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++++.||+|+||.||+|+++ +|+.||||+++.+. ...++|++|+++|++|+|+|||+++|+|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457889999999999999999975 58899999987543 3456799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
|++|+|..++.......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999877667799999999999999999999999 9999999999999999999999999999977655544
Q ss_pred eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
......|+..|||||++.++.|+.++|||||||+||||++|..+|.... ....+.+.+... ....+.+++
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 4455568899999999999999999999999999999999888775432 222333332211 136788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+||+.++.
T Consensus 250 ~~cl~~dP~ 258 (287)
T d1opja_ 250 RACWQWNPS 258 (287)
T ss_dssp HHHTCSSGG
T ss_pred HHHcCCCHh
Confidence 999988753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=390.33 Aligned_cols=227 Identities=29% Similarity=0.448 Sum_probs=193.3
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++++.||+|+||.||+|+.+ +|+.||||++... .....+.+++|+++|+.++|+|||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999975 6889999998632 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||++|+|.+++...+. +.+..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999986554 89999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~i 595 (607)
.....||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+.++
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~l 234 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFPDFVTEGARDL 234 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 334579999999999999999999999999999999999999997642 1222221111 113677889
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 235 i~~~L~~dp 243 (263)
T d2j4za1 235 ISRLLKHNP 243 (263)
T ss_dssp HHHHTCSSG
T ss_pred HHHHccCCH
Confidence 999998775
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=394.05 Aligned_cols=231 Identities=30% Similarity=0.523 Sum_probs=184.6
Q ss_pred hCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++++.||+|+||.||+|+++ ..||||+++... .+..+.|++|+++|++++|+|||+++|++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357899999999999999999874 369999997543 3445689999999999999999999999754 56899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||++|+|+++++..+. .+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999976443 489999999999999999999998 999999999999999999999999999986644322
Q ss_pred -ceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh------------
Q 007351 524 -HITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI------------ 587 (607)
Q Consensus 524 -~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~------------ 587 (607)
.......||..|||||++.+ ..|+.++|||||||+||||++|+.||.+.... ..+.......
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCGGGSCTT
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcchhcccc
Confidence 23345679999999999874 35889999999999999999999999864321 1111111110
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 238 ~~~~l~~li~~cl~~dp~ 255 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRD 255 (276)
T ss_dssp CCHHHHHHHHHHTCSSGG
T ss_pred chHHHHHHHHHHcCCCHh
Confidence 125788999999987753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=386.16 Aligned_cols=231 Identities=25% Similarity=0.444 Sum_probs=198.3
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++.+.||+|+||.||+|++++++.||||+++... ..+++|++|+++|++++|+||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999998543 345789999999999999999999999999999999999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|..++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999888765433 488999999999999999999998 999999999999999999999999999987665554445
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLVF 597 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~ 597 (607)
....|+.+|||||++.+..++.++|||||||++|||++ |+.||.+.. ..++.+.+... ....+.+++.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 55678999999999999999999999999999999998 899997642 23333222211 1267899999
Q ss_pred HhhhcCCC
Q 007351 598 LCQQNSNS 605 (607)
Q Consensus 598 ~C~~~~~~ 605 (607)
+||+.++.
T Consensus 236 ~cl~~dP~ 243 (258)
T d1k2pa_ 236 SCWHEKAD 243 (258)
T ss_dssp HTTCSSGG
T ss_pred HHccCCHh
Confidence 99988753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=393.66 Aligned_cols=230 Identities=27% Similarity=0.362 Sum_probs=191.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|+++++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++|+|+||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999974 78999999996432 233467899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||++|+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999998877654 89999999999999999999999 99999999999999999999999999998765332
Q ss_pred -cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhH------hhHHHHHH
Q 007351 523 -THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNL------IDAKILFK 594 (607)
Q Consensus 523 -~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~------~~~~~~~~ 594 (607)
.......+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+. .+. .....+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIKLEYDFPEKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHcCCCCCCccCCHHHHH
Confidence 223345679999999999999999999999999999999999999998642 1122111 110 11366788
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 240 li~~~L~~dP 249 (288)
T d1uu3a_ 240 LVEKLLVLDA 249 (288)
T ss_dssp HHHTTSCSSG
T ss_pred HHHHHccCCH
Confidence 9999998775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=393.98 Aligned_cols=232 Identities=22% Similarity=0.351 Sum_probs=194.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
+.|++++.||+|+||.||+|++. +|+.||||+++.......+.|++|+++|++|+|+|||++++++.+++..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 68899999998776666778999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|..++....+ .+++..++.|+.||++||+|||++ +|||||||++||||+.++++||+|||+++...... ..
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 99999988765432 489999999999999999999999 99999999999999999999999999997654322 12
Q ss_pred eeccccCCCCCchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH---------hhHHH
Q 007351 526 TTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL---------IDAKI 591 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~-----~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~---------~~~~~ 591 (607)
.....||..|||||++. +..|+.++|||||||+||||++|+.||.+.... +.+.+..+. .....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCCCCCccccCCHH
Confidence 33467999999999984 456889999999999999999999999865321 122222211 11367
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 245 ~~~li~~~L~~dp~ 258 (288)
T d2jfla1 245 FKDFLKKCLEKNVD 258 (288)
T ss_dssp HHHHHHHHSCSSTT
T ss_pred HHHHHHHHccCChh
Confidence 78999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=402.02 Aligned_cols=199 Identities=28% Similarity=0.442 Sum_probs=178.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+++|+++|+.++|+|||+++++|.+++..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999964 789999999976533 334679999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||++|+|++++++.+. +.+..+++++.||++||+|||+ + +|+|||||++||||+++|++||+|||+|+...+..
T Consensus 85 y~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999987654 8999999999999999999996 5 89999999999999999999999999998764332
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 33468999999999999999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=389.00 Aligned_cols=235 Identities=22% Similarity=0.342 Sum_probs=181.2
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEe--CCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 441 (607)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.... ...+.+.+|+++|++++|+|||++++++.+ ++..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999864 789999999975432 334568999999999999999999999865 4567999
Q ss_pred EEecCCCchhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 442 YDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDC--HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
||||++|+|.+++... .+..+++..+++++.||++||+|||++. ..+|||||||++||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988642 2345899999999999999999999861 11499999999999999999999999999987
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------hhH
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL--------IDA 589 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~--------~~~ 589 (607)
..... ......+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... ...
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~s 239 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIPYRYS 239 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCCTTSC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCcccC
Confidence 65432 23345679999999999999999999999999999999999999997642 2222222111 113
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+||+.++.
T Consensus 240 ~~l~~li~~~L~~dp~ 255 (269)
T d2java1 240 DELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHcCCChh
Confidence 6788999999987753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-47 Score=392.40 Aligned_cols=232 Identities=28% Similarity=0.463 Sum_probs=182.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc---EEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR---EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~---~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++.++||+|+||.||+|+++ +|+ .||||++..... ...++|.+|+++|++|+|+|||+++|+|..++..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45778899999999999999975 232 588998865443 3446799999999999999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||++|+|.+++..... .+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876433 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred Ccce----eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------h
Q 007351 522 NTHI----TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------D 588 (607)
Q Consensus 522 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~ 588 (607)
.... .....|+..|||||++.++.++.++|||||||+||||++ |+.||.+.. ..++.+.+... .
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCCCTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCccc
Confidence 2211 122457889999999999999999999999999999998 899997642 33343333221 1
Q ss_pred HHHHHHHHHHhhhcCCC
Q 007351 589 AKILFKLVFLCQQNSNS 605 (607)
Q Consensus 589 ~~~~~~i~~~C~~~~~~ 605 (607)
...+.+++.+||+.++.
T Consensus 259 ~~~l~~li~~cl~~~P~ 275 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRN 275 (299)
T ss_dssp CHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHcCCCHh
Confidence 36788999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=384.95 Aligned_cols=231 Identities=27% Similarity=0.440 Sum_probs=190.3
Q ss_pred CCCcccce-ecccCcEEEEEEEeC---CCcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNL-LGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~-IG~G~fG~Vyk~~~~---~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|.+.++ ||+|+||.||+|.++ ++..||||+++..... ..++|++|+++|++|+|+|||+++|+|.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45777775 999999999999864 3457999999755433 45679999999999999999999999864 568999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||++|+|.+++...+ ..+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999876543 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred Ccc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 522 NTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 522 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
... ......|+..|||||++.++.++.++|||||||+||||++ |+.||.+.. ..++.+.+... ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCCH
Confidence 332 2234568899999999999999999999999999999998 999998643 23333332211 126
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 240 ~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 240 ELYALMSDCWIYKWE 254 (285)
T ss_dssp HHHHHHHHTTCSSGG
T ss_pred HHHHHHHHHcCCCHh
Confidence 788999999987753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=388.17 Aligned_cols=232 Identities=30% Similarity=0.457 Sum_probs=188.7
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecC
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 446 (607)
++|++++.||+|+||.||+|++++++.||||+++.. ....+.|++|+.+|++++|+|||+++|+|. ++..+||||||.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 569999999999999999999988889999999744 344578999999999999999999999985 566899999999
Q ss_pred CCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCccee
Q 007351 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (607)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 526 (607)
+|+|..++.......++|.++++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999888765555699999999999999999999999 999999999999999999999999999987655544445
Q ss_pred eccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHhh--------HHHHHHHHHH
Q 007351 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLID--------AKILFKLVFL 598 (607)
Q Consensus 527 ~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~~--------~~~~~~i~~~ 598 (607)
....|+..|||||++.++.++.++|||||||+||||++|..+|.... ...++.++++... .+.+.+++.+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMPCPPECPESLHDLMCQ 249 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence 55678999999999999999999999999999999999777665432 2233344332111 3678899999
Q ss_pred hhhcCCC
Q 007351 599 CQQNSNS 605 (607)
Q Consensus 599 C~~~~~~ 605 (607)
||+.++.
T Consensus 250 cl~~dP~ 256 (285)
T d1fmka3 250 CWRKEPE 256 (285)
T ss_dssp HTCSSGG
T ss_pred HcccCHh
Confidence 9987753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-46 Score=393.64 Aligned_cols=229 Identities=22% Similarity=0.326 Sum_probs=194.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++++.||+|+||.||+|+.. +|+.||||+++.......+.+++|+++|++|+|+|||++++++.+++..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 78999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc--CCCcEEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGls~~~~~~~~ 523 (607)
++|+|.+++..... .+++..++.|++||++||+|||++ +|||||||++||||+ +++.+||+|||+++.......
T Consensus 106 ~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 106 SGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999998865432 489999999999999999999999 999999999999995 467899999999987654332
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~~~~ 592 (607)
.....||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 334579999999999999999999999999999999999999997642 2222221110 012567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 257 ~~li~~~L~~dP 268 (350)
T d1koaa2 257 KDFIRKLLLADP 268 (350)
T ss_dssp HHHHHHHCCSSG
T ss_pred HHHHHHHccCCh
Confidence 889999998765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=380.02 Aligned_cols=225 Identities=27% Similarity=0.402 Sum_probs=183.3
Q ss_pred CcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe----CCceEEE
Q 007351 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLI 441 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV 441 (607)
|+..+.||+|+||.||+|++. +++.||||+++... ....+.|++|+++|++|+|+|||++++++.. ++..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355678999999999999975 68899999987543 2334579999999999999999999999875 2356899
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--EEecCCCCCCEEEc-CCCcEEEEeccccccc
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLD-NNFEAQVSDFGLAKLA 518 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DFGls~~~ 518 (607)
||||++|+|.++++... .+++..++.|+.||++||+|||++ + |||||||++||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999997654 389999999999999999999998 6 99999999999996 5789999999999864
Q ss_pred ccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHh---------HhhH
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVN---------LIDA 589 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~---------~~~~ 589 (607)
... .....+||..|||||++.+ .++.++|||||||+||||++|+.||.+... ...+.+... ....
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGGGCCC
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCCCcccCccCC
Confidence 332 2334679999999999875 599999999999999999999999975421 112222111 1113
Q ss_pred HHHHHHHHHhhhcCC
Q 007351 590 KILFKLVFLCQQNSN 604 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~ 604 (607)
..+.+++.+|++.++
T Consensus 240 ~~~~~li~~~l~~dp 254 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNK 254 (270)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHccCCH
Confidence 567899999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=391.74 Aligned_cols=230 Identities=24% Similarity=0.341 Sum_probs=177.9
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.+.|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+++|+++|+.|+|+|||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 689999999975433 234568899999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGls~~~~~ 520 (607)
||++|+|.+++...+. +.+..+..++.||++||+|||++ +|||||||++|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999976544 99999999999999999999999 999999999999994 578999999999986543
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDA 589 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~ 589 (607)
.. .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... ...
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCCCccccCCC
Confidence 32 2334679999999999999999999999999999999999999997642 1222221111 012
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+|++.++.
T Consensus 238 ~~~~~li~~~L~~dP~ 253 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPE 253 (307)
T ss_dssp HHHHHHHHHHSCSSGG
T ss_pred HHHHHHHHHHccCCHh
Confidence 5678899999987753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=386.71 Aligned_cols=223 Identities=27% Similarity=0.425 Sum_probs=188.3
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
.|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|++|+|+|||++++++.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999864 7889999999755432 23568999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
||.+|+|..++...+ .+++..++.|++||++||+|||++ +|||||||++||||++++++||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999977766544 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred ceeeccccCCCCCchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----------hH
Q 007351 524 HITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-----------DA 589 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~---~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-----------~~ 589 (607)
....||..|||||++.+ +.|+.++|||||||+||||++|+.||.+.. ....+.+.. ..
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCCSCTTSC
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCCCCCCCCCC
Confidence 33579999999999864 458999999999999999999999997542 111121111 13
Q ss_pred HHHHHHHHHhhhcCCC
Q 007351 590 KILFKLVFLCQQNSNS 605 (607)
Q Consensus 590 ~~~~~i~~~C~~~~~~ 605 (607)
..+.+++.+||+.++.
T Consensus 241 ~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp HHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHCcCChh
Confidence 6788999999987753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=390.30 Aligned_cols=230 Identities=26% Similarity=0.375 Sum_probs=195.4
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|+++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|+||+++++++.+++..+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999996 47999999999743 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+|+|+.++...+. +.+..++.++.||+.||+|||++ +|||||||++||||+++|.+||+|||+++......
T Consensus 85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999987654 88999999999999999999999 99999999999999999999999999998654433
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~i 595 (607)
. .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+..... ......++
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 2 3445689999999999999999999999999999999999999998642 22222221110 13556889
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.+++
T Consensus 236 i~~~L~~dP~ 245 (337)
T d1o6la_ 236 LAGLLKKDPK 245 (337)
T ss_dssp HHHHTCSSTT
T ss_pred HHhhccCCch
Confidence 9999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=381.27 Aligned_cols=233 Identities=29% Similarity=0.442 Sum_probs=185.4
Q ss_pred CCCcccceecccCcEEEEEEEeCCC-----cEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g-----~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
+.|++.++||+|+||.||+|.++++ ..||||+++..... ...+|++|+++|++|+|+|||+++|+|.+++..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4588899999999999999987532 36999999755443 34579999999999999999999999999999999
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||.+++|.+++.... ..+.+.++++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999988776543 3589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCc--ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
... .......|+..|||||++.++.++.++|||||||+||||++|..+|.... ...++.+.+... ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCCCCchhhHH
Confidence 322 22333568999999999999999999999999999999999777765432 233333333211 126
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 241 ~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 241 AIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHCcCCHh
Confidence 789999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-46 Score=391.80 Aligned_cols=229 Identities=23% Similarity=0.305 Sum_probs=195.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 445 (607)
++|++++.||+|+||.||+|+.. +|+.||||+++.......+.+++|+++|++|+|+|||++++++.+++..|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999964 79999999998766666678899999999999999999999999999999999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc--CCCcEEEEecccccccccCCc
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DFGls~~~~~~~~ 523 (607)
++|+|++++...+ ..+++.+++.|+.||++||+|||++ +|||||||++||||+ +++.+||+|||+++.......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988776543 2489999999999999999999999 999999999999997 678999999999987654332
Q ss_pred ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-----------hhHHHH
Q 007351 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-----------IDAKIL 592 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-----------~~~~~~ 592 (607)
.....|+..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+.... .....+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 334568999999999999999999999999999999999999997642 2222221111 013567
Q ss_pred HHHHHHhhhcCC
Q 007351 593 FKLVFLCQQNSN 604 (607)
Q Consensus 593 ~~i~~~C~~~~~ 604 (607)
.+++.+|++.++
T Consensus 260 ~~li~~~L~~dp 271 (352)
T d1koba_ 260 KDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHTTSCSSG
T ss_pred HHHHHHHccCCh
Confidence 889999998765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=379.86 Aligned_cols=230 Identities=23% Similarity=0.317 Sum_probs=192.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc------hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++++.||+|+||.||+|+.+ +|+.||||+++.... ...+.|++|+++|++|+|+|||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999974 789999999964321 2356799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC----cEEEEeccc
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DFGl 514 (607)
+||||||++|+|.+++...+. +++..++.++.||++||+|||++ +|||||||++||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999977553 99999999999999999999999 999999999999998776 599999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH--------
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------- 586 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------- 586 (607)
++....... .....|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..+..+....
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNYEFEDE 238 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCCCCCHH
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCch
Confidence 987644332 334578999999999999999999999999999999999999998642 1122111110
Q ss_pred ---hhHHHHHHHHHHhhhcCCC
Q 007351 587 ---IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ---~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.++.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~ 260 (293)
T d1jksa_ 239 YFSNTSALAKDFIRRLLVKDPK 260 (293)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGG
T ss_pred hcCCCCHHHHHHHHHHccCChh
Confidence 0124567899999987753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=379.53 Aligned_cols=224 Identities=27% Similarity=0.435 Sum_probs=183.7
Q ss_pred ceecccCcEEEEEEEeCC---CcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEecCC
Q 007351 373 NLLGEGGFGSVYKGYLPD---GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (607)
Q Consensus 373 ~~IG~G~fG~Vyk~~~~~---g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 447 (607)
+.||+|+||.||+|.+++ ++.||||+++... ....++|++|+++|++|+|+|||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4679999996443 2334679999999999999999999999864 567899999999
Q ss_pred CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce--
Q 007351 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-- 525 (607)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~-- 525 (607)
|+|.++++.... +++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987554 89999999999999999999998 99999999999999999999999999998765443322
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
.....|+.+|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....+.+++
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~~~~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGERMGCPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 234568999999999999999999999999999999998 899998642 23333332221 136788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+||+.++.
T Consensus 244 ~~cl~~dp~ 252 (277)
T d1xbba_ 244 NLCWTYDVE 252 (277)
T ss_dssp HHHTCSSTT
T ss_pred HHHcCCCHh
Confidence 999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=388.32 Aligned_cols=235 Identities=24% Similarity=0.418 Sum_probs=192.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCC-C-----cEEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD-G-----REVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~-g-----~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
.++|+++++||+|+||.||+|++.+ + ..||||++.... ......+.+|+++|.++ +|+|||+++++|.+++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999998642 2 369999986443 33446799999999998 89999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCC
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGR---------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (607)
.+||||||++|+|.++|+.... ..+++..+++|+.||++||+|||++ +|||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 2478999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 007351 497 SNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP 574 (607)
Q Consensus 497 ~NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~ 574 (607)
+||||+.++.+||+|||+++........ ......||..|||||++.++.|+.++|||||||+||||++ |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 3345668999999999999999999999999999999997 8999976432
Q ss_pred CCchhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 575 LGDESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 575 ~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
+..+.+.++.. ....+.+++.+||+.++.
T Consensus 273 --~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~ 309 (325)
T d1rjba_ 273 --DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309 (325)
T ss_dssp --SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred --HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 22333333221 136789999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-46 Score=384.85 Aligned_cols=227 Identities=29% Similarity=0.378 Sum_probs=192.0
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++++.||+|+||.||+|+.+ +|+.||||+++.. .....+.+++|+++|+.++|+|||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999974 6899999999643 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
|||.+|+|..++..... +.+..++.++.||+.||+|||++ +|||||||++||||+++|.+||+|||+++...+.
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999998887654 78888899999999999999999 9999999999999999999999999999876433
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhH------hhHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNL------IDAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~------~~~~~~~~i 595 (607)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+. .+. .....+.++
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAELRFPPFFNEDVKDL 231 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 234679999999999999999999999999999999999999997642 1121111 110 013567888
Q ss_pred HHHhhhcCCC
Q 007351 596 VFLCQQNSNS 605 (607)
Q Consensus 596 ~~~C~~~~~~ 605 (607)
+.+|++.++.
T Consensus 232 i~~~L~~dp~ 241 (316)
T d1fota_ 232 LSRLITRDLS 241 (316)
T ss_dssp HHHHTCSCTT
T ss_pred HHHHhhhCHH
Confidence 9999877653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-45 Score=386.94 Aligned_cols=226 Identities=27% Similarity=0.293 Sum_probs=192.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 442 (607)
++|++++.||+|+||.||+|+++ +|+.||||+++... ....+.+++|+++|+.++|+|||++++++..++..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 56999999999999999999974 79999999986322 233456899999999999999999999999999999999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~ 522 (607)
||+.+|+|..++...+. +++..++.|+.||+.||+|||++ +|||||||++||||+.+|.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999877654 89999999999999999999999 9999999999999999999999999999876432
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-------hHHHHHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI-------DAKILFKL 595 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~-------~~~~~~~i 595 (607)
.....||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+..... ....+.++
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~l 268 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 234579999999999999999999999999999999999999997642 11221111110 13678899
Q ss_pred HHHhhhcCC
Q 007351 596 VFLCQQNSN 604 (607)
Q Consensus 596 ~~~C~~~~~ 604 (607)
+.+|++.++
T Consensus 269 i~~~L~~dP 277 (350)
T d1rdqe_ 269 LRNLLQVDL 277 (350)
T ss_dssp HHHHSCSCT
T ss_pred HHHHhhhCH
Confidence 999998775
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-45 Score=387.16 Aligned_cols=231 Identities=27% Similarity=0.356 Sum_probs=188.7
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHH---HHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAE---VEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~E---i~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+++| +++|+.++|+|||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999965 68999999986321 1223334444 56666678999999999999999999
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
||||||.+|+|..+|..... +.+..++.++.||+.||+|||++ +|||||||++||||+++|.+||+|||+++...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999977654 88999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHH
Q 007351 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKI 591 (607)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~ 591 (607)
... ....+||..|||||++.+ ..|+.++|||||||+||||++|+.||.+........+.+.... .....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence 432 334579999999999975 5689999999999999999999999986543222222222110 12366
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.++.
T Consensus 236 ~~~li~~~L~~dP~ 249 (364)
T d1omwa3 236 LRSLLEGLLQRDVN 249 (364)
T ss_dssp HHHHHHHHTCSSTT
T ss_pred HHHHHHHHcccCHH
Confidence 88999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=373.14 Aligned_cols=232 Identities=27% Similarity=0.396 Sum_probs=180.5
Q ss_pred hCCCcccceecccCcEEEEEEEeCC----CcEEEEEEeecCCch-hHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
.++|++++.||+|+||.||+|++.. +..||||+++..... ..+.|++|+++|++++|+|||+++|++. ++..+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998643 346889988654433 3456999999999999999999999985 567899
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
|||||.+|+|..++.... ..+++..+++++.||++||+|||++ +|||||||++|||+++++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999988876543 3589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHH
Q 007351 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKI 591 (607)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~ 591 (607)
..........|+..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..++.+.+... ....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHH
Confidence 54444556678999999999999999999999999999999998 899997653 33333332221 1367
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+||+.++.
T Consensus 238 ~~~li~~cl~~dp~ 251 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPS 251 (273)
T ss_dssp HHHHHHHHTCSSGG
T ss_pred HHHHHHHHcCCCHh
Confidence 89999999988753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=377.79 Aligned_cols=229 Identities=26% Similarity=0.413 Sum_probs=191.4
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC---chhHHHHHHHHHHHH-HccCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIIS-RIHHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|++++.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.++. .++|+|||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 78999999997432 223345667777665 68999999999999999999999
Q ss_pred EEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccC
Q 007351 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~ 521 (607)
||||++|+|.++++.... +++.+++.++.||+.||+|||++ +|+|||||++|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999987654 88999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhH-------hhHHHHHH
Q 007351 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNL-------IDAKILFK 594 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~~~~~ 594 (607)
. .......||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+.... .....+.+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~d 232 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYPRWLEKEAKD 232 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCccCCHHHHH
Confidence 3 23344679999999999999999999999999999999999999997642 2222221110 01367889
Q ss_pred HHHHhhhcCC
Q 007351 595 LVFLCQQNSN 604 (607)
Q Consensus 595 i~~~C~~~~~ 604 (607)
++.+|++.++
T Consensus 233 li~~~L~~dP 242 (320)
T d1xjda_ 233 LLVKLFVREP 242 (320)
T ss_dssp HHHHHSCSSG
T ss_pred HHHHhcccCC
Confidence 9999998765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-45 Score=368.91 Aligned_cols=231 Identities=27% Similarity=0.406 Sum_probs=184.3
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCc----
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR---- 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 437 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....|++|+++|+.++|+||+++++++..++.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999996 4799999999975433 233568999999999999999999999887543
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.|||||||++++|..++...+. +++.+++.|+.||++||+|||++ +|||||||++||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 6899999999999988876654 89999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCc--ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-HHHhH--------
Q 007351 518 ALDANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-EWVNL-------- 586 (607)
Q Consensus 518 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~~~~~-------- 586 (607)
...... ......+||..|||||++.+..++.++|||||||+||||++|+.||.+.. ..++. +..+.
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPIPPSAR 237 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCGGGT
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCCCCchh
Confidence 533222 23344679999999999999999999999999999999999999997642 11111 11110
Q ss_pred --hhHHHHHHHHHHhhhcCC
Q 007351 587 --IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 587 --~~~~~~~~i~~~C~~~~~ 604 (607)
.....+.+++.+|++.++
T Consensus 238 ~~~~s~~l~~li~~~L~~dp 257 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNP 257 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSG
T ss_pred ccCCCHHHHHHHHHHccCCH
Confidence 012668899999998775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=376.22 Aligned_cols=231 Identities=26% Similarity=0.439 Sum_probs=185.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc----EEEEEEeecCC-chhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 440 (607)
++|++.++||+|+||.||+|++. +|+ .||||+++... .+..++|++|+++|++++|+|||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999864 444 58999886433 3456789999999999999999999999976 45678
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccccccccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~ 520 (607)
++||+.+|+|.+++.... ..+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 889999999988777653 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHH
Q 007351 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAK 590 (607)
Q Consensus 521 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~ 590 (607)
.... ......||..|||||++.++.|+.++|||||||+||||+| |+.||.+.. ..++.+.+... ...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERLPQPPICTI 240 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHHHHHTCCCCCCTTBCH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCCCCCCCcccCH
Confidence 4333 2334568999999999999999999999999999999998 788887643 23333332221 136
Q ss_pred HHHHHHHHhhhcCCC
Q 007351 591 ILFKLVFLCQQNSNS 605 (607)
Q Consensus 591 ~~~~i~~~C~~~~~~ 605 (607)
.+.+++.+||+.++.
T Consensus 241 ~~~~li~~cl~~dP~ 255 (317)
T d1xkka_ 241 DVYMIMVKCWMIDAD 255 (317)
T ss_dssp HHHHHHHHHTCSSGG
T ss_pred HHHHHHHHhCCCChh
Confidence 788999999987753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=372.48 Aligned_cols=196 Identities=28% Similarity=0.394 Sum_probs=167.0
Q ss_pred ccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchh-----HHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 371 DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 371 ~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++++||+|+||+||+|++. +|+.||||+++...... .+.+++|+++|++++|+|||++++++..++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999964 68999999996543221 24688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
|.++++..++.... .+++..++.+++||++||+|||++ +|+|||||++|||+++++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99888776665443 488889999999999999999999 9999999999999999999999999999866544322
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
....+||..|||||++.+. .|+.++|||||||+||||++|+.||.+.
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 3345799999999998754 5799999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.1e-45 Score=368.84 Aligned_cols=230 Identities=23% Similarity=0.344 Sum_probs=191.5
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCch---------hHHHHHHHHHHHHHcc-CCCceeEEeEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---------GEREFKAEVEIISRIH-HRHLVSLVGYCIS 434 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~---------~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 434 (607)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+++|+++|++|+ |+||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999996 47899999999754321 1235889999999997 9999999999999
Q ss_pred CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEeccc
Q 007351 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (607)
Q Consensus 435 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGl 514 (607)
++..|||||||++|+|.++++.++. +++.++++++.||++||+|||++ +|||||||++||||++++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999987654 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcceeeccccCCCCCchhhhcC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-HHhH-
Q 007351 515 AKLALDANTHITTRVMGTFGYMAPEYASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WVNL- 586 (607)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~-~~~~- 586 (607)
++...... .....+||..|++||++.+ ..++.++|||||||+||||++|+.||.+.. .....+ ..+.
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~~~ 231 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSGN 231 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHHhCC
Confidence 98765433 2344679999999999863 346789999999999999999999998643 112111 1110
Q ss_pred ---------hhHHHHHHHHHHhhhcCCC
Q 007351 587 ---------IDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ---------~~~~~~~~i~~~C~~~~~~ 605 (607)
.....+.+++.+|++.+++
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~~p~ 259 (277)
T d1phka_ 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQ 259 (277)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChh
Confidence 1135678999999988753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=370.59 Aligned_cols=226 Identities=27% Similarity=0.447 Sum_probs=183.9
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEe-CCceEEEEEec
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYV 445 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~ 445 (607)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+.|++|+++|++++|+||++++|+|.+ ++..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4688889999999999999999 6789999998643 345679999999999999999999999865 45679999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcce
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~~ 525 (607)
++|+|.++|+......+++..+++|+.||++||+|||++ +|||||||++|||+++++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999765544589999999999999999999998 99999999999999999999999999998654322
Q ss_pred eeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh--------hHHHHHHHH
Q 007351 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------DAKILFKLV 596 (607)
Q Consensus 526 ~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~i~ 596 (607)
....++..|||||++.+..++.++|||||||+||||++ |+.||.+. ...++.+++... ....+.+++
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 23457889999999999999999999999999999998 68777654 234555554321 136788999
Q ss_pred HHhhhcCCC
Q 007351 597 FLCQQNSNS 605 (607)
Q Consensus 597 ~~C~~~~~~ 605 (607)
.+||+.++.
T Consensus 234 ~~cl~~dP~ 242 (262)
T d1byga_ 234 KNCWHLDAA 242 (262)
T ss_dssp HHHTCSSGG
T ss_pred HHHcccCHh
Confidence 999988753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=373.19 Aligned_cols=230 Identities=20% Similarity=0.300 Sum_probs=192.0
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
.++|++++.||+|+||.||+|+.. +|+.||||+++... .+...+++|+++|+.++|+|||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999975 68899999997643 3455688999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC--CCcEEEEecccccccccCC
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDAN 522 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DFGls~~~~~~~ 522 (607)
|.+|+|+++++..+ ..+++.+++.|+.||++||+|||++ +|+|||||++||||++ ++.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999997654 2489999999999999999999999 9999999999999974 4589999999998764433
Q ss_pred cceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-HhH----------hhHHH
Q 007351 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-VNL----------IDAKI 591 (607)
Q Consensus 523 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~-~~~----------~~~~~ 591 (607)
......++..|||||++.+..|+.++|||||||+||||++|+.||.+.. ..++.+. .+. .....
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCChhhccCCCHH
Confidence 2334568999999999999999999999999999999999999997642 1121111 110 01245
Q ss_pred HHHHHHHhhhcCCC
Q 007351 592 LFKLVFLCQQNSNS 605 (607)
Q Consensus 592 ~~~i~~~C~~~~~~ 605 (607)
+.+++.+|++.++.
T Consensus 234 ~~~li~~~L~~dp~ 247 (321)
T d1tkia_ 234 AMDFVDRLLVKERK 247 (321)
T ss_dssp HHHHHHTTSCSSGG
T ss_pred HHHHHHHHccCChh
Confidence 68899999987753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-45 Score=373.52 Aligned_cols=239 Identities=27% Similarity=0.441 Sum_probs=194.5
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCchh-HHHHHHHHHHHHHccCCCceeEEeEEE
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCI 433 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~ 433 (607)
+++..+++|++.+.||+|+||.||+|+++ +++.||||+++...... .++|++|+++|+.++|+||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999863 35789999997654443 457999999999999999999999999
Q ss_pred eCCceEEEEEecCCCchhHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 007351 434 SDDRRLLIYDYVPNNTLYFHLHGEG----------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (607)
Q Consensus 434 ~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (607)
.++..++||||+.+|+|.++++... ...+.+..+++|+.||++||+|||++ +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999886432 22478899999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCC-CC
Q 007351 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PV 569 (607)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~-Pf 569 (607)
||||++||||+.++.+||+|||+++.....+. .......|+..|||||++.+..|+.++|||||||+||||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999986544332 23345678899999999999999999999999999999999965 66
Q ss_pred CCCCCCCchhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 570 DASQPLGDESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 570 ~~~~~~~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
.+. .+.++.+.+... ....+.+++.+||+.++.
T Consensus 244 ~~~---~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~ 284 (301)
T d1lufa_ 244 YGM---AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 284 (301)
T ss_dssp TTS---CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCC---CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChh
Confidence 653 223333332211 135678999999988763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=370.97 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=182.9
Q ss_pred HHHHhhCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHc-cCCCceeEEeEE
Q 007351 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYC 432 (607)
Q Consensus 361 el~~~~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 432 (607)
+.+...++|++++.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++.++ +|+||+++++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334578999999999999999999853 346899999975443 3445688888888887 689999999998
Q ss_pred EeCC-ceEEEEEecCCCchhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCC
Q 007351 433 ISDD-RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497 (607)
Q Consensus 433 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~ 497 (607)
...+ ..++|||||++|+|.++++... ...+++..+++++.||++||+|||++ +|||||||++
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 7654 6799999999999999987542 23488999999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCC
Q 007351 498 NILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR-KPVDASQPL 575 (607)
Q Consensus 498 NILl~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~-~Pf~~~~~~ 575 (607)
||||++++.+||+|||+++........ ......||..|||||++.+..++.++|||||||+||||++|. .||.+...
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~- 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999866543332 334567999999999999999999999999999999999975 56765421
Q ss_pred CchhHHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 576 GDESLVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 576 ~~~~l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
...+.+..+.. ....+.+++.+||+.++.
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 243 -DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp -SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence 22222222211 136788999999987753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=366.96 Aligned_cols=231 Identities=25% Similarity=0.426 Sum_probs=180.4
Q ss_pred CCCcccceecccCcEEEEEEEeC--CC--cEEEEEEeecC---CchhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~--~g--~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 439 (607)
++|++.+.||+|+||.||+|+++ ++ ..||||+++.. .....++|.+|+++|++++|+||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56999999999999999999863 22 36899998643 23334679999999999999999999999965 5678
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
||||||++|+|.+++..+.. .+.+..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999887765433 489999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCcc--eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHhHh---------
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWVNLI--------- 587 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~l~~~~~~~--------- 587 (607)
..... ......|+..|||||++.+..++.++|||||||+||||++ |+.||.+.. ..+..+++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCCCCCTT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCCCCccc
Confidence 44332 2234567889999999999999999999999999999998 899997642 23333332111
Q ss_pred hHHHHHHHHHHhhhcCCC
Q 007351 588 DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 240 ~~~~l~~li~~cl~~dp~ 257 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPE 257 (273)
T ss_dssp CCHHHHHHHHHHTCSSGG
T ss_pred ccHHHHHHHHHHcCCChh
Confidence 136788999999988763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=375.77 Aligned_cols=229 Identities=23% Similarity=0.317 Sum_probs=185.9
Q ss_pred CCCccc-ceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHc-cCCCceeEEeEEEe----CCceE
Q 007351 367 DGFADQ-NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS----DDRRL 439 (607)
Q Consensus 367 ~~y~~~-~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~~ 439 (607)
++|.+. ++||+|+||.||+|+. .+|+.||||+++. ...+++|++++.++ +|+|||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 568776 5699999999999996 4789999999863 35678899987665 89999999999875 35679
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC---CCcEEEEeccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAK 516 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DFGls~ 516 (607)
||||||++|+|+++|...+...+++.+++.|++||++||+|||++ +|+|||||++||||++ ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999999999999876656799999999999999999999999 9999999999999975 5679999999998
Q ss_pred ccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHH--------H---H
Q 007351 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVE--------W---V 584 (607)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~--------~---~ 584 (607)
....... ....+|+..|||||++.+..|+.++|||||||+||||++|+.||.+........ +.+ + .
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 7654332 344679999999999999999999999999999999999999997643221111 100 0 0
Q ss_pred hHhhHHHHHHHHHHhhhcCCC
Q 007351 585 NLIDAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 585 ~~~~~~~~~~i~~~C~~~~~~ 605 (607)
.......+.+++.+|++.++.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTT
T ss_pred cccCCHHHHHHHHHHccCChh
Confidence 011235678899999987764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=363.72 Aligned_cols=201 Identities=23% Similarity=0.405 Sum_probs=171.6
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+|||++++++.+++..+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 4789999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.++.+ .++.......+.+..++.++.||+.||+|||++ +|||||||++|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9976544 444444445699999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......|+..|+|||++.... ++.++|||||||++|||++|+.||.+.
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 234457999999999987765 478999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=369.52 Aligned_cols=197 Identities=29% Similarity=0.438 Sum_probs=163.7
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHH--HHHHHHHHccCCCceeEEeEEEeCC----ceEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFK--AEVEIISRIHHRHLVSLVGYCISDD----RRLL 440 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~g~~~~~~----~~~l 440 (607)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+++. +|+..+..++|+||++++++|.+++ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4678889999999999999998 7899999998643 233444 4555556789999999999998765 4689
Q ss_pred EEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
|||||++|+|.++|+.. .++|..+++++.|++.||+|||+. ...+|||||||++||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999865 389999999999999999999963 1249999999999999999999999999999
Q ss_pred cccccCCcc---eeeccccCCCCCchhhhcCCC------CCchhhHHHHHHHHHHHHcCCCCCC
Q 007351 516 KLALDANTH---ITTRVMGTFGYMAPEYASSGK------LTEKSDVFSFGVVLLELITGRKPVD 570 (607)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~------~~~~~DVwSlGvll~ELltg~~Pf~ 570 (607)
+........ .....+||..|||||++.+.. ++.++|||||||+||||++|..+|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 876554332 223467999999999987643 5678999999999999999988774
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=367.53 Aligned_cols=228 Identities=27% Similarity=0.433 Sum_probs=184.2
Q ss_pred cceecccCcEEEEEEEeCCC----cEEEEEEeecC-CchhHHHHHHHHHHHHHccCCCceeEEeEEEeC-CceEEEEEec
Q 007351 372 QNLLGEGGFGSVYKGYLPDG----REVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDYV 445 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g----~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~Ey~ 445 (607)
.++||+|+||+||+|++.++ ..||||+++.. .....++|++|+++|++|+|+||++++|+|... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 25899999743 334456799999999999999999999998764 5789999999
Q ss_pred CCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc-
Q 007351 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (607)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~- 524 (607)
++|+|.++++.... .+.+..+++++.||++||+|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999998876543 478889999999999999999999 9999999999999999999999999999876543322
Q ss_pred --eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh--------hHHHHHH
Q 007351 525 --ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI--------DAKILFK 594 (607)
Q Consensus 525 --~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~--------~~~~~~~ 594 (607)
......|+..|+|||++....++.++|||||||+||||++|+.||..... ..++.+++... ..+.+.+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 22335689999999999999999999999999999999999998875432 12222222111 1357889
Q ss_pred HHHHhhhcCCC
Q 007351 595 LVFLCQQNSNS 605 (607)
Q Consensus 595 i~~~C~~~~~~ 605 (607)
++.+||+.++.
T Consensus 266 li~~cl~~dP~ 276 (311)
T d1r0pa_ 266 VMLKCWHPKAE 276 (311)
T ss_dssp HHHHHTCSSGG
T ss_pred HHHHHcCCCHh
Confidence 99999988753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=365.14 Aligned_cols=235 Identities=25% Similarity=0.386 Sum_probs=193.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 437 (607)
.++|++++.||+|+||.||+|++. +++.||||+++..... ...+|.+|+++++++ +|+|||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367889999999999999999852 4568999999765443 445799999999999 69999999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 438 RLLIYDYVPNNTLYFHLHGEG----------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
.+||||||.+|+|.++++... ...+++..+++|+.||++||+|||++ +|||||||++||||
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999987543 23588999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCc-ceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 007351 502 DNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l 580 (607)
+.++.+||+|||+++....... .......|+..|||||++.+..++.++|||||||+||||+++..+|...... +..+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 9999999999999987655433 3344567899999999999999999999999999999999955554433222 2233
Q ss_pred HHHHhH--------hhHHHHHHHHHHhhhcCC
Q 007351 581 VEWVNL--------IDAKILFKLVFLCQQNSN 604 (607)
Q Consensus 581 ~~~~~~--------~~~~~~~~i~~~C~~~~~ 604 (607)
.++++. .....+.+++.+||+.++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCCh
Confidence 333322 123778999999998775
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-43 Score=360.31 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=172.9
Q ss_pred CCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEEe
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 444 (607)
++|++.+.||+|+||.||+|++++|+.||||+++.... ...+.+.+|+++|++++|+||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999998999999999975432 2346799999999999999999999999999999999999
Q ss_pred cCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCcc
Q 007351 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (607)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~~ 524 (607)
+.++.+..+.+..+ .+++..+++|++||++||+|||++ +|||||||++||||++++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 98887777766554 499999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 525 ~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
......++..|++||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 23344688999999998765 4689999999999999999999999754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=364.13 Aligned_cols=234 Identities=29% Similarity=0.406 Sum_probs=189.6
Q ss_pred hCCCcccceecccCcEEEEEEEeCC--------CcEEEEEEeecCCch-hHHHHHHHHHHHHHc-cCCCceeEEeEEEeC
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 435 (607)
.++|++++.||+|+||.||+|++.+ +..||||+++.+... ...++.+|+.++.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578899999999999999998532 247999999765543 446789999999998 799999999999999
Q ss_pred CceEEEEEecCCCchhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEE
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (607)
+..++|||||++|+|+++++.+.. ..+++.+++++++||+.||+|||++ +|||||||++|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999976532 3489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 007351 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (607)
Q Consensus 502 ~~~~~vkL~DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELlt-g~~Pf~~~~~~~~~~ 579 (607)
+.++.+||+|||+++........ ......|+..|||||++.++.|+.++|||||||+||||++ |+.||.+.. ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HHH
Confidence 99999999999999876544332 2344568899999999999999999999999999999998 688887532 233
Q ss_pred HHHHHhHh--------hHHHHHHHHHHhhhcCCC
Q 007351 580 LVEWVNLI--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 580 l~~~~~~~--------~~~~~~~i~~~C~~~~~~ 605 (607)
+.++++.. ....+.+++.+||+.+++
T Consensus 246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1fgka_ 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS 279 (299)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHh
Confidence 33333221 126789999999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=366.15 Aligned_cols=231 Identities=29% Similarity=0.455 Sum_probs=186.6
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCc--EEEEEEeecCC-chhHHHHHHHHHHHHHc-cCCCceeEEeEEEeCCceEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGR--EVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~--~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 441 (607)
++|+++++||+|+||.||+|+++ +|. .||||+++... ....++|.+|+++|+++ +|+|||+++|+|.+++..+||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888999999999999999975 444 47788876433 33456799999999999 799999999999999999999
Q ss_pred EEecCCCchhHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcE
Q 007351 442 YDYVPNNTLYFHLHGE--------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (607)
Q Consensus 442 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (607)
|||+++|+|.++|+.+ ....+++..+++++.||++||.|||++ +|||||||++|||+++++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998754 234689999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCCchhHHHHHhH
Q 007351 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PVDASQPLGDESLVEWVNL 586 (607)
Q Consensus 508 kL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~-Pf~~~~~~~~~~l~~~~~~ 586 (607)
||+|||+++....... .....|+..|+|||.+.+..++.++|||||||+||||++|.. ||.+. ...++.+++..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHGGG
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHh
Confidence 9999999986543322 223458999999999999999999999999999999999765 56543 23333343322
Q ss_pred h--------hHHHHHHHHHHhhhcCCC
Q 007351 587 I--------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 587 ~--------~~~~~~~i~~~C~~~~~~ 605 (607)
. ....+.+++.+||+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~ 268 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPY 268 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChh
Confidence 1 136789999999987753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=362.97 Aligned_cols=225 Identities=25% Similarity=0.370 Sum_probs=183.8
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc------hhHHHHHHHHHHHHHcc--CCCceeEEeEEEeCCc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG------QGEREFKAEVEIISRIH--HRHLVSLVGYCISDDR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~ 437 (607)
++|+++++||+|+||.||+|+.. +|+.||||+++.... .....+.+|+++|++++ |+|||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999964 789999999864321 11234778999999997 8999999999999999
Q ss_pred eEEEEEecCC-CchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-CCcEEEEecccc
Q 007351 438 RLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLA 515 (607)
Q Consensus 438 ~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DFGls 515 (607)
.++||||+.+ +++.+++.... .+++..++.++.||++||+|||++ +|||||||++||||+. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 57777776654 389999999999999999999999 9999999999999984 579999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH---HhHhhHHH
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW---VNLIDAKI 591 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~---~~~~~~~~ 591 (607)
+..... ......||..|||||++.+..+ +.++|||||||+||||++|+.||.+. .+..+. ........
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIRGQVFFRQRVSSE 230 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHCCCCCSSCCCHH
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hHHhhcccCCCCCCCHH
Confidence 865432 2345679999999999987766 56789999999999999999999752 111111 00112366
Q ss_pred HHHHHHHhhhcCC
Q 007351 592 LFKLVFLCQQNSN 604 (607)
Q Consensus 592 ~~~i~~~C~~~~~ 604 (607)
+.+++.+|++.++
T Consensus 231 ~~~li~~~L~~dp 243 (273)
T d1xwsa_ 231 CQHLIRWCLALRP 243 (273)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHccCCH
Confidence 7889999998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=363.07 Aligned_cols=234 Identities=26% Similarity=0.444 Sum_probs=191.8
Q ss_pred hCCCcccceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCce
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 438 (607)
.++|++++.||+|+||.||+|+++ +++.||||+++.... +....|++|+++|++++|+||++++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367889999999999999999863 357899999975433 3345689999999999999999999999999999
Q ss_pred EEEEEecCCCchhHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 439 LLIYDYVPNNTLYFHLHGE--------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
+||||||.+|+|..+++.. ....+++..+.+++.||++||.|||++ +|||||||++||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999998887542 223478899999999999999999998 99999999999999999999999
Q ss_pred ecccccccccCCcc-eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCchhHHHHHhH-h
Q 007351 511 DFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR-KPVDASQPLGDESLVEWVNL-I 587 (607)
Q Consensus 511 DFGls~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~-~Pf~~~~~~~~~~l~~~~~~-~ 587 (607)
|||+++........ ......|+..|||||.+.++.++.++|||||||+||||++|+ .||.+. ....+.+.+.. .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVMEGG 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHHTTC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhCC
Confidence 99999876544332 234457899999999999999999999999999999999985 566542 22222222111 0
Q ss_pred -------hHHHHHHHHHHhhhcCCC
Q 007351 588 -------DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~ 277 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPK 277 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCcccchHHHHHHHHHHcCCChh
Confidence 126789999999987653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=357.17 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=168.2
Q ss_pred hCCCcccceecccCcEEEEEEEeC-C-CcEEEEEEeecCCc--hhHHHHHHHHHHHHHc---cCCCceeEEeEEEe----
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-D-GREVAIKQLKIGGG--QGEREFKAEVEIISRI---HHRHLVSLVGYCIS---- 434 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~-g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~---- 434 (607)
.++|++++.||+|+||.||+|++. + ++.||||+++.... .....+.+|+++|+.| +|+||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999963 4 56799999964322 2234567788877766 79999999999863
Q ss_pred -CCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecc
Q 007351 435 -DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (607)
Q Consensus 435 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFG 513 (607)
+...+++|||+.++.+...... ....+++..++.+++||+.||+|||++ +|||||||++|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 2357899999998877554443 334589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+++...... ......||..|||||++.+..|+.++|||||||+||||++|+.||.+.
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 997553322 334567999999999999999999999999999999999999999764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-41 Score=347.27 Aligned_cols=231 Identities=19% Similarity=0.258 Sum_probs=187.7
Q ss_pred hCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccC-CCceeEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 443 (607)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+++|+++++.|+| +||+.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 467999999999999999999964 68899999886432 23457889999999975 899999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcC-----CCcEEEEeccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLA 518 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DFGls~~~ 518 (607)
|+ +++|.++++..+. .+.+..+.+++.|++.||+|||++ +|||||||++||||+. ++.+||+|||+++..
T Consensus 82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 6788888876543 589999999999999999999999 9999999999999964 578999999999876
Q ss_pred ccCCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHhHh-----
Q 007351 519 LDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWVNLI----- 587 (607)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~~~~~~~----- 587 (607)
.+.... .....+||..|||||++.+..++.++|||||||++|||++|+.||.+..........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 543221 233467999999999999999999999999999999999999999876544333222211110
Q ss_pred -------hHHHHHHHHHHhhhcC
Q 007351 588 -------DAKILFKLVFLCQQNS 603 (607)
Q Consensus 588 -------~~~~~~~i~~~C~~~~ 603 (607)
....+.+++..|++.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~ 259 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLA 259 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCC
T ss_pred hHHhcCCCCHHHHHHHHHHhcCC
Confidence 0145777888888654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=347.93 Aligned_cols=233 Identities=21% Similarity=0.262 Sum_probs=179.8
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCce-eEEeEEEeCCceEEEEE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV-SLVGYCISDDRRLLIYD 443 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E 443 (607)
.++|++++.||+|+||.||+|++ .+|+.||||+++.... ..++.+|+++++.++|.|++ .+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46799999999999999999986 4689999999875432 34578999999999877655 45555667778899999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEc---CCCcEEEEeccccccccc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLALD 520 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DFGls~~~~~ 520 (607)
|+.+ +|...+.... ..+++..+++++.||++||+|||++ +|||||||++|||++ .+..+||+|||+++...+
T Consensus 84 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCCC-BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EcCC-chhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9955 4544444332 2489999999999999999999999 999999999999985 456799999999987755
Q ss_pred CCcc------eeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHHhHh------
Q 007351 521 ANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWVNLI------ 587 (607)
Q Consensus 521 ~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~-l~~~~~~~------ 587 (607)
.... ......||..|||||++.+..++.++|||||||++|||++|+.||.......... ..++....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 4322 2344679999999999999999999999999999999999999997654322221 11111110
Q ss_pred -----hHHHHHHHHHHhhhcCCC
Q 007351 588 -----DAKILFKLVFLCQQNSNS 605 (607)
Q Consensus 588 -----~~~~~~~i~~~C~~~~~~ 605 (607)
....+.+++.+||+.++.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~ 261 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFD 261 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTT
T ss_pred HhccCCCHHHHHHHHHHccCChh
Confidence 125578899999987653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=358.29 Aligned_cols=233 Identities=27% Similarity=0.369 Sum_probs=190.9
Q ss_pred CCCcccceecccCcEEEEEEEeC----CCcEEEEEEeecCC----chhHHHHHHHHHHHHHccC-CCceeEEeEEEeCCc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGG----GQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 437 (607)
++|++++.||+|+||.||+|+.. +|+.||||+++... ....+.+++|+++|++++| +||+++++++..++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 57899999986432 2334568899999999977 799999999999999
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.++||||+.+|+|++++...+. +....++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987654 67888899999999999999999 999999999999999999999999999987
Q ss_pred cccCCcceeeccccCCCCCchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-H-HHh------Hh
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV-E-WVN------LI 587 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~DVwSlGvll~ELltg~~Pf~~~~~~~~~~l~-~-~~~------~~ 587 (607)
.............|+..|++||++.+. .++.++|||||||+||||++|+.||.+.......... + ... ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 655444444556799999999999765 4678999999999999999999999876433222111 1 100 01
Q ss_pred hHHHHHHHHHHhhhcCC
Q 007351 588 DAKILFKLVFLCQQNSN 604 (607)
Q Consensus 588 ~~~~~~~i~~~C~~~~~ 604 (607)
....+.+++.+|++.++
T Consensus 259 ~s~~~~~li~~~l~~dP 275 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDP 275 (322)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHcccCH
Confidence 24678889999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=351.78 Aligned_cols=201 Identities=22% Similarity=0.370 Sum_probs=167.1
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEe--------C
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS--------D 435 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 435 (607)
++|++.+.||+|+||.||+|++ ++|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5799999999999999999996 479999999986442 2344678999999999999999999998865 3
Q ss_pred CceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 436 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
+..++||||+.++.+..+..... .+....++.+++||++||+|||++ +|||||||++||||++++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 45789999998887765554433 488899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcc---eeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTH---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+........ .....+||..|+|||++.+. .|+.++|||||||+||||++|+.||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 765433221 22335699999999998865 6899999999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=357.26 Aligned_cols=196 Identities=31% Similarity=0.421 Sum_probs=163.6
Q ss_pred CCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEEeCC------ceEE
Q 007351 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------RRLL 440 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~l 440 (607)
+|+++++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++|+|+||++++++|.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999975 689999999975432 3357999999999999999999986532 3689
Q ss_pred EEEecCCCchhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCC-cEEEEeccccccc
Q 007351 441 IYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLA 518 (607)
Q Consensus 441 V~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DFGls~~~ 518 (607)
|||||.++.+..+++. .....+++..++.|++||++||+|||++ +|||||||++||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987754443321 2334589999999999999999999998 999999999999998764 8999999999876
Q ss_pred ccCCcceeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 519 LDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ....+|+..|+|||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 44332 334578999999998875 46899999999999999999999999754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=352.38 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=168.3
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC----ceE
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----RRL 439 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~ 439 (607)
.++|+++++||+|+||.||+|+. .+|+.||||+++.... ...+.+++|+++|+.|+|+||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999986 4899999999964433 34467899999999999999999999987654 345
Q ss_pred EEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccc
Q 007351 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (607)
Q Consensus 440 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~ 519 (607)
+++||+.+|+|++++... .+.+..++.++.||++||+|||++ +|||||||++||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 666777799999999764 389999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcc--eeeccccCCCCCchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 520 DANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... .....+|+..|+|||++.. ..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 43221 2344678999999999854 56788999999999999999999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=353.55 Aligned_cols=197 Identities=26% Similarity=0.391 Sum_probs=164.6
Q ss_pred hhCCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCC-----
Q 007351 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (607)
Q Consensus 365 ~~~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 436 (607)
..++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|+.|+|+|||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3468999999999999999999964 699999999975432 33457899999999999999999999998654
Q ss_pred -ceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccc
Q 007351 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (607)
Q Consensus 437 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls 515 (607)
..+|||||| +++|..+++.. .+++..++.+++||+.||+|||++ +|||||||++|||++.++.+||+|||++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 56677766543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 516 KLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
+..... ....+|+..|||||++.+. .++.++|||||||+||||++|+.||.+.
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 865432 2346789999999998864 5688999999999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=340.06 Aligned_cols=199 Identities=22% Similarity=0.380 Sum_probs=174.9
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeCCceEEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 443 (607)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....+++|+++|+.++|+||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 788999999975433 345678999999999999999999999999999999999
Q ss_pred ecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccccccCCc
Q 007351 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (607)
Q Consensus 444 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~~~~~~~ 523 (607)
|+.+++|..+++..+. +.+..++.+++|+++||+|||++ +|||||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999999888776544 88999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q 007351 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDA 571 (607)
Q Consensus 524 ~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~ 571 (607)
......++..|++||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 233445778999999988665 68999999999999999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-40 Score=343.60 Aligned_cols=193 Identities=20% Similarity=0.324 Sum_probs=167.2
Q ss_pred CCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeC--CceEEEE
Q 007351 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISD--DRRLLIY 442 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~ 442 (607)
++|+++++||+|+||.||+|+. .+|+.||||+++.. ..+.+++|+++|+.++ |+||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 47899999998643 3567899999999995 99999999998754 4688999
Q ss_pred EecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCC-CcEEEEecccccccccC
Q 007351 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDA 521 (607)
Q Consensus 443 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DFGls~~~~~~ 521 (607)
|||.+++|..+++ .+.+..++.+++||++||+|||++ +|||||||++||||+.+ +.+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999977643 389999999999999999999999 99999999999999865 46999999999876543
Q ss_pred CcceeeccccCCCCCchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.. .....+|..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 22 3445689999999998875 4799999999999999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=342.77 Aligned_cols=196 Identities=24% Similarity=0.335 Sum_probs=159.5
Q ss_pred CCCcccceecccCcEEEEEEEeC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHccCCCceeEEeEEEeC------Cc
Q 007351 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (607)
Q Consensus 367 ~~y~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 437 (607)
++|+++++||+|+||+||+|++. +|+.||||+++... ......+.+|+++|+.++|+||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 69999999997543 23345689999999999999999999998643 56
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.|+|||||.++.+. .+.. .+++..++.+++||+.||+|||++ ||+|||||++|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHH-hhhc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 79999999766554 4432 388999999999999999999999 999999999999999999999999999886
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 54322 234457899999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=342.59 Aligned_cols=197 Identities=25% Similarity=0.382 Sum_probs=166.2
Q ss_pred hCCCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHccCCCceeEEeEEEeC-----Cc
Q 007351 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DR 437 (607)
Q Consensus 366 ~~~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 437 (607)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|+.|+|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999996 4799999999975432 3345689999999999999999999998643 34
Q ss_pred eEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 438 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+++|||+.+|+|.++++.+ .+++..++.|++||+.||+|||++ +|+|||||++|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888899999988653 389999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCcceeeccccCCCCCchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 518 ALDANTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.... .....|+..|||||++.+.. ++.++|||||||+||||++|+.||.+.
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 4322 23456888999999877654 688999999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-35 Score=306.56 Aligned_cols=197 Identities=21% Similarity=0.264 Sum_probs=159.8
Q ss_pred CCcccceecccCcEEEEEEEe-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-----------CCCceeEEeEEEeC
Q 007351 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----------HRHLVSLVGYCISD 435 (607)
Q Consensus 368 ~y~~~~~IG~G~fG~Vyk~~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~~ 435 (607)
+|+++++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+++|+.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999996 47999999999743 223456788999988875 47899999988654
Q ss_pred --CceEEEEEecCCCc-hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCEEecCCCCCCEEEcCCC------
Q 007351 436 --DRRLLIYDYVPNNT-LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNF------ 505 (607)
Q Consensus 436 --~~~~lV~Ey~~~gs-L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~------ 505 (607)
...+++|+++.++. +...........+.+..++.+++||++||+|||+ + +|+|||||++||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 35566777665553 3444444455568899999999999999999998 5 899999999999997654
Q ss_pred cEEEEecccccccccCCcceeeccccCCCCCchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 007351 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (607)
Q Consensus 506 ~vkL~DFGls~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ELltg~~Pf~~~ 572 (607)
.+||+|||.++..... ....+|+..|||||++.+..++.++|||||||+|+||++|+.||...
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 4999999999865432 23457899999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.6e-26 Score=217.76 Aligned_cols=170 Identities=16% Similarity=0.176 Sum_probs=122.7
Q ss_pred CcccceecccCcEEEEEEEeCCCcEEEEEEeecCCc------------------hhHHHHHHHHHHHHHccCCCceeEEe
Q 007351 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG------------------QGEREFKAEVEIISRIHHRHLVSLVG 430 (607)
Q Consensus 369 y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~il~~l~HpnIv~l~g 430 (607)
+.+++.||+|+||.||+|++.+|+.||||+++.... .....+.+|+.+|.++.|.|++.+++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356799999999999999988999999998753211 01123567889999999999999887
Q ss_pred EEEeCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCEEecCCCCCCEEEcCCCcEEEE
Q 007351 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (607)
Q Consensus 431 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (607)
+. ..+|+|||++++.+.. +......+++.||+++|+|||++ +|+|||||++||||+++ .++|+
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 63 3489999998876543 23334567899999999999998 99999999999999976 59999
Q ss_pred ecccccccccCCccee-eccccCCCCCchhhhcCCCCCchhhHHHHHHHHH
Q 007351 511 DFGLAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560 (607)
Q Consensus 511 DFGls~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~DVwSlGvll~ 560 (607)
|||+++.....+.... .+.+.. + -| ...+.|..++||||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~~---~-~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVRN---I-IT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHHH---H-HH-HHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHHH---H-HH-HHcCCCCCcccHHHHHHHHh
Confidence 9999976543322100 000000 0 01 11356788899999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.19 E-value=4.7e-11 Score=116.89 Aligned_cols=150 Identities=15% Similarity=0.077 Sum_probs=108.7
Q ss_pred HHHHHhhCCCcccceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHcc-CCCceeEEeEEEeCCce
Q 007351 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (607)
Q Consensus 360 eel~~~~~~y~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 438 (607)
.++.+..+.|+..+..+.++.+.||+... +++.++||+...........+.+|..+|+.|. +--+.++++++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667787777666666689999875 67778889875443333446788999998885 55578999998888899
Q ss_pred EEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------
Q 007351 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED---------------------------------- 484 (607)
Q Consensus 439 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------------------------------- 484 (607)
++|||++++..+...+... . ...+++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886554321 1 1233455566666666642
Q ss_pred ----------------------CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 485 ----------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 485 ----------------------~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
....++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012479999999999999877677999999864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.80 E-value=8.5e-09 Score=99.89 Aligned_cols=132 Identities=17% Similarity=0.131 Sum_probs=88.9
Q ss_pred ceecccCc-EEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccC--CCceeEEeEEEeCCceEEEEEecCCCc
Q 007351 373 NLLGEGGF-GSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNNT 449 (607)
Q Consensus 373 ~~IG~G~f-G~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gs 449 (607)
+.+..|.. +.||+...+++..++||..... ....+.+|+++|+.|.. ..+.++++++..++..++||||+++..
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 34455553 6899999878888999976533 23357888888888753 446788988888888999999998876
Q ss_pred hhHhhhcCCCCCCCHHHHHHHHHHHHHH---------------------------------------------------H
Q 007351 450 LYFHLHGEGRPVLDWATRVKIAAGAARG---------------------------------------------------L 478 (607)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~g---------------------------------------------------L 478 (607)
+.... +.. ..++.++.+. +
T Consensus 93 ~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 93 LLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 53211 000 0111222222 2
Q ss_pred HHHHHc----CCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 479 AYLHED----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 479 ~~LH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
..|.+. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 333322 123489999999999999886678999999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.67 E-value=7.8e-08 Score=99.74 Aligned_cols=77 Identities=16% Similarity=0.189 Sum_probs=50.8
Q ss_pred cceecccCcEEEEEEEeC-CCcEEEEEEeec----CCc---hhHHHHHHHHHHHHHcc-C--CCceeEEeEEEeCCceEE
Q 007351 372 QNLLGEGGFGSVYKGYLP-DGREVAIKQLKI----GGG---QGEREFKAEVEIISRIH-H--RHLVSLVGYCISDDRRLL 440 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~-~g~~VAVK~l~~----~~~---~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~l 440 (607)
.+.||.|....||+.... +++.|+||.-.. ... .......+|.+.|+.+. + ..+.+++++ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 467899996531 111 12234567888888774 2 446777755 4567789
Q ss_pred EEEecCCCch
Q 007351 441 IYDYVPNNTL 450 (607)
Q Consensus 441 V~Ey~~~gsL 450 (607)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.16 E-value=2.7e-06 Score=85.45 Aligned_cols=137 Identities=15% Similarity=0.124 Sum_probs=83.3
Q ss_pred cCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc--eeEEe-----EEEeCCceEEEEEecCCCch
Q 007351 378 GGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL--VSLVG-----YCISDDRRLLIYDYVPNNTL 450 (607)
Q Consensus 378 G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g-----~~~~~~~~~lV~Ey~~~gsL 450 (607)
+....||++++++|+.|++|+.+.. .....++..|+.+|..|...+| +..+. .+..++..+.+++|+.|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4457899999999999999987643 3345678889999998864333 22221 23445667889999976533
Q ss_pred h--------------Hhhhc-------CCCCCCCHHHH-------------------HHHHHHHHHHHHHHHH----cCC
Q 007351 451 Y--------------FHLHG-------EGRPVLDWATR-------------------VKIAAGAARGLAYLHE----DCH 486 (607)
Q Consensus 451 ~--------------~~l~~-------~~~~~l~~~~~-------------------~~i~~qia~gL~~LH~----~~~ 486 (607)
. ..+|. ..+..+++... ..+...+.+.++.+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 01111 01112222211 1122222233333332 234
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.++||+|++..|||++++ ..|+||+.++.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 589999999999999754 45899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.05 E-value=5.7e-06 Score=85.27 Aligned_cols=73 Identities=19% Similarity=0.237 Sum_probs=51.5
Q ss_pred cceecccCcEEEEEEEeCC--------CcEEEEEEeecCCchhHHHHHHHHHHHHHccCCC-ceeEEeEEEeCCceEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIY 442 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 442 (607)
.+.|+.|-.-.+|++.+.+ .+.|.|++.- ......+..+|.++++.+...+ ..++++++. .++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 3568889999999998754 3457777654 2233456778999999986334 468888763 37899
Q ss_pred EecCCCch
Q 007351 443 DYVPNNTL 450 (607)
Q Consensus 443 Ey~~~gsL 450 (607)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.01 E-value=1.2e-05 Score=79.84 Aligned_cols=158 Identities=15% Similarity=0.138 Sum_probs=86.3
Q ss_pred ccHHHHHHhhCCCcccce-----ecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCc--eeEE
Q 007351 357 FTYEELVKATDGFADQNL-----LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL--VSLV 429 (607)
Q Consensus 357 ~~~eel~~~~~~y~~~~~-----IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~ 429 (607)
++.+++.....+|.++++ |..|--...|+.+.++ +.+++|++... ....++..|+++|..|++.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-CcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 456778888888877554 4466667889998855 45899987532 233456667888888754332 1111
Q ss_pred e------EEEeCCceEEEEEecCCCchh--------------Hhhhc--CC-----CCCCCHHHHH--------------
Q 007351 430 G------YCISDDRRLLIYDYVPNNTLY--------------FHLHG--EG-----RPVLDWATRV-------------- 468 (607)
Q Consensus 430 g------~~~~~~~~~lV~Ey~~~gsL~--------------~~l~~--~~-----~~~l~~~~~~-------------- 468 (607)
. +...++..+.++.++.+.... ..++. .. ..........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 122344556677776654321 01110 00 0000000000
Q ss_pred -HHHHHHHHHHHHHHH----cCCCCEEecCCCCCCEEEcCCCcEEEEecccccc
Q 007351 469 -KIAAGAARGLAYLHE----DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (607)
Q Consensus 469 -~i~~qia~gL~~LH~----~~~~~ivHrDLkp~NILl~~~~~vkL~DFGls~~ 517 (607)
.+...+...++++.. .+..+|||+|++.+|||++++..+-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 011112222222222 2345899999999999999987778999999863
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=92.78 E-value=0.12 Score=49.55 Aligned_cols=135 Identities=13% Similarity=0.082 Sum_probs=75.1
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHHHccCCCceeEEeEEE------------------
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI------------------ 433 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~------------------ 433 (607)
.++--+|+-|..|. .. ++..++||.. .....+.|..|+...-.+.-++. +++..+.
T Consensus 74 i~~s~~Gs~Gv~FV-~~-e~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqm-RvI~~~~~E~~~~~~~~l~~~e~d~ 147 (342)
T d1cjaa_ 74 IERSEKGTEGLFFV-ET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKV-RVVSSNSEEGTNMLECLAAIDKSFR 147 (342)
T ss_dssp EEECCSTTSCEEEE-EE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCE-EEEESSSHHHHHHHHHHHHHCSSSC
T ss_pred eEEeecCCceEEEE-Ec-CCceEEEecC---CchHHHHHHHHHHHHhCCCCCce-EEecCCCHHHHHHHHHHhcCCChhH
Confidence 33334455555554 44 5677888853 33444556666666666666763 3333221
Q ss_pred -----eCCceEEEEEecCCCchhHhhhcCCCCCCCHHHHHHHHHHH--HHHH-HHHHHcCCCCEEecCC-CCCCEEEcCC
Q 007351 434 -----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA--ARGL-AYLHEDCHPRIIHRDI-KSSNILLDNN 504 (607)
Q Consensus 434 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi--a~gL-~~LH~~~~~~ivHrDL-kp~NILl~~~ 504 (607)
.++-.+++|||+.|..|.+.-.......+.. +.+.++ +-++ .++++.....+++|+- ++.|||++++
T Consensus 148 ~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~----~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n 223 (342)
T d1cjaa_ 148 VITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSER 223 (342)
T ss_dssp HHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred HHHHHHhcccceeeeccCCccccccccccchhhhcH----HHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecC
Confidence 1234689999998777654432111111221 223332 2333 3455444445666643 7889999877
Q ss_pred C-cEEEEeccccc
Q 007351 505 F-EAQVSDFGLAK 516 (607)
Q Consensus 505 ~-~vkL~DFGls~ 516 (607)
+ .+..+|=|...
T Consensus 224 ~~~~~~IDs~i~~ 236 (342)
T d1cjaa_ 224 GATVVPIDSKIIP 236 (342)
T ss_dssp TTCEEECSCCCCC
T ss_pred CcEEEEecCCccc
Confidence 6 78899977764
|
| >d1bo1a_ d.143.1.2 (A:) Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SAICAR synthase-like superfamily: SAICAR synthase-like family: Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta domain: Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.70 E-value=1.3 Score=43.56 Aligned_cols=108 Identities=15% Similarity=0.152 Sum_probs=58.0
Q ss_pred cceecccCcEEEEEEEeCCCcEEEEEEeecCCchhHHHHHHHHHHHH-Hc--cCCC--ceeEEeEEEe----CCceEEEE
Q 007351 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIIS-RI--HHRH--LVSLVGYCIS----DDRRLLIY 442 (607)
Q Consensus 372 ~~~IG~G~fG~Vyk~~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~-~l--~Hpn--Iv~l~g~~~~----~~~~~lV~ 442 (607)
.+..+.|..|..|.-. .+..++||.+... +.+.|++-+.-+- .+ .|++ |.+++|.+.. ....++||
T Consensus 94 ~~~~s~GkSGs~F~~t--~D~rfiiKti~~~---E~~~l~~~l~~Y~~h~~~~n~~TLL~k~~Gly~i~~~~~~~~fvVM 168 (383)
T d1bo1a_ 94 INSDSQGRCGTRFLTT--YDRRFVIKTVSSE---DVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVT 168 (383)
T ss_dssp EECCCC----CCEEEC--TTSSEEEECCCHH---HHHHHHHHHHHHHHHHHTTTTCCSSCCEEEEEEEEETTEEEEEEEE
T ss_pred ccccccCCcCCeEEEe--cCCcEEEEEeCHH---HHHHHHHHHHHHHHHHHhcCCCcCHHhhheeeEEEeCCceEEEEEE
Confidence 3446778888777643 4568999988632 2222332222222 12 2444 8899997642 22458899
Q ss_pred EecCCCchhH-------------------------------hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 007351 443 DYVPNNTLYF-------------------------------HLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484 (607)
Q Consensus 443 Ey~~~gsL~~-------------------------------~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~ 484 (607)
+.+-.+.+.. ++.......+....+..++.||.+=.++|.+.
T Consensus 169 ~Nlf~~~~~i~~~yDLKGS~~~R~~~~~~~~~~~~~lKD~df~~~~~~i~l~~~~k~~l~~ql~~D~~fL~~~ 241 (383)
T d1bo1a_ 169 RNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQL 241 (383)
T ss_dssp ECSSCSSSCCSEEEEECCCSSSSCSCSGGGSSSCCEECHHHHHHTTCCCCCCSSHHHHHHHHHHHHHHHHHHH
T ss_pred eccccCCcccceeEeccCcccccCcCcccccccchhhhhHHHHhccCCeeeCHHHHHHHHHHHHHHHHHHHHC
Confidence 8765332210 11111222344455677889999999999987
|